Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular response to type I interferon (GO:0071357),0.8682726829256718,2.3924974939028436,0.0,0.0,0.0,18/41,3.86%,IFIT3;RSAD2;OAS3;STAT1;STAT2;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;XAF1;IFIT2;BST2;IFI35;ADAR;GBP2
prerank,type I interferon signaling pathway (GO:0060337),0.8682726829256718,2.3924974939028436,0.0,0.0,0.0,18/41,3.86%,IFIT3;RSAD2;OAS3;STAT1;STAT2;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;XAF1;IFIT2;BST2;IFI35;ADAR;GBP2
prerank,defense response to symbiont (GO:0140546),0.7824683505010842,2.3614281428244417,0.0,0.0,0.0,24/92,5.02%,IFIT3;RSAD2;OAS3;STAT1;ZBP1;STAT2;OASL;NLRC5;EIF2AK2;IRF7;OAS2;IFIH1;SAMHD1;IFIT1;ISG15;MOV10;IFIT2;BST2;MLKL;CD40;CGAS;RTP4;CNOT7;TLR8
prerank,defense response to virus (GO:0051607),0.7734427600800234,2.34758114136226,0.0,0.0,0.0,25/100,5.02%,IFIT3;RSAD2;OAS3;STAT1;ZBP1;STAT2;CXCL10;OASL;NLRC5;EIF2AK2;IRF7;OAS2;IFIH1;SAMHD1;IFIT1;ISG15;MOV10;IFIT2;BST2;MLKL;CD40;CGAS;RTP4;CNOT7;TLR8
prerank,negative regulation of viral process (GO:0048525),0.8032802801738269,2.2938340056255884,0.0,0.0,0.0,26/57,10.16%,RSAD2;OAS3;STAT1;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;PML;TRIM14;ZC3HAV1;BST2;ZFP36;TRIM21;CCL5;ILF3;SLPI;UBP1;N4BP1;PPIA;BANF1;SRPK1;PROX1;TNIP1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.850651056145897,2.2758450138274773,0.0,0.0,0.0,10/36,1.52%,PARP14;ZBP1;NLRC5;AXL;HSPA1B;PARP9;IRGM;CASP4;CXCR4;WNT5A
prerank,regulation of viral genome replication (GO:0045069),0.7973107914333026,2.274713344925376,0.0,0.0,0.0,27/56,10.41%,RSAD2;OAS3;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;ZC3HAV1;BST2;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;ILF3;SLPI;N4BP1;PPIA;BANF1;VAPB;SRPK1;PROX1;TNIP1;STAU1
prerank,negative regulation of viral genome replication (GO:0045071),0.8149969189328751,2.2269767828241003,0.0,0.0,0.0,20/40,10.16%,RSAD2;OAS3;OASL;EIF2AK2;OAS2;IFIH1;PARP10;IFIT1;ISG15;ZC3HAV1;BST2;RESF1;CCL5;ILF3;SLPI;N4BP1;BANF1;SRPK1;PROX1;TNIP1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.790432266287435,2.2055168354785484,0.0,0.0,0.0,14/45,4.23%,OAS3;STAT1;SP100;OASL;IRF7;OAS2;PML;CAMK2D;TRIM25;B2M;CAMK2B;TRIM21;GBP2;HCK
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.7764830452729552,2.1775764203038324,0.0,0.0,0.0,8/48,0.89%,PARP14;OAS3;USP18;STAT2;NLRC5;SAMHD1;ISG15;NR1H2
prerank,negative regulation of innate immune response (GO:0045824),0.8090682254312606,2.1674726808176565,0.0,0.0,0.0,13/34,4.99%,OAS3;USP18;STAT2;TRAFD1;NLRC5;SAMHD1;ISG15;DHX58;NMI;TRIM21;USP15;CNOT7;SUSD4
prerank,cellular response to interferon-gamma (GO:0071346),0.7205614604873737,2.151634107167617,0.0,0.0,0.0,24/88,5.48%,OAS3;STAT1;GBP4;SP100;OASL;IRF7;OAS2;PML;GBP5;CCL7;DAPK3;CAMK2D;WNT5A;TRIM25;B2M;CAMK2B;GBP3;TRIM21;GBP2;CD47;HCK;CCL5;GBP7;CX3CL1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.8048663585349958,2.088344499939316,0.0,0.00015423318209224743,0.002,10/29,4.86%,OAS3;USP18;ZBP1;STAT2;NLRC5;SAMHD1;ISG15;WNT5A;CNOT7;HSP90AB1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.7649598135180994,2.070896204627885,0.0,0.0002148247893427732,0.003,14/38,7.25%,DDX60;OASL;GBP5;DHX58;IFI35;SASH1;NMI;ADAM8;USP15;CCL5;TLR8;LY86;POLR3B;DHX9
prerank,positive regulation of innate immune response (GO:0045089),0.7824851332239078,2.038655175227658,0.0,0.0008020125468796867,0.012,11/30,7.25%,ZBP1;NLRC5;GBP5;IFI35;WNT5A;NMI;ADAM8;CCL5;TLR8;POLR3B;DHX9
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.8803602944214348,2.022989733652533,0.0,0.0012531446044995104,0.018,6/15,0.28%,OAS3;USP18;STAT2;NLRC5;SAMHD1;ISG15
prerank,response to interferon-gamma (GO:0034341),0.6882313249385029,2.0170778478712355,0.0,0.0014153162591994473,0.021,18/67,7.06%,STAT1;GBP4;SP100;GBP5;BST2;CCL7;DAPK3;WNT5A;GBP3;CD40;CXCL16;TRIM21;GBP2;CD47;CCL5;GBP7;CX3CL1;AQP4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.8074612444083429,2.002510317878849,0.0,0.002116421998710284,0.032,8/23,4.86%,PARP14;STAT1;NLRC5;PARP9;IRGM;NR1H2;SOCS1;HSP90AB1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.9072990396378819,1.9878292722145472,0.0,0.002902019084104129,0.047,5/11,0.46%,PARP14;PARP12;PARP10;PARP9;PARP11
prerank,positive regulation of type I interferon production (GO:0032481),0.6632777542210722,1.985177824552436,0.0,0.0028070439140789037,0.048,22/73,12.41%,OAS3;STAT1;ZBP1;IRF7;OAS2;IFIH1;ISG15;DHX58;DHX33;NFKB2;CGAS;DHX36;TLR8;CTNNB1;NFKB1;POLR3B;DHX9;POLR3GL;POLR2K;RIOK3;PTPN11;PRKDC
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.884787579692637,1.9834965598261587,0.0,0.002816591682494138,0.051,4/13,5.39%,PARP10;PARP9;NAMPT;NAPRT
prerank,protein ADP-ribosylation (GO:0006471),0.7521769954994639,1.9613687005225668,0.0,0.004602458365616384,0.085,7/28,4.18%,PARP14;PARP12;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,regulation of type I interferon production (GO:0032479),0.6458564830971883,1.9502467634796368,0.0,0.005971506463180275,0.113,23/84,9.91%,ZBP1;NLRC5;IRF7;IFIH1;ISG15;UBE2L6;ILRUN;DHX58;TRIM25;DHX33;NFKB2;CGAS;TRIM21;IKBKE;DHX36;CTNNB1;NFKB1;POLR3B;CYLD;DHX9;POLR3GL;POLR2K;TRAF3
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.9069481889559521,1.936858560494935,0.0,0.007579018568013039,0.152,2/10,2.19%,CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.9069481889559521,1.936858560494935,0.0,0.007579018568013039,0.152,2/10,2.19%,CNGB1;CACNA2D4
prerank,positive regulation of interferon-beta production (GO:0032728),0.7229370689934566,1.9351294226417184,0.0,0.007441751035950938,0.156,9/33,7.25%,OAS3;IRF7;OAS2;IFIH1;ISG15;DHX58;TLR8;POLR3B;DHX9
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6903724832430601,1.9268961455544902,0.0,0.008762729678870651,0.182,13/49,16.37%,PARP14;PARP9;IL15;CRLF1;CD40;STAT3;CCL5;LYN;JAK2;PIBF1;FGFR3;IL18;ARL2BP
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.8135468249363047,1.9167966485508086,0.0,0.010884455993367176,0.224,6/18,4.64%,DDX60;OASL;DHX58;BIRC2;USP15;NOP53
prerank,positive regulation of defense response to virus by host (GO:0002230),0.7581831843604365,1.9135565507070469,0.0012224938875305623,0.011477076101898966,0.241,5/24,2.91%,STAT1;PARP9;DTX3L;AIM2;CGAS
prerank,NAD biosynthetic process (GO:0009435),0.7807188510462745,1.9123493167463022,0.0,0.011295010035222253,0.246,4/20,5.39%,PARP10;PARP9;NAMPT;NAPRT
prerank,positive regulation of interferon-alpha production (GO:0032727),0.7781550957563111,1.9095551280131156,0.0,0.011448082322395527,0.255,6/19,7.25%,STAT1;IRF7;IFIH1;DHX36;TLR8;DHX9
prerank,sensory perception of chemical stimulus (GO:0007606),-0.670973940451401,-1.8911080812864152,0.003436426116838488,1.0,0.765,5/15,10.65%,GNAL;ADCY3;UBR3;SYT10;GNAS
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.8493872516119718,1.8876806558100478,0.002886002886002886,0.01776332476878056,0.382,6/13,5.90%,STAT1;OASL;OAS2;CRLF1;STAT3;IL27
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.8760080446581724,1.8715261590837404,0.0,0.023969238616972453,0.484,3/11,0.94%,IRF7;AXL;NOD2
prerank,response to interferon-beta (GO:0035456),0.7547579385968366,1.8651270591131393,0.0,0.025829521730389913,0.521,7/22,4.77%,STAT1;IRGM;XAF1;BST2;AIM2;PNPT1;IKBKE
prerank,erythrocyte development (GO:0048821),-0.747094064289175,-1.8645815822751344,0.0033003300330033004,1.0,0.853,7/10,23.89%,NCKAP1L;ZBTB7A;DMTN;ABCB10;ALAS1;LYAR;ALAS2
prerank,regulation of innate immune response (GO:0045088),0.6546006677892432,1.862485837179663,0.0,0.026552343962766768,0.546,19/57,8.27%,USP18;TRAFD1;SAMHD1;PARP9;GBP5;DHX58;IFI35;BIRC2;NMI;TRIM21;ADAM8;CCL5;HSP90AB1;TLR8;ERAP1;POLR3B;DHX9;N4BP1;ABCE1
prerank,regulation of interferon-alpha production (GO:0032647),0.7317600171688085,1.8604798869996861,0.0,0.027123618772944957,0.559,6/23,7.25%,STAT1;IRF7;IFIH1;DHX36;TLR8;DHX9
prerank,regulation of interferon-beta production (GO:0032648),0.661416361156815,1.8519257032081742,0.0,0.03132184135786885,0.611,14/46,12.30%,OAS3;IRF7;OAS2;IFIH1;ISG15;DHX58;TLR8;POLR3B;DHX9;TRAF3;RIOK3;RELB;PTPN11;REL
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.802273505099118,1.84921127146169,0.0030211480362537764,0.032054119883513796,0.624,4/14,4.26%,DDX60;OASL;DHX58;USP15
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6537244509611279,1.8460059508377078,0.0,0.0334686005140177,0.649,9/57,4.81%,PARP14;PARP9;IL15;CRLF1;SOCS1;CD40;STAT3;CCL5;CNOT7
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5965281348291118,-1.8435145587058341,0.0037593984962406013,0.8969662104622091,0.904,12/18,22.44%,DLG4;GRIN1;PRKCZ;NLGN2;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS2;CUX2;SHANK1
prerank,cellular response to zinc ion (GO:0071294),-0.635480811318329,-1.8425293856108846,0.0,0.6796574110375683,0.909,8/15,1.99%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X
prerank,cellular response to cadmium ion (GO:0071276),-0.5395317446783401,-1.8271847059598771,0.0,0.6279093604339793,0.939,10/24,5.67%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X;EGFR;MAPK3
prerank,cellular response to virus (GO:0098586),0.7044040725378462,1.8223517430086662,0.0,0.05052679045342026,0.79,13/30,18.12%,CXCL10;IFIH1;IRGM;CCL5;MAPK14;ZC3H12A;RIOK3;HSP90AA1;LGALS9;BAX;RRP1B;POU2F2;GBF1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.8032025795492537,1.8168823052229912,0.00145985401459854,0.053915782496027714,0.816,4/13,7.25%,AXL;IFIH1;WNT5A;DHX9
prerank,response to cadmium ion (GO:0046686),-0.5379359965115655,-1.8140241896689366,0.0,0.5924202667185994,0.952,10/26,5.67%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X;EGFR;MAPK3
prerank,regulation of defense response to virus by host (GO:0050691),0.6940149316240801,1.8135089283410302,0.002403846153846154,0.05614087828157807,0.839,7/30,7.25%,STAT1;PARP9;DTX3L;AIM2;CGAS;TARBP2;DHX9
prerank,response to interferon-alpha (GO:0035455),0.7721707005651963,1.8120637884552453,0.0,0.056164192599801314,0.845,5/16,2.40%,EIF2AK2;AXL;BST2;KLHL20;ADAR
prerank,cellular response to interferon-beta (GO:0035458),0.8020411658703873,1.8021915988636208,0.0,0.06500402830249279,0.896,4/14,1.78%,STAT1;IRGM;AIM2;PNPT1
prerank,detection of visible light (GO:0009584),0.7725302353656209,1.8011522932793378,0.0,0.06485162566574355,0.899,2/16,2.19%,CNGB1;CACNA2D4
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.8484466094167599,1.7994430211066346,0.001445086705202312,0.06546863290289616,0.902,4/11,5.99%,STAT1;WNT5A;SOX9;FGFR2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7233180383243999,-1.785279737572295,0.0031746031746031746,0.5721997365784409,0.98,3/10,16.70%,MAPK7;KLF4;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7233180383243999,-1.785279737572295,0.0031746031746031746,0.5721997365784409,0.98,3/10,16.70%,MAPK7;KLF4;MAP2K5
prerank,maintenance of protein location in nucleus (GO:0051457),0.725058276147843,1.7805360726274428,0.003968253968253968,0.08715487411038297,0.949,10/20,11.61%,SP100;PML;SKP1;CHCHD10;MORC3;SUPT7L;TAF8;BARD1;SUN2;TAF3
prerank,cellular response to leucine starvation (GO:1990253),-0.6919022366746477,-1.7743771053210484,0.0058823529411764705,0.5632036639854725,0.984,5/10,7.56%,IMPACT;GCN1;RRAGD;RRAGB;LARS1
prerank,positive regulation of immune system process (GO:0002684),0.7606239992143451,1.7714612686528906,0.0,0.09789147935482011,0.966,3/16,2.00%,RSAD2;IL15;PIK3CD
prerank,regulation of protein kinase C signaling (GO:0090036),0.7799991752463562,1.765715234058575,0.004243281471004243,0.10538690380044048,0.972,5/14,10.83%,WNT11;WNT5A;CD40;SPHK2;ADGRV1
prerank,metanephric mesenchyme development (GO:0072075),0.8271890253923776,1.7650889406294712,0.0015267175572519084,0.10442203360373521,0.973,1/10,0.06%,STAT1
prerank,negative regulation of type I interferon production (GO:0032480),0.6425557627355453,1.764448207119898,0.0,0.10345568711342626,0.975,12/40,12.30%,NLRC5;IFIH1;ISG15;UBE2L6;ILRUN;DHX58;TRIM25;IKBKE;CYLD;RELB;HAVCR2;REL
prerank,myoblast fusion (GO:0007520),-0.6604405444602063,-1.7602802030285467,0.0,0.5758146721708447,0.989,6/12,13.76%,CD81;KCNH1;JAM2;PTGFRN;CD9;ADGRB3
prerank,regulation of defense response (GO:0031347),0.5919349538644485,1.7591894065353655,0.0,0.10883078911384209,0.982,23/76,16.29%,USP18;ZBP1;SAMHD1;PIK3AP1;CASP4;NOD2;DHX58;WNT5A;BIRC2;HCK;AREL1;ERAP1;BCL6;CYLD;N4BP1;TRAF3;APOE;FCGR2B;BIRC3;JAK2;MYD88;ADAMTS12;LRP8
prerank,positive regulation of immune response (GO:0050778),0.6109903725383496,1.7538923699127316,0.0,0.11555411907754733,0.99,19/64,17.40%,RSAD2;IL15;NOD2;GBP5;IFI35;NMI;ADAM8;CCL5;TLR8;POLR3B;DHX9;SPHK2;RIOK3;XBP1;FCGR2B;STX4;MYB;LGALS9;PTPRC
prerank,defense response to bacterium (GO:0042742),0.572750422407327,1.7496749038571335,0.0,0.12095166071576757,0.991,12/105,5.78%,OAS3;GBP4;OAS2;ISG15;IRGM;GALP;NOD2;NOD1;STAB2;GBP2;GBP7;SLPI
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.7587592476838315,1.745517179490906,0.004225352112676056,0.1259159698601108,0.992,4/15,2.46%,EIF2AK2;GBP5;USP50;DHX33
prerank,UV-damage excision repair (GO:0070914),-0.6510209282120945,-1.7420470653221358,0.006269592476489028,0.613773746784978,0.993,6/12,19.06%,INO80;XPC;SIRT1;ACTR5;ERCC1;XPA
prerank,positive regulation of response to external stimulus (GO:0032103),0.5646948653166282,1.7379493087631397,0.0,0.13720143212691782,0.993,28/128,11.18%,DDX60;ZBP1;OASL;IL15;AGT;GBP5;DHX58;IFI35;WNT5A;SASH1;NMI;ADAM8;CD47;PTGER4;USP15;CCL5;TLR8;CX3CL1;LY86;LRSAM1;POLR3B;USF1;DHX9;APP;TNIP1;PPM1F;RIOK3;ABCC1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.794695500097979,1.7376804944587774,0.01,0.13542755725819272,0.994,6/11,8.46%,WNT5A;SFRP2;RUNX1;YJEFN3;ETV6;YTHDF2
prerank,positive regulation of T cell migration (GO:2000406),0.7112483786983375,1.7376328675764705,0.001310615989515072,0.1331444536339273,0.994,8/20,16.65%,CXCL10;DOCK8;WNT5A;CCL5;APP;OXSR1;AIF1;STK39
prerank,regulation of T cell chemotaxis (GO:0010819),0.785535596041685,1.7357541296543735,0.001483679525222552,0.1340652329423883,0.994,3/11,4.36%,CXCL10;WNT5A;CCL5
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.7703318325306173,1.7334355327549018,0.00430416068866571,0.13647580172736,0.995,5/13,10.58%,MOV10;ZC3HAV1;PNPT1;CNOT7;ZC3H12A
prerank,phospholipid homeostasis (GO:0055091),0.7983393716287623,1.7266547167684414,0.007309941520467836,0.14786284598927338,0.996,3/11,4.69%,ABCA1;ABCG1;TLCD2
prerank,sensory perception of smell (GO:0007608),-0.6556362068129635,-1.722862169952025,0.020895522388059702,0.6617477986277137,0.993,3/11,4.38%,ADCY3;UBR3;SYT10
prerank,lymphocyte chemotaxis (GO:0048247),0.6399779920242369,1.7227235356781998,0.0011862396204033216,0.15285130253334028,0.997,8/34,5.88%,CXCL10;CCL7;PIK3CD;CXCL16;ADAM8;CCL5;CX3CL1;CH25H
prerank,response to alcohol (GO:0097305),-0.5008690702174207,-1.7204608623680915,0.0,0.6254714692020106,0.994,9/27,11.37%,CCR5;TGFB1;GRIN2A;GRIN2B;TGFBR3;GRIN1;ABCA2;CCL3;PMVK
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6226887670620183,1.7145176903896548,0.0011723329425556857,0.16770655221359165,0.998,12/42,16.65%,CXCL10;CXCL9;CCL7;CCL5;CX3CL1;ACKR3;CIB1;CCL14;GPR35;RBM15;OXSR1;STK39
prerank,regulation of cytokine production (GO:0001817),0.5528950325918406,1.7138779899601246,0.0,0.16646459640020372,0.998,23/126,10.56%,IGF2BP1;ZBP1;EIF2AK2;IRF7;IFIH1;ISG15;IL15;AGT;ICOSLG;PIK3CD;IGF2BP3;TRIM21;CD47;PTGER4;CD276;BCL6;SNAI2;N4BP1;LYN;PPP1R11;MAPK14;TRAF3;CCDC88B
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5826699820019332,1.7130535401028832,0.0010869565217391304,0.16570813083991065,0.998,22/69,17.40%,OAS3;OAS2;IFIH1;NOD2;WNT5A;CLU;TNFRSF8;STAT3;DHX9;TMEM106A;APP;HMGB1;SPHK2;HAVCR2;PTPN11;PSEN1;ARFGEF2;JAK2;TLR2;LGALS9;TLR3;PTPRC
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5800560563196949,1.704271652512209,0.0,0.18412871388779475,0.999,23/73,17.40%,OAS3;OAS2;IFIH1;NOD2;WNT5A;CLU;TNFRSF8;STAT3;ADAM8;DHX9;TMEM106A;APP;HMGB1;SPHK2;HAVCR2;PTPN11;PSEN1;ARFGEF2;JAK2;TLR2;LGALS9;TLR3;PTPRC
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.6114385160815144,-1.7038335851992388,0.02531645569620253,0.6624316416295384,0.998,6/13,13.61%,CHST1;OGA;MGAT3;CHST7;PGM3;CHST3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.7361719329181748,1.7034020582074432,0.007082152974504249,0.18365488806718794,0.999,7/16,10.97%,MOV10;ZFP36;TARDBP;PLEKHN1;DHX36;ZC3H12A;ZFP36L1
prerank,water transport (GO:0006833),0.774826934366496,1.7023360535660317,0.002967359050445104,0.18376997053042823,0.999,3/12,9.06%,AQP11;AQP4;PDPN
prerank,negative regulation of DNA binding (GO:0043392),0.6519998714578257,1.695961932146875,0.006218905472636816,0.19630419421904796,0.999,5/28,4.10%,SP100;ILRUN;PER2;MAD2L2;SUMO3
prerank,response to peptide (GO:1901652),0.6478301617705586,1.6959062227142576,0.004944375772558714,0.19361442180833008,0.999,8/33,9.51%,STAT1;STAT2;NOD2;IRS1;STAT3;CACNA1A;EIF2B2;PRNP
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6501318898590512,1.6941216912894264,0.0049504950495049506,0.195476438362718,0.999,5/29,2.94%,STAT1;STAT2;IL15;STAT3;NMI
prerank,pyroptosis (GO:0070269),0.7256867021352528,1.691531469482199,0.008344923504867872,0.19937530657587213,0.999,4/15,7.25%,ZBP1;CASP4;AIM2;DHX9
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.8163388044217998,1.690274880034235,0.009077155824508321,0.19981648214211375,0.999,3/10,5.99%,STAT1;SOX9;FGFR2
prerank,regulation of response to external stimulus (GO:0032101),0.5470565318058837,1.6898039661980888,0.0,0.1983084402233928,0.999,30/121,16.66%,USP18;ZBP1;SAMHD1;PIK3AP1;CNGB1;CASP4;NOD2;DHX58;CXCR4;WNT5A;BIRC2;CD55;HCK;CX3CL1;AREL1;ERAP1;BCL6;CYLD;N4BP1;P2RX4;TRAF3;CAMKMT;USP14;FCGR2B;BIRC3;JAK2;MYD88;ADAMTS12;LRP8;METAP2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5952105295517001,-1.684650814517755,0.0231023102310231,0.7169127061611092,0.999,8/13,26.13%,ABHD16A;MOGAT3;DGAT1;MGLL;ABHD12;FAAH;ABHD6;DGAT2
prerank,fluid transport (GO:0042044),0.7618164915143438,1.6842600127734002,0.004291845493562232,0.21010055353091528,0.999,3/12,9.06%,AQP11;AQP4;PDPN
prerank,embryonic heart tube development (GO:0035050),0.754555422677597,1.6817182023217647,0.0027100271002710027,0.21317968371912197,0.999,2/14,2.82%,PITX2;ACVR1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6381402936694202,1.6810503935459766,0.007308160779537149,0.21218179344964697,0.999,5/32,8.61%,CXCL10;CXCL9;GALP;RNASE7;FAM3A
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.74802314956488,1.6788935425360092,0.0056657223796034,0.21500105583659293,0.999,6/14,8.50%,ETNK1;ETNK2;SLC27A1;PCYT2;LPIN2;CEPT1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.7499396915066243,1.6761934069624507,0.010115606936416185,0.21983011629108884,0.999,3/12,0.46%,PARP12;PARP10;PARP11
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6546347845399407,1.6719526581524575,0.007653061224489796,0.22816003814122587,1.0,4/25,5.48%,CXCL10;CXCL9;THY1;CX3CL1
prerank,myelin maintenance (GO:0043217),0.8024195997202686,1.6712396003826724,0.0074850299401197605,0.22728639522991614,1.0,5/10,9.47%,CXCR4;CLU;DEGS1;EPB41L3;ABCD1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6344384638181257,-1.6675810058685459,0.021406727828746176,0.7689166083705531,1.0,7/12,20.90%,TGFB1;SIRT7;RBM4;AAAS;PTPN14;NEDD4;TPR
prerank,response to cytokine (GO:0034097),0.5406265510114108,1.6667191903310865,0.0,0.23663037873256607,1.0,31/141,12.30%,STAT1;SP100;EIF2AK2;CD274;ISG15;PML;XAF1;BST2;CXCR4;KLHL20;ADAR;CD40;CXCL16;STAT3;ASAH2;PTPN18;TRIM21;IKBKE;IGBP1;SRF;PTPN7;APP;LDLRAP1;TIMP2;GCH1;ALDH1A2;COL3A1;RELB;GGT7;PTPN11;REL
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4927034669754673,-1.665781164288626,0.005208333333333333,0.7331240853313412,1.0,10/26,5.88%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X;SLC39A14;SLC39A7
prerank,regulation of viral life cycle (GO:1903900),0.6882880046822878,1.664907574059802,0.0078125,0.23915434379846082,1.0,5/21,7.75%,AXL;TRIM14;TRIM25;TRIM21;PPIA
prerank,positive regulation of type 2 immune response (GO:0002830),0.7226973679524394,1.663127624513549,0.016713091922005572,0.24168982272113895,1.0,2/14,0.94%,RSAD2;NOD2
prerank,positive regulation of response to stimulus (GO:0048584),0.611603813684328,1.6603537929261494,0.008264462809917356,0.24624144049638383,1.0,12/40,14.60%,RSAD2;IFIH1;IL15;WNT5A;B2M;CGAS;DHX9;ECHDC3;YPEL3;IER5;FCGR2B;NSMCE1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5704864799862566,1.6600866429527432,0.0,0.24421748338850924,1.0,25/72,17.56%,USP18;STAT1;ZBP1;AXL;SPPL2A;SOCS1;BIRC2;RBCK1;RUNX1;HSP90AB1;CFLAR;CYLD;ABCE1;RNF31;PTPN11;RACK1;SHARPIN;BIRC3;JAK2;IFNAR2;PIAS1;IRAK1;ELF1;PTPRC;CDC37
prerank,thymus development (GO:0048538),-0.6047231680243399,-1.6580458042186466,0.016666666666666666,0.7345967289830054,1.0,3/13,6.69%,ZBTB1;FOXE1;FGF10
prerank,cellular response to fluid shear stress (GO:0071498),-0.6315897546601859,-1.6572598166525794,0.009345794392523364,0.6995304347521171,1.0,9/12,31.24%,MTSS1;ASS1;MAPK7;KLF4;MAP2K5;MEF2C;SREBF2;HAS2;HDAC3
prerank,protein heterooligomerization (GO:0051291),-0.5462268156244918,-1.6563668492502968,0.014134275618374558,0.6697534779076948,1.0,7/17,14.30%,GRIN2B;KCNC2;GRIN1;MAT2A;TMEM120A;CPSF7;FARSA
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5329103256561141,-1.6559990468441255,0.026415094339622643,0.6402185344668221,1.0,12/18,29.44%,CACNG7;TSHZ3;NLGN2;CACNG8;NRXN1;SHANK3;CCR2;CACNG2;CACNG3;CCL2;CACNG5;PTK2B
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.712278185754066,1.655404214628466,0.01278409090909091,0.255422559111137,1.0,4/15,10.29%,RNF213;NPHP3;DACT1;SPEF1
prerank,regulation of response to interferon-gamma (GO:0060330),0.7288232674282689,1.653668232230633,0.016172506738544475,0.25790855182967654,1.0,4/14,4.86%,STAT1;PARP9;SOCS1;HSP90AB1
prerank,response to zinc ion (GO:0010043),-0.48831059246219777,-1.6518692102513506,0.019138755980861243,0.6296650576706387,1.0,8/25,1.99%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X
prerank,innate immune response (GO:0045087),0.5253144300402801,1.6518337462522827,0.0,0.26075545572637454,1.0,38/217,12.30%,CXCL10;SP100;NLRC5;IRF7;IFIH1;IFIT1;ISG15;IRGM;PML;TRIM14;NOD2;BST2;DHX58;ALPK1;TRIM25;PIK3CD;B2M;ADAR;CD40;CXCL16;TRIM21;CYBB;HCK;TLR8;SLPI;TRIM39;CYLD;ATAD3A;RNASE7;LYN;APP;HMGB1;SRPK1;GCH1;IRAK4;RELB;TRIM26;REL
prerank,cellular response to copper ion (GO:0071280),-0.570567514707885,-1.6497326428199448,0.019305019305019305,0.6115032799014497,1.0,8/16,1.99%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.6221554081570212,-1.6492792206156612,0.016666666666666666,0.5883761606905676,1.0,8/12,20.98%,DOCK4;DOCK7;TPM1;ADAMTS1;IGFBP5;DOCK5;PRKG1;MEF2C
prerank,monocyte differentiation (GO:0030224),-0.6603428286918687,-1.6490018558925996,0.01675977653631285,0.5659503547734908,1.0,4/10,6.24%,PPARG;MT1G;THOC5;PDE1B
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.5461074149596611,-1.6450076990281144,0.019230769230769232,0.5598007741408494,1.0,9/17,19.52%,SYK;PRKCQ;PRKCZ;RARA;CEBPB;SLC7A5;CD86;IRF4;CD28
prerank,cellular response to chemokine (GO:1990869),0.5907264202831188,1.6439056075720158,0.004618937644341801,0.2826314493330318,1.0,11/46,12.50%,CXCL10;CXCL9;CCL7;DOCK8;CCL5;CX3CL1;ACKR3;ZC3H12A;LRCH1;CCL14;GPR35
prerank,mesenchyme development (GO:0060485),0.717603614822737,1.640576831113385,0.008450704225352112,0.29046514850315686,1.0,4/15,9.54%,WNT11;SFRP2;FGFR2;BMPR2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.7550212388291283,1.6393693689472808,0.015037593984962405,0.2913942597297514,1.0,8/11,17.08%,DHX36;NCBP2;BARD1;ZFP36L1;AHCYL1;PAPOLA;NCBP1;ZC3H3
prerank,response to purine-containing compound (GO:0014074),0.6789394354769143,1.6358485966288163,0.02054794520547945,0.3000109031210828,1.0,3/17,8.96%,STAT1;TRPM2;P2RX4
prerank,negative regulation of interferon-gamma production (GO:0032689),0.6509832051508971,1.6346910418129472,0.010282776349614395,0.3006373894147804,1.0,6/23,12.12%,AXL;CD274;HMGB1;PRNP;ZC3H12A;HAVCR2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7545899257347204,1.633025903160906,0.013177159590043924,0.3033929042472499,1.0,3/11,7.72%,AGT;ABCG1;LIPC
prerank,zinc ion homeostasis (GO:0055069),-0.4731565395533342,-1.6324266984456157,0.017045454545454544,0.5895774710979874,1.0,10/28,5.88%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X;SLC39A14;SLC39A7
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.567549165619111,-1.6290712280151423,0.020689655172413793,0.58245738160581,1.0,6/15,13.61%,CHST1;OGA;MGAT3;GNPDA1;CHST7;CHST3
prerank,erythrocyte differentiation (GO:0030218),-0.4200642019360815,-1.6269847963608524,0.0,0.5707397602291233,1.0,19/44,23.89%,RPS14;UBA5;NCKAP1L;TGFBR3;KMT2E;CASP3;ID2;DMTN;PTPN2;ABCB10;ALAS1;JAK3;SLC25A5;LYAR;CDK5RAP3;ZFPM1;INHBA;HIPK2;ALAS2
prerank,positive regulation of viral genome replication (GO:0045070),0.6364166531735244,1.6269276426014403,0.0037546933667083854,0.32141070531071614,1.0,12/29,11.59%,IFIT1;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;PPIA;VAPB;SRPK1;STAU1;HACD3
prerank,regulation of RNA metabolic process (GO:0051252),0.5693140554133285,1.626497201637935,0.004439511653718091,0.31935808889925665,1.0,12/59,11.85%,OAS3;IGF2BP1;OASL;OAS2;FASTK;IGF2BP3;HNRNPH1;YTHDF2;CLK3;HNRNPL;MITF;HNRNPH3
prerank,monocyte chemotaxis (GO:0002548),0.6167054431277764,1.626321414172418,0.0049504950495049506,0.3167642667618559,1.0,5/32,5.48%,CALCA;FLT1;CCL7;CCL5;CX3CL1
prerank,nerve growth factor signaling pathway (GO:0038180),0.7695092109044221,1.622170138794157,0.013313609467455622,0.3276403529582356,1.0,4/10,13.46%,BDNF;MAGI2;RAPGEF2;RAPGEF1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.6276573855003649,-1.6216433518113331,0.023178807947019868,0.5725463742379866,1.0,6/12,23.49%,ZBTB1;PRKCQ;CCR2;CARD9;CLEC6A;IL1B
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6985376603877642,1.6211508738723621,0.01532033426183844,0.32786272916441594,1.0,3/15,8.81%,AGT;SOX9;GDNF
prerank,lung development (GO:0030324),0.6059107106394319,1.618315305627121,0.01600985221674877,0.33442335061225753,1.0,9/33,11.33%,WNT11;CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,cellular response to dsRNA (GO:0071359),0.7042103993849769,1.6157861220609437,0.005625879043600563,0.34030493165640036,1.0,6/15,10.95%,IFIH1;IFIT1;CGAS;DHX9;NPM1;RIOK3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6016363154004462,1.6122987980618406,0.018226002430133656,0.34970277666068283,1.0,4/30,2.87%,CD274;ISG15;NOD2;STAT3
prerank,protein homotetramerization (GO:0051289),0.5821958972778357,1.6113972434876986,0.00585480093676815,0.34995509016730947,1.0,12/49,13.78%,SAMHD1;SYCP1;GBP5;TRPM2;B2M;SOD2;AQP4;TK1;ALDH1A2;HPRT1;ACOT13;SHMT1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4779396006539636,-1.6109263892729684,0.04020100502512563,0.5960889817328374,1.0,14/26,22.44%,DLG4;GRIN1;PRKCZ;NLGN2;SLC8A3;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS2;SLC8A2;CUX2;SHANK1
prerank,negative regulation of DNA replication (GO:0008156),-0.5922759802011363,-1.6102840190368077,0.020477815699658702,0.5800919332913088,1.0,6/13,17.60%,WAPL;CDAN1;RAD17;S100A11;TERF1;TSPYL2
prerank,vitamin transport (GO:0051180),0.6223280241250264,1.609971121794608,0.00984009840098401,0.35156792858575986,1.0,8/29,9.47%,SLC27A1;SLC2A6;SLC46A1;SLC19A1;SLC52A2;SLC35F3;PDPN;AMN
prerank,reverse cholesterol transport (GO:0043691),0.7252174065909676,1.6078249064023395,0.01702127659574468,0.3564510716904306,1.0,5/13,12.35%,ABCA1;ABCG1;CLU;LIPC;APOE
prerank,positive regulation of viral process (GO:0048524),0.5581909441021058,1.6076565673289647,0.0033594624860022394,0.35386929769975334,1.0,17/60,11.59%,AXL;IFIT1;POLR2G;ADAR;PKN2;TARBP2;LARP1;CCL5;CNOT7;DHX9;MDFIC;PPIA;POLR2K;VAPB;SRPK1;STAU1;HACD3
prerank,receptor signaling pathway via STAT (GO:0097696),0.6275362710162838,1.60504091562534,0.01272264631043257,0.3604600835698148,1.0,4/25,2.94%,STAT1;STAT2;STAT3;NMI
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.6282800527955006,1.6028628721743508,0.008771929824561403,0.36503527492096194,1.0,5/26,3.46%,TRAFD1;ILRUN;DHX58;NMI;TRIM21
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7283981714098247,1.602415314808782,0.021929824561403508,0.36318409083131264,1.0,3/12,8.81%,AGT;SOX9;GDNF
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7506732504700466,1.601551203342667,0.019461077844311378,0.36305518422826183,1.0,3/10,1.72%,NAMPT;NOD2;KDR
prerank,cellular response to exogenous dsRNA (GO:0071360),0.7380282145493813,1.6000267357997555,0.014792899408284023,0.3658824203822999,1.0,4/12,7.25%,IFIH1;IFIT1;CGAS;DHX9
prerank,sprouting angiogenesis (GO:0002040),0.5589396223006684,1.5929103382250203,0.009080590238365494,0.39013829368400693,1.0,8/51,11.22%,RNF213;LOXL2;KDR;CDH13;YJEFN3;SRF;BMPER;VEGFD
prerank,pancreas development (GO:0031016),0.7125395375343347,1.590730616538943,0.02654867256637168,0.39529896924110525,1.0,6/12,15.25%,CCDC40;TCF7L2;NPHP3;MET;PROX1;SELENOT
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5946314423417549,1.5906062520457365,0.012254901960784314,0.3924107911439372,1.0,4/32,5.48%,CXCL10;CXCL9;THY1;CX3CL1
prerank,regulation of interleukin-4 production (GO:0032673),-0.5058610205239928,-1.5903662582431635,0.04932735426008968,0.6464267141949852,1.0,12/21,26.62%,SYK;PRKCQ;PRKCZ;RARA;CEBPB;SLC7A5;CD86;IRF4;CD28;ZFPM1;FCER1G;LEF1
prerank,regulation of activated T cell proliferation (GO:0046006),0.5976412293688306,1.5869483186684206,0.020202020202020204,0.40388418484190086,1.0,7/30,16.81%,CD274;ICOSLG;TNFSF9;HMGB1;PRNP;IL18;LGALS9
prerank,regulation of immune response (GO:0050776),0.5172318360442724,1.585663953383057,0.002053388090349076,0.40577036506447056,1.0,23/135,8.83%,RSAD2;IRF7;CLEC2D;SAMHD1;IL15;TREML2;DHX58;SPPL2A;PIANP;BIRC2;B2M;LAG3;CD40;GPR108;NPDC1;CD276;ERAP1;BCL6;N4BP1;SH2D1A;LAIR1;LYN;FCGR1A
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6511009273370699,1.5828226016412321,0.02165087956698241,0.41372462918856046,1.0,5/19,7.25%,IFIH1;PARP9;WNT5A;RUNX1;DHX9
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6270292578751062,-1.5825881161790694,0.0375,0.6606505981927375,1.0,7/11,30.04%,TGFB1;EFNB2;FZD7;MEF2C;SOX6;GREM1;BMP2
prerank,positive regulation of defense response (GO:0031349),0.5317176577354356,1.5820133431487942,0.0032119914346895075,0.4133987152093813,1.0,20/89,11.18%,ZBP1;IL15;AGT;GBP5;IFI35;WNT5A;NMI;ADAM8;CD47;PTGER4;CCL5;TLR8;CX3CL1;LRSAM1;POLR3B;DHX9;APP;TNIP1;RIOK3;ABCC1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6485772537110956,1.5816282295869297,0.022606382978723406,0.4115828139018192,1.0,4/18,3.82%,SLAMF1;IFI35;NMI;ENPP3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.6150197639908976,1.580296301588681,0.018633540372670808,0.41322702247545845,1.0,7/26,7.75%,NOL3;GPR37L1;SOD2;FBXO7;NME5;GPR37;PPIA
prerank,sarcomere organization (GO:0045214),0.6134113431498901,1.579772164305779,0.020227560050568902,0.4120585979844456,1.0,3/27,3.83%,MYOZ2;CSRP1;ACTN2
prerank,genitalia development (GO:0048806),0.7177625057236701,1.5792088535677304,0.0361794500723589,0.41103143027583944,1.0,3/12,12.26%,WNT5A;CHD7;PTPN11
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6788667732287719,1.5756436159946436,0.03763440860215054,0.422188459657835,1.0,5/15,4.81%,TENT4A;POLR2G;ZFP36;AGO2;CNOT7
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6751598826703458,1.5752714016176244,0.033921302578018994,0.4203748764469878,1.0,6/16,8.48%,TMEM161A;CLU;SFRP2;CDKN2D;SNAI2;ACKR3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4829043060385015,-1.5747011730700802,0.013452914798206279,0.6724204656148108,1.0,12/23,22.30%,TECR;HACD1;ELOVL5;DGAT1;FAR1;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;ACSL4;ELOVL6
prerank,cytokine-mediated signaling pathway (GO:0019221),0.490111529759029,1.5747000205155124,0.0,0.4193141193760553,1.0,117/532,14.87%,IFIT3;RSAD2;OAS3;STAT1;STAT2;CXCL10;SP100;OASL;IRF7;OAS2;SAMHD1;IFIT1;ISG15;CXCL9;EDAR;PML;IL15;CRLF1;XAF1;NOD2;IFIT2;PSMB10;BST2;CCL7;TNFSF9;CAMK2D;IL15RA;IFI35;NOD1;SKP1;AIM2;IRS1;PSME2;SOCS1;TRIM25;BIRC2;PIK3CD;B2M;TNFRSF8;CAMK2B;PSMA5;SLC27A1;ADAR;CD40;SOD2;STAT3;IL21R;BCL2L11;PSME4;GRB10;TRIM21;MAP3K8;GBP2;IL17RC;HCK;CCL5;TXNDC17;JUNB;CX3CL1;CCND1;IL27;PSMA3;NFKB1;BCL6;MT3;CSF1;IL10RA;CSNK2B;HNRNPA2B1;PPIA;TNFRSF17;IL12RB2;PSMB9;ACKR3;FCGR1A;LEPR;SOCS5;RBX1;IRF9;VAV1;HSPA8;TRAF3;RORA;COMMD7;BTRC;HNRNPDL;PSMD2;CCL14;TRAF5;PIM1;TNFSF8;IL10RB;IRAK4;SOS1;TRIM26;PTPN11;PSME3;SOCS2;GPR35;PIK3CB;LIMS1;RAPGEF1;ST18;NUMBL;BIRC3;STX4;JAK2;FYN;IFNAR2;AIP;PSMA4;IL1RAP;SOX2;IRS2;TNIP2;MYD88;HSP90AA1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.7183056087434468,1.5740050090403523,0.02077562326869806,0.41902787427179533,1.0,4/12,9.06%,CXCL10;DOCK8;CCL5;APP
prerank,hyaluronan metabolic process (GO:0030212),0.6245873285805035,1.571933368099918,0.020860495436766623,0.42418944862308433,1.0,6/23,3.12%,HAS3;SPAM1;HYAL1;STAB2;HYAL4;HAS1
prerank,ncRNA 3'-end processing (GO:0043628),-0.559682602336111,-1.5701552415440334,0.026578073089700997,0.6737700730103657,1.0,9/14,30.79%,ERI1;TRNT1;INTS12;INTS2;ELAC2;INTS6;TOE1;INTS5;INTS6L
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5135792729695164,1.56407720131138,0.0,0.4533391464116244,1.0,29/112,17.40%,OAS3;OAS2;IFIH1;NOD2;SLAMF1;ILRUN;WNT5A;CLU;ZFP36;TNFRSF8;STAT3;CD47;CX3CL1;DHX9;TMEM106A;APP;HMGB1;SPHK2;ZC3H12A;HAVCR2;PTPN11;PSEN1;ARFGEF2;JAK2;TLR2;DICER1;LGALS9;TLR3;PTPRC
prerank,glycerol metabolic process (GO:0006071),0.7364202844492518,1.5617379222209433,0.03186646433990895,0.46041689518177703,1.0,4/10,6.33%,COQ2;TPI1;PDXP;COQ3
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6349155587852156,1.5611170131675807,0.01989389920424403,0.4593970724159122,1.0,3/20,2.89%,RSAD2;B2M;CD55
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5829356103538834,1.5604700239392195,0.02045728038507822,0.4585370030100481,1.0,10/35,12.41%,STAT1;HSPA1B;ZFP36;STAT3;BRD1;LYN;MAPK14;ZFP36L1;LDB1;PRKDC
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6672856688863145,1.5602815759187678,0.030726256983240222,0.45581297671392423,1.0,3/15,3.63%,NOL3;CLU;FXN
prerank,defense response to protozoan (GO:0042832),0.6994184820998215,1.5596250431957528,0.049707602339181284,0.4554189343862609,1.0,4/12,5.14%,GBP4;CD40;GBP2;GBP7
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7352475923765954,1.559526663110093,0.031203566121842496,0.4524835972821581,1.0,3/10,8.77%,AXL;RAPGEF2;LYN
prerank,autophagy of nucleus (GO:0044804),-0.5345272590258565,-1.5577199074257964,0.02888086642599278,0.7089074730042421,1.0,6/16,12.58%,ATG5;ULK2;ATG2B;ATG2A;ATG9A;ATG3
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5840109844974797,1.5571889636164342,0.020833333333333332,0.45903424006702076,1.0,5/32,8.96%,CXCL10;CXCL9;THY1;CX3CL1;P2RX4
prerank,respiratory tube development (GO:0030323),0.5911444147006282,1.556273720190229,0.028535980148883373,0.4595546528886059,1.0,8/28,11.33%,CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,protein autoubiquitination (GO:0051865),0.5255161730310465,1.5559504556376695,0.003409090909090909,0.45735782530710545,1.0,14/61,8.78%,RNF213;DTX3L;NFX1;RNF4;TRIM21;RNFT1;BFAR;CNOT4;UBE2B;RNF11;UBE3A;LRSAM1;AMFR;RNF19B
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6931213246853875,1.5554790713077637,0.031161473087818695,0.45619512243915417,1.0,4/13,4.61%,PLXNA3;PLXNB2;NRP2;PLXNB3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.5611321377680376,1.5549796910218607,0.01740139211136891,0.45503470795955087,1.0,9/42,5.35%,PARP10;ISG15;SYCP1;UBE2L6;TRIM25;POLD4;CDKN2D;RFC4;RFC1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7443552970580456,1.5544250376955218,0.03582554517133956,0.45421781511402404,1.0,1/10,0.46%,CNGB1
prerank,cell differentiation in spinal cord (GO:0021515),-0.626388801707363,-1.5524940800316505,0.050746268656716415,0.7136305079712265,1.0,8/10,37.39%,SOX13;ZC4H2;MDGA2;SOX4;MDGA1;SOX6;LHX1;ISL1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5067181392591036,-1.5520881120215662,0.03435114503816794,0.6965766301344356,1.0,10/18,22.30%,TECR;HACD1;ELOVL5;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;ACSL4;ELOVL6
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.7116121602534992,1.5519545792925011,0.03526093088857546,0.4623644692579011,1.0,3/11,8.26%,STAT1;STAT3;IL12RB2
prerank,amino acid import across plasma membrane (GO:0089718),-0.4607801307187998,-1.5505683551360705,0.022321428571428572,0.6852531332559468,1.0,7/24,16.29%,SLC1A2;SLC7A2;SLC16A2;SLC3A2;SLC7A5;SLC1A4;SLC1A1
prerank,respiratory system development (GO:0060541),0.5824470014730627,1.548768818029412,0.024539877300613498,0.4725354169347162,1.0,9/32,11.33%,CHD7;CCDC40;FGFR2;ITGA3;WNT7B;NPHP3;PDPN;PROX1;FGF9
prerank,ruffle organization (GO:0031529),0.6592443528011349,1.5479460122896984,0.040502793296089384,0.47283930693554305,1.0,9/16,16.08%,CYFIP1;CARMIL1;PIP5K1A;AIF1L;PLEKHA1;CORO1B;RAC1;INPP5K;AIF1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6075957313245448,-1.5479247425049243,0.04437869822485207,0.679071629626838,1.0,10/11,39.28%,ASAH1;SIRT1;EGR1;WNT4;BMP5;STAR;DGKQ;BMP2;NR1H4;FGFR4
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6930662368673193,1.5473441149457756,0.03138373751783167,0.47234390670453824,1.0,4/13,12.94%,GPR37L1;GPR37;MET;RACK1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.564612947256705,1.5454605363033045,0.020047169811320754,0.4765726097276084,1.0,6/40,3.63%,NOL3;TNFSF10;CLU;MLLT11;BCL2L11;FXN
prerank,development of primary male sexual characteristics (GO:0046546),0.5785847853284899,1.5444746516774335,0.023557126030624265,0.4778044306712392,1.0,6/34,5.43%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,negative regulation of cell division (GO:0051782),-0.6030712411940087,-1.543541876857277,0.05228758169934641,0.6810368874378008,1.0,8/11,32.36%,ZFYVE19;ORC6;MYC;VPS4A;E2F8;AURKB;CHMP4C;E2F7
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.7129549799808755,1.5432950055840275,0.036284470246734396,0.4800221210695017,1.0,2/11,3.85%,SP100;MAD2L2
prerank,secondary palate development (GO:0062009),0.677012865459907,1.5419164175851918,0.029585798816568046,0.4826204696953014,1.0,4/14,7.85%,WNT11;WNT5A;CHD7;SMAD2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6734912380832933,1.5406656983200357,0.029871977240398292,0.48491015271923993,1.0,4/15,8.96%,KDR;MET;SMOC2;P2RX4
prerank,male gonad development (GO:0008584),0.5777779101477044,1.540126911114189,0.02494061757719715,0.4841221267046348,1.0,6/34,5.43%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,regulation of spindle assembly (GO:0090169),0.6006623521788095,1.5385753392943105,0.024675324675324677,0.4881789694275803,1.0,5/25,4.22%,HSPA1B;CHMP4B;CHMP1B;RNF4;DYNC1H1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.542251031547166,1.5382638749421358,0.0223463687150838,0.48645599258900996,1.0,17/51,19.90%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;TMEM106A;APP;HMGB1;TMED10;PANX1;JAK2;MYD88;LGALS9;RIPK2;TYROBP
prerank,regulation of coagulation (GO:0050818),-0.6140849239329697,-1.5349407232350565,0.05142857142857143,0.7028798309868589,1.0,5/11,28.81%,EPHB2;HS3ST5;F2R;CAV1;PROCR
prerank,protein heterotetramerization (GO:0051290),-0.5618482705995627,-1.5348502604168288,0.050955414012738856,0.6872654323964257,1.0,4/13,14.30%,GRIN2B;GRIN1;CPSF7;FARSA
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.547301129197363,1.5321527506153392,0.022093023255813953,0.5108989179518237,1.0,12/44,10.97%,MOV10;ZC3HAV1;POLR2G;PNPT1;ZFP36;AGO2;YTHDF1;CNOT7;DHX36;YTHDF2;ZC3H12A;ZFP36L1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6101209556187728,1.5317827419874492,0.03968253968253968,0.5092003531511611,1.0,5/23,8.81%,AGT;PIK3CD;SOX9;SIRT6;GDNF
prerank,lamellipodium assembly (GO:0030032),0.5933268213431688,1.5276581718081723,0.023809523809523808,0.524598463356431,1.0,11/26,13.91%,CDH13;SPATA13;PARVB;CYFIP1;CARMIL1;ARHGEF7;CCDC88A;SPEF1;SRGAP2;WHAMM;RAC1
prerank,mRNA stabilization (GO:0048255),0.5560665862759671,1.5275528009747792,0.020070838252656435,0.5217551369867771,1.0,11/40,15.56%,IGF2BP1;ZFP36;TARDBP;LARP1;DHX9;GDNF;MAPK14;TENT5A;TENT5C;MYD88;TAF15
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.593638141180371,1.5255130073716032,0.040051679586563305,0.5281861744656063,1.0,10/25,14.69%,CHMP4A;CHMP4B;CHMP1B;MVB12A;RILP;LEPROT;CHMP3;LEPROTL1;LYST;DENND10
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.7373566495313282,1.5247842484097276,0.038922155688622756,0.5280861703137434,1.0,2/10,1.74%,PARP14;SOCS1
prerank,negative regulation of cartilage development (GO:0061037),0.7054278917728686,1.5244697602148745,0.04,0.5262330137674794,1.0,5/13,15.88%,WNT11;SOX9;SNAI2;PTPN11;ADAMTS12
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6896976768433726,1.52276619604739,0.04142011834319527,0.5306172296766499,1.0,1/12,0.04%,OAS3
prerank,cellular response to retinoic acid (GO:0071300),0.5461782768795483,1.5225941815727666,0.02364066193853428,0.527960651520374,1.0,11/42,15.65%,WNT11;WNT5A;BRINP3;SOX9;WNT7B;RET;LTK;LYN;SNW1;ZNF35;ADNP2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.7049512638747637,1.5220911317884243,0.0361794500723589,0.5269665262013157,1.0,3/11,5.48%,LMX1A;WNT5A;CTNNB1
prerank,folic acid metabolic process (GO:0046655),0.6486626179641827,1.5213262305163657,0.03064066852367688,0.5275066365886866,1.0,4/18,5.34%,MTHFR;DHFR;SLC46A1;SLC19A1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5861556235240017,-1.5204977800701591,0.06086956521739131,0.7322527981422687,1.0,4/10,13.17%,STK10;WASL;JAM2;AKT1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5400371097062385,1.5196261524505166,0.03526734926052332,0.5320077319494867,1.0,15/45,19.90%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;TMEM106A;APP;PANX1;JAK2;MYD88;LGALS9;RIPK2;TYROBP
prerank,folic acid-containing compound metabolic process (GO:0006760),0.6343762675183208,1.5194418861365167,0.04755434782608696,0.5295758902359401,1.0,4/19,5.34%,MTHFR;DHFR;SLC46A1;SLC19A1
prerank,amide transport (GO:0042886),0.5948344438487513,1.5192717074223214,0.03934010152284264,0.5270351013529582,1.0,13/26,22.40%,SLC27A1;AQP11;SLC46A1;SLC19A1;SLC14A2;ABCB9;PDPN;PLEKHA3;TAP1;GLTP;ABCG2;SLC5A6;CERT1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6067511106044681,1.5187630657145135,0.030183727034120734,0.5262371909161612,1.0,6/26,8.81%,HSPA1B;EYA4;UNC5B;SNAI2;RET;GDNF
prerank,androgen receptor signaling pathway (GO:0030521),0.6893050209725033,1.517888710601798,0.05429864253393665,0.5271808804822319,1.0,4/11,5.71%,DAXX;DDX5;PMEPA1;ARID1A
prerank,oxoacid metabolic process (GO:0043436),0.5907080132647214,1.5169860053866742,0.03495630461922597,0.5282432051418736,1.0,6/27,7.68%,TPST1;LIPT1;AGXT;GRHPR;THAP4;SULT6B1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.5642551583328561,-1.5152620542353719,0.04195804195804196,0.7388980023568007,1.0,3/12,4.73%,TGFB1;PPARG;ESR1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6843564061930993,1.5144282265241835,0.027737226277372264,0.5366741999555074,1.0,3/13,1.72%,NAMPT;NOD2;KDR
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6180307951708306,-1.514365180009718,0.06451612903225806,0.7269486917327143,1.0,4/10,10.24%,PTPN12;APOD;SNCA;PTPN2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.6430537908303658,1.5126494689828582,0.04742547425474255,0.541498355053128,1.0,5/17,10.05%,NOL3;SOD2;NME5;PPIA;UBQLN1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.49879821170250604,1.510621266017817,0.008394543546694649,0.5477386412110901,1.0,23/95,16.68%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;NFKB1;HMGB1;MAPK14;GIT1;ZC3H12A;XBP1;STAP1;FCGR2B;TNIP2;MYD88;TLR2;TNIP3;IRAK1;UPF1;ACOD1
prerank,response to exogenous dsRNA (GO:0043330),0.6361600317765608,1.5097272349829256,0.042582417582417584,0.548779389836181,1.0,4/18,7.25%,IFIH1;IFIT1;CGAS;DHX9
prerank,organophosphate biosynthetic process (GO:0090407),0.5484075453847191,1.5096903990017858,0.031476997578692496,0.5458039101179216,1.0,11/37,11.25%,TPI1;ITPKC;MOCS3;PCYT2;AGPAT5;PIP5K1A;PPIP5K1;NFS1;GNPAT;MOCOS;TPK1
prerank,response to peptide hormone (GO:0043434),0.5409226581093802,1.5096725223569711,0.021251475796930343,0.542816673774479,1.0,9/43,11.49%,STAT1;STAT2;IRS1;SLC27A1;STAT3;EIF2B2;ZFP36L1;XBP1;EIF6
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5210045337810654,1.5091408272673443,0.023809523809523808,0.5421797390540819,1.0,10/63,7.22%,SP100;NOL3;TNFSF10;PML;AGT;ACVR1;FEM1B;CFLAR;TCF7L2;CYLD
prerank,retinoic acid metabolic process (GO:0042573),0.6638874724168985,1.5085529147305041,0.04709141274238227,0.5416175462305615,1.0,3/14,10.66%,BCO2;CYP26B1;ALDH1A2
prerank,maintenance of protein localization in organelle (GO:0072595),0.6296311094718564,1.508304876598175,0.0431266846361186,0.53975668430854,1.0,8/19,11.61%,PML;SKP1;CHCHD10;MORC3;SUPT7L;TAF8;HK1;TAF3
prerank,cellular response to purine-containing compound (GO:0071415),0.7063903021336273,1.5073853089088136,0.060240963855421686,0.5408627808335643,1.0,2/10,3.75%,TRPM2;SLC8A1
prerank,multivesicular body assembly (GO:0036258),0.5752745326143347,1.5071824241350842,0.034482758620689655,0.5388494105544481,1.0,14/30,22.41%,CHMP4A;CHMP4B;CHMP1B;MVB12A;VPS37A;CHMP3;VPS28;HGS;RAB11A;IST1;CHMP5;CHMP1A;TSG101;VPS36
prerank,negative regulation of protein transport (GO:0051224),0.5971659312298367,1.5071754403239475,0.04430379746835443,0.5359162411471049,1.0,5/25,12.35%,RSAD2;RSC1A1;PPM1F;RHBDF2;APOE
prerank,modulation by symbiont of entry into host (GO:0052372),0.6423460794515132,1.5062309942551122,0.04336043360433604,0.537156668437117,1.0,3/16,3.46%,TRIM14;TRIM25;TRIM21
prerank,neurotrophin signaling pathway (GO:0038179),0.6117852168142098,1.5042981035878642,0.03800786369593709,0.5431237684996921,1.0,7/21,13.46%,BDNF;MAGI2;RAPGEF2;BCAR1;DDIT4;SOS1;RAPGEF1
prerank,cellular response to alkaloid (GO:0071312),0.6388974168961632,1.5036261853527353,0.03994490358126722,0.5432117684075239,1.0,4/17,4.28%,CASP7;SLC8A1;CASP6;CRHBP
prerank,dendritic cell differentiation (GO:0097028),0.6047296834433097,1.5013467302597618,0.03543307086614173,0.5509308769613849,1.0,4/22,8.77%,AXL;TRPM2;BATF3;LYN
prerank,regulation of cell projection organization (GO:0031344),0.6723752562982979,1.5010276640933997,0.045706371191135735,0.5494804544948763,1.0,3/13,2.58%,MOV10;SPRY2;SEMA4D
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.5324979221656456,-1.5008240806223825,0.07392996108949416,0.7719909542796181,1.0,4/15,13.42%,TGFB1;IRAK3;TGFB2;JAK3
prerank,cellular response to interleukin-15 (GO:0071350),0.6783901133451162,1.5005547101562864,0.04836415362731152,0.5459042677725974,1.0,3/13,2.87%,IL15;IL15RA;STAT3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.6783901133451162,1.5005547101562864,0.04836415362731152,0.5459042677725974,1.0,3/13,2.87%,IL15;IL15RA;STAT3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6376358296386364,1.500265093047214,0.05725699067909454,0.5444451621696084,1.0,5/17,16.08%,CXCL10;CCL5;HMGB1;CXCL17;AIF1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5614715297010106,1.4993582264195346,0.03398058252427184,0.5450483567122205,1.0,3/35,1.39%,STAT1;FLT1;XDH
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5430747020511538,-1.4991859381798351,0.06070287539936102,0.7635932443132463,1.0,8/13,40.12%,KCND3;KCNT2;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4
prerank,regulation of endothelial cell migration (GO:0010594),0.5028627284085179,1.4991065388006808,0.006458557588805167,0.5432695146656503,1.0,19/85,13.91%,SP100;AGT;WNT5A;KDR;PIK3CD;NRP2;SASH1;RHOJ;BCAR1;SMOC2;BMPER;BMPR2;PROX1;ZC3H12A;RIN2;APOE;PIK3CB;NRP1;RAC1
prerank,negative regulation of chemokine production (GO:0032682),0.6589956722077333,1.4988186053140282,0.06030855539971949,0.5417064927230691,1.0,1/14,0.04%,OAS3
prerank,regulation of protein modification process (GO:0031399),0.530090731672501,1.4967571676874638,0.027522935779816515,0.5479885084327488,1.0,17/50,19.47%,STAT2;PML;PLXNB2;SOCS1;NOP53;KDM4D;MT3;CCDC88A;LYN;PHIP;PUM3;NDUFS4;SPRED3;CORO1C;FNIP2;SPRED1;PIN1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4933968200082101,1.4965933298558787,0.0063025210084033615,0.5459597590762072,1.0,26/101,16.68%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;HCK;CCL5;NFKB1;LYN;HMGB1;MAPK14;GIT1;ZC3H12A;XBP1;STAP1;PRKCE;TNIP2;MYD88;TNIP3;IL18;IRAK1;UPF1;ACOD1
prerank,positive regulation of heart contraction (GO:0045823),-0.4786386119133079,-1.496236445106004,0.06153846153846154,0.7622265015413235,1.0,14/19,49.38%,ATP2A2;TGFB2;TRPM4;SCN3B;CHGA;RYR2;KCNQ1;ATP1A2;APLN;ADM;EDN3;EDN2;NPPA;EDN1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.7094537240296942,1.495665734121923,0.05286343612334802,0.5474502863844372,1.0,1/10,0.10%,SP100
prerank,endosome organization (GO:0007032),0.5432949098126996,1.4954355389473895,0.02441860465116279,0.5456127996589626,1.0,13/41,13.58%,DNAJC13;USP50;SNX33;WASHC4;RILP;SNX10;TMEM9;VPS11;HOOK2;RAB22A;HOOK1;ARFGEF2;HOOK3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5362229790518078,1.4950258412946353,0.04033214709371293,0.5446698088259811,1.0,13/42,13.91%,KDR;UTRN;CDH13;THY1;CX3CL1;CSF1;MYOC;CIB1;PPM1F;RIN2;LIMS1;NRP1;RAC1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6200282497393013,1.4945242504200096,0.04054054054054054,0.5413434314085346,1.0,5/21,8.81%,HSPA1B;EYA4;UNC5B;SNAI2;GDNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6200282497393013,1.4945242504200096,0.04054054054054054,0.5413434314085346,1.0,5/21,8.81%,HSPA1B;EYA4;UNC5B;SNAI2;GDNF
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.626314324040272,1.4936215092679272,0.05672823218997362,0.5424856758328109,1.0,4/18,8.81%,AGT;NOD2;FXN;GDNF
prerank,response to retinoic acid (GO:0032526),0.512999159187959,1.4931927720582387,0.021040974529346623,0.5416860237730835,1.0,14/59,12.99%,WNT11;TMEM161A;WNT5A;RARG;BRINP3;CDKN2D;SOX9;WNT7B;RET;CTSH;LTK;LYN;SNW1;ZNF35
prerank,cell proliferation in forebrain (GO:0021846),-0.5924233528179343,-1.4928362780450133,0.07803468208092486,0.7613600044898432,1.0,5/10,7.87%,NUMB;DOCK7;PCM1;AKNA;CEP120
prerank,pyruvate metabolic process (GO:0006090),-0.37407660846202445,-1.4920917770768793,0.026785714285714284,0.7499753362596702,1.0,17/52,11.13%,ENO1;VDAC1;SRR;PDHB;PFKL;GLO1;SLC16A1;PGAM1;PGAM4;PKM;PDHA1;HOGA1;PFKFB2;ME2;ENO2;PGK1;ME1
prerank,regulation of superoxide anion generation (GO:0032928),-0.5391781459667102,-1.4920768002556404,0.07194244604316546,0.735899604882166,1.0,2/14,0.30%,TGFB1;SYK
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.5556336037063321,-1.4916203261507415,0.060498220640569395,0.7241242367290096,1.0,2/13,0.30%,TGFB1;SYK
prerank,negative regulation of viral release from host cell (GO:1902187),0.6678427401139577,1.4914900526521233,0.06512301013024602,0.5465290795907284,1.0,4/13,12.03%,PML;TRIM21;CHMP3;TRIM26
prerank,sympathetic nervous system development (GO:0048485),0.6438852386931864,1.490718316656817,0.04881450488145049,0.5472261344683862,1.0,6/15,18.19%,NRP2;CTNNB1;TFAP2B;GDNF;NRP1;NF1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5903338881491675,1.4891745729762438,0.05141388174807198,0.55134939373693,1.0,6/25,12.41%,STAT1;HSPA1B;STAT3;BRD1;MAPK14;PRKDC
prerank,myelination (GO:0042552),0.5311986928139671,1.4890513286369775,0.023121387283236993,0.5493347953836902,1.0,18/46,19.94%,PMP22;CXCR4;CNTNAP1;DEGS1;MYOC;EPB41L3;EIF2B2;B4GALT5;ABCD1;ARHGEF10;SCN2A;PLLP;ACER3;MPZ;SCN8A;NF1;EIF2B5;PLP1
prerank,inner ear morphogenesis (GO:0042472),0.6117987737034167,1.4885000415091278,0.03689567430025445,0.5490008350796348,1.0,5/22,6.05%,CHD7;MYO3B;SOX9;FGFR2;TTC39C
prerank,positive regulation of chromosome organization (GO:2001252),0.6540401412268423,1.4884016799354112,0.05314685314685315,0.5468289273211229,1.0,7/15,12.58%,PML;DHX36;RTEL1;FEN1;SIRT6;PPP1R10;DDX11
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.6084531891843568,-1.4881679946853328,0.05654761904761905,0.7261743842334695,1.0,6/10,19.26%,RCC2;CDC42;APC;RACGAP1;ECT2;KNSTRN
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7042408597645746,1.4865311156550862,0.043076923076923075,0.5496554798966272,1.0,5/10,14.42%,ASCC3;ALKBH1;MPG;ALKBH2;ASCC2
prerank,DNA dealkylation (GO:0035510),0.7042408597645746,1.4865311156550862,0.043076923076923075,0.5496554798966272,1.0,5/10,14.42%,ASCC3;ALKBH1;MPG;ALKBH2;ASCC2
prerank,regulation of mitochondrial depolarization (GO:0051900),0.701309796943046,1.4863980943986572,0.042042042042042045,0.5476111262035851,1.0,5/10,12.94%,KDR;MLLT11;MYOC;ABCD1;RACK1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.49992306274761666,1.4861353865690559,0.009594882729211088,0.5462433686775546,1.0,21/84,13.91%,AGT;WNT5A;KDR;PIK3CD;CD40;NRP2;SASH1;MAP2K3;BCAR1;MET;SMOC2;P2RX4;HMGB1;BMPR2;MAPK14;PROX1;ZC3H12A;RIN2;PIK3CB;NRP1;RAC1
prerank,regulation of mitochondrial fission (GO:0090140),0.598459210045381,1.484879166043462,0.039540816326530615,0.5491809154637066,1.0,3/24,2.15%,STAT2;KDR;FIS1
prerank,mesoderm formation (GO:0001707),0.6280121343174668,1.4845292240069032,0.054758800521512385,0.5481605849035391,1.0,5/17,9.54%,ITGA2;ITGA3;SMAD2;SCX;BMPR2
prerank,translesion synthesis (GO:0019985),0.5366420308591898,1.4830098523641515,0.04074505238649592,0.5524933875272111,1.0,10/42,5.35%,PARP10;ISG15;UBE2L6;TRIM25;POLDIP2;POLD4;POLE2;MAD2L2;RFC4;RFC1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.48992643571573885,-1.4819840085079177,0.06810035842293907,0.7395054640938039,1.0,5/16,7.56%,GPR137C;GPR137B;RRAGD;RRAGB;LARS1
prerank,multivesicular body organization (GO:0036257),0.5621499328541861,1.4817607389735485,0.037758830694275276,0.5555514921088238,1.0,14/31,22.41%,CHMP4A;CHMP4B;CHMP1B;MVB12A;VPS37A;CHMP3;VPS28;HGS;RAB11A;IST1;CHMP5;CHMP1A;TSG101;VPS36
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6788635049168592,1.4813825222834966,0.05649717514124294,0.5546175475397833,1.0,6/11,18.05%,ARHGEF7;PDPN;KANK1;CORO1B;RREB1;CORO1C
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6826527996711896,1.4808351472439734,0.06259314456035768,0.5544509560759356,1.0,4/10,16.65%,WNT5A;CCL5;OXSR1;STK39
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.6515562335333982,1.4793079894834515,0.06881405563689605,0.5589322486384868,1.0,7/13,16.43%,PIK3AP1;UNC93B1;PIK3R4;IRAK4;TNIP2;MYD88;IRAK1
prerank,base conversion or substitution editing (GO:0016553),0.689101842686787,1.4789814904887082,0.06287425149700598,0.5578225108021766,1.0,2/11,2.40%,APOBEC1;ADAR
prerank,positive regulation of immune effector process (GO:0002699),0.5763420858704613,1.4780719057180385,0.04621309370988447,0.559594274791166,1.0,2/27,1.27%,DDX60;DHX58
prerank,regulation of T cell migration (GO:2000404),0.6235613507538226,1.4778333706112237,0.04768211920529802,0.5580806113796866,1.0,5/18,10.86%,CXCL10;DOCK8;CCL5;APP;LRCH1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5858616695728937,-1.4764469036945793,0.09302325581395349,0.7487894705822774,1.0,7/10,28.05%,TGFB1;CST3;DPP4;TNFRSF1B;FAP;EMILIN1;CHADL
prerank,regulation of T cell proliferation (GO:0042129),0.5100335605026628,1.4760093263571525,0.02564102564102564,0.5635756552798838,1.0,11/61,11.57%,CD274;IL15;TNFSF9;SDC4;CCL5;IL27;CD276;NCK1;NCK2;CCDC88B;TNFSF8
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.6005296293595923,1.4756926511585466,0.05188067444876784,0.5625455639927195,1.0,10/22,21.15%,XDH;GADD45G;SASH1;ZC3H12A;MAP3K4;MINK1;PRMT1;RELL1;MFHAS1;GADD45A
prerank,response to UV-B (GO:0010224),0.6645147013987278,1.4753395667625582,0.07386363636363637,0.5615068065715104,1.0,2/12,1.26%,MSH2;HYAL1
prerank,response to sterol (GO:0036314),-0.5576520366719084,-1.4742232832871869,0.06796116504854369,0.7459369221472303,1.0,6/11,11.37%,CCR5;TGFB1;ABCA2;INSIG1;CCL3;PMVK
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5198097869031946,1.4741096040109491,0.03579676674364896,0.5642788166533423,1.0,5/48,5.48%,CXCL10;CXCL9;CAMK2D;THY1;CX3CL1
prerank,regulation of response to biotic stimulus (GO:0002831),0.5707714862603411,1.472260986670327,0.044444444444444446,0.5699279579420522,1.0,11/28,16.29%,SAMHD1;DHX58;BIRC2;CD55;CX3CL1;ERAP1;N4BP1;TRAF3;FCGR2B;BIRC3;LRP8
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.536173486414288,-1.4708873652544094,0.07666666666666666,0.7471258571939141,1.0,8/12,31.78%,WASL;AKT1;NBL1;BMP5;CCN3;GREM1;DUSP1;PLCB1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.613164253643378,1.4706405721087392,0.06349206349206349,0.5745382206720457,1.0,5/18,8.58%,NOL3;SOD2;NME5;PPIA;NONO
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.5089739465571622,-1.4668303937149942,0.08992805755395683,0.7509162099070081,1.0,8/16,32.80%,SLC39A14;PRMT5;C3;CHGA;ACP3;GRP;PDE6G;NECAB2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5731663311670826,1.4664488925950818,0.04488778054862843,0.5913616749869096,1.0,4/25,2.89%,NOD2;WNT5A;B2M;CD55
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6099991035525624,1.4663589130332555,0.055248618784530384,0.5892569250006412,1.0,3/19,1.51%,HSPA1B;CHMP4B;CHMP1B
prerank,mRNA destabilization (GO:0061157),0.5425467983390949,1.4648851134437426,0.036101083032490974,0.5932809697437267,1.0,16/38,19.30%,MOV10;ZFP36;TARDBP;YTHDF1;PLEKHN1;DHX36;YTHDF2;ZC3H12A;ZFP36L1;DIS3L2;MEX3D;TUT7;UPF1;METTL14;DCPS;RC3H2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3759344472496238,-1.4648784279615987,0.008849557522123894,0.7462045354901404,1.0,22/46,24.87%,GRM3;CDH2;CACNG7;GRIK1;TSHZ3;DGKZ;HOMER1;NLGN2;CACNG8;NRXN1;SHANK3;CCR2;GRM8;CLN3;UNC13A;CACNG2;SYT1;MEF2C;CACNG3;MAPK8IP2;CCL2;DRD2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.525309408764376,-1.4648241173285148,0.07641196013289037,0.7343446934087327,1.0,5/14,15.54%,DYRK1A;NIPBL;SAP30BP;ZBTB7B;ING2
prerank,cholesterol efflux (GO:0033344),0.5979605979688702,1.4645599136346374,0.06282051282051282,0.5922750307810911,1.0,7/20,17.01%,ABCA1;ABCG1;APOE;NPC1;NPC2;SOAT2;SOAT1
prerank,cochlea morphogenesis (GO:0090103),0.7053217404603376,1.4631475414258173,0.0637037037037037,0.5962128573421207,1.0,2/10,5.43%,MYO3B;SOX9
prerank,megakaryocyte differentiation (GO:0030219),-0.5465271033527445,-1.462545607430602,0.06389776357827476,0.7321836278156473,1.0,3/11,32.96%,UBA5;ZFPM1;TAL1
prerank,positive regulation of T cell activation (GO:0050870),0.5029227154208346,1.4611574339888578,0.022296544035674472,0.6028589505030721,1.0,22/62,21.28%,CD274;IL15;NOD2;DOCK8;THY1;CD47;CCL5;CD276;NCK1;NCK2;CCDC88B;XBP1;AIF1;LGALS9;MDK;FLOT2;PTPRC;SIRPA;LCK;VCAM1;CD46;RHOH
prerank,lysine metabolic process (GO:0006553),0.6578588630043753,1.4611089456465067,0.08104196816208394,0.59807706832778,1.0,6/12,15.56%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,lysine catabolic process (GO:0006554),0.6578588630043753,1.4611089456465067,0.08104196816208394,0.59807706832778,1.0,6/12,15.56%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.6577378691556343,1.4601459611003036,0.06705539358600583,0.5999612213825606,1.0,5/13,13.47%,KDR;SFRP2;CTNNB1;NOTCH4;NRP1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6964035195706082,1.4601452272012252,0.08177905308464849,0.597444588165338,1.0,3/10,6.05%,ACTN2;PDXP;CARMIL1
prerank,protein homooligomerization (GO:0051260),0.4790704226459208,1.4601312481171258,0.011410788381742738,0.5949825716506396,1.0,20/114,11.64%,RNF213;SAMHD1;SYCP1;GBP5;PNPT1;TRPM2;B2M;ATL1;MLKL;SOD2;AQP11;RBMX;AQP4;TRMT61B;TK1;RS1;G3BP2;ALDH1A2;HPRT1;POLQ
prerank,histone monoubiquitination (GO:0010390),0.5764515577626196,1.4600219326995874,0.05747126436781609,0.59304232978203,1.0,7/24,11.45%,DTX3L;SKP1;RNF40;UBE2E1;RING1;WAC;RYBP
prerank,regulation of lymphocyte activation (GO:0051249),0.6642883649043918,1.4592919948422636,0.06417910447761194,0.593959343911909,1.0,3/12,8.00%,THEMIS2;CCL5;DCAF15
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5685271490830617,1.4589380527954698,0.06719367588932806,0.5931993008155468,1.0,10/26,15.32%,AIM2;PSME2;USP50;STAT3;EPHA4;LYN;PSME3;FYN;APH1A;APH1B
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6803151261197804,1.4584351358568828,0.07101449275362319,0.5929612105860268,1.0,2/11,2.48%,IGF2BP1;IGF2BP3
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6180615091889484,1.4579359336950073,0.06429548563611491,0.5927291805865996,1.0,3/17,0.96%,EIF2AK2;NOD2;TAOK3
prerank,regulation of interleukin-10 production (GO:0032653),0.5263298002666128,1.4566970157492258,0.034924330616996506,0.5957971167136219,1.0,5/44,4.00%,CD274;ISG15;NOD2;STAT3;CD47
prerank,response to interleukin-1 (GO:0070555),0.4910838614340626,1.456429707111996,0.022702702702702703,0.5945040261755873,1.0,21/73,16.81%,CCL7;HYAL1;GBP3;CD40;GBP2;CD47;RBMX;CCL5;SOX9;CX3CL1;IGBP1;NFKB1;APP;ZC3H12A;CCL14;MYD88;ADAMTS12;IRAK1;UPF1;ACOD1;LGALS9
prerank,chordate embryonic development (GO:0043009),0.5136082007561272,1.456147394075097,0.023755656108597284,0.5932863462934784,1.0,10/55,10.66%,WNT11;EGFL8;WNT5A;CHD7;FGFR2;WNT7B;DACT1;PROX1;KIAA1217;ALDH1A2
prerank,positive regulation of catalytic activity (GO:0043085),0.5307896561874338,1.4550700728072525,0.03676470588235294,0.5959389802726671,1.0,13/37,15.72%,NOD2;MSH2;AZIN2;FXN;MT3;MAPK14;CIB1;PSEN1;CHTOP;STX4;APH1A;PHACTR4;NHEJ1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6204070772203115,1.4532955156067318,0.06770098730606489,0.6015698026708253,1.0,3/16,2.36%,NR1H2;PNPLA2;SLC27A1
prerank,renal system development (GO:0072001),0.5045110804909106,1.451725397337375,0.03794642857142857,0.6063014351273712,1.0,7/52,10.65%,STAT1;AGT;GREB1L;TFAP2B;NPHP3;PROX1;IFT27
prerank,"phototransduction, visible light (GO:0007603)",0.641370604120424,1.4517042342548656,0.0715307582260372,0.6040017200664031,1.0,1/14,0.46%,CNGB1
prerank,protein alkylation (GO:0008213),0.5794805037480746,1.4513537907982144,0.05821474773609314,0.603267790842904,1.0,9/22,17.35%,PRMT2;METTL21A;GSPT1;EEF2KMT;CAMKMT;FAM98B;ETF1;PRMT1;PRMT3
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4951211385117054,1.4506597894924467,0.03723986856516977,0.6041920311787253,1.0,20/66,19.96%,NOD2;GBP5;AIM2;WNT5A;USP50;STAT3;TLR8;CX3CL1;TMEM106A;APP;GIT1;ZC3H12A;PANX1;JAK2;MYD88;LGALS9;CD33;RIPK2;TYROBP;SIRPA
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.550366415489346,1.4503983380998442,0.06859205776173286,0.6030447589822857,1.0,5/30,3.59%,PARP14;SOCS1;SEMA4D;THY1;SFRP2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5869954578437004,-1.448128308894953,0.08069164265129683,0.7801823323057843,1.0,5/10,12.65%,EMC2;EMC3;EMC8;EMC9;MMGT1
prerank,regulation of inflammatory response (GO:0050727),0.4605625669045122,1.4479029963764447,0.0010131712259371835,0.6118136988135476,1.0,42/190,17.34%,USP18;ZBP1;PIK3AP1;IL15;CASP4;AGT;AOAH;NOD2;IFI35;WNT5A;BIRC2;NMI;ENPP3;CD47;PTGER4;HCK;CCL5;CX3CL1;AREL1;BCL6;CYLD;DHX9;APP;RORA;TNIP1;ABCC1;APOE;CXCL17;RB1;SHARPIN;VAMP2;BIRC3;JAK2;DAGLA;MYD88;TLR2;ADAMTS12;PPARD;IL18;ACOD1;MDK;TLR3
prerank,cellular response to gamma radiation (GO:0071480),-0.4905486200874824,-1.4471889954762154,0.07692307692307693,0.7718820745019402,1.0,7/17,22.40%,MAP3K20;XRCC5;KDM1A;TP53;HRAS;YAP1;CRYAB
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.5770145045200397,-1.4471263499954319,0.07736389684813753,0.7603819690256811,1.0,5/10,22.94%,MTMR1;MTMR4;MTMR9;ABCA3;PHB2
prerank,neutrophil chemotaxis (GO:0030593),0.5069049585535903,1.4469253081381317,0.03389830508474576,0.6136140038238526,1.0,7/53,7.75%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA
prerank,neutrophil migration (GO:1990266),0.5009747736198094,1.446865569352859,0.02924634420697413,0.6115111619603463,1.0,10/58,13.09%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA;CCL14;IRAK4;PIP5K1C
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6197753636615545,1.4464371826970426,0.0584144645340751,0.6109944519569226,1.0,6/16,12.41%,PARP9;DTX3L;MAD2L2;KDM4D;SHLD1;PRKDC
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5747355303945307,1.4442221900497216,0.061696658097686374,0.61881925624879,1.0,6/24,16.08%,CXCL10;CCL5;LYN;HMGB1;CXCL17;AIF1
prerank,positive regulation of chemokine production (GO:0032722),0.52004990436073,1.4440614312858273,0.04322429906542056,0.6171640781421281,1.0,10/44,17.34%,OAS3;EIF2AK2;WNT5A;APP;HMGB1;TLR2;AIF1;IL18;LGALS9;TLR3
prerank,in utero embryonic development (GO:0001701),0.5714940855254075,1.4435197192511464,0.05977584059775841,0.6172692639904516,1.0,4/25,6.45%,EGFL8;CHD7;FGFR2;WNT7B
prerank,connective tissue development (GO:0061448),0.549336296390944,1.4435137584017554,0.05959475566150179,0.6149324064119308,1.0,13/35,18.96%,NAMPT;HYAL1;DDRGK1;ARID5B;SOX9;ITGB8;SCX;XBP1;COL11A2;SOX5;SH3PXD2B;SPTLC2;CREB3L2
prerank,sterol transport (GO:0015918),0.5969118083625469,1.4428166078826838,0.05255878284923928,0.6157504694522675,1.0,8/19,20.83%,LDLRAP1;STARD3;NPC1;NPC2;OSBP;LDLR;OSBPL2;MSR1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4597492695352037,1.4418330489958384,0.004073319755600814,0.6176825703735935,1.0,42/175,15.90%,STAT1;EDAR;PSMB10;CCL7;TNFSF9;HYAL1;AIM2;PSME2;BIRC2;ZFP36;TNFRSF8;PSMA5;GBP3;CD40;PSME4;GBP2;CRHBP;CCL5;TXNDC17;CX3CL1;PSMA3;DHX9;TNFRSF17;PSMB9;TRAF3;COMMD7;CIB1;ZC3H12A;ZFP36L1;PSMD2;CCL14;TRAF5;TNFSF8;PSME3;LIMS1;ST18;BIRC3;JAK2;PSMA4;INPP5K;ADAMTS12;CD27
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6124982271272033,1.4417901948471106,0.07181571815718157,0.6155559789643135,1.0,8/16,22.41%,CHMP4A;CHMP4B;LEPROT;LEPROTL1;VPS28;CHMP5;TMEM50A;VPS36
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4713865131614975,1.4404378725472646,0.007223942208462332,0.6191815757251732,1.0,24/121,16.37%,PARP14;PARP9;IL15;AGT;CRLF1;SEMA4D;CD40;ACVR1;STAT3;CCL5;EPHA4;DOK7;CSPG4;LYN;FCGR1A;PRNP;PTPN11;NRP1;JAK2;PIBF1;FGFR3;IL18;LRP8;ARL2BP
prerank,nuclear membrane organization (GO:0071763),0.6013543896069844,1.4400737729287338,0.06394557823129252,0.6186347810694947,1.0,4/19,9.92%,CHMP4B;TOR1AIP1;TARDBP;UBXN2B
prerank,regulation of vasoconstriction (GO:0019229),0.5528638099114291,1.439880215549335,0.07304785894206549,0.6171082549381619,1.0,4/27,9.54%,AGT;PER2;ZDHHC21;BMPR2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6332857101056093,1.4386683817418184,0.08498583569405099,0.6205273935553368,1.0,3/13,12.27%,PER2;MAD2L2;PSEN1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.40710224663057726,-1.4385378471188233,0.04878048780487805,0.7856775369938894,1.0,12/32,17.31%,APOD;RCC2;CLASP2;DMTN;JAG1;SRC;SEMA3E;NEXMIF;ACER2;HOXA7;MAP4K4;ITGB1BP1
prerank,regulation of presynapse organization (GO:0099174),-0.47174639748913644,-1.4382155284350016,0.08171206225680934,0.7643109206270051,1.0,11/18,29.96%,IL1RAPL1;IL1RAPL2;LRFN5;SNCA;SLITRK1;GPC4;SLITRK3;SLITRK2;MDGA1;PTPRD;WNT7A
prerank,regulation of presynapse assembly (GO:1905606),-0.47174639748913644,-1.4382155284350016,0.08171206225680934,0.7643109206270051,1.0,11/18,29.96%,IL1RAPL1;IL1RAPL2;LRFN5;SNCA;SLITRK1;GPC4;SLITRK3;SLITRK2;MDGA1;PTPRD;WNT7A
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6507253443257414,1.437923187828522,0.07766990291262135,0.6217156707158727,1.0,4/13,5.44%,EID2B;PRICKLE1;SOX9;SRA1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.5342378320689187,-1.4377409068407077,0.08383233532934131,0.7551324557251542,1.0,4/12,15.54%,NIPBL;SAP30BP;ZBTB7B;ING2
prerank,insulin secretion (GO:0030073),0.5988197902453147,1.4374990491887674,0.06035665294924554,0.6213451632795476,1.0,4/19,8.16%,CLTRN;GAL;RAB11B;SNX19
prerank,DNA geometric change (GO:0032392),0.5637945929010901,1.4372001675045198,0.05662805662805663,0.6204208365294327,1.0,11/24,15.30%,ASCC3;DHX36;MCM9;RTEL1;DHX9;HNRNPA2B1;HMGB1;HMGB3;ZRANB3;DDX11;RECQL5
prerank,regulation of interferon-gamma production (GO:0032649),0.4903872415403161,1.436830902835246,0.0350109409190372,0.6199072254521975,1.0,12/71,12.12%,AXL;CD274;ISG15;CD47;TLR8;IL27;CD276;IL12RB2;HMGB1;PRNP;ZC3H12A;HAVCR2
prerank,cellular response to UV-A (GO:0071492),-0.5566403737696637,-1.436496303486336,0.09171597633136094,0.7501741123823471,1.0,7/11,36.26%,MMP1;CERS1;MMP2;OPN3;PPID;MME;TIMP1
prerank,DNA double-strand break processing (GO:0000729),-0.47727888402516916,-1.4358968386567204,0.060836501901140684,0.7419008796662871,1.0,10/18,24.23%,NBN;UBE2V2;EXD2;SLX4;DNA2;BRCA1;RNF138;SETMAR;MRE11;RAD50
prerank,protein import (GO:0017038),0.48457945112145795,1.4337288797125267,0.026483050847457626,0.6316397629132058,1.0,29/84,17.52%,CLU;FIS1;RANBP6;RAB8B;SNX33;STAT3;LAMP2;NUP153;KPNB1;CSE1L;PRICKLE1;GDAP1;NXT1;RPAIN;ABCD1;PEX2;PPP1R10;SAMM50;HSPA4;IPO8;APOE;TNPO2;NUP155;HSP90AA1;RANBP17;PEX5;PEX13;ATAD1;NUP88
prerank,negative regulation of protein ubiquitination (GO:0031397),0.5071014109718581,1.4335508140813888,0.044167610419026046,0.6301376125717931,1.0,12/50,13.32%,HSPA1B;ISG15;DTX3L;SPRY2;PER2;UBXN1;CAMLG;N4BP1;ARRB2;PRR7;VPS28;HDAC8
prerank,negative regulation of neuron death (GO:1901215),0.4756760693869838,1.4332903917654933,0.023379383634431455,0.6291403406131789,1.0,19/93,12.35%,CHMP4A;CHMP4B;CRLF1;MSH2;UNC5B;BDNF;SOD2;FBXO7;ADAM8;NENF;MT3;NRBP2;CSF1;AGAP2;GDNF;MAG;SORL1;PPARGC1A;APOE
prerank,gene silencing by miRNA (GO:0035195),0.5420142551785447,1.4331951305056978,0.05731707317073171,0.6273033786688423,1.0,12/32,17.17%,MOV10;ZFP36;ZC3H7A;ADAR;AGO2;TARBP2;CNOT7;NOTCH4;EIF6;ZC3H7B;DICER1;PRKRA
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4837424837234848,1.4318236337151036,0.02832244008714597,0.631354085690234,1.0,8/75,5.48%,STAT1;CXCL10;PML;SPRY2;MECP2;COL4A2;YJEFN3;CTNNB1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4867767628787339,1.4309433454915108,0.034519956850053934,0.6331299765241972,1.0,17/72,14.64%,PIK3AP1;AGT;FLT1;UNC5B;KDR;PIK3CD;SEMA4D;CCL5;SOX9;MYDGF;MYOC;LYN;INSR;ROR2;PIK3CB;JAK2;IRS2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5713405408034233,1.430852165296089,0.07529722589167767,0.6311874548074691,1.0,6/24,8.48%,TMEM161A;CLU;SFRP2;CDKN2D;SNAI2;ACKR3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.46556845771925287,1.4306943823854976,0.02072538860103627,0.6295762816290822,1.0,26/114,14.40%,STAT1;EDAR;PSMB10;TNFSF9;AIM2;PSME2;BIRC2;TNFRSF8;PSMA5;CD40;PSME4;TXNDC17;PSMA3;TNFRSF17;PSMB9;TRAF3;COMMD7;PSMD2;TRAF5;TNFSF8;PSME3;LIMS1;ST18;BIRC3;JAK2;PSMA4
prerank,postreplication repair (GO:0006301),0.507894678771331,1.4303146160279578,0.04513888888888889,0.6290963665595274,1.0,10/45,5.97%,PARP10;ISG15;MSH2;UBE2L6;TRIM25;POLD4;UBE2B;RFC4;RFC1;WDR33
prerank,regulation of angiogenesis (GO:0045765),0.45531656632783035,1.4300877342879093,0.005040322580645161,0.6279255212997025,1.0,29/192,11.45%,STAT1;CXCL10;SP100;PML;FLT1;HYAL1;WNT5A;SPRY2;KDR;PIK3CD;AGO2;CD40;MECP2;SASH1;SFRP2;RUNX1;COL4A2;YJEFN3;CTNNB1;RHOJ;MYDGF;ITGB8;HTATIP2;CTSH;SMOC2;BMPER;ZC3H12A;VEGFD;XBP1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6796485154003866,1.4289371402067608,0.07879656160458452,0.6310165531147267,1.0,5/10,14.87%,CLU;HSP90AB1;SORL1;RB1;HSP90AA1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.42559279553669044,-1.4286978477906531,0.041666666666666664,0.7583428030512447,1.0,12/24,21.81%,CDH2;CTNNA1;OLFM2;RBM4;CTNNA2;CDC42;CAMK1;BNIP2;BOC;ABL1;MEF2C;TCF3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5512653567083221,1.4278312708582546,0.05381727158948686,0.6336672992105286,1.0,5/29,7.22%,TNFSF10;PML;AGT;RET;CYLD
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6369413721621348,1.4271218014761282,0.09259259259259259,0.6346099542165171,1.0,4/13,9.05%,SP100;NUP153;MDFIC;BARD1
prerank,regulation of cholesterol esterification (GO:0010872),0.6857816916386655,1.4270361820324151,0.07976366322008863,0.6327795160816595,1.0,3/10,12.35%,AGT;ABCG1;APOE
prerank,lipid homeostasis (GO:0055088),0.49822733342906644,1.4261774612617952,0.03409090909090909,0.6343209130542439,1.0,21/57,21.55%,ACOXL;ABCA1;USF2;ABCG1;PNPLA2;TLCD2;FBXW7;USF1;ABHD8;ABCD1;THADA;XBP1;APOE;IRS2;ACOX1;PNPLA3;NR1D2;DDX3X;ZBTB20;ADCK1;PNPLA8
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6332203966002685,1.4246466621519192,0.09610027855153204,0.6391505786121504,1.0,4/13,4.81%,POLR2G;ZFP36;AGO2;CNOT7
prerank,lipid droplet formation (GO:0140042),0.6796457551021322,1.4245962620402484,0.09523809523809523,0.6371505711870477,1.0,2/10,2.72%,AUP1;CDS1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.6583111163756227,1.4234545543483212,0.10074074074074074,0.6400735358031122,1.0,3/10,8.58%,PCGF5;MECP2;DNMT3A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.5315483943135737,1.422463579289456,0.0729665071770335,0.6424202899055628,1.0,14/36,16.35%,DDRGK1;AQP11;USP25;NOP53;HSP90AB1;UBXN1;TRIM39;CAMLG;N4BP1;UCHL5;WAC;RYBP;RPL11;OPHN1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.48569512168445916,1.42209434871625,0.034178610804851156,0.6418427032596701,1.0,15/69,12.35%,CRLF1;MSH2;UNC5B;BDNF;SOD2;ADAM8;CX3CL1;MT3;NRBP2;AGAP2;NONO;GDNF;MAG;PPARGC1A;APOE
prerank,negative regulation of immune effector process (GO:0002698),0.6344653357811308,1.421475230676187,0.09064327485380116,0.6425341250896525,1.0,5/13,15.41%,CD55;ENPP3;CD47;HAVCR2;CD300A
prerank,regulation of postsynapse organization (GO:0099175),-0.42795796990653434,-1.4212466595440882,0.0625,0.7776059713226753,1.0,12/28,11.79%,PDLIM5;IL1RAPL1;CFL1;ARHGAP44;SRCIN1;HOMER1;PPFIA2;TANC2;SHANK3;ABHD17B;ABHD17C;ZDHHC15
prerank,granulocyte chemotaxis (GO:0071621),0.49405809478670504,1.4203668014444069,0.042600896860986545,0.6454365888926753,1.0,7/55,7.75%,CXCL10;CXCL9;CCL7;PIK3CD;CCL5;CX3CL1;PPIA
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6454252834165828,1.4201797803504541,0.0851063829787234,0.6441772905043186,1.0,7/13,17.52%,LTV1;LSG1;RRS1;ABCE1;NPM1;EIF6;NUP88
prerank,determination of bilateral symmetry (GO:0009855),0.5628444598390049,1.4196211145857853,0.07045735475896168,0.6446040826598196,1.0,4/25,6.83%,PITX2;ODAD2;NPHP3;KIF3B
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6723696130742357,1.4193019548658128,0.08761329305135952,0.6439144779173926,1.0,2/10,1.16%,MTHFR;DHFR
prerank,regulation of phosphorylation (GO:0042325),0.46693728375548055,1.4191290083601267,0.018556701030927835,0.6425756713394574,1.0,38/120,19.63%,STAT2;NLRC5;PML;NUP37;PLXNB2;SOCS1;ANKLE2;MCM7;SLC2A6;CCL5;NUP153;NOP53;CDKN2D;KDM4D;RAE1;CCDC88A;LYN;BARD1;APP;PRKAG1;PHIP;EIF6;STAP1;LDB2;LDB1;PSEN1;DYNLL1;NRP1;NUP155;DSCAM;NDUFS4;PTGES3;NUP88;CORO1C;FNIP2;TESK1;PIN1;NUP133
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6116428874027187,1.4190350105046763,0.0957004160887656,0.638739045745401,1.0,5/15,10.97%,ZFP36;AGO2;CNOT7;DHX36;ZFP36L1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6116428874027187,1.4190350105046763,0.0957004160887656,0.638739045745401,1.0,5/15,10.97%,ZFP36;AGO2;CNOT7;DHX36;ZFP36L1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4932624663902931,1.4189568285139857,0.045351473922902494,0.6369692529816559,1.0,14/50,17.34%,EIF2AK2;NOD2;IFI35;NOD1;SASH1;NMI;APP;RTKN2;LIMS1;TLR2;CD27;IRAK1;LGALS9;TLR3
prerank,midbody abscission (GO:0061952),0.6009819960124153,1.417897743347628,0.09405255878284924,0.6395884629734544,1.0,3/17,1.51%,CHMP4A;CHMP4B;CHMP1B
prerank,mesonephros development (GO:0001823),-0.5470842067183079,-1.4178803492054888,0.12149532710280374,0.7812750662611136,1.0,7/11,35.74%,FGF10;ZBTB16;PAX8;OSR1;BMP4;GATA3;BMP7
prerank,B cell mediated immunity (GO:0019724),0.6717349629958251,1.417706842200257,0.09295352323838081,0.6383386705362138,1.0,4/10,15.90%,MSH2;TLR8;FCGR2B;CD27
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.5445877203616158,1.4173894265011717,0.0705596107055961,0.6376887220593744,1.0,12/30,12.65%,DDRGK1;NOP53;HSP90AB1;UBXN1;TRIM39;CAMLG;N4BP1;UCHL5;WAC;RYBP;USP14;SVIP
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4547351681386201,1.4173420182615537,0.011178861788617886,0.6357980674949072,1.0,39/149,16.98%,EIF2AK2;HSPA1B;TRIM14;AGT;NOD2;NOD1;AIM2;WNT5A;CLU;TRIM25;DDRGK1;DHX33;CD40;NFKB2;STAT3;RBCK1;TRIM21;ADAM8;RHEBL1;CX3CL1;CFLAR;NFKB1;DHX9;PPIA;RNF31;APP;CIB1;NPM1;RTKN2;TRAF5;RNF25;IL1RAP;PRKCH;MYD88;TLR2;IL18;IRAK1;LGALS9;FLOT2
prerank,positive regulation of neuron migration (GO:2001224),-0.5489300822939781,-1.4170305252977564,0.09620991253644315,0.7742920983917015,1.0,7/11,13.81%,NIPBL;SHTN1;KIF20B;SEMA6A;DAB2IP;NSMF;ARHGEF2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.47605051925242914,-1.4169521630054163,0.1015625,0.754806677998025,1.0,8/16,25.10%,APOD;RCC2;CLASP2;DMTN;SRC;ITGB1BP1;DUSP22;ARHGAP6
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.47605051925242914,-1.4169521630054163,0.1015625,0.754806677998025,1.0,8/16,25.10%,APOD;RCC2;CLASP2;DMTN;SRC;ITGB1BP1;DUSP22;ARHGAP6
prerank,heterocycle biosynthetic process (GO:0018130),0.6212696137728642,1.4163900608683397,0.07534246575342465,0.6379069339688895,1.0,4/14,10.49%,MOCS3;NFS1;GCH1;MOCOS
prerank,negative regulation of viral transcription (GO:0032897),0.6308310127281965,1.4160548331312695,0.09130434782608696,0.6373200515589952,1.0,4/13,7.01%,TRIM14;ZFP36;TRIM21;UBP1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6134607988862092,1.4157375101921432,0.08819345661450925,0.636600703473077,1.0,6/14,21.03%,CCL7;WNT5A;CCL5;OXSR1;STK39;CCL4
prerank,response to organophosphorus (GO:0046683),0.60492107745255,1.4155349730682678,0.0881542699724518,0.6354785222259918,1.0,1/16,0.06%,STAT1
prerank,RNA metabolic process (GO:0016070),0.45632765430042954,1.4154092517676193,0.01440329218106996,0.6339992994684481,1.0,46/127,19.35%,APOBEC1;TP53RK;POLR2G;PNPT1;XRN2;ADAR;AGO2;HNRNPH1;RBMX;DHX36;RNASEH2A;NCBP2;NOL9;HNRNPK;RBMS2;DDX20;ALKBH1;HNRNPM;DHX9;HNRNPA2B1;RNASEH2C;POLR2K;HNRNPL;DDX24;ZC3H12A;HNRNPH3;HNRNPA1;DDX54;ATXN1;PAPOLA;RNASE1;DUSP11;DDX39B;RBM39;NCBP1;RNASEH2B;RBM3;LAGE3;DICER1;METTL14;HNRNPA3;TBRG4;RBPMS;FASTKD2;WTAP;HNRNPF
prerank,regulation of extracellular matrix organization (GO:1903053),0.5993550726955618,1.4151016488923742,0.09423347398030943,0.6333328567314654,1.0,8/15,23.22%,AGT;RUNX1;AEBP1;RB1;RIC1;ANGPTL7;DDR2;NOTCH1
prerank,inflammatory response (GO:0006954),0.44971706183029886,1.4150385801370844,0.0030120481927710845,0.6316201128483271,1.0,34/195,12.87%,CXCL10;TPST1;CXCL9;SIGLEC1;CCL7;HYAL1;NOD1;CXCR4;PIK3CD;NFX1;CD40;STAT3;FPR3;ADAM8;CYBB;PTGER4;CRHBP;CCL5;TACR1;CX3CL1;TAC1;NFKB1;TMIGD3;PTGER3;HMGB1;TAC4;C3AR1;IL17D;CCL14;ABCF1;IL10RB;RELB;REL;FCGR2B
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4539269636684119,1.4140266926260423,0.02481902792140641,0.6340496644503613,1.0,29/136,13.53%,SP100;NLRC5;PARP10;AIM2;PRMT2;RBCK1;TRIM21;MAD2L2;ID3;BHLHE40;TCF7L2;TMIGD3;CYLD;PRNP;MEN1;TRAF3;PROX1;ARRB2;COMMD7;BTRC;ZC3H12A;SIK1;PIM1;TAF3;HAVCR2;PAXIP1;RB1;MDFI;PTCH1
prerank,protein targeting to lysosome (GO:0006622),0.5807870474078127,1.4132565072761707,0.0774365821094793,0.6354867353601124,1.0,8/20,15.28%,CLU;LAMP2;GNPTAB;GGA3;NAGPA;HSPA8;SORL1;HGS
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4586679140153119,1.4131486419387829,0.012282497441146366,0.6339261989414765,1.0,33/132,16.57%,IRGM;TRIM14;MOV10;ZC3HAV1;DTX3L;IRS1;PNPT1;PNPLA2;SNX33;TRIM21;ADAM8;CNOT7;SH3GLB1;VPS11;DACT1;ENTPD5;APP;HMGB1;INSR;ABCD1;ZSWIM8;SNX9;ZC3H12A;PSEN1;APOE;SVIP;PIK3CB;BAD;IRS2;HSP90AA1;TMEM59;PHKG2;UPF1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5439779845120728,-1.4125315736494461,0.07536231884057971,0.7621139226558726,1.0,7/12,34.88%,SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;TRIAP1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.52055379198554,1.4110939026082547,0.07234539089848308,0.6411609610776574,1.0,12/37,11.45%,PML;DDRGK1;NOP53;HSP90AB1;UBXN1;TRIM39;CAMLG;CSNK2A2;N4BP1;UCHL5;WAC;RYBP
prerank,T cell migration (GO:0072678),0.6326459279816284,1.4110777261033656,0.08477011494252873,0.6392235457663754,1.0,3/13,2.73%,CXCL10;PIK3CD;CXCL16
prerank,regulation of AMPA receptor activity (GO:2000311),-0.41833018825718377,-1.4110476669441008,0.039473684210526314,0.7582822601723515,1.0,17/25,29.76%,CACNG7;SHISA9;NLGN2;SHISA6;CACNG8;SHANK3;GSG1L;PRRT1;SHISA7;CACNG2;MEF2C;CACNG3;SHANK1;MAPK8IP2;CACNG5;ADRB2;SHISA8
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.529313236521851,1.4110446020674543,0.08292682926829269,0.6373297040834902,1.0,10/33,18.57%,STAT1;HSPA1B;STAT3;BRD1;MAPK14;PRKDC;MTURN;PRMT1;ACVR2A;HOXA5
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3146579436616586,-1.4105771219109067,0.0,0.7505347250753389,1.0,33/91,18.72%,TRAM1;RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;SSR1;RPL31;RPL36A;SEC61A1;RPLP2;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;SIL1;SRP19;UBA52;RPS25;RPS27A;RPL18;RPL38;RPL34
prerank,negative regulation of catalytic activity (GO:0043086),0.563172671379032,1.4104059638633597,0.0783289817232376,0.6380699039960382,1.0,4/24,8.07%,IFIT1;PARP9;MT3;CAND1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.32087053175326014,-1.4102612865715212,0.0,0.7427104389698911,1.0,32/87,18.72%,RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;RPL31;RPL36A;SEC61A1;RPLP2;RPL7;RPL39;RPS9;RPS18;RPL37;SEC61B;RPL13A;ZFAND2B;SRP19;UBA52;RPS25;RPS27A;RPL18;RPL38;RPL34
prerank,regulation of leukocyte migration (GO:0002685),-0.4846448186215454,-1.4102309969941056,0.09215017064846416,0.7338456475749635,1.0,6/16,18.54%,CD81;NCKAP1L;HMOX1;RAC2;HOXA7;ANXA1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5000767704570396,1.4100521421806382,0.04691075514874142,0.6376874216202567,1.0,15/52,12.58%,ZBTB17;ATP6V0D1;YIF1A;KLHDC3;SRPRA;HYOU1;GOSR2;MYDGF;CUL7;GFPT1;VAPB;XBP1;PDIA6;EXTL3;DDX11
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6041701533250995,1.4095387423899028,0.09336941813261164,0.6379486758766899,1.0,7/15,21.97%,AGT;NFKB1;CSF1;PRKCH;IL18;MSR1;MAPK9
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4836229671443968,1.4087511143052005,0.049783549783549784,0.6394591292414133,1.0,19/68,17.70%,IFIH1;NOD2;WNT5A;STAT3;TLR8;DHX9;TMEM106A;APP;HMGB1;SPHK2;IL17D;XBP1;PTPN11;MYD88;TLR2;AIF1;LGALS9;TLR3;POU2F2
prerank,dicarboxylic acid transport (GO:0006835),0.5427213640694407,1.4082604493672997,0.07178217821782178,0.6396576072680971,1.0,7/28,9.06%,SLC25A22;ABCC2;SLC26A1;SLC46A1;SLC19A1;SLC25A10;PDPN
prerank,positive regulation of T cell proliferation (GO:0042102),0.48948500202755457,1.4079613858989015,0.05849268841394826,0.6389849887445394,1.0,10/55,10.56%,CD274;IL15;ICOSLG;TNFSF9;CCL5;CD276;NCK1;HMGB1;NCK2;CCDC88B
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6649768851073243,1.4074468003851717,0.09865470852017937,0.6392113803466706,1.0,3/10,16.81%,CD274;PRNP;LGALS9
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6503061041592896,1.407379603304157,0.0899854862119013,0.6375386588254,1.0,2/12,5.43%,NOD2;SOX9
prerank,positive regulation of binding (GO:0051099),0.47049002919741595,1.40654630977057,0.029347826086956522,0.6393543772156501,1.0,40/84,27.24%,PARP9;DTX3L;TRIB3;B2M;TRIM21;KDM4D;CDT1;TCF7L2;EDF1;AMFR;DHX9;RAPGEF2;DACT1;BAMBI;MET;APP;HMGB1;MEN1;PSEN1;APOE;DDX11;SPPL3;NCBP1;RPL11;HMBOX1;STK3;PIN1;RIPK2;PLAUR;USP33;IDE;CAPRIN2;SIRT2;ADD2;NVL;LRP1;TXN;TIAM1;MED25;FKBP1A
prerank,regulation of DNA metabolic process (GO:0051052),-0.3707316004002259,-1.4063369560851753,0.03546099290780142,0.7395290448869701,1.0,17/44,19.63%,XRCC5;MPV17;SIRT7;NBN;UBE2V2;KDM1B;POLH;TERF2IP;PARG;YLPM1;KPNA1;WDR18;THOC1;TOM1L1;KPNA2;MYC;RADX
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5119277112745659,1.4062305283684888,0.06876456876456877,0.6388249331426247,1.0,8/40,15.46%,GBP4;STAB2;GBP2;GBP7;RNASE7;PPP1R11;MYD88;TLR2
prerank,positive regulation of heart rate (GO:0010460),-0.4609549977381955,-1.4060501368933727,0.09293680297397769,0.7317841414372996,1.0,4/17,13.22%,ATP2A2;TPM1;TRPM4;SCN3B
prerank,regulation of osteoblast proliferation (GO:0033688),0.5975675523076929,1.4060310674805874,0.10270270270270271,0.6378338950955242,1.0,4/17,13.47%,EIF2AK2;FGFR2;HPSE;NELL1
prerank,epithelial cell migration (GO:0010631),0.5119074225999091,1.4058836388702074,0.07957244655581948,0.6366216890720618,1.0,4/37,3.98%,STAT1;LOXL2;CDH13;PKN2
prerank,early endosome to late endosome transport (GO:0045022),0.5693823272824883,1.4045882895463868,0.08962868117797695,0.6403568928992498,1.0,12/20,26.20%,RILP;HOOK2;STX8;KIF16B;HOOK1;ANKRD27;HOOK3;WDR91;BECN1;EEA1;PTPN23;SNF8
prerank,RNA splicing (GO:0008380),0.47024521032604927,1.4043800113455718,0.02536997885835095,0.6394514676985213,1.0,35/95,17.95%,NOL3;TARDBP;MAGOHB;TXNL4A;PRPF18;NCBP2;RRAGC;CDK12;NONO;BCAS2;RNPC3;SRPK1;RSRC1;WDR83;RNPS1;HNRNPH3;PPARGC1A;USP39;SNRPD2;SNRPD1;DBR1;DDX39B;SNRPG;NCBP1;DHX16;GEMIN2;SRSF7;SF3B4;NRDE2;SRSF4;DDX47;SNRNP48;DDX23;SLU7;SCNM1
prerank,regulation of viral release from host cell (GO:1902186),0.5719611691773397,1.4043660829460667,0.10596026490066225,0.6375939716814252,1.0,8/21,22.16%,PML;TRIM25;TRIM21;CHMP3;TRIM26;TRIM62;TRIM13;TSG101
prerank,nucleotide catabolic process (GO:0009166),0.5927002147371175,1.4042537018972816,0.0896551724137931,0.636148571466229,1.0,2/16,1.39%,SAMHD1;XDH
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4920042057327512,1.4042477985866149,0.05668934240362812,0.6342970436332058,1.0,11/49,17.34%,HSPA1B;NOD2;NOD1;STAT3;TLR8;HMGB1;IL17D;MYD88;TLR2;LGALS9;TLR3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5506167801265661,1.4041541206456534,0.07484662576687116,0.6327658857905694,1.0,6/27,6.89%,AGT;NR1H2;ABCA1;ABCG1;NFKB1;CSF1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.470833357007357,1.4038921985255488,0.03488372093023256,0.6319200412365307,1.0,26/88,23.84%,STAT1;XDH;WNT5A;KDR;PIK3CD;CDH13;NRP2;PLXNB3;MYDGF;EGFL7;BMPR2;PROX1;VEGFD;APOE;NRP1;AGGF1;NF1;ACVRL1;SPARC;F3;AKT3;FGF2;STAT5A;VASH1;PTPRM;ANG
prerank,gonad development (GO:0008406),0.5146681800355959,1.4035031511916902,0.06481481481481481,0.6316795134166476,1.0,6/41,5.43%,MSH2;WNT5A;TFAP2C;KITLG;LRP2;SOX9
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.5479714178219521,1.4015552498799286,0.08897243107769423,0.6382545585392306,1.0,6/27,8.50%,ETNK1;ETNK2;SLC27A1;PCYT2;LPIN2;CEPT1
prerank,regulation of axon guidance (GO:1902667),0.6455658779263374,1.4005835963084439,0.10549777117384844,0.6405487232463316,1.0,5/10,15.05%,TUBB2B;YTHDF1;ZSWIM8;NRP1;MYCBP2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.44665851210287655,1.4004297041797569,0.009054325955734407,0.6393792935411199,1.0,66/186,24.15%,RNF213;WNT11;PSMB10;WNT5A;PSME2;PSMA5;PSME4;GRB10;TMEM170B;SFRP2;MAD2L2;PRICKLE1;PFDN5;SOX9;PSMA3;TCF7L2;HMGXB4;NPHP3;SNAI2;AMFR;BICC1;CYLD;FRZB;PSMB9;DACT1;RBX1;DKK3;APCDD1;PSMD2;SCYL2;PSME3;APOE;MDFI;LZTS2;RACK1;CXXC4;DAB2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD8;STK3;PSMD9;PSMF1;WWOX;STK11;PSMB6;PSMC2;PSMD12;GLI3;RUVBL2;PSMD4;CUL3;LIMD1;CHD8;AXIN1;PSMA2;TLE5;KREMEN1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6343036614729946,1.4002381548585132,0.11143695014662756,0.636547916159527,1.0,4/12,12.04%,MYOZ2;RCAN1;PRNP;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.6343036614729946,1.4002381548585132,0.11143695014662756,0.636547916159527,1.0,4/12,12.04%,MYOZ2;RCAN1;PRNP;DYRK2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.6537212254046598,1.398670288132631,0.1057542768273717,0.6413862876265402,1.0,5/11,11.25%,ENPP3;SLC25A19;DCK;NT5C3A;TPK1
prerank,regulation of protein acetylation (GO:1901983),-0.524798861656393,-1.3982912979589366,0.10256410256410256,0.7524455614414817,1.0,6/12,14.51%,TERF2IP;SIRT1;GSK3B;CAMK1;FAM161A;RAPGEF3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5580997174742136,-1.3966792581869076,0.09142857142857143,0.7498984953991796,1.0,7/11,34.88%,SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;TRIAP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.5473075462925252,-1.3956083348084833,0.0880503144654088,0.745372258248172,1.0,7/11,24.95%,EXOSC10;LARP7;EXOSC5;EXOSC3;TENT4B;FBL;PARN
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6321736908966856,1.3952458215153658,0.09606986899563319,0.6550512810188319,1.0,2/12,0.58%,CHMP4A;CHMP4B
prerank,negative regulation of lipid storage (GO:0010888),0.5766701894724916,1.395186699307155,0.1164021164021164,0.6534437673020894,1.0,5/19,4.73%,NR1H2;ABCA1;ABCG1;PNPLA2;OSBPL8
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5010635256422278,1.3946451667075779,0.060141509433962265,0.6539139009653986,1.0,4/41,3.83%,CLTRN;KCNMB3;CTSS;ACTN2
prerank,actin filament bundle organization (GO:0061572),-0.3881553891190363,-1.3943513052063234,0.06779661016949153,0.7420494077520832,1.0,7/33,7.63%,ADD1;PLS3;CALD1;DPYSL3;MICAL1;EPS8;DMTN
prerank,response to cholesterol (GO:0070723),-0.46713735913079224,-1.3943472134960138,0.0996309963099631,0.7338374274430485,1.0,8/17,11.37%,CCR5;TGFB1;GRAMD1A;LRP6;GRAMD1B;ABCA2;CCL3;PMVK
prerank,regulation of phosphate metabolic process (GO:0019220),0.5941572764786685,1.394278196934673,0.10620689655172413,0.6536287355558433,1.0,6/16,12.27%,MCM7;SMG7;IGBP1;BARD1;SMG5;PSEN1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.43413379319013856,1.394102338494996,0.001,0.6524400712171496,1.0,114/509,17.40%,DDX60;OASL;EIF2AK2;AXL;PIK3AP1;EDAR;WNT11;TNFSF10;TRIM14;AGT;NOD2;BST2;FLT1;UNC5B;DHX58;IFI35;NOD1;TRIB3;WNT5A;SPRY2;ALPK1;IRS1;KDR;TRIM25;BIRC2;MIOS;PIK3CD;FIS1;GPR37L1;DHX33;SEMA4D;CD40;CDH13;CANT1;KITLG;SASH1;CGAS;NMI;BCL2L11;TGFA;RBCK1;LRP2;TRIM21;ADAM8;USP15;CCL5;SIAH1;OSBPL8;IKBKE;DHX36;HSP90AB1;RRAGC;SOX9;CX3CL1;MYDGF;FGFR2;CFLAR;TCF7L2;GPR37;RET;TSPAN6;TMEM106A;MYOC;RAPGEF2;TMEM9B;MET;LYN;RNF31;P2RX4;APP;HMGB1;INSR;VAV1;ROR2;SPHK2;HPSE;ADGRV1;FGF9;RTKN2;TRAF5;IRAK4;NEK6;PTPN11;REL;LAMTOR3;MIER1;RACK1;PIK3CB;LIMS1;BAD;SHARPIN;AKAP13;BIRC3;RAC1;JAK2;FYN;SOX2;IRS2;TNIP2;MYD88;HSP90AA1;TLR2;BMF;CD27;FGFR3;IL18;IRAK1;MIB2;ZDHHC13;LGALS9;BAX;RUNDC3A;TLR3;PTPRC
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.44431852782893605,1.393897434195678,0.006030150753768844,0.6514124130767233,1.0,34/182,12.94%,PARP14;PARP10;PARP9;MOV10;APOBEC1;ABCC2;XDH;KDR;DDRGK1;AGO2;TARDBP;MECP2;RBL1;SFRP2;RUNX1;CNOT7;HSP90AB1;FBXW7;NFKB1;WDR54;PTRH2;ITGB8;APP;DNMT1;LRPAP1;ZC3H12A;SETDB2;MAP2K2;HAVCR2;PSEN1;REL;APOE;RB1;RACK1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5950439487658731,1.393083837685559,0.10026737967914438,0.6529509961744699,1.0,4/17,5.69%,SASH1;CD55;CX3CL1;LY86
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6429685885161963,1.3929827270863866,0.09710144927536232,0.6515783945843007,1.0,4/12,11.24%,APOBEC1;RESF1;DNMT1;SETDB2
prerank,regulation of p38MAPK cascade (GO:1900744),0.5187727375116331,1.3924095632492992,0.07004830917874397,0.6521506120075847,1.0,15/35,21.15%,XDH;GADD45G;SASH1;CYLD;ZC3H12A;DUSP10;MAP3K4;DLG1;MINK1;PRMT1;LGALS9;RELL1;MFHAS1;PER1;GADD45A
prerank,regulation of chromatin binding (GO:0035561),0.6664291288599904,1.3919026300441686,0.10070921985815603,0.6524372068866251,1.0,7/10,20.12%,PARP9;DTX3L;KDM4D;CDT1;DDX11;HMBOX1;BTAF1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5976760899654168,1.391469802406794,0.11675824175824176,0.6525475962540328,1.0,2/16,1.74%,PARP14;SOCS1
prerank,stress granule assembly (GO:0034063),0.5655877630813789,1.3907491443058193,0.09439124487004104,0.6537862504003541,1.0,9/20,23.99%,YTHDF1;DYNC1H1;YTHDF2;EIF2S1;OGFOD1;CSDE1;DDX3X;G3BP1;UBAP2L
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5042284406610182,-1.390004020767483,0.10576923076923077,0.7424467145645163,1.0,6/13,18.35%,DYRK1A;PTTG1IP;SIRT1;MIF;KDM1A;PSMD10
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5614776545213901,1.3897822609534731,0.09436435124508519,0.6561605165316364,1.0,7/22,16.89%,SOCS1;LAG3;RUNX1;BCL6;NFATC2;DUSP10;MDK
prerank,cholesterol transport (GO:0030301),0.49653339480159614,1.3892151917392583,0.07101947308132875,0.6569661203564353,1.0,16/45,22.58%,ABCA1;ABCG1;CLU;LIPC;LDLRAP1;STARD3;APOE;NPC1;NPC2;SOAT2;OSBP;SOAT1;LDLR;OSBPL2;MSR1;ABCA5
prerank,endothelial cell migration (GO:0043542),0.5104641359810769,1.3884636347969876,0.07013301088270858,0.6584133142671938,1.0,3/37,2.74%,STAT1;LOXL2;CDH13
prerank,negative regulation of cytokine production (GO:0001818),0.44436531704014,1.387770448914099,0.012170385395537525,0.659602555825195,1.0,39/163,20.31%,NLRC5;AXL;IFIH1;CD274;ISG15;SLAMF1;UBE2L6;ILRUN;DHX58;TRIM25;ZFP36;PTGER4;IKBKE;TLR8;CX3CL1;CYLD;N4BP1;HMGB1;PPP1R11;ABCD1;PRNP;ZC3H12A;HAVCR2;CHID1;FCGR2B;RAC1;CD84;PIBF1;NPTN;ACOD1;LGALS9;ANXA4;PTPRC;ASB1;PIN1;CD33;TYROBP;SIRPA;APPL2
prerank,nucleoside salvage (GO:0043174),0.6645673825307997,1.3875748986376657,0.13063063063063063,0.6586112634198212,1.0,5/10,14.96%,DCK;TK1;TK2;HPRT1;UCKL1
prerank,negative regulation of viral life cycle (GO:1903901),0.5977518474602982,1.3873754633340485,0.11797752808988764,0.6576254326805928,1.0,5/15,12.03%,BST2;LY6E;PPIA;GSN;TRIM26
prerank,nucleocytoplasmic transport (GO:0006913),0.5077305033780892,1.3872979107932846,0.07451923076923077,0.6561382524240459,1.0,16/40,15.69%,PHAX;NCBP2;LSG1;DDX20;NXT1;HTATIP2;NPM1;RSRC1;HNRNPA1;ATXN1;GEMIN7;SNRPD2;SNRPD1;SNRPG;NCBP1;GEMIN2
prerank,positive regulation of translational initiation (GO:0045948),0.5889562582991524,1.3870856004639849,0.0845442536327609,0.6553019297852398,1.0,8/18,20.51%,POLR2G;YTHDF1;LARP1;CCL5;YTHDF2;MTOR;EIF2B5;DDX3X
prerank,positive regulation of double-strand break repair (GO:2000781),0.5086468417984482,1.3862260033141023,0.07655502392344497,0.6570613789550757,1.0,11/39,12.58%,PARP9;DTX3L;TIMELESS;ACTR2;MAD2L2;KDM4D;SLF2;ARID2;SHLD1;PRKDC;DDX11
prerank,positive regulation of dendrite development (GO:1900006),-0.5673839542285499,-1.3852242176659761,0.14040114613180515,0.752300607516249,1.0,5/10,12.11%,COBL;ALK;DAB2IP;ZDHHC15;VLDLR
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5510764185028896,1.3833333687066556,0.09838274932614555,0.667566179262778,1.0,8/21,14.61%,AIM2;BIRC2;USP50;MT3;PSMB9;BIRC3;FYN;SOX2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5485537375098003,1.3829578966065519,0.09431524547803617,0.6672777080767806,1.0,8/24,12.35%,PSME2;UBE3A;EPHA4;CTSC;UCHL5;USP14;PSME3;APOE
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.6287094256916104,1.3821362927980305,0.11127596439169139,0.6692186130504681,1.0,4/11,12.91%,AUP1;RNF5;POMT2;RNF185
prerank,positive regulation of vasculature development (GO:1904018),0.4603951612353458,1.382004279817087,0.04978813559322034,0.6679409764584007,1.0,17/94,11.45%,FLT1;HYAL1;WNT5A;KDR;PIK3CD;AGO2;CD40;SASH1;SFRP2;RUNX1;MYDGF;ITGB8;CTSH;SMOC2;ZC3H12A;VEGFD;XBP1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6297759953147204,1.3803111711991658,0.11849710982658959,0.6734581502986415,1.0,2/12,1.61%,RER1;GPAA1
prerank,positive regulation of cytokine production (GO:0001819),0.4363508175483508,1.3798391866057798,0.001004016064257028,0.6737444380716034,1.0,49/292,12.41%,ZBP1;EIF2AK2;IRF7;IFIH1;HSPA1B;CD274;ISG15;IL15;AGT;NOD2;GBP5;DHX58;NOD1;WNT5A;PIK3CD;DHX33;CD40;NFKB2;STAT3;CGAS;RUNX1;PTGER4;DHX36;TLR8;CTNNB1;IL27;CD276;NFKB1;POLR3B;DHX9;TMEM106A;IL12RB2;POLR3GL;APP;HMGB1;POLR2K;MAPK14;RORA;SPHK2;TMED10;CCDC88B;HPSE;IL17D;XBP1;SORL1;HAVCR2;PTPN11;CXCL17;PRKDC
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.45485258647293964,1.3796680716408387,0.028066528066528068,0.6726530834704396,1.0,27/104,15.28%,PKMYT1;IRGM;TRIB3;SLC27A1;CCNJ;THY1;SLC8A1;CCND2;CDKN2D;CCND1;CDK12;ETAA1;CCNT2;CAB39;CNPPD1;MTCP1;MNAT1;CIB1;MAP2K2;RB1;TELO2;CCNI;ACTB;SERTAD1;EZH2;CALM3;HGS
prerank,mesonephric tubule development (GO:0072164),0.6016400740288291,1.3783076658095172,0.0953058321479374,0.6768079878816811,1.0,2/15,5.99%,WNT11;FGFR2
prerank,plasma membrane tubulation (GO:0097320),0.6111609613574793,1.3775876028372434,0.1274787535410765,0.6781925031420881,1.0,5/13,13.44%,CHMP4A;SNX33;FNBP1L;SNX9;WHAMM
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.40273547863144554,-1.377548731547389,0.07281553398058252,0.7726452262061413,1.0,11/26,22.22%,GPR137B;MAFB;RARA;PTPN2;CCL3;TMEM178A;CEACAM1;HOXA7;MYC;ZFPM1;INHBA
prerank,regulation of nuclear division (GO:0051783),0.5663518292299845,1.3767580453471577,0.10962566844919786,0.6800309178246812,1.0,4/20,6.27%,PKMYT1;DAPK3;PDXP;CUL7
prerank,regulation of fibroblast proliferation (GO:0048145),0.49048396879624856,1.3758645042623348,0.07424593967517401,0.6819978576695608,1.0,7/45,9.50%,PARP10;AGT;WNT5A;MORC3;CTNNB1;DHX9;PEX2
prerank,mitotic cytokinetic process (GO:1902410),0.5614775972270262,1.3757476609864903,0.09814323607427056,0.6807293664272791,1.0,3/20,1.51%,CHMP4A;CHMP4B;CHMP1B
prerank,histone H2B ubiquitination (GO:0033523),0.6607427924433502,1.375018254324085,0.11951588502269289,0.6821576969071752,1.0,4/10,9.78%,DTX3L;RNF40;UBE2E1;WAC
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.566069582417158,1.3739256228064347,0.09973045822102426,0.6851983641469934,1.0,6/19,13.06%,XDH;SPRY2;ADAMTS3;MYO1C;SMOC2;PIK3CB
prerank,regulation of translational initiation (GO:0006446),0.4796977028125007,1.3734110149248502,0.06229508196721312,0.6855681136460461,1.0,24/63,20.51%,POLR2G;EIF4A2;AGO2;YTHDF1;LARP1;CCL5;NCBP2;EIF4EBP2;ALKBH1;YTHDF2;NCK1;EIF2B2;NCK2;EIF4H;NPM1;EIF4G3;EIF1B;NCBP1;EIF2B5;EIF4B;EIF5;CSDE1;GLE1;DDX3X
prerank,regulation of ERAD pathway (GO:1904292),0.6357926987220983,1.3729185097447054,0.11571428571428571,0.6857810884740766,1.0,5/11,12.91%,AQP11;USP25;RNFT1;UBXN1;RNF185
prerank,regulation of feeding behavior (GO:0060259),0.6192470958495859,1.3723296329653907,0.12556732223903178,0.6866499523019176,1.0,3/11,14.63%,STAT3;LEPR;CFAP20
prerank,blood circulation (GO:0008015),0.4837219237343357,1.372232774767553,0.08132875143184422,0.6852116375865542,1.0,5/49,10.20%,STAT1;CXCL10;TBC1D8;CYB5R3;C3AR1
prerank,eosinophil migration (GO:0072677),0.604655738265409,1.370994045287653,0.1101813110181311,0.6869803651638571,1.0,3/14,5.48%,CCL7;CCL5;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.604655738265409,1.370994045287653,0.1101813110181311,0.6869803651638571,1.0,3/14,5.48%,CCL7;CCL5;CX3CL1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5234048858498489,1.370828273632821,0.09622411693057248,0.685982366042193,1.0,11/29,17.17%,ZC3H7A;ADAR;AGO2;TARBP2;SRRT;HNRNPA2B1;SMAD2;ZC3H7B;TUT7;DICER1;PRKRA
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5481969933073868,1.3707207543725548,0.0987012987012987,0.6846096921595861,1.0,8/23,21.13%,IFI35;NMI;CYLD;TSPAN6;ZC3H12A;UACA;DDX3X;ADIPOR1
prerank,central nervous system neuron development (GO:0021954),0.586844561259296,1.369095626040885,0.11596180081855388,0.689978197786005,1.0,5/15,19.09%,HSP90AB1;RAPGEF2;B4GALT5;HSP90AA1;GBA2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4556032528254061,1.3681404479306443,0.05726405090137858,0.6922345089724946,1.0,24/93,15.93%,EIF2AK2;EDAR;NOD2;TAOK3;SLAMF1;XDH;GADD45G;SASH1;TRAF4;WNT7B;TPD52L1;APP;HMGB1;TRAF3;ZC3H12A;TRAF5;FCGR2B;MAP3K4;STK25;MINK1;TAOK2;MTURN;CD27;PRMT1
prerank,regulation of stem cell proliferation (GO:0072091),0.5747604864499423,1.367373636609027,0.13287671232876713,0.6939100756471377,1.0,1/17,0.13%,EIF2AK2
prerank,regulation of chemokine production (GO:0032642),0.5015210458549896,1.3653183946441243,0.09397590361445783,0.7012443760501159,1.0,9/36,17.34%,EIF2AK2;WNT5A;SNAI2;APP;TLR2;AIF1;IL18;LGALS9;TLR3
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.49196006543542325,1.3646339193566825,0.09134045077105575,0.7023553453245063,1.0,17/41,25.44%,THY1;CD47;CCL5;CX3CL1;PODXL;MEGF10;PTPRU;MDK;LCK;PLAUR;CITED2;GCNT2;PIEZO1;JAK1;MAGI1;PTPN23;TNF
prerank,positive regulation of inflammatory response (GO:0050729),0.45831284669911254,1.3633177529406448,0.046137339055793994,0.7063308215850682,1.0,14/86,11.18%,ZBP1;IL15;AGT;IFI35;WNT5A;NMI;ADAM8;CD47;PTGER4;CX3CL1;DHX9;APP;TNIP1;ABCC1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5729938119311091,1.3625706680773475,0.10591471801925723,0.7078369849666561,1.0,6/17,17.13%,CLU;FIS1;SOD2;TIMM50;BAD;BAX
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4390718014814433,-1.3624982179335248,0.09187279151943463,0.8241863500897381,1.0,8/20,20.14%,ITGAV;CASP3;GSK3B;CASP9;APPL1;DCC;BAK1;FAS
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.47812899006829834,1.361766071326826,0.08622620380739082,0.7095254118570996,1.0,14/50,17.56%,PKMYT1;CCNJ;CCND2;HSP90AB1;CDKN2D;CCND1;CCNT2;CNPPD1;MNAT1;CCNI;ACTB;SERTAD1;CCNK;CDC37
prerank,regulation of microtubule nucleation (GO:0010968),0.6448383034419197,1.3614676100660223,0.14586466165413534,0.7091321202840264,1.0,4/10,10.43%,HSPA1B;MECP2;ARHGEF7;GIT1
prerank,cellular response to lipid (GO:0071396),0.43136368805085507,1.3613874572458535,0.015166835187057633,0.7076778361598652,1.0,39/191,16.68%,CXCL10;AXL;CD274;CXCL9;WNT11;IRGM;NOD2;WNT5A;IRS1;ZFP36;CRHBP;BRINP3;ADCY5;SOX9;NFKB1;WNT7B;RET;LTK;LYN;HMGB1;MAPK14;RORA;SPHK2;GIT1;ZC3H12A;SNW1;XBP1;STAP1;NR3C1;LCOR;UBE2L3;ZNF35;TNIP2;MYD88;ADNP2;TNIP3;IRAK1;UPF1;ACOD1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6026282664079676,1.3611562510270723,0.13020134228187918,0.7068916477575966,1.0,3/13,3.33%,NR1H2;CLU;AQP11
prerank,protein methylation (GO:0006479),0.492575077727042,1.3606741176069572,0.08294392523364486,0.7072422330198067,1.0,14/40,17.43%,PRMT2;METTL21A;GSPT1;NTMT1;NSD3;SETD3;EEF2KMT;CAMKMT;FAM98B;EZH2;ETF1;PRMT1;PRMT3;ATPSCKMT
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6263962904127285,1.3602934878887298,0.12944523470839261,0.7073285656204149,1.0,3/12,1.79%,NR1H2;ABCA1;ABCG1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5145247111177139,1.3602624614084502,0.09592326139088729,0.7056912390106537,1.0,11/35,14.25%,CLU;B2M;RAB21;HNRNPK;MKLN1;LDLRAP1;LRPAP1;PIK3CB;RAC1;SMAP1;SNAP91
prerank,cellular response to ionizing radiation (GO:0071479),-0.3545716967828383,-1.3597650800016463,0.04,0.8257065428267054,1.0,18/47,20.05%,MAP3K20;XRCC5;INO80;NIPBL;RHNO1;SPIDR;SIRT1;EEF1D;HUS1;KDM1A;TP53;CDKN1A;HRAS;RAD1;YAP1;NET1;ECT2;RAD51AP1
prerank,lamellipodium organization (GO:0097581),0.5248306364538572,1.3597376264968968,0.1206896551724138,0.7061491613134472,1.0,11/29,16.79%,CDH13;SPATA13;PARVB;CYFIP1;CARMIL1;ARHGEF7;CCDC88A;SPEF1;WHAMM;RAC1;SNX1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.48501525079817326,1.358924324475925,0.08542141230068337,0.7082128121270502,1.0,13/47,14.48%,TRIB3;SLC27A1;ACADL;FBXW7;NFKB1;SNAI2;RAPGEF2;PROX1;ZC3H12A;SIK1;CLK2;FYN;ERLIN2
prerank,sterol homeostasis (GO:0055092),0.4663932533097437,1.3586513180444912,0.07119386637458927,0.7075978476109058,1.0,20/65,20.66%,NR1H2;ABCA1;ABCG1;LIPC;ABCD1;LDLRAP1;RORA;RALY;XBP1;EPHX2;APOE;NPC1;NPC2;IL18;SOAT2;SOAT1;MTTP;LDLR;TTC39B;CYP39A1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.5104660461646651,1.3583895632159084,0.09285714285714286,0.7070056664802322,1.0,13/38,17.44%,XDH;TRIB3;OTUD3;NOP53;PPP2R5C;MAGI2;ARRB2;CIB1;PLEKHA1;RACK1;PIK3CB;INPP5K;PHLDA3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6067760585646077,1.3581181924996915,0.13196480938416422,0.7063868371285713,1.0,5/14,13.47%,KDR;PIK3CD;MYO1C;VEGFD;NRP1
prerank,embryonic hemopoiesis (GO:0035162),0.6172465099721524,1.3580729645843086,0.1151685393258427,0.7048250399350413,1.0,3/12,5.61%,KDR;KITLG;KMT2A
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.47863330753444855,1.3566407540551846,0.08126410835214447,0.7094281400314608,1.0,13/54,13.32%,HSPA1B;ISG15;SPRY2;PER2;TRIM21;CTNNB1;UBXN1;CAMLG;N4BP1;ARRB2;PRR7;VPS28;HDAC8
prerank,T cell homeostasis (GO:0043029),-0.5320289151659149,-1.3561800618764757,0.15835777126099707,0.8313629700738076,1.0,8/10,42.40%,NCKAP1L;AKT1;JAK3;FAS;PMAIP1;FOXP3;FADD;RIPK3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4508755432906403,1.3561124931039117,0.059009483667017915,0.7099058071589216,1.0,12/88,6.30%,IGF2BP1;EIF2AK2;TM4SF20;DAPK3;DHFR;RGP1;IGF2BP3;LARP1;CNOT7;ILF3;DHX36;NFKB1
prerank,natural killer cell activation (GO:0030101),0.5407636708579229,1.355983441752231,0.11026615969581749,0.7087468785631061,1.0,4/23,9.30%,AXL;PIK3CD;IL21R;ELF4
prerank,homocysteine metabolic process (GO:0050667),0.6204926697712067,1.3559277842027146,0.12965722801788376,0.7073161807179247,1.0,1/11,0.30%,MTHFR
prerank,regulation of cellular component biogenesis (GO:0044087),0.49844352740468106,1.3555703425869692,0.10082063305978899,0.7071303845539204,1.0,10/39,14.87%,PARP10;IRGM;AGT;VPS11;RAPGEF2;HSPA8;PTPN11;APOE;RAPGEF1;HSP90AA1
prerank,neuron projection regeneration (GO:0031102),0.633673782146437,1.3553141583429356,0.13935681470137826,0.7065895202421838,1.0,3/10,7.93%,DHFR;GAP43;MAPK8IP3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.567333374209484,1.3545141331211976,0.11836734693877551,0.7083799977319257,1.0,5/18,14.28%,STAT1;STAT3;PTPN11;ST18;JAK2
prerank,regulation of necroptotic process (GO:0060544),0.5370873011287606,1.3540938275474146,0.11068211068211069,0.7084918109819702,1.0,9/23,17.56%,ZBP1;BIRC2;MLKL;CFLAR;CYLD;BIRC3;HSP90AA1;FLOT2;CDC37
prerank,Golgi to endosome transport (GO:0006895),0.5697963198516877,1.3524258716425304,0.12397820163487738,0.7142383319918649,1.0,9/16,19.65%,KLHL20;AP2A1;DOP1B;KIF16B;RAB14;CORO7;VPS13A;GBF1;VPS13C
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.559445945025887,1.3520901160378065,0.12789115646258503,0.7140981571714876,1.0,7/18,14.69%,DNAJC13;RAB21;VPS11;CHMP3;MAP2K2;DAB2;DENND10
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5054171447128937,1.3518253716299504,0.1090458488228005,0.7136045408916067,1.0,9/35,12.52%,ESR2;DAXX;DDX5;EGLN2;PMEPA1;UBE3A;ARID1A;NR3C1;DDX54
prerank,epidermal cell differentiation (GO:0009913),0.4927280405516534,1.3499694791924002,0.08875739644970414,0.7199303818139169,1.0,5/41,6.60%,PITX2;CLIC4;WNT5A;CTNNB1;PIP5K1A
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5606496982362235,1.349960057949504,0.12091038406827881,0.7182584337595789,1.0,3/18,9.14%,ICOSLG;TNFSF9;HMGB1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4346079468297934,1.3497908358541635,0.02346938775510204,0.7172025708026581,1.0,32/150,16.22%,AXL;PIK3AP1;TRIB3;SPRY2;IRS1;PIK3CD;KITLG;TGFA;LRP2;ADAM8;OSBPL8;HSP90AB1;CX3CL1;MYDGF;FGFR2;TCF7L2;RET;MYOC;MET;P2RX4;INSR;VAV1;HPSE;FGF9;PTPN11;PIK3CB;RAC1;FYN;IRS2;HSP90AA1;FGFR3;IL18
prerank,hyaluronan catabolic process (GO:0030214),0.5672224526134966,1.349577274453001,0.1270718232044199,0.7164574318388776,1.0,4/18,2.88%,SPAM1;HYAL1;STAB2;HYAL4
prerank,positive regulation of protein binding (GO:0032092),0.4700820993765699,1.349464280872805,0.09714285714285714,0.7152996690958848,1.0,27/56,27.24%,DTX3L;TRIB3;BDNF;B2M;TRIM21;TCF7L2;AMFR;RAPGEF2;DACT1;BAMBI;APP;MEN1;PSEN1;APOE;SPPL3;RPL11;STK3;PIN1;RIPK2;USP33;IDE;CAPRIN2;ADD2;NVL;LRP1;TIAM1;FKBP1A
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5356789347351336,-1.349310500545414,0.12797619047619047,0.8516565672463996,1.0,6/11,20.43%,TGFB1;CASP8;ID2;RIPK1;PF4;IL34
prerank,regulation of mRNA metabolic process (GO:1903311),0.6278213397781978,1.3487680518868796,0.13082706766917293,0.71669256505428,1.0,5/11,15.33%,SRPK3;DHX9;SLTM;SRPK1;NCBP1
prerank,response to cAMP (GO:0051591),0.49447834749970576,1.348248269984211,0.11032863849765258,0.717295264969118,1.0,8/37,16.25%,STAT1;CRHBP;RAPGEF2;ZFP36L1;AKAP9;RAPGEF1;INPP5K;NDUFS4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4561956454649821,1.347946518857272,0.07258938244853738,0.7170287993404478,1.0,28/73,21.79%,EIF2AK2;PSMB10;PSME2;PSMA5;KITLG;PSME4;RUNX1;DHX36;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;PSMD2;LDB1;PSME3;PRKDC;PSMA4;MYB;PUS7;METTL14;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,positive regulation of peptidase activity (GO:0010952),0.5496898434407715,1.3478373295454162,0.11436170212765957,0.7158383599646643,1.0,12/20,27.54%,PSME2;DDRGK1;CTSH;PSME3;APH1A;APH1B;TANK;VCP;PSENEN;GRN;VSIR;PRELID1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.6234074215567843,1.3477846175288675,0.15281899109792285,0.7143940782529181,1.0,4/10,14.79%,NR1H2;SLC45A3;ABCD1;LPGAT1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5027803034957031,1.34682484372987,0.08946078431372549,0.7169455939785264,1.0,7/36,9.28%,WNT11;MOV10;WNT5A;AGO2;CTNNB1;TCF7L2;PLCB3
prerank,positive regulation of epithelial cell migration (GO:0010634),0.45044347669851686,1.3467424071575929,0.056782334384858045,0.7156915270790718,1.0,24/92,17.25%,AGT;HYAL1;WNT5A;KDR;PIK3CD;NRP2;SASH1;SOX9;CTSH;BCAR1;SMOC2;BMPR2;PROX1;PPM1F;ZC3H12A;RIN2;PRKCE;PIK3CB;NRP1;RAC1;RREB1;RAB11A;MTOR;IQSEC1
prerank,mRNA catabolic process (GO:0006402),0.48569290219142847,1.346126855053554,0.09906759906759907,0.7167685454776858,1.0,20/44,24.01%,HSPA1B;PNPT1;ZFP36;XRN2;DDX5;XRN1;DCP2;YTHDF2;DIS3L2;EXOSC9;NUDT16;TUT7;UPF1;LSM5;ERN1;EXOSC4;AGO4;RNH1;ZFP36L2;PDE12
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.5747757116494211,1.345170713964168,0.10860366713681241,0.7191371452758807,1.0,6/16,16.99%,ESR2;DDX5;EGLN2;ARID1A;DDX54;TRIP4
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.48483793003353115,1.3448723736464383,0.10058479532163743,0.7188314644685764,1.0,10/43,16.22%,STAT1;CDH13;CCL5;CX3CL1;DNMT1;LDLRAP1;FGF9;BMPR1A;AIF1;IL18
prerank,neuron fate commitment (GO:0048663),-0.4818656326236331,-1.344045197680065,0.12110726643598616,0.8643506048283878,1.0,9/14,44.55%,MYT1L;ID2;POU3F2;ISL1;SHH;PAX6;DLL4;EPOP;DLL1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.510493978315784,1.34361657701222,0.13665389527458494,0.7225948676685544,1.0,6/29,7.71%,DTX3L;TRIB3;ARRDC4;FEM1B;FBXW7;DCUN1D4
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5853229090544735,1.3421629962422825,0.1278735632183908,0.7274056056279515,1.0,11/15,34.15%,MET;SMOC2;P2RX4;FGF2;NOTCH1;SEMA5A;PRKD1;FGF1;LGMN;PRKD2;TMSB4X
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5549501642860207,1.3404645420805468,0.13630041724617525,0.7334881911151094,1.0,6/19,12.04%,PML;MSH2;AEN;SNW1;DDIT4;DYRK2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5841628931394278,1.340408120560846,0.1325136612021858,0.7320836446757251,1.0,5/15,12.63%,ZFP36;BCL2L11;ZFP36L1;NR3C1;UBE2L3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5230258820110252,-1.3403085910681631,0.15286624203821655,0.8712259882973965,1.0,4/11,23.46%,PRKCQ;NFKBID;CARD9;CLEC6A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4947505749580239,1.3398145476692194,0.11557177615571776,0.7330353573053674,1.0,8/32,12.04%,PML;MSH2;MYBBP1A;DDX5;AEN;SNW1;DDIT4;DYRK2
prerank,myofibril assembly (GO:0030239),0.4796808110358348,1.3396009978764853,0.12177985948477751,0.7322693535274503,1.0,4/42,6.12%,MYOZ2;CSRP1;ACTN2;CFLAR
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5347140567916513,1.339478396018914,0.12169312169312169,0.7311476457349008,1.0,10/24,19.19%,KDR;THY1;DUSP3;MYOC;PPM1F;LIMS1;NRP1;RAC1;IQSEC1;TSC1
prerank,regulation of RNA export from nucleus (GO:0046831),0.6154447562779333,1.3391828557269485,0.14201183431952663,0.7307182584575452,1.0,4/11,16.15%,NUP153;NCBP2;DHX9;NRDE2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.6118226477139846,1.338966483028676,0.14589235127478753,0.7266639186691868,1.0,6/11,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,coenzyme A biosynthetic process (GO:0015937),0.6118226477139846,1.338966483028676,0.14589235127478753,0.7266639186691868,1.0,6/11,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.6118226477139846,1.338966483028676,0.14589235127478753,0.7266639186691868,1.0,6/11,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,nuclear body organization (GO:0030575),0.6079037928800848,1.3388507003416272,0.14684287812041116,0.7254976727323085,1.0,2/12,2.06%,PML;USP50
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4511950677934582,1.3387977929245927,0.07692307692307693,0.7240787269928796,1.0,21/85,15.91%,NOD2;HYAL1;ZFP36;B2M;SGPP2;TGFA;AQP11;SFRP2;LAMC1;SOX9;FGFR2;TCF7L2;PEX2;ZFP36L1;FGF9;PRKDC;DUSP10;LIMS1;BAD;SOX2;MCC
prerank,sphingoid metabolic process (GO:0046519),0.6123612233026499,1.3386302364684277,0.14507042253521127,0.7231628981579996,1.0,3/12,9.99%,SGPP2;ASAH2;SPHK2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.44066147625464097,1.3383243498315651,0.04963805584281282,0.7229008860750067,1.0,24/113,14.89%,NOD2;HYAL1;WNT5A;KDR;PIK3CD;CDH13;NRP2;TGFA;LAMC1;PLXNB3;SOX9;MYDGF;FGFR2;TCF7L2;EGFL7;BMPR2;PROX1;VEGFD;FGF9;XBP1;BAD;NRP1;RREB1;AGGF1
prerank,histone H2A monoubiquitination (GO:0035518),0.5689460316095536,1.3364166076534545,0.11715481171548117,0.7296153198353834,1.0,5/17,11.45%,PCGF5;SKP1;PCGF6;RING1;RYBP
prerank,protein insertion into ER membrane (GO:0045048),-0.35735375487464455,-1.3362889355315322,0.06432748538011696,0.8788255062793242,1.0,19/37,23.59%,TRAM1;EMC2;CCDC47;EMC3;EMC8;CYB5A;HMOX1;GET3;UBE2J2;SEC61G;EMC9;MMGT1;SEC61B;UBL4A;WDR83OS;OTOF;EMC6;STX1A;ALDH3A2
prerank,negative regulation of cell growth (GO:0030308),0.43323911989337455,1.3360531326315919,0.05170630816959669,0.7296246904796396,1.0,26/121,13.20%,HSPA1B;WNT11;PML;ESR2;BST2;HYAL1;SFRP2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;FRZB;ST7L;BMPR2;SPHK2;EI24;SLIT3;MAG;SERTAD2;RB1;ENPP1;RACK1;FGF13;APBB1
prerank,negative regulation of protein secretion (GO:0050709),0.48433194701609467,1.335993427659033,0.12077294685990338,0.7282677593487058,1.0,2/38,1.64%,RSAD2;IRS1
prerank,protein localization to nucleus (GO:0034504),0.43721362639689243,1.3355251155628296,0.06418219461697723,0.7287182490317057,1.0,28/102,17.52%,PML;TOR1AIP2;TOR1AIP1;SKP1;RANBP6;STAT3;GBP2;CHCHD10;NUP153;NOP53;MORC3;KPNB1;CSE1L;PRICKLE1;NXT1;RRS1;RPAIN;SUPT7L;TAF8;PPP1R10;TAF3;IPO8;TNPO2;NUP155;RPL11;ARL2BP;RANBP17;NUP88
prerank,lipoxygenase pathway (GO:0019372),-0.4908245829947059,-1.3354891376422593,0.13059701492537312,0.873634766673088,1.0,3/14,4.65%,HPGD;LTC4S;ALOX5AP
prerank,lipid droplet organization (GO:0034389),0.55100917903375,1.3352868398383073,0.11447368421052631,0.7281686548637076,1.0,7/22,24.23%,AUP1;CDS1;PPIA;FAF2;PNPLA3;ZFYVE1;BSCL2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5588018608493168,1.33516507623676,0.135752688172043,0.7270684403698909,1.0,8/18,19.75%,BCL2L11;RNFT1;NCK1;XBP1;FCGR2B;RNF185;BAX;ERN1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6123618591573969,1.3342916394274484,0.14431486880466474,0.7294884517687571,1.0,5/12,19.13%,IRGM;FYCO1;INSR;JMJD4;UVRAG
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5186171810759319,1.3339240175642602,0.12484076433121019,0.7294233915836014,1.0,8/26,20.51%,RSAD2;IFI35;HMGB1;WDFY1;TLR2;TLR3;MFHAS1;DDX3X
prerank,skeletal muscle organ development (GO:0060538),0.5190147936403915,1.3338749338589777,0.1279373368146214,0.7280387094839471,1.0,2/26,6.12%,MYOZ2;CFLAR
prerank,positive regulation of endocytosis (GO:0045807),0.48061259265328304,1.3334773362492525,0.104959630911188,0.7280862977668415,1.0,12/45,14.72%,AXL;CLU;B2M;RAB21;HNRNPK;LDLRAP1;ANKFY1;STAP1;APOE;VPS28;DAB2;TFR2
prerank,sensory perception (GO:0007600),-0.34261212402955704,-1.333196237833609,0.043795620437956206,0.8747211998734442,1.0,25/45,32.74%,GNAL;OPRM1;CDH23;GNAS;WHRN;PENK;CHRNA7;MYO7A;CCR2;KCNA2;PTGES;SCN9A;NTSR2;CHRNA4;CCL2;P2RX7;OPRL1;OPRK1;CLRN1;TTC8;USH2A;PNOC;ALOXE3;PDYN;KCNK4
prerank,protein targeting to peroxisome (GO:0006625),0.5142521693096658,1.3331500276951997,0.12974296205630356,0.7278808708413375,1.0,10/29,17.41%,FIS1;RAB8B;PEX7;LONP2;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5918714889616796,1.3329675817181141,0.1539568345323741,0.7270456853596665,1.0,3/14,3.83%,GAL;ATP1B3;ACTN2
prerank,regulation of vasculature development (GO:1901342),0.5202315619849518,1.3329251514804672,0.1272264631043257,0.7256607788209511,1.0,4/26,9.41%,SP100;CTNNB1;HTATIP2;BMPER
prerank,negative regulation of translation (GO:0017148),0.4446057311776197,1.3328989501737616,0.07309322033898305,0.7242342188654717,1.0,12/87,5.65%,IGF2BP1;EIF2AK2;DAPK3;DHFR;IGF2BP3;AGO2;YTHDF1;LARP1;CNOT7;ILF3;DHX36;EIF4EBP2
prerank,relaxation of muscle (GO:0090075),0.5867253949307625,1.3327320045915123,0.1278735632183908,0.7234555043365872,1.0,5/13,16.74%,CAMK2D;SLC8A1;P2RX4;GSN;KCNJ2
prerank,negative regulation of defense response to virus (GO:0050687),0.6231516427743705,1.33267195349391,0.17113095238095238,0.722160555720198,1.0,3/10,7.35%,ILRUN;TARBP2;TSPAN6
prerank,embryonic eye morphogenesis (GO:0048048),0.6272566561412838,1.3326668834723878,0.1438953488372093,0.7206323681689443,1.0,3/11,7.89%,RARG;FBN1;MFAP5
prerank,intracellular sterol transport (GO:0032366),0.6001541536872939,1.3312982971223049,0.1553672316384181,0.7248982676799754,1.0,6/13,19.17%,ABCA1;ABCG1;NPC1;NPC2;OSBP;OSBPL2
prerank,carboxylic acid metabolic process (GO:0019752),0.49915420201646626,1.3307796954895839,0.13064713064713065,0.725590005152978,1.0,8/33,15.78%,LIPT1;AGXT;GRHPR;ST6GAL1;CYB5R3;ST3GAL1;GNE;GLUD1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4630888069101024,1.3305535035991456,0.0875,0.7250325952518131,1.0,12/61,9.63%,PML;EYA4;TMEM161A;MECP2;APLF;DHX36;RTEL1;DHX9;SIRT6;SMOC2;HMGB1;PPP1R10
prerank,cellular response to interleukin-1 (GO:0071347),0.42814568058209407,1.3304166276965461,0.04679552390640895,0.7241597385058525,1.0,50/143,21.79%,NOD2;PSMB10;CCL7;HYAL1;NOD1;SKP1;PSME2;PSMA5;GBP3;CD40;PSME4;MAP3K8;GBP2;CD47;RBMX;CCL5;SOX9;CX3CL1;PSMA3;NFKB1;PSMB9;RBX1;BTRC;ZC3H12A;PSMD2;CCL14;IRAK4;PSME3;ST18;PSMA4;IL1RAP;TNIP2;MYD88;ADAMTS12;IRAK1;UPF1;ACOD1;PSMD7;UBE2V1;PSMD8;PSMD9;TAB3;TANK;RIPK2;SIRPA;PSMF1;CCL4;PSMB6;PSMC2;PSMD12
prerank,response to gamma radiation (GO:0010332),-0.40199651788296875,-1.3300733305202104,0.09401709401709402,0.878719255346232,1.0,12/24,28.32%,MAP3K20;XRCC5;DCUN1D3;FANCD2;KDM1A;TP53;HRAS;YAP1;MYC;CRYAB;LIG4;TSPYL5
prerank,regulation of protein kinase B signaling (GO:0051896),0.424092118912226,1.3292067621836492,0.021148036253776436,0.727747632407343,1.0,42/193,16.22%,AXL;PIK3AP1;XDH;TRIB3;SPRY2;IRS1;PIK3CD;KITLG;TGFA;LRP2;ADAM8;OTUD3;NOP53;OSBPL8;HSP90AB1;CX3CL1;PPP2R5C;MYDGF;FGFR2;TCF7L2;RET;MAGI2;MYOC;MET;P2RX4;INSR;VAV1;ARRB2;CIB1;HPSE;PLEKHA1;FGF9;PTPN11;RACK1;PIK3CB;RAC1;FYN;IRS2;HSP90AA1;INPP5K;FGFR3;IL18
prerank,protein polyubiquitination (GO:0000209),0.417423072498441,1.3291752528016236,0.008016032064128256,0.7263417285330697,1.0,101/297,22.66%,RNF213;HERC6;TRIM14;IRF2BP1;PSMB10;UBE2L6;DTX3L;SKP1;FBXL16;PSME2;UBE2W;BIRC2;KLHL20;PSMA5;CDC26;RNF4;TMEM129;SASH1;FBXO7;PSME4;ANAPC5;RBCK1;TRIM21;RNF5;BFAR;SIAH1;UBE2B;FBXW7;CTNNB1;UBE3A;AREL1;PSMA3;LRSAM1;RNF114;AMFR;SPSB1;FBXW8;DCAF15;PSMB9;ANAPC4;RNF19B;RNF31;RBX1;UBE2E3;BARD1;UBE2E1;TRAF3;ARIH1;BTRC;PSMD2;CDC16;TRAF5;CDC27;SMURF1;PSME3;NPEPPS;FBXL14;UBE2L3;FBXL19;SHARPIN;MYLIP;UBE4B;LONRF1;PSMA4;RUSC1;UBE2Q1;DZIP3;NHLRC3;HECTD2;ANAPC2;LMO7;RNF166;MIB2;FBXL5;UBE2K;HECTD1;TRIM2;TRIM62;WWP1;PSMD7;RFFL;UBE2V1;PSMD8;RC3H2;PSMD9;SPOP;FBXO30;PSMF1;MKRN1;PSMB6;RNF216;ANKRD39;UNKL;PSMC2;PSMD12;HUWE1;SMURF2;STUB1;UBR2;FBXW2;PSMD4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6020920364327913,1.3290936846015478,0.1509433962264151,0.7250964915777209,1.0,9/13,28.76%,SIRT6;HMGB1;MDK;ITGA4;AKT3;FGF2;PDPK1;PLCG1;SP1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.620240833496838,1.3289203729685357,0.1253731343283582,0.724332386484652,1.0,3/12,8.77%,BST2;CSF1;LYN
prerank,positive regulation of angiogenesis (GO:0045766),0.4374640151423561,1.32832059266646,0.06555671175858481,0.7254625598393545,1.0,19/108,11.45%,FLT1;HYAL1;WNT5A;KDR;PIK3CD;AGO2;CD40;SASH1;SFRP2;RUNX1;MYDGF;ITGB8;CTSH;SIRT6;SMOC2;BMPER;ZC3H12A;VEGFD;XBP1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4669168683190821,-1.328040240936338,0.11824324324324324,0.8787550359859001,1.0,3/14,6.20%,ATP1B1;DMD;ANK3
prerank,protein targeting to membrane (GO:0006612),0.43994356712701915,1.327646186578542,0.07257203842049093,0.7268344012366447,1.0,16/83,9.50%,CHMP4A;CHMP4B;GOLGA7;FIS1;RAB8B;MYO1C;AQP11;RTP4;ZDHHC21;SRPRA;ZDHHC20;GDAP1;VPS37A;NACA;ABCD1;PEX2
prerank,myeloid cell development (GO:0061515),-0.43374385648561553,-1.3274149456105728,0.11673151750972763,0.8727251550871854,1.0,7/18,16.98%,NCKAP1L;DMTN;SRC;ABCB10;ALAS1;FOXP1;LYAR
prerank,protein K11-linked ubiquitination (GO:0070979),0.5167826027101914,1.3272851709263485,0.1316818774445893,0.7268680065203148,1.0,10/27,12.63%,UBE2W;CDC26;RNF4;ANAPC5;UBE2B;ANAPC4;UBE2E3;CDC16;CDC27;UBE2L3
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5234843435256018,-1.3268281354961686,0.17575757575757575,0.8586524903354898,1.0,4/10,16.92%,CDC42;APC;CDC42EP1;CDC42EP2
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5234843435256018,-1.3268281354961686,0.17575757575757575,0.8586524903354898,1.0,4/10,16.92%,CDC42;APC;CDC42EP1;CDC42EP2
prerank,epithelial structure maintenance (GO:0010669),0.6137456666214993,1.3265879646221221,0.13777777777777778,0.7282353623567088,1.0,1/11,0.94%,NOD2
prerank,regulation of blood circulation (GO:1903522),0.4988654185068982,1.3260927811777912,0.1188118811881188,0.7287912291537321,1.0,4/34,7.02%,AGT;CAMK2D;PER2;TMIGD3
prerank,regulation of mRNA catabolic process (GO:0061013),0.42958280155437945,1.3254645112697956,0.05154639175257732,0.7299859721617366,1.0,42/121,23.77%,IGF2BP1;MOV10;ZC3HAV1;PSMB10;PSME2;PNPT1;ZFP36;PSMA5;IGF2BP3;PSME4;YTHDF1;CNOT7;DHX36;XRN1;PSMA3;DCP2;PSMB9;YTHDF2;HSPA8;ZC3H12A;ZFP36L1;PSMD2;PSME3;EXOSC9;PSMA4;UPF1;PCBP4;PSMD7;PSMD8;SET;RC3H2;PSMD9;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;EXOSC4;PSMD4;ZC3H14;ZFP36L2;PSMA2
prerank,cellular response to cytokine stimulus (GO:0071345),0.41615827649832576,1.3249399633728354,0.002,0.7307589009852588,1.0,91/416,16.81%,STAT1;STAT2;CXCL10;GBP4;AXL;IFIT1;IRGM;CRLF1;GBP5;CCL7;DAPK3;HYAL1;DOCK8;CXCR4;AIM2;WNT5A;SOCS1;PNPT1;PIK3CD;ZFP36;GBP3;CD40;STAT3;BCL2L11;ASAH2;PTPN18;GRB10;GBP2;CD47;HCK;CRHBP;RBMX;CCL5;JUNB;GBP7;SOX9;CX3CL1;CCND1;NFKB1;BCL6;CSF1;IL10RA;AQP4;DHX9;RO60;IL12RB2;LEPR;SOCS5;PTPN7;LDLRAP1;VAV1;HSPA8;RORA;CIB1;ZC3H12A;LRCH1;ZFP36L1;CCL14;XBP1;PIM1;IL10RB;IRAK4;SOS1;PTPN11;SOCS2;PIK3CB;RAPGEF1;NUMBL;SHMT1;STX4;JAK2;FYN;IFNAR2;IL1RAP;SOX2;HSP90AA1;INPP5K;CRK;TLR2;ADAMTS12;OXSR1;AIF1;IL18;LRP8;IRAK1;UPF1;PTPN9;STK39;ACOD1;CSK;LGALS9
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.47142131242297036,1.3246850681179088,0.11384976525821597,0.7303243558700856,1.0,13/45,16.05%,PARP9;ZC3H7A;TDRD7;LARP1;TCOF1;CYFIP1;NOLC1;APP;PUM3;MATR3;ZC3H7B;RBM3;MEX3D
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5177982320064716,-1.3238524832711902,0.13569321533923304,0.8623941475921878,1.0,7/11,36.03%,ALG10B;TREM2;NOS1AP;AKAP6;LRRC55;RNF207;KCNIP2
prerank,secondary alcohol metabolic process (GO:1902652),0.48470541089230296,1.3234678321618607,0.10767468499427263,0.7340075285412652,1.0,16/42,23.27%,ABCA1;ABCG1;CH25H;IDH1;LDLRAP1;STARD3;CYP27A1;APOE;PPARD;SOAT2;SOAT1;EBP;GBA2;IDH3A;ABCA5;CLN6
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4811322201979812,1.3232746148836674,0.13523131672597866,0.7332842970914252,1.0,10/40,13.95%,CLU;B2M;RAB21;HNRNPK;MAGI2;INSR;LDLRAP1;ARRB2;SCYL2;DAB2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.5059630625880902,1.3228314659762135,0.11274509803921569,0.7336099716184945,1.0,14/33,26.53%,SP100;EVL;APOE;DUSP10;MCC;CORO1C;SVBP;ACVRL1;ADIPOR1;VASH1;PTPRM;PTPN23;PFN2;PTEN
prerank,cholesterol homeostasis (GO:0042632),0.4554261248713833,1.3227582372662277,0.0967032967032967,0.7324408463431353,1.0,19/64,20.66%,NR1H2;ABCA1;ABCG1;LIPC;LDLRAP1;RORA;RALY;XBP1;EPHX2;APOE;NPC1;NPC2;IL18;SOAT2;SOAT1;MTTP;LDLR;TTC39B;CYP39A1
prerank,ether lipid biosynthetic process (GO:0008611),0.6330947013985704,1.3226991308452942,0.15015015015015015,0.7311900631454754,1.0,5/10,15.98%,PEX7;LPCAT2;GNPAT;CHPT1;PEDS1
prerank,regulation of monocyte differentiation (GO:0045655),0.5791118346553118,1.3223888273018891,0.15472779369627507,0.7310085518545775,1.0,3/14,10.97%,IRF7;CSF1;ZFP36L1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5670048905221123,1.3208930200766136,0.14511494252873564,0.7360658761345975,1.0,2/15,1.21%,AGT;CAMK2D
prerank,protein tetramerization (GO:0051262),0.4573412826712079,1.3202335961622602,0.08379888268156424,0.737409617848378,1.0,12/67,13.78%,SAMHD1;SYCP1;GBP5;TRPM2;B2M;SOD2;AQP4;TK1;ALDH1A2;HPRT1;ACOT13;SHMT1
prerank,regulation of viral transcription (GO:0046782),0.4780883909199016,1.3202290313836,0.12603062426383982,0.7359261413174291,1.0,9/39,9.31%,TRIM14;POLR2G;ZFP36;TRIM21;TARBP2;UBP1;DHX9;MDFIC;POLR2K
prerank,intracellular cholesterol transport (GO:0032367),0.5809666492112323,1.320181443088902,0.15862068965517243,0.7346361574611814,1.0,8/15,19.17%,ABCA1;ABCG1;LDLRAP1;NPC1;NPC2;OSBP;LDLR;OSBPL2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.44135871645917224,1.3201755911642412,0.08278867102396514,0.7331663582712722,1.0,18/76,17.26%,NLRC5;PARP10;AIM2;PRMT2;RBCK1;TRIM21;TMIGD3;CYLD;TRAF3;ARRB2;COMMD7;G3BP2;ZC3H12A;HAVCR2;MTURN;IRAK1;ACOD1;ANXA4
prerank,male meiosis I (GO:0007141),-0.44722830971112376,-1.3193928015789007,0.1413793103448276,0.8722730096035369,1.0,9/16,45.37%,ING2;FOXJ3;DDX4;SYCP3;BRDT;HSF2BP;SLC25A31;TDRD9;MOV10L1
prerank,lipid translocation (GO:0034204),0.5411303230172048,1.3192418818943934,0.14656290531776914,0.7357085136518196,1.0,6/21,15.76%,ATP10A;ABCA1;ATP8A1;ABCC1;ATP11A;ATP9B
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4716221920952839,-1.3190282106736435,0.1461794019933555,0.8657568163356775,1.0,7/14,25.50%,CD81;CARD11;IKBKG;CD226;TESPA1;NECTIN2;RPS3
prerank,membrane lipid catabolic process (GO:0046466),-0.5166961022009142,-1.3189655242460279,0.138328530259366,0.8582159567837943,1.0,5/10,25.44%,PDXDC1;FUCA1;SMPDL3B;SMPD2;PPT1
prerank,regulation of viral entry into host cell (GO:0046596),0.5006467771016925,1.3187334192641438,0.13382899628252787,0.7362819478671103,1.0,8/30,18.07%,TRIM14;TRIM25;TRIM21;LY6E;GSN;TRIM26;LGALS9;TRIM62
prerank,muscle tissue development (GO:0060537),0.5871952282817922,1.3186254993371493,0.14540059347181009,0.7352886602930127,1.0,4/13,18.19%,SRPK3;CSRP1;PTCH1;NF1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5870834719725144,1.3186179525451314,0.14513788098693758,0.7338434975290856,1.0,5/13,12.85%,ENTPD3;ENPP3;ENTPD6;ENTPD5;ENPP1
prerank,regulation of programmed cell death (GO:0043067),0.42531620259540026,1.3180266278643147,0.03971486761710794,0.7350010166072696,1.0,23/161,8.36%,STAT1;CXCL10;AGT;DAPK3;TNFSF9;DAXX;CLU;BIRC2;RARG;TMEM219;ACTN1;TARDBP;BCL2L11;ACTN2;CASP6;RSL1D1;NOP53;OSGIN1;SOX9;SRA1;BCL6;HTATIP2;BCAR1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5556385838983561,1.3179227094166936,0.1506276150627615,0.7340122495995345,1.0,4/17,11.00%,STAT1;MAML2;SNW1;NOTCH4
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5126492195751915,1.3170692095378842,0.13671875,0.7361713268435989,1.0,6/26,9.63%,CDC25B;PKN2;DUSP3;SMOC2;APP;PPP1R10
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.4606987829856142,1.3168112432360017,0.1016949152542373,0.7357544644139178,1.0,18/55,20.61%,TNFSF10;PML;AGT;FIS1;BCL2L11;SIAH1;TRIM39;CYLD;TPD52L1;RACK1;BAD;BMF;BAX;CRADD;BECN1;BCAP31;WWOX;LCK
prerank,histone H2A ubiquitination (GO:0033522),0.5562823970903037,1.3165496287121068,0.15130674002751032,0.7353772066114235,1.0,5/17,11.45%,DTX3L;SKP1;UBE2B;RING1;RYBP
prerank,regulation of transferase activity (GO:0051338),0.5629768765436779,1.3157285178671019,0.14496644295302014,0.7372894965631585,1.0,4/17,12.25%,NLRC5;FEM1B;LDB2;LDB1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5403154717869141,1.3147290000843765,0.15416098226466576,0.7401549422594871,1.0,7/19,17.86%,CABYR;CCDC40;ADCY10;NPHP3;AQP4;ODAD4;SPAG17
prerank,regulation of vasculogenesis (GO:2001212),0.5689900423611366,1.314650382901522,0.15363511659807957,0.7390525767700599,1.0,4/14,11.72%,XDH;KDR;RAPGEF2;RIN2
prerank,neuromuscular process controlling balance (GO:0050885),-0.5042476449833597,-1.3144332802609235,0.15605095541401273,0.8686456778694043,1.0,7/12,29.72%,CDH23;NRXN1;MYO7A;CLN3;SHANK1;CLRN1;TIFAB
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5063692132627508,1.314319753274492,0.13375,0.7389967092659138,1.0,11/29,18.41%,TRAPPC3;COG3;GOLGA5;COPE;GOSR2;COG8;COG2;VTI1B;NAPA;GOSR1;COPB2
prerank,regulation of endopeptidase activity (GO:0052548),0.4538672276774414,1.3128867893970388,0.097669256381798,0.7436629703366081,1.0,11/59,15.32%,AGT;PSME2;BIRC2;SERPINC1;PSMA3;PSMB9;TIMP2;PSME3;BIRC3;APH1A;APH1B
prerank,retinal metabolic process (GO:0042574),0.6070189931893817,1.3127704469195542,0.16353111432706222,0.742692430869213,1.0,2/12,7.90%,BCO2;RDH11
prerank,RNA processing (GO:0006396),0.41995664011601874,1.3119397015839074,0.043478260869565216,0.7447923393356084,1.0,56/176,18.73%,NOL3;APOBEC1;TENT4A;XRN2;ADAR;TARDBP;MAGOHB;PRPF18;HNRNPH1;NCBP2;NOL9;RRAGC;HNRNPK;CDK12;RBMS2;DDX20;HNRNPA2B1;NONO;BCAS2;RNPC3;SRPK1;HNRNPL;TSEN2;RSRC1;RNPS1;HNRNPH3;PPARGC1A;DDX54;USP39;ATXN1;SNRPD2;SNRPD1;DUSP11;AURKAIP1;DDX39B;SNRPG;RBM39;NCBP1;RBM3;DHX16;GEMIN2;SRSF7;SF3B4;NRDE2;SRSF4;TUT7;DDX47;DICER1;SNRNP48;TSEN34;DDX23;SLU7;SCNM1;LSM5;RBPMS;FASTKD2
prerank,visual perception (GO:0007601),0.4377929382207204,1.311125201713307,0.11312700106723586,0.746823075639015,1.0,12/84,15.24%,CABP4;CNGB1;EYA4;CACNA2D4;CRYGN;IMPG2;RS1;ATXN7;ADGRV1;RGS16;CHRNB2;BBS2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4941010930910996,1.3110835234628984,0.12530413625304138,0.7455322650496493,1.0,6/31,15.41%,CD274;SDC4;LST1;LYN;FCGR2B;CD300A
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5920676844064116,1.3108397421100637,0.1608876560332871,0.7451648167196331,1.0,5/13,12.94%,DDRGK1;BFAR;ATF6B;NCK1;RACK1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.43457218085151605,1.3106277125929193,0.07547169811320754,0.7446111956625887,1.0,22/100,14.64%,PIK3AP1;AGT;FLT1;UNC5B;KDR;PIK3CD;SEMA4D;CCL5;NOP53;SOX9;PPP2R5C;MYDGF;PIP5K1A;MYOC;ENTPD5;LYN;INSR;ROR2;PIK3CB;PIP5K1C;JAK2;IRS2
prerank,positive regulation of kinase activity (GO:0033674),0.4288726780520274,1.3101628295189724,0.06882168925964546,0.7450934511705674,1.0,21/107,10.39%,AXL;FLT1;KDR;DAXX;LCP2;CACUL1;EPHA4;TRAF4;FGFR2;MAP2K3;CSF1;RET;EPHA6;AGAP2;RAPGEF2;LTK;MET;INSR;PRKAG1;ROR2;SNX9
prerank,negative regulation of angiogenesis (GO:0016525),0.4375580233158777,1.3094319828236063,0.08191489361702127,0.7467418132788253,1.0,8/84,5.48%,STAT1;CXCL10;PML;SPRY2;MECP2;COL4A2;YJEFN3;CTNNB1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.46391217951529956,1.3092573282389288,0.11811023622047244,0.7460426402650792,1.0,13/49,15.93%,MOV10;DPY30;MYL9;RBBP5;RUNX1;CNOT4;KMT2A;WDR5;CIB1;EIF6;RBM15;MTURN;PRMT1
prerank,Rac protein signal transduction (GO:0016601),0.5441833404240553,1.3088080060754188,0.16321243523316062,0.7464747292897905,1.0,13/18,29.07%,CDH13;CYFIP1;HACD3;RAC1;DBNL;AIF1;NCKAP1;RHOH;BRK1;FARP2;TIAM1;WASF1;HACE1
prerank,negative regulation of cellular component movement (GO:0051271),0.5604429585906501,1.308402110381639,0.1563380281690141,0.7467406445477925,1.0,2/15,2.31%,SP100;ACTN1
prerank,protein import into peroxisome membrane (GO:0045046),0.5367093881531964,1.3081742484442367,0.14921465968586387,0.7462599261171906,1.0,8/22,17.41%,FIS1;RAB8B;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1
prerank,cAMP-mediated signaling (GO:0019933),0.5128139937563616,1.3059111849204719,0.13178294573643412,0.7543602773575108,1.0,4/24,8.10%,PDE7B;GAL;SOX9;RAPGEF2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.43401291350344656,1.3055842848522756,0.09100642398286937,0.7542535463673216,1.0,19/76,17.34%,EIF2AK2;NOD2;IFI35;NOD1;SASH1;NMI;CYLD;TSPAN6;APP;ZC3H12A;RTKN2;LIMS1;DLG1;UACA;TLR2;CD27;IRAK1;LGALS9;TLR3
prerank,regulation of smooth muscle contraction (GO:0006940),0.5337469688671214,1.305509215638685,0.14285714285714285,0.753119741758846,1.0,4/20,7.27%,DAPK3;ZDHHC21;SETD3;SRF
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4584946453082481,1.3052261202739315,0.10801781737193764,0.7529371997830955,1.0,11/54,13.79%,HSPA1B;CASP4;SPPL2A;BIRC2;RBCK1;CFLAR;CYLD;RNF31;RACK1;SHARPIN;BIRC3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.36571408572692543,-1.3045255751045401,0.08241758241758242,0.900425283272171,1.0,14/33,23.35%,APOD;PPARG;PDCD4;HMOX1;TPM1;IGFBP5;TRIB1;PRKG1;CDKN1A;CDKN1B;MEF2C;TNFAIP3;EFEMP2;IGFBP3
prerank,positive regulation of cartilage development (GO:0061036),0.5585014014315223,1.3042509562267517,0.16925064599483206,0.7557284640215919,1.0,8/17,22.87%,LOXL2;SOX9;SCX;BMPR2;SOX5;MDK;ACVRL1;PKDCC
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5498485211821729,1.3040456038342336,0.16036505867014342,0.7551845619103282,1.0,2/18,0.67%,SAMHD1;AOAH
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5226229345968754,1.3035094302571808,0.1553784860557769,0.7559978393718058,1.0,6/21,18.27%,AGXT;LPIN2;LDHD;CYP26B1;PPARD;ACOX1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5082642893910287,1.3033026226061697,0.14125,0.7554345648817049,1.0,6/29,16.81%,CXCL10;CCL5;HMGB1;CXCL17;AIF1;LGALS9
prerank,retina homeostasis (GO:0001895),0.5294030933073929,1.3031196123932605,0.14877102199223805,0.75477659010584,1.0,5/23,15.48%,CNGB1;B2M;POTEF;ACTB;CCDC66
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5171088505595337,1.3030893696820933,0.16087516087516088,0.7534786590592973,1.0,10/24,25.44%,CENPJ;CCL5;IL10RA;IL10RB;JAK2;PIBF1;NOTCH1;CRLF3;OCIAD1;TNF
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5404993280026309,1.302947067242809,0.1479944674965422,0.7526471613880215,1.0,7/19,13.91%,KDR;THY1;MYOC;PPM1F;LIMS1;NRP1;RAC1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5567035735888984,1.3028535693388308,0.15881561238223418,0.7515903503412786,1.0,1/16,0.24%,CD274
prerank,positive regulation of leukocyte migration (GO:0002687),0.5077353416733554,1.302746881328663,0.1373762376237624,0.750590276251743,1.0,6/27,16.89%,THY1;ADAM8;CSF1;AIF1;JAM3;MDK
prerank,cellular response to peptide (GO:1901653),0.4537072351817885,1.3020028442064127,0.1111111111111111,0.7521500876447419,1.0,15/56,14.33%,CASP4;NOD2;NOD1;TIMELESS;EPHA4;CACNA1A;APP;PRNP;ZFP36L1;ABCC1;XBP1;PSEN1;DDX11;FCGR2B;FYN
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5061025950947226,1.3016407487056778,0.15186615186615188,0.7521871419307473,1.0,12/25,23.76%,AUP1;UBE2W;RNF5;POMT2;NGLY1;LONP1;RNF185;KLHL15;STUB1;CUL3;VCP;HDAC6
prerank,protein localization to synapse (GO:0035418),-0.49380723608660354,-1.3013001024556778,0.16,0.9050891731608335,1.0,7/12,22.44%,DLG4;NRXN2;NLGN2;NRXN1;ZDHHC15;ZDHHC12;SHANK1
prerank,regulation of centrosome duplication (GO:0010824),0.4944885196849359,1.3012119898989765,0.15808823529411764,0.7524901459709569,1.0,10/30,15.01%,CHMP4B;CHMP1B;CENPJ;XRCC3;NPM1;CEP131;CHMP3;CEP295;TMEM67;GEN1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5615885596554349,1.3009505350900306,0.1581196581196581,0.752146743446013,1.0,4/16,9.69%,GPR37L1;PLCB3;BMPR2;KLK1
prerank,regulation of mitotic spindle organization (GO:0060236),0.48049962291125226,1.3009408263053561,0.14547677261613692,0.7507965035577656,1.0,6/35,11.29%,HSPA1B;CHMP4B;CHMP1B;DYNC1H1;RAE1;CHMP3
prerank,macrophage activation (GO:0042116),0.4898011019046542,1.3007067234253358,0.13961813842482101,0.7503829891743069,1.0,9/34,16.08%,IFI35;CLU;NMI;CX3CL1;TMEM106A;APP;JAK2;CRTC3;AIF1
prerank,regulation of cartilage development (GO:0061035),0.5425451283477649,1.3003062388117967,0.16137566137566137,0.7505754945050167,1.0,6/18,16.89%,WNT11;SOX9;SCX;BMPR2;SOX5;MDK
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4963706299511476,1.299625900221389,0.13451776649746192,0.752064987710124,1.0,7/28,12.41%,PARP9;DTX3L;ACTR2;MAD2L2;KDM4D;SHLD1;PRKDC
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.5198778526227468,-1.2990228972555995,0.16566265060240964,0.9062271056149546,1.0,6/10,22.86%,APOD;WASL;AKT1;RIPOR2;CD200R1;CD200
prerank,proteoglycan biosynthetic process (GO:0030166),0.48806154111662686,1.2984927354657163,0.14443084455324356,0.7553464610015186,1.0,7/31,12.38%,EXT1;XYLT2;CANT1;FAM20B;BMPR2;CSGALNACT2;EXTL3
prerank,import into cell (GO:0098657),0.4728109522925846,1.2984144717722101,0.12922002328288706,0.7543209151713244,1.0,8/41,6.94%,SLC27A1;SLC38A1;LRP2;SLC46A1;SLC19A1;LRSAM1;IL10RA;SLC11A2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.476012336998338,1.297829450921196,0.1332533013205282,0.755409414494012,1.0,17/37,25.29%,IRGM;SPRY2;S1PR2;TNKS1BP1;CAB39;APP;DDIT4;INPP5K;CALM3;UBE2K;SPRED3;SPRED1;RIPK2;AXIN1;CALM2;WNK3;SIRT2
prerank,regulation of protein ubiquitination (GO:0031396),0.42352002922580617,1.2978250144402161,0.09024134312696747,0.754037379984193,1.0,25/108,15.97%,HSPA1B;ISG15;SPRY2;PER2;DAXX;BIRC2;SASH1;HSP90AB1;FBXW7;PRICKLE1;UBE3A;UBXN1;CAMLG;N4BP1;UBQLN1;ARRB2;PRR7;VPS28;PAXIP1;UBE2L3;HDAC8;BIRC3;HSP90AA1;MYCBP2;SPRTN
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4770080564974395,1.2976664568696445,0.13734939759036144,0.7533215557881608,1.0,14/40,22.93%,SLC27A1;SLC38A2;SLC38A1;SLC19A1;SLC38A3;SLC25A10;SLC38A6;SLC7A6;ABCC1;SLC36A4;ABCC5;SLC7A7;SLC5A6;SLC25A30
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6025236170165778,1.297362013717744,0.1589895988112927,0.7532693530106046,1.0,3/11,9.14%,CD274;RUNX1;HMGB1
prerank,negative regulation of phagocytosis (GO:0050765),0.5402971603538553,1.2961303295085431,0.1643646408839779,0.7570899473902717,1.0,8/17,19.96%,CD47;HMGB1;FCGR2B;RACK1;CD300A;TLR2;CD300LF;SIRPA
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5971240691439631,1.2961192244539306,0.17339312406576982,0.7557797433104726,1.0,3/11,7.25%,ZFP36;STAT3;DHX9
prerank,AMP metabolic process (GO:0046033),0.5819379162249277,1.2958661258794215,0.16393442622950818,0.7554731758191773,1.0,5/13,18.85%,XDH;ADSL;AK4;AK3;AMPD3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5673972062091284,1.295803148710227,0.16106442577030813,0.7543310782119009,1.0,5/14,15.54%,ENTPD3;ENTPD6;NUDT5;ENTPD5;NUDT16
prerank,microtubule-based transport (GO:0099111),0.5671744516100767,1.295720837321672,0.18428571428571427,0.7532895568776651,1.0,3/13,6.17%,CABYR;CCDC40;ADCY10
prerank,positive regulation of protein kinase activity (GO:0045860),0.41840532248334883,1.2950504477866642,0.05635245901639344,0.75475628222885,1.0,38/148,16.29%,IRGM;CALCA;AGT;TAOK3;DAXX;CLU;SLC27A1;LCP2;CCL5;HSP90AB1;CACUL1;ETAA1;EPHA4;TRAF4;PAK3;CAB39;DOK7;MAP2K3;CSF1;AGAP2;MTCP1;RAPGEF2;CCDC88A;FCGR1A;INSR;PRNP;PRKAG1;TNIK;SNX9;CIB1;MAP2K2;TELO2;EZH2;HSP90AA1;MINK1;CALM3;TAOK2;LRP8
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5136497747884007,1.2949026724396475,0.1556420233463035,0.7540060047144042,1.0,7/24,12.94%,NR1H2;CLU;AQP11;USP25;UBXN1;XBP1;RACK1
prerank,protein monoubiquitination (GO:0006513),0.4721807340922655,1.2947886635693395,0.1461352657004831,0.7530467131567231,1.0,9/36,9.78%,DTX3L;TRIM25;UBE2W;RNF40;TRIM21;UBE2B;RBX1;UBE2E1;WAC
prerank,relaxation of cardiac muscle (GO:0055119),0.5693956861545605,1.2947020782635585,0.18289085545722714,0.7520710088253408,1.0,5/13,16.74%,CAMK2D;SLC8A1;P2RX4;GSN;KCNJ2
prerank,adipose tissue development (GO:0060612),0.6051623367049634,1.294676528659091,0.19047619047619047,0.7508193359286793,1.0,5/11,18.30%,NAMPT;ARID5B;XBP1;SH3PXD2B;SPTLC2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4445726834637555,1.2943806836245488,0.11700975081256772,0.7507600574610468,1.0,15/66,15.91%,STAT1;XDH;B2M;AQP11;SFRP2;FBXW7;SOX9;FGFR2;SNAI2;NFIB;PEX2;APOE;DUSP10;SOX2;MCC
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6082435859438887,1.2942101571148963,0.17134416543574593,0.7501817673883515,1.0,3/10,11.65%,HSPA1B;DNAJB6;SORL1
prerank,tRNA wobble base modification (GO:0002097),0.5731469618544163,1.29325392950475,0.1683599419448476,0.7527565661103428,1.0,4/14,6.88%,TRMT9B;MOCS3;ADAT2;ALKBH1
prerank,regulation of myotube differentiation (GO:0010830),0.515578522522974,1.2928711150778018,0.15206185567010308,0.752962676852998,1.0,11/24,23.50%,BDNF;MMP14;MAPK14;SIK1;XBP1;ATP11A;SMYD1;HDAC1;PIEZO1;NOTCH1;HDAC4
prerank,aspartate family amino acid catabolic process (GO:0009068),0.5349345066754103,1.2927064527368908,0.1766304347826087,0.7522620359502517,1.0,6/19,15.56%,HYKK;ALDH7A1;DLD;AASS;GCDH;PIPOX
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4339743925639028,-1.2926623877159973,0.1455223880597015,0.9241991806115654,1.0,7/17,18.54%,ARRB1;BCL3;PTPN22;CACTIN;KLF4;MAP2K5;ANXA1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.622165378985315,1.292383843045893,0.17889908256880735,0.7521935824462883,1.0,3/10,9.69%,PFKM;GFPT1;HK1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5023075916547015,1.2922171299286145,0.1601513240857503,0.7515858299278976,1.0,7/27,16.17%,CAMK2D;FXYD4;UTRN;FXYD6;FXYD5;DLG1;SCN1B
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5570220176227286,1.291849461692625,0.1768033946251768,0.7517587819741405,1.0,6/14,20.33%,XDH;SPRY2;NOTCH4;SPRED3;SPRED1;ZEB1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5220977800249011,-1.2917700046435954,0.2132132132132132,0.9201261771659134,1.0,5/10,14.74%,UBAC2;UBE2J1;INSIG1;UBE2G2;YOD1
prerank,regulation of cell growth (GO:0001558),0.40812053208752175,1.2912336607404824,0.03423967774420947,0.7528804065630972,1.0,47/204,15.76%,HSPA1B;WNT11;PML;AGT;ESR2;BST2;CAMK2D;HYAL1;SGK3;SGK2;CXCL16;KIF26A;MMP14;SFRP2;FXN;MAD2L2;DDX49;EGLN2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;ATAD3A;FRZB;BCAR1;ST7L;BMPR2;SPHK2;OGFR;CIB1;EI24;SLIT3;ARHGEF11;SOCS2;SERTAD2;RB1;ENPP1;RACK1;APBB1;EXOSC9;PRDM11;NCBP1;TAOK2;ADNP2;CHPT1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4560311921327654,-1.290807776001319,0.1532567049808429,0.9162732846230162,1.0,7/15,21.67%,ABHD16A;HOGA1;ABHD12;SARDH;GGT5;PRODH;ALDH4A1
prerank,response to tumor necrosis factor (GO:0034612),0.4262039939412933,1.2903077555241003,0.08677248677248678,0.755448704465994,1.0,22/91,16.68%,CCL7;HYAL1;ZFP36;GBP3;CD40;CXCL16;GBP2;CRHBP;CCL5;CX3CL1;IGBP1;DHX9;GCH1;CIB1;ZC3H12A;ZFP36L1;CCL14;GGT7;JAK2;INPP5K;ADAMTS12;ACOD1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.49042893159084044,1.2900665516249277,0.15451174289245984,0.7551047142766927,1.0,6/31,11.74%,MOCS3;FDFT1;NFS1;GCH1;MOCOS;DHRS11
prerank,negative regulation of gene expression (GO:0010629),0.40777347502414185,1.2900297381913979,0.01503006012024048,0.753948273823728,1.0,70/302,19.19%,PARP14;IGF2BP1;EIF2AK2;HSPA1B;PARP10;PARP9;MOV10;ABCC2;DAPK3;DHFR;XDH;KDR;PNPT1;ZFP36;DDRGK1;IGF2BP3;AGO2;TARDBP;MECP2;RBL1;SFRP2;RUNX1;PTGER4;LARP1;CNOT7;ILF3;DHX36;FBXW7;NFKB1;PTRH2;ITGB8;DCP2;N4BP1;YTHDF2;DNMT3A;APP;DNMT1;PPP1R11;ZC3H12A;SETDB2;MAP2K2;HAVCR2;PSEN1;REL;APOE;RB1;FCGR2B;RACK1;SHMT1;DIS3L2;PATL2;EZH2;NPTN;BMPR1A;NUDT16;SLC24A3;TIPARP;ENC1;PUS7;DICER1;LGALS9;FLOT2;MRPL13;LSM5;HDAC1;CAPRIN1;HINFP;ASB1;TERF2;TSC1
prerank,regulation of stem cell population maintenance (GO:2000036),0.5363022110418831,1.2895580478482596,0.16644113667117727,0.7544961225018345,1.0,4/18,15.15%,LOXL2;ESRRB;WDR43;ZC3H13
prerank,regulation of cell population proliferation (GO:0042127),0.4009768348014927,1.289446752105109,0.002,0.7536279741501687,1.0,115/691,13.10%,IFIT3;STAT1;STAT2;CXCL10;EIF2AK2;HSPA1B;CXCL9;NAMPT;PML;IL15;AGT;CRLF1;FLT1;SLAMF1;IFI35;TFAP2C;SGK3;SGK2;IRS1;KDR;ZBTB17;CLU;BIRC2;RARG;GAREM1;DDRGK1;TIMELESS;TNFRSF8;GDF9;SOD2;CDH13;MECP2;KITLG;STAT3;NMI;TGFA;CDC25B;ECRG4;AQP11;S1PR2;SFRP2;FXN;RUNX1;CD47;HCK;NACC1;CCND2;TMEM115;CNOT7;TIPIN;JUNB;CDKN2D;OSGIN1;CACUL1;CHERP;SOX9;CTNNB1;CX3CL1;P3H1;PPP2R5C;FGFR2;TCF7L2;BCL6;TFAP2B;CSF1;TMIGD3;CSNK2B;MAGI2;TBC1D8;FRZB;MEIS3;RAPGEF2;CTSH;CCDC88A;IL12RB2;ARID2;BAMBI;LTK;LYN;GDNF;PDPN;APP;SCX;NCK2;INSR;BMPR2;MEN1;ROR2;PROX1;PHIP;CIB1;NPM1;ALDH1A2;CDK10;FAM98B;ZFP36L1;DNAJA3;CTCF;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;IER5;KLF10;THAP12;NOP2;CAPNS1;PRKDC;TSPO;RPS6;CAPN1;CGREF1;LIMS1
prerank,positive regulation of cell motility (GO:2000147),0.408214687332083,1.2893189704963863,0.041289023162134945,0.7528559197178271,1.0,47/205,17.33%,WNT11;FLT1;CCL7;SPRY2;KDR;CPNE3;PIK3CD;DDRGK1;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;STAT3;MYO1C;MMP14;RUFY3;CCL5;FAM83H;CARMIL1;PODXL;CSF1;SNAI2;RET;ELP6;MAPRE1;MYOC;CTSH;BCAR1;PDPN;INSR;ROR2;CIB1;PPM1F;SUN2;XBP1;RACK1;DAB2;STX4;CFAP20;MIEN1;SPAG9;AIF1;SEMA3D;MGAT5;MDK;CBLL1
prerank,regulation of establishment of planar polarity (GO:0090175),0.42890236069209164,1.288783665138221,0.09883103081827843,0.753904062615481,1.0,22/88,14.40%,WNT11;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;PSME4;PRICKLE1;AP2A1;PSMA3;NPHP3;PSMB9;DACT1;ROR2;ARRB2;SPEF1;AP2S1;PSMD2;SMURF1;PSME3;RAC1;PSMA4
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40638862583377366,1.2880910258319969,0.027135678391959798,0.7554279350271157,1.0,52/234,16.98%,EIF2AK2;HSPA1B;TRIM14;AGT;NOD2;ESR2;NOD1;AIM2;WNT5A;CLU;TRIM25;DDRGK1;DHX33;CD40;NFKB2;STAT3;ARID5B;RBCK1;TRIM21;ADAM8;IKBKE;RHEBL1;CTNNB1;CX3CL1;CFLAR;LPAR5;NFKB1;DHX9;SRF;PPIA;TFDP1;RNF31;APP;CRTC1;CIB1;NPM1;RTKN2;TRAF5;TRIM26;PPARGC1A;RNF25;BUD31;IL1RAP;PRKCH;MYD88;CRTC3;TLR2;IL18;LRP8;IRAK1;LGALS9;FLOT2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4317063186771874,1.2878850720713644,0.09304812834224599,0.7550043419596807,1.0,33/78,25.87%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;UBQLN2;NOP53;PRICKLE1;DET1;SIRT6;RNF19B;SOCS5;RBX1;PLK3;UBQLN1;ARIH1;RACK1;DAB2;PIAS1;HECTD1;BCAP31;RNF180;HSPBP1;USP5;NUB1;STUB1;DNAJB2;SUMO1;VCP;BBS7;SIRT2;RAD23A;DDA1
prerank,ether lipid metabolic process (GO:0046485),0.5756042363966938,1.2869860542678009,0.1768033946251768,0.7573491655461716,1.0,7/14,21.00%,TMEM86B;PEX7;GNPAT;PEDS1;PAFAH1B1;PLA2G6;NCEH1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5194489842026456,1.2866000876571995,0.1544502617801047,0.7577556565974456,1.0,6/19,16.81%,PIK3AP1;NMI;PRKCE;TNIP3;IRAK1;LGALS9
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5451939666135726,1.2865768295594884,0.16877637130801687,0.7565414239065752,1.0,2/16,1.21%,AGT;CAMK2D
prerank,regulation of mitotic nuclear division (GO:0007088),0.4444393148273016,1.286314164278159,0.13166855845629966,0.7563373773089046,1.0,11/55,14.38%,PKMYT1;DAPK3;TGFA;CHEK1;PDXP;CUL7;CDK5RAP2;INSR;PHIP;ANAPC15;AURKAIP1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5827258392195429,1.286117391961303,0.2072463768115942,0.7558483445374885,1.0,4/12,12.41%,CCND1;PLK3;WAC;PRKDC
prerank,regulation of fatty acid oxidation (GO:0046320),0.5509747891801049,1.2856934443390517,0.16890080428954424,0.7563133879853936,1.0,5/16,12.33%,LONP2;ACADL;SOX9;ABCD1;PPARGC1A
prerank,regulation of anoikis (GO:2000209),0.5305344103938361,1.285491887831372,0.18083670715249664,0.7557708639110363,1.0,8/19,24.63%,MYBBP1A;PTRH2;SNAI2;SIK1;MCL1;NOTCH1;TLE5;PIK3CA
prerank,histone exchange (GO:0043486),-0.36003121176249087,-1.2852033405036405,0.10191082802547771,0.9308781652464035,1.0,21/37,32.56%,CENPO;ZNHIT1;KNL1;CENPA;ITGB3BP;SPTY2D1;CENPL;MIS18BP1;CENPK;CENPU;CENPC;DMAP1;CENPX;CENPQ;VPS72;CENPH;ANP32E;CENPI;MIS18A;CENPW;RNF8
prerank,determination of left/right symmetry (GO:0007368),0.47549146578328716,1.2848167840937976,0.148859543817527,0.7572249003345434,1.0,5/37,6.83%,PITX2;ODAD2;CCDC40;NPHP3;KIF3B
prerank,presynapse organization (GO:0099172),0.5926187494308952,1.2844404299799062,0.17543859649122806,0.7574771203109968,1.0,3/10,16.20%,WNT5A;LRRTM3;NLGN3
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.5975456813941371,1.283856693269133,0.19196428571428573,0.75847006346444,1.0,6/11,25.07%,RAB21;VPS11;SORL1;DAB2;MSN;PTPN23
prerank,negative regulation of autophagosome assembly (GO:1902902),0.575678803273872,1.2837654591547951,0.15955983493810177,0.7575334108663058,1.0,2/13,0.58%,CHMP4A;CHMP4B
prerank,positive regulation of vasoconstriction (GO:0045907),-0.47419638372677053,-1.2826070455730938,0.18151815181518152,0.933932640869462,1.0,10/13,52.61%,TRPM4;F2R;CAV1;SMTNL2;AVPR2;TBXA2R;OXTR;AVPR1A;ADRA1A;ADRA1B
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5074161582769795,1.282302745891967,0.17048346055979643,0.7621308990706867,1.0,7/26,14.16%,MYOZ2;RCAN1;CHERP;PRNP;CIB1;DYRK2;SPPL3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5452510269662703,1.2818555318284008,0.1814569536423841,0.7625660311316454,1.0,5/16,17.02%,PPCS;SLC25A1;SCD5;GCDH;ACAT1
prerank,T cell receptor signaling pathway (GO:0050852),0.4121603401744008,1.281280836815575,0.07017543859649122,0.7637413401624071,1.0,45/138,21.79%,THEMIS2;PSMB10;ICOSLG;SKP1;PSME2;PIK3CD;PSMA5;PSME4;LCP2;RBCK1;THY1;CD276;PAK3;PSMA3;NFKB1;PSMB9;BCAR1;NCK1;EIF2B2;RNF31;BTRC;ZC3H12A;PSMD2;PSME3;PIK3CB;SPPL3;FYN;PSMA4;CSK;PTPRC;PAG1;PSMD7;EIF2B5;EIF2B3;PSMD8;DENND1B;RC3H2;PSMD9;PDE4B;RIPK2;PSMF1;LCK;PSMB6;PSMC2;PSMD12
prerank,protein complex oligomerization (GO:0051259),0.4289997862126415,1.280441016423979,0.10286320254506894,0.7658028377915744,1.0,13/85,11.64%,RNF213;NOL3;PNPT1;ATL1;AQP11;RBMX;TRMT61B;TMEM120B;TWNK;RS1;G3BP2;ZC3H12A;POLQ
prerank,cellular response to heat (GO:0034605),0.48409549946269065,1.280369645031679,0.15,0.7648192150181412,1.0,13/35,24.83%,HSPA1B;DAXX;DHX36;HSP90AB1;IER5;TRPV4;HSP90AA1;SLU7;HSBP1;STUB1;SUMO1;VCP;YWHAE
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4999354375697595,1.2797046992300107,0.16709511568123395,0.7663731991429223,1.0,13/27,28.84%,NAA50;KAT8;SGF29;KAT7;RUVBL2;KAT6A;KAT5;KAT2B;RUVBL1;EP300;BRD8;ATAT1;NAT8
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4372536619478513,1.2794267821688352,0.1254054054054054,0.7663063928447243,1.0,11/74,10.21%,NOL3;HSPA1B;TNFSF10;EYA4;UNC5B;ACVR1;CFLAR;TCF7L2;SNAI2;GDNF;PHIP
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.44803654505656804,1.2791386145678916,0.13921113689095127,0.766229668365236,1.0,13/48,18.23%,PML;MSH2;CHEK2;BCL2L11;AEN;IKBKE;SNW1;DDIT4;DYRK2;PRKDC;BAX;PHLDA3;FNIP2
prerank,mononuclear cell differentiation (GO:1903131),0.5052375043205886,1.2789021757548322,0.16057441253263707,0.7658443463754112,1.0,6/24,14.16%,AXL;TRPM2;BATF3;LYN;RELB;IKZF1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6038887704505294,1.2786033675161528,0.1816816816816817,0.7657787657438723,1.0,2/10,1.57%,XDH;SPRY2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.603936110312558,1.2785804757377237,0.18816388467374812,0.763310739576638,1.0,4/11,11.49%,ZFP36;AGO2;NOTCH4;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),0.603936110312558,1.2785804757377237,0.18816388467374812,0.763310739576638,1.0,4/11,11.49%,ZFP36;AGO2;NOTCH4;EIF6
prerank,response to muramyl dipeptide (GO:0032495),0.5803211932345536,1.2783904410922082,0.17762237762237762,0.7628591124474646,1.0,2/12,1.42%,NOD2;NOD1
prerank,negative regulation of defense response (GO:0031348),0.43049305944476157,1.2780669635181159,0.10683760683760683,0.7629094142726396,1.0,21/77,21.66%,TRAFD1;AOAH;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;RORA;APOE;CXCL17;RB1;SHARPIN;PPARD;ACOD1;MFHAS1;SIRPA;TNFAIP8L2;MAPKBP1;PRKCD;VPS35
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5419608517465432,1.2774726087424757,0.18232044198895028,0.7640105190333709,1.0,3/17,2.89%,MSH2;STAT3;CD55
prerank,mitochondrial fission (GO:0000266),0.5380033456178424,1.2773560467979674,0.19385026737967914,0.7631746555964094,1.0,8/16,23.67%,MTFR2;FIS1;GDAP1;DNM2;MTFP1;SLC25A46;OPA1;DNM3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.439198630833226,1.2769431416034858,0.11335578002244669,0.763580558597109,1.0,14/62,12.62%,NOL3;TMEM161A;CLU;SOD2;SFRP2;HYOU1;CDKN2D;NME5;SNAI2;PPIA;ACKR3;RTKN2;XBP1;ARMC10
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.41519240577599426,1.2767769068788521,0.08350730688935282,0.7629742869019048,1.0,30/122,16.71%,NLRC5;NAMPT;NOD2;IRS1;PLXNB2;KDR;PPP1R3E;YTHDF1;ZCCHC4;CDT1;NFKB1;DHX9;TMEM106A;SMOC2;INSR;NPM1;XBP1;EIF6;DYRK2;LDB1;PRKDC;UPF3A;STN1;JAK2;IRS2;RBM3;TLR2;PRMT1;MTOR;METTL14
prerank,actin filament bundle assembly (GO:0051017),-0.35103594332627247,-1.2765840810714582,0.13736263736263737,0.9517597887121401,1.0,7/33,7.63%,ADD1;PLS3;CALD1;DPYSL3;MICAL1;EPS8;DMTN
prerank,synaptonemal complex organization (GO:0070193),0.5502377014465413,1.2760904066710117,0.18503401360544217,0.7632707011233911,1.0,2/15,10.06%,SYCP1;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.5502377014465413,1.2760904066710117,0.18503401360544217,0.7632707011233911,1.0,2/15,10.06%,SYCP1;TEX11
prerank,extracellular transport (GO:0006858),0.5673572771267801,1.2757461377930766,0.19676945668135096,0.7633726808370529,1.0,3/13,6.17%,CABYR;CCDC40;ADCY10
prerank,cellular response to misfolded protein (GO:0071218),0.5175432179216812,1.2754896631345716,0.18503937007874016,0.7631456579469855,1.0,9/20,23.56%,AUP1;UBE2W;RNF5;POMT2;RNF185;KLHL15;STUB1;CUL3;VCP
prerank,cytosolic transport (GO:0016482),0.41790005773833905,1.275483342598892,0.10041407867494824,0.7619119195357024,1.0,50/108,26.20%,VPS51;RGP1;KLHL20;RILP;AP2A1;GOSR2;VPS53;TBC1D23;HOOK2;VPS54;DOP1B;BAIAP3;STX8;KIF16B;HOOK1;STX16;RAB14;ARL1;ANKFY1;ANKRD27;CORO7;VPS50;TMEM87A;VPS52;RIC1;VTI1B;HOOK3;PREPL;SPAG9;VPS26A;SNX1;VPS13A;LAMP1;GBF1;GOSR1;WDR91;BECN1;VPS13C;VPS35;SNX2;STX6;RAB29;EEA1;DENND2A;RBSN;PTPN23;CCDC91;DCTN1;TBC1D17;SNF8
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5564606382391261,1.2752368425001268,0.20907840440165062,0.7616156094814365,1.0,4/15,8.32%,ACVR1;CSNK2B;MAGI2;DACT1
prerank,response to lipopolysaccharide (GO:0032496),0.4085834551866534,1.275217651439029,0.06917599186164802,0.760436084971977,1.0,26/138,16.81%,CXCL10;AXL;CD274;CXCL9;IRGM;NOD2;WNT5A;ZFP36;SLPI;NFKB1;HMGB1;MAPK14;GCH1;GIT1;ZC3H12A;XBP1;STAP1;GGT7;JAK2;TNIP2;MYD88;TNIP3;IRAK1;UPF1;ACOD1;LGALS9
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4401552065449577,1.2750022097354585,0.11991199119911991,0.7600676844647271,1.0,20/67,16.08%,AXL;FLT1;KDR;NRP2;ELMO2;CYBB;CYFIP1;BCAR1;NCK1;NCK2;VAV1;MAPK14;VEGFD;PIK3CB;NRP1;RAC1;FYN;HSP90AA1;CRK;BAIAP2
prerank,cellular response to interleukin-6 (GO:0071354),0.48897891722502373,1.2746671319245453,0.1712846347607053,0.7602197647952476,1.0,6/26,14.28%,STAT1;STAT3;NFKB1;PTPN11;ST18;JAK2
prerank,response to copper ion (GO:0046688),-0.4112230095517786,-1.274379359582013,0.1702127659574468,0.9535539289354098,1.0,8/20,1.99%,MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.33959474925151767,-1.2741582053805502,0.10404624277456648,0.9466066557838921,1.0,8/37,10.55%,IL1RAPL1;CD164;ADGRL1;FAT4;CADM3;NECTIN1;ALCAM;TENM3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5036766961921028,1.273098755755634,0.17884130982367757,0.7650797382618564,1.0,9/25,21.71%,HSPA1B;DNAJB4;HSPA8;SDF2;BAG1;PTGES3;HSPA14;ERO1A;DNAJC7
prerank,negative regulation of DNA recombination (GO:0045910),0.46033962537282824,1.2730047873611237,0.1519138755980861,0.7641798255365491,1.0,10/43,12.49%,MSH2;POLR2G;DAXX;CGAS;MAD2L2;RTEL1;POLR2K;POLQ;SHLD1;ZRANB3
prerank,endocrine system development (GO:0035270),0.5105155096936267,1.2727764834101352,0.16452442159383032,0.7638680476988235,1.0,6/21,18.19%,WNT11;TG;DKK3;SOX2;MDK;NF1
prerank,B cell proliferation (GO:0042100),0.5377930070106722,1.2725223553087275,0.19131614654002713,0.7637737343766731,1.0,2/17,2.63%,GAPT;CD40
prerank,DNA modification (GO:0006304),-0.3949571106256684,-1.272173498922081,0.16228070175438597,0.9472233464010861,1.0,10/22,17.51%,PARP2;PARP1;TERF2IP;EXOSC5;OGG1;EXOSC3;NEIL1;PARP3;NEIL3;TERF1
prerank,peroxisomal membrane transport (GO:0015919),0.49897332377919057,1.2713153169523717,0.1735330836454432,0.7673323284830091,1.0,10/27,20.45%,FIS1;RAB8B;PEX7;GDAP1;ABCD1;PEX2;PEX5;PEX13;ATAD1;ABCD4
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5535823644518877,1.2713151345646618,0.19460227272727273,0.766092312604693,1.0,5/14,14.64%,IRS1;ARPP19;SLC45A3;PPARGC1A;IRS2
prerank,regulation of translation (GO:0006417),0.4076844096506139,1.2710656289467999,0.06545820745216516,0.7658831125182326,1.0,52/173,21.13%,IGF2BP1;EIF2AK2;DAPK3;DHFR;PLXNB2;EIF4A2;IGF2BP3;YTHDF1;LARP1;CNOT7;ILF3;DHX36;NCBP2;GSPT1;TCOF1;CYFIP1;ZCCHC4;ALKBH1;DHX9;NOLC1;EIF2B2;APP;EIF4H;NPM1;PUM3;EIF6;PRKDC;UPF3A;RACK1;EIF4G3;SHMT1;EIF1B;PATL2;ETF1;NCBP1;RBM3;MTOR;ENC1;UPF1;PUS7;METTL14;MRPL13;CAPRIN1;EIF4B;OGFOD1;TSC1;EIF5;CSDE1;GLE1;DDX3X;MTG2;RPL5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.42754106190530533,1.2707567699321332,0.10631578947368421,0.7659090465838608,1.0,23/84,19.47%,IGF2BP1;EIF2AK2;DAPK3;DHFR;CLU;IGF2BP3;LARP1;CNOT7;ILF3;DHX36;GGA3;PRNP;SORL1;APOE;RACK1;SHMT1;PATL2;ENC1;PUS7;MRPL13;CAPRIN1;TSC1;PIN1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5740037398195772,1.2706177161302696,0.2023121387283237,0.7652261944124013,1.0,1/13,0.17%,AXL
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.41773174625511594,1.2699686699912398,0.08586387434554973,0.7665296163741475,1.0,10/110,8.40%,CXCL10;CXCL9;CALCA;ABCA1;RXFP2;S1PR2;PTGER4;ADCY5;RAPGEF2;PTGER3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5169396878566412,1.2697288829528957,0.17670682730923695,0.7663323217553623,1.0,4/20,10.05%,HSPA1B;DAXX;HSP90AB1;UBQLN1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4925844124866439,1.2692099389040636,0.17440401505646172,0.7672345709135318,1.0,5/27,9.52%,NOD2;FLT1;IRS1;AGAP2;PIK3R4
prerank,regulation of cell division (GO:0051302),0.4337594751907771,1.2691060679677175,0.11668484187568157,0.7664865991031041,1.0,23/72,19.52%,ESRRB;SFRP2;PDXP;PRPF40A;FGFR2;SH3GLB1;KLHL13;ZFYVE26;PLK3;PIK3R4;GIT1;CIB1;KLHL9;RACK1;AHCTF1;MLLT3;CALM3;RAB11A;BIRC6;UVRAG;BECN1;PIN1;SMYD5
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5990390827004419,1.2686658308072631,0.20926756352765322,0.7669933608520947,1.0,4/10,13.47%,RGP1;EPHA4;RIC1;NELL1
prerank,ncRNA metabolic process (GO:0034660),0.47277293188846015,1.2683480676358603,0.17312348668280872,0.7670284270118088,1.0,9/37,17.17%,AGO2;DTD1;TARBP2;BCDIN3D;MEPCE;DTD2;TUT7;DICER1;PRKRA
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5080056984206975,1.2682759191225954,0.1797175866495507,0.7661023712386466,1.0,11/23,24.70%,IRGM;S1PR2;TNKS1BP1;CAB39;APP;CALM3;UBE2K;RIPK2;AXIN1;CALM2;WNK3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.40520177072552155,1.2682674038628894,0.05263157894736842,0.7649290295341985,1.0,41/170,18.45%,IGF2BP1;ZUP1;TRIM14;IGF2BP3;TARDBP;TRIM21;CGGBP1;SLC8A1;TAPBP;HNRNPK;AFF1;TRIM39;RO60;GDNF;APP;KIF16B;MKLN1;PROX1;ZC3H12A;MARF1;ZFP36L1;HNRNPDL;CTCF;NKAP;TRIM26;PSEN1;APOE;PRDM4;NELL1;POGZ;SOX2;PRDM11;ADNP2;NPAT;AIF1;PCBP4;PTPRC;ZNF445;ZNF513;LDLR;HINFP
prerank,negative regulation of apoptotic process (GO:0043066),0.39504582430533974,1.2679877944063271,0.006006006006006006,0.7648017107760466,1.0,74/444,12.75%,RNF213;IFIT3;NOL3;AXL;HSPA1B;WNT11;CRLF1;MSH2;UNC5B;WNT5A;SPRY2;COMP;KDR;BDNF;BIRC2;DDRGK1;KLHL20;SEMA4D;SOD2;ASAH2;LRP2;ANKLE2;FXN;ADAM8;BFAR;HCK;CCND2;CDKN2D;SOX9;HNRNPK;CTNNB1;CX3CL1;AREL1;MYDGF;CFLAR;IGBP1;NFKB1;TMBIM4;MT3;NRBP2;PTRH2;TFAP2B;SNAI2;CSNK2A2;ATAD3A;AGAP2;HTATIP2;CTSH;LTK;GDNF;BARD1;PDPN;SCX;PLK3;DNAJB6;PHIP;CIB1;ZC3H12A;NPM1;NUAK2;MAG;XBP1;PIM1;CBX4;BAG1;NAA35;ARHGAP10;PSEN1;PPARGC1A;APOE;PRKDC;SOCS2;DFFA;RB1
prerank,regulation of multicellular organismal development (GO:2000026),0.4995660045554676,1.2670726559082826,0.17120622568093385,0.7673121585349972,1.0,6/25,10.99%,OAS2;DHX36;SCX;INSR;HPSE;RAB14
prerank,regulation of stem cell differentiation (GO:2000736),0.4213378903542678,1.2670495545584737,0.11864406779661017,0.7661710249320076,1.0,33/89,23.77%,EIF2AK2;PSMB10;PSME2;ESRRB;PSMA5;PSME4;RUNX1;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;GDNF;PSMD2;LDB1;PSME3;PRKDC;PSMA4;MYB;BMPR1A;PUS7;PSMD7;PSMD8;PSMD9;SMYD5;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;NOTCH1;ZFP36L2;PSMA2
prerank,regulation of cholesterol storage (GO:0010885),0.550948073424502,1.2664655099818296,0.19040902679830748,0.7672206597749218,1.0,3/15,1.79%,NR1H2;ABCA1;ABCG1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.426835504039099,1.2662951887740377,0.1306695464362851,0.7667300035860619,1.0,28/80,19.79%,RER1;ARF3;KIF26A;KIF3C;COG3;ERGIC3;COPE;TMEM115;TAPBP;KIF2C;ARF5;KIF3B;TMED10;KDELR1;SCFD1;RINT1;NAPA;KIF2A;ATP9B;ARF4;KLC2;ERGIC2;TMED3;GBF1;COPB2;GOLPH3L;UVRAG;RAB1A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4435135707396085,1.2659450212883032,0.13591160220994475,0.7668723987134503,1.0,16/63,17.88%,PML;CHEK2;CNOT4;CNOT7;CCND1;TNKS1BP1;TFDP1;PLK3;WAC;TFDP2;PRKDC;E2F4;PRMT1;PCBP4;BAX;CRADD
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4267400690935825,1.265192745666914,0.14162162162162162,0.768782935046411,1.0,28/72,22.66%,PSMB10;SKP1;PSME2;BIRC2;PSMA5;NFKB2;PSME4;PSMA3;PSMB9;BTRC;PSMD2;RELB;PSME3;REL;BIRC3;PSMA4;IRAK1;DICER1;TLR3;COPS8;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5023557565871382,1.2650694843434391,0.19472361809045227,0.7680938372832365,1.0,7/24,8.69%,B2M;TAPBPL;TAPBP;ERAP1;ABCB9;SEC24D;SEC23A
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4920127051961485,1.2648930347424718,0.17518248175182483,0.767590746621171,1.0,6/28,12.20%,CLU;DDRGK1;OSBPL7;FBXW7;CTSC;SMURF1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.38131497573971,-1.2644508013058358,0.12807881773399016,0.9719006890472494,1.0,14/25,25.50%,CARD11;TRAF2;PNP;TRAF6;CCR2;CD86;GLMN;ANXA1;IRF4;CD28;IL1B;IL1A;CD80;RPS3
prerank,cellular response to nitrogen compound (GO:1901699),0.5198712669326783,1.2643863619355251,0.1868279569892473,0.7683647317526745,1.0,6/20,18.95%,DAXX;TIMELESS;RIOK3;DDX11;RTF2;DDI2
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4298450974450813,1.2641363780740942,0.13928182807399347,0.7681055867434412,1.0,25/70,21.79%,EIF2AK2;PSMB10;PSME2;PSMA5;PSME4;RUNX1;KMT2A;PSMA3;PSMB9;YTHDF2;LMO2;PSMD2;LDB1;PSME3;PRKDC;PSMA4;MYB;PUS7;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,regulation of B cell activation (GO:0050864),0.4928464829911999,1.2639289427366547,0.1677175283732661,0.7678034586622542,1.0,5/25,14.67%,THEMIS2;NOD2;ZFP36L1;FCGR2B;TNIP2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.47429085268950405,-1.2636769674727941,0.1806853582554517,0.9672919959486997,1.0,7/12,20.44%,SYT2;RIMS1;RIMS3;UNC13A;SYT8;RIMS2;SYT1
prerank,ureteric bud development (GO:0001657),0.5418627481746242,1.2632505346934775,0.16997167138810199,0.7693558327190658,1.0,2/17,5.99%,WNT11;FGFR2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.4100499156028219,1.263192792842122,0.09558067831449127,0.7683760408797209,1.0,54/132,23.57%,NOL3;SRPK3;PWP2;TXNL4A;PRPF18;ERAL1;TARBP2;MDN1;NOP53;HSP90AB1;DDX20;RRS1;PPAN;DHX9;SRPK1;TGS1;EIF4H;EIF6;EIF3A;CELF6;NOP2;PRKDC;USP39;DENR;SART1;CLNS1A;GEMIN7;SNRPD2;SNRPD1;DDX39B;HSP90AA1;SNRPG;NCBP1;GEMIN2;RPL23A;RPL11;DICER1;PTGES3;DDX23;RSL24D1;RPL24;EIF4B;RPL3;MRPS11;SNUPN;EIF5;RPL5;SRSF5;SF3A2;RPL6;SRSF10;SART3;LSM4;SNRPD3
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5016097612366446,-1.2624417890389907,0.2123076923076923,0.9648848363985174,1.0,5/11,22.82%,AGBL4;ATG5;AGTPBP1;ICMT;LCMT1
prerank,myeloid dendritic cell activation (GO:0001773),0.5658991652685723,1.2623939525783565,0.2143928035982009,0.7702511687857694,1.0,3/12,9.14%,SLAMF1;BATF3;HMGB1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.4865030692990254,1.2622309131942433,0.17189460476787954,0.769691130382859,1.0,10/30,21.71%,HSPA1B;DNAJB4;ENTPD5;HSPA8;SDF2;BAG1;PTGES3;HSPA14;ERO1A;DNAJC7
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5158305414330352,1.2621661713091674,0.17662007623888182,0.768785204307626,1.0,9/24,22.87%,LOXL2;SOX9;SNAI2;PTPN11;SOX5;ADAMTS12;MDK;ACVRL1;PKDCC
prerank,protein localization to mitochondrion (GO:0070585),0.5889760841758165,1.2621468512330942,0.20206489675516223,0.7676806457954262,1.0,2/11,9.69%,ISG15;HK1
prerank,replicative senescence (GO:0090399),0.575244174452529,1.2620405323432078,0.21212121212121213,0.7669430630589522,1.0,2/12,4.46%,CHEK2;CHEK1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5309747303009005,1.2610462826211954,0.20806241872561768,0.7696833469689683,1.0,5/18,12.63%,ZFP36;BCL2L11;ZFP36L1;NR3C1;UBE2L3
prerank,SNARE complex assembly (GO:0035493),0.5947839883363324,1.2604848017080785,0.19196428571428573,0.7707170919013487,1.0,5/10,19.13%,CLTRN;VAMP1;VAMP2;VAMP4;UVRAG
prerank,protein polymerization (GO:0051258),0.4400214670411383,1.2600016709218285,0.14093959731543623,0.7714858673159463,1.0,17/56,19.70%,CHMP4A;CHMP4B;CENPJ;GAS7;TPPP3;CHMP3;CORO7;GSN;TRPV4;FGF13;RAC1;JAK2;AIF1;UBE2K;TTC17;PIN1;GPX4
prerank,positive regulation of cell adhesion (GO:0045785),0.4257463988752652,1.2594899479490538,0.1385606874328679,0.7723445405682535,1.0,16/74,14.28%,FBLN2;HYAL1;SFRP2;ADAM8;CD47;CCL5;EPHA4;RET;MEGF10;CIB1;DUSP26;PPM1F;LIMS1;RAC1;STX4;JAK2
prerank,RNA catabolic process (GO:0006401),0.45325235911877315,1.2593041659502178,0.1629802095459837,0.7718802722671148,1.0,20/46,24.23%,HSPA1B;PNPT1;ZFP36;XRN2;RNASEH2A;DCP2;FEN1;RNASEH2C;YTHDF2;DIS3L2;NCBP1;RNASEH2B;NUDT16;LSM5;ERN1;RNASEH1;AGO4;RNH1;ZFP36L2;RNASE3
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5910420049006722,1.2584395668056954,0.21720116618075802,0.7740478777422132,1.0,2/10,5.48%,WNT5A;CTNNB1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5566277612016527,1.2573820559496744,0.20689655172413793,0.7770659772201599,1.0,5/15,14.72%,NOD2;GBP5;STAT3;IL17D;MYD88
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4044378129040412,1.257182931854627,0.059837728194726165,0.7766699895913752,1.0,58/161,24.15%,WNT11;PSMB10;WNT5A;PSME2;PSMA5;PSME4;TMEM170B;SFRP2;MAD2L2;PRICKLE1;PFDN5;SOX9;PSMA3;TCF7L2;NPHP3;SNAI2;AMFR;BICC1;CYLD;FRZB;PSMB9;DACT1;RBX1;DKK3;PSMD2;SCYL2;PSME3;APOE;LZTS2;DAB2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD8;STK3;PSMD9;PSMF1;STK11;PSMB6;PSMC2;PSMD12;GLI3;RUVBL2;PSMD4;CUL3;LIMD1;CHD8;AXIN1;PSMA2;TLE5;KREMEN1
prerank,regulation of macrophage differentiation (GO:0045649),-0.4415943853855156,-1.2571810506591754,0.19572953736654805,0.9789418903059328,1.0,7/15,22.22%,CASP8;ID2;RIPK1;PTPN2;PF4;IL34;INHBA
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4453945150857373,-1.257073797752607,0.20238095238095238,0.9717447443265252,1.0,7/14,21.65%,NFKBIA;FAF1;KEAP1;NFKBIE;NFKBIB;PSMD10;CCDC22
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.40559239356171706,-1.2569987140040508,0.15625,0.9646278500294783,1.0,11/21,24.13%,CHSY1;VCAN;CSGALNACT1;CHST7;CHST15;CHST3;BGN;DCN;BCAN;UGDH;CSPG5
prerank,histone H3-K4 methylation (GO:0051568),0.49230690090409945,1.2566680457773218,0.1641025641025641,0.777370802930752,1.0,7/26,14.85%,DPY30;RBBP5;KMT2A;MEN1;WDR5;PAXIP1;TET2
prerank,protein stabilization (GO:0050821),0.4054516539194172,1.2565558680463673,0.06882591093117409,0.7766236086555167,1.0,44/168,19.90%,HSPA1B;IRGM;ZSWIM7;CLU;FKBPL;GOLGA7;CHEK2;RAB21;ATP1B3;LAMP2;COG3;OTUD3;NOP53;UBE2B;HSP90AB1;MORC3;SEC16A;FBXW7;P3H1;EPHA4;MT3;TRIM39;CDC37L1;CAMLG;CCT4;CCT7;CCT3;BAG1;PPARGC1A;TELO2;TNIP2;HSP90AA1;RPL11;FLOT2;PRKRA;PTGES3;LAMP1;CDC37;IFT46;STK3;TSC1;PIN1;AAK1;TYROBP
prerank,cellular response to growth factor stimulus (GO:0071363),0.4044297949237071,1.2564389184127727,0.08094262295081968,0.7758634693601212,1.0,44/151,20.37%,FLT1;HYAL1;WNT5A;SPRY2;KDR;CPNE3;ZFP36;GAREM1;ACVR1;HAS1;LRP2;CCL5;DUSP3;SOX9;CTNNB1;MAP2K3;SNAI2;MAGI2;RAPGEF2;BCAR1;BMPR2;MAPK14;CIB1;ZFP36L1;PTPN11;GAS1;NR3C1;RACK1;LIMS1;RAPGEF1;NRP1;CORO1B;INPP5K;BMPR1A;SOX5;ADAMTS12;PDE3A;STMN2;ACVR2A;DSTYK;ERN1;ACVRL1;APPL2;WWOX
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5682894298750976,1.2563724497990059,0.19327731092436976,0.7749795595751076,1.0,3/14,4.06%,DDRGK1;BCL2L11;BFAR
prerank,autonomic nervous system development (GO:0048483),0.5256022194275255,1.256327228301997,0.19489247311827956,0.7739633410514095,1.0,6/17,18.19%,KIF26A;TFAP2B;GDNF;NRP1;PHACTR4;NF1
prerank,regulation of histone modification (GO:0031056),0.5571296120213084,1.2563201590273587,0.19913419913419914,0.7728244996203228,1.0,2/13,10.82%,MTHFR;SETD5
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.5425009251375956,1.2557626854365127,0.19040902679830748,0.7739889825295335,1.0,4/15,11.94%,BDNF;BCAR1;DDIT4;SOS1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4038475188618947,1.2549620363424134,0.11076923076923077,0.7760377278726873,1.0,24/140,15.25%,CHRNA9;CALCA;CXCR4;FIS1;CD55;FPR3;SLC8A1;PTGER4;ADCY5;TACR1;GNA15;TAC1;PTGER3;CACNA1A;ACKR3;P2RX4;HMGB1;TAC4;C3AR1;GPR35;TRPV4;SPPL3;NPTN;SELENOT
prerank,fatty acid beta-oxidation (GO:0006635),0.4405936407861891,1.2544403909073807,0.1622554660529344,0.7769059360606373,1.0,16/51,21.17%,MCAT;ACOXL;ACADL;ECI2;AUH;ABCD1;PEX2;ACADS;GCDH;PPARD;HADHA;ACAT1;ACOX1;HADH;ABCD4;DECR2
prerank,somite development (GO:0061053),0.5883472490196164,1.253507019819242,0.21726190476190477,0.7795281973812973,1.0,4/11,22.45%,SFRP2;PTCH1;MTHFD1;PPP2R3A
prerank,focal adhesion assembly (GO:0048041),0.5050580490829162,1.2526472030868618,0.2102496714848883,0.7818194461163273,1.0,9/21,17.13%,ACTN1;THY1;ACTN2;PEAK1;ARHGEF7;PIP5K1A;WHAMM;TAOK2;BCR
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3952583575535836,-1.2518676507926034,0.15086206896551724,0.9780247369564535,1.0,11/22,20.66%,PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;GTF2H3;XPA;GTF2H4
prerank,regulation of cellular component movement (GO:0051270),0.43967594838903323,1.2518628537253051,0.1658878504672897,0.783655104002755,1.0,9/49,9.79%,SP100;DAPK3;ACTN1;YTHDF1;PKN2;IGBP1;LYN;PDPN;ZSWIM8
prerank,modification-dependent protein catabolic process (GO:0019941),0.39676322339342474,1.2514427328629176,0.06559031281533804,0.7841605747739734,1.0,53/193,19.31%,RNF213;ISG15;UBE2L6;DTX3L;TRIM25;CDC26;FBXO7;ANAPC5;RNF40;RNF5;BFAR;CNOT4;SIAH1;UBQLN2;UBE2B;RNF11;AREL1;RNF114;AMFR;SPSB1;ANAPC4;RNF19B;RBX1;PPP1R11;UBE2E1;UBQLN1;ARIH1;ELOC;BTRC;CDC16;XBP1;CDC27;LONP1;RNF149;SMURF1;FBXL14;UBE2L3;RNF185;ANAPC15;MYLIP;UBE4B;UBR4;UBA1;ANAPC2;RNF166;UBE2K;KLHL15;BIRC6;RFFL;WDR91;PTTG1;RC3H2;PSMD9
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4339331414828916,1.2511589005855874,0.15575620767494355,0.7841767454640041,1.0,15/59,20.66%,MCAT;PER2;OSBPL7;CH25H;LIPC;OSBPL3;ALDH1A2;XBP1;CYP27A1;OSBPL9;OSBP;OXSM;OSBPL2;ELOVL4;CYP39A1
prerank,positive regulation of cell population proliferation (GO:0008284),0.39086752573815425,1.2508043259091814,0.021,0.7844468585159303,1.0,88/423,17.40%,STAT1;NAMPT;IL15;AGT;CRLF1;NOD2;BST2;FLT1;SLAMF1;HYAL1;WNT5A;IRS1;KDR;GAREM1;DDRGK1;GDF9;CDH13;MECP2;KITLG;TGFA;CDC25B;AQP11;S1PR2;SFRP2;FXN;LAMC1;CD47;HCK;NACC1;CCL5;CCND2;CNOT7;TIPIN;CACUL1;SOX9;CX3CL1;FGFR2;TCF7L2;TFAP2B;CSF1;TBC1D8;DHX9;MEGF10;MEIS3;CTSH;IL12RB2;SIRT6;BAMBI;LYN;GDNF;SCX;INSR;PROX1;PHIP;CIB1;NPM1;HPSE;FAM98B;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;PIM1;NOP2;CAPNS1;RPS6;CAPN1;BAD;CHTOP;STX4;PRKCH;SERTAD1;IRS2;EZH2;BMPR1A;PRMT1;ACER3;FGFR3;AIF1;IL18;NDUFS4;TCIRG1;RBPJ;MDK;RPS15A;PTPRC
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4624941715399425,1.2507843706653359,0.18396226415094338,0.7833600861772375,1.0,4/38,6.12%,SP100;TNFSF10;FEM1B;CFLAR
prerank,apoptotic mitochondrial changes (GO:0008637),0.46907110923693324,1.2504177213288654,0.1814859926918392,0.7836380580874116,1.0,7/32,13.26%,IFIT2;CLU;FIS1;SOD2;TIMM50;BAD;NDUFS1
prerank,regulation of cell aging (GO:0090342),0.5721380533828415,1.249696568311634,0.213089802130898,0.785398154912613,1.0,3/11,11.87%,PNPT1;RSL1D1;NEK6
prerank,protein kinase A signaling (GO:0010737),0.5550010308636426,1.2495953365938286,0.20658682634730538,0.7846519456565817,1.0,1/12,0.59%,GAL
prerank,regulation of cytoplasmic transport (GO:1903649),0.5825489116486289,1.2495813745971105,0.20485584218512898,0.7835579534378028,1.0,4/11,14.69%,DNAJC13;CHMP3;MAP2K2;DENND10
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5635575147173381,1.2491150992143938,0.2183406113537118,0.784374490295706,1.0,4/12,15.88%,XDH;SPRY2;PIK3CB;ADAMTS12
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5092820779112412,1.2480804259594367,0.21141374837872892,0.7874080521792247,1.0,7/21,11.82%,KDR;PTGER4;SOX9;MT3;CTSH;ZFP36L1;MAP2K2
prerank,regulation of cardiac conduction (GO:1903779),0.4365383891873207,1.2480499549802138,0.1547212741751991,0.7863487929955804,1.0,9/54,10.98%,AGT;ASPH;FXYD4;ATP1B3;SLC8A1;ITPR1;NPPC;FXYD6;AHCYL1
prerank,pre-miRNA processing (GO:0031054),0.5610336455650242,1.2479979001440284,0.2028169014084507,0.7853943751362531,1.0,6/14,17.17%,ADAR;AGO2;TARBP2;TUT7;DICER1;PRKRA
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4960515674363947,1.247778864140314,0.18840579710144928,0.7851287695299013,1.0,9/21,22.01%,PGD;PGM2L1;PGLS;HK1;RPIA;DERA;RPE;TKT;TALDO1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.443676904888105,-1.247534774484672,0.2168284789644013,0.9890727885700327,1.0,4/14,12.53%,XRCC5;TERF2IP;PINX1;NABP2
prerank,tRNA modification (GO:0006400),0.4264407977275369,1.2473754299616033,0.15555555555555556,0.785525426781075,1.0,21/62,21.54%,TPRKB;TRMT9B;OSGEP;MOCS3;BCDIN3D;ADAT2;TRMT1;TRMT13;ALKBH1;AARS1;TRMT61B;THADA;WDR4;DUS2;PUS7;THUMPD3;TYW3;GTPBP3;METTL1;TARBP1;PUS10
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3745855842134126,-1.2473353098675342,0.1688888888888889,0.9824776130497135,1.0,9/24,18.66%,TGFB1;NUMB;RHOQ;DMTN;TMBIM1;GDI1;ABI3;ITGB1BP1;PICALM
prerank,autophagy of peroxisome (GO:0030242),0.5687096710737862,1.2472388899511806,0.21242774566473988,0.7849418918280564,1.0,5/12,16.91%,NBR1;PIK3R4;MAP1LC3B;RB1CC1;PEX5
prerank,peripheral nervous system development (GO:0007422),0.49219439523195235,1.2464315181390488,0.19440914866581957,0.7870319726076522,1.0,5/23,18.19%,PMP22;BDNF;GDNF;SCN8A;NF1
prerank,diterpenoid metabolic process (GO:0016101),0.4329522009429639,1.2464059486797299,0.15056179775280898,0.7859986394199102,1.0,9/55,13.22%,BCO2;SDC3;SDC4;LRP2;RDH11;AGRN;AKR1B10;APOE;ALDH1A1
prerank,icosanoid biosynthetic process (GO:0046456),-0.49967548111405313,-1.2461382433015058,0.20118343195266272,0.9802306950369192,1.0,2/10,4.65%,LTC4S;ALOX5AP
prerank,response to iron ion (GO:0010039),0.5661273839668235,1.246116263314726,0.22346368715083798,0.7860073693770877,1.0,4/12,14.72%,B2M;FXN;SLC11A2;TFR2
prerank,outflow tract septum morphogenesis (GO:0003148),0.5001662448736425,1.2459849070701612,0.18043202033036848,0.7853900488420111,1.0,7/24,15.34%,NRP2;ACVR1;LRP2;FGFR2;BMPR2;NRP1;BMPR1A
prerank,lymphocyte mediated immunity (GO:0002449),0.5639711711786464,1.2447118667849972,0.23008849557522124,0.789128471771565,1.0,2/12,2.89%,MSH2;CD55
prerank,regulation of centrosome cycle (GO:0046605),0.5013958109306023,1.2446252162834315,0.20155038759689922,0.7883396297842069,1.0,8/21,18.09%,CHMP4B;CHMP1B;XRCC3;NPM1;CEP131;CHMP3;GEN1;CHMP5
prerank,nucleic acid metabolic process (GO:0090304),0.41547213163731644,1.244624924924216,0.1423948220064725,0.7871971085816211,1.0,23/69,19.35%,POLR2G;XRN2;HNRNPH1;RBMX;NCBP2;HNRNPK;HNRNPM;FEN1;HNRNPA2B1;POLR2K;HNRNPL;DDX24;HNRNPA1;DDX54;ENPP1;DNASE2;DUSP11;RECQL5;NCBP1;METTL14;HNRNPA3;WTAP;HNRNPF
prerank,negative chemotaxis (GO:0050919),-0.34438483090135397,-1.2436840816799168,0.10695187165775401,0.982991040003614,1.0,19/33,29.01%,SEMA4C;UNC5C;ITGAV;SEMA4G;SEMA4A;EPHA7;SEMA6A;SEMA4B;SEMA3E;RHOA;ITGB3;NTN1;SEMA6D;SEMA4F;ROBO1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,regulation of protein localization to cell surface (GO:2000008),0.47360290885422934,1.2430311725107202,0.19146341463414634,0.7923587996167754,1.0,16/33,25.74%,BDNF;SNX33;ACTN2;HSP90AB1;CTNNB1;RAB11B;LEPROT;LEPROTL1;STX4;GBF1;TYROBP;TM9SF4;RAB11FIP5;COMMD1;TNF;TMEM35A
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4869182681685227,1.242468367277191,0.2002503128911139,0.793307175864152,1.0,6/25,17.13%,TNFSF10;MLLT11;BCL2L11;BAD;BMF;BAX
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5434670662387666,1.2423737142198077,0.20523415977961432,0.7925110706749504,1.0,3/15,7.13%,SAT1;DDC;SMOX
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.39716743319821574,1.242343829040222,0.07661290322580645,0.7914774649193237,1.0,63/208,22.04%,STAT1;EDAR;TNFSF10;TRIM14;NOD2;BST2;NOD1;WNT5A;ALPK1;TRIM25;BIRC2;CD40;CANT1;RBCK1;TRIM21;IKBKE;DHX36;CX3CL1;TRAF4;CFLAR;TRIM39;TSPAN6;TMEM106A;TMEM9B;RNF31;TRAF3;RORA;SPHK2;TNIP1;ZC3H12A;RIOK3;TRAF5;IRAK4;NEK6;REL;MIER1;SHARPIN;AKAP13;BIRC3;TNIP2;MYD88;TNIP3;IRAK1;MIB2;ZDHHC13;LGALS9;CXXC5;TRIM62;TFG;UBE2V1;TAB3;TANK;RIPK2;PER1;TRIM13;ZFAND6;MAPKBP1;RHOH;OPTN;LITAF;ROR1;S100A13;GOLT1B
prerank,protein modification by small protein conjugation (GO:0032446),0.3881772463982734,1.2422428742012024,0.025050100200400802,0.7907338848220388,1.0,91/361,18.78%,RNF213;IFIH1;ISG15;TRIM14;DTX3L;NUP37;SKP1;UBE2W;NFX1;DDRGK1;KLHL20;TMEM129;UVSSA;HLTF;CUL5;ARRDC4;FBXO7;RNF40;MOCS3;TRIM21;SUMO2;SUMO3;CNOT4;NUP153;UBE2B;TNFAIP1;FBXW7;AREL1;HERC2;CUL7;TRIM39;UBE2M;VPS11;DET1;AMFR;KLHL13;SPSB1;FBXW8;DCUN1D4;DCAF15;CAND1;RAE1;UCHL3;RBX1;UBE2E3;BARD1;UBA2;PEX2;UBE2E1;WAC;ZSWIM8;VCPIP1;ARRB2;ARIH1;ELOC;BTRC;RNF103-CHMP3;CDC16;CDC27;TRIM26;SMURF1;KLHL9;PRKDC;UBE2L3;RACK1;MYLIP;RNF25;NSMCE2;NUP155;MYCBP2;RNF103;LZTR1;PIAS1;UBA1;PIAS2;LMO7;ENC1;MIB2;PEX5;FBXL5;PEX13;UBE2K;CBLL1;NUP88;BIRC6;CAND2;TRIM62;WWP1;PCNP;MGRN1;ASB1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.36693129934596624,-1.2419434599555979,0.14673913043478262,0.98335860754363,1.0,7/26,12.68%,TGFB1;SULF1;CCBE1;NOX1;C3;BRCA1;CCR2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4179046176308793,1.2414657417920554,0.16021505376344086,0.7914796597189981,1.0,22/78,16.49%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;KIF3B;SEC24D;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;FCGR2B;DYNLL1;KIF2A;SEC24A;KLC2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4179046176308793,1.2414657417920554,0.16021505376344086,0.7914796597189981,1.0,22/78,16.49%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;KIF3B;SEC24D;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;FCGR2B;DYNLL1;KIF2A;SEC24A;KLC2
prerank,double-strand break repair (GO:0006302),0.39750932508371906,1.2412968796625,0.08717948717948718,0.7909776930156526,1.0,39/158,15.72%,SAMHD1;PARP9;TENT4A;DTX3L;ZSWIM7;SEM1;CHEK2;APLF;POLM;MAD2L2;AP5Z1;HELQ;POLB;TNKS1BP1;KDM4D;HERC2;MCM9;BRIP1;UBXN1;RAD51C;FEN1;ERCC4;XRCC3;ACTR8;BARD1;HMGB1;ZFYVE26;CIB1;POLQ;PRKDC;PAXIP1;APBB1;NSMCE2;NSMCE1;DCLRE1A;GEN1;RMI1;RECQL5;NHEJ1
prerank,chemical homeostasis (GO:0048878),0.4284669681357196,1.2412842946270943,0.16981132075471697,0.7898963058281139,1.0,19/61,21.55%,ACOXL;USF2;PNPLA2;AQP11;TLCD2;FBXW7;USF1;ABHD8;AQP4;THADA;IRS2;SLC4A2;ACOX1;PNPLA3;NR1D2;DDX3X;ZBTB20;ADCK1;PNPLA8
prerank,regulation of histone methylation (GO:0031060),0.5499853903178946,1.2411616028887584,0.2272069464544139,0.7892261754180048,1.0,3/13,13.37%,MTHFR;AASS;CHTOP
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5444411977457738,1.2410124536414096,0.21861777150916784,0.7886952486690169,1.0,6/15,18.10%,NR1H2;SLC27A1;FBXW7;SIK1;SREBF1;LDLR
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5972395453895425,1.2409466695151126,0.21820809248554912,0.7878345188073549,1.0,5/10,22.87%,LOXL2;SOX9;SOX5;ACVRL1;PKDCC
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.463062902006399,1.240796745092233,0.1928746928746929,0.7873298989730843,1.0,7/31,12.63%,TRIB3;SKP1;ARRDC4;FBXW7;DCUN1D4;BTRC;UBE2L3
prerank,regulation of autophagosome assembly (GO:2000785),0.46216694768848693,1.2402809778150983,0.20818291215403129,0.7881596028881286,1.0,5/33,6.36%,CHMP4A;CHMP4B;UBQLN2;LRSAM1;SH3GLB1
prerank,regulation of receptor binding (GO:1900120),0.5909451341378235,1.2401510486067389,0.20790629575402636,0.7874881565360181,1.0,2/10,2.20%,BDNF;B2M
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.41967328796802394,1.2385879004506593,0.13976164680390032,0.7925908874452909,1.0,24/75,24.65%,WNT5A;KDR;PIK3CD;CDH13;NRP2;PLXNB3;MYDGF;SIRT6;EGFL7;HMGB1;BMPR2;PROX1;VEGFD;NRP1;AGGF1;MDK;ITGA4;F3;AKT3;FGF2;STAT5A;PDPK1;ANG;SCG2
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5115330813235281,1.2385363844282502,0.21853388658367912,0.7916499095165382,1.0,4/19,14.64%,IRS1;PNPLA2;ABCD1;IRS2
prerank,cytoplasmic translational initiation (GO:0002183),0.5286677019623968,1.238517329150664,0.21191135734072022,0.790611054952647,1.0,8/17,21.50%,EIF4A2;EIF4H;EIF3A;DENR;EIF2B3;EIF4B;EIF5;EIF3I
prerank,negative regulation of DNA metabolic process (GO:0051053),0.48677995373903266,1.238220677621253,0.20077720207253885,0.7906752115466802,1.0,10/24,20.17%,MSH2;KMT2A;RTEL1;ERCC4;BMPR2;ZRANB3;DFFA;DACH1;TERF2;ACVRL1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.43926724337496525,-1.23771497856357,0.20912547528517111,0.9866757496820778,1.0,7/15,18.29%,SORBS1;ARRB1;PDLIM1;SRC;RHOA;FAM171A1;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.43926724337496525,-1.23771497856357,0.20912547528517111,0.9866757496820778,1.0,7/15,18.29%,SORBS1;ARRB1;PDLIM1;SRC;RHOA;FAM171A1;KCTD13
prerank,retinoid metabolic process (GO:0001523),0.41836541621593687,1.237559454253699,0.13864628820960698,0.792141297381032,1.0,11/71,13.22%,BCO2;SDC3;SDC4;LRP2;RDH11;CYP26B1;AGRN;ALDH1A2;AKR1B10;APOE;ALDH1A1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5055481014068419,1.2369577586936118,0.20822281167108753,0.7933381777017616,1.0,8/20,17.35%,TRIB3;SLC27A1;ACADL;FBXW7;ASXL3;SIK1;ERLIN2;PRMT3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4800909973022543,1.236943806396201,0.20984455958549222,0.7922858919045378,1.0,4/26,1.58%,IFIH1;NOD2;NOD1;ALPK1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.3359744780454256,-1.2367875219668651,0.136986301369863,0.9834391844011933,1.0,17/38,24.84%,CENPO;ASF1A;HAT1;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;HIRA;CENPK;CENPU;CENPC;CENPX;ATRX;ASF1B;CENPQ;CENPH
prerank,endothelial cell differentiation (GO:0045446),0.569734320754083,1.2366729802927618,0.22060957910014514,0.7922728187726819,1.0,4/12,10.08%,KDR;EDF1;BMPR2;PROX1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3858380285068502,1.2358592166461904,0.03003003003003003,0.7944347077418897,1.0,119/341,23.59%,RNF213;PML;PSMB10;UBE2L6;DTX3L;PSME2;TRIM25;UBE2W;BIRC2;KLHL20;PSMA5;UBAP1;CDC26;RNF4;FBXO7;PSME4;ANAPC5;RBCK1;RNF40;FEM1B;RNF5;MVB12A;BFAR;CNOT4;SIAH1;UBQLN2;UBE2B;TNFAIP1;RNF11;KCTD17;FBXW7;CTNNB1;PPP2R5C;AREL1;PSMA3;UBXN1;RNF114;AMFR;SPSB1;PSMB9;ANAPC4;RNF19B;RBX1;VPS37A;PPP1R11;UBE2E1;ZSWIM8;UBXN2B;UBQLN1;ARRB2;ARIH1;ELOC;BTRC;UBXN11;RNF122;PSMD2;CDC16;XBP1;CDC27;RNF149;SMURF1;PSME3;FBXL14;VPS28;UBE2L3;FBXL19;RNF185;ANAPC15;SHARPIN;ZRANB1;MYLIP;UBE4B;PSMA4;NHLRC3;APPBP2;UBR4;UBA1;ATE1;ANAPC2;GID4;RNF166;UBE2K;KLHL15;BIRC6;TRIM2;WWP1;PSMD7;PCNP;RFFL;WDR91;PSMD8;PTTG1;RC3H2;PSMD9;ZFAND2A;SPOP;PSMF1;TRIM13;PSMB6;RNF216;PSMC2;NUB1;PSMD12;USP33;HUWE1;UBQLN4;SMURF2;TSG101;STUB1;ADRM1;PSMD4;CUL3;PELI1;KCTD21;KAT5;FEM1A;FEM1C;VCP;MAEA
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5479013951529836,1.2357207248652766,0.2404692082111437,0.7938634263858673,1.0,6/13,16.50%,IRS1;PPP1R3E;INSR;DYRK2;IRS2;PHKG2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4679108108413685,1.2353940494925177,0.18650306748466258,0.7939686186642122,1.0,14/33,25.15%,BDNF;GRIK3;EIF4EBP2;ABR;CACNA1A;IQSEC2;GRID1;NLGN3;LRP8;BCR;LRRC4;GRIK4;GRIK5;GRIK2
prerank,regulation of T cell mediated immunity (GO:0002709),-0.49000816363593996,-1.234799138194394,0.2063953488372093,0.9849532240038686,1.0,5/10,14.68%,ZBTB1;TRPM4;TNFRSF1B;CCR2;WAS
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.45507041494855927,1.2346134324022981,0.19567827130852342,0.7959387280100122,1.0,11/37,15.54%,PNPT1;XRN2;ENTPD3;ENTPD6;RNASEH2A;NUDT5;RNASEH2C;ENTPD5;NCBP1;RNASEH2B;NUDT16
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4178997220577503,1.2344708318181756,0.1526147278548559,0.7953900790700587,1.0,31/76,25.87%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;NOP53;FBXW7;PRICKLE1;DET1;RNF19B;SOCS5;RBX1;ARIH1;SMURF1;RACK1;DAB2;PIAS1;HECTD1;RNF180;HSPBP1;USP5;NUB1;STUB1;DNAJB2;SUMO1;VCP;AXIN1;BBS7;SIRT2;RAD23A;DDA1
prerank,endochondral bone morphogenesis (GO:0060350),0.5826498839445917,1.2339405016588507,0.2353823088455772,0.7963306951263232,1.0,5/11,16.05%,COL13A1;SCX;BMPR2;TRPV4;FGFR3
prerank,alcohol catabolic process (GO:0046164),0.5901749238656255,1.2339366512122687,0.23502994011976047,0.7952399964838138,1.0,3/10,12.35%,MT3;CYP27A1;APOE
prerank,positive regulation of protein depolymerization (GO:1901881),0.5816548791238862,1.2337451889412072,0.24193548387096775,0.7948920436678787,1.0,4/11,18.71%,PDXP;TRPV4;STMN2;CFL2
prerank,positive regulation of synaptic transmission (GO:0050806),-0.28619719423653667,-1.2337329776792383,0.06976744186046512,0.9825333830778964,1.0,28/72,21.51%,GRIN2A;GRIN2B;CACNG7;DLG4;PRKCZ;TSHZ3;RGS14;EPHB2;NLGN2;SLC8A3;FLOT1;CACNG8;NRXN1;RIMS1;SHANK3;STX1B;CHRNA7;RIMS3;CCR2;SHISA7;ZDHHC12;RIMS2;CACNG2;KCTD13;PLK2;SYT1;CACNG3;SLC8A2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4086864478188738,1.2328129940285246,0.1544973544973545,0.7974817869412026,1.0,23/87,19.35%,HYAL1;POLR2G;ZFP36;HNRNPH1;CCL5;NCBP2;FGFR2;HNRNPM;POLR2K;KIF16B;ZFP36L1;RAB14;FGF9;HNRNPA1;PTPN11;TIAL1;NCBP1;FGFR3;FLRT2;FIBP;DSTYK;SPRED1;HNRNPF
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5659577952018161,1.2318223198720912,0.2519201228878648,0.8004013114379954,1.0,3/10,15.33%,DHX36;NCBP2;NCBP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.43756366247405337,1.231599253775338,0.19908466819221968,0.8002110649675831,1.0,9/51,16.89%,CXCL10;CCL5;CSF1;HMGB1;VEGFD;CXCL17;AIF1;LGALS9;MDK
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5318869856399087,1.2315912426751252,0.23333333333333334,0.7991515745357314,1.0,6/15,16.03%,IRS1;SLC45A3;LDLRAP1;PRKCE;IRS2;PPARD
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.41973451310858956,1.231534793441077,0.1721132897603486,0.7982758975135428,1.0,19/67,18.86%,FBLN2;UTRN;CDH13;CX3CL1;CARMIL1;ARHGEF7;CSF1;MYOC;CIB1;PPM1F;LIMS1;NRP1;RAC1;JAK2;RREB1;CRK;MDK;VIT;TESK1
prerank,regulation of mitotic cell cycle (GO:0007346),0.39264385920592143,1.231354081508492,0.10435663627152988,0.797893545026988,1.0,36/171,13.12%,PKMYT1;PSMB10;DAPK3;SKP1;PSME2;PSMA5;CDC26;ASAH2;PSME4;ANAPC5;CDC25B;RNF40;PKN2;BRINP3;DUSP3;SRA1;PDXP;PSMA3;CUL7;CYLD;PSMB9;ANAPC4;SMOC2;APP;UBE2E1;BTRC;CDK10;PSMD2;SIK1;CDC16;CDC27;NEK6;GAS1;PSME3;RB1;ANAPC15
prerank,negative regulation of T cell proliferation (GO:0042130),0.4748838203011997,1.2312325389172991,0.2037037037037037,0.797275384858282,1.0,3/28,9.51%,CD274;SDC4;PRNP
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.5626979383178029,1.2311511276198002,0.22816901408450704,0.796480145514637,1.0,3/12,13.97%,CLTRN;BAIAP3;STX4
prerank,positive regulation of mRNA processing (GO:0050685),0.5081813346219183,1.23095832193676,0.19786096256684493,0.7961773562774747,1.0,8/21,15.92%,RBMX;DHX36;NCBP2;SNW1;DAZAP1;NCBP1;RBM3;SF3B4
prerank,positive regulation of acute inflammatory response (GO:0002675),0.5442292610795018,1.2308313852263812,0.23404255319148937,0.7955819093415218,1.0,2/14,8.40%,ADAM8;PTGER3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.456566631060809,-1.2307161273690432,0.21739130434782608,0.9886287389860405,1.0,5/13,10.62%,CD81;SAR1A;GCC2;SAR1B;INSIG1
prerank,regulation of amyloid fibril formation (GO:1905906),0.5480726051022378,1.2300883089986532,0.24084507042253522,0.7973396185840012,1.0,6/15,12.35%,CLU;PFDN5;APP;PSEN1;PFDN4;APOE
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.46405646586941496,1.2299035016787803,0.2066420664206642,0.7969972330846529,1.0,5/33,8.23%,AGT;TGFA;DOK1;FBXW7;CCDC88A
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.49930373179729354,1.2298312248937653,0.20310478654592498,0.796159985974749,1.0,7/20,17.24%,CLU;HSP90AB1;HSPA4;LONP1;PSMG2;HSP90AA1;PTGES3
prerank,positive regulation of cell migration (GO:0030335),0.3871803407558943,1.229780214855112,0.06106106106106106,0.7952868260146123,1.0,59/253,17.40%,WNT11;FLT1;CCL7;HYAL1;SPRY2;KDR;CPNE3;PIK3CD;DDRGK1;AGO2;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;STAT3;MYO1C;MMP14;RUFY3;CCL5;SYDE1;SOX9;FAM83H;CARMIL1;ARHGEF7;PODXL;CSF1;SNAI2;RET;ELP6;MAPRE1;MYOC;RAPGEF2;CTSH;BCAR1;PDPN;INSR;BMPR2;ROR2;CIB1;PPM1F;SUN2;XBP1;PRKCE;RACK1;NRP1;DAB2;STX4;RREB1;MIEN1;SPAG9;AIF1;SEMA3D;RAB11A;MTOR;MGAT5;MDK;CBLL1;PTPRC
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5030036325749518,1.229220093182126,0.2220708446866485,0.796346153885428,1.0,9/20,20.11%,PML;CAMK2D;FIS1;KCTD17;THADA;PSEN1;BAX;BCAP31;TGM2
prerank,regulation of neuron apoptotic process (GO:0043523),0.4079960658596766,1.2289305259305403,0.14421052631578948,0.7963538423426795,1.0,24/96,19.23%,CRLF1;MSH2;UNC5B;BDNF;SOD2;ADAM8;EGLN2;CTNNB1;MT3;NRBP2;TFAP2B;AGAP2;GDNF;PRNP;MAG;PPARGC1A;APOE;AKT1S1;MDK;BAX;TRIM2;RETREG1;NF1;SET
prerank,regulation of DNA binding (GO:0051101),0.4443441494027473,1.2287239325190251,0.18213457076566125,0.7960775996958837,1.0,9/44,14.28%,SP100;ILRUN;SUMO3;CDT1;EDF1;CSNK2B;HMGB1;MDFI;JAK2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.46803101621944315,1.228377880573678,0.22084367245657568,0.7963257461413247,1.0,7/30,8.48%,TMEM161A;CLU;SFRP2;CDKN2D;RTEL1;SNAI2;ACKR3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.43218488734982907,1.2282017150936684,0.1605351170568562,0.7959229414772809,1.0,19/54,23.43%,KDR;CD40;MECP2;MAP2K3;CSNK2B;P2RX4;HMGB1;MAPK14;APOE;SH3BP1;NF1;ACVRL1;GADD45A;AKT3;FGF2;ATP5F1B;STAT5A;VASH1;PDPK1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.40826222707815185,-1.2276111442484634,0.15901060070671377,0.9948881749462917,1.0,8/17,21.47%,EMC2;EMC3;EMC8;GET3;EMC9;MMGT1;UBL4A;EMC6
prerank,cellular response to superoxide (GO:0071451),0.56229171380458,1.2273859776599156,0.24665676077265974,0.7980768948910345,1.0,3/10,14.26%,SOD2;MT3;PRDX2
prerank,myelination in peripheral nervous system (GO:0022011),0.5457234639571291,1.2273794400784024,0.2295774647887324,0.7970296926463776,1.0,5/13,18.19%,CNTNAP1;MYOC;ARHGEF10;DICER1;NF1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.400697427352618,1.2263268572143744,0.160676532769556,0.7999252093796482,1.0,29/94,23.61%,PML;CASP4;TRIB3;MYBBP1A;CHEK2;CUL5;MLLT11;BCL2L11;DDX5;ITPR1;IKBKE;PPM1F;DIABLO;SCN2A;PRKDC;BAD;BAX;FNIP2;STK24;ERO1A;ERN1;DDX3X;JMY;MCL1;STK11;PRKCD;BCL2L2;CUL3;ARL6IP5
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.4298597203203968,-1.2261850180200669,0.21052631578947367,0.9938734450454851,1.0,9/15,23.49%,ANP32B;GSK3B;CAMK1;RAPGEF3;TP53;BAG3;TPR;RBM22;IL1B
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4769791714720241,1.225947662924188,0.220795892169448,0.8003497722109207,1.0,6/26,14.08%,TPI1;GBGT1;B4GALT5;SCCPDH;TNIP1;ALG11
prerank,angiogenesis involved in wound healing (GO:0060055),0.5773342496819429,1.2259308220743066,0.24925373134328357,0.7993535254155353,1.0,3/11,10.67%,KDR;SRF;HPSE
prerank,regulation of glycogen metabolic process (GO:0070873),0.5569248626254527,1.2258951203517225,0.2303448275862069,0.7984190791344516,1.0,5/12,20.62%,PPP1R3E;PPP1R3D;RUBCNL;INPP5K;PPP1R3B
prerank,miRNA metabolic process (GO:0010586),0.5097647009360835,1.225580207481929,0.23828125,0.7986198298139038,1.0,7/20,17.17%,AGO2;TARBP2;BCDIN3D;DIS3L2;TUT7;DICER1;PRKRA
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.40802187054018774,1.2248941468651693,0.15409139213602552,0.8002702067878692,1.0,28/86,19.82%,CLU;HCK;EVL;CX3CL1;PDXP;CARMIL1;MAPRE1;CDK5RAP2;NCK1;MET;APP;NCK2;PROX1;SNX9;PSEN1;APOE;AKAP9;RB1;SYNPO;PRKCE;TRPV4;RAC1;BAIAP2;BAIAP2L1;STMN2;CFL2;NUMA1;NCKAP1
prerank,mitochondrial genome maintenance (GO:0000002),-0.4725569303462962,-1.2244462233872477,0.23384615384615384,0.994634928486419,1.0,4/11,6.41%,MPV17;SLC25A4;PARP1;SLC25A36
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.408015413736109,1.2243370277649674,0.1509433962264151,0.8014048804973714,1.0,34/85,25.87%,HSPA1B;TRIB3;CLU;DDRGK1;RNFT1;SUMO2;NOP53;OSBPL7;FBXW7;PRICKLE1;DET1;RNF19B;SOCS5;RBX1;ARIH1;RNF185;RACK1;DAB2;PIAS1;HECTD1;RNF180;HSPBP1;USP5;PSMC2;NUB1;STUB1;DNAJB2;SUMO1;TMTC3;VCP;BBS7;SIRT2;RAD23A;DDA1
prerank,mRNA metabolic process (GO:0016071),0.4067604156750021,1.2243364895524484,0.14846235418875928,0.8003363406567082,1.0,36/90,24.22%,HSPA1B;PNPT1;ZFP36;DDX5;PRPF18;NCBP2;DCP2;HNRNPA2B1;YTHDF2;NONO;PPARGC1A;USP39;DIS3L2;PCF11;AURKAIP1;SNRPG;NCBP1;NUDT16;GEMIN2;SRSF7;SF3B4;SRSF4;LSM5;TBRG4;ERN1;PCBP3;SRSF5;SF3A2;TCERG1;AGO4;SRSF2;RNH1;ZFP36L2;SNRPD3;RNASE4;SON
prerank,double-strand break repair via break-induced replication (GO:0000727),0.553349932049758,1.2237261051126704,0.24158125915080528,0.8016160792924308,1.0,5/12,18.17%,MCM2;MCM7;MCM4;GINS2;GINS4
prerank,proteasomal protein catabolic process (GO:0010498),0.38684979466019614,1.2234283277103757,0.09403437815975733,0.8017552522959968,1.0,74/201,23.77%,PML;PSMB10;PSME2;UBE2W;BIRC2;KLHL20;PSMA5;RNF4;PSME4;RBCK1;FEM1B;RNF5;BFAR;SIAH1;UBE2B;TNFAIP1;KCTD17;FBXW7;CTNNB1;PPP2R5C;AREL1;PSMA3;UBXN1;SPSB1;PSMB9;RBX1;ZSWIM8;UBXN2B;ARRB2;BTRC;UBXN11;RNF122;PSMD2;SMURF1;PSME3;FBXL19;RNF185;SHARPIN;UBE4B;PSMA4;NHLRC3;APPBP2;ATE1;ENC1;GID4;UBE2K;TRIM2;WWP1;PSMD7;PCNP;RFFL;SOCS6;DDI2;PSMD8;PSMD9;ZFAND2A;SPOP;PSMF1;TRIM13;PSMB6;RNF216;PSMC2;PSMD12;HUWE1;SMURF2;STUB1;PSMD4;CUL3;PELI1;KAT5;FEM1C;VCP;MAEA;PSMA2
prerank,amyloid precursor protein metabolic process (GO:0042982),0.5125783276282683,1.2230323771733886,0.22040816326530613,0.8022814820298687,1.0,6/18,15.32%,ABCG1;LDLRAP1;PSEN1;APOE;APH1A;APH1B
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.44346191773192656,-1.2229463935264262,0.17525773195876287,0.9937240192659572,1.0,7/15,21.61%,TGFB1;CST3;CLASP2;DPP4;FAP;CLASP1;DDR1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.4825310115557452,-1.222869627963641,0.20943952802359883,0.9740551467905512,1.0,6/10,17.83%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.4825310115557452,-1.222869627963641,0.20943952802359883,0.9740551467905512,1.0,6/10,17.83%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,t-circle formation (GO:0090656),-0.4825310115557452,-1.222869627963641,0.20943952802359883,0.9740551467905512,1.0,6/10,17.83%,NBN;SLX4;DNA2;SMARCAL1;TERF1;ERCC1
prerank,negative regulation of growth (GO:0045926),0.3981244712469808,1.2224149578684351,0.1422680412371134,0.8036904975331386,1.0,25/121,13.20%,HSPA1B;WNT11;PML;ESR2;BST2;HYAL1;PNPT1;SFRP2;GNG4;CDKN2D;OSGIN1;SERTAD3;BCL6;MT3;FRZB;ST7L;BMPR2;SPHK2;EI24;SLIT3;SERTAD2;RB1;ENPP1;RACK1;APBB1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4395063497737138,1.2223777558623254,0.19406392694063926,0.802769413024921,1.0,6/46,6.24%,STAT1;CDH13;CCL5;CTNNB1;CX3CL1;TCF7L2
prerank,negative regulation of T cell differentiation (GO:0045581),0.5799139863428224,1.2223011762545393,0.2327718223583461,0.8019793949060228,1.0,4/10,23.81%,LAG3;MDK;GLI3;IRF1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3575792119765692,-1.222278581651174,0.15023474178403756,0.9698723635422511,1.0,13/29,20.66%,RPA1;PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;RPA3;GTF2H3;XPA;GTF2H4
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.4012754417726849,-1.2222002686809614,0.19066147859922178,0.9638035481472782,1.0,4/18,4.73%,TGFB1;TMBIM6;RPS26;ESR1
prerank,vitamin D metabolic process (GO:0042359),0.5454092533902485,1.2221050003511564,0.24597364568081992,0.8017357624967643,1.0,1/13,3.43%,LRP2
prerank,regulation of cholesterol transport (GO:0032374),0.5050255963064694,1.2218054715388558,0.22162162162162163,0.8018802888739348,1.0,4/20,12.95%,NR1H2;YJEFN3;NFKB1;TSPO
prerank,phospholipid transport (GO:0015914),0.4349683214692886,1.2217820079509902,0.20856820744081173,0.80091228921903,1.0,15/52,19.73%,ATP10A;ABCA1;ABCG1;ATP8A1;OSBPL8;PITPNM1;ABCC1;APOE;ATP11A;NPC2;ATP9B;MTTP;LDLR;OSBPL2;PCTP
prerank,positive regulation of ossification (GO:0045778),0.4464519571600025,1.2213442426588181,0.2190034762456547,0.8014915025441317,1.0,9/39,15.34%,ISG15;WNT5A;ACVR1;SLC8A1;BMPR2;ADGRV1;PTPN11;NELL1;BMPR1A
prerank,regulation of microtubule polymerization (GO:0031113),-0.32127979599371387,-1.2212299756167349,0.17088607594936708,0.9614243085824691,1.0,9/40,9.55%,PAK1;DYRK1A;FES;DRG1;PRUNE1;CLIP1;TUBB4A;SNCA;ARL2
prerank,vasodilation (GO:0042311),0.5400145497143258,1.2206923253219009,0.23397913561847988,0.8030756614088127,1.0,1/13,2.68%,SOD2
prerank,cellular defense response (GO:0006968),0.44788033596613375,1.220373306581831,0.2170263788968825,0.8032926620504772,1.0,2/40,0.33%,LGALS3BP;CXCL9
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.37907742460794386,-1.2202076954624947,0.18433179723502305,0.9595357644709394,1.0,7/23,16.78%,MPP1;NCKAP1L;C5AR2;RAC2;DPP4;RIPOR2;C1QBP
prerank,regulation of interleukin-6 production (GO:0032675),0.4070044808954313,1.219935563846942,0.15148305084745764,0.8038993260692661,1.0,23/96,17.70%,IFIH1;NOD2;SLAMF1;WNT5A;STAT3;CD47;TLR8;CX3CL1;DHX9;TMEM106A;APP;HMGB1;SPHK2;ZC3H12A;IL17D;XBP1;PTPN11;MYD88;TLR2;AIF1;LGALS9;TLR3;POU2F2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5147199498576758,1.2198582663618662,0.2313937753721245,0.8031410331203879,1.0,8/16,22.11%,CGAS;MAD2L2;POLQ;SHLD1;KLHL15;SMCHD1;FBH1;UBQLN4
prerank,zinc ion transport (GO:0006829),0.5005240767709765,1.219479542956405,0.22267206477732793,0.8035969148031793,1.0,5/21,11.37%,TRPM2;SLC30A1;SLC30A5;MT3;SLC30A6
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.44274630749560956,-1.2194599885415276,0.21498371335504887,0.9561925880622406,1.0,6/13,22.30%,TECR;HACD1;ELOVL5;ELOVL1;ELOVL7;ELOVL6
prerank,response to glucocorticoid (GO:0051384),0.48009159802743606,1.219126005499812,0.23464373464373464,0.8038395859061945,1.0,6/26,12.63%,ZFP36;BCL2L11;ZFP36L1;SLIT3;NR3C1;UBE2L3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.40778392031483557,1.2188463738487656,0.17270788912579957,0.8038189049953772,1.0,20/85,14.40%,WNT11;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;PSME4;PRICKLE1;AP2A1;PSMA3;MAGI2;PSMB9;ROR2;ARRB2;AP2S1;PSMD2;SMURF1;PSME3;RAC1;PSMA4
prerank,protein ubiquitination (GO:0016567),0.3788494319891792,1.2186155907882907,0.02,0.8036142223273127,1.0,141/471,22.34%,RNF213;HERC6;ISG15;TRIM14;IRF2BP1;PSMB10;UBE2L6;DTX3L;SKP1;FBXL16;PSME2;TRIM25;UBE2W;BIRC2;NFX1;KLHL20;PSMA5;RNF4;TMEM129;UVSSA;HLTF;CUL5;SASH1;ARRDC4;FBXO7;PSME4;RBCK1;RNF40;TRIM21;RNFT1;BFAR;CNOT4;SIAH1;UBE2B;TNFAIP1;RNF11;FBXW7;CTNNB1;UBE3A;AREL1;PSMA3;LRSAM1;HERC2;CUL7;TRIM39;VPS11;DET1;RNF114;AMFR;KLHL13;SPSB1;FBXW8;DCAF15;CAND1;PSMB9;UCHL3;RNF19B;RNF31;RBX1;UBE2E3;BARD1;PEX2;UBE2E1;WAC;ZSWIM8;VCPIP1;ARRB2;ARIH1;ELOC;BTRC;RNF122;PSMD2;RNF103-CHMP3;CDC16;CDC27;TRIM26;SMURF1;PSME3;NPEPPS;FBXL14;KLHL9;PRKDC;UBE2L3;FBXL19;RNF185;RACK1;MYLIP;RNF25;UBE4B;LONRF1;PSMA4;RUSC1;UBE2Q1;DZIP3;MYCBP2;NHLRC3;RNF103;HECTD2;LZTR1;UBA1;LMO7;ENC1;RNF166;MIB2;PEX5;FBXL5;PEX13;UBE2K;CBLL1;BIRC6;TRIM2;CAND2;TRIM62;WWP1;PSMD7;PCNP;MGRN1;ASB1;UBE2V1;PSMD8;RC3H2;PSMD9;SPOP;VPS18;FBXO30;PSMF1;MKRN2;TRIM13;MKRN1;USP5;PSMB6;UNKL;PSMC2;NUB1;PSMD12;HUWE1;FBH1;SMURF2;STUB1;RRAGA;UBR2
prerank,positive regulation of chemotaxis (GO:0050921),0.4433618487809726,1.2185517924139428,0.20116959064327486,0.8027790998341167,1.0,11/43,16.89%,KDR;CDH13;MET;SMOC2;P2RX4;PPM1F;NRP1;STX4;DSCAM;AIF1;MDK
prerank,regulation of kinase activity (GO:0043549),0.40287169139823614,1.2179403381664016,0.1598317560462671,0.8039681034469162,1.0,22/89,19.25%,NLRC5;AXL;FLT1;KDR;RBL1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;INSR;ROR2;LDB2;LDB1;RB1;IRS2;FGFR3;PLCE1;DSTYK;NPRL2;CAMKK2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.46451385145815455,-1.2179401766900053,0.21782178217821782,0.9560298598438267,1.0,3/12,4.99%,TGFB1;AR;SELENOS
prerank,receptor catabolic process (GO:0032801),0.4806448283902667,1.217814622044001,0.21528662420382166,0.803405146486866,1.0,11/24,19.26%,MVB12A;AP2A1;SH3GLB1;KIF16B;PIK3R4;AP2S1;SMURF1;MYLIP;SNX25;UVRAG;BECN1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.42581743827126073,1.2177499561637994,0.19798657718120805,0.8025930190436362,1.0,7/57,4.40%,TNFSF10;KDR;FIS1;MLLT11;BCL2L11;FBXO7;CHCHD10
prerank,ribosomal large subunit assembly (GO:0000027),0.48434316109521286,1.2174478359514325,0.23145780051150894,0.8027038028426344,1.0,14/24,22.09%,MDN1;NOP53;RRS1;PPAN;DHX30;NOP2;RPL23A;RPL11;RSL24D1;RPL24;FASTKD2;RPL3;RPL5;RPL6
prerank,endoderm development (GO:0007492),0.5409600126484189,1.217328014966056,0.2460881934566145,0.802094146993468,1.0,2/13,9.40%,LAMC1;KIF16B
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.45825377206108786,1.2173208518428298,0.2285012285012285,0.801082471039031,1.0,11/32,22.45%,DHFR;ESRRB;CDT1;BACH1;TFDP1;TFDP2;RB1;NPAT;HINFP;ORC1;CDK16
prerank,diol metabolic process (GO:0034311),0.516215777429926,1.2171256129970938,0.24091520861372812,0.8007710293900743,1.0,7/19,21.47%,SGPP2;ASAH2;SPHK2;GCH1;HSP90AA1;PRKG2;PLPP2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4997767212093604,1.2171103256569222,0.22811671087533156,0.7998062382323825,1.0,7/19,20.64%,KDR;TRPM2;FIS1;PRNP;PTPRC;BCAP31;VCAM1
prerank,immunoglobulin mediated immune response (GO:0016064),0.5790670377199745,1.2170926287808332,0.23830409356725146,0.7988439272576154,1.0,4/10,15.90%,GAPT;TLR8;FCGR2B;CD27
prerank,mitotic metaphase plate congression (GO:0007080),0.42546253180761817,1.2165877874151123,0.2135593220338983,0.7997539910071355,1.0,16/51,19.26%,CHMP4A;CHMP4B;CHMP1B;KPNB1;KIF2C;CDT1;RRS1;CHMP3;PIBF1;MIS12;RAB11A;CHAMP1;RMDN1;CHMP5;NDC80;BECN1
prerank,protein autoprocessing (GO:0016540),0.5119815397928476,1.216244513624548,0.22908093278463648,0.8001051965278125,1.0,2/17,3.63%,CASP4;FXN
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4009037537696719,1.2162128915539625,0.16996871741397288,0.7991924099310718,1.0,40/100,25.87%,HSPA1B;TRIB3;CLU;DDRGK1;SUMO2;NOP53;HSP90AB1;PRICKLE1;UBXN1;TRIM39;CAMLG;DET1;N4BP1;UCHL5;RNF19B;SOCS5;RBX1;WAC;ARIH1;RYBP;RACK1;DAB2;PIAS1;RPL11;HECTD1;TLK2;RNF180;HSPBP1;USP5;NUB1;UBQLN4;STUB1;DNAJB2;SUMO1;VCP;BBS7;COMMD1;SIRT2;RAD23A;DDA1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4637787021814129,1.2152736957231982,0.2258852258852259,0.8017458930917216,1.0,12/32,21.57%,SLC27A1;CSNK2B;CSNK2A2;LPIN2;CEPT1;ABHD3;CHPT1;PCYT1A;PCTP;SLC44A1;CHKA;PCYT1B
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4432256180891119,1.2151501237524294,0.1997677119628339,0.8011764769673105,1.0,15/42,19.19%,FBLN2;THY1;CX3CL1;PDPN;PPM1F;PIK3CB;LIMS1;RAC1;JAK2;MINK1;TBCD;CORO1C;VIT;NF1;TSC1
prerank,positive regulation of T cell differentiation (GO:0045582),0.45046530781900657,1.2149316298041923,0.22195121951219512,0.8009921291303086,1.0,12/36,21.81%,TNFSF9;SOCS1;ADAM8;BCL6;XBP1;NKAP;DUSP10;SART1;MDK;CD46;RHOH;GLI3
prerank,histone ubiquitination (GO:0016574),0.49306433380690406,1.2146923943366288,0.2320730117340287,0.8009282974333477,1.0,5/21,9.78%,DTX3L;RNF40;UBE2B;UBE2E1;WAC
prerank,plasma membrane invagination (GO:0099024),0.46488259704312485,1.214629753798442,0.21598002496878901,0.8001707750640151,1.0,11/29,20.83%,SNX33;GULP1;FCGR1A;SNX9;ARHGAP25;GSN;FCGR2B;SH3BP1;AIF1;MYH9;MSR1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.35917255387712477,-1.2145426261658308,0.15,0.9635511147353586,1.0,6/24,11.40%,TGFB1;SULF1;CCBE1;NOX1;C3;BRCA1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4465858627484546,-1.2143220308605729,0.24381625441696114,0.9582969997613641,1.0,6/13,21.54%,GOPC;NFKBIA;KEAP1;NFKBIE;DBN1;YWHAB
prerank,telomere maintenance via recombination (GO:0000722),0.5499125112059344,1.214103671420286,0.27105666156202146,0.8011195818298731,1.0,4/11,14.34%,TPRKB;ERCC4;XRCC3;NSMCE2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.47204656917194326,1.2140152671831348,0.22813688212927757,0.8004731509695908,1.0,10/25,19.47%,CENPJ;KIF2C;STMN4;TPPP3;STMN3;TRPV4;FGF13;KIF2A;STMN2;PIN1
prerank,negative regulation of cell death (GO:0060548),0.3998761264336272,1.2138709325335568,0.17293233082706766,0.7999833738166847,1.0,16/88,14.33%,HSPA1B;WNT11;CHMP4A;CHMP4B;CLU;NENF;MT3;CSF1;NCK1;LRPAP1;SPEF1;SRGAP2;SORL1;PPARGC1A;DUS2;FYN
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5577434346205581,1.2132566906697448,0.25,0.8013501251241942,1.0,6/12,13.32%,CTNNB1;FEN1;CTCF;DDX11;RB1;HDAC8
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5633827198133818,1.213117518542644,0.22840409956076135,0.8008858257131632,1.0,4/11,18.09%,SLC18A2;ABCD1;FYN;ABCB7
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.40166948403296554,1.2130979454929574,0.16631578947368422,0.7999543518019935,1.0,20/101,15.21%,IRGM;NOD2;FLT1;WNT5A;SLC27A1;CD40;ADAM8;CCND2;CCND1;ETAA1;CAB39;MTCP1;TPD52L1;RAPGEF2;PROX1;CIB1;MAP2K2;TELO2;EZH2;CALM3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5503012042762927,1.2126783005671153,0.25,0.7984892401878915,1.0,6/12,14.34%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5503012042762927,1.2126783005671153,0.25,0.7984892401878915,1.0,6/12,14.34%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5503012042762927,1.2126783005671153,0.25,0.7984892401878915,1.0,6/12,14.34%,ANAPC5;ANAPC4;CDC16;CDC27;RB1;NSMCE2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.47978956545282264,1.212648118855793,0.23341836734693877,0.797613316624896,1.0,8/24,21.96%,TRPM2;ITPR1;CHERP;HTR2A;PTPRC;ERO1A;LCK;FGF2
prerank,B cell receptor signaling pathway (GO:0050853),-0.34958940856649035,-1.2124977305280382,0.1783783783783784,0.9592272651887851,1.0,6/32,3.83%,NFAM1;SYK;CD38;SH2B2;NCKAP1L;LAT2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5469996940491124,1.2124460677115219,0.2604166666666667,0.7973471382592715,1.0,5/12,14.64%,IRS1;PPP1R3E;INSR;DYRK2;IRS2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4841703403369881,1.2121084802846935,0.20998719590268886,0.7976004728435943,1.0,9/23,25.44%,CENPJ;CCL5;IL10RA;IL10RB;MGAT5;NOTCH1;CRLF3;OCIAD1;TNF
prerank,regulation of cellular component organization (GO:0051128),0.3912975590574989,1.211573307578945,0.14651639344262296,0.7986411330601221,1.0,35/135,17.70%,IRGM;AGT;CAMK2D;WNT5A;SGK3;SGK2;SEMA4D;CDH13;STK38L;MAD2L2;EGLN2;ATAD3A;RAPGEF2;BCAR1;RAB5C;HSPA8;SSRP1;OGFR;AP2S1;SETD5;ARHGEF11;PTPN11;APOE;SOCS2;RAPGEF1;STON1;HSP90AA1;MLLT3;TAOK2;CHPT1;MTOR;OPHN1;CAMSAP2;PLCE1;STON2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5732894623249498,1.2113575774203507,0.26646706586826346,0.7984736665165801,1.0,2/10,5.27%,TGFA;FBXW7
prerank,lymphocyte migration (GO:0072676),0.45558249005212614,1.2106797972295849,0.22235872235872237,0.7998573258969669,1.0,6/32,11.09%,CCL7;ADAM8;CCL5;CX3CL1;RET;CCL14
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.512984893547615,1.2106497751494523,0.23961218836565096,0.7989849995159981,1.0,9/17,24.43%,HSP90AB1;MAGI2;CALM3;CD300A;MTOR;PTPRC;CD33;PPP1R12A;CALM2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.44593667090378875,1.2102087784948339,0.1995249406175772,0.7996978967210395,1.0,15/36,26.47%,SOCS1;CENPJ;CCL5;IL10RA;LEPROT;IL10RB;JAK2;HGS;PTPRC;ADIPOR1;NOTCH1;CRLF3;OCIAD1;TNF;DOT1L
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5770527877446577,1.2101080488041323,0.26226993865030673,0.7990611107813281,1.0,5/10,14.89%,CAMK2B;NETO1;APP;SYNGR1;NPTN
prerank,skeletal system development (GO:0001501),0.3919828912784414,1.2100974821244967,0.1363173957273652,0.7981095851996852,1.0,19/148,7.77%,WNT11;EXT1;COL13A1;HYAL1;WNT5A;COMP;DDRGK1;CHD7;MMP14;PTGER4;TCOF1;SOX9;P3H1;FGFR2;ITGB8;ANKH;FBN1;FRZB;MYOC
prerank,peptidyl-lysine modification (GO:0018205),0.3963467569839874,1.209914145911639,0.16037735849056603,0.7978557138591036,1.0,41/99,27.30%,IFIH1;LIPT1;LOXL2;NUP37;METTL21A;SENP3;SUMO2;SUMO3;NUP153;SENP5;RAE1;UBA2;VIPAS39;USPL1;NSMCE2;NUP155;GCSH;PIAS1;PIAS2;ATPSCKMT;NUP88;NUP133;NUP43;SENP7;SENP2;SUMO1;HDAC4;KAT5;HDAC6;PLOD3;KAT2B;LOX;TRIM28;NUP205;EEF1AKMT1;SIRT2;PIAS4;SEH1L;EYA1;NUP188;EP300
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4066011974890936,1.2088568819994723,0.19271948608137046,0.8008659273307864,1.0,22/79,16.49%,CTSS;LAG3;KIF26A;KIF3C;DYNC1H1;RILP;KIF2C;AP2A1;DYNC1LI2;ACTR1A;KIF3B;SEC24D;AP1S1;SEC23A;AP2S1;DNM2;CAPZB;FCGR2B;DYNLL1;KIF2A;SEC24A;KLC2
prerank,rRNA catabolic process (GO:0016075),-0.41736475901264425,-1.207424242845862,0.23943661971830985,0.9736313733316954,1.0,7/16,14.40%,EXOSC7;EXOSC10;DIS3;DIS3L;EXOSC5;EXOSC3;DEDD2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4725696296002636,1.2067331140019217,0.24005134788189988,0.8079904188643191,1.0,9/26,14.34%,ANAPC5;CDK5RAP2;ANAPC4;CDC16;CDC27;NEK6;RB1;ANAPC15;NSMCE2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.4895733938149734,-1.2065742345266568,0.25301204819277107,0.9712168224646316,1.0,6/10,27.43%,VDAC1;BIN1;FKBP1B;CBARP;ADRA2A;SESTD1
prerank,tRNA metabolic process (GO:0006399),0.5083176399384647,1.205378103795462,0.24353741496598638,0.8121678200899448,1.0,7/17,17.03%,TRPT1;DTD1;AARS1;ADAT1;DTD2;YARS2;RPP30
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5656809310034736,1.20533200978636,0.24153166421207659,0.8113520324950481,1.0,4/11,11.24%,RESF1;SIRT6;DNMT1;SETDB2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.47038435000169493,1.2052040558676518,0.2390488110137672,0.8108238067967003,1.0,7/26,14.79%,NR1H2;TRIB3;ACADL;SLC45A3;EIF6;ERLIN2;LPGAT1
prerank,amino sugar metabolic process (GO:0006040),0.5773645156105403,1.2049549302531524,0.24655436447166923,0.8108154247418361,1.0,5/10,14.59%,ST6GAL1;GFPT1;ST3GAL1;GNE;SLC35A3
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.38080497676623987,-1.2048056869887118,0.2391304347826087,0.9720187488513664,1.0,6/22,12.68%,STIM1;GRM3;CAP2;EDNRB;PALM;CCR2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.46337140367129187,1.2044201296314359,0.2285012285012285,0.8118342411230703,1.0,11/29,19.00%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPIA;PPP6R3;TELO2;HSP90AA1;PTGES3;TERF2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5621214862290422,1.2043862329972677,0.27153284671532846,0.8109600609354006,1.0,3/10,11.00%,MAD2L2;PPM1F;NOTCH4
prerank,negative regulation of blood pressure (GO:0045776),0.5395498171561317,1.2040244148532888,0.25513196480938416,0.8112885846343182,1.0,2/13,9.54%,GPR37L1;BMPR2
prerank,lipid catabolic process (GO:0016042),0.5050331732820528,1.2039485041928544,0.24585635359116023,0.8105671016651083,1.0,4/18,8.33%,ACADL;MT3;LIPC;HSD11B1
prerank,RNA methylation (GO:0001510),0.41861087829935245,1.2037820025533905,0.21666666666666667,0.8101983267148066,1.0,23/60,20.92%,BCDIN3D;MRM2;ZCCHC4;MEPCE;TFB2M;TRMT13;TRMT61B;THADA;TGS1;DIMT1;NOP2;TRMT10C;RBM15;ZC3H13;METTL14;CBLL1;THUMPD3;TYW3;GTPBP3;BUD23;WTAP;METTL1;TARBP1
prerank,sulfur compound transport (GO:0072348),0.46238751215405516,1.2036643346634928,0.22193548387096773,0.8096895129457844,1.0,14/27,26.34%,SLC27A1;SLC26A1;SLC25A19;SLC25A10;SLC35F3;SLC13A4;ABCG2;SLC5A6;MGST1;SLC6A6;SLC25A30;SLC26A7;SLC36A1;SLC25A26
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5448002361821825,1.2031397237507153,0.23880597014925373,0.8106226754736301,1.0,4/14,15.88%,SOX9;SNAI2;PTPN11;ADAMTS12
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5528583537983905,1.2027209383812307,0.2626112759643917,0.8111598912024821,1.0,6/11,16.93%,ARID1B;CHEK1;ARID1A;SERTAD2;SERTAD1;ELOF1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5270957715666951,1.2024554147855038,0.24822695035460993,0.8111316542184467,1.0,2/13,3.75%,CAMK2D;SLC8A1
prerank,mitochondrion morphogenesis (GO:0070584),0.5533235952657517,1.201938334555873,0.25768667642752563,0.8121011231993169,1.0,3/11,9.75%,PNPT1;FIS1;SLIRP
prerank,negative regulation of proteolysis (GO:0045861),0.444896213485445,1.2018471637220873,0.24484848484848484,0.8114237694452889,1.0,8/34,15.02%,TM4SF20;TRIM21;EPHA4;CST7;PRNP;TIMP2;GAS1;TMEM59
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.565710743602428,1.2018005245913927,0.26707132018209406,0.8105874625811552,1.0,2/11,2.36%,NR1H2;SLC27A1
prerank,glycogen biosynthetic process (GO:0005978),0.5403490542632885,1.2017608934569386,0.24123422159887797,0.8087655702011737,1.0,3/12,7.78%,PER2;PGM2L1;PGM1
prerank,glucan biosynthetic process (GO:0009250),0.5403490542632885,1.2017608934569386,0.24123422159887797,0.8087655702011737,1.0,3/12,7.78%,PER2;PGM2L1;PGM1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.37565980251640335,1.2016974785738515,0.036,0.8080179431270295,1.0,113/476,20.46%,STAT1;SP100;IRF7;PARP9;WNT11;PML;AGT;LHX2;NR1H2;HAS3;ESR2;DTX3L;WNT5A;TRIM45;ESRRB;PRMT2;RNF4;TEAD2;CHEK2;ACVR1;STAT3;MLLT11;ARID1B;RUNX1;MAD2L2;USP21;ILF3;NCOA1;MRPL12;SERTAD3;SOX9;CTNNB1;KMT2A;ARID1A;NSD3;TCF4;SMARCC2;ZXDC;NFKB1;EDF1;SETD3;MT3;NFATC2;TFAP2B;MAP2K3;RET;MDFIC;RAI1;SMAD2;CDK5RAP2;BAMBI;NFIB;POU3F1;SCX;ELF4;WAC;RORA;MED12;PHIP;BTRC;RGMB;NPM1;FOXK1;DNM2;NOTCH4;CTCF;MITF;RYBP;ARHGEF11;MAP2K2;ZNF423;ILF2;PSEN1;PPARGC1A;APOE;BRPF1;APBB1;SMARCA1;KDM8;CASZ1;SOX2;RREB1;CREB5;MYB;INPP5K;PRDM11;MLLT3;TAF15;NPAT;PPARD;KAT8;BRD7;MED16;ELF1;TRIP4;TNNI2;ENY2;CAND2;HDAC1;HINFP;ZKSCAN3;CREB3L2;UBE2V1;CAMKK2;PSMD9;SS18L1;SEC14L2;POU3F3;MED24;ACVRL1;NR1D2;SPIN1;ZFP90
prerank,pinocytosis (GO:0006907),0.5589931794972631,1.2013316062197776,0.2600896860986547,0.8083509159662132,1.0,2/10,6.05%,SNX33;CARMIL1
prerank,regulation of T cell activation (GO:0050863),0.4300639363928126,1.2010518225230622,0.23564593301435408,0.8084085727549079,1.0,12/42,20.61%,TNFSF9;THY1;CD47;CCL5;DUSP3;IL27;CCDC88B;TNFSF8;PAG1;SIRPA;TNFAIP8L2;LCK
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.538682816194793,1.2005275236114619,0.2540381791483113,0.8093719782774847,1.0,6/13,16.93%,ARID1B;CHEK1;ARID1A;SERTAD2;SERTAD1;ELOF1
prerank,negative regulation of cell junction assembly (GO:1901889),-0.35784858439645617,-1.199939766407576,0.22660098522167488,0.98539243811066,1.0,6/25,10.34%,APOD;RCC2;ROCK1;CLASP2;DMTN;SRC
prerank,central nervous system myelination (GO:0022010),0.5609073713927445,1.1997534607192133,0.28466076696165193,0.8113657407364228,1.0,5/11,21.69%,CLU;CNTNAP1;B4GALT5;PLP1;TENM4
prerank,neurogenesis (GO:0022008),-0.3115570163875777,-1.1996664676780435,0.14906832298136646,0.9803921633359554,1.0,12/43,13.32%,BTBD1;LPAR1;TRAK2;FAT4;SPOCK1;WDR62;CIT;RYK;TGFB2;EPHB1;METTL3;CLN5
prerank,regulation of actin filament depolymerization (GO:0030834),0.5516328453756931,1.1996433308456491,0.270042194092827,0.810780944270978,1.0,6/12,28.44%,PDXP;PLEKHH2;SH3BP1;CFL2;PIK3CA;SEMA5A
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3835799713491707,1.1994579740813323,0.14285714285714285,0.8105176829373079,1.0,71/173,27.55%,TRAPPC3;YIF1A;CD55;TGFA;DYNC1H1;COG3;ERGIC3;COPE;TMEM115;HYOU1;SEC16A;ANK1;GOSR2;CNIH3;COG8;DYNC1LI2;ACTR1A;NRBP2;TMED5;SEC24D;CTSC;SEC23A;VAPB;TMED10;TRAPPC12;COG2;CAPZB;KDELR1;SCFD1;DYNLL1;WHAMM;VTI1B;NAPA;MIA2;VAMP4;SEC24A;NRBP1;ARF4;ERGIC2;TMED1;TMED3;DCTN3;GBF1;GOSR1;COPB2;CNIH1;TFG;BCAP31;RAB1A;TMED7;ERGIC1;GOLT1A;TRAPPC6A;RAB2A;F8;CUL3;RAB29;CNIH4;ANK2;BCAP29;TBC1D20;DCTN1;SEC22B;ARCN1;DYNC1LI1;KDELR2;CAPZA2;COG7;COPB1;SPTBN1;COG1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5238745000302661,1.19928326367974,0.2398921832884097,0.8102165870961944,1.0,3/16,15.49%,SLC2A6;SLC45A3;SLC2A9
prerank,cellular response to glucose starvation (GO:0042149),0.4321002728698006,1.199078990586852,0.22769953051643194,0.8100002556736846,1.0,10/41,12.06%,MYBBP1A;KPTN;SH3GLB1;PIK3R4;PRKAG1;ZC3H12A;NUAK2;SIK1;XBP1;HNRNPA1
prerank,regulation of gene expression (GO:0010468),0.3722554870837838,1.1988713916165814,0.008,0.8098228155965339,1.0,179/903,17.50%,PARP14;IGF2BP1;HSPA1B;PARP10;PARP9;WNT11;ZUP1;PML;TRIM14;MOV10;THAP7;ABCC2;ESR2;DAPK3;ICOSLG;XDH;WNT5A;MYBBP1A;TFAP2C;SPRY2;KDR;FASTK;DAXX;CLU;ESRRB;PIK3CD;NFX1;DDRGK1;ZC3H7A;SAP30L;IGF2BP3;AGO2;ZFPL1;TARDBP;TEAD2;NFKB2;CHEK2;MECP2;STAT3;ZFP37;CHD7;TDRD7;SLC38A2;TRIM21;RBL1;SFRP2;CGGBP1;SLC8A1;RUNX1;HNRNPH1;BHLHE40;LARP1;NKX6-2;SRRT;CNOT7;DHX36;MZF1;NFXL1;SERTAD3;FBXW7;PFDN5;SOX9;TAPBP;HNRNPK;ZNF2;NSD3;CD276;ZSCAN26;NFKB1;BCL6;EDF1;AFF1;ZBTB38;BACH1;MT3;PTRH2;TRIM39;NFATC2;ITGB8;CSF1;SNAI2;SAP30;RO60;CTSH;YTHDF2;NONO;ACTR8;LYN;GDNF;POU3F1;CLK3;APP;SCX;DNMT1;INSR;HNRNPL;MAPK14;PRKAG1;TRAF3;RORA;PROX1;PPM1F;ZC3H12A;DNM2;FAM98B;MARF1;ZFP36L1;HNRNPDL;CTCF;NAB1;SETDB2;HCFC2;FGF9;MITF;RYBP;GSN;MAP2K2;HNRNPH3;ZNF423;NKAP;STAP1;TRIM26;HAVCR2;LDB1;PSEN1;REL;EPHX2;PPARGC1A;APOE;NR3C1;UBE2L3;RB1;RACK1;PRDM4;ZNF35;ATXN1;PIK3CB;LIMS1;MATR3;APBB1;CLK2;NELL1;ZC3H7B;POGZ;ASCC2;CASZ1;SOX2;MYD88;RREB1;EZH2;MYB;PRDM11;MBNL2;HGS;BMPR1A;TLR2;TDG;MYCBP;GTF2IRD1;ADNP2;NPAT;SLC24A3;TIPARP;AIF1;RPL11;DENND4A;MTOR;ZNHIT3;ZBTB4;DICER1;RBPJ;LGALS9;FLOT2;TRIP4;PCBP4;RRP1B;TLR3;PTPRC;TULP3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4111907107854962,1.1985836805917627,0.18985976267529667,0.8099224794656985,1.0,16/72,17.88%,SP100;PML;CHEK2;CNOT4;CNOT7;TNKS1BP1;TFDP1;PLK3;TFDP2;PAXIP1;E2F4;MYO6;PRMT1;PCBP4;BAX;CRADD
prerank,fatty acid oxidation (GO:0019395),0.4170095336244275,1.1985784353123758,0.20361990950226244,0.8089739296516033,1.0,16/57,21.13%,MCAT;ACADL;ECI2;AUH;ABCD1;PEX2;PPARGC1A;ACADS;PPARD;HADHA;ACAT1;PEX13;ACOX1;HADH;ABCD4;ADIPOR1
prerank,muscle organ development (GO:0007517),0.4144398994974169,1.1985446590017939,0.1963882618510158,0.8081160631035565,1.0,5/54,5.00%,CXCL10;MEF2B;UTRN;ITGB1BP2;COPRS
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3861822513975622,1.1983746447771433,0.15228426395939088,0.8077734316472288,1.0,46/158,22.04%,EDAR;TNFSF10;TRIM14;NOD2;BST2;NOD1;ALPK1;TRIM25;BIRC2;CD40;CANT1;RBCK1;TRIM21;IKBKE;DHX36;CX3CL1;CFLAR;TSPAN6;TMEM106A;TMEM9B;RNF31;TRAF5;IRAK4;NEK6;REL;MIER1;SHARPIN;AKAP13;BIRC3;TNIP2;MYD88;IRAK1;MIB2;ZDHHC13;LGALS9;CXXC5;TRIM62;TFG;UBE2V1;TAB3;RIPK2;TRIM13;LITAF;ROR1;S100A13;GOLT1B
prerank,vesicle organization (GO:0016050),0.4291572944302276,1.1982413456229082,0.20253164556962025,0.807336250854664,1.0,12/46,13.58%,DNAJC13;USP50;SNX33;WASHC4;SNX10;VPS11;HOOK2;RAB22A;HOOK1;FNBP1L;ARFGEF2;HOOK3
prerank,positive regulation of JNK cascade (GO:0046330),0.40924578450622656,1.1971675453909112,0.20810514786418402,0.8104041508440691,1.0,17/70,15.90%,EDAR;NOD2;TAOK3;SLAMF1;GADD45G;TRAF4;WNT7B;TPD52L1;APP;HMGB1;TRAF3;TRAF5;FCGR2B;MINK1;TAOK2;MTURN;CD27
prerank,error-free translesion synthesis (GO:0070987),-0.37438814903409917,-1.1968166141076193,0.20093457943925233,0.986021088849527,1.0,14/22,19.73%,RPA1;RFC2;POLH;UBB;RCHY1;NPLOC4;RFC3;UBC;UBA52;UFD1;RPS27A;RPA3;RFC5;POLD1
prerank,inorganic anion transport (GO:0015698),0.4147244475409378,1.1967355843906207,0.21857304643261607,0.8110958384471052,1.0,16/53,23.24%,CLIC4;SLC26A1;ENPP3;CLCN2;CLCN6;SLC25A10;TTYH1;ANO10;ENPP1;SLC13A4;ANO5;CLCN1;GLRA1;CLIC1;SLC25A30;SLC26A7
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5167983980752097,1.1958780767550694,0.2541899441340782,0.81333598528224,1.0,5/15,12.14%,ENTPD3;ENTPD6;ENTPD5;CMPK2;AK4
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5524013116358462,1.1954525411846808,0.26725403817914833,0.813906298037185,1.0,5/11,16.81%,PIK3CD;RAPGEF2;LYN;PIK3CB;LGALS9
prerank,B cell activation involved in immune response (GO:0002312),0.5265577330121191,1.195445535609859,0.25630252100840334,0.8129714890096266,1.0,2/13,0.99%,GAPT;MSH2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.44657388054793684,-1.1952389585895444,0.25838926174496646,0.9860535895613499,1.0,7/12,39.59%,GRIN1;RAB27A;TLR4;ZNF205;ADGRB1;MMP8;SLC5A3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.44089828942848697,1.1950987542650433,0.23289315726290516,0.8132331474470116,1.0,9/36,14.43%,TAOK3;DUSP3;IGBP1;CYLD;PPIA;DACT1;MEN1;DUSP10;DLG1
prerank,regulation of telomere maintenance (GO:0032204),0.4699746580826978,1.1948579918297697,0.25227568270481143,0.8131359785624566,1.0,10/26,19.00%,PML;DHX36;RTEL1;ERCC4;SIRT6;PPP1R10;SMG5;HDAC8;UPF1;TERF2
prerank,cation transmembrane transport (GO:0098655),0.4298850288514773,1.1944608732820523,0.23333333333333334,0.8136790427029661,1.0,11/44,22.41%,TRPM5;TRPM2;TRPM6;SLC25A19;TRPM3;SFXN2;TRPM7;SLC36A4;SFXN1;MFSD12;ABCC9
prerank,positive regulation of protein acetylation (GO:1901985),-0.44446091784282815,-1.194440334241975,0.2376237623762376,0.9833054379522348,1.0,5/12,14.51%,DIP2B;TERF2IP;CAMK1;FAM161A;RAPGEF3
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5552744209295725,1.1943279574693944,0.26440177252584934,0.8131687772928264,1.0,4/11,11.70%,SNX33;ACTN2;LEPROT;LEPROTL1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4561091286249006,-1.1937836915475295,0.2676923076923077,0.9803173953899509,1.0,8/11,37.39%,ZFPM2;TGFB2;JAG1;SOX4;BMP4;HEY2;GATA3;ISL1
prerank,amino acid transmembrane transport (GO:0003333),0.4248663573192468,1.19353767855217,0.2661290322580645,0.8151736575931707,1.0,13/45,21.96%,SLC25A22;SLC38A2;SLC38A1;SLC38A3;SLC38A6;SLC7A6;SFXN2;SLC25A12;SLC36A4;SFXN1;SLC7A7;MFSD12;SLC6A6
prerank,intracellular pH reduction (GO:0051452),-0.33238137454225936,-1.1933841704711716,0.15555555555555556,0.9759677627678249,1.0,10/33,13.24%,ATP6V0A1;ATP6V1H;ATP6V1E1;DMXL1;ATP6V1C1;ATP6V1D;GPR89B;GPR89A;DMXL2;ATP6V1A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4338636149327549,1.1932381876103169,0.23266745005875442,0.8153747160146129,1.0,10/43,19.96%,CD274;SLAMF1;ILRUN;CX3CL1;ZC3H12A;HAVCR2;DICER1;LGALS9;CD33;SIRPA
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3884780410289257,1.1931143429838007,0.17525773195876287,0.8148995157784789,1.0,24/124,12.28%,WNT11;MOV10;PSMB10;WNT5A;PSME2;DAAM1;PSMA5;AGO2;PSME4;SFRP2;PRICKLE1;CTNNB1;AP2A1;PSMA3;TCF7L2;FRZB;PSMB9;PLCB3;ROR2;ARRB2;AP2S1;PSMD2;SMURF1;PSME3
prerank,carnitine shuttle (GO:0006853),-0.4535514280610303,-1.1927946984548659,0.2246153846153846,0.9726658587164217,1.0,8/11,38.54%,CPT2;THRSP;CPT1A;ACACB;PRKAG2;PRKAA2;CPT1B;MID1IP1
prerank,regulation of protein localization to nucleus (GO:1900180),0.42822394522470464,1.192786365122831,0.2224744608399546,0.8151450327724605,1.0,4/43,4.10%,PARP9;ILRUN;DTX3L;SUMO3
prerank,negative regulation of cell cycle (GO:0045786),-0.2715610349586007,-1.1924284286379712,0.12048192771084337,0.9684357106541179,1.0,28/73,25.93%,TGFB1;PTPRK;HPGD;PDCD4;BTG2;BRINP1;RPS6KA2;NUDT6;RUNX3;APC;NR2F2;CEBPA;SIPA1;BTG1;PPP1R13B;INCA1;SCRIB;BRINP2;TSPYL2;HEXIM1;CDKN1B;NLRP2B;INHBA;NR4A1;CDK5RAP1;FOXC1;NUPR1;HTRA2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4594823654472122,-1.1920933531534208,0.25732899022801303,0.9640523259261417,1.0,7/11,31.84%,VAT1;TFRC;ZDHHC6;MUL1;PRKN;BNIP3;PID1
prerank,neuron cell-cell adhesion (GO:0007158),-0.42898937602633175,-1.1915047331792397,0.23684210526315788,0.9607736432082391,1.0,4/14,8.56%,ASTN1;NRXN2;NLGN2;NRXN1
prerank,DNA replication initiation (GO:0006270),0.4426297314349054,1.1914900946206004,0.2381516587677725,0.8189357151386261,1.0,6/37,6.00%,MCM2;LRWD1;POLE2;MCM7;MCM4;CDT1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4671256428532944,1.1913832693212791,0.25548387096774194,0.818383065834541,1.0,8/24,14.95%,IRS1;PPP1R3E;PPP1R3D;INSR;DYRK2;ENPP1;IRS2;INPP5K
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5728857448006749,1.191376836287702,0.2765321375186846,0.817450352569843,1.0,3/10,10.95%,DHX58;TSPAN6;RIOK3
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.49809120889542974,1.1912139828803512,0.2549019607843137,0.8171016931943782,1.0,7/18,23.22%,CXCR4;TMEM98;SLC45A3;MDK;NF1;TENM4;NOTCH1
prerank,protein oxidation (GO:0018158),0.5525524678891054,1.1910919828938913,0.282089552238806,0.8166219663526784,1.0,1/11,0.54%,LOXL2
prerank,B cell activation (GO:0042113),-0.2785709342156533,-1.1902716884918292,0.10975609756097561,0.9604353464736912,1.0,25/68,23.11%,NFAM1;GPR183;CASP8;KLF6;LAT2;DCAF1;ZBTB7A;CTPS1;BANK1;EPHB2;LYL1;PTPN2;FCRL1;DNAJB9;JAK3;SLC25A5;CD86;ADGRG3;BTK;MEF2C;CHRNA4;RASGRP1;TCF3;PHB2;CLCF1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5681627554068496,1.1902108775504934,0.26283048211508553,0.8188641360914494,1.0,3/10,16.65%,CAMK2D;PRKCE;STK39
prerank,metal ion homeostasis (GO:0055065),-0.32354693360259856,-1.189528210302505,0.14124293785310735,0.9579095507044825,1.0,11/40,11.99%,SLC12A6;SLC12A2;GRIN1;ANK3;TMTC2;SNCA;COX11;LETM1;FAM20A;WFS1;SELENON
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3147078895963144,-1.1893173214136261,0.1597222222222222,0.953307327958743,1.0,13/39,16.09%,TRAK2;WASL;MYO1G;BICDL1;NDE1;HTT;PPFIA2;TANC2;FBXW11;MYO7A;MYO1B;MYO5B;CLN3
prerank,ureteric bud morphogenesis (GO:0060675),0.5063645441191925,1.1890700931165448,0.26732673267326734,0.8220966270497329,1.0,2/16,8.81%,WNT11;GDNF
prerank,steroid metabolic process (GO:0008202),0.40165603570921543,1.1890386048206023,0.19823788546255505,0.8212534047329024,1.0,11/72,13.69%,LRP2;HSD17B7;DHRS4;HSD11B1;FDFT1;CYP26B1;STARD3;DHRS11;CYP27A1;TSPO;NPC1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.42493179347256793,1.1890034843858,0.2192090395480226,0.8204493098164299,1.0,13/54,17.88%,PML;CHEK2;CNOT4;CNOT7;TNKS1BP1;TFDP1;PLK3;TFDP2;E2F4;PRMT1;PCBP4;BAX;CRADD
prerank,ribosome assembly (GO:0042255),0.4282290170259165,1.1887280418895372,0.24595842956120093,0.82053239968748,1.0,22/47,22.09%,PWP2;SBDS;ERAL1;MDN1;NOP53;RRS1;PPAN;NPM1;EIF6;NOP2;MRPS2;RPL23A;RPL11;DHX37;RSL24D1;RPL24;RPL3;MRPS11;MRPL22;DDX3X;RPL5;RPL6
prerank,heme catabolic process (GO:0042167),0.523118148358604,1.1886059421313848,0.26895565092989987,0.8190923579603203,1.0,6/14,20.01%,ABCC2;SLCO1B1;ABCC1;BLVRB;HMOX2;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.523118148358604,1.1886059421313848,0.26895565092989987,0.8190923579603203,1.0,6/14,20.01%,ABCC2;SLCO1B1;ABCC1;BLVRB;HMOX2;ABCG2
prerank,establishment of protein localization to organelle (GO:0072594),0.40527086620343583,1.1884542121429023,0.2064516129032258,0.8187014844360802,1.0,24/72,20.31%,RANBP6;STAT3;LAMP2;NUP153;KPNB1;CSE1L;PRICKLE1;LRSAM1;NXT1;IL10RA;RPAIN;PPP1R10;HK1;IPO8;NEURL1B;TNPO2;NUP155;RAB11A;RANBP17;LAMP1;NUP88;CD68;NUP133;APPL2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.45713489366710164,1.1884330239925485,0.24320987654320989,0.8178379730279377,1.0,9/28,20.61%,NOD2;THY1;CD47;CCDC88B;PRKDC;TNIP2;TYROBP;SIRPA;LCK
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.27950821563041994,-1.1881406469044917,0.10784313725490197,0.9523363244888636,1.0,26/68,20.66%,CSTF3;CSTF2;POLR1A;FIP1L1;PABPN1;ERCC3;TBP;TTF1;ERCC2;PRMT5;MAZ;SNRPE;SYMPK;TAF1D;SNRPF;CPSF7;POLR2F;CPSF4;POLR1C;TAF1A;POLR1H;GTF2H3;POLR2A;CLP1;MTERF2;GTF2H4
prerank,positive regulation of MAPK cascade (GO:0043410),0.3726011902741095,1.1878407803320485,0.11923847695390781,0.8190922300738088,1.0,45/245,16.81%,EIF2AK2;NOD2;TAOK3;FLT1;CCL7;SLAMF1;SPRY2;KDR;GAREM1;GPR37L1;DHX33;CD40;ADAM8;CCL5;FBXW7;CX3CL1;MYDGF;FGFR2;MT3;GPR37;RET;TMEM106A;TPD52L1;RAPGEF2;ACKR3;APP;HMGB1;INSR;BMPER;ROR2;ARRB2;CIB1;CCL14;HTR2A;PTPN11;APOE;NRP1;SOX2;EZH2;STK25;TAOK2;MTURN;FGFR3;IRAK1;LGALS9
prerank,bile acid metabolic process (GO:0008206),0.4657121935060705,1.1878195062004293,0.2529335071707953,0.8182302546164463,1.0,10/27,20.66%,OSBPL7;CH25H;OSBPL3;CYP27A1;NPC1;OSBPL9;OSBP;GBA2;OSBPL2;CYP39A1
prerank,skeletal muscle contraction (GO:0003009),0.4882423514897892,1.187616701879807,0.2557510148849797,0.8180677607379311,1.0,5/19,22.06%,TNNC1;STAC3;TNNI2;RCSD1;MYH14
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4264072160701747,-1.1869425769202544,0.21428571428571427,0.9515105834283146,1.0,8/15,29.29%,PTTG1IP;SIRT1;MIF;KDM1A;ING2;TAF9;TAF9B;PRKN
prerank,negative regulation of response to external stimulus (GO:0032102),0.3903892830426781,1.1868182976613164,0.17463617463617465,0.8200003454870255,1.0,27/105,21.96%,TRAFD1;AOAH;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;DUSP3;EPHA4;RORA;APOE;CXCL17;RB1;SHARPIN;CRK;PPARD;ACOD1;CERS2;MFHAS1;RTN4RL1;SIRPA;TNFAIP8L2;MAPKBP1;PRKCD;VPS35;FGF2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4585537825607786,1.186596008230584,0.26765799256505574,0.8198534216338716,1.0,5/25,11.71%,EXT1;HAS3;HAS1;CSGALNACT2;B3GALNT1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.45390530279197405,1.1864669465189277,0.2521525215252153,0.819370750357848,1.0,8/28,13.91%,HSPA1B;MECP2;MAPRE1;CDK5RAP2;MET;GIT1;AKAP9;RAC1
prerank,dendritic spine morphogenesis (GO:0060997),-0.4127743733030511,-1.1860974042513643,0.23134328358208955,0.9492140943951054,1.0,6/15,10.44%,WASL;DLG4;CDC42;EPHB2;SHANK3;EPHB1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5497065521769116,1.1859549912691647,0.28422619047619047,0.8202835384298158,1.0,5/10,20.31%,GRB10;RSC1A1;ENPP1;INPP5K;APPL2
prerank,negative regulation of translational initiation (GO:0045947),0.5319977690382947,1.1858502129438557,0.2710674157303371,0.8197236572899466,1.0,3/13,5.65%,AGO2;LARP1;EIF4EBP2
prerank,regulation of platelet aggregation (GO:0090330),-0.4062160406822129,-1.185786744370544,0.2518518518518518,0.9449735436783371,1.0,7/17,17.79%,SYK;PRKCQ;DMTN;CEACAM1;CD9;PRKG1;F11R
prerank,cellular lipid catabolic process (GO:0044242),0.45312137794341945,1.1856753487363396,0.24871794871794872,0.8194759814274076,1.0,4/27,8.34%,AOAH;ACADL;MT3;LPIN2
prerank,regulation of protein processing (GO:0070613),0.4797655507857964,1.1854518745686105,0.24057217165149544,0.8194286877930635,1.0,5/21,15.02%,ADAM8;RUNX1;PRNP;GAS1;TMEM59
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5529243005651778,1.1853836757341283,0.27232142857142855,0.8187302657536379,1.0,3/10,17.36%,ABCA1;APOE;ZDHHC8
prerank,regulation of MAP kinase activity (GO:0043405),0.394787748184511,1.1851855925674344,0.20957446808510638,0.8185096259867389,1.0,19/92,16.43%,AGT;NOD2;FLT1;TRIB3;SPRY2;CD40;ADAM8;CDK12;TPD52L1;PAQR3;LYN;SORL1;APOE;PIK3CB;EZH2;INPP5K;HGS;CD300A;IRAK1
prerank,positive regulation of neuron projection development (GO:0010976),0.3911267750570605,1.1851795153699327,0.19957081545064378,0.8176033157570967,1.0,25/85,18.44%,WNT5A;PLXNB2;BDNF;CAMK2B;RETREG3;PLXNB3;DHX36;CX3CL1;P3H1;RET;MAGI2;RAPGEF2;LTK;LYN;ROR2;APOE;RAPGEF1;NPTN;DBNL;SCN1B;LRP8;MDK;STMN2;FUT9;CAPRIN1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.4497795738510647,-1.1847901963470053,0.2147239263803681,0.943564215838264,1.0,4/12,11.57%,DPYSL3;CTPS1;UMPS;CRMP1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3818289776364418,1.1841814530134904,0.17435897435897435,0.8202510578309784,1.0,24/142,15.86%,CHRNA9;CALCA;CXCR4;WNT5A;FIS1;CD55;FPR3;SLC8A1;PTGER4;ADCY5;TACR1;TAC1;PTGER3;CACNA1A;ACKR3;HMGB1;TAC4;C3AR1;GPR35;TRPV4;SPPL3;NPTN;SELENOT;HCRTR1
prerank,negative regulation of macrophage activation (GO:0043031),0.5039222834518811,1.184131011603994,0.2704225352112676,0.8195230784631031,1.0,6/16,18.10%,CX3CL1;CST7;ZC3H12A;FCGR2B;PTPRC;LDLR
prerank,microtubule nucleation (GO:0007020),-0.3749221290230225,-1.183921294086358,0.188,0.9416944152769214,1.0,11/20,20.07%,NDE1;TPPP;TUBGCP3;CLASP2;TUBGCP4;TUBGCP6;TUBGCP2;CCDC57;GOLGA2;TPX2;CLASP1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5550988902648929,1.1834935729795328,0.28296296296296297,0.8208630171204023,1.0,2/10,6.59%,GPR37L1;GPR37
prerank,regulation of cellular senescence (GO:2000772),0.46000948999932967,1.1833980460403657,0.2455470737913486,0.8202696601820311,1.0,12/28,23.04%,PNPT1;B2M;CGAS;RBL1;RSL1D1;YPEL3;NEK6;EEF1E1;ZKSCAN3;TERF2;AKT3;VASH1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.3284841729676714,-1.1832048269861926,0.15979381443298968,0.9390887626860044,1.0,9/33,15.71%,GPR137B;MAFB;TRAF6;CAMK4;CCL3;UBASH3B;TMEM178A;CEBPB;CCR1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.394073059230857,1.1827624510394144,0.22175290390707497,0.8216713589416049,1.0,11/76,12.50%,CALCA;AGT;FPR3;ACTN2;TACR1;GNA15;GNA14;PTGER3;C3AR1;HTR2A;GPR35
prerank,regulation of steroid metabolic process (GO:0019218),0.4733080448009108,1.1825147539448821,0.25777202072538863,0.8216220701158232,1.0,9/23,24.92%,ABCG1;ACADL;RORA;EPHX2;APOE;PANK2;TTC39B;STUB1;ACADVL
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5078328062954667,1.1814051916657136,0.27034482758620687,0.8248107470087526,1.0,7/14,14.91%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;MYB
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4507975410803659,1.1812950597866052,0.2607099143206854,0.8243295158093114,1.0,10/30,19.72%,IRF7;BIRC2;CD40;IKBKE;TRAF3;BIRC3;TNIP3;TLR3;CD300LF;TANK
prerank,cell-substrate junction assembly (GO:0007044),0.4456017986389328,1.1810848816014161,0.24607961399276237,0.8242109475276614,1.0,7/33,6.60%,ACTN1;THY1;LAMC1;ACTN2;PEAK1;ARHGEF7;PIP5K1A
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.40802548446905396,1.18097693629654,0.24503311258278146,0.8236729614980661,1.0,15/56,19.68%,NOD2;NOD1;ALPK1;CTSS;TLR8;UNC93B1;HMGB1;TRAF3;IRAK4;MYD88;TLR2;IRAK1;TLR3;LACC1;TAB3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4105228721122478,1.1809027126238527,0.2336655592469546,0.8229923229623705,1.0,31/60,29.24%,MOV10;MECP2;DHX36;SOX9;CTNNB1;CCND1;TCF7L2;NFKB1;SRF;MED12;PAXIP1;MED27;MED16;BAX;MED10;MED7;MED24;CDK8;AGO4;MED8;TRIM28;ATF7IP;CDKN2A;PTEN;AGO1;MED25;AGO3;SUB1;MED26;CSF1R;MED13
prerank,activation of protein kinase B activity (GO:0032148),0.456737386741033,1.1806216518723684,0.25092707045735474,0.8230350650108024,1.0,8/29,16.32%,WNT5A;OSBPL8;MT3;PPIA;CCDC88A;INSR;IL18;MTOR
prerank,ganglion development (GO:0061548),0.541602924112365,1.180320486760217,0.28156748911465895,0.8232414332401164,1.0,3/11,13.47%,NRP2;CTNNB1;NRP1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4844941948241391,1.1803043331294176,0.2618421052631579,0.8223731363554299,1.0,9/19,19.76%,CAMK2B;DHX36;CUL7;FBXW8;CUX1;DBNL;LRP8;CAPRIN1;SS18L1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.44012406948307214,-1.18000357166046,0.2484076433121019,0.9461990408897825,1.0,3/12,8.41%,FBXW4;LRP6;TGFB2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.43226043023014676,1.1799455887062555,0.23272727272727273,0.822775586545488,1.0,7/35,16.99%,PDE7B;GAL;SOX9;RAPGEF2;APOE;PDE3A;NUDT4
prerank,peptide catabolic process (GO:0043171),0.48342148929783535,1.1798091940033955,0.2480106100795756,0.822381385601652,1.0,9/23,24.78%,ERAP1;CPQ;CTSH;GGT7;NPEPPS;CHAC2;IDE;TRHDE;ECE1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3652780605877179,1.1793128197229847,0.006,0.8233377747061006,1.0,237/1082,18.57%,STAT1;CXCL10;SP100;NLRC5;IRF7;HELZ2;PARP9;WNT11;PITX2;NAMPT;PML;GAL;AGT;LHX2;LMX1A;NR1H2;HAS3;NOD2;ESR2;DTX3L;USF2;PCGF5;MEF2B;WNT5A;TFAP2C;ZBTB17;TRIM45;ESRRB;PRMT2;RARG;DDRGK1;DHX33;AGO2;RBM14;RNF4;TEAD2;CD40;NFKB2;CHEK2;CDH13;ACVR1;STAT3;MLLT11;ARID1B;ACTR2;RBL1;SFRP2;ELK3;RUNX1;MAD2L2;USP21;RBMX;CHCHD10;KLF15;CHEK1;ILF3;DHX36;MZF1;JUNB;UBTF;NCOA1;MRPL12;SERTAD3;SOX9;CTNNB1;CX3CL1;PFKM;KMT2A;PAXBP1;ARID1A;CCNT2;ZNF76;MYDGF;FGFR2;NSD3;TCF7L2;TCF4;SMARCC2;ZXDC;NFKB1;CREBRF;ASXL3;EDF1;ZBTB38;SETD3;THAP3;MT3;USF1;ACTR3;NFATC2;TFAP2B;MAP2K3;RET;UBP1;DHX9;SRF;MDFIC;RAI1;HTATIP2;SMAD2;MRTFA;GLIS3;MEIS3;ATF6B;TFDP1;CDK5RAP2;LPIN2;BAMBI;NCK1;LMO2;MET;GDNF;ATF1;NFIB;METTL23;POU3F1;APP;SCX;HMGB1;NCK2;ELF4;CRTC1;MAML2;AGRN;BMPR2;MEN1;BPTF;WAC;RORA;MED12;PROX1;TNIP1;PHIP;BTRC;RGMB;ZC3H12A;NPM1;FOXK1;DNM2;MAX;SNW1;NOTCH4;CTCF;MITF;GALR1;RYBP;XBP1;TFDP2;IER5;ARHGEF11;ECD;MAP2K2;KLF10;ICE2;ZNF423;ILF2;LDB2;LDB1;PSEN1;REL;PPARGC1A;APOE;PRKDC;SERTAD2;NR3C1;BRPF1;PRDM4;E2F4;APBB1;HDAC8;ST18;MYO6;POGZ;DAB2;WDR43;BCL11B;SMARCA1;KDM8;CASZ1;SERTAD1;SOX2;TNIP2;TFR2;RREB1;DDX39B;TET2;CREB5;MYB;INPP5K;CRTC3;PRDM11;MLLT3;CAMTA2;BMPR1A;TLR2;SMARCD2;TAF15;NPAT;ARF4;MEF2A;PPARD;TNIP3;LAGE3;IL18;MTOR;LMO7;SREBF1;CCNK;ZBED4;KAT8;RBPJ;BRD7;MED16;CHCHD2;ELOF1;ELF1;TRIP4;MPND;IER2;RRP1B;TLR3;TNNI2;PELP1;ENY2;ZBTB49;POU2F2;ZNF513;PTOV1;CAND2;ACVR2A;FOSL2;HDAC1;HINFP;GABPB1;GABPB2;MED10;HOXA5
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5076499838953653,1.179301140206552,0.2671957671957672,0.8224643128832649,1.0,9/16,26.35%,CLU;SRF;LRPAP1;APOE;HDAC1;IFNGR1;HMGCR;TNF;LRP1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.4632119344871249,1.1791426108932195,0.2570332480818414,0.8221497452442574,1.0,8/26,21.96%,TRPM2;ITPR1;CHERP;HTR2A;PTPRC;ERO1A;LCK;FGF2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.45665448464348257,1.178959264387759,0.24334600760456274,0.8218481152387659,1.0,3/27,7.25%,AGT;WNT5A;DHX9
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.48403184849467124,1.1787949574225205,0.25102319236016374,0.8215015851412379,1.0,6/19,16.89%,AXL;MMP14;XBP1;PRKDC;CD27;MDK
prerank,histone lysine methylation (GO:0034968),0.4411349963415643,1.1787669958702793,0.23386114494518878,0.8207072994778416,1.0,10/33,16.10%,DPY30;RBBP5;KMT2A;SETD3;MEN1;WDR5;SETDB2;PAXIP1;EZH2;SMYD1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3799089094737266,-1.1787460187878878,0.2,0.9458794396264503,1.0,9/20,21.54%,RPGRIP1L;RNF157;GRK3;SNCA;RGS14;GRK2;CRY1;GPRASP1;YWHAB
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4579352494401626,1.178534900408483,0.2608142493638677,0.8206511321609463,1.0,13/25,25.39%,PLXNB3;EVL;KANK1;RAP1GAP;CDK10;ODF2L;CAPZB;STAP1;TESK1;ARHGAP24;PRKCD;EVI5L;PFN2
prerank,sulfur amino acid metabolic process (GO:0000096),0.47471839650801795,1.1783836701686545,0.2602921646746348,0.8202849183724774,1.0,8/24,23.03%,MTHFR;SMS;MSRA;GCLC;MTHFD1;GADL1;MMUT;TXN2
prerank,cell part morphogenesis (GO:0032990),0.524071934485764,1.1780840829124688,0.2824207492795389,0.8204307296098362,1.0,3/13,9.75%,PNPT1;FIS1;SLIRP
prerank,epithelial to mesenchymal transition (GO:0001837),0.42128274685091194,1.178052287988815,0.2271689497716895,0.8196278638030903,1.0,9/47,13.10%,LOXL2;WNT5A;DDX5;SOX9;CTNNB1;CUL7;SNAI2;NOTCH4;LIMS1
prerank,regulation of GTPase activity (GO:0043087),0.37450014989872915,1.1778903677854278,0.15821501014198783,0.8193534183847697,1.0,51/177,21.07%,WNT11;CCL7;PLXNA3;RASA4;DOCK8;RGP1;PLXNB2;SEMA4D;CD40;THY1;CCL5;PLXNB3;CX3CL1;EPHA4;ARHGEF7;RAPGEF6;RAPGEF2;RAP1GAP;AGRN;VAV1;SNX9;STMN3;LRCH1;CCL14;SRGAP2;RGS16;CHN1;ARHGAP11A;RACK1;SIPA1L1;RIC1;FGD6;LIMS1;RAPGEF1;ASAP3;EZH2;CRK;SH3BP1;OCRL;TBC1D2;RRP1B;NF1;CPEB2;ARAP1;PIN1;SGSM3;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,cytoplasmic translation (GO:0002181),-0.2714313666332388,-1.1778503676508862,0.12244897959183673,0.9443052263305486,1.0,31/91,18.72%,RPS12;RPL13;RPS14;DRG1;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;RPL8;RPL21;TMA7;FTSJ1;RPL22L1;RPL31;RPL36A;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;UBA52;RPS25;RPS27A;RPL18;RPL38;RPL34
prerank,regulation of secretion (GO:0051046),0.526961651206749,1.1777677915508944,0.29250720461095103,0.8188942933800819,1.0,1/13,0.18%,OAS2
prerank,regulation of neuron death (GO:1901214),0.39648538864780325,1.177761429199016,0.2102454642475987,0.8180263578432074,1.0,18/82,14.33%,CHMP4A;CHMP4B;WNT5A;DAXX;CLU;NENF;EGLN2;CCL5;RILPL1;CSF1;PRNP;SORL1;DDIT4;PPARGC1A;AKT1S1;FCGR2B;EIF2S1;FYN
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5500317677434938,1.1775482998413564,0.29675425038639874,0.8178734234414003,1.0,3/10,16.65%,CAMK2D;PRKCE;STK39
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5316541311815897,1.1775350269533553,0.2833333333333333,0.8170184038937417,1.0,4/12,14.64%,IRS1;ABCD1;PPARGC1A;IRS2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4872718603972904,1.1774062273532662,0.26002587322121606,0.8165781225017554,1.0,8/20,19.77%,KPNB1;ACADL;LDLRAP1;EPHX2;APOE;SREBF1;TTC39B;SEC14L2
prerank,positive regulation of GTPase activity (GO:0043547),0.371300867545316,1.177380461079198,0.15539858728557013,0.8157746522211795,1.0,59/188,21.07%,WNT11;CCL7;DOCK8;RGP1;TBC1D1;SEMA4D;CD40;THY1;CCL5;SYDE1;CX3CL1;ARHGEF7;PIP5K1A;TBC1D8;RAPGEF6;RAPGEF2;ABR;RAP1GAP;SYDE2;AGRN;SIPA1L2;TBC1D8B;SNX9;ARHGAP25;CCL14;SRGAP2;ARHGEF10;RGS16;ARHGAP11A;RACK1;SIPA1L1;RIC1;LIMS1;TIAM2;RAPGEF1;ASAP3;EZH2;SH3BP1;TBCK;BCR;TBC1D2;RALGAPB;ARHGAP29;CORO1C;NF1;ARAP1;SIPA1L3;TSC1;ARHGAP24;PIN1;ARHGAP42;SGSM1;SGSM3;TBC1D4;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,phosphatidylcholine metabolic process (GO:0046470),0.404837460742801,1.1772976015792675,0.23819978046103182,0.8151734412965158,1.0,20/70,21.57%,NR1H2;TMEM86B;SLC27A1;PLA2G12A;CSNK2B;CSNK2A2;LIPC;LPIN2;CEPT1;LPCAT2;ABHD3;CHPT1;PCYT1A;PLA2G4E;PCTP;SLC44A1;PLA2G6;CHKA;PNPLA8;PCYT1B
prerank,positive regulation of viral life cycle (GO:1903902),0.473124577832013,1.1771807189005485,0.25882352941176473,0.814710349238991,1.0,1/22,0.17%,AXL
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.44183851755606696,1.1771326176643666,0.24090338770388958,0.8139869790306863,1.0,9/34,14.34%,TGFA;ANAPC5;ANAPC4;INSR;PHIP;CDC16;CDC27;RB1;NSMCE2
prerank,tRNA wobble uridine modification (GO:0002098),0.5179507330005328,1.1769347178818539,0.28466076696165193,0.8137620743740747,1.0,3/14,6.10%,TRMT9B;MOCS3;TRMU
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.42052756031945193,1.1769265302595244,0.24882629107981222,0.8128984054288059,1.0,11/42,12.37%,TIMELESS;CGAS;ACTR2;MAD2L2;CHEK1;RTEL1;ARID2;SIRT6;POLQ;SHLD1;PPP4R2
prerank,import into nucleus (GO:0051170),0.40272221004361186,1.1767791516436978,0.2113289760348584,0.8125487687761265,1.0,25/73,20.31%,RANBP6;STAT3;NUP153;KPNB1;CSE1L;PRICKLE1;DDX20;NXT1;RPAIN;HTATIP2;PPP1R10;IPO8;HNRNPA1;TNPO2;GEMIN7;SNRPD2;SNRPD1;NUP155;SNRPG;GEMIN2;RANBP17;NUP88;SNUPN;NUP133;APPL2
prerank,carbohydrate derivative transport (GO:1901264),0.4974166607828819,1.1767686932213517,0.2756756756756757,0.8117035318211496,1.0,4/18,4.40%,ABCG1;SLC15A3;SLC15A2;SLC25A19
prerank,negative regulation of secretion by cell (GO:1903531),0.431777128858507,1.1766235874909297,0.2538552787663108,0.8113809580834765,1.0,4/38,12.35%,RSAD2;SLC30A1;RHBDF2;APOE
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.47559915451563456,-1.1763631946608428,0.2777777777777778,0.9448565193708555,1.0,4/10,16.70%,IRAK3;MAPK7;KLF4;MAP2K5
prerank,positive regulation of cell junction assembly (GO:1901890),0.41341415839592105,1.176270167820296,0.23502824858757063,0.811768338721606,1.0,13/56,16.20%,AGT;KDR;BDNF;CLSTN1;THY1;MYOC;PPM1F;LIMS1;NRP1;RAC1;IL1RAP;CLSTN3;NLGN3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.45756989658842223,1.1750040232097207,0.2697201017811705,0.8154824951609521,1.0,7/26,17.34%,IRF7;BIRC2;GPR108;BIRC3;TLR2;FLOT2;TLR3
prerank,macromolecule catabolic process (GO:0009057),0.4593347118152848,1.174835560972628,0.2715736040609137,0.8151915638662501,1.0,14/26,23.27%,MVB12A;SIAH1;LRSAM1;SH3GLB1;UCHL3;KIF16B;PIK3R4;SMURF1;MTOR;SNX25;UVRAG;BECN1;IDE;CLN6
prerank,negative regulation of binding (GO:0051100),0.39711285852190337,1.174007437947327,0.23779193205944799,0.8171996851189257,1.0,15/81,14.28%,SP100;IFIT1;IFIT2;ILRUN;SUMO3;SLPI;DACT1;LRPAP1;SORL1;DDX11;MDFI;RACK1;DAB2;ACTB;JAK2
prerank,regulation of apoptotic process (GO:0042981),0.3651945383263266,1.1733960992396921,0.027,0.8186021807377427,1.0,110/676,13.38%,IFIT3;STAT1;ZBP1;CXCL10;NOL3;AXL;HSPA1B;WNT11;TNFSF10;AGT;IFIT2;DAPK3;TNFSF9;WNT5A;SPRY2;COMP;KDR;DAXX;CLU;BIRC2;PRMT2;RARG;GADD45G;DDRGK1;KLHL20;TNFRSF8;TMEM219;ACTN1;SEMA4D;TARDBP;MLLT11;BCL2L11;LRP2;ANKLE2;SFRP2;PLEKHN1;FXN;ACTN2;CASP6;BFAR;EGLN2;HCK;SIAH1;CCND2;RSL1D1;NOP53;OSGIN1;SOX9;SRA1;HNRNPK;CTNNB1;CX3CL1;AREL1;MYDGF;ARHGEF7;CFLAR;NFKB1;BCL6;TMBIM4;DDX20;MT3;TFAP2B;ATAD3A;FRZB;PPIA;HTATIP2;CTSH;ABR;BCAR1;LTK;GDNF;BARD1;PDPN;SCX;HMGB1;PLK3;VAV1;SPHK2;PHIP;PRR7;CIB1;DIABLO;NPM1;DNM2;PHLDA1;NUAK2;DNAJA3;RNF122;RNPS1;RYBP;XBP1;ARHGEF11;PIM1;CBX4;BAG1;SOS1;NAA35;ARHGAP10;GAS1;PSEN1;PRKDC;SOCS2;AKT1S1;DFFA;RACK1;RPS6;BAD;APBB1;AKAP13;TIAM2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.51953340896717,1.1730225667365106,0.2916666666666667,0.8190445105301517,1.0,5/15,17.74%,SNX33;ADAM8;SNX9;APOE;SH3D19
prerank,regulation of mRNA processing (GO:0050684),0.44097478047812116,1.1707716551493836,0.24519230769230768,0.8262941457996812,1.0,11/32,17.55%,SRPK3;HNRNPK;DHX9;SLTM;SRPK1;ZFP36L1;AHCYL1;PAPOLA;RBM39;NCBP1;CWC22
prerank,positive regulation of axonogenesis (GO:0050772),0.427281634340699,1.1706864124003935,0.24263839811542992,0.8257258157053041,1.0,6/43,4.61%,PLXNA3;PLXNB2;BDNF;SEMA4D;RUFY3;PLXNB3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.483131853883073,-1.170430708156499,0.2819767441860465,0.9627417435375792,1.0,2/10,4.99%,SIRT7;SELENOS
prerank,response to progesterone (GO:0032570),0.4906676908165266,1.1703615096371678,0.29532967032967034,0.8260578478622638,1.0,3/18,5.56%,CATSPER4;ABHD2;UBE3A
prerank,quinone biosynthetic process (GO:1901663),0.5031174650028484,1.1700990685748147,0.2984441301272984,0.8261310089587323,1.0,3/14,6.33%,COQ2;COQ10B;COQ3
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5297260609666042,1.1700222829394658,0.2930513595166163,0.8255238498516513,1.0,3/11,10.01%,ATL1;VAPB;VCPIP1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.46227147838263943,1.1697633534809593,0.27137546468401486,0.8255534183708073,1.0,6/26,14.87%,CLU;HSP90AB1;TMEM106A;P2RX4;INSR;HSP90AA1
prerank,endothelial tube morphogenesis (GO:0061154),0.5572372240525004,1.1694767915398128,0.28396946564885495,0.825678350268361,1.0,4/10,20.17%,CTNNB1;CSNK2B;RBPJ;ACVRL1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4303461930131979,1.1691999316000974,0.24231678486997635,0.8257719543682446,1.0,11/39,18.91%,CAMK2D;FXYD4;UTRN;NETO1;FXYD6;FXYD5;PRKCE;FGF13;SCN1B;STK39;GLRX
prerank,nitrogen compound transport (GO:0071705),0.3753896285886045,1.1684032278158616,0.19835560123329907,0.8277933557505683,1.0,34/141,22.40%,ZG16;ABCC2;CHMP1B;SLC18A2;ARRDC4;SLC38A2;SLC38A1;LRP2;SLC15A3;SLC15A2;RILP;SLC52A2;ARRDC2;SLC38A3;SLC35F3;PDPN;SLC7A6;AMN;ABCC1;CHMP3;CMTM6;VAMP2;DENND10;SLC25A47;SLC25A45;MYH9;FLVCR1;ABCG2;SLC44A1;SLC7A7;SLC6A6;CHMP1A;HSP90B1;CERT1
prerank,regulation of peptide hormone secretion (GO:0090276),0.40021747388292916,1.1676687651304054,0.25331858407079644,0.8295678340380717,1.0,9/67,8.44%,PER2;CHD7;CRHBP;CCL5;ITPR1;TFAP2B;SYT7;KCNS3;CACNA1A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.47740939813248745,1.1676047948212467,0.28706199460916443,0.8289043094340071,1.0,5/20,16.65%,CAMK2D;ACTN2;CAB39;PRKCE;STK39
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.3252565371324183,-1.1675003803099282,0.21164021164021163,0.9692578982442361,1.0,10/33,13.52%,CSTF3;CSTF2;FIP1L1;PABPN1;MAZ;SNRPE;SYMPK;SNRPF;CPSF7;CPSF4
prerank,regulation of nervous system development (GO:0051960),0.43610393589852936,1.1670914675994586,0.2451219512195122,0.8298792833656167,1.0,7/37,8.46%,PER2;BHLHE40;NKX6-2;CTNNB1;CX3CL1;NPHP3;YTHDF2
prerank,camera-type eye development (GO:0043010),0.4629133251208247,1.1669093422995076,0.2835249042145594,0.8296760136600773,1.0,2/25,7.49%,PITX2;FBN1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.497058157398342,1.1667132994444247,0.2909090909090909,0.829559379102927,1.0,4/16,11.57%,TNFSF9;IL27;LST1;TNFSF8
prerank,organelle transport along microtubule (GO:0072384),-0.32092698374940687,-1.1662456213093917,0.22043010752688172,0.9691339179038058,1.0,8/31,9.60%,TRAK2;BICDL1;NDE1;HTT;CDC42;TMEM201;FBXW11;UBB
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.49635507821808217,1.165921815666035,0.3012729844413013,0.831560713274138,1.0,5/18,18.19%,PARP10;MORC3;PEX2;CD300A;NF1
prerank,Rho protein signal transduction (GO:0007266),-0.2953553835962323,-1.1646120758713068,0.15789473684210525,0.9706219349022911,1.0,20/53,20.92%,CFL1;ARHGAP5;ROCK1;PLEKHG5;ARHGDIB;SHTN1;ARHGEF1;EPS8;CDC42;COL1A2;RHOU;RIPOR1;RHOA;WAS;CDC42EP1;ARHGEF3;CDC42EP2;NTN1;RTKN;TAX1BP3
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3309579678131048,-1.1645633998404676,0.21621621621621623,0.9657890393217734,1.0,13/29,36.28%,BLMH;HOGA1;SARDH;KMO;PRODH;IL4I1;ALDH4A1;DDO;GOT2;CBS;IDO2;THNSL2;DAO
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.2594704157218489,-1.1642691887816514,0.16666666666666666,0.9618421307613856,1.0,24/107,12.68%,STIM1;ATP1B1;MT1B;MT1G;MT1E;MT1A;MT1M;MT1H;MT1F;MT1X;TPT1;TMCO1;SLC39A14;SLC39A7;ATP2A2;CCL13;SLC10A7;SLC8A3;ATP2C1;CCL15;SLC39A12;CCL3;CHRNA7;CCR2
prerank,negative regulation of cell motility (GO:2000146),0.37858129254634854,1.163705646253511,0.21694214876033058,0.8385979974093547,1.0,29/108,21.54%,WNT11;BST2;CLIC4;THY1;SFRP2;PLXNB3;DUSP3;CX3CL1;EPHA4;ARHGAP4;TMIGD3;MAGI2;ARID2;KANK1;MITF;SRGAP2;SRGAP3;DUSP10;CRK;PTPRU;DACH1;NF1;STK24;SINHCAF;PIN1;RAP2A;ACVRL1;MCTP1;CITED2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4302677225308609,1.163637712560785,0.24907521578298397,0.8379715644577739,1.0,13/37,23.07%,FIS1;BCL2L11;SIAH1;NCK1;RACK1;BAD;BMF;BAX;BECN1;BCAP31;LCK;FBH1;NACC2
prerank,negative regulation of immune system process (GO:0002683),0.49630361794142974,1.163467849205216,0.28763440860215056,0.8376919316951534,1.0,5/16,12.87%,SOX9;LYN;IL17D;COL3A1;FCGR2B
prerank,cholesterol metabolic process (GO:0008203),0.3998130385180776,1.1634235795277028,0.2366412213740458,0.8369619162338129,1.0,22/68,23.72%,ABCA1;ABCG1;HSD17B7;CH25H;MT3;FDFT1;LDLRAP1;STARD3;CYP27A1;APOE;GGPS1;PPARD;SOAT2;IDI1;SOAT1;EBP;GBA2;HMGCS1;ABCA5;HMGCR;CLN6;SNX17
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3656492935705418,1.1629603113554867,0.12712712712712712,0.8377509619928183,1.0,108/314,23.91%,PML;PSMB10;SKP1;AUP1;FBXL16;PSME2;TRIM25;UBE2W;BIRC2;KLHL20;PSMA5;CDC26;RNF4;TMEM129;CUL5;PSME4;ANAPC5;RBCK1;ECRG4;FEM1B;RNF5;BFAR;SIAH1;UBQLN2;UBE2B;TNFAIP1;KCTD17;FBXW7;CTNNB1;PPP2R5C;AREL1;PSMA3;UBXN1;AMFR;SPSB1;PSMB9;ANAPC4;RBX1;TMUB2;UBE2E1;ZSWIM8;UBXN2B;UBQLN1;ARRB2;FAM8A1;BTRC;UBXN11;RNF122;PSMD2;RNF103-CHMP3;CDC16;CDC27;FAF2;SMURF1;PSME3;FBXL14;FBXL19;RB1;RNF185;ANAPC15;SHARPIN;UBE4B;ANKZF1;PSMA4;ERLIN2;TMEM67;NHLRC3;RNF103;APPBP2;AMN1;ANAPC2;GID4;FBXL5;UBE2K;KLHL15;TRIM2;WWP1;STT3B;PSMD7;PCNP;RFFL;PSMD8;PTTG1;PSMD9;ZFAND2A;SPOP;PSMF1;TRIM13;PSMB6;RNF216;PSMC2;PSMD12;HUWE1;SMURF2;HSP90B1;STUB1;UBR2;PSMD4;DNAJB2;CUL3;PELI1;KAT5;FEM1A;FEM1C;VCP;MAEA;PSMA2;UBR1
prerank,regulation of cell migration (GO:0030334),0.36497633940193286,1.162844476545175,0.091,0.8373129305289644,1.0,80/382,16.89%,WNT11;BST2;FLT1;CCL7;PLXNA3;CLIC4;SPRY2;SGK3;PLXNB2;KDR;CPNE3;PIK3CD;DDRGK1;CAMK2B;SEMA4D;SOD2;CXCL16;CDH13;ACVR1;SASH1;STAT3;MYO1C;SPATA13;THY1;MMP14;SFRP2;RUFY3;CCL5;PLXNB3;OSGIN1;DUSP3;CX3CL1;FAM83H;EPHA4;CARMIL1;PODXL;ARHGAP4;CSF1;SNAI2;RET;TMIGD3;MAGI2;ELP6;MAPRE1;MYOC;CTSH;BCAR1;ARID2;PDPN;KANK1;INSR;TBCCD1;ROR2;CIB1;PPM1F;SUN2;FGF9;MITF;XBP1;SRGAP2;SRGAP3;SORL1;LDB2;LDB1;DUSP10;RACK1;RAC1;DAB2;STX4;KIF2A;AMOTL2;IGSF10;MINK1;MIEN1;SPAG9;AIF1;SEMA3D;MGAT5;PTPRU;MDK
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4878888773779908,1.162762632975413,0.29880478087649404,0.8367259715239068,1.0,7/18,17.64%,MTHFR;SMS;SLC25A12;MSRA;FOLH1;MTHFD1;GADL1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5422916719323904,1.162697875687741,0.2929745889387145,0.8360833217418732,1.0,1/11,3.52%,RTP4
prerank,regulation of protein transport (GO:0051223),0.4515316385464119,1.1624824279941717,0.27204030226700254,0.8360117289812591,1.0,14/27,26.66%,P3H1;GAPVD1;HSPA8;PPM1F;SCFD1;RHBDF2;STXBP5L;LLGL1;SNX12;TNF;CHP1;NDFIP1;PTPN1;DNAJA1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4371505554035026,1.162318680964927,0.2695214105793451,0.835766713448061,1.0,8/34,13.47%,FLT1;SPRY2;KDR;MAP2K3;MAPK14;VEGFD;GAS1;NRP1
prerank,maturation of LSU-rRNA (GO:0000470),0.46056590331379443,1.1623129600288515,0.2685069008782936,0.8349116648109791,1.0,9/26,17.85%,DDX18;RSL1D1;LAS1L;RPL7L1;EIF6;NOP2;ZNHIT3;RPL10A;WDR12
prerank,endothelial cell proliferation (GO:0001935),0.498105744848854,1.1618713894473174,0.29583333333333334,0.8356781782650684,1.0,6/17,20.17%,LOXL2;BMPER;BMPR2;DLG1;ERN1;ACVRL1
prerank,modified amino acid transport (GO:0072337),0.5082093552210952,1.161584076339729,0.3049645390070922,0.8358422079183095,1.0,6/15,21.84%,SLC46A1;SLC19A1;PDPN;CTNS;SLC5A6;MGST1
prerank,regulation of interleukin-8 production (GO:0032677),0.3926127030825382,1.1612972666483183,0.2502732240437158,0.8360121801366448,1.0,17/69,21.46%,HSPA1B;NOD2;NOD1;STAT3;TLR8;HMGB1;IL17D;MYD88;TLR2;LGALS9;ANXA4;TLR3;PTPRC;CD33;RAB1A;MAPKBP1;F3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4683533485428104,1.161215342700052,0.2859078590785908,0.8354283410432595,1.0,8/21,18.18%,SPPL2A;RBMX;ERAP1;PSEN1;SPPL3;APH1A;HM13;MYH9
prerank,negative regulation of signal transduction (GO:0009968),0.3668769664883968,1.1609804179686476,0.14788732394366197,0.8354614460748241,1.0,53/249,15.88%,AGT;SLAMF1;XDH;SPRY2;IRS1;SOCS1;BDNF;DLK2;ACVR1;KIF26A;ASAH2;PTPN18;GRB10;KIF7;MMP14;SFRP2;CD47;CRHBP;CCL5;SIAH1;GPR108;FBXW7;CX3CL1;HMGXB4;SNAI2;CSNK2A2;FRZB;DACT1;YTHDF2;NCK1;LYN;LEPROT;SOCS5;EGFL7;KANK1;CYP26B1;LRPAP1;BTRC;DKK3;APCDD1;DDIT4;RB1;MDFI;ENPP1;RACK1;PIK3CB;CXXC4;PTCH1;EZH2;INPP5K;HGS;PHACTR4;ADAMTS12
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4779462783845301,1.1606372107487057,0.2791005291005291,0.8358265654577651,1.0,5/19,12.85%,TPST1;SLC26A1;SULT6B1;SLC26A2;ENPP1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5387745427351418,1.1601107623528324,0.29017857142857145,0.8368231044718151,1.0,3/10,15.70%,CD40;LYN;BTLA
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.4756093953239068,1.1599511972349654,0.2756324900133156,0.8365232634889224,1.0,8/21,14.95%,PAQR3;CNKSR3;NCK1;NCK2;PPM1F;DDIT4;RACK1;INPP5K
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.39676668392378106,1.1595555132330255,0.23835319609967498,0.8370485441087051,1.0,28/67,25.96%,PSMB10;PSME2;B2M;PSMA5;PSME4;CYBB;TAPBP;PSMA3;PSMB9;FCGR1A;PSMD2;PSME3;SNAP23;PSMA4;PSMD7;PSMD8;PSMD9;TAP1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2;CYBA;PSMD1;SEC22B;PSMD11
prerank,sensory perception of light stimulus (GO:0050953),0.38707792261984497,1.159103314590846,0.2505353319057816,0.8378015248209698,1.0,11/87,15.24%,CABP4;CNGB1;EYA4;CRYGN;IMPG2;RS1;ATXN7;ADGRV1;RGS16;CHRNB2;BBS2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.43044733448907546,1.1589715710032724,0.26383981154299174,0.837437191745037,1.0,9/38,14.87%,CLU;CD47;HSP90AB1;P2RX4;INSR;ZC3H12A;RAC1;JAK2;HSP90AA1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3925204095411713,-1.1580444753165804,0.23577235772357724,0.9805406955731745,1.0,6/17,15.21%,COX15;COX10;NDUFA4;COX8A;COX6C;COX7B
prerank,membrane protein proteolysis (GO:0033619),0.4239716474192817,1.157449209130894,0.27137546468401486,0.8421453460520266,1.0,13/37,18.18%,SPPL2A;RBMX;ERAP1;NFKB1;RET;CTSH;PSEN1;NAPSA;SPPL3;APH1A;APH1B;HM13;MYH9
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.447964068207416,1.1573520171258174,0.2936802973977695,0.8416497569428344,1.0,13/30,22.80%,BLZF1;GOLGA7;SEC16A;GGA3;AMN;VAMP2;VAMP4;BBS2;PREPL;VAMP5;GOLPH3L;OPTN;RAB10
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4527614563285236,1.1573333065455527,0.27915632754342434,0.8408507087088901,1.0,13/26,27.95%,ATP1B3;ACTN2;CAB39;NETO1;AKAP9;VAMP2;DLG1;STK39;KCNS1;ANK2;YWHAE;ITGB1;CACNA1D
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4706842806435533,1.1567335021327092,0.30250990752972257,0.8420955862292221,1.0,4/21,10.32%,TUBD1;KIF7;UCHL5;PDCL
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3560313348585262,-1.156500443888515,0.2422907488986784,0.9813827758872322,1.0,10/23,19.06%,PARP1;XPC;COPS2;UBB;UBC;GPS1;UBA52;COPS6;RPS27A;XPA
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.40024555782931565,-1.1563495081061301,0.2673992673992674,0.9768985692303883,1.0,3/15,11.40%,UBR3;TGFB2;BRCA1
prerank,RNA modification (GO:0009451),0.4115892651578512,1.1561446753697455,0.2638731596828992,0.8432562488072393,1.0,12/54,12.16%,TRMT9B;ADAR;BCDIN3D;ADAT2;MRM2;MEPCE;TRMT1;ALKBH1;PUS7L;AARS1;WDR4;NOP2
prerank,canonical Wnt signaling pathway (GO:0060070),0.39759781240877645,1.1560474406474015,0.25412541254125415,0.8427398755830376,1.0,8/68,7.61%,WNT11;WNT5A;RARG;SFRP2;CTNNB1;TCF7L2;WNT7B;FRZB
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3727521684277475,1.1558155517022322,0.20285423037716616,0.842687661091742,1.0,12/152,6.59%,CXCL10;CXCL9;CALCA;ABCA1;RXFP2;GPR37L1;S1PR2;PTGER4;ADCY5;GNA15;GNA14;GPR37
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.46191457458420543,1.1557433880209147,0.2979002624671916,0.8420657788265019,1.0,8/24,16.25%,COQ10B;SDHAF4;MT3;GFPT1;LEPR;PPARGC1A;NDUFS1;NDUFS4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4257557087917713,1.15555361321239,0.2742123687281214,0.8418517378955044,1.0,16/40,26.73%,PML;CLU;FBXW7;UBE3A;TRIM39;CSNK2A2;SMURF1;RPL11;RPL5;NUB1;UBQLN4;AXIN1;COMMD1;RAD23A;PTEN;UFL1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.47931350245079685,1.155441796712792,0.2988357050452781,0.8414386611073209,1.0,4/21,5.80%,ZFP36;CNOT4;CNOT7;TNKS1BP1
prerank,aminoglycan biosynthetic process (GO:0006023),0.4062806523942803,1.155199660669496,0.26436781609195403,0.8414568140578716,1.0,5/49,3.12%,EXT1;XYLT2;SDC3;SDC4;HAS1
prerank,autophagosome maturation (GO:0097352),0.43324083405112124,1.1547258316498856,0.3092909535452323,0.842280431190331,1.0,9/32,13.51%,LAMP2;VPS33A;LIX1;RUBCNL;UBQLN1;VIPAS39;CHMP3;MAP1LC3B;VTI1B
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.48130807655812613,1.1536638663481582,0.3074829931972789,0.8452509048039353,1.0,7/16,14.91%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;MYB
prerank,negative regulation of complement activation (GO:0045916),0.5398618147850264,1.1531864249606882,0.2997032640949555,0.8461744379633604,1.0,2/10,4.99%,CD55;SUSD4
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4044523179934777,1.1524038185313232,0.2799539170506912,0.8481896468365094,1.0,12/55,16.68%,AGT;BCO2;XDH;MT3;DHRS4;MAPK14;SPHK2;ZC3H12A;EIF6;RAC1;ARF4;ACOD1
prerank,sensory perception of taste (GO:0050909),-0.45916766053606173,-1.152289163613142,0.29829545454545453,0.9880891326265214,1.0,7/10,54.10%,PKD2L1;PKD1L3;ASIC3;TAS1R3;TAS1R1;ASIC1;CD36
prerank,mitochondrial RNA metabolic process (GO:0000959),0.4934514350001335,1.1522840644442154,0.29411764705882354,0.8477215392303935,1.0,4/14,9.89%,PNPT1;MRPL12;TFB2M;TWNK
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4501796317133591,1.151961115789196,0.3022670025188917,0.848021074693112,1.0,4/29,9.05%,NR1H2;TMEM86B;PLA2G12A;LPCAT2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.44420513399208894,1.150727882068071,0.2938209331651955,0.8514999029641093,1.0,7/27,14.95%,IRS1;SOCS1;GRB10;NCK1;KANK1;ENPP1;INPP5K
prerank,regulation of double-strand break repair (GO:2000779),0.4180533315868046,1.15061070484707,0.275,0.851061441753199,1.0,9/39,12.58%,PML;TIMELESS;ACTR2;CHEK1;RTEL1;SLF2;SIRT6;PPP4R2;DDX11
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4625746029438225,1.1505816821152925,0.29842931937172773,0.8503042871390109,1.0,3/22,9.05%,SP100;MDFIC;BARD1
prerank,bile acid and bile salt transport (GO:0015721),0.46231541632758033,1.1503447571967564,0.275,0.8502827619698402,1.0,4/24,6.50%,ABCC2;SLCO1C1;NCOA1;SLCO1B1
prerank,mesenchymal cell differentiation (GO:0048762),0.40370033478788125,1.150269434103533,0.28859060402684567,0.8496772413926339,1.0,11/51,14.37%,LOXL2;WNT5A;DDX5;SOX9;CTNNB1;FGFR2;CUL7;SNAI2;NOTCH4;LIMS1;RANBP3L
prerank,positive regulation of dendritic spine development (GO:0060999),0.47976763444038734,1.1497190790380194,0.30434782608695654,0.8507390708089749,1.0,7/20,18.44%,CAMK2B;DHX36;PSEN1;APOE;DBNL;LRP8;CAPRIN1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.36168828763040134,1.1491111833789363,0.15995975855130784,0.8519994588163372,1.0,64/260,17.09%,CNGB1;PMP22;CENPJ;CEP19;ATP6V0D1;BBIP1;RAB8B;CDH13;SPATA13;B9D2;ACTR2;S1PR2;CEP162;ACTN2;PARVB;RILP;CYFIP1;RILPL1;SNX10;TTC39C;CARMIL1;ARHGEF7;PIP5K1A;ACTR3;NPHP3;KIF3B;AIF1L;RAPGEF6;RAPGEF2;CCDC88A;MKS1;CFAP54;TNIK;FNBP1L;SPEF1;WDR35;TMEM138;CEP131;EXOC6;SRGAP2;FXYD5;GSN;DYNLT2B;DYNLL1;FGD6;WHAMM;NRP1;RAC1;PIBF1;DZIP1;CFAP20;INPP5K;TMEM67;MINK1;BBS2;CCDC66;ARF4;AIF1;RAB11A;OPHN1;WDR19;DYNC2H1;OCRL;CEP89
prerank,ncRNA transcription (GO:0098781),0.5121660774840945,1.1489111624552817,0.2832618025751073,0.8518649176914126,1.0,9/13,23.84%,SNAPC2;RPAP2;USPL1;POLR1G;CAVIN1;BRF1;SPIN1;GTF3C1;ANG
prerank,positive regulation of tissue remodeling (GO:0034105),0.5490249381050871,1.1488554057209253,0.31952662721893493,0.8512410238837309,1.0,1/10,0.61%,IL15
prerank,spliceosomal complex assembly (GO:0000245),0.414051410697175,1.148791919260788,0.286368843069874,0.8506032289191552,1.0,11/46,15.33%,NOL3;SRPK3;TXNL4A;SRPK1;CELF6;USP39;SNRPD2;SNRPD1;DDX39B;SNRPG;NCBP1
prerank,regulation of chemotaxis (GO:0050920),0.4431877031398942,1.1486963793216842,0.2977667493796526,0.8500808013887949,1.0,10/30,16.08%,CXCR4;YTHDF1;DUSP3;P2RX4;ZSWIM8;PPM1F;USP14;STX4;MYCBP2;AIF1
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.44981713151009184,-1.1482822399631651,0.30094043887147337,0.99844214392183,1.0,7/12,24.13%,UST;VCAN;BGN;DSEL;DCN;BCAN;CSPG5
prerank,negative regulation of endocytosis (GO:0045806),0.45933423111097665,1.1474027349888896,0.29873417721518986,0.8538498694048066,1.0,6/24,15.41%,NR1H2;SNX33;LRSAM1;RUBCN;RAC1;CD300A
prerank,protein mannosylation (GO:0035268),0.46392013902872087,1.1473705151404316,0.31398416886543534,0.8530995370517818,1.0,7/22,18.10%,DPY19L4;TMTC1;POMT1;POMT2;CRPPA;TMTC4;DPY19L1
prerank,regulation of heart contraction (GO:0008016),0.3798700768659284,1.1471551858772073,0.23734177215189872,0.8529948981748713,1.0,12/90,10.98%,AGT;ASPH;CAMK2D;FXYD4;ATP1B3;SLC8A1;ITPR1;TMIGD3;NPPC;FXYD6;P2RX4;AHCYL1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.40082652622887,-1.1468136429452567,0.2915129151291513,0.9990567534827737,1.0,10/16,29.94%,NAPEPLD;SIRT1;ZBTB7B;VSTM2A;SOX13;FLCN;FTO;FNDC5;TFE3;METRNL
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.500477321919675,1.1466760275397971,0.3126760563380282,0.8538467304041364,1.0,4/14,14.64%,IRS1;LONP2;ABCD1;IRS2
prerank,vasculature development (GO:0001944),0.49727575480807834,1.1465178173381987,0.31163434903047094,0.8535476792601583,1.0,6/16,24.63%,FBXW7;BMPR2;NOTCH4;ACVRL1;STK11;PIK3CA
prerank,positive regulation of ATPase activity (GO:0032781),0.4125502779160234,1.1462889250090549,0.289044289044289,0.8534920784642477,1.0,7/41,13.37%,MSH2;TOR1AIP2;TOR1AIP1;ATP1B3;DHX9;DYNLL1;CHTOP
prerank,response to amino acid (GO:0043200),-0.3212663924827211,-1.1459807215925513,0.23036649214659685,0.9971568532504135,1.0,11/31,16.49%,TMBIM6;GRIN1;RRAGD;GLRB;RRAGB;LARS1;NSMF;GLRA3;SLC38A9;CAPN2;LAMTOR2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.41406715371704195,1.1459212688193243,0.27488151658767773,0.8539508794156152,1.0,2/42,0.60%,IRGM;GALP
prerank,positive regulation of phospholipase activity (GO:0010518),0.4704677337260391,1.1458733490712925,0.31402831402831405,0.8532680390427844,1.0,9/22,23.43%,FLT1;CCL5;FGFR2;ARL1;ARF4;FGFR3;ABL2;FGF2;PDPK1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.40810977825111944,1.1458470588806717,0.2681242807825086,0.8516585628362097,1.0,13/51,17.06%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;CHMP3;REEP3;AHCTF1;NUP155;IST1;PPP2R2A
prerank,mitotic nuclear membrane organization (GO:0101024),0.40810977825111944,1.1458470588806717,0.2681242807825086,0.8516585628362097,1.0,13/51,17.06%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;CHMP3;REEP3;AHCTF1;NUP155;IST1;PPP2R2A
prerank,dopaminergic neuron differentiation (GO:0071542),0.4759475229084167,1.1457311839817306,0.2967914438502674,0.8511707636319699,1.0,2/19,5.48%,LMX1A;CTNNB1
prerank,regulation of protein export from nucleus (GO:0046825),0.45465910185451897,1.1456498767899423,0.3059125964010283,0.8506250810178556,1.0,3/23,9.05%,SP100;TCF7L2;BARD1
prerank,endomembrane system organization (GO:0010256),0.3670613352731676,1.1447318600510619,0.20689655172413793,0.8530312277321376,1.0,49/178,19.98%,DNAJC13;VPS51;TOR1AIP2;BLZF1;USP50;TJAP1;ATL1;SNX33;COG3;GOLGA8B;GOLGA5;TLCD2;WASHC4;SEC16A;SNX10;ARHGEF7;CUL7;VPS11;TMED5;HOOK2;RAB22A;FBXW8;DOP1B;RAB43;VAPB;HOOK1;UBXN2B;TMED10;TRAPPC12;COG2;ARL1;SUN2;ARHGAP21;ARFGEF2;REEP3;HOOK3;PLEKHM2;NUP155;SYNGR1;DYNC2H1;TMED1;TMED3;GBF1;GOLPH3L;SERP1;OSBPL2;GORASP2;RAB1A;VPS18
prerank,COPII vesicle coating (GO:0048208),0.40021601365612125,1.1446200524129717,0.27593818984547464,0.8509221970688585,1.0,20/61,22.99%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,vesicle coating (GO:0006901),0.40021601365612125,1.1446200524129717,0.27593818984547464,0.8509221970688585,1.0,20/61,22.99%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.40021601365612125,1.1446200524129717,0.27593818984547464,0.8509221970688585,1.0,20/61,22.99%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,negative regulation of transferase activity (GO:0051348),0.4364372441243951,1.1445900993109932,0.28880407124681934,0.8501849143613265,1.0,7/28,14.95%,DTX3L;ZFP36;EIF4A2;ERCC4;MEN1;IRS2;INPP5K
prerank,regulation of oxidoreductase activity (GO:0051341),0.5083909694074162,1.1445087670418421,0.3181148748159057,0.849612705494753,1.0,2/13,6.57%,NOD2;MT3
prerank,positive regulation of cell cycle (GO:0045787),0.3929977435404839,1.1444813135466847,0.29456521739130437,0.8488662862939266,1.0,11/62,10.08%,CDC25B;TRIM21;PKN2;CCND2;CHEK1;DUSP3;CCND1;FGFR2;SMOC2;APP;PROX1
prerank,regulation of JNK cascade (GO:0046328),0.3757743711755119,1.1443398276512324,0.2571127502634352,0.8485369938705073,1.0,23/101,15.90%,EDAR;NOD2;TAOK3;SLAMF1;GADD45G;DUSP3;TRAF4;WNT7B;CYLD;MAPK8IP3;TPD52L1;DACT1;APP;HMGB1;MEN1;TRAF3;TRAF5;DUSP10;FCGR2B;MINK1;TAOK2;MTURN;CD27
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4572221005256966,1.1437405065127695,0.3001245330012453,0.8497941844267138,1.0,11/25,23.34%,TXNL4A;BCAS2;WDR83;DBR1;GEMIN2;SF3B4;SRSF4;DDX23;SLU7;SRSF10;TRA2B
prerank,positive regulation of hydrolase activity (GO:0051345),0.36794891654279,1.1437136761352784,0.20743034055727555,0.8490527556945783,1.0,39/137,21.07%,WNT11;CCL7;DOCK8;RGP1;SEMA4D;CD40;THY1;CCL5;CX3CL1;ARHGEF7;RAPGEF6;RAPGEF2;CTSH;RAP1GAP;AGRN;SNX9;CCL14;SRGAP2;RGS16;ARHGAP11A;RACK1;RIC1;LIMS1;RAPGEF1;ASAP3;EZH2;CALM3;SH3BP1;TBC1D2;NF1;FNTA;ARAP1;PIN1;SGSM3;TGM2;RGS10;DOCK10;CCL4;MMUT
prerank,negative regulation of transport (GO:0051051),0.39882265914912157,1.1437104485121998,0.2786516853932584,0.8482328614969827,1.0,25/51,30.59%,NR1H2;BST2;SNX33;LRSAM1;RSC1A1;PPM1F;FCGR2B;RACK1;RUBCN;TLR2;SIRPA;MCTP1;ERBB3;ARL6IP5;SNX12;SYT11;NDFIP1;PTEN;PIP4P2;CTTNBP2NL;MTMR2;LILRB1;RAB7A;PRKD1;LGALS3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.494161648735695,1.1434502579014318,0.2949438202247191,0.8482554310815954,1.0,5/15,16.03%,NR1H2;SLC45A3;PPARGC1A;LPGAT1;PPARD
prerank,regulation of autophagosome maturation (GO:1901096),0.5171380288616824,1.1433040564167192,0.3241758241758242,0.8479559301674789,1.0,2/13,3.93%,IRGM;FYCO1
prerank,protein sumoylation (GO:0016925),0.40267414063388557,1.1425697882317816,0.27419354838709675,0.8497141910749866,1.0,21/49,26.90%,IFIH1;NUP37;SUMO2;SUMO3;NUP153;RAE1;UBA2;NSMCE2;NUP155;PIAS1;PIAS2;NUP88;NUP133;NUP43;SUMO1;TRIM28;NUP205;PIAS4;SEH1L;EYA1;NUP188
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2755703332012517,-1.142442888993803,0.17708333333333334,1.0,1.0,20/70,14.90%,TGFB1;CASP8;CASP8AP2;TRAF2;BLOC1S2;ITGAV;CASP3;TGFB2;RIPK1;GSK3B;DAB2IP;CASP9;ACVR1B;TRADD;RNF41;TNFRSF1B;APPL1;HIPK1;DEDD2;DCC
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5399322535395948,1.1423204771822515,0.3220858895705521,0.8497657106084813,1.0,4/10,14.64%,IRS1;SLC45A3;PRKCE;IRS2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4404029782231572,1.1416057480300938,0.2802469135802469,0.851441184991738,1.0,9/29,19.72%,IRF7;BIRC2;CD40;IKBKE;TRAF3;BIRC3;TLR3;CD300LF;TANK
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4258998556201901,-1.1414750665901388,0.2781456953642384,1.0,1.0,4/12,6.20%,ATP1B1;DMD;ATP1B2;ANK3
prerank,superoxide anion generation (GO:0042554),0.5113538534544074,1.1411940699920837,0.3101449275362319,0.8521461785405564,1.0,2/13,4.67%,CYBB;TAFA4
prerank,regulation of tissue remodeling (GO:0034103),0.48429896419457585,1.1411449276267716,0.30578512396694213,0.8514846869140553,1.0,7/18,20.48%,IL15;RUNX1;SYT7;LEPR;IL18;MDK;DDR2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3816294042884012,1.1411052712318512,0.2651113467656416,0.8507843474752743,1.0,29/84,22.99%,PSMB10;PSME2;PSMA5;CDC26;PSME4;ANAPC5;ECRG4;PSMA3;PSMB9;ANAPC4;UBE2E1;PSMD2;CDC16;CDC27;PSME3;RB1;ANAPC15;PSMA4;ANAPC2;PSMD7;PSMD8;PTTG1;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;CUL3
prerank,positive regulation of phagocytosis (GO:0050766),0.4077112637038238,1.1410269477340178,0.3002309468822171,0.8502369744851133,1.0,11/47,20.31%,IL15;IL15RA;C4B;CD47;TUB;STAP1;FCGR2B;PTPRC;CD300LF;SIRPA;APPL2
prerank,nuclear membrane reassembly (GO:0031468),0.4032203877562713,1.1408607591248716,0.28668941979522183,0.8499838017396505,1.0,14/54,17.06%,CHMP4A;CHMP4B;CC2D1B;NUP37;ANKLE2;KPNB1;BANF1;UBXN2B;CHMP3;REEP3;AHCTF1;NUP155;IST1;PPP2R2A
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5297440538944928,1.1408308588414502,0.3123123123123123,0.8492528039314096,1.0,5/11,23.30%,TIMELESS;TIPIN;ZRANB3;FBH1;LIG3
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.36045863199121875,-1.1405920520580624,0.2698412698412698,1.0,1.0,7/21,16.64%,TGFB1;ROCK1;SRGN;TRPM4;CCL3;CCR1;ECM1
prerank,glycerolipid metabolic process (GO:0046486),0.5259026907074239,1.140313240481612,0.3136966126656848,0.8501391509513216,1.0,5/11,20.01%,PDXP;PIP5K1A;DGKB;DGKA;PNPLA3
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4612544240933478,1.1403026203518287,0.30647291941875826,0.849352915763835,1.0,10/20,23.14%,BIRC2;MLKL;CFLAR;CYLD;BIRC3;HSP90AA1;FLOT2;CDC37;STUB1;PELI1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.36611903171153076,-1.1393181835906605,0.2867647058823529,1.0,1.0,13/20,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.44222016930761154,1.1386220387440233,0.3110831234256927,0.8546417003200731,1.0,4/27,12.50%,CALCA;GNA15;C3AR1;GPR35
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.401518468279775,1.1383284420550328,0.27334083239595053,0.8548551388385006,1.0,15/56,16.20%,HYAL1;MECP2;ANAPC5;CDC25B;CCND2;CCND1;RAD51C;TFDP1;ANAPC4;CDC16;CDC27;RB1;NSMCE2;AIF1;RAB11A
prerank,regulation of response to stress (GO:0080134),0.5406547751563227,1.1379889550498263,0.3357041251778094,0.8552410782432108,1.0,3/10,9.94%,SLC38A2;CRHBP;MLC1
prerank,protein K48-linked ubiquitination (GO:0070936),0.39665202085557494,1.1379596438540962,0.27828054298642535,0.8545170008955844,1.0,10/54,9.60%,DTX3L;RNF4;RNF5;BFAR;UBE2B;UBE3A;AMFR;RBX1;UBE2E3;UBE2E1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3302340893538092,-1.1378036019860118,0.23195876288659795,1.0,1.0,7/29,8.85%,GPR183;CD38;CD81;NCKAP1L;SASH3;EPHB2;TFRC
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4179180367964842,1.1375640660206394,0.301909307875895,0.8550867355024394,1.0,11/41,16.29%,AGT;BDNF;TGFA;FBXW7;EPHA4;DOK7;FCGR1A;PRNP;STAP1;FYN;LRP8
prerank,myelin assembly (GO:0032288),0.5364135380631624,1.1374503151543367,0.31610044313146235,0.8546179833785222,1.0,3/10,8.27%,PMP22;CNTNAP1;EPB41L3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.37263924181622454,1.1373741484805222,0.2668711656441718,0.8540620773714394,1.0,37/119,21.20%,PIGW;SOCS1;ARF3;PIK3CD;SLC27A1;ITPKC;CDS1;SYNJ1;PITPNM1;SBF1;PIP5K1A;PIGV;SOCS5;PI4KB;PIK3R4;EFR3A;CDIPT;RAB14;PLEKHA1;SOCS2;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;INPP5K;MTMR14;PGAP2;OCRL;PIGQ;SOCS6;PIGB;PGAP3;SOCS4;PI4KA;SACM1L;SOCS7
prerank,regulation of dendrite development (GO:0050773),-0.305729616519267,-1.1371675563201395,0.2484076433121019,1.0,1.0,12/37,14.90%,SDC2;COBL;ALK;CSMD3;BCL11A;GSK3B;DAB2IP;NSMF;ZDHHC15;VLDLR;ADGRB3;DCC
prerank,DNA damage checkpoint signaling (GO:0000077),-0.33030868237327393,-1.1368239516869556,0.2350230414746544,0.9989751191217298,1.0,12/28,17.59%,MAP3K20;NBN;USP28;CEP63;RHNO1;DONSON;HUS1;RAD17;CLSPN;E2F1;STK33;RAD1
prerank,regulation of hormone secretion (GO:0046883),-0.3894719090975219,-1.1368189752054434,0.299625468164794,0.9941826439239962,1.0,4/15,21.03%,SCG5;VAMP3;ANXA1;OSM
prerank,mesenchyme morphogenesis (GO:0072132),0.49121680031186166,1.1364299175886903,0.32329842931937175,0.8564838546833704,1.0,6/17,23.22%,ACVR1;SOX9;SMAD2;BMPR1A;ACVRL1;NOTCH1
prerank,cation transport (GO:0006812),0.3592864042568944,1.1363837594037576,0.22695035460992907,0.8558374014529104,1.0,20/167,13.05%,TRPM5;CATSPER4;CNGB1;KCNMB3;TRPM2;TRPM6;SLC18A2;LRP2;SLC8A1;PANX2;SLC11A2;KCNS3;SLC7A6;KCNA4;TRPM3;PANX1;ANO10;KCNK3;SCN2A;FGF13
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5379849409237065,1.136332525775611,0.3268365817091454,0.8551931574834173,1.0,2/10,4.42%,THAP7;KLF15
prerank,response to ethanol (GO:0045471),-0.40038746152345717,-1.1355135814927693,0.27756653992395436,0.9944596393781722,1.0,3/14,3.94%,GRIN2A;GRIN2B;GRIN1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.4304480139773398,-1.134910079682451,0.2973856209150327,0.9918860110428085,1.0,5/11,22.35%,ASF1A;HAT1;HIRA;ATRX;ASF1B
prerank,gland development (GO:0048732),0.3993204681279275,1.1349092290909444,0.28378378378378377,0.8594595874221086,1.0,11/59,11.45%,WNT11;GFER;ARID5B;SOX9;FGFR2;MET;TG;PROX1;DKK3;NOTCH4;XBP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5355871583606671,1.1344667354658178,0.3378995433789954,0.860199866878507,1.0,6/11,25.64%,PRR7;GSN;ST18;LGALS9;PLAUR;PIH1D1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4214320696525399,1.1340438736076965,0.2963855421686747,0.8608290452342883,1.0,12/36,23.30%,SP100;MECP2;CSNK2B;HMGB1;APOE;SVBP;ACVRL1;GADD45A;FGF2;VASH1;NOTCH1;PTPRM
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4836504428480515,1.1336589599204905,0.3196159122085048,0.8613685881158578,1.0,2/17,7.72%,NR1H2;LIPC
prerank,neutrophil activation (GO:0042119),0.5137757752767227,1.1335594648399077,0.3414985590778098,0.8608508069191492,1.0,2/12,4.36%,IL15;CCL5
prerank,water-soluble vitamin metabolic process (GO:0006767),0.38955864344655416,1.1333750521443846,0.2795100222717149,0.8606573160073844,1.0,18/68,21.07%,MTHFR;DHFR;SLC25A19;SLC46A1;SLC19A1;SLC52A2;CYB5R3;AMN;ABCC1;TPK1;ENPP1;SHMT1;PANK2;MCCC1;MTHFD1;ABCD4;SLC5A6;MMUT
prerank,telomere maintenance via telomerase (GO:0007004),0.4394038812051437,1.1333249243168368,0.30635118306351183,0.8600261934650445,1.0,10/28,19.00%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPP6R3;TELO2;HSP90AA1;PTGES3;TERF2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4420560450822081,-1.1332258488882498,0.2804878048780488,0.9894921020106023,1.0,3/11,13.42%,SYK;STAT5B;JAK3
prerank,cellular response to interleukin-2 (GO:0071352),-0.4420560450822081,-1.1332258488882498,0.2804878048780488,0.9894921020106023,1.0,3/11,13.42%,SYK;STAT5B;JAK3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.34852681854675777,1.1328922754598594,0.009,0.8606889185043132,1.0,346/1667,18.75%,STAT1;STAT2;CXCL10;SP100;NLRC5;IRF7;HELZ2;PARP9;PITX2;MYOZ2;SIM1;NAMPT;LOXL2;GAL;MOV10;THAP7;SP110;LHX2;LMX1A;NR1H2;NOD2;CC2D1B;IRF2BP1;ESR2;USF2;CAMK2D;ETV3;PCGF5;VRTN;MEF2B;TCF24;TRIB3;WNT5A;ZNF483;TFAP2C;PER2;GMEB2;CCNL1;ZBTB17;ESRRB;ZFP36;RARG;BRD2;NFX1;HTATSF1;DDRGK1;BBX;AGO2;RBM14;RNF4;SEMA4D;TEAD2;ZBTB2;CD40;NFKB2;SOD2;CDH13;MECP2;ACVR1;STAT3;ARID1B;ARID5B;ZFP37;TGFA;BATF3;ACTR2;RBL1;SFRP2;DDX5;ZNF471;MTA3;ELK3;CGGBP1;PCGF6;RUNX1;MAD2L2;ID3;BHLHE40;ZHX3;NACC1;NKX6-2;RBMX;KLF15;CIC;CCNL2;GATAD2A;NOP53;DHX36;MZF1;BRWD3;JUNB;ZSCAN12;NCOA1;ZNF23;SOX9;SRA1;HNRNPK;CTNNB1;CX3CL1;CCND1;CDK12;PFKM;KMT2A;ZNF2;PAXBP1;ARID1A;CCNT2;TRAK1;ZNF76;MYDGF;MBD2;ZSCAN22;FGFR2;ZSCAN26;IGBP1;SMARCE1;TCF7L2;TCF4;SMARCC2;ZXDC;ZBTB43;NFKB1;BCL6;CREBRF;ASXL3;ZBTB38;SETD3;BRIP1;BACH1;DDX20;THAP3;USF1;ZSCAN29;ACTR3;NFATC2;TFAP2B;SNAI2;SAP30;UBP1;DHX9;SRF;ETV6;MTA2;RAI1;IKZF2;TADA2A;HTATIP2;SMAD2;MRTFA;GLIS3;MED13L;MEIS3;ATF6B;TFDP1;DACT1;LPIN2;SIRT6;RPAP2;NCK1;DNMT3A;AEBP1;LMO2;AASS;SLTM;MET;ELP2;GDNF;ATF1;HOXA9;NFIB;METTL23;POU3F1;APP;SCX;HMGB1;DACH2;LCORL;NCK2;ELF4;TADA2B;CRTC1;MAML2;HR;PLK3;PEX2;IRF9;AGRN;BMPR2;MEN1;MAPK14;BPTF;ZSCAN20;MNAT1;LIN9;NR2C1;RORA;MED12;PROX1;TNIP1;PHIP;ELOC;NCOA5;KDM3B;DUSP26;ZC3H12A;NPM1;FOXK1;MAX;SNW1;NOTCH4;DNAJA3;CTCF;HCFC2;ZBTB5;MITF;GALR1;XBP1;SKIL;TFDP2;IER5;CBX4;TAF3;HMGB3;ECD;KLF10;NKAP;CUX1;RELB;UXT;TEF;NOP2;LDB2;LDB1;PSEN1;REL;PPARGC1A;APOE;PRKDC;HOXB6;NR3C1;LCOR;FBXL19;RB1;MIER1;MDFI;PRDM4;E2F4;ZNF35;ATXN1;APBB1;HDAC8;PTCH1;PGBD1;BUD31;ST18;ZBTB21;TIAL1;DBX2;MYO6;POGZ;MED29;DAB2;BCL11B;SMARCA1;IKZF1;ZNF418;CASZ1;DLG1;MYPOP;SOX2;TNIP2;TFR2;RREB1;EZH2;TET2;CREB5;MYB;POU6F1;CRTC3;ZBTB24;ZBTB34;CAMTA2;ERF;BMPR1A;CRK;KLF16;TLR2;SOX5;SMARCD2;GTF2IRD1;PIAS1;NPAT;ARF4;RCOR3;MEF2A;KDM7A;CARF;PROX2;PIAS2;PPARD;MED27;TNIP3;LAGE3;IL18;LMO7;SREBF1;CCNK;ZBED4;ZBTB4;DICER1;KAT8;RBPJ;BRD7;MED16;CHCHD2;ELF1;ID4;HMBOX1;MPND;BAX;IER2;ANXA4;RRP1B;TLR3;LRRFIP1;ZNF445;PELP1;ENY2;ZBTB49;POU2F2;CXXC5;DACH1;ZNF513;PTOV1;ACVR2A;FNIP2;FOSL2;HDAC1;HINFP;GABPB1;GABPB2;MED10;HOXA5;PRRX1;HSBP1;CTBP1
prerank,granulocyte differentiation (GO:0030851),-0.36994074244423863,-1.1327740746673547,0.3025830258302583,0.9865859047322327,1.0,9/18,17.39%,CBFA2T3;LBR;RXRA;JAGN1;RARA;CDK4;CEBPA;E2F1;CDKN1A
prerank,receptor recycling (GO:0001881),0.5388363384843378,1.1327558481523143,0.3245227606461087,0.8603249047431075,1.0,3/10,12.81%,RAB11B;SORL1;ARFGEF2
prerank,positive regulation of vasculogenesis (GO:2001214),0.534151700589049,1.1323295067571157,0.336283185840708,0.8609851258004503,1.0,3/10,11.72%,KDR;RAPGEF2;RIN2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5036622366990883,1.1322053134694343,0.3309659090909091,0.8605546889176963,1.0,1/13,0.31%,CLTRN
prerank,positive regulation of cell death (GO:0010942),0.394211663868026,1.1318391917798845,0.2836644591611479,0.8610331538470757,1.0,13/59,14.33%,WNT5A;DAXX;CLU;RARG;MT3;HTATIP2;PRNP;PRR7;ZC3H12A;DDIT4;FCGR2B;EIF2S1;FYN
prerank,negative regulation of cellular catabolic process (GO:0031330),0.38690351622582975,1.1311021747680723,0.2877939529675252,0.8627962544488098,1.0,21/63,22.25%,RGP1;STAT3;MT3;IL10RA;MET;LEPR;TIMP2;FOXK1;SORL1;RIC1;RUBCN;NELL1;EIF4G3;BMF;NRDE2;MTOR;ZKSCAN3;TAB3;TLK2;MCL1;RRAGA
prerank,ganglioside biosynthetic process (GO:0001574),0.4921942404134735,1.1309351268616434,0.3207810320781032,0.8625471667375346,1.0,4/15,9.71%,ST6GALNAC4;ST6GALNAC6;B4GALT5;ST3GAL1
prerank,cardiac muscle cell differentiation (GO:0055007),0.46307610689883105,1.130889943415318,0.335978835978836,0.8619019207106633,1.0,4/21,13.32%,ACVR1;SLC8A1;SIK1;AKAP13
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4206298237817297,1.1307713100325627,0.2977461447212337,0.8615401226933491,1.0,15/36,22.80%,BLZF1;GOLGA7;RILPL1;GGA3;AMN;NECTIN3;VAMP2;VAMP4;BBS2;PREPL;VAMP5;GOLPH3L;GORASP2;OPTN;RAB10
prerank,skeletal muscle tissue development (GO:0007519),0.4251039815052666,1.1305148692096811,0.30493827160493825,0.8616479897742668,1.0,2/32,6.12%,MYOZ2;CFLAR
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3803672706663554,-1.1304057206985667,0.2781954887218045,0.9910024281235056,1.0,8/17,22.64%,PPARG;PDCD4;TPM1;PRKG1;CDKN1A;CDKN1B;MEF2C;EFEMP2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3431583426551014,-1.1303548937565024,0.25203252032520324,0.9865705799194632,1.0,5/22,8.69%,ROCK1;NCKAP1L;CRY2;PTPA;GSK3B
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4771499536581919,1.1302385193808637,0.32388663967611336,0.8618173022527928,1.0,5/17,10.50%,SFRP2;CCL5;PODXL;RET;CIB1
prerank,photoreceptor cell development (GO:0042461),-0.40850966892109386,-1.1298767380885792,0.314878892733564,0.9837830134332242,1.0,10/14,50.62%,MYO7A;DCX;MFSD2A;CEP290;RP1;RORB;AHI1;TH;CDHR1;TOPORS
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5339916945703058,1.1298586612454695,0.33676470588235297,0.8623046739418412,1.0,3/10,16.29%,ISG15;DIS3L2;TUT7
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4741678829620105,1.1298465530584632,0.31543624161073824,0.8615358505979989,1.0,5/18,9.11%,TNFAIP1;ITGA3;MYOC;MET;KANK1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.42249850338130723,1.1298240348160487,0.3062730627306273,0.8607996882581626,1.0,10/35,16.10%,PLXNA3;PLXNB2;SEMA4D;NRP2;PLXNB3;MET;NRP1;RAC1;SH3BP1;SEMA3D
prerank,regulation of transmembrane transport (GO:0034762),0.4286409739922316,1.1296310081389276,0.30111524163568776,0.8606866433966377,1.0,5/31,16.74%,CLTRN;TRIB3;PIM1;ACTB;KCNJ2
prerank,renal absorption (GO:0070293),0.5390774900875552,1.1296101985038525,0.3185840707964602,0.8599451151494683,1.0,3/10,11.78%,MAGED2;SLC15A2;GSN
prerank,positive regulation of lipid localization (GO:1905954),0.5184428028078094,1.1283242415218222,0.34011627906976744,0.863724318992895,1.0,3/11,10.58%,IKBKE;NFKB1;ZC3H12A
prerank,diol biosynthetic process (GO:0034312),0.4957171321222512,1.1282738299325656,0.3364864864864865,0.8630915686741836,1.0,6/15,18.30%,DHFR;ASAH2;SPHK2;GCH1;ACER3;SPTLC2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.47141051147783114,1.1282140485316443,0.306970509383378,0.8624882464973926,1.0,9/18,23.05%,RGP1;VPS11;DACT1;RIC1;NELL1;HSP90AA1;WDR91;VPS35;MSN
prerank,protein targeting to ER (GO:0045047),-0.24381518920272252,-1.1280102617293775,0.11764705882352941,0.9867664559939556,1.0,36/99,18.72%,RPS12;RPL13;RPS14;RPS28;RPL10;RPL23;RPL17;RPS26;RPLP0;RPL9;RPS17;SGTB;RPL8;RPL21;GET3;RPL31;SPCS3;RPL36A;SEC61G;SEC61A1;RPLP2;RPL7;RPL39;RPS9;RPS18;RPL37;RPL13A;ZFAND2B;SRP19;UBA52;RPS25;RPS27A;RPL18;RPL38;SRPRB;RPL34
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.4873614858898627,1.1276369396011408,0.33062330623306235,0.8635948470611778,1.0,3/15,12.35%,ABCG1;LIPC;APOE
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.4640290698437215,1.1275825203743903,0.3202702702702703,0.862959299314603,1.0,4/21,10.08%,LRP2;CTNNB1;CX3CL1;PROX1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.35187143661050674,1.1272550443352363,0.1831831831831832,0.8633096223991042,1.0,53/291,16.84%,CXCL10;AXL;CD274;CXCL9;WNT11;IRGM;NOD2;WNT5A;IRS1;ZFP36;CRHBP;BRINP3;DHX36;RRAGC;SOX9;PDXP;NFKB1;WNT7B;MT3;RET;RAPGEF2;LTK;LYN;P2RX4;HMGB1;MAPK14;RORA;GIT1;ZC3H12A;SNW1;ZFP36L1;GLRA2;XBP1;STAP1;LCOR;AKAP9;LAMTOR3;ZNF35;RAPGEF1;SHMT1;ACTB;TNIP2;MYD88;INPP5K;ERCC6L2;TLR2;ADNP2;TNIP3;MTOR;IRAK1;UPF1;ACOD1;PDE3A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.4027908067740142,1.12704866693719,0.3051044083526682,0.8632053914732863,1.0,7/47,7.93%,EIF2AK2;NOD2;TAOK3;IGBP1;NBR1;PPIA;MAPK8IP3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.48670925778872465,1.1268809897960212,0.3104359313077939,0.8629823651923604,1.0,6/17,19.77%,ABCG1;KPNB1;APOE;ERLIN2;SREBF1;SEC14L2
prerank,negative regulation of cell projection organization (GO:0031345),0.39608427788358824,1.1261712756606292,0.3211845102505695,0.8646468437393511,1.0,16/48,17.79%,SPRY2;EPHA4;MT3;PAQR3;RAPGEF2;KANK1;PRNP;CIB1;MAG;APOE;TRPV4;MYLIP;FYN;PTPN9;STMN2;ITM2C
prerank,glycosaminoglycan metabolic process (GO:0030203),0.39283389388703327,1.1260438069312715,0.2878103837471783,0.8643162781042885,1.0,6/54,3.12%,EXT1;XYLT2;SDC3;HYAL4;SDC4;HAS1
prerank,microglial cell activation (GO:0001774),0.456332507254019,1.1258318036463768,0.31645569620253167,0.8642376582755245,1.0,7/21,20.32%,CLU;CX3CL1;APP;JAK2;AIF1;TYROBP;IFNGR1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.4610214836469507,1.1257035662502017,0.32512953367875647,0.8638931541542387,1.0,5/20,16.15%,MOV10;AGO2;CNOT7;EIF6;NRDE2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.531543445371682,1.1256259593456075,0.3308270676691729,0.8633646415705248,1.0,5/12,18.10%,CLU;PFDN5;PFDN4;APOE;LDLR
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4437432820017561,1.1255648811490107,0.3132075471698113,0.8627793455786181,1.0,5/25,7.33%,PML;HSP90AB1;EPHA4;TRIM39;CSNK2A2
prerank,ubiquinone metabolic process (GO:0006743),0.4773959791002404,1.1255411878736894,0.34269662921348315,0.8620527178247734,1.0,3/15,6.33%,COQ2;COQ10B;COQ3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.45777641829586907,1.1255228374114916,0.33159947984395316,0.8613079086480643,1.0,2/22,0.94%,IL15;NOD2
prerank,snRNA processing (GO:0016180),-0.37792670800317557,-1.125339743913663,0.25862068965517243,0.9922143587563902,1.0,8/16,30.79%,INTS10;INTS12;INTS2;TUT1;INTS6;TOE1;INTS5;INTS6L
prerank,regulation of protein phosphorylation (GO:0001932),0.3568233117392948,1.1252575740919455,0.19257773319959878,0.8614573600740362,1.0,47/256,14.95%,STAT2;IRGM;PML;XDH;PLXNB2;KDR;SOCS1;DAXX;SEMA4D;TARDBP;CD40;CCND2;NOP53;SOX9;CCND1;PPP2R5C;KDM4D;MYDGF;MT3;PPIA;PAQR3;CCDC88A;LYN;LEPR;APP;INSR;BMPER;PRNP;MEN1;TNIK;PHIP;MOB1B;CIB1;ZC3H12A;NPM1;VEGFD;FGF9;PPP2R5D;PRKDC;RACK1;RAC1;DAB2;FYN;RB1CC1;HSP90AA1;NPTN;INPP5K
prerank,response to thyroid hormone (GO:0097066),0.5021257621557697,1.1249940764110262,0.3372262773722628,0.8615851848670683,1.0,3/13,8.64%,CTSS;CTSH;LMO2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4404533915627368,-1.124901973939777,0.30275229357798167,0.9893484026112617,1.0,3/11,8.85%,EPN1;E2F2;SEMA6A
prerank,rRNA modification (GO:0000154),0.45812537221883226,1.1247706149386,0.32981530343007914,0.8615551157509441,1.0,5/21,9.96%,MRM2;ZCCHC4;TFB2M;GAR1;DIMT1
prerank,negative regulation of organelle assembly (GO:1902116),0.41681433548315383,1.1245071601554417,0.3157262905162065,0.861664083132761,1.0,7/35,11.96%,CHMP4A;CHMP4B;RBM14;CDK5RAP2;CDK10;ODF2L;SCFD1
prerank,negative regulation of cell population proliferation (GO:0008285),0.35282012290630144,1.1242515563395783,0.168,0.8617460044484763,1.0,65/351,16.82%,IFIT3;EIF2AK2;HSPA1B;PARP10;PML;IFI35;WNT5A;PER2;ZBTB17;RARG;B2M;TNFRSF8;SOD2;CDH13;NMI;AQP11;SFRP2;TMEM115;CNOT7;MORC3;CDKN2D;CHERP;SOX9;CTNNB1;P3H1;PPP2R5C;TFAP2B;TMIGD3;CSNK2B;MAGI2;FRZB;RAPGEF2;TFDP1;ARID2;LYN;PDPN;APP;NCK2;PEX2;BMPR2;MEN1;ROR2;PROX1;CIB1;NPM1;ALDH1A2;CDK10;DNAJA3;CTCF;KLF10;THAP12;DUSP10;CGREF1;NELL1;ST18;DIS3L2;JAK2;SOX2;HGS;CD300A;MCC;AIF1;EEF1E1;BRD7;PTPRU
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4495383796567931,1.1242219559467657,0.3363057324840764,0.8610509174460597,1.0,7/23,17.13%,BCL2L11;SAMM50;HSPA4;BAD;HSP90AA1;BMF;BAX
prerank,regulation of protein binding (GO:0043393),0.3681940501275261,1.124099973694274,0.27150259067357513,0.8606768079556523,1.0,25/114,16.11%,IFIT1;IFIT2;DTX3L;TRIB3;B2M;TRIM21;SLPI;TCF7L2;AMFR;RAPGEF2;DACT1;BAMBI;APP;LDLRAP1;MEN1;LRPAP1;SORL1;PSEN1;DDX11;RACK1;DAB2;ACTB;SPPL3;CRK;RPL11
prerank,eye morphogenesis (GO:0048592),0.47158511761056493,1.123643433973975,0.32793522267206476,0.8614508340211338,1.0,4/19,7.89%,RARG;STAT3;FBN1;MFAP5
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4529439717508464,1.1234892597140531,0.3203125,0.8611600499345257,1.0,7/22,17.01%,THY1;DUSP3;SH2D1A;PRNP;FCGR2B;CD300A;UBASH3A
prerank,regulation of interleukin-12 production (GO:0032655),0.40187391170437153,1.1232753624945087,0.3089430894308943,0.8610789649548574,1.0,15/47,24.20%,SLAMF1;CD40;CD47;TLR8;HMGB1;MAPK14;PIBF1;TLR2;LGALS9;MDK;TLR3;RIPK2;LTB;IRF5;LILRA5
prerank,negative regulation of response to stimulus (GO:0048585),0.39172916254656875,1.123219820535349,0.31620111731843575,0.8604659314947839,1.0,20/60,22.53%,NR1H2;CLU;ACVR1;KIF26A;AQP11;RBL1;THY1;LYN;SOCS5;COL3A1;GGT7;FCGR2B;ZKSCAN3;TERF2;VPS13C;APPL2;MCTP1;AKT3;PIM3;ERBB3
prerank,negative regulation of protein metabolic process (GO:0051248),0.40660686250722733,1.1231470734544957,0.33021077283372363,0.8599294414778069,1.0,16/48,19.47%,CLU;AZIN2;MAD2L2;HSP90AB1;RILP;PFDN5;NFKB1;AGAP2;PRNP;AZIN1;PFDN4;APOE;CD84;FLOT2;LDLR;PIN1
prerank,regulation of monooxygenase activity (GO:0032768),-0.337832762885077,-1.1230691611519688,0.28936170212765955,0.9916821809974011,1.0,13/23,24.21%,WASL;LYPLA1;EGFR;SNCA;DDAH1;NOSTRIN;AKT1;POR;CAV1;SPR;IL1B;IL1A;NOS1AP
prerank,regulation of intracellular protein transport (GO:0033157),-0.3205777388827073,-1.1227469319481453,0.2356020942408377,0.9884260317247332,1.0,9/32,12.34%,TGFB1;OAZ2;SIRT7;OAZ1;PCM1;GCC2;KIF20B;ZFAND1;RIPOR1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5092512891553692,1.1225809297784806,0.34801762114537443,0.8611674044850106,1.0,3/12,8.64%,CTSS;CTSH;LMO2
prerank,cellular response to calcium ion (GO:0071277),0.37949557210004503,1.122307815482514,0.29714912280701755,0.8612720568253562,1.0,10/67,10.83%,CAMK2D;RASA4;CLIC4;WNT5A;CPNE3;TRPM2;CRHBP;SYT7;SYT3;ADGRV1
prerank,response to ketone (GO:1901654),0.44351549733295814,1.1218291755259133,0.3411458333333333,0.8621212960187687,1.0,4/24,11.13%,CATSPER4;ABHD2;UBE3A;SLIT3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.38607616006957884,1.1216935149413634,0.3081967213114754,0.8618061011345994,1.0,16/64,19.19%,DAPK3;UTRN;CDH13;THY1;PEAK1;DUSP3;CX3CL1;CSF1;MYOC;CIB1;LDB1;PIK3CB;MINK1;CORO1C;NF1;TSC1
prerank,protein processing (GO:0016485),0.3661477459525986,1.121464263609256,0.28480340063761955,0.8617743836349054,1.0,22/102,18.95%,CASP4;CTSS;PRSS12;ADAMTS3;MMP14;FXN;LONP2;CTSH;AEBP1;PCSK7;KLK1;SPCS1;PSEN1;PITRM1;PTCH1;SPPL3;APH1A;APH1B;SPRTN;METAP2;HM13;DDI2
prerank,protein destabilization (GO:0031648),0.42976967239698555,1.1210060989693125,0.3234567901234568,0.8625842517774659,1.0,9/32,14.38%,IRGM;TRIM21;GGA3;CTSH;PEX2;PRNP;BTRC;GSN;KDM8
prerank,receptor internalization (GO:0031623),-0.303460267814655,-1.1207764208836297,0.1937984496124031,0.9916391471095686,1.0,15/44,21.20%,SYK;CALCRL;CD81;ARRB1;GRK3;SNCA;TFRC;GRK2;RAB31;CEACAM1;CD9;SAG;PICALM;NEDD4;CAV1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.38960246386781633,1.1204904580140123,0.31456953642384106,0.8635434319997976,1.0,14/63,17.40%,CD274;IL15;CD40;CCL5;CD276;NFATC2;NCK1;NCK2;CCDC88B;IRS2;CHRNB2;AIF1;IL18;PTPRC
prerank,dermatan sulfate metabolic process (GO:0030205),-0.42859526662472347,-1.120390444934534,0.30363036303630364,0.9886668165363307,1.0,7/13,24.13%,UST;VCAN;BGN;DSEL;DCN;BCAN;CSPG5
prerank,phosphate ion homeostasis (GO:0055062),0.5226861422022291,1.12019715589176,0.3469387755102041,0.8637339131923766,1.0,2/10,12.85%,TFAP2B;ENPP1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4228909624993062,-1.1197157416965713,0.34256055363321797,0.9869424806815591,1.0,6/12,33.52%,ANXA6;UBASH3B;FKBP1B;MTLN;PTK2B;RYR2
prerank,positive regulation of bone mineralization (GO:0030501),0.4172541517769782,1.1195549068079247,0.3133971291866029,0.8652038744047055,1.0,8/35,18.19%,ISG15;ACVR1;SLC8A1;BMPR2;ADGRV1;NELL1;BMPR1A;ACVR2A
prerank,xenobiotic transport (GO:0042908),0.47878384791041717,1.1190881166192994,0.32297297297297295,0.8660204391438391,1.0,5/17,20.40%,ABCC2;SLC15A2;ABCC1;ABCG2;ABCC5
prerank,anion transmembrane transport (GO:0098656),0.3868887092167852,1.1188120674178639,0.3003337041156841,0.8661826561312752,1.0,22/67,23.61%,SLC25A22;SLC27A1;SLC25A19;SLC25A1;SLC19A1;SLC35B1;SLC25A10;ABCC1;SFXN2;SLC35B4;SLC13A4;SLC35A3;SLC25A12;SLC36A4;SFXN1;SLC35C2;ABCC5;SLC5A6;MFSD12;SLC1A3;SLC25A30;ARL6IP5
prerank,negative regulation of programmed cell death (GO:0043069),0.349644201054346,1.1184957510956237,0.1743486973947896,0.8664528358522623,1.0,53/355,12.43%,IFIT3;NOL3;AXL;HSPA1B;WNT11;WNT5A;SPRY2;COMP;KDR;BIRC2;DDRGK1;KLHL20;SEMA4D;LRP2;ANKLE2;FXN;BFAR;HCK;CCND2;SOX9;HNRNPK;CTNNB1;CX3CL1;AREL1;MYDGF;CFLAR;NFKB1;TMBIM4;MT3;TFAP2B;ATAD3A;HTATIP2;CTSH;LTK;MET;GDNF;BARD1;PDPN;SCX;PLK3;PHIP;CIB1;NPM1;NUAK2;XBP1;PIM1;CBX4;BAG1;NAA35;ARHGAP10;PSEN1;PRKDC;SOCS2
prerank,tyrosine metabolic process (GO:0006570),0.5139228006659236,1.1181211695488904,0.34934497816593885,0.8669642928283678,1.0,1/11,4.38%,THAP4
prerank,positive regulation of cellular respiration (GO:1901857),-0.42745773767229245,-1.1180783164307588,0.32398753894080995,0.9890182579858355,1.0,3/11,6.65%,PINK1;ISCU;IFNAR1
prerank,aminoglycan metabolic process (GO:0006022),0.5279629551930382,1.117923521852252,0.33987915407854985,0.8668382621159266,1.0,1/10,0.90%,XYLT2
prerank,RNA interference (GO:0016246),0.47893831458068914,1.1179016473855738,0.3523035230352303,0.8661427039936432,1.0,10/17,28.17%,AGO2;TARBP2;DHX9;NRDE2;DICER1;PRKRA;AGO4;TSN;AGO1;AGO3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.35343170132402607,1.11767957108877,0.2283702213279678,0.8661409190164906,1.0,79/248,24.15%,WNT11;PSMB10;DAPK3;WNT5A;PSME2;PSMA5;PSME4;TMEM170B;SFRP2;MAD2L2;UBE2B;PRICKLE1;PFDN5;SOX9;CTNNB1;FGFR2;PSMA3;TCF7L2;NFKB1;TMEM9;NPHP3;SNAI2;AMFR;BICC1;CYLD;FRZB;PSMB9;DACT1;BAMBI;RBX1;USP34;KANK1;BTRC;DKK3;PSMD2;SCYL2;PSEN1;PSME3;APOE;LZTS2;PLEKHA4;DAB2;CTNND2;LMBR1L;PSMA4;SOX2;MLLT3;MCC;PTPRU;MDK;TPBG;HDAC1;PSMD7;PSMD8;STK3;PSMD9;PIN1;PSMF1;DDX3X;STK11;PSMB6;USP8;PSMC2;PSMD12;GLI3;SMURF2;RUVBL2;PSMD4;GPRC5B;CUL3;LIMD1;XIAP;VCP;CHD8;AXIN1;PSMA2;CAPRIN2;TLE5;KREMEN1
prerank,regulation of neuron differentiation (GO:0045664),-0.2547979594561106,-1.1173148295272681,0.13636363636363635,0.9876158099629269,1.0,24/76,22.51%,IMPACT;ZFHX3;ZFHX2;ROCK1;ALK;MOSMO;BIN1;REST;BRINP1;MMD2;ID2;RHOA;ARHGEF2;BRINP2;HOXD3;NRCAM;ZC4H2;ECT2;CDK5RAP3;NREP;NBL1;MEF2C;TCF3;DISP3
prerank,negative regulation of neurogenesis (GO:0050768),0.4127905381046075,1.1171561348289578,0.3249701314217443,0.8671371248733769,1.0,14/34,26.53%,B2M;THY1;RUFY3;RAPGEF2;MAG;SORL1;HOOK3;NF1;APPL2;NOTCH1;LINGO1;LRP4;TNF;PTEN
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.33927972802720663,-1.1166892031966105,0.2857142857142857,0.9856604599872325,1.0,7/23,12.18%,INPP5F;MTMR1;MTMR4;INPP5B;MTMR9;SYNJ2;MTMR10
prerank,regulation of cilium movement (GO:0003352),0.5230522823327168,1.116023334615328,0.3615733736762481,0.8701528502478153,1.0,2/10,5.16%,ODAD2;CCDC40
prerank,regulation of glucose import (GO:0046324),0.42822229510343235,1.115948079571384,0.32589838909541513,0.8695878894370551,1.0,8/30,14.64%,IRS1;ARPP19;GRB10;OSBPL8;INSR;PTPN11;ENPP1;IRS2
prerank,regulation of JUN kinase activity (GO:0043506),-0.3086143001264915,-1.1156702892289931,0.24581005586592178,0.9851097609960376,1.0,9/33,10.48%,PAK1;TRAF2;PDCD4;MAP3K11;TRAF6;PTPN22;DVL3;DAB2IP;MAPK8IP1
prerank,regulation of cell cycle process (GO:0010564),0.3662594665367729,1.1156182245747688,0.30165289256198347,0.869956918376547,1.0,28/104,19.47%,PKMYT1;DAPK3;DYNC1H1;CHEK1;TIPIN;SOX9;CTNNB1;PDXP;PRPF40A;CUL7;SH3GLB1;CSNK2A2;KLHL13;YTHDF2;ZFYVE26;PLK3;PIK3R4;GIT1;KLHL9;AHCTF1;CALM3;NUDT16;RAB11A;BIRC6;NUMA1;UVRAG;BECN1;PIN1
prerank,nucleosome organization (GO:0034728),0.39228405253954,1.1156148828783137,0.2972972972972973,0.8691910235787179,1.0,12/55,11.05%,DAXX;BRD2;NAP1L2;SOX9;ARID1A;SMARCE1;SMARCC2;ARID2;BPTF;CHAF1B;NPM1;CTCF
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4910418146450751,1.1155408891659178,0.3599419448476052,0.8686545966383944,1.0,3/14,9.47%,ACOXL;ECI2;ABCD1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.35672433662182984,1.115340918201853,0.2599388379204893,0.8685758051926494,1.0,48/163,21.79%,THEMIS2;PSMB10;ICOSLG;SKP1;PSME2;PIK3CD;PSMA5;PSME4;LCP2;RBCK1;THY1;CD276;PAK3;PSMA3;NFKB1;NFATC2;PSMB9;BCAR1;NCK1;EIF2B2;RNF31;BTRC;ZC3H12A;PSMD2;PLEKHA1;PSME3;PIK3CB;SPPL3;FYN;PSMA4;BLNK;CSK;PTPRC;PAG1;PSMD7;EIF2B5;EIF2B3;PSMD8;DENND1B;RC3H2;PSMD9;PDE4B;RIPK2;PSMF1;LCK;PSMB6;PSMC2;PSMD12
prerank,response to unfolded protein (GO:0006986),0.392271291544199,1.1150778804624204,0.3434004474272931,0.8686663409743803,1.0,15/48,21.28%,HSPA1B;DAXX;ERP44;HSP90AB1;DNAJB4;HSPA8;HSPA4;HSPB3;HSP90AA1;DNAJC4;BAX;STT3B;HSPA14;ERN1;OPTN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.38891914132725935,1.1149401642405277,0.3217877094972067,0.8683539098522403,1.0,6/57,2.15%,TNFSF10;ASPH;NOD1;AIM2;USP50;FIS1
prerank,negative regulation of ATPase activity (GO:0032780),0.4821478367120761,1.1148845887364514,0.3419170243204578,0.8677608671290944,1.0,2/16,9.67%,IFIT1;THADA
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4461324635572228,1.11426156143541,0.3537675606641124,0.8691048095581156,1.0,7/22,16.52%,PSMB10;PSMA5;PSME4;PSMA3;PSMB9;PSMA4;ENC1
prerank,negative regulation of nervous system development (GO:0051961),0.47480470917801054,1.1142351282140857,0.33972602739726027,0.8684395230204518,1.0,8/17,25.44%,B2M;SLIT1;SORL1;HOOK3;TLR2;APPL2;NOTCH1;TNF
prerank,negative regulation of B cell proliferation (GO:0030889),0.5176568537626746,1.1139965174064608,0.3629842180774749,0.868458999699644,1.0,4/11,19.90%,LYN;FCGR2B;CD300A;TYROBP
prerank,negative regulation of mitochondrion organization (GO:0010823),0.41987624291879466,1.113816496755104,0.3370233702337023,0.8682716727393095,1.0,3/33,3.63%,NOL3;CLU;FXN
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.44908374850687505,1.1135376145638767,0.31398416886543534,0.86847549119169,1.0,7/21,19.97%,DHX36;SRF;MED12;MITF;PAXIP1;MED16;MED24
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4267430852983294,1.1132853206431244,0.34413965087281795,0.8685556422632849,1.0,7/28,14.95%,IRS1;SOCS1;GRB10;NCK1;KANK1;ENPP1;INPP5K
prerank,regulation of sensory perception of pain (GO:0051930),-0.42664433674674185,-1.1130914365566784,0.3323353293413174,0.9907321317523186,1.0,6/11,29.53%,ZFHX2;CCL3;MGLL;F2R;ACP3;CCN3
prerank,regulation of adaptive immune response (GO:0002819),0.46834216520043603,1.1130307994910502,0.3419618528610354,0.8686195817725932,1.0,1/18,0.14%,IRF7
prerank,pre-replicative complex assembly (GO:0036388),0.38273298779981063,1.112957286960707,0.31359649122807015,0.8680974174712754,1.0,23/64,22.66%,PSMB10;PSME2;MCM2;PSMA5;PSME4;MCM7;MCM4;CDT1;PSMA3;PSMB9;PSMD2;PSME3;ORC3;PSMA4;PSMD7;PSMD8;PSMD9;ORC1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,DNA replication checkpoint signaling (GO:0000076),0.47762674186491105,1.1127205644151592,0.3412587412587413,0.8681375902448648,1.0,3/16,6.00%,TIMELESS;TIPIN;CDT1
prerank,response to hydroxyurea (GO:0072710),0.5167471685036138,1.1120846540631548,0.35683453237410073,0.8694731271162252,1.0,5/11,19.72%,TIMELESS;DDX11;RTF2;DDI2;KAT7
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4248741890457202,1.1118423820228076,0.33455882352941174,0.869517345177223,1.0,11/32,19.82%,ACTR2;CYFIP1;CARMIL1;ARHGEF7;ACTR3;CORO1B;RAC1;RREB1;PLCE1;CORO1C;NCKAP1
prerank,glial cell development (GO:0021782),0.4415796201100655,1.1117368110079804,0.34777070063694265,0.8691215510932707,1.0,9/25,18.89%,MT3;EIF2B2;MXRA8;APP;TLR2;MDK;NF1;EIF2B5;EIF2B3
prerank,stress-activated MAPK cascade (GO:0051403),0.38411069974854395,1.1116717920718129,0.3125,0.8685834953291666,1.0,21/61,21.97%,NOD2;NOD1;SKP1;ZFP36;MAP3K8;PTGER4;NFKB1;MAP2K3;MAPK14;BTRC;ZFP36L1;TNIP2;MINK1;TAOK2;IRAK1;LGALS9;UBE2V1;TAB3;RIPK2;MAP4K2;MAPK9
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.494901922398836,1.1114300835189617,0.3452722063037249,0.8686558859244968,1.0,7/13,27.39%,CDK5RAP2;XRCC3;ANAPC15;GEN1;NDC80;DYNC1LI1;MAD2L1
prerank,basement membrane organization (GO:0071711),0.48634031468373284,1.1114115261003272,0.3635097493036212,0.867945459428926,1.0,6/14,25.02%,CTSS;LAMB2;NID2;FLRT2;NTN4;NTNG2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3314685293305825,-1.1113236610273527,0.29896907216494845,0.9931871735995317,1.0,14/30,24.13%,ARSB;CHSY1;VCAN;CSGALNACT1;CHST7;CHST15;CHST3;BGN;DSEL;NDNF;DCN;BCAN;UGDH;CSPG5
prerank,protein transport (GO:0015031),0.3480696632581067,1.1109234957787764,0.201,0.8688481066057425,1.0,92/332,20.00%,ZG16;ABCA1;BLZF1;CHMP1B;ABCG1;CLU;ARF3;GOLGA7;TBC1D1;ATP6V0D1;RAB8B;SNX33;ARRDC4;RAB21;LRP2;LAMP2;RAB12;RILP;AP2A1;STX7;LRSAM1;ARRDC2;HERC2;ARF5;GGA3;TMED5;KIF3B;VPS33A;IL10RA;TBC1D8;UNC93B1;RAB22A;RAB43;RAB11B;RAB5C;STX8;AMN;STX16;TMED10;TBC1D8B;SNX9;NPM1;DNM2;IFT27;TMEM167A;VIPAS39;RAB14;ARL1;CHMP3;RAB24;SCFD1;APOE;NEURL1B;CMTM6;ARL5C;RIC1;VAMP2;MYO6;NAPB;NAPA;STX4;FAM91A1;MIA2;VAMP4;DENND10;TFR2;BBS2;PREPL;ARF4;VPS26A;RAB32;TCIRG1;TBCK;SNX1;MTTP;TBC1D2;ATP6V1B2;TMED1;VAMP5;ATP6V1G1;SLU7;TMED3;MYH9;SVBP;COPB2;GOLPH3L;ATP6V1G2;RAB5B;SGSM1;RAB1A;SGSM3;TBC1D4
prerank,keratinocyte differentiation (GO:0030216),0.4311204741191441,1.1107636111076133,0.34125,0.8686227681165609,1.0,3/29,6.60%,CLIC4;WNT5A;PIP5K1A
prerank,COPII-coated vesicle budding (GO:0090114),0.3829121729701874,1.1105001375058086,0.3067685589519651,0.8687205062600885,1.0,21/68,22.99%,TRAPPC3;TGFA;SEC16A;GOSR2;CNIH3;SEC24D;CTSC;PPP6R3;SEC23A;VAPB;TMED10;SCFD1;NAPA;SEC24A;CNIH1;TFG;RAB1A;TRAPPC9;TRAPPC6A;F8;CUL3
prerank,striated muscle tissue development (GO:0014706),0.42223034864578074,1.1104912889644476,0.3203026481715006,0.8679877948715715,1.0,3/29,9.54%,MYOZ2;CFLAR;BMPR2
prerank,postsynaptic membrane organization (GO:0001941),-0.3743791547791921,-1.110305955314343,0.30278884462151395,0.9926195449126294,1.0,5/17,8.90%,DLG4;NRXN2;NLGN2;NRXN1;SHANK3
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3690005049775187,1.1101393911847237,0.28450106157112526,0.8683877335967441,1.0,22/95,15.30%,SAMHD1;ZSWIM7;MCM2;SEM1;MCM7;AP5Z1;MCM4;HELQ;KDM4D;MCM9;RAD51C;FEN1;ERCC4;XRCC3;ZFYVE26;POLQ;GINS2;NSMCE2;NSMCE1;GEN1;RMI1;RECQL5
prerank,regulation of amyloid-beta formation (GO:1902003),0.4142479945487806,1.1098389688755974,0.33137485311398357,0.86869086133954,1.0,9/34,12.35%,ABCG1;CLU;EPHA4;GGA3;PRNP;TMED10;SORL1;LRRTM3;APOE
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3674610740636708,1.109435494800797,0.3042105263157895,0.8692392400667283,1.0,26/91,17.70%,DNAJC13;RAB8B;CDH13;RAB21;HCK;RAB12;CPLX1;SYT7;RAB11B;RAB5C;AP2S1;CHMP3;MAP2K2;SCFD1;RINT1;GAS1;VAMP2;NRP1;STON1;STX4;DENND10;RAB11A;OPHN1;STXBP5L;PTPRC;STON2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4542438981460396,1.1093427576445563,0.33587786259541985,0.8688123056954098,1.0,2/19,0.90%,EXT1;XYLT2
prerank,epithelium development (GO:0060429),0.369580060146866,1.1091718103255546,0.2858649789029536,0.8686077290618192,1.0,14/107,14.28%,STAT1;KDR;TIMELESS;CASP6;SOX9;FGFR2;WNT7B;SNAI2;DACT1;PROX1;ALDH1A2;HNRNPH3;PTCH1;JAK2
prerank,homotypic cell-cell adhesion (GO:0034109),0.4106166492897123,1.1090194616687343,0.3293269230769231,0.86834024973239,1.0,11/39,18.18%,CSRP1;ACTN1;MYL9;MEGF10;PPIA;MEGF11;TJP2;PIK3CB;ACTB;FIBP;MYH9
prerank,cellular response to amyloid-beta (GO:1904646),0.41568250122091505,1.1087966518584436,0.3333333333333333,0.8683085052207046,1.0,9/35,14.33%,CASP4;EPHA4;CACNA1A;APP;PRNP;ABCC1;PSEN1;FCGR2B;FYN
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.35211154709532455,-1.1085528799235624,0.3007518796992481,0.9951995073763483,1.0,4/20,7.77%,TGFB1;NUMB;RHOQ;TMBIM1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.38722836456270315,-1.107952378217459,0.3238993710691824,0.9931851975851669,1.0,7/15,17.83%,PARP1;NBN;TERF2IP;SLX4;PINX1;TERF1;ERCC1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.35763429525056695,1.1071906757172056,0.2976313079299691,0.87296487078589,1.0,35/129,18.83%,PKMYT1;SKP1;CENPJ;CHEK2;ARPP19;CDC25B;DYNC1H1;BACH1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;KDM8;HSP90AA1;MASTL;TUBB4B;PPME1;PPP2R2A;DCTN3;PAFAH1B1;BRSK1;CEP135
prerank,O-glycan processing (GO:0016266),0.3892883835510253,1.1070798871803262,0.3217097862767154,0.8725523195644337,1.0,12/54,19.15%,ST6GALNAC4;GALNT7;GALNT15;ST6GAL1;GCNT4;B4GALT5;ST3GAL1;XXYLT1;GALNT1;GXYLT1;GALNT13;GALNT14
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4378755930521616,1.106534452250224,0.330379746835443,0.8736350691065995,1.0,5/26,9.25%,TGFA;FBXW7;SOCS5;APP;NCK2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.49859063472311854,1.106453681299728,0.3490427098674521,0.873166666140267,1.0,3/12,7.11%,KLF15;PODXL;MAGI2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4494356291410326,1.1061318315215327,0.36175710594315247,0.8734682288299939,1.0,9/21,24.95%,EXT1;XYLT2;HPSE;EXTL3;HS3ST4;HS6ST1;XYLT1;HS6ST2;EXT2
prerank,transition metal ion transport (GO:0000041),0.40540745399640116,1.1060676790014143,0.3341375150784077,0.8729038540913004,1.0,14/35,25.60%,SLC30A1;SLC30A5;MT3;SLC11A2;TTYH1;TFR2;TRPC4;SLC31A1;SLC31A2;COX17;TRPC1;SLC30A9;CP;ATP7B
prerank,cellular potassium ion homeostasis (GO:0030007),-0.41263477402326515,-1.1059987333236667,0.3436426116838488,0.9967522331428386,1.0,3/13,3.63%,ATP1B1;SLC12A2;ATP1B2
prerank,filopodium assembly (GO:0046847),0.48062599748765156,1.1055996458842832,0.3576341127922971,0.873641376335831,1.0,5/16,13.03%,SPATA13;S1PR2;SPEF1;SRGAP2;FGD6
prerank,RNA stabilization (GO:0043489),0.4142139620612807,1.1055254748036447,0.3381995133819951,0.873124035452096,1.0,7/33,15.56%,PHAX;LARP1;DHX36;GDNF;TENT5A;TENT5C;TAF15
prerank,negative regulation of cellular process (GO:0048523),0.34377540321814976,1.1053876949856822,0.172,0.8728357942997865,1.0,79/521,13.20%,IFIT3;SP100;EIF2AK2;HSPA1B;WNT11;PML;CHMP4B;NR1H2;ESR2;BST2;PLXNA3;HYAL1;IFI35;PLXNB2;ZBTB17;CLU;RARG;TNFRSF8;ACTN1;SEMA4D;SOD2;CDH13;NMI;AQP11;SFRP2;GNG4;PLXNB3;TMEM115;CNOT7;CDKN2D;OSGIN1;SERTAD3;CHERP;CTNNB1;P3H1;PPP2R5C;BCL6;PODXL;MT3;TFAP2B;TMIGD3;CSNK2B;MAGI2;TMEM98;FRZB;RAPGEF2;ST7L;ARID2;NCK1;LYN;PDPN;APP;NCK2;BMPR2;MEN1;ROR2;SPHK2;LRPAP1;PROX1;SPEF1;CIB1;NPM1;ALDH1A2;CDK10;EI24;NOTCH4;DNAJA3;CTCF;SLIT3;SRGAP2;KLF10;THAP12;SERTAD2;RB1;ENPP1;FCGR2B;RACK1;CGREF1;APBB1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5050510323674244,1.105217449538082,0.3592375366568915,0.8726011381639737,1.0,5/12,17.40%,RUNX1;LYN;CD300A;ELF1;PTPRC
prerank,cell-matrix adhesion (GO:0007160),0.37008867379646465,1.1051888911877072,0.3265741728922092,0.8719504059655653,1.0,21/95,17.60%,SIGLEC1;COL13A1;ITGA2;ACTN1;THY1;ACTN2;PEAK1;ARHGEF7;ITGA3;PIP5K1A;ITGB8;MKLN1;HPSE;COL3A1;WHAMM;RAC1;TAOK2;NID2;ADAMTS12;BCR;ITGA4
prerank,fatty acid biosynthetic process (GO:0006633),0.37874298154213043,1.1051394130538958,0.3274336283185841,0.8713537941493896,1.0,16/63,21.17%,MCAT;ABHD2;ASAH2;DEGS1;FADS3;LIPC;SCD5;ABCD1;XBP1;HACD3;EPHX2;ABHD3;OXSM;GPX4;ELOVL4;DECR2
prerank,dendrite morphogenesis (GO:0048813),-0.30453829142136246,-1.1051228726714577,0.25842696629213485,0.9957642921077805,1.0,10/35,11.88%,SDC2;WASL;DLG4;MAP6;CTNNA2;CDC42;EPHB2;SHANK3;EPHB1;CHRNA7
prerank,cellular response to interleukin-7 (GO:0098761),0.4713437856584256,1.1050980044746417,0.34924965893587995,0.8699815492171602,1.0,5/17,14.64%,IRS1;SOCS1;STAT3;SOCS2;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4713437856584256,1.1050980044746417,0.34924965893587995,0.8699815492171602,1.0,5/17,14.64%,IRS1;SOCS1;STAT3;SOCS2;IRS2
prerank,negative regulation of cell migration (GO:0030336),0.3566472402136611,1.1044989728752665,0.29111338100102147,0.8711739983483445,1.0,36/137,21.96%,WNT11;BST2;CLIC4;HAS1;THY1;SFRP2;PLXNB3;EVL;DUSP3;CX3CL1;EPHA4;ARHGAP4;TMIGD3;MAGI2;ARID2;KANK1;COL3A1;MITF;SRGAP2;SRGAP3;DUSP10;RAC1;BMPR1A;MCC;PTPRU;DACH1;CORO1C;NF1;STK24;SINHCAF;RAP2A;ACVRL1;ADIPOR1;MCTP1;CITED2;FGF2
prerank,positive regulation of histone methylation (GO:0031062),0.430170640097754,1.1040520171998927,0.3329032258064516,0.8719401801365012,1.0,8/24,14.91%,CTNNB1;KMT2A;DNMT1;WDR5;SNW1;PAXIP1;CHTOP;MYB
prerank,apoptotic DNA fragmentation (GO:0006309),0.47563221177479054,1.1039856527521845,0.3706293706293706,0.8714317843147917,1.0,5/16,16.69%,KPNB1;HMGB1;DFFA;DNASE2;DICER1
prerank,DNA replication (GO:0006260),0.3633910106398604,1.1038391090699673,0.2989583333333333,0.8711342747885631,1.0,20/105,9.92%,MCM2;TIMELESS;POLD4;POLE2;MCM7;CHEK1;TIPIN;RNASEH2A;MCM4;RFC4;POLB;POLG2;RFC1;MCM9;BRIP1;RPAIN;FEN1;BARD1;WDHD1;PTMS
prerank,negative regulation of centrosome duplication (GO:0010826),0.5004818247269757,1.1038083771130143,0.3713850837138508,0.8704884264878973,1.0,6/11,23.97%,RBM14;CDK5RAP2;NPM1;TMEM67;MDM1;KAT2B
prerank,regulation of filopodium assembly (GO:0051489),-0.30035030390996986,-1.1036056304876096,0.3051948051948052,0.9974356416086337,1.0,11/38,11.17%,MYO10;WASL;DPYSL3;ARHGAP44;PPP1R16B;FXR2;CDC42;RHOQ;DMTN;PALM;GPM6A
prerank,negative regulation of cellular component organization (GO:0051129),0.37529873062628943,1.1034492309612836,0.3282937365010799,0.8709454217539767,1.0,15/74,13.24%,HSPA1B;SPRY2;CLU;SNX33;NOP53;CARMIL1;LRSAM1;RTEL1;HSPA8;DNAJB6;DNM2;RIOK3;SORL1;SVIP;RUBCN
prerank,organic acid transport (GO:0015849),0.3649513063828028,1.1032435558263276,0.3034410844629823,0.8708680479756192,1.0,14/94,9.34%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC26A1;SLC38A1;SLC46A1;NCOA1;SLC19A1;SLCO1B1;SLC38A3;SLC25A10;PDPN;SLC7A6
prerank,cellular response to topologically incorrect protein (GO:0035967),0.41952332379584456,1.1030564375167011,0.3469640644361834,0.8707201831848058,1.0,3/31,1.94%,HSPA1B;DAXX;UBE2W
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3919658218001575,1.1028300087531242,0.3370660694288914,0.870765330619493,1.0,21/54,22.59%,PAK1IP1;MDN1;RSL1D1;NOP53;LAS1L;RRS1;PPAN;NPM1;EIF6;NOP2;NOP16;RPL23A;RPL11;RPL10A;WDR12;RSL24D1;RPL24;RPL3;RPL5;RPL6;LTO1
prerank,positive regulation of transport (GO:0051050),0.3672809135751635,1.1027336933320826,0.3326133909287257,0.8703186004676549,1.0,27/85,26.35%,IL15;IL15RA;SGK2;CD47;DYNC1H1;CHCHD10;KMT2A;TUB;MLC1;APOE;FCGR2B;DAB2;ACTB;TFR2;INPP5K;BAX;CBLL1;NUMA1;SIRPA;C2CD5;CYBA;ACSL3;TNF;ANXA2;CHP1;CALY;LRP1
prerank,negative regulation of histone modification (GO:0031057),0.48796290826449024,1.1022465128728653,0.3724696356275304,0.8711466125772409,1.0,5/14,19.23%,THAP7;AASS;SPHK2;CTBP1;SET
prerank,response to axon injury (GO:0048678),0.46094830466879844,1.1022299379133462,0.34350132625994695,0.870453983604472,1.0,4/18,8.96%,DHFR;GAP43;MAPK8IP3;P2RX4
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.34936218122711427,-1.1017981551101454,0.3046594982078853,1.0,1.0,6/18,8.69%,APOD;CTNNA1;POLR1A;UFM1;CABP1;GSK3B
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.49618023062221805,1.1017671623195318,0.3589041095890411,0.8712615964391263,1.0,7/13,25.74%,SNX33;HSP90AB1;STX4;TYROBP;TM9SF4;TNF;TMEM35A
prerank,macroautophagy (GO:0016236),0.3564611465969504,1.1014163588018027,0.3136645962732919,0.871631691574104,1.0,28/118,17.18%,CHMP4A;CHMP4B;ILRUN;MVB12A;LAMP2;VPS33A;NBR1;CSNK2B;LIX1;RUBCNL;CSNK2A2;TOMM5;VPS37A;PIK3R4;PRKAG1;UBQLN1;EI24;VIPAS39;CHMP3;VPS28;MAP1LC3B;DYNLL1;VTI1B;RB1CC1;MTMR14;HGS;TCIRG1;TOMM40
prerank,primary neural tube formation (GO:0014020),0.4216458646570176,1.1011296838596536,0.347239263803681,0.8718444847787925,1.0,4/30,5.37%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,macrophage activation involved in immune response (GO:0002281),0.4861870173989679,1.1011075090147535,0.350210970464135,0.8711801413264,1.0,2/13,2.94%,IFI35;NMI
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.361619625151381,1.1008755231144296,0.33263378803777544,0.8712100595162104,1.0,32/94,21.79%,NOD2;PSMB10;NOD1;SKP1;PSME2;PSMA5;PSME4;MAP3K8;PSMA3;NFKB1;PSMB9;RBX1;BTRC;PSMD2;IRAK4;PSME3;ST18;PSMA4;IL1RAP;TNIP2;MYD88;IRAK1;PSMD7;UBE2V1;PSMD8;PSMD9;TAB3;RIPK2;PSMF1;PSMB6;PSMC2;PSMD12
prerank,lipid biosynthetic process (GO:0008610),0.37028578340442747,1.1008369801105038,0.33189655172413796,0.8705815454841853,1.0,20/77,23.14%,MCAT;PCYT2;AGPAT5;PIP5K1A;ACSL5;LIPC;FDFT1;SCD5;GNPAT;XBP1;DHRS11;GGPS1;PAM;SREBF1;ACSS2;OXSM;ELOVL4;SRD5A1;DOLPP1;HMGCR
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4180805029387859,1.1005893581494373,0.35403726708074534,0.8706503164103572,1.0,3/28,4.65%,CASP4;TRIB3;ITPR1
prerank,protein localization to microtubule organizing center (GO:1905508),0.475444917573629,1.1004532361953163,0.3451202263083451,0.8704044055090623,1.0,9/15,27.48%,SNX10;NEDD1;CEP131;HOOK3;PIBF1;CEP83;BBS4;CEP192;CCDC14
prerank,embryonic organ development (GO:0048568),0.3831120224714284,1.100122546764627,0.32926829268292684,0.8707883594437767,1.0,9/61,8.81%,COL13A1;KDR;TEAD2;KITLG;KMT2A;FGFR2;WNT7B;TBC1D23;GDNF
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.37179937540004393,1.0998063349336673,0.32508073196986004,0.8711223016488491,1.0,19/72,20.55%,POLR2G;HNRNPH1;NCBP2;FGFR2;HNRNPM;POLR2K;KIF16B;RAB14;FGF9;HNRNPA1;PTPN11;TIAL1;NCBP1;FGFR3;FLRT2;FIBP;SPRED1;HNRNPF;FGFRL1
prerank,nucleosome assembly (GO:0006334),0.4252221972014531,1.0991843356716795,0.35112692763938314,0.8724335340589507,1.0,6/31,10.61%,DAXX;BRD2;NAP1L2;SOX9;CHAF1B;NPM1
prerank,programmed necrotic cell death (GO:0097300),0.46704703465971004,1.099139742345147,0.35048678720445064,0.8718360650632746,1.0,6/18,17.34%,ALKBH7;MLKL;CYLD;ITPK1;TRPM7;TLR3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.47852030662821365,1.098915051881,0.37252124645892354,0.8718635274523887,1.0,7/16,17.95%,DDX5;HNRNPM;DHX9;RBM17;RSRC1;SLU7;SCNM1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.29056608275315765,-1.098893883294282,0.2689655172413793,1.0,1.0,13/39,17.31%,RCC2;SPOCK1;CORO2B;DMTN;JAG1;SEMA3E;RHOA;NEXMIF;ACER2;HOXA7;FZD7;MAP4K4;ITGB1BP1
prerank,rRNA methylation (GO:0031167),0.4497610508325932,1.0988413020335455,0.34274193548387094,0.871364240971542,1.0,9/22,20.56%,MRM2;MRM3;ZCCHC4;TFB2M;DIMT1;NOP2;METTL15;BUD23;EMG1
prerank,negative regulation of leukocyte activation (GO:0002695),0.47540476089805306,1.0985810891064849,0.3541963015647226,0.8714962902823771,1.0,6/15,18.65%,ZC3H12A;HAVCR2;FCGR2B;CD84;CD300A;CD300LF
prerank,glutamate receptor signaling pathway (GO:0007215),-0.29272715748085515,-1.098332728562575,0.24113475177304963,1.0,1.0,7/37,6.14%,GRM3;GRIN2A;GRIN2B;GRIK1;GRIN1;HOMER1;HOMER3
prerank,chromatin remodeling at centromere (GO:0031055),-0.32852022316629836,-1.098265906550034,0.2983425414364641,1.0,1.0,13/31,24.84%,CENPV;CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH
prerank,protein K48-linked deubiquitination (GO:0071108),0.4388755559725221,1.0982630100157451,0.3588456712672522,0.8717644383486497,1.0,9/23,21.86%,USP50;USP25;OTUD3;USP34;VCPIP1;USP37;USP5;USP8;USP33
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3650092705493233,1.0980466062867582,0.3262935586061246,0.871759720299942,1.0,30/87,23.77%,PSMB10;SKP1;PSME2;PRMT2;PSMA5;PSME4;RBL1;CDKN2D;PSMA3;PSMB9;DACT1;RBX1;ZFP36L1;PSMD2;PSME3;RB1;PSMA4;DLG1;BRD7;PSMD7;PSMD8;PSMD9;WEE1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;ZFP36L2;PSMA2
prerank,regulation of cell cycle phase transition (GO:1901987),0.36413006038455453,1.0979839342601792,0.3273305084745763,0.8712461447424404,1.0,28/91,21.79%,PSMB10;SKP1;PSME2;PSMA5;CDC26;PSME4;ANAPC5;FBXW7;PSMA3;TRIM39;PSMB9;ANAPC4;UBE2E1;BTRC;PSMD2;CDC16;CDC27;PSME3;ANAPC15;PSMA4;ANAPC2;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3397569717883301,1.0978859608695666,0.137,0.8708381623575432,1.0,146/807,15.01%,STAT1;SP100;IRF7;PARP9;WNT11;MYOZ2;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;IRF2BP1;ESR2;TRIB3;WNT5A;MYBBP1A;TFAP2C;PER2;DAXX;PRMT2;ZFP36;RARG;NFX1;TIMELESS;SEMA4D;ZBTB2;MECP2;STAT3;ARID5B;ZFP37;BATF3;SFRP2;DDX5;MTA3;ELK3;CGGBP1;PCGF6;RUNX1;MAD2L2;ID3;BHLHE40;ZHX3;NACC1;EID2B;NKX6-2;CIC;GATAD2A;NOP53;CNOT7;ILF3;MZF1;PRICKLE1;PFDN5;SOX9;CTNNB1;CCND1;MBD2;FGFR2;IGBP1;SMARCE1;TCF7L2;SMARCC2;NFKB1;BCL6;ZBTB38;BACH1;DDX20;MT3;TFAP2B;SNAI2;SAP30;ETV6;MDFIC;MTA2;SMAD2;GLIS3;DACT1;SIRT6;NONO;DNMT3A;AEBP1;AASS;HMGB1;PLK3;PEX2;MEN1;HSPA8;BPTF;RING1;NR2C1;PROX1;COMMD7;NCOA5;BTRC;DUSP26;PPM1F;FOXK1;DKK3;MAX;SNW1;NOTCH4;DNAJA3;CTCF;NAB1;SETDB2;HCFC2;ZBTB5;MITF;SKIL;TFDP2;CBX4;TAF3;KLF10;ZNF423;NKAP;CUX1;UXT;LDB2;LDB1;PSEN1;NR3C1;LCOR;RB1;MIER1;MDFI;ATXN1;LIMS1;APBB1;HDAC8;PTCH1;ZBTB21;DAB2;IKZF1;ZMYND15;KDM8;DLG1;MYPOP;SOX2;RREB1;EZH2;RBM15;MYB;INPP5K;POU6F1;PRDM11
prerank,long-term synaptic potentiation (GO:0060291),-0.35134130528321234,-1.0978571400724306,0.325,0.9985846910135153,1.0,6/21,8.19%,GRIN2A;GRIN2B;PRKCZ;TSHZ3;RGS14;SLC8A3
prerank,gliogenesis (GO:0042063),-0.3920678207978266,-1.0973868204157364,0.31636363636363635,0.9962699206121288,1.0,6/15,22.45%,CDH2;TGFB2;METTL3;CD9;ANXA1;METRN
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.36072933541570584,1.0972639685092187,0.30809128630705396,0.8721607970737816,1.0,22/118,13.36%,STAT2;SP100;FMNL2;SEMA4D;RUFY3;CTNNB1;EPHA4;FGFR2;PAK3;BCL6;HTATIP2;GDNF;ZMYM3;BMPER;TNIK;PHIP;INF2;PHLDB1;CAPZB;CHN1;SIPA1L1;ZRANB1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3341162033082975,-1.097235356449972,0.30120481927710846,0.9885837054525081,1.0,8/23,17.04%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;PPP1R13B;TP53;E2F1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3341162033082975,-1.097235356449972,0.30120481927710846,0.9885837054525081,1.0,8/23,17.04%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;PPP1R13B;TP53;E2F1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.41356113096528385,1.097190439560866,0.3659730722154223,0.8716768474062219,1.0,16/33,28.73%,IRS1;PIK3CD;LTK;ZFP36L1;PLEKHA1;HTR2A;PIK3CB;NYAP2;NF1;ERBB3;PIK3CA;SIRT2;PTEN;PIK3R5;HTR2B;PIK3R1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.37568797260834863,1.0967857083546797,0.3344262295081967,0.8722484586926136,1.0,10/65,8.23%,AGT;SPRY2;CDH13;TGFA;MVB12A;DOK1;DUSP3;ARHGEF7;WDR54;CCDC88A
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.34174047483560166,1.0965008291958986,0.199,0.8724622111440604,1.0,121/497,20.51%,IGF2BP1;EIF2AK2;WNT11;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;DAPK3;DHFR;TRIB3;WNT5A;MYBBP1A;PER2;DAXX;PRMT2;TIMELESS;IGF2BP3;MECP2;ARID5B;SFRP2;MTA3;ELK3;PCGF6;ID3;BHLHE40;LARP1;ZHX3;NACC1;EID2B;NKX6-2;CIC;GATAD2A;CNOT7;ILF3;DHX36;PRICKLE1;PFDN5;SOX9;CTNNB1;MBD2;SMARCE1;TCF7L2;SMARCC2;BCL6;ZBTB38;MT3;TFAP2B;MDFIC;SMAD2;NONO;BMPR2;MEN1;HSPA8;RING1;PROX1;COMMD7;BTRC;PPM1F;FOXK1;DKK3;SNW1;CTCF;NAB1;SETDB2;TFDP2;CBX4;KLF10;ZNF423;NKAP;LDB1;NR3C1;RB1;ENPP1;RACK1;ATXN1;LIMS1;ZBTB21;SHMT1;IKZF1;ZMYND15;KDM8;PATL2;EZH2;RBM15;MYB;INPP5K;PRDM11;RCOR3;PPARD;GCLC;ENC1;ZBTB4;PUS7;KAT8;BAHD1;RBPJ;BRD7;ID4;HMBOX1;MRPL13;DACH1;HDAC1;WWP1;CAPRIN1;HINFP;CTBP1;ZKSCAN3;TSC1;SET;KAT7;POU3F3;PER1;BTAF1;ACVRL1;NR1D2;SFMBT1;ZEB1;BCOR;DDX3X
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4252467651223389,1.0963999783761225,0.33669609079445145,0.872078468930861,1.0,5/27,11.40%,PML;PER2;BHLHE40;CRTC1;SIK1
prerank,photoperiodism (GO:0009648),0.42214343065496696,1.0962396109214818,0.34625,0.871874360686675,1.0,5/28,11.40%,PML;PER2;BHLHE40;CRTC1;SIK1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.44363845380287936,1.095980102838048,0.3403141361256545,0.8720207191565171,1.0,3/22,6.12%,B2M;CD55;STX7
prerank,negative regulation of reproductive process (GO:2000242),-0.3644682896220842,-1.0958895521594174,0.30268199233716475,0.9896261640686828,1.0,4/17,7.97%,SULF1;PAEP;ARHGDIB;WDR77
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4108190374814304,1.0956083323010566,0.3600944510035419,0.8724847853478188,1.0,14/37,23.08%,NOD2;GBP5;STAT3;ABCD1;MAPK14;ZC3H12A;IL17D;CHID1;MYD88;SIRPA;PER1;APPL2;PLD3;ADCY7
prerank,piRNA metabolic process (GO:0034587),-0.34992864164157234,-1.0948370840556416,0.31153846153846154,0.9896737619273012,1.0,10/19,48.34%,TEX15;EXD1;DDX4;PIWIL2;TDRD12;GPAT2;TDRD9;MOV10L1;PIWIL4;PIWIL1
prerank,collagen fibril organization (GO:0030199),0.36555850031620396,1.0945794941739637,0.31163287086446106,0.8751090165056234,1.0,15/88,12.53%,LOXL2;COL13A1;P4HA1;ADAMTS3;COL9A1;COL4A2;COL14A1;P3H1;COL5A3;COL8A1;COL22A1;SCX;COL3A1;ADAMTS2;COL11A2
prerank,regulation of mRNA stability (GO:0043488),0.35095739336446236,1.0944641268533832,0.30337078651685395,0.8747506292564138,1.0,46/145,24.01%,IGF2BP1;PSMB10;PSME2;ZFP36;PSMA5;IGF2BP3;PSME4;YTHDF1;LARP1;DHX36;XRN1;PSMA3;DCP2;PSMB9;YTHDF2;GDNF;HSPA8;NPM1;ZFP36L1;PSMD2;TENT5A;PSME3;TENT5C;EXOSC9;PSMA4;TAF15;MEX3D;METTL14;PCBP4;TBRG4;PSMD7;PSMD8;SET;RC3H2;PSMD9;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;EXOSC4;PSMD4;ZC3H14;ZFP36L2;PSMA2;PDE12
prerank,response to UV-A (GO:0070141),-0.3841620534406581,-1.0944454599956102,0.3222591362126246,0.9870718719986719,1.0,7/14,26.23%,MMP1;EGFR;AKT1;CERS1;MMP2;OPN3;PPID
prerank,nuclear migration (GO:0007097),-0.4143010761915009,-1.094324798380766,0.36271186440677966,0.9835046663812267,1.0,7/13,12.16%,DOCK7;PCM1;TMEM201;CEP120;FBXW11;SYNE3;CLMN
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.43727882425849357,1.0942825273248324,0.35509138381201044,0.8746288248096029,1.0,13/24,27.47%,FBXW7;CTNNB1;TFAP2B;PRNP;BAX;NF1;TYROBP;MCL1;TNF;CDK5R1;GRN;SRPK2;CDK5
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.39852710034895455,1.0941623286978763,0.36042402826855124,0.8742931751533609,1.0,10/40,16.89%,LOXL2;CTNNB1;TCF7L2;SMAD2;BAMBI;PDPN;DAB2;EZH2;MTOR;MDK
prerank,positive regulation of signaling (GO:0023056),-0.2967719990842391,-1.0941219779767217,0.27439024390243905,0.9802976908291555,1.0,15/37,24.10%,INPP5F;DLG4;HOMER1;SNCA;RIMS1;NSF;VAMP3;RIMS3;SCRIB;CDKN2AIP;RIMS2;KCTD13;SYT1;NMU;CD80
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.341504717289964,1.093708639532111,0.223,0.8750625230246448,1.0,103/417,20.38%,WNT11;PML;LOXL2;CALCA;THAP7;CIART;NR1H2;TRIB3;WNT5A;MYBBP1A;PER2;DAXX;PRMT2;TIMELESS;EIF4A2;MECP2;ARID5B;SFRP2;MTA3;ELK3;PCGF6;ID3;BHLHE40;ZHX3;NACC1;EID2B;NKX6-2;CIC;GATAD2A;CNOT7;ILF3;PRICKLE1;PFDN5;SOX9;CTNNB1;MBD2;SMARCE1;TCF7L2;SMARCC2;BCL6;ZBTB38;MT3;TFAP2B;MDFIC;SMAD2;NONO;MEN1;HSPA8;RING1;PROX1;COMMD7;BTRC;PPM1F;FOXK1;DKK3;SNW1;CTCF;NAB1;SETDB2;TFDP2;CBX4;KLF10;ZNF423;NKAP;LDB1;NR3C1;RB1;ATXN1;LIMS1;ZBTB21;IKZF1;ZMYND15;KDM8;EZH2;RBM15;MYB;INPP5K;PRDM11;RCOR3;PPARD;GCLC;ZBTB4;KAT8;BAHD1;RBPJ;BRD7;ID4;HMBOX1;DACH1;HDAC1;WWP1;HINFP;CTBP1;ZKSCAN3;SET;KAT7;POU3F3;PER1;BTAF1;NR1D2;SFMBT1;ZEB1;BCOR
prerank,calcium ion import across plasma membrane (GO:0098703),0.49499494745279804,1.093644326237383,0.3838383838383838,0.8745334128875555,1.0,3/14,12.84%,TRPM2;SLC8A1;TRPV4
prerank,regulation of microtubule-based process (GO:0032886),-0.3070562367706973,-1.0936064716469693,0.26011560693641617,0.9783097190722664,1.0,9/36,11.76%,MACF1;ROCK1;MAP6;TPPP;MARK4;KLHL42;CLASP2;GSK3B;APC
prerank,regulation of histone acetylation (GO:0035065),0.4167934051441055,1.0930167920366691,0.3583743842364532,0.8758317300111628,1.0,11/33,19.23%,THAP7;CHEK1;KMT2A;TADA2A;TADA2B;SETD5;PPARGC1A;PAXIP1;BRD7;CTBP1;SET
prerank,mitotic sister chromatid segregation (GO:0000070),0.3617137110807222,1.092742275717038,0.3305351521511018,0.875994537605308,1.0,25/98,19.35%,CHMP4A;CHMP4B;TENT4A;CHMP1B;HASPIN;NAA50;KPNB1;KIF2C;WRAP73;CSNK2B;RRS1;CSNK2A2;CHMP3;NCAPG2;RB1;POGZ;DIS3L2;PIBF1;MIS12;RAB11A;CHMP5;NDC80;SET;BECN1;PDS5B
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3365164126552109,1.0927413171834537,0.063,0.8752694653540168,1.0,302/1645,17.10%,STAT1;STAT2;SP100;IRF7;PARP9;WNT11;PITX2;SIM1;PML;LOXL2;CALCA;AGT;THAP7;SP110;LHX2;LMX1A;CIART;NR1H2;HAS3;CC2D1B;IRF2BP1;ESR2;DAPK3;DHFR;DTX3L;USF2;CAMK2D;ETV3;PCGF5;VRTN;MEF2B;TCF24;TRIB3;WNT5A;MYBBP1A;ZNF483;TFAP2C;PER2;GMEB2;DAXX;CCNL1;ZBTB17;TRIM45;ESRRB;PRMT2;BRD2;NFX1;HTATSF1;TIMELESS;SAP30L;BBX;ZFPL1;RNF4;TEAD2;ZBTB2;NFKB2;SOD2;CHEK2;MECP2;ACVR1;STAT3;MLLT11;ARID1B;ARID5B;ZFP37;TGFA;BATF3;CHD7;SFRP2;DDX5;ZNF471;MTA3;ELK3;PCGF6;RUNX1;MAD2L2;ID3;USP21;BHLHE40;ZHX3;NACC1;EID2B;NKX6-2;KLF15;SRRT;CIC;CCNL2;GATAD2A;CNOT7;ILF3;DHX36;MZF1;BRWD3;NFXL1;JUNB;ZSCAN12;NCOA1;MRPL12;SERTAD3;PRICKLE1;ZNF23;PFDN5;SOX9;SRA1;HNRNPK;CTNNB1;KMT2A;ZNF2;ARID1A;CCNT2;TRAK1;ZNF76;MBD2;ZSCAN22;CDT1;NSD3;ZSCAN26;SMARCE1;TCF7L2;TCF4;SMARCC2;ZXDC;ZBTB43;NFKB1;BCL6;CREBRF;EDF1;ZBTB38;SETD3;BRIP1;BACH1;MT3;USF1;ZSCAN29;NFATC2;TFAP2B;MAP2K3;SNAI2;RET;SAP30;UBP1;DHX9;SRF;ETV6;MDFIC;RAI1;IKZF2;TADA2A;HTATIP2;SMAD2;GLIS3;MED13L;MEIS3;ATF6B;TFDP1;CDK5RAP2;BAMBI;NONO;SLTM;ACTR8;ELP2;ATF1;HOXA9;NFIB;POU3F1;SCX;HMGB1;DACH2;LCORL;ELF4;POLR2K;INSR;TADA2B;HR;IRF9;MEN1;MAPK14;HSPA8;BPTF;ZSCAN20;MNAT1;RING1;WAC;LIN9;NR2C1;RORA;MED12;PROX1;PHIP;ELOC;COMMD7;BTRC;RGMB;KDM3B;PPM1F;NPM1;FOXK1;DNM2;DKK3;SETD5;MAX;SNW1;NOTCH4;CTCF;NAB1;SETDB2;HCFC2;ZBTB5;MITF;RYBP;TFDP2;ARHGEF11;CBX4;HMGB3;MAP2K2;KLF10;ZNF423;NKAP;CUX1;RELB;UXT;TEF;ILF2;NOP2;LDB1;PSEN1;REL;PPARGC1A;APOE;HOXB6;NR3C1;LCOR;BRPF1;UBE2L3;FBXL19;RB1;E2F4;ZNF35;ATXN1;LIMS1;APBB1;PGBD1;ST18;ZBTB21;TIAL1;DBX2;MED29;BCL11B;SMARCA1;IKZF1;ZNF418;ZMYND15;KDM8;ASCC2;CASZ1;MYPOP;SOX2;RREB1;EZH2;CREB5;RBM15;MYB;INPP5K;POU6F1;PRDM11;ZBTB24;MLLT3;ZBTB34;CAMTA2;ERF;CRK;KLF16;SOX5;SMARCD2;TAF15;MYCBP;GTF2IRD1;PIAS1;NPAT;RCOR3;MEF2A;KDM7A;CARF;PROX2;PIAS2;PPARD;MED27;GCLC;DENND4A;ZNHIT3;SREBF1;CCNK;ZBTB4;KAT8;BAHD1;RBPJ;BRD7;MED16;ELF1;TRIP4;ID4;HMBOX1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5036149820632947,1.092691956690351,0.38823529411764707,0.8746895261797094,1.0,4/11,21.13%,SOCS1;LEPROT;HGS;ADIPOR1
prerank,positive regulation of cellular senescence (GO:2000774),0.5197499241700818,1.0926419123176,0.38837920489296635,0.8741280055026691,1.0,4/10,16.67%,B2M;CGAS;YPEL3;EEF1E1
prerank,tube closure (GO:0060606),0.41807695835258235,1.0924563941739824,0.3567901234567901,0.8740001498732755,1.0,4/31,5.37%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3517661423294555,1.092210863883912,0.30010172939979657,0.8741123461841294,1.0,38/172,16.96%,ETNK1;ETNK2;CPNE3;ARF3;PIK3CD;SLC27A1;CDS1;SYNJ1;PLA2G12A;PCYT2;PITPNM1;SBF1;AGPAT5;PIP5K1A;ABHD8;CSNK2B;CSNK2A2;LPIN2;CEPT1;LPCAT2;PI4KB;PIK3R4;GNPAT;DGKB;CDIPT;RAB14;PLEKHA1;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;ABHD3;INPP5K;MTMR14;CHPT1;DGKA;OCRL
prerank,regulation of membrane depolarization (GO:0003254),0.4553707961391095,1.091902725473731,0.3476510067114094,0.874378590075238,1.0,3/18,16.17%,CAMK2D;ABCD1;SCN1B
prerank,RNA transport (GO:0050658),0.372898080750555,1.0916468198931581,0.33515881708652795,0.8745284003436306,1.0,19/71,17.88%,PNPT1;ZFP36;MAGOHB;NUP153;NCBP2;HNRNPA2B1;RAE1;ZFP36L1;RNPS1;RBFOX1;HNRNPA1;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;SRSF7;SRSF4;SLU7
prerank,positive regulation of autophagy (GO:0010508),0.3672268386944425,1.0914676878077016,0.3513227513227513,0.8743981528733004,1.0,14/81,13.11%,IRGM;TRIM14;KDR;FBXO7;TRIM21;LARP1;SH3GLB1;HMGB1;PLK3;WAC;ZC3H12A;SVIP;PIK3CB;BAD
prerank,cellular response to UV (GO:0034644),-0.2601059262594196,-1.0914187798758712,0.26582278481012656,0.9827593613308427,1.0,29/76,21.12%,ZBTB1;PTPRK;IMPACT;MMP1;PARP1;INO80;USP28;YY1;RHNO1;XPC;SIRT1;ACTR5;NSMCE3;CASP9;TAF1;METTL3;KDM1A;TP53;CERS1;CDKN1A;ERCC1;BAK1;XPA;MYC;USP47;POLD1;NEDD4;SMPD1;COPS9
prerank,supramolecular fiber organization (GO:0097435),0.33997985389544993,1.0911369770044606,0.27127127127127126,0.874727193108695,1.0,65/334,14.71%,LOXL2;CALCA;COL13A1;UBE2L6;CENPJ;B2M;ACTN1;P4HA1;KATNAL1;ADAMTS3;COL9A1;MYO1C;ELMO2;MAD2L2;COL4A2;RHOF;RUFY3;DYNC1H1;PPP1R9A;SIAH1;EVL;HSP90AB1;COL14A1;KIF2C;P3H1;CARMIL1;GGA3;COL5A3;HOOK2;COL8A1;COL22A1;SAMD14;STMN4;CCDC88A;BCAR1;APP;SCX;BFSP1;PLK3;HOOK1;DNAJB6;TPPP3;STMN3;CIB1;CCDC88B;ARHGAP25;COL3A1;SORL1;CORO7;GSN;FAT1;TMOD3;ADAMTS2;COL11A2;TRPV4;FGF13;CLIP2;WHAMM;CORO1B;HOOK3;MYO6;RAC1;APH1A;DLG1;KIF2A
prerank,ubiquinone biosynthetic process (GO:0006744),0.4658274623123446,1.091111096157045,0.3649222065063649,0.8741011107595649,1.0,3/15,6.33%,COQ2;COQ10B;COQ3
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.33823384831388525,1.0910185768660965,0.196,0.8737023278025309,1.0,102/572,14.96%,STAT1;SP100;IRF7;PARP9;MYOZ2;LOXL2;THAP7;NR1H2;IRF2BP1;ESR2;TRIB3;TFAP2C;PER2;ZFP36;RARG;NFX1;SEMA4D;ZBTB2;MECP2;STAT3;ARID5B;ZFP37;BATF3;DDX5;MTA3;CGGBP1;RUNX1;MAD2L2;ID3;BHLHE40;GATAD2A;NOP53;MZF1;SOX9;CCND1;MBD2;FGFR2;IGBP1;TCF7L2;NFKB1;BCL6;BACH1;DDX20;TFAP2B;SNAI2;SAP30;SRF;ETV6;MTA2;SMAD2;GLIS3;DACT1;SIRT6;DNMT3A;AEBP1;AASS;NFIB;HMGB1;PLK3;PEX2;MEN1;BPTF;NR2C1;PROX1;NCOA5;DUSP26;MAX;SNW1;NOTCH4;DNAJA3;CTCF;HCFC2;ZBTB5;MITF;SKIL;CBX4;TAF3;KLF10;NKAP;CUX1;UXT;LDB2;LDB1;PSEN1;NR3C1;LCOR;RB1;MIER1;MDFI;ATXN1;APBB1;HDAC8;PTCH1;ZBTB21;DAB2;DLG1;MYPOP;SOX2;RREB1;EZH2;MYB;POU6F1
prerank,mitochondrial transcription (GO:0006390),0.5051682449040259,1.090920029538908,0.36574746008708275,0.8732876989625684,1.0,6/10,26.00%,MRPL12;TFB2M;TWNK;TEFM;TFAM;SLC25A33
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.4652516680355564,1.0903033086285903,0.3684931506849315,0.8745927037229227,1.0,8/18,23.43%,FLT1;SIRT6;HMGB1;MDK;ITGA4;AKT3;FGF2;PDPK1
prerank,cellular protein-containing complex assembly (GO:0034622),0.3467472089047499,1.0901476065211235,0.31749241658240646,0.8743650181384548,1.0,32/160,15.36%,CLTRN;CHMP4A;CHMP4B;CLU;NUP153;HSP90AB1;CCDC40;NSG2;TCF4;CSNK2B;DHX9;FMOD;SMAD2;NCK1;NCK2;EIF4H;SNX9;SAMM50;AP2S1;VAMP1;HSPA4;CHMP3;LONP1;VAMP2;POGZ;AHCTF1;TBCC;PSMG2;VAMP4;MIS12;HSP90AA1;TBCD
prerank,phosphorylation (GO:0016310),0.3391767580225084,1.0901444389467492,0.256,0.8736545564167914,1.0,98/385,19.25%,EIF2AK2;WNT11;TAOK3;DAPK3;GLYCTK;CAMK2D;TP53RK;RSKR;SGK3;SGK2;FASTK;PIK3CD;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;STAT3;HASPIN;CDC25B;STK38L;PKN2;HCK;CHEK1;GNPTAB;IKBKE;ILF3;PEAK1;MORC3;CDK12;MKNK1;PAK3;NRBP2;RET;FAM20B;GMFB;LTK;LYN;CLK3;NADK;APP;INSR;SRPK1;PIK3R4;BMPR2;HK1;PRKAG1;DGKB;CERKL;CDK19;SPHK2;DGKK;TNIK;CDK10;NUAK2;CDK20;BCKDK;SIK1;PIM1;FGGY;NEK6;DYRK2;PRKDC;PRKCE;PIK3CB;CLK2;JAK2;FYN;PRKCH;PANK2;FAM20C;STK25;MINK1;BMPR1A;NRBP1;TAOK2;OXSR1;MTOR;TBCK;IRAK1;STK39;CSK;DGKA;BCR;SNRK;PRKG2;BIRC6;ACVR2A;FNIP2;COPS8;DGKI;MARK1;CTBP1;BRSK1;NEK7;STK3;STK24;CAMKK2
prerank,N-terminal protein amino acid modification (GO:0031365),0.47720295034686555,1.0900822585056662,0.36834733893557425,0.8731146764459604,1.0,4/14,16.66%,NAA50;NTMT1;NAA35;METAP2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3716717583466168,1.0897879943981315,0.343042071197411,0.8733308552236292,1.0,28/70,25.96%,PSMB10;PSME2;B2M;PSMA5;PSME4;CYBB;TAPBP;PSMA3;PSMB9;FCGR1A;PSMD2;PSME3;SNAP23;PSMA4;PSMD7;PSMD8;PSMD9;TAP1;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2;CYBA;PSMD1;SEC22B;PSMD11
prerank,positive regulation of lipid kinase activity (GO:0090218),0.42229911500059586,1.0893557178109772,0.36363636363636365,0.8740434219054934,1.0,3/29,1.64%,NOD2;FLT1;IRS1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.3956775168135867,1.0891756843681397,0.3574766355140187,0.8739098214126675,1.0,7/40,15.34%,ISG15;ACVR1;SLC8A1;BMPR2;ADGRV1;NELL1;BMPR1A
prerank,regulation of inclusion body assembly (GO:0090083),0.5034959767314544,1.089159921913883,0.3914327917282127,0.8732534590186551,1.0,2/11,9.81%,HSPA1B;DNAJB6
prerank,protein-containing complex assembly (GO:0065003),0.34649111200408056,1.0891254717676144,0.2822822822822823,0.8726399405990314,1.0,46/259,13.83%,NOL3;PML;TRAPPC3;SKP1;AIM2;GPAA1;TEAD2;CD40;TGFA;RBBP5;LAMC1;MDN1;CHCHD10;SEC16A;TSPAN4;SOX9;TAPBP;CTNNB1;CX3CL1;KMT2A;GOSR2;CNIH3;TCF7L2;SKAP2;SEC24D;DET1;CSNK2B;DHX9;CTSC;PPP6R3;CAND1;SEC23A;RBX1;MEN1;MNAT1;TMED10;SNX9;SAMM50;ZC3H12A;MITF;SCFD1;PPARGC1A;BAD;VAMP2;PYGO1;NAPA
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34777088573641696,1.0885332415452675,0.29969727547931385,0.8738532299565096,1.0,52/190,21.28%,STAT1;IFI35;XDH;TRIB3;NMI;OTUD3;NOP53;ITPR1;UBE2B;DUSP3;PPP2R5C;TRIM39;MAP2K3;MAGI2;CYLD;TSPAN6;LYN;MAPK14;RORA;ARRB2;TNIP1;CIB1;ZC3H12A;ARHGAP25;RIOK3;PLEKHA1;RTKN2;DDIT4;AKT1S1;RACK1;PIK3CB;INPP5K;UACA;SH3BP1;TNIP3;PDE3A;PHLDA3;NF1;RFFL;MGRN1;SPRED1;NPRL2;TSC1;NPRL3;TANK;PER1;DDX3X;PLAUR;MCL1;ADIPOR1;MAPKBP1;RHOH
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3898588438517199,1.088398673482592,0.3492605233219568,0.8735607665237312,1.0,10/47,12.35%,AGT;NR1H2;TCOF1;CYFIP1;NFKB1;CSF1;NOLC1;APP;PUM3;APOE
prerank,positive regulation of cellular protein localization (GO:1903829),0.3728256905057152,1.0881846642595563,0.34598698481561824,0.8735163448016262,1.0,18/69,21.06%,PARP9;DTX3L;DDRGK1;SNX33;HSP90AB1;CDT1;CCDC88A;TRAPPC12;VPS28;STX4;FYN;TESK1;NUMA1;NDC80;KAT7;TYROBP;TM9SF4;ENTR1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.42335587247836176,1.0881653023210751,0.34285714285714286,0.8728735882646723,1.0,4/25,8.96%,CDH13;ITPR1;TMBIM4;P2RX4
prerank,proteoglycan metabolic process (GO:0006029),0.42030987343890586,1.0881590266271643,0.3717948717948718,0.8721861975819027,1.0,10/26,23.62%,CANT1;FAM20B;BMPR2;CSGALNACT2;HPSE;HS3ST4;ADAMTS12;XYLT1;CHST11;CHST12
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.45844114955016935,1.0875608307615725,0.3684210526315789,0.8733753624839528,1.0,4/18,6.83%,MECP2;CDC25B;CCND1;RAD51C
prerank,cellular response to hormone stimulus (GO:0032870),0.3709019322295443,1.0875231521998474,0.3602209944751381,0.8728059533329333,1.0,13/69,12.63%,CTSS;STAT3;CRHBP;NCOA1;SRA1;CTSH;LMO2;ZFP36L1;SLIT3;XBP1;SOCS2;NR3C1;UBE2L3
prerank,protein targeting (GO:0006605),0.352886365621248,1.0873414201233553,0.3385416666666667,0.872704549718187,1.0,26/118,17.56%,GOLGA7;FIS1;MYO1C;FBXO7;AQP11;RTP4;LAMP2;ZDHHC21;LONP2;SRPRA;ZDHHC20;TRAK1;GDAP1;TOMM5;VPS37A;NACA;SPCS1;FUT10;SORL1;TSPO;PITRM1;AIP;TAOK2;RPL11;TOMM40;CDC37
prerank,bone morphogenesis (GO:0060349),0.48587051201922266,1.0865952432081796,0.3810178817056396,0.8743823084091545,1.0,4/14,16.05%,FGFR2;CYP26B1;BMPR2;FGFR3
prerank,organic substance transport (GO:0071702),0.3558786374733159,1.0863934425927322,0.33541666666666664,0.8743212246906942,1.0,19/121,13.37%,ZG16;ABCA1;CHMP1B;ABCG1;SLC18A2;ARRDC4;LRP2;ATP8A1;SLC19A1;RILP;ARRDC2;SLCO1B1;ABCB9;SLC35F3;ABCD1;AMN;CHMP3;CMTM6;VAMP2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4427933366177091,1.0861666032187918,0.3816300129366106,0.8743552150632605,1.0,6/22,17.74%,SNX33;ADAM8;TIMP2;SNX9;APOE;SH3D19
prerank,stem cell differentiation (GO:0048863),-0.2934648615622685,-1.0858775574669597,0.32075471698113206,0.9996738112827525,1.0,11/39,17.40%,LRP6;BATF;FBXL17;JARID2;TGFB2;NELFB;GPM6A;HMGA2;TP53;EEF1AKMT4-ECE2;FOXO4
prerank,regulation of protein secretion (GO:0050708),0.3557664673437435,1.0851734432799582,0.3305785123966942,0.8768589402868102,1.0,16/119,13.20%,RSAD2;PER2;ABCG1;ADAM8;CCL5;ITPR1;P3H1;TFAP2B;SYT7;KCNS3;PPIA;CACNA1A;TMED10;RHBDF2;APOE;APBB1
prerank,protein trimerization (GO:0070206),0.47963905349075997,1.0851019709180618,0.37980085348506404,0.8756844930403018,1.0,2/14,2.61%,PNPT1;MLKL
prerank,protein homotrimerization (GO:0070207),0.47963905349075997,1.0851019709180618,0.37980085348506404,0.8756844930403018,1.0,2/14,2.61%,PNPT1;MLKL
prerank,calcineurin-mediated signaling (GO:0097720),-0.43181965405431555,-1.0850639795651742,0.3519736842105263,0.9948011504198542,1.0,2/10,1.84%,PPP3R1;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.43181965405431555,-1.0850639795651742,0.3519736842105263,0.9948011504198542,1.0,2/10,1.84%,PPP3R1;PPP3CC
prerank,nuclear export (GO:0051168),0.368686263694307,1.0847109596859574,0.3414893617021277,0.8762440189093843,1.0,22/80,17.88%,PHAX;MAGOHB;NUP153;WASHC4;NCBP2;CSE1L;LSG1;RAE1;RNPS1;HNRNPA1;SMURF1;ZC3H11A;ATXN1;CHTOP;RANBP3L;NUP155;DDX39B;NCBP1;SRSF7;SRSF4;RANBP17;SLU7
prerank,B cell homeostasis (GO:0001782),0.5105224661401008,1.0845749628961563,0.37593984962406013,0.8759682905549078,1.0,3/10,8.77%,GAPT;CAMLG;LYN
prerank,snRNA 3'-end processing (GO:0034472),-0.35267574291228154,-1.0844446978975166,0.34980988593155893,0.9931578360539163,1.0,12/19,35.10%,EXOSC7;EXOSC5;INTS12;EXOSC3;INTS2;TUT1;INTS6;TOE1;INTS5;INTS6L;USB1;EXOSC8
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4549864050948586,1.084292644524847,0.38722826086956524,0.8761995152949728,1.0,6/18,14.00%,MMP14;STX7;STX8;LDLRAP1;VTI1B;ACTB
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.446237171059847,1.0842265937290358,0.3699731903485255,0.8757087501231068,1.0,4/19,8.04%,NANS;GMPPB;MPI;GFPT1
prerank,protein neddylation (GO:0045116),0.4825820130416269,1.0841976710463663,0.413589364844904,0.8750929560563915,1.0,3/13,8.98%,UBE2M;DCUN1D4;RBX1
prerank,generation of neurons (GO:0048699),0.3425392897140249,1.0839591034617164,0.31419939577039274,0.8751969976632327,1.0,39/190,19.81%,WNT11;LHX2;LMX1A;WNT5A;PER2;PLXNB2;TUBB2B;RUNX1;BHLHE40;CTNNB1;CX3CL1;NGRN;WNT7B;NRBP2;RAPGEF2;DTNB;YTHDF2;MET;DDIT4;LDB1;FGF13;NRP1;RAC1;SMARCA1;DNER;LRP12;ADNP2;OPHN1;PEX13;IER2;ITM2C;DCDC2;FUT9;PAFAH1B1;MARK1;BRSK1;MAP1B;PIN1;CCK
prerank,negative regulation of peptidase activity (GO:0010466),0.38489915989471085,1.0838462987092223,0.36259977194982895,0.8748587989540016,1.0,5/47,10.23%,AGT;SERPINC1;UBXN1;CST7;TIMP2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3701586148823728,-1.0837762895134297,0.3333333333333333,0.9916594628698349,1.0,8/17,32.99%,PDE3B;ALK;AKT1;IL1B;ADRA2A;APOC1;MFSD2A;HCAR2
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.45870300060820324,1.0835196357904249,0.3714670255720054,0.8752195248120122,1.0,5/16,15.30%,MCM2;MCM7;MCM4;TWNK;RECQL5
prerank,regulation of blood coagulation (GO:0030193),-0.3183126020978974,-1.0834387523381042,0.3287037037037037,0.9891050279356898,1.0,10/27,28.22%,DMTN;EPHB2;VTN;ENPP4;FAP;F2R;CAV1;THBD;CD34;ST3GAL4
prerank,centromere complex assembly (GO:0034508),-0.3113202771748425,-1.083333904092805,0.3235294117647059,0.9856610056396897,1.0,16/36,24.84%,CENPV;CENPO;CENPE;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPF;DLGAP5;CENPX;CENPQ;CENPH
prerank,sodium ion homeostasis (GO:0055078),0.43746964104714814,1.0831734529961965,0.3763157894736842,0.8756391638286998,1.0,3/21,6.71%,ATP1B3;SLC8A1;TFAP2B
prerank,triglyceride catabolic process (GO:0019433),0.4491259794058068,1.082877748229145,0.36363636363636365,0.8758332069564121,1.0,2/19,7.72%,PNPLA2;LIPC
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4329204121425937,1.0828004557917421,0.37139107611548555,0.8753775917380174,1.0,3/22,8.96%,AGT;CAMK2D;P2RX4
prerank,DNA-dependent DNA replication (GO:0006261),0.35231955087476813,1.0826914700152095,0.3309203722854188,0.8750189470095978,1.0,43/128,24.11%,PSMB10;PSME2;MCM2;LRWD1;PSMA5;PSME4;POLD4;POLE2;MCM7;MCM4;RFC4;POLB;POLG2;RFC1;CDT1;PSMA3;RPAIN;PSMB9;WDHD1;TWNK;PSMD2;PSME3;ORC3;GINS2;PSMA4;RECQL5;DDX23;GINS4;PSMD7;PSMD8;PSMD9;PRIM1;ORC1;PSMF1;GINS3;PSMB6;PSMC2;PSMD12;PSMD4;SSBP1;TEFM;PSMA2;POLG
prerank,positive regulation of cellular component movement (GO:0051272),0.43084981845972714,1.082531404688372,0.35974025974025975,0.8748091293722434,1.0,7/24,21.18%,TUBB2B;LYN;PDPN;CFAP20;CAVIN1;CCDC25;STK11
prerank,protein-DNA complex assembly (GO:0065004),0.35364093072355113,1.082266673581854,0.3391933815925543,0.8750080199089391,1.0,23/116,12.45%,PSMB10;PSME2;DAXX;MCM2;BRD2;PSMA5;PSME4;NAP1L2;MCM7;CHD1L;MCM4;SOX9;CDT1;PSMA3;TCF4;PSMB9;RBX1;MNAT1;CHAF1B;NPM1;PSMD2;PSME3;ORC3
prerank,oligodendrocyte development (GO:0014003),0.4791052731303859,1.0822135611570356,0.37302725968436157,0.8744641073048095,1.0,6/15,19.94%,CNTNAP1;EIF2B2;B4GALT5;EIF2B5;EIF2B3;PLP1
prerank,regulation of centriole replication (GO:0046599),0.446672780641243,1.082112326359857,0.3692098092643052,0.8741097333980786,1.0,5/18,14.32%,CENPJ;RBM14;CDK5RAP2;NPM1;CEP295
prerank,zinc ion transmembrane transport (GO:0071577),0.43832915403594186,1.0819102885121876,0.3748378728923476,0.8740738535071932,1.0,6/22,19.43%,TRPM2;SLC30A1;SLC30A5;SLC30A6;SLC39A10;SLC39A3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4335105088408143,1.081824773145876,0.3599476439790576,0.8736317564800256,1.0,6/22,16.96%,BDNF;MAGI2;RAPGEF2;CIB1;RAPGEF1;STMN2
prerank,histone H3 acetylation (GO:0043966),0.39960269854298147,1.081803864462939,0.367612293144208,0.8730029394913691,1.0,17/40,24.80%,JADE3;BRD1;KAT14;TADA2A;SUPT7L;WDR5;LDB1;BRPF1;SGF29;KAT7;PER1;ING5;TADA1;KAT6A;JADE2;KAT2B;YEATS2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.36771328359003375,1.0817786663877733,0.3643243243243243,0.8723814975102213,1.0,32/74,26.41%,PSMB10;PSME2;PSMA5;PSME4;EGLN2;PSMA3;BACH1;PSMB9;RBX1;ELOC;PSMD2;PSME3;PSMA4;RBPJ;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;CITED2;PSMC2;PSMD12;PSMD4;LIMD1;NOTCH1;PSMA2;CUL2;SIRT2;EPAS1;PSMD1;PSMD11;HIGD1A
prerank,"phagocytosis, engulfment (GO:0006911)",0.39154811101433956,1.0817486068707576,0.3788235294117647,0.8717713943597718,1.0,13/36,21.28%,GULP1;XKR7;MEGF10;FCGR1A;ARHGAP25;GSN;FCGR2B;RAC1;SH3BP1;AIF1;MYH9;MSR1;RHOH
prerank,response to chemokine (GO:1990868),0.49115032672260456,1.0816345858361305,0.38549075391180654,0.8714144798426573,1.0,5/13,16.65%,DOCK8;ZC3H12A;LRCH1;OXSR1;STK39
prerank,cellular protein catabolic process (GO:0044257),0.3749132629122834,1.080945037437203,0.3690078037904125,0.8729240349040064,1.0,14/59,16.39%,CTSS;CHEK2;RNF5;RAB12;AP2A1;RSPRY1;CTSC;CTSH;AP2S1;LONP1;MYLIP;AFG1L;ADAMTS12;TCIRG1
prerank,regulation of neuron projection arborization (GO:0150011),0.4628571152232989,1.0807348897481723,0.37656903765690375,0.872887704796293,1.0,2/15,1.52%,MOV10;WNT5A
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4298168690750068,1.0807161995483092,0.3670076726342711,0.8722521453291954,1.0,5/22,11.89%,ABCG1;CLU;EPHA4;LYN;LRRTM3
prerank,pentose-phosphate shunt (GO:0006098),0.4842175314929943,1.0804329930359802,0.39274924471299094,0.8723980309187402,1.0,7/11,22.01%,PGD;PGLS;RPIA;DERA;RPE;TKT;TALDO1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.34453988894981064,1.0804079017404957,0.32621951219512196,0.8717852609506694,1.0,23/151,12.35%,NOD2;CCL7;SLAMF1;SPRY2;KDR;GAREM1;CCL5;FBXW7;CX3CL1;FGFR2;MT3;RAPGEF2;ACKR3;APP;HMGB1;BMPER;ROR2;ARRB2;CIB1;CCL14;HTR2A;PTPN11;APOE
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4367951624311185,1.0800364819649886,0.3775,0.8722805024088296,1.0,3/22,9.99%,NOD2;WNT5A;SPHK2
prerank,regulation of organelle assembly (GO:1902115),0.3649773569321937,1.0798226334118755,0.3607456140350877,0.8722930899331076,1.0,31/73,28.47%,CENPJ;TBC1D1;RNF4;HCK;UBQLN2;RABEP2;VPS11;TBC1D8;CYLD;TRAPPC12;NPM1;GSN;DYNC2LI1;DYNLT2B;CEP295;TBC1D2;DCDC2;NPRL2;NPRL3;SGSM3;TSG101;MSN;IFT140;TBC1D2B;TBC1D20;TBC1D17;STX18;TBC1D15;PDCD6IP;CEP76;TBC1D9B
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.51505131736533,1.0798214335158953,0.38904899135446686,0.8709206875431822,1.0,6/10,25.44%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.51505131736533,1.0798214335158953,0.38904899135446686,0.8709206875431822,1.0,6/10,25.44%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.35210677797878115,1.079592454271853,0.35544041450777203,0.8709722064100632,1.0,14/113,8.98%,ISG15;CLTRN;ABCA1;GBP5;CLU;USP50;DHX33;BCL2L11;CHD1L;CDT1;SH3GLB1;SLF2;ERCC4;RBX1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.4394284765707317,1.0795361873227387,0.39948453608247425,0.8704604686004502,1.0,5/21,10.61%,MECP2;CDC25B;CCND1;RAD51C;NPM1
prerank,fatty acid catabolic process (GO:0009062),0.36536557842968087,1.0792339628529322,0.37777777777777777,0.8707321596819014,1.0,19/67,21.07%,MCAT;ABHD2;ACADL;ECI2;MCEE;AUH;LPIN2;ABCD1;PEX2;ABHD3;ACADS;PPARD;HADHA;ACAT1;PEX13;ACOX1;HADH;ABCD4;MMUT
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33888537783090494,1.0791800946046457,0.3033033033033033,0.8702332272592493,1.0,51/308,16.32%,EIF2AK2;LOXL2;IL15;AGT;ABCA1;CXCR4;WNT5A;PER2;ESRRB;PIK3CD;GADD45G;SLC27A1;AGO2;ACVR1;GRB10;MAD2L2;PTGER4;DYNC1H1;ACADL;SYDE1;SOX9;CTNNB1;SMAD2;SIRT6;BAMBI;GDNF;LEPR;B4GALT5;PDPN;SCX;BMPR2;LRPAP1;CCDC88B;XBP1;SORL1;SHLD1;PTPN11;PPARGC1A;APOE;PAXIP1;BAD;DAB2;JAK2;PRKCH;RREB1;EZH2;INPP5K;BMPR1A;SOX5;IL18;MTOR
prerank,negative regulation of JNK cascade (GO:0046329),0.4042981361535154,1.079094958256543,0.3709090909090909,0.8698161292010057,1.0,6/31,12.73%,TAOK3;DUSP3;CYLD;DACT1;MEN1;DUSP10
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4510776405410165,1.0789645477076484,0.3715469613259669,0.869561660497223,1.0,8/17,25.29%,SPRY2;DDIT4;INPP5K;CALM3;SPRED3;SPRED1;CALM2;SIRT2
prerank,bile acid biosynthetic process (GO:0006699),0.4338456865820064,1.0789463542411442,0.392,0.8689430394895356,1.0,8/24,20.66%,OSBPL7;CH25H;OSBPL3;CYP27A1;OSBPL9;OSBP;OSBPL2;CYP39A1
prerank,nitric oxide metabolic process (GO:0046209),0.47731162654557424,1.0786490242608042,0.38264580369843526,0.8691913034004273,1.0,3/14,10.24%,CYB5B;CYB5R3;GCH1
prerank,intestinal lipid absorption (GO:0098856),0.5014574351873748,1.0785925371221636,0.3746268656716418,0.868704157512137,1.0,2/11,18.10%,SOAT2;LDLR
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.42537054195676416,1.0784985751634188,0.36855345911949683,0.8683471049620568,1.0,8/26,14.95%,ZFP36;GAREM1;DUSP3;SOX9;SNAI2;ZFP36L1;PTPN11;INPP5K
prerank,regulation of osteoblast differentiation (GO:0045667),0.36349041600192444,1.0784945630329692,0.3600844772967265,0.8676788905862166,1.0,16/82,15.34%,SEMA4D;ACVR1;DDX5;ZHX3;SOX9;FGFR2;WNT7B;SNAI2;NBR1;BAMBI;BMPR2;MEN1;NELL1;PTCH1;RANBP3L;BMPR1A
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3806162537235482,1.0782211628908112,0.3812785388127854,0.8678866707170245,1.0,12/51,13.91%,WNT11;CD47;EVL;CX3CL1;CARMIL1;MYOC;CCDC88A;PPM1F;ARHGEF10;SYNPO;NRP1;RAC1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4780864968671907,1.078170599138432,0.37906647807637905,0.8673637447567688,1.0,4/14,14.72%,ZFP36;TARDBP;MAPK14;MYD88
prerank,cell cycle G2/M phase transition (GO:0044839),0.34818232921430503,1.0781237547509905,0.34496919917864477,0.8668502291818911,1.0,34/130,18.83%,PKMYT1;SKP1;CENPJ;CHEK2;ARPP19;CDC25B;DYNC1H1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;KDM8;HSP90AA1;MASTL;TUBB4B;PPME1;PPP2R2A;DCTN3;PAFAH1B1;BRSK1;CEP135
prerank,activation of protein kinase A activity (GO:0034199),-0.36396060809687425,-1.077747071917524,0.34539473684210525,1.0,1.0,4/16,6.48%,ADCY9;PRRC1;ADCY3;PRKACB
prerank,phospholipid translocation (GO:0045332),0.4179112679249113,1.077431288963088,0.3774752475247525,0.8683675296572538,1.0,6/28,15.76%,ATP10A;ABCA1;ATP8A1;ABCC1;ATP11A;ATP9B
prerank,body fluid secretion (GO:0007589),-0.37357536343914793,-1.0773225249944753,0.3709090909090909,1.0,1.0,10/15,48.73%,ZBTB7B;GUCA1B;GPAT4;NPR1;APLN;VIP;PRLR;OXTR;CSN3;SLC22A2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.39398850400376034,-1.0770009699459933,0.3395061728395062,0.998232656980149,1.0,3/12,11.67%,GPR183;MFNG;LFNG
prerank,calcium ion import into cytosol (GO:1902656),0.48013417452411694,1.0768046905969484,0.3991477272727273,0.869653879396239,1.0,3/15,12.84%,TRPM2;SLC8A1;TRPV4
prerank,histone H3 deacetylation (GO:0070932),0.46388416263371934,1.076750371463244,0.3816901408450704,0.8691273079591121,1.0,9/15,25.36%,PER2;SIRT6;HDAC8;HDAC1;PER1;HDAC2;HDAC4;SIRT2;SMARCAD1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3343577064075784,1.076748009393718,0.194,0.8684621217865617,1.0,170/834,18.57%,STAT1;CXCL10;NLRC5;IRF7;HELZ2;PITX2;NAMPT;GAL;LMX1A;NR1H2;NOD2;USF2;PCGF5;MEF2B;WNT5A;TFAP2C;ZBTB17;ESRRB;RARG;DDRGK1;AGO2;RBM14;RNF4;CD40;NFKB2;CDH13;ACVR1;STAT3;ACTR2;RBL1;SFRP2;ELK3;RUNX1;RBMX;KLF15;DHX36;MZF1;JUNB;NCOA1;SOX9;CTNNB1;CX3CL1;CDK12;PFKM;KMT2A;PAXBP1;CCNT2;ZNF76;MYDGF;MEPCE;FGFR2;TCF7L2;TCF4;NFKB1;CREBRF;ASXL3;ZBTB38;SETD3;THAP3;USF1;ACTR3;TFAP2B;UBP1;DHX9;SRF;HTATIP2;SMAD2;MRTFA;GLIS3;MEIS3;ATF6B;TFDP1;LPIN2;NCK1;LMO2;MET;GDNF;ATF1;NFIB;METTL23;APP;SCX;HMGB1;NCK2;ELF4;CRTC1;MAML2;AGRN;BMPR2;MEN1;BPTF;RORA;MED12;PROX1;TNIP1;PHIP;ZC3H12A;NPM1;MAX;SNW1;NOTCH4;MITF;GALR1;XBP1;TFDP2;IER5;ECD;KLF10;LDB2;LDB1;REL;PPARGC1A;PRKDC;NR3C1;PAXIP1;PRDM4;E2F4;APBB1;HDAC8;ST18;MYO6;POGZ;DAB2;BCL11B;SMARCA1;CASZ1;SOX2;TNIP2;TFR2;RREB1;TET2;MYB;CRTC3;CAMTA2;BMPR1A;TLR2;SMARCD2;NPAT;ARF4;MEF2A;PPARD;TNIP3;LAGE3;IL18;LMO7;SREBF1;CCNK;ZBED4;KAT8;RBPJ;MED16;CHCHD2;ELF1;MPND;IER2;RRP1B;TLR3;PELP1;ZBTB49;POU2F2;ZNF513;PTOV1;ACVR2A;FOSL2;HDAC1;HINFP;GABPB1;GABPB2;MED10;HOXA5
prerank,endocardial cushion development (GO:0003197),0.4476324631354527,1.0767227212575476,0.3849056603773585,0.867863349969421,1.0,6/21,23.22%,ACVR1;SOX9;BMPR2;BMPR1A;ACVRL1;NOTCH1
prerank,positive regulation of macrophage migration (GO:1905523),0.4473092833761072,1.0767122949415393,0.39867549668874175,0.8672250643649156,1.0,6/19,16.89%,CCL5;CX3CL1;CSF1;P2RX4;CXCL17;MDK
prerank,regulation of ERBB signaling pathway (GO:1901184),0.4635491760992093,1.0767089139618864,0.38239339752407153,0.8665628997443899,1.0,6/15,16.78%,CDH13;PTPN18;MVB12A;WDR54;RHBDF2;RBPJ
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3392120702189526,-1.0764903005534823,0.3173913043478261,0.9964191542939541,1.0,8/22,24.66%,SORBS1;PPARG;AKT1;CREB1;CREBL2;DISP3;IL1B;EEF1A2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4609605192877799,1.0761170536909452,0.3911806543385491,0.8677996295157763,1.0,7/15,22.77%,ACTR2;ACTR3;ARPC5;WHAMM;ARPC1B;JMY;IQGAP2
prerank,cellular component assembly (GO:0022607),0.3398912231534752,1.075847627421752,0.30360721442885774,0.8679884764690241,1.0,52/253,16.62%,SYCP1;PML;HAS3;WNT5A;GPAA1;TEAD2;CD40;HAS1;YTHDF1;LAMC1;PARVB;MDN1;CHCHD10;TLCD2;TSPAN4;CCDC40;SOX9;CYFIP1;TAPBP;RHOJ;KMT2A;STX7;SKAP2;DET1;AIF1L;YTHDF2;MNAT1;VCPIP1;TEX11;CHAF1B;SPEF1;SNX9;MITF;GSN;LRRTM3;PPARGC1A;LIMS1;VAMP2;CORO1B;BSN;RAC1;ACTB;IL1RAP;STK25;SH3BP1;BAIAP2;AIF1;NLGN3;OPHN1;BAIAP2L1;LLGL1;WDR19
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.49250601837723,1.0757293390913398,0.386685552407932,0.867661429668598,1.0,7/12,28.73%,BCL2L11;XBP1;BAX;ERN1;ATF6;PTPN1;PIK3R1
prerank,negative regulation of cellular protein localization (GO:1903828),0.40120621542509366,1.0757070155697832,0.3678571428571429,0.8670629540340589,1.0,7/34,11.70%,ILRUN;SNX33;ACTN2;CDT1;LEPROT;UBXN2B;LEPROTL1
prerank,protein localization to organelle (GO:0033365),0.34473454478563115,1.0756978115110614,0.3425357873210634,0.8664305662338879,1.0,30/133,19.10%,ISG15;GBP5;TOR1AIP1;AUP1;DDRGK1;GBP2;LAMP2;COG3;FAM83H;SNX10;DHX9;TUB;CNTLN;PAQR3;APP;TRAM2;PRNP;WDR35;ARL1;SORL1;ZNF423;VAMP2;BBS2;RPL11;RAB11A;LAMP1;TULP3;GBF1;SERP1;CD68
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.46635326024043794,1.0752923568840551,0.3911917098445596,0.8670368280242724,1.0,3/16,5.43%,TRIB3;ACADL;SOX9
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.35375655500227354,1.0750630403783517,0.35867237687366166,0.8670570320690396,1.0,15/95,10.06%,EXT1;XYLT2;HAS3;HYAL1;SDC3;SDC4;HAS1;FMOD;B4GALT4;B4GALT1;CSPG4;B4GALT5;AGRN;ST3GAL1;CSGALNACT2
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2659806913802024,-1.0749225803992593,0.3028169014084507,0.9982597575840157,1.0,18/49,17.59%,MAP3K20;NBN;USP28;CEP63;BCL3;RHNO1;BATF;NDRG1;CASP9;DONSON;HUS1;RAD17;TP53;CLSPN;ACER2;E2F1;STK33;RAD1
prerank,inhibitory synapse assembly (GO:1904862),0.5020994627608084,1.0748214230798823,0.3801526717557252,0.8671312697730998,1.0,5/11,21.79%,WNT5A;FGF13;LGI2;CBLN4;GABRB2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5114007753258538,1.074300122708783,0.39274924471299094,0.868079796772087,1.0,2/10,6.57%,GRB10;MT3
prerank,positive regulation of actin filament polymerization (GO:0030838),0.38239623092801456,1.074087037371092,0.37203791469194314,0.8680443991288405,1.0,11/44,16.36%,HCK;EVL;CARMIL1;NCK1;NCK2;SNX9;GSN;PRKCE;WHAMM;BAIAP2;BAIAP2L1
prerank,dopamine metabolic process (GO:0042417),-0.3422141873132599,-1.0740222106200803,0.376425855513308,0.9978570374981511,1.0,11/18,36.28%,SNCAIP;SNCA;TGFB2;MAOA;MAOB;DRD2;MOXD1;PRKN;DRD3;LRTOMT;DAO
prerank,response to organonitrogen compound (GO:0010243),0.3917706961533589,1.0736806442422147,0.36798088410991636,0.8686247438579866,1.0,13/38,25.01%,DHFR;TRPM2;RNF5;RRAGC;GLRA2;RNF185;MTOR;KAT7;GLRA1;KYNU;IRF5;VCP;HLCS
prerank,negative regulation of T cell activation (GO:0050868),0.40142273094345166,1.0736144779985437,0.3808948004836759,0.8681462427816609,1.0,5/35,12.87%,CD274;SDC4;DUSP3;HAVCR2;FCGR2B
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5029004173500542,1.0734873722685083,0.39824304538799415,0.8678846748666891,1.0,3/11,13.89%,UQCRQ;UQCR10;CYC1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.47993970085157683,1.0733345810620203,0.3875862068965517,0.8676865497599114,1.0,3/13,12.85%,TPST1;SULT6B1;ENPP1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.26322977869444153,-1.0732937512811687,0.33043478260869563,0.9967595912151503,1.0,16/57,11.41%,DLGAP1;GRIN2A;GRIN2B;LRRC7;CACNG7;DLG4;SHISA9;GRIN1;OPRM1;DAPK1;DLG3;NLGN2;SHISA6;CACNG8;GSG1L;PRRT1
prerank,bicellular tight junction assembly (GO:0070830),-0.2801700463105837,-1.073223432714994,0.3284671532846715,0.993297220927693,1.0,22/46,35.32%,PAK2;ARL2;APC;PRKCI;F11R;ECT2;MARVELD2;STRN;CLDN14;PECAM1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;MPP7;CLDN5
prerank,axon guidance (GO:0007411),0.34223897065570513,1.0731471761558544,0.3248730964467005,0.8675932050233889,1.0,42/201,16.35%,PLXNA3;UNC5B;CXCR4;WNT5A;PLXNB2;BDNF;PIK3CD;SEMA4D;NRP2;GRB10;DOK1;SIAH1;GAP43;PLXNB3;EVL;CYFIP1;EPHA4;RET;DOK6;DOK5;EPHA6;GDNF;NFIB;RAP1GAP;GFRA2;LYPLA2;SLIT3;SLIT1;SOS1;PTPN11;CHN1;PIK3CB;NRP1;RAC1;FYN;IRS2;NPTN;DSCAM;DSCAML1;SEMA3D;SCN1B;OPHN1
prerank,regulation of protein localization (GO:0032880),0.37594918101459784,1.072789363435789,0.37250554323725055,0.8680457832122205,1.0,13/58,14.87%,TRIM14;TRIM25;TRIM21;RSL1D1;HSP90AB1;FBXW7;DNAJB6;PPM1F;RAB14;RACK1;PLEKHM2;DLG1;HSP90AA1
prerank,cartilage development (GO:0051216),0.3895313400211442,1.0727581150059766,0.37528344671201813,0.8674782783866056,1.0,12/49,16.05%,HYAL1;DDRGK1;RUNX1;SOX9;ITGB8;SNX19;NFIB;SCX;COL11A2;TRPV4;SOX5;FGFR3
prerank,mitotic cell cycle phase transition (GO:0044772),0.3405956206673585,1.072202283150521,0.33232931726907633,0.8684997242537045,1.0,50/204,18.83%,PKMYT1;CHMP4B;SKP1;CENPJ;CHEK2;ACVR1;CUL5;ARPP19;CDC25B;CCNJ;DYNC1H1;CCND2;GSPT1;CDKN2D;CACUL1;CCND1;ACTR1A;MAPRE1;TPD52L1;CDK5RAP2;PRKAR2B;TAF2;PLK3;MNAT1;BTRC;DNM2;PHLDA1;NEDD1;MAX;CEP131;CEP152;CDC16;CDC27;CEP70;AKAP9;RB1;DYNLL1;CCNI;KDM8;HSP90AA1;MASTL;USP37;TUBB4B;PPME1;PPP2R2A;DCTN3;PAFAH1B1;HINFP;BRSK1;CEP135
prerank,recombinational repair (GO:0000725),0.3635204829113212,1.0714444608176301,0.3671444321940463,0.8702326286461639,1.0,18/77,15.30%,SAMHD1;ZSWIM7;SEM1;AP5Z1;HELQ;KDM4D;MCM9;RAD51C;FEN1;ERCC4;XRCC3;ZFYVE26;POLQ;NSMCE2;NSMCE1;GEN1;RMI1;RECQL5
prerank,positive regulation of cellular process (GO:0048522),0.3341838228983312,1.0713988840739619,0.251,0.8696945999890249,1.0,99/565,16.08%,NAMPT;IL15;CRLF1;FLT1;SLAMF1;IL15RA;HYAL1;WNT5A;IRS1;KDR;ZFP36;GAREM1;DDRGK1;GDF9;CXCL16;MECP2;KITLG;TGFA;CDC25B;AQP11;TRIM21;S1PR2;MMP14;SFRP2;FXN;ADAM8;DDX49;CD47;DYNC1H1;HCK;NACC1;CCL5;CCND2;CHEK1;CNOT7;DHX36;TIPIN;HSP90AB1;CACUL1;SOX9;CX3CL1;CCND1;EPHA4;FGFR2;MT3;TFAP2B;CSF1;TBC1D8;SRF;TUB;MEIS3;CTSH;IL12RB2;BAMBI;LYN;CST7;GDNF;P2RX4;PDPN;SCX;INSR;MLC1;PROX1;PHIP;ECHDC3;PRR7;CIB1;DUSP26;ZC3H12A;NPM1;FAM98B;ZFP36L1;CCL14;CEP131;VEGFD;FGF9;RTKN2;XBP1;IER5;NOP2;CAPNS1;FCGR2B;RPS6;CAPN1;CHTOP;RAC1;STX4;EXOSC9;SERTAD1;NSMCE1;IRS2;EZH2;NCBP1;TLR2;ADNP2;PRMT1;ACER3;FGFR3;AIF1
prerank,extracellular matrix assembly (GO:0085029),0.42585849226473294,1.0711958382677969,0.4071246819338422,0.8696422090135917,1.0,3/23,3.81%,HAS3;HAS1;LAMB2
prerank,negative regulation of protein processing (GO:0010955),0.4874088085624778,1.0702664831264257,0.402002861230329,0.8718218707010741,1.0,4/12,23.74%,PRNP;GAS1;TMEM59;SNX12
prerank,toxin transport (GO:1901998),0.49702983308945803,1.070141654041831,0.3949329359165425,0.8715411707791136,1.0,5/10,31.16%,ANTXR1;ANTXR2;RAB29;ADAM10;RAB40B
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3625090683570868,1.0700580901009067,0.3681917211328976,0.871131959631366,1.0,14/77,12.75%,NOL3;CLU;BDNF;ACVR1;ASAH2;FXN;CX3CL1;CFLAR;TCF7L2;CSNK2A2;PHIP;RTKN2;PSME3;RB1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4631992243413027,1.0698092590618133,0.3877551020408163,0.8712463562260098,1.0,3/15,11.22%,KDR;CDH13;VEGFD
prerank,synapse assembly (GO:0007416),0.3630689318812389,1.069531688921668,0.37402885682574916,0.8714398051290921,1.0,14/67,16.20%,SLITRK6;PCDHB13;WNT5A;PLXNB2;BDNF;SDK1;LRRTM3;PCDHB16;FGF13;DNER;LGI2;DBNL;DSCAM;NLGN3
prerank,positive regulation of cell aging (GO:0090343),0.5026258475183909,1.0692720211170754,0.3975720789074355,0.8715728245433282,1.0,4/11,16.67%,B2M;CGAS;YPEL3;EEF1E1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3116629469841955,-1.0691564326246512,0.3068181818181818,1.0,1.0,8/29,11.62%,PAK1;UBA5;CBFB;ESR1;KANK2;UFM1;BRCA1;GPAM
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.37288651650811455,-1.068932475483103,0.3709677419354839,1.0,1.0,3/15,19.10%,QDPR;KMO;IL4I1
prerank,protein targeting to mitochondrion (GO:0006626),0.37711603691486056,1.0689309621843635,0.3804100227790433,0.8719711033921226,1.0,14/52,17.51%,FIS1;FBXO7;TOMM40L;GDAP1;TOMM5;TIMM50;SAMM50;HSPA4;TSPO;PITRM1;AIP;HSP90AA1;TOMM40;MIPEP
prerank,regulation of defense response to virus (GO:0050688),0.47626800992239293,1.0688342680249734,0.3848396501457726,0.8716003603199034,1.0,3/14,9.91%,ILRUN;DHX9;TRAF3
prerank,regulation of cell junction assembly (GO:1901888),0.42594683888310264,1.0686318080969022,0.3929471032745592,0.8715810594688717,1.0,8/27,15.11%,MYO1C;RUNX1;SNAI2;RAPGEF2;SETD5;RAPGEF1;PRKCH;CHRNB2
prerank,positive regulation of glucose import (GO:0046326),0.43656509225271006,1.0682310962832124,0.3858267716535433,0.8720937814005087,1.0,6/21,14.64%,IRS1;ARPP19;OSBPL8;INSR;PTPN11;IRS2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.34901136469370453,1.0679703930404498,0.36907216494845363,0.8722546196669643,1.0,25/110,17.13%,EIF2AK2;IRGM;ABCA1;CLU;BCL2L11;HCK;NOP53;CDT1;SH3GLB1;SLF2;HSPA8;RIOK3;SORL1;GSN;PTPN11;APOE;SVIP;RB1;RACK1;NAPB;NAPA;HSP90AA1;BMF;PEX5;BAX
prerank,regulation of cell death (GO:0010941),0.35217289940018115,1.067943720341156,0.37122002085505734,0.871678672656782,1.0,17/94,15.93%,HSPA1B;WNT11;CHMP4B;CLU;CCL5;RILPL1;MT3;NCK1;LRPAP1;SPEF1;PRR7;ZC3H12A;SRGAP2;DUS2;NOA1;ADNP2;ACER3
prerank,regulation of phagocytosis (GO:0050764),0.374566718605788,1.0677987952297128,0.39724454649827784,0.8714579592069813,1.0,12/53,20.11%,IL15;IL15RA;CD47;HCK;SYT7;TUB;FCGR2B;RACK1;TLR2;PTPRC;SIRPA;TGM2
prerank,positive regulation of cation channel activity (GO:2001259),0.39137136245072424,1.067416979450856,0.39354066985645936,0.8719329086553901,1.0,7/40,17.43%,GAL;CTSS;ACTN2;CALM3;NLGN3;STAC3;ATPSCKMT
prerank,blood vessel diameter maintenance (GO:0097746),0.3949398275165925,1.0668512998626087,0.37515527950310557,0.8730459997732897,1.0,2/34,1.59%,AGT;PER2
prerank,regulation of TORC1 signaling (GO:1903432),-0.29579524508041555,-1.0667419779446876,0.35911602209944754,1.0,1.0,6/33,7.56%,GPR137C;GPR137B;RRAGD;RRAGB;CASTOR2;LARS1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4989141884581462,1.0667188407116812,0.3988522238163558,0.872151654318635,1.0,4/11,10.73%,MEPCE;CCT4;CCT7;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4989141884581462,1.0667188407116812,0.3988522238163558,0.872151654318635,1.0,4/11,10.73%,MEPCE;CCT4;CCT7;CCT3
prerank,coenzyme A metabolic process (GO:0015936),0.46678003033828663,1.0666120022005836,0.38966480446927376,0.8718144929039202,1.0,6/14,22.33%,PPCS;SLC25A16;PANK2;ACAT1;DCAKD;PPCDC
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4234563631013868,1.066508511394989,0.3879849812265332,0.8714770847276607,1.0,7/26,18.30%,ASAH2;CYB5B;CYB5R3;SPHK2;GCH1;ACER3;SPTLC2
prerank,cellular component maintenance (GO:0043954),0.4852809714840188,1.0663593820157435,0.38552437223042835,0.8712878117056749,1.0,4/12,14.33%,ITGA3;INSR;PRNP;FYN
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.38138240654472244,-1.0663148749532942,0.348993288590604,1.0,1.0,8/15,24.13%,UST;VCAN;CSGALNACT1;BGN;DSEL;DCN;BCAN;CSPG5
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3434129452581997,1.0663075550350471,0.3588667366211962,0.8707970144771732,1.0,37/138,21.65%,AXL;FLT1;KDR;BDNF;LCP2;HCK;EPHA4;FGFR2;CSF1;RET;NPPC;EPHA6;BCAR1;LTK;MET;LYN;INSR;BMPR2;GFRA2;ROR2;STAP1;PIK3CB;RAPGEF1;JAK2;FYN;FGFR3;BLNK;PTPRU;MPZL1;ACVR2A;POLR1G;NPR2;PTPRF;DDR2;LCK;YES1;ROR1
prerank,anterograde axonal transport (GO:0008089),0.38877783924480314,1.0662892360184866,0.3866822429906542,0.8701941424113996,1.0,7/37,12.10%,BLOC1S4;RAB21;TRAK1;KIF3B;MAPK8IP3;AP3M2;AP3S2
prerank,cellular response to fatty acid (GO:0071398),0.4840904713209632,1.0662015606650694,0.413075780089153,0.8698018457728045,1.0,2/12,10.58%,IRS1;ZC3H12A
prerank,embryonic skeletal system development (GO:0048706),0.40264067292043826,1.0661912721681885,0.39408866995073893,0.8691788448366277,1.0,4/35,10.12%,WNT11;WNT5A;HOXA9;KIAA1217
prerank,negative regulation of endopeptidase activity (GO:0010951),0.3792189197860265,1.066143537350798,0.3927355278093076,0.8686640817332556,1.0,5/47,11.65%,AGT;SERPINC1;MT3;TIMP2;SORL1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.38138488275823407,-1.0658600681024835,0.3522727272727273,1.0,1.0,7/15,20.33%,FLOT1;EHD1;CAMK1;TREM2;RIPOR2;RAPGEF3;ADAM9
prerank,Golgi organization (GO:0007030),0.3506593168171712,1.0654071776652498,0.3747412008281574,0.8702563463646913,1.0,39/112,23.13%,VPS51;BLZF1;TJAP1;COG3;GOLGA8B;GOLGA5;SEC16A;GOSR2;ARHGEF7;CUL7;TMED5;FBXW8;RAB43;PLK3;UBXN2B;STX16;VCPIP1;TMED10;TRAPPC12;COG2;ARL1;ARHGAP21;VTI1B;PLEKHM2;VAMP4;STK25;DYNC2H1;TMED1;TMED3;GBF1;GOLPH3L;GORASP2;RAB1A;TMED7;OPTN;HUWE1;RAB2A;STX6;RAB29
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4546999554447131,1.0650426392721886,0.39355742296918766,0.8707118447224105,1.0,5/16,11.57%,DHX36;RTEL1;HNRNPA2B1;ERCC4;SMG5
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.39383741048649445,-1.0649050909920459,0.3835616438356164,1.0,1.0,4/14,13.97%,TMBIM6;SELENOS;HERPUD1;CREB3
prerank,brain development (GO:0007420),0.3408010175963213,1.064868632147583,0.37104994903160043,0.8705819243007371,1.0,30/136,16.49%,VPS51;CXCR4;PLXNB2;GRIN2D;PAFAH1B3;SYNJ1;PHGDH;CIC;PITPNM1;UBE3A;TBC1D23;MEIS3;RAPGEF2;CDK5RAP2;NFIB;BPTF;PROX1;DNAJC30;SCYL2;DDIT4;PTPN11;ATXN1;PTCH1;SMARCA1;CTNS;POU6F1;BBS2;DSCAML1;NDUFS4;DHX37
prerank,telomere maintenance (GO:0000723),0.37637255971294853,1.0646009581012845,0.3788748564867968,0.87068786379039,1.0,9/50,14.34%,SP100;TPRKB;POLD4;RTEL1;ERCC4;XRCC3;PRKDC;STN1;NSMCE2
prerank,protein localization to Golgi apparatus (GO:0034067),0.41432748852573786,1.0645667571824726,0.40601503759398494,0.8701410008409961,1.0,11/27,21.28%,GBP5;PAQR3;TMED10;ARL1;SORL1;ARL5C;VPS13D;VPS13A;GBF1;VPS13C;OPTN
prerank,regulation of cellular response to heat (GO:1900034),0.35869024483027945,1.064319612154868,0.3900862068965517,0.8702411347561421,1.0,21/77,20.35%,HSPA1B;CAMK2D;NUP37;CAMK2B;NUP153;HSP90AB1;RAE1;HSPA8;DNAJB6;CHORDC1;IER5;BAG1;AKT1S1;NUP155;HSP90AA1;MTOR;PTGES3;NUP88;HSBP1;NUP133;NUP43
prerank,cellular senescence (GO:0090398),0.4189079608023971,1.0639949539217626,0.3882646691635456,0.8706225405587689,1.0,9/27,22.93%,PML;ECRG4;SRF;MAPK14;NSMCE2;TERF2;PRKCD;OPA1;KAT6A
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.34472228082841955,-1.0638791153394602,0.35648148148148145,1.0,1.0,3/22,3.11%,PDE3B;APOD;ALK
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3694840255265037,1.0634296154569645,0.3931718061674009,0.8716403939671908,1.0,11/62,11.49%,MOV10;DPY30;MYL9;RBBP5;RUNX1;CNOT4;KMT2A;LYN;HOXA9;WDR5;EIF6
prerank,hemopoiesis (GO:0030097),0.35753858864896526,1.063239053485157,0.3950749464668094,0.8715334690544221,1.0,16/87,11.37%,FLT1;WNT5A;KDR;KITLG;SBDS;SFRP2;RUNX1;YJEFN3;KMT2A;FGFR2;ETV6;MFAP5;YTHDF2;FUT10;NOTCH4;RTKN2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.35269080989726537,1.06318254584914,0.38306878306878306,0.871050573435567,1.0,19/93,14.95%,IRGM;SPRY2;BDNF;SFRP2;MAD2L2;HSP90AB1;TNKS1BP1;MTCP1;PAQR3;CNKSR3;NCK1;APP;NCK2;PPM1F;DDIT4;AKAP9;RACK1;HSP90AA1;INPP5K
prerank,liver development (GO:0001889),0.40207718244901736,1.0626687764053344,0.40296662546353523,0.8719378297462301,1.0,7/32,11.45%,GFER;ARID5B;CCDC40;NPHP3;MET;PROX1;XBP1
prerank,positive regulation of receptor internalization (GO:0002092),0.42870538400950453,1.062619984613018,0.41825613079019075,0.8714375016749563,1.0,5/22,17.41%,MAGI2;INSR;ARRB2;SCYL2;ATAD1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.4597532836141805,1.0626029258046086,0.4084507042253521,0.8708323874132239,1.0,2/14,5.02%,SLAMF1;TLR8
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.35183041910430957,1.062566991442385,0.38995726495726496,0.8702950039959712,1.0,26/88,18.53%,BLOC1S4;GOLGA7;KLHL20;AP2A1;AP1S1;DOP1B;APP;KIF16B;HSPA8;DNM2;RAB14;EXOC6;SORL1;CORO7;SCFD1;ARFGEF2;VAMP2;NAPA;STX4;SNAP23;HGS;LLGL1;VPS13A;SH3D19;GBF1;DTNBP1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.4225081396739693,-1.0622001409111002,0.38636363636363635,1.0,1.0,6/10,26.12%,HMOX1;HOXA7;CD200R1;CD200;BMP5;EMILIN1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.27918216139289953,-1.062125943609647,0.34306569343065696,1.0,1.0,14/40,21.81%,IMPACT;REST;BRINP1;MMD2;RHOA;ARHGEF2;BRINP2;HOXD3;NRCAM;ZC4H2;ECT2;NBL1;MEF2C;TCF3
prerank,apical protein localization (GO:0045176),-0.4249516626031661,-1.06187527561967,0.38109756097560976,0.9980499536542985,1.0,2/10,1.44%,ATP8B1;GOPC
prerank,regulation of cellular response to stress (GO:0080135),0.34751969902672797,1.0617915605406523,0.40041710114702816,0.8719704806968862,1.0,26/115,17.52%,HSPA1B;CAMK2D;NUP37;PNPT1;CAMK2B;SLC38A2;CRHBP;NUP153;RSL1D1;HSP90AB1;AMFR;RAE1;ABCD1;HSPA8;DNAJB6;NPM1;CHORDC1;NEK6;BAG1;AKT1S1;NUP155;HSP90AA1;MTOR;CHCHD2;PTGES3;NUP88
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.48676944098451363,1.0616246043479978,0.40772532188841204,0.8718505181401494,1.0,3/11,16.65%,ACTN2;CAB39;STK39
prerank,positive regulation of stem cell differentiation (GO:2000738),0.46141183198338853,1.061448111714049,0.4199192462987887,0.8717937143108473,1.0,3/16,15.46%,DHX36;SOX9;SOX5
prerank,calcium-mediated signaling (GO:0019722),0.35571404147743524,1.0611439188312688,0.38181818181818183,0.8720724002986275,1.0,12/93,9.51%,IRGM;CXCR4;KDR;TRPM2;FIS1;RCAN1;SLC8A1;PPP1R9A;SAMD14;ACKR3;P2RX4;PRNP
prerank,response to estrogen (GO:0043627),0.4048611494891946,1.0610815547346673,0.38681592039800994,0.8716285677039952,1.0,4/31,5.44%,TRIM25;RBBP5;CRHBP;SRA1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.48432794319097844,1.0609365312506924,0.42877906976744184,0.8714027493248258,1.0,4/13,14.48%,NFKB1;DKK3;APOE;ERLIN2
prerank,actin nucleation (GO:0045010),0.4251303478955087,1.0607253236598475,0.3962516733601071,0.8713959407312891,1.0,7/21,22.77%,ACTR2;ACTR3;ARPC5;WHAMM;ARPC1B;JMY;IQGAP2
prerank,neural tube closure (GO:0001843),0.39967191430618365,1.060624364823124,0.40898058252427183,0.8710532477350641,1.0,4/34,5.37%,MTHFR;PLXNB2;LRP2;PRICKLE1
prerank,regulation of humoral immune response (GO:0002920),0.3802606756349058,1.0604678581895977,0.39376443418013857,0.870884415350788,1.0,7/44,16.23%,CLU;C4B;CD55;SUSD4;C3AR1;FCGR2B;C1QB
prerank,endocytic recycling (GO:0032456),0.3696476593686037,1.0604674450187324,0.387458006718925,0.8702447963069151,1.0,21/50,26.20%,VPS51;VPS53;DENND1A;RAB11B;RAB14;ANKRD27;VPS50;VPS52;CMTM6;VPS26A;DENND1B;ENTR1;VPS35;ACAP2;STX6;VPS39;SNX17;SNX12;ARL4C;PTPN23;SNF8
prerank,organic anion transport (GO:0015711),0.3615984721693697,1.0603952421197367,0.4095744680851064,0.8698248880610707,1.0,16/76,20.40%,CA4;CYB5R2;SLCO1C1;SLC2A6;SLC25A19;SLC19A1;SLC52A2;SLCO1B1;SLC35B1;SLC35B4;CA2;SLC35A3;SLC4A2;SLC35C2;ABCG2;ABCC5
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.39197645142920856,1.0602823699325523,0.3828502415458937,0.8695115892681852,1.0,8/38,9.51%,AGT;THY1;EPHA4;DOK7;FCGR1A;APP;NCK2;PRNP
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.42235732142300103,1.060160536106026,0.38423028785982477,0.8692362617867078,1.0,5/25,14.87%,CLU;HSP90AB1;P2RX4;INSR;HSP90AA1
prerank,intraciliary retrograde transport (GO:0035721),0.4820835873701718,1.0593239913322505,0.43001443001443,0.8710788216508415,1.0,7/12,26.76%,WDR35;DYNC2LI1;DYNLT2B;WDR19;DYNC2H1;IFT140;IFT43
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.44549431520496063,1.0592843728746286,0.40915208613728127,0.8705633207698966,1.0,4/18,10.20%,FPR3;BCAR1;LYN;C3AR1
prerank,regulation of epithelial cell migration (GO:0010632),0.38147748979472157,1.05891262995346,0.4015748031496063,0.8710041203441558,1.0,15/51,18.05%,HYAL1;SASH1;EVL;SOX9;RHOJ;CTSH;BMPER;BMPR2;PPM1F;DUSP10;PRKCE;RREB1;MCC;RAB11A;CORO1C
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3750716827914729,1.0588784078446012,0.3911525029103609,0.8704688939796175,1.0,16/48,23.08%,PPCS;SLC26A1;ADCY5;ADCY10;SLC25A16;NPPC;SLC26A2;ADSL;PANK2;ACAT1;AMPD3;NPR2;AK5;DCAKD;PPCDC;ADCY7
prerank,positive regulation of transferase activity (GO:0051347),0.34035932211470904,1.0588534973396009,0.3780737704918033,0.8698963427884578,1.0,22/142,9.96%,AXL;FLT1;DTX3L;TRIB3;KDR;ARRDC4;HSP90AB1;RFC4;POLG2;FBXW7;CTNNB1;EPHA4;FGFR2;RET;CCT4;EPHA6;HNRNPA2B1;DCUN1D4;LTK;MET;INSR;ROR2
prerank,negative regulation of immune response (GO:0050777),0.3404423690074189,1.0587537071898312,0.3730886850152905,0.869572144704266,1.0,19/154,12.87%,TRAFD1;CALCA;RXFP2;ILRUN;DHX58;NMI;TRIM21;ENPP3;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;COL3A1;HAVCR2;RHBDF2;FCGR2B
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.24597024168262482,-1.058612370952583,0.34,1.0,1.0,23/87,17.79%,TGFB1;ZMIZ2;PTPRK;HPGD;USP9X;PXN;TGFBR3;PRKCZ;TWSG1;SIRT1;TGFB2;COL1A2;UBB;SRC;RHOA;UBC;APPL1;CBL;SMAD6;UBA52;SMAD4;RPS27A;F11R
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3493036239979341,1.0574941837809098,0.3958115183246073,0.8727052696021859,1.0,21/98,17.82%,AGT;NR1H2;XDH;SLCO1C1;CCL5;MT3;CSF1;MAGI2;DHRS4;INSR;MAPK14;ARRB2;ZC3H12A;SCYL2;IL10RB;APOE;PPARD;ACOD1;CHCHD2;ATAD1;GHITM
prerank,atrioventricular valve development (GO:0003171),0.4695852116887559,1.0570858304474529,0.40558510638297873,0.873326437878035,1.0,4/14,15.34%,ACVR1;BMPR2;SLIT3;BMPR1A
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3873179962487963,1.0569159630020313,0.3952380952380952,0.8731801999668231,1.0,7/39,13.00%,PWP2;LTV1;NOB1;ERAL1;NPM1;RIOK3;RPS6
prerank,nitric oxide biosynthetic process (GO:0006809),0.4773180478884055,1.0568302073839158,0.3997134670487106,0.8728049034621459,1.0,3/13,10.24%,CYB5B;CYB5R3;GCH1
prerank,positive regulation of ERAD pathway (GO:1904294),0.4740370960345074,1.0565799213511504,0.3997134670487106,0.872898577599303,1.0,4/13,12.91%,RNFT1;UBQLN2;UBQLN1;RNF185
prerank,positive regulation of translation (GO:0045727),0.352234812311702,1.0565761714317625,0.3993610223642173,0.8722717623956087,1.0,23/94,18.73%,POLR2G;PLXNB2;AGO2;YTHDF1;LARP1;CCL5;DHX36;ZCCHC4;NGRN;RCC1L;DHX9;YTHDF2;NPM1;EIF6;PRKDC;TRMT10C;UPF3A;RBM3;MTOR;METTL14;JMJD4;EIF2B5;FASTKD2
prerank,acylglycerol homeostasis (GO:0055090),0.4433877456616803,1.0565452646970972,0.4148936170212766,0.8717230869396388,1.0,6/20,21.55%,LIPC;RORA;APOE;APOC4;IL18;PNPLA8
prerank,myotube differentiation (GO:0014902),-0.35149976632513863,-1.0565336888520063,0.38434163701067614,1.0,1.0,5/17,25.17%,KCNH1;JAM2;ADGRB3;MEF2C;NOS1
prerank,cellular copper ion homeostasis (GO:0006878),0.46860714735871817,1.0564482395635713,0.4147018030513176,0.8713761483606374,1.0,6/14,25.60%,APP;PRNP;COX19;SLC31A1;SLC31A2;ATP7B
prerank,mRNA transport (GO:0051028),0.3504323041129043,1.0552173062202703,0.40380549682875266,0.8744999599180134,1.0,31/101,21.86%,NUP37;ZFP36;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;ZFP36L1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.43978120944836013,1.0551278738927603,0.4077025232403719,0.8741471489025203,1.0,4/18,11.89%,ABCG1;CLU;EPHA4;LRRTM3
prerank,production of siRNA involved in RNA interference (GO:0030422),0.507163504519624,1.0546116196259299,0.4223880597014925,0.8751191869545873,1.0,4/10,17.17%,AGO2;TARBP2;DICER1;PRKRA
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3321278622895696,1.0545299738541798,0.34734734734734735,0.8747054599923689,1.0,62/327,16.59%,PML;THAP7;ESR2;DAPK3;MYBBP1A;DAXX;ESRRB;NFX1;SAP30L;ZFPL1;TEAD2;NFKB2;CHEK2;STAT3;ZFP37;CHD7;BHLHE40;NKX6-2;SRRT;MZF1;NFXL1;SERTAD3;PFDN5;ZNF2;NSD3;ZSCAN26;EDF1;ZBTB38;BACH1;NFATC2;SNAI2;SAP30;NONO;ACTR8;INSR;RORA;DNM2;NAB1;HCFC2;RALY;MITF;RYBP;ZNF423;LDB1;PPARGC1A;NR3C1;UBE2L3;RB1;ZNF35;ATXN1;APBB1;ASCC2;CASZ1;SOX2;RREB1;EZH2;MYB;MYCBP;GTF2IRD1;DENND4A;ZNHIT3;ZBTB4
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4543280084454937,1.0542558142620673,0.4165497896213184,0.8748298600746306,1.0,2/16,3.75%,CAMK2D;SLC8A1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.37153043435258765,1.0539304272258032,0.3967136150234742,0.8752012659760845,1.0,17/49,22.68%,FIS1;BCL2L11;SIAH1;CYLD;UBQLN1;RTKN2;RACK1;BAD;BMF;BAX;BECN1;BCAP31;DDX3X;LCK;PLAUR;MCL1;BCL2L2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.37836186947327355,1.0537536245026293,0.4048723897911833,0.8750897107091279,1.0,10/43,16.18%,IRS1;SOCS1;GRB10;NCK1;KANK1;SORL1;PTPN11;ENPP1;INPP5K;GKAP1
prerank,respiratory electron transport chain (GO:0022904),0.47111349383362505,1.053374215803215,0.4071942446043165,0.8756232562252911,1.0,4/14,14.80%,SLC25A22;NDUFA5;PPARGC1A;SLC25A12
prerank,regulation of protein import into nucleus (GO:0042306),-0.2950278623968084,-1.0532433816449327,0.35195530726256985,1.0,1.0,13/36,22.88%,TGFB1;APOD;EFCAB7;UFM1;CABP1;PIK3R2;ZIC1;UBR5;DMAP1;BAG3;ECT2;TPR;RBM22
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.49110764254100514,1.0528188958135727,0.42363112391930835,0.8766421000447349,1.0,4/11,17.83%,DHFR;GCH1;HSP90AA1;PRKG2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.47141980438927467,1.0527773236485005,0.42045454545454547,0.8761285964196921,1.0,1/12,1.21%,CAMK2D
prerank,microvillus assembly (GO:0030033),0.454696717851088,1.0521950700650753,0.4233983286908078,0.8771983340554682,1.0,6/14,19.49%,RAPGEF6;RAPGEF2;TNIK;FXYD5;MINK1;RAP2A
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3973043702598122,1.0518220293053582,0.40240963855421685,0.877687685043643,1.0,11/33,19.00%,HSP90AB1;RFC1;TNKS1BP1;RTEL1;GAR1;PPP6R3;TELO2;STN1;HSP90AA1;PTGES3;TERF2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3692292747471116,1.0515791294728676,0.40045766590389015,0.8777854229365032,1.0,17/51,19.82%,TAOK3;BDNF;CNTNAP1;GAS7;EPB41L3;TNIK;DNM2;ANKRD27;SRGAP2;MINK1;DBNL;TAOK2;NYAP2;DICER1;SNX1;DTNBP1;NCKAP1
prerank,negative regulation of cell differentiation (GO:0045596),0.3371922022959829,1.0513522415955752,0.3917004048582996,0.8778433809311722,1.0,31/181,14.91%,NR1H2;ABCA1;XDH;TRIB3;WNT5A;SPRY2;ABCG1;ESRRB;SEMA4D;SFRP2;MAD2L2;EID2B;SOX9;SRA1;NPHP3;SNAI2;NBR1;YTHDF2;BAMBI;HOXA9;MEN1;RORA;ADGRV1;NOTCH4;PTPN11;RB1;ENPP1;PTCH1;RANBP3L;SOX2;MYB
prerank,regulation of cell morphogenesis (GO:0022604),0.4028767682930087,1.0513277081411463,0.4027603513174404,0.877284045925242,1.0,9/30,17.74%,MOV10;FMNL2;PDPN;ZMYM3;PHIP;CAPZB;ZRANB1;ZMYM6;SH3D19
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.36209384190821625,1.0513055505780655,0.4039301310043668,0.8767168778122111,1.0,17/69,15.33%,AUP1;TRIM25;TMEM129;RNF5;UBQLN2;AMFR;TMUB2;UBQLN1;FAM8A1;RNF103-CHMP3;FAF2;RNF185;UBE4B;ANKZF1;ERLIN2;TMEM67;RNF103
prerank,cellular response to hydroxyurea (GO:0072711),0.4991391392462767,1.051014810788032,0.42433234421364985,0.8769523921406721,1.0,4/10,18.95%,TIMELESS;DDX11;RTF2;DDI2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3564323687551373,1.0510051475012434,0.4078807241746539,0.8763568102978799,1.0,17/83,15.74%,DHFR;ACVR1;CUL5;GSPT1;CDKN2D;CACUL1;CCND1;CDT1;BACH1;TFDP1;PLK3;MNAT1;MAX;TFDP2;RB1;USP37;NPAT
prerank,tight junction assembly (GO:0120192),-0.2682830629084016,-1.050766088695608,0.36764705882352944,1.0,1.0,23/49,35.32%,PAK2;ARL2;APC;PRKCI;F11R;ECT2;MARVELD2;LSR;STRN;CLDN14;PECAM1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;MPP7;CLDN5
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3474616898615873,-1.0503722692179422,0.33695652173913043,1.0,1.0,6/17,18.35%,DYRK1A;PTTG1IP;SIRT1;MIF;KDM1A;PSMD10
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.41158940622371665,1.0501882725991822,0.4163473818646232,0.8782152289843584,1.0,6/25,20.63%,AGT;DOK1;CCDC88A;RBPJ;ARAP1;PLAUR
prerank,positive regulation of cell projection organization (GO:0031346),0.3399020876782008,1.0501168645318104,0.39648033126293997,0.8778262705085803,1.0,28/115,18.44%,PLXNA3;WNT5A;PLXNB2;BDNF;CAMK2B;RETREG3;PLXNB3;CX3CL1;P3H1;CARMIL1;CUL7;RET;MAGI2;FBXW8;RAPGEF2;LTK;LYN;ROR2;CUX1;APOE;TIAM2;RAPGEF1;NPTN;SCN1B;MDK;STMN2;FUT9;CAPRIN1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.40610101997794135,1.0501055109704331,0.4086845466155811,0.877233492967799,1.0,6/27,11.82%,ZFP36;AGO2;STAT3;DDX5;DHX9;MAP2K2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4348395283331349,1.0500584222603673,0.41721854304635764,0.8767461856520978,1.0,6/20,17.17%,ZC3H7A;AGO2;TARBP2;ZC3H7B;DICER1;PRKRA
prerank,skin development (GO:0043588),0.36291338471583046,1.0495109334302524,0.3956043956043956,0.877757619354055,1.0,7/65,11.27%,CLIC4;WNT5A;ITGA3;PIP5K1A;COL5A3;MET;COL3A1
prerank,peptidyl-tyrosine modification (GO:0018212),0.367868459232365,1.0493825989578893,0.41609977324263037,0.8775260926145783,1.0,8/56,9.33%,TPST1;FLT1;KDR;HCK;EPHA4;FGFR2;LYN;INSR
prerank,microvillus organization (GO:0032528),0.46193458481972643,1.0493330050420644,0.41595441595441596,0.8770331837875703,1.0,6/13,19.49%,RAPGEF6;RAPGEF2;TNIK;FXYD5;MINK1;RAP2A
prerank,histone modification (GO:0016570),0.34183356297375533,1.0487141901671677,0.41412012644889357,0.8782687630151583,1.0,42/109,28.74%,EYA4;PRMT2;RBM14;MTA3;NAA50;USP21;UBE2B;NTMT1;NSD3;MT3;MTA2;ATXN7;MIER1;EZH2;RCOR3;PRMT1;KAT8;EYA2;ENY2;HDAC1;SGF29;PRKCD;HUWE1;RUVBL2;HDAC2;KAT6A;HDAC4;KAT5;HDAC6;HLCS;SIRT2;EYA3;EHMT2;RUVBL1;EYA1;UFL1;EP300;UBE2N;BRD8;USP22;HDAC5;NEK11
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41153663936648505,1.0486113294291706,0.4224137931034483,0.8779573941674151,1.0,8/26,24.80%,CLTRN;ADCY5;BAIAP3;STX4;PLA2G6;PIM3;CDK16;CFTR
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.35305649156168306,1.0479180373053032,0.39805825242718446,0.8793996223106326,1.0,18/74,21.82%,LOXL2;SPRY2;SFRP2;MAD2L2;CTNNB1;SMAD2;BAMBI;PDPN;PHLDB1;DAB2;EZH2;MTOR;MDK;SPRED3;SPRED1;ADIPOR1;USF3;GCNT2
prerank,cellular response to chemical stress (GO:0062197),0.34789688109981826,1.0477013183809225,0.42,0.8794009108338001,1.0,20/96,16.91%,HSPA1B;TMEM161A;PNPT1;SOD2;CYBB;SRXN1;MT3;PPIA;GSR;ZC3H12A;LONP1;PPARGC1A;TRPV4;STX4;EIF2S1;PRDX2;ADNP2;MSRA;AIF1;CHCHD2
prerank,protein deacylation (GO:0035601),-0.32501394664005506,-1.0476908767000357,0.3915094339622642,1.0,1.0,7/23,10.92%,SIRT7;LYPLA1;SIRT1;LYPLAL1;ABHD17B;SIRT5;ABHD17C
prerank,positive regulation of insulin secretion (GO:0032024),0.38321080333942537,1.0475987351847433,0.40093786635404455,0.8790822760314646,1.0,10/36,20.54%,CLTRN;TCF7L2;BAIAP3;MYRIP;BAD;STX4;IRS2;GLUD1;PSMD9;PLA2G6
prerank,negative regulation of macroautophagy (GO:0016242),0.4132787198972886,1.0474636245130504,0.4366373902132999,0.8788773040581755,1.0,8/26,19.19%,CHMP4A;CHMP4B;NRBP2;SCFD1;RUBCN;MTOR;FEZ2;TSC1
prerank,vasculogenesis (GO:0001570),0.39740994372537375,1.047416066004453,0.39596469104665827,0.8784029612544123,1.0,5/32,9.09%,KDR;CUL7;WNT7B;ITGB8;EGFL7
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3293975178220147,1.0472472696935602,0.346,0.87826772919604,1.0,70/366,16.59%,PML;THAP7;ESR2;DAPK3;MYBBP1A;DAXX;ESRRB;NFX1;SAP30L;ZFPL1;TEAD2;NFKB2;CHEK2;STAT3;ZFP37;CHD7;BHLHE40;NKX6-2;SRRT;MZF1;NFXL1;TCOF1;SERTAD3;PFDN5;CYFIP1;ZNF2;NSD3;ZSCAN26;EDF1;ZBTB38;BACH1;NFATC2;SNAI2;SAP30;CCDC88A;NOLC1;NONO;ACTR8;APP;INSR;RORA;DNM2;PUM3;NAB1;HCFC2;MITF;RYBP;ZNF423;LDB1;PPARGC1A;ORC3;NR3C1;UBE2L3;RB1;ZNF35;ATXN1;APBB1;ASCC2;CASZ1;SOX2;RREB1;EZH2;MYB;USP37;RBM3;MYCBP;GTF2IRD1;DENND4A;ZNHIT3;ZBTB4
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3721857812691711,1.046919635710159,0.4293915040183697,0.8786094344075556,1.0,18/50,23.56%,TUBD1;KIF7;FGFR2;UCHL5;RORA;PDCL;BTRC;GAS1;RACK1;PTCH1;TULP3;DCDC2;MGRN1;GLI3;HERC4;KCTD21;TTC23;VCP
prerank,protein modification by small protein removal (GO:0070646),0.3300350691022343,1.0460799888387364,0.38038038038038036,0.8804459091794379,1.0,81/252,24.14%,USP18;IFIH1;PSMB10;PSME2;BIRC2;INO80E;USP50;PSMA5;PSME4;SENP3;USP25;USP21;USP15;OTUD3;POLB;USP40;PSMA3;SENP5;CYLD;SMAD2;UCHL5;PSMB9;UCHL3;ACTR8;USP34;BARD1;TADA2B;COPS7B;TRAF3;VCPIP1;JOSD2;ARRB2;TNIP1;ZC3H12A;FOXK1;OTUD1;ATXN7;PSMD2;USP14;PSME3;USPL1;ZRANB1;USP45;BIRC3;ACTB;PSMA4;TNIP2;USP37;HGS;TNIP3;OTULINL;INO80C;BABAM2;COPS8;PSMD7;OTUD6B;PSMD8;BECN1;PSMD9;MBD6;NFRKB;PSMF1;USP5;PSMB6;USP8;PSMC2;PSMD12;SENP8;USP33;COPS7A;SENP7;SMURF2;ADRM1;PSMD4;SENP2;VCP;PSMA2;KAT2B;ACTL6A;USP10;USP32
prerank,central nervous system neuron axonogenesis (GO:0021955),0.4723179573222448,1.045207367936974,0.4071942446043165,0.8824053650740756,1.0,5/12,15.11%,HSP90AB1;B4GALT5;HSP90AA1;MYCBP2;CHRNB2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.33584246321637523,1.0451064971067645,0.39081632653061227,0.8820932728079581,1.0,33/166,16.71%,NR1H2;IRS1;PLXNB2;CLU;SLC27A1;PPP1R3E;ARPP19;YTHDF1;CCL5;HSP90AB1;ZCCHC4;CDT1;DHX9;SLC45A3;SMOC2;P2RX4;INSR;NPM1;EIF6;DYRK2;LDB1;PPARGC1A;PRKDC;UPF3A;STN1;IRS2;LPGAT1;HSP90AA1;RBM3;PRMT1;MTOR;SREBF1;METTL14
prerank,positive regulation of interleukin-12 production (GO:0032735),0.3985257213689318,1.0450303445130078,0.4290953545232274,0.8816888092556078,1.0,10/31,23.41%,CD40;HMGB1;MAPK14;TLR2;LGALS9;MDK;TLR3;RIPK2;LTB;IRF5
prerank,membrane organization (GO:0061024),0.3302145171360647,1.044807860457998,0.39518555667001004,0.8817054638128358,1.0,53/227,18.10%,CHMP4A;CHMP4B;TOR1AIP2;TOR1AIP1;CHMP1B;WNT5A;AZIN2;TGFA;ACTR2;LRP2;RTP4;SYNJ1;TLCD2;AP2A1;SH3GLB1;ACTR3;GAPVD1;CCDC88A;TIMM50;LPCAT2;VAPB;LDLRAP1;HSPA8;UBXN2B;ARRB2;FNBP1L;SNX9;AP2S1;NECAP1;DNM2;SUN2;CHMP3;ARPC5;PIP5K1C;VAMP2;REEP3;VTI1B;NPC1;NAPA;DAB2;ACTB;SNAP23;VAMP4;PLEKHA3;NUP155;SYNGR1;HGS;OCRL;EPN2;STON2;CORO1C;CHMP5;LDLR
prerank,peroxisome organization (GO:0007031),0.4169759123766051,1.04472023042104,0.41935483870967744,0.8813556141828943,1.0,5/25,9.50%,FIS1;PEX7;LONP2;ABCD1;PEX2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.47314034428915624,1.0441993964774394,0.4334763948497854,0.88230358964369,1.0,6/13,21.64%,BCL2L11;BAD;BMF;BAX;RHOT2;VDAC2
prerank,cognition (GO:0050890),0.38251898088054936,1.0440632125398817,0.42207053469852107,0.8820739156583158,1.0,13/42,18.38%,CHD7;CYFIP1;PTCHD1;DOP1B;METTL23;APP;LINS1;SETD5;CTNS;CHRNB2;MAGT1;NF1;SOBP
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3599156263319692,1.0439309819539537,0.40250855188141393,0.8818346811999842,1.0,10/55,10.67%,SPAM1;HYAL1;SDC3;STAB2;HYAL4;SDC4;FMOD;CSPG4;AGRN;HPSE
prerank,regulation of axonogenesis (GO:0050770),0.3723898565837515,1.043814683418446,0.41836734693877553,0.8815562754472369,1.0,11/51,13.38%,PLXNA3;PLXNB2;THY1;RUFY3;PLXNB3;EPHA4;PAK3;MAG;CHN1;SIPA1L1;TIAM2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3866369331196667,1.0435096607301968,0.43757431629013077,0.8818422644612862,1.0,12/39,21.20%,SOCS1;PIK3CD;ITPKC;SOCS5;PI4KB;EFR3A;SOCS2;PIK3CB;SOCS6;SOCS4;PI4KA;SOCS7
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.28885731485550736,-1.0428999982140696,0.3655913978494624,1.0,1.0,13/32,18.28%,POLR1A;MAPK3;ERCC3;TBP;ERCC2;RRN3;TAF1D;TAF1;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3
prerank,heterochromatin assembly (GO:0031507),0.42487370829180765,1.0426718238834973,0.4096228868660598,0.8836502945253923,1.0,10/20,25.97%,ZNFX1;MBD2;NRDE2;BAHD1;HDAC1;SMCHD1;SIRT2;CDKN2A;EZH1;HELLS
prerank,cellular response to arsenic-containing substance (GO:0071243),0.4548840444056329,1.0424550556421055,0.4311797752808989,0.8836661820839938,1.0,7/15,23.56%,DAXX;DHX36;ZC3H12A;HNRNPA1;CPEB2;DDX3X;VCP
prerank,plasma membrane organization (GO:0007009),0.36209814043127303,1.0422550790810667,0.416389811738649,0.8836123988862491,1.0,12/61,13.97%,CHMP4A;CXCR4;SNX33;TLCD2;DEGS1;SYT7;EPB41L3;ABCD1;FNBP1L;SNX9;WHAMM;STX4
prerank,positive regulation of DNA repair (GO:0045739),0.370426454878347,1.042170237204303,0.4105504587155963,0.8832360019911855,1.0,20/46,28.17%,EYA4;TMEM161A;TIMELESS;SLF2;DHX9;HMGB1;DDX11;ZCWPW1;EYA2;BABAM2;SLF1;SMCHD1;TIGAR;XRCC1;TRIM28;EYA3;FMN2;EYA1;UBE2N;BABAM1
prerank,apical junction assembly (GO:0043297),-0.26221187202245627,-1.0421684075154876,0.3671875,1.0,1.0,27/53,35.32%,CTNNA1;PAK2;ARL2;APC;PRKCI;RHOA;F11R;ECT2;MARVELD2;VCL;STRN;CLDN14;PECAM1;WDR1;ESAM;FRMPD2;RAMP2;OCLN;RAB13;PARD6A;CLDN18;PARD3;CLDN1;CDH5;RHOC;MPP7;CLDN5
prerank,actin filament capping (GO:0051693),-0.3454576778440531,-1.0420704804845153,0.36220472440944884,1.0,1.0,3/18,13.01%,ADD1;EPS8;CAPG
prerank,barbed-end actin filament capping (GO:0051016),-0.3454576778440531,-1.0420704804845153,0.36220472440944884,1.0,1.0,3/18,13.01%,ADD1;EPS8;CAPG
prerank,dendritic cell chemotaxis (GO:0002407),0.4605230893560309,1.041855815653915,0.4350282485875706,0.8835247295743806,1.0,4/14,9.14%,CXCR4;TRPM2;CCL5;HMGB1
prerank,copper ion homeostasis (GO:0055070),0.4445423498225701,1.0418344646402056,0.41112618724559025,0.8829734107901026,1.0,8/17,25.60%,APP;PRNP;COX19;SLC31A1;SLC31A2;XIAP;COMMD1;ATP7B
prerank,sphingosine metabolic process (GO:0006670),0.447193752388832,1.041832324020116,0.4146666666666667,0.8823674411300825,1.0,6/17,21.47%,SGPP2;ASAH2;SPHK2;ACER3;SPTLC2;PLPP2
prerank,cellular protein modification process (GO:0006464),0.32144889784079433,1.0417441596731043,0.324,0.8820322270487377,1.0,259/983,22.56%,PARP14;EIF2AK2;PARP10;PARP9;ISG15;WNT11;LIPT1;LOXL2;ZC3HAV1;TAOK3;PSMB10;DAPK3;GLYCTK;UBE2L6;MACROD1;CAMK2D;TP53RK;RSKR;SKP1;FBXL16;GPAA1;SGK3;SGK2;PSME2;FASTK;PNPLA2;DCAF17;PIK3CD;BRD2;KLHL20;CAMK2B;PSMA5;CHEK2;ACVR1;CUL5;MAPK6;HASPIN;RCN1;FBXO7;PSME4;CDC25B;PTPN18;USP25;RBBP5;SERPINC1;STK38L;LAMC1;LAMB2;FEM1B;PKN2;ART4;HCK;COG3;CHEK1;IKBKE;ILF3;PEAK1;MORC3;FBXW7;TNC;CDK12;P3H1;PPP2R5C;PDXP;SBF1;MPI;MKNK1;PAK3;PTAR1;PSMA3;CUL7;SETD3;MT3;NRBP2;UBE2M;DUSP29;CSF1;RET;NAGPA;KLHL13;FBN1;SPSB1;FBXW8;FAM20B;GMFB;CAND1;RAB11B;SEPHS1;PSMB9;SIRT6;TIMM50;LTK;NGLY1;UCHL3;LYN;SOCS5;CLK3;MXRA8;B4GALT5;PTPN7;RBX1;APP;INSR;LRRC41;SRPK1;PIK3R4;BMPR2;UBE2E1;MEN1;ST3GAL1;WDR5;PRKAG1;CDK19;COPS7B;WSB2;TNIK;ELOC;BTRC;DAD1;DUSP26;PPM1F;FUT10;CDK10;ASB7;NUAK2;CDK20;PSMD2;BCKDK;COL3A1;SIK1;PDIA6;PIM1;PPP2R5D;B3GALNT1;NEK6;ASB10;DYRK2;PSME3;APOE;FBXL14;PPP4R2;KLHL9;PRKDC;SOCS2;UBE2L3;KTN1;FBXL19;DUSP10;PRKCE;GGCX;DUSP16;CLK2;NPC1;DCAF4;RPN1;DUSP11;JAK2;FYN;PSMA4;PRKCH;FAM20C;STK25;MINK1;BMPR1A;NRBP1;TAOK2;ARF4;ATE1;OXSR1;TIPARP;MSRA;RAB11A;MTOR;LMO7;TBCK;IRAK1;PTPN9;STK39;METAP2;CSK;PTPRU;ASB3;FBXL5;PPP2R2A;SPARCL1;BCR;JMJD4;ST8SIA1;PTPRC;SNRK;PRKG2;BIRC6;GAD1;ACVR2A;FUT9;FNIP2;COPS8;DUSP8;STT3B;PSMD7;MARK1;CTBP1;ASB1;SERP1;BRSK1;SOCS6;GLRX;NEK7;PSMD8;STK3;STK24;OGFOD1;CAMKK2;PTPRB;PSMD9;UBL5;PIGK;ERO1A;AAK1;ERN1;RAB1A;TGM2;FBXO30;ACVRL1;PSMF1;PTPRF;APLP2;PPP2R5A;TLK2;LCK;DDOST;LHPP;MAP4K2;YES1;STK11;SUMF1;PSMB6;PRKCD;CDK9;ABL2;PSMC2;NUB1;PSMD12;GCNT2;SENP8;AKT3;DCAF5;MAPK9;ASB13;COPS7A;HSP90B1;PIM3;MMP15;CDK8;CDK16;PPP2R3A;PTP4A2;RAB2A;FBXW2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.38820796419475373,1.041602023172671,0.4307692307692308,0.8818235840723618,1.0,16/35,27.24%,HSP90AB1;CSNK2B;MAGI2;PPP6R3;PPP1R11;MASTL;CALM3;CD300A;MTOR;TSC1;HSP90B1;PPP1R12A;CALM2;TIPRL;BOD1;FKBP1A
prerank,muscle cell differentiation (GO:0042692),-0.3058485926420066,-1.041540570841105,0.3681592039800995,1.0,1.0,13/32,21.96%,SEMA4C;DMD;NINJ1;NEBL;SPEG;MRTFB;KDM1A;WNT5B;GLMN;TMEM204;MTLN;MEF2C;NEB
prerank,pseudouridine synthesis (GO:0001522),0.46286382714794266,1.041534459299782,0.4289985052316891,0.8814122090692464,1.0,5/13,24.56%,PUS7L;GAR1;PUS7;PUS10;NHP2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4723338065780151,1.0414945212688096,0.4367816091954023,0.8809272514335732,1.0,6/12,22.13%,PCGF5;CDYL;RBM15;LRIF1;SMCHD1;PCGF3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.4264691047269742,1.041426042507195,0.40794701986754967,0.8805156770240966,1.0,4/19,9.06%,SLCO1C1;NFKB1;TMEM106A;APP
prerank,global genome nucleotide-excision repair (GO:0070911),-0.31036500579574716,-1.0408256568249776,0.37264150943396224,1.0,1.0,12/26,20.66%,PARP1;ERCC3;XPC;ERCC2;UBB;UBC;UBA52;RPS27A;ERCC1;GTF2H3;XPA;GTF2H4
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.44722707215021273,1.0400719091753137,0.41068917018284107,0.8838716201859007,1.0,4/17,9.51%,THY1;DUSP3;SH2D1A;PRNP
prerank,positive regulation of neuron death (GO:1901216),0.37489638488364607,1.0399488854575325,0.42660550458715596,0.8836121573575231,1.0,13/46,19.90%,WNT5A;DAXX;CLU;CTNNB1;TFAP2B;PRNP;DDIT4;FCGR2B;EIF2S1;FYN;BAX;NF1;TYROBP
prerank,regulation of ossification (GO:0030278),0.38773263546789505,1.0395541013211556,0.41058823529411764,0.8841713930834386,1.0,10/36,16.89%,WNT5A;ACVR1;SOX9;NBR1;ANKH;BMPR2;PTPN11;ENPP1;RBPJ;MDK
prerank,regulation of lipase activity (GO:0060191),-0.377629173542275,-1.0394780359808085,0.3901639344262295,1.0,1.0,4/13,14.63%,SNCA;PCSK6;RHOA;LPL
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.4774101413136913,1.039226346018047,0.40795287187039764,0.8845771730331649,1.0,4/12,14.96%,DCK;TK1;TK2;UCKL1
prerank,negative regulation of nuclear division (GO:0051784),0.46892577048854656,1.0391899291765654,0.44478063540090773,0.8840801945602637,1.0,5/11,29.32%,CHEK1;AURKAIP1;TOM1L2;FBXO5;NME6
prerank,tRNA methylation (GO:0030488),0.3884106762521181,1.0390755293343221,0.4188034188034188,0.8838004218752412,1.0,12/34,22.66%,BCDIN3D;TRMT1;TRMT13;TRMT61B;THADA;TRMT10C;THUMPD3;TYW3;GTPBP3;METTL1;TARBP1;TRDMT1
prerank,negative regulation of anoikis (GO:2000811),0.45521350385829745,1.038870298039081,0.43459302325581395,0.8837812324039842,1.0,6/14,27.51%,PTRH2;SNAI2;MCL1;NOTCH1;PIK3CA;ITGB1
prerank,homologous chromosome segregation (GO:0045143),0.4210613220981684,1.03812346171286,0.4375838926174497,0.8853235468192096,1.0,1/20,0.40%,SYCP1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3678575392530664,1.0379304921451764,0.4393939393939394,0.8852755386554055,1.0,12/47,16.03%,ZFP36;CDS1;SFRP2;MEDAG;AAMDC;FRZB;ZC3H12A;ZFP36L1;XBP1;PIM1;RREB1;PPARD
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.35766698714332296,1.037737393242188,0.4420131291028446,0.8852248199331482,1.0,17/66,20.51%,HYAL1;PSME2;PRMT2;RBL1;CCND2;CDKN2D;CCND1;TFDP1;DACT1;PSME3;RB1;DLG1;AIF1;BRD7;WEE1;APPL2;DDX3X
prerank,axon extension (GO:0048675),0.41575908274547596,1.0376247483008523,0.42462311557788945,0.8849195532396543,1.0,9/23,19.02%,NRP2;HSP90AB1;CYFIP1;SLIT3;SLIT1;NRP1;HSP90AA1;NLGN3;MAP1B
prerank,protein O-linked glycosylation (GO:0006493),0.3444660382617105,1.0375203455912656,0.43756558237145854,0.8846126288603625,1.0,22/96,19.15%,ST6GALNAC4;TMTC1;POMT1;TRAK1;POMT2;GALNT7;GALNT15;ST6GAL1;GCNT4;GALNTL6;B4GALT5;ST3GAL1;XXYLT1;B3GLCT;GALNT18;CRPPA;TET2;GALNT1;TMTC4;GXYLT1;GALNT13;GALNT14
prerank,mitotic recombination (GO:0006312),0.4453898293159011,1.0373753638715009,0.4267605633802817,0.8844100522359419,1.0,4/15,15.01%,TPRKB;XRCC3;NSMCE2;GEN1
prerank,regulation of complement activation (GO:0030449),0.3743415507138272,1.0373267306122422,0.4290697674418605,0.8839418949007111,1.0,5/40,10.20%,CLU;C4B;CD55;SUSD4;C3AR1
prerank,lymphocyte differentiation (GO:0030098),0.3537457112036327,1.0371197153161975,0.43042071197411,0.883904725191339,1.0,17/68,21.28%,AXL;MSH2;PIK3CD;CHD7;LEPR;RELB;LMBR1L;IKZF1;NHEJ1;BLNK;PTPRC;ITGA4;KAT7;LCK;VCAM1;TPD52;RHOH
prerank,ion transport (GO:0006811),0.3395102402483371,1.037017517327795,0.4171907756813417,0.8835834454084904,1.0,20/111,16.45%,CNGB1;SLC25A22;AQP11;SLC26A1;SLC8A1;SLC15A3;SLC15A2;PANX2;SLC12A5;LASP1;SLC25A10;TRPM3;PANX1;SLC26A2;ANO10;TSPO;CTNS;CHRNB2;SLC24A3;SLC4A2
prerank,ncRNA catabolic process (GO:0034661),-0.30109163472668665,-1.0369932177525865,0.39805825242718446,1.0,1.0,10/28,18.88%,EXOSC7;EXOSC10;RBM7;DIS3;DIS3L;EXOSC5;EXOSC3;DEDD2;TENT4B;NUDT16L1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.40770134613336756,-1.0369446706038978,0.37537537537537535,1.0,1.0,4/11,16.91%,ARRB1;GRK3;GRK2;SAG
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3619802647471792,1.0368685303442258,0.4134831460674157,0.8834132276370757,1.0,29/59,29.24%,MOV10;MECP2;SOX9;CTNNB1;CCND1;TCF7L2;NFKB1;MED12;MITF;MED27;MED16;BAX;MED10;MED7;MED24;CDK8;AGO4;MED8;TRIM28;CDKN2A;PTEN;AGO1;MED25;SETX;AGO3;MED26;JUN;CSF1R;MED13
prerank,positive regulation of reproductive process (GO:2000243),0.38868477862353207,1.0366251250327705,0.4132029339853301,0.8834855879927177,1.0,8/31,22.14%,AGO2;TACR1;SYDE1;TAC4;PDE3A;GLRA1;LHFPL2;SMURF2
prerank,regulation of muscle contraction (GO:0006937),0.40296066549007603,1.0363263200695199,0.44654088050314467,0.8837358591024254,1.0,3/26,5.31%,DAPK3;MYL9;TNNC1
prerank,toll-like receptor signaling pathway (GO:0002224),0.3438079598103519,1.0359848045629696,0.4247881355932203,0.884174705697062,1.0,19/84,17.34%,PIK3AP1;CTSS;BIRC2;NMI;TLR8;UNC93B1;HMGB1;PIK3R4;TRAF3;TNIP1;IRAK4;BIRC3;TNIP2;MYD88;TLR2;TNIP3;IRAK1;LGALS9;TLR3
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4651054879876527,1.0357364006374874,0.4431818181818182,0.8842753321005282,1.0,4/13,13.86%,NOL9;RPS21;RRS1;KRI1
prerank,motile cilium assembly (GO:0044458),0.4702079453247108,1.035661862391383,0.43219076005961254,0.8838862676359682,1.0,3/12,12.97%,CCDC40;SPATA6;E2F4
prerank,mesenchymal to epithelial transition (GO:0060231),-0.414380665761246,-1.0355991678467886,0.40181268882175225,1.0,1.0,5/10,33.97%,SALL1;FZD7;PAX8;BMP4;GATA3
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4648553121243594,1.035535542546029,0.4291845493562232,0.8836222776172974,1.0,4/13,18.76%,DDX5;EEF1E1;SPRED3;SPRED1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.32532701208458165,1.0354735349575495,0.3867735470941884,0.8831846878126778,1.0,60/336,12.58%,IRF7;SAMHD1;PML;TAOK3;MSH2;DTX3L;MACROD1;ALKBH7;TIMELESS;CHEK2;CGAS;BCL2L11;PSME4;POLE2;APLF;RBBP5;MCM7;CHEK1;NOP53;UBE2B;IKBKE;CHD1L;RFC4;POLB;CCND1;ETAA1;HERC2;BCL6;MCM9;ZBTB38;BACH1;RTEL1;NFATC2;SLF2;RAD51C;ALKBH1;CHCHD6;RPAIN;FEN1;ERCC4;XRCC3;LYN;BARD1;POLK;PLK3;WDHD1;MEN1;MAPK14;MNAT1;WAC;VCPIP1;CIB1;ZC3H12A;NPM1;POLQ;DYRK2;PSEN1;PRKDC;ZRANB3;DDX11
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3595794016728449,1.0353469857340472,0.4225663716814159,0.8829579581717255,1.0,19/55,22.66%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PSMA3;PSMB9;RBX1;PSMD2;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,cellular response to mechanical stimulus (GO:0071260),0.3722355109463121,1.0351803874215877,0.4486301369863014,0.8828276707602157,1.0,16/46,24.72%,TNFRSF8;CD40;PTGER4;CHEK1;TLR8;SOX9;NFKB1;BAD;MYD88;TLR3;CRADD;GADD45A;PIEZO1;TLR7;IRF1;MAP2K4
prerank,tRNA aminoacylation (GO:0043039),0.38456147349547437,1.0350649956685343,0.43353293413173655,0.8825534629388956,1.0,10/37,18.72%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;EEF1E1;YARS2;PPA1
prerank,cellular response to glucose stimulus (GO:0071333),0.394963953364353,1.0347703707312115,0.43407960199004975,0.8828000880994459,1.0,11/30,27.05%,CLTRN;RAB11B;XBP1;RACK1;SELENOT;ERN1;ZBTB20;RAB11FIP5;TRA2B;KCNB1;PTPRN
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4075516200119043,1.0342626286113503,0.4465894465894466,0.8836576160210692,1.0,6/25,15.21%,CAMK2D;CTNNA3;AKAP9;FGF13;DLG1;CALM3
prerank,regulation of receptor recycling (GO:0001919),-0.3532415484655146,-1.0341656831736006,0.41946308724832215,1.0,1.0,5/16,15.65%,INPP5F;SNCA;NSF;VAMP3;SCRIB
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.36221322683473145,1.0338637029154474,0.41496598639455784,0.8842147242640201,1.0,20/53,23.77%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;BCKDK;AZIN1;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2
prerank,isotype switching (GO:0045190),0.4777683253485206,1.033806336070064,0.44571428571428573,0.8837760836875584,1.0,1/10,0.99%,MSH2
prerank,proteolysis (GO:0006508),0.32455729433679537,1.0337200724831859,0.4272818455366098,0.883407793643757,1.0,46/252,18.41%,CASP4;CASP7;ADAM33;SPPL2A;LAP3;CTSS;ADAMTS3;USP25;MMP14;TMPRSS5;CASP6;LONP2;UBE3A;ERAP1;CUL7;RET;CPQ;RSPRY1;CTSC;NLN;CTSH;DPP3;AEBP1;PCSK7;SPCS1;ADGRV1;LONP1;PSEN1;NPEPPS;CAPN1;PITRM1;PTCH1;NAPSA;SPPL3;APH1A;APH1B;CAPN5;HTRA3;ADAMTS12;SPRTN;LRP8;METAP2;MIPEP;FOLH1;HM13;SVBP
prerank,Notch signaling pathway (GO:0007219),0.3533979238206137,1.0329002737005288,0.4444444444444444,0.8851550609420336,1.0,12/59,16.89%,STAT1;DTX3L;SNAI2;MAML2;SNW1;NOTCH4;ZNF423;PSEN1;APH1A;APH1B;RBPJ;MDK
prerank,response to growth factor (GO:0070848),0.37669821530290987,1.0327054584073283,0.4432624113475177,0.8851353016319873,1.0,11/41,20.17%,CPNE3;ACVR1;LRP2;CTNNB1;BMPR2;CIB1;RACK1;SOX2;BMPR1A;ACVR2A;ACVRL1
prerank,regulation of immune effector process (GO:0002697),0.37155850476231667,1.0327030148681307,0.42857142857142855,0.8845368535669563,1.0,7/41,16.23%,CLU;C4B;CD55;SUSD4;C3AR1;FCGR2B;C1QB
prerank,chromatin assembly (GO:0031497),0.38185018195189774,1.0326155035372928,0.42538190364277323,0.8842058752491482,1.0,7/38,11.05%,DAXX;BRD2;NAP1L2;SOX9;CHAF1B;NPM1;CTCF
prerank,embryonic organ morphogenesis (GO:0048562),0.38068715015758675,1.0325944372744258,0.431980906921241,0.8836647573055096,1.0,6/42,8.82%,RARG;ACVR1;FGFR2;FBN1;MFAP5;HOXA9
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4569884817839984,1.0325443353654227,0.43162393162393164,0.8832292573314101,1.0,2/15,3.85%,DTX3L;MAD2L2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.34378532496485825,1.0324294490606154,0.4310915104740904,0.8829549689671393,1.0,22/73,24.16%,MYBBP1A;TFAP2C;MECP2;MYO1C;CGGBP1;DNMT3A;DNMT1;POLR2K;SPHK2;CTCF;TAF1B;ACTB;EZH2;TDG;POLR1G;TAF1C;SMYD5;TASOR;HDAC4;HDAC6;KAT2B;POLR1F
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3899732110852669,1.0323937552862932,0.4533333333333333,0.8824525281653104,1.0,9/34,21.96%,NOD2;FLT1;IRS1;PIK3R4;RUBCN;FGFR3;WDR91;TNFAIP8L3;FGF2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.339646001268878,1.0323856753363052,0.41778697001034126,0.8818726063994066,1.0,24/109,15.23%,PIGW;ARF3;PIK3CD;SLC27A1;CDS1;SYNJ1;PLA2G12A;PITPNM1;SBF1;PIP5K1A;PLCB3;PI4KB;PIK3R4;CDIPT;RAB14;PLEKHA1;PIK3CB;PIP5K1C;INPP4B;PLEKHA4;PLEKHA3;LPGAT1;INPP5K;MTMR14
prerank,CENP-A containing chromatin organization (GO:0061641),-0.30727929025496237,-1.0322779674981328,0.37823834196891193,1.0,1.0,15/29,32.17%,CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH;CENPI;MIS18A;CENPW
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.30727929025496237,-1.0322779674981328,0.37823834196891193,1.0,1.0,15/29,32.17%,CENPO;KNL1;CENPA;ITGB3BP;CENPL;MIS18BP1;CENPK;CENPU;CENPC;CENPX;CENPQ;CENPH;CENPI;MIS18A;CENPW
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3715257187842025,1.0316212691220636,0.4460093896713615,0.8834784927620066,1.0,10/44,15.41%,AGT;SPRY2;PAQR3;LYN;SORL1;APOE;DUSP10;PIK3CB;INPP5K;CD300A
prerank,negative regulation of kinase activity (GO:0033673),-0.24325746527317332,-1.031433154553717,0.45348837209302323,1.0,1.0,17/62,13.67%,CEP85;TAB1;PPM1E;DEPTOR;LRP6;PRKRIP1;PAK2;GSKIP;SNCA;QARS1;TSC2;DBNDD2;CEP43;UBASH3B;AKT1;CEACAM1;TRIB1
prerank,negative regulation of MAPK cascade (GO:0043409),0.33905013858380845,1.0313602769606722,0.4362486828240253,0.8836337493063761,1.0,25/87,19.96%,AGT;SPRY2;DUSP3;IGBP1;DUSP29;PPIA;PAQR3;CNKSR3;LYN;TNIP1;DUSP26;SORL1;APOE;DUSP10;PIK3CB;DLG1;INPP5K;CD300A;SPRED3;PTPRC;NF1;SPRED1;PIN1;RANBP9;SIRPA
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4728871054299556,1.0312060241711158,0.4459665144596651,0.8834774596992833,1.0,2/13,2.75%,ESR2;ABHD2
prerank,DNA recombination (GO:0006310),0.3796111705598356,1.0309953541198638,0.42962056303549573,0.8834915176349882,1.0,9/37,15.30%,MSH2;RTEL1;RAD51C;RPAIN;XRCC3;HMGB1;HMGB3;GEN1;RECQL5
prerank,sterol metabolic process (GO:0016125),0.3571438656035374,1.0308733835703123,0.4400871459694989,0.8832644109090493,1.0,17/60,23.27%,ABCA1;ABCG1;CH25H;CYP26B1;LDLRAP1;STARD3;CYP27A1;APOE;PPARD;SOAT2;SOAT1;EBP;GBA2;CYP39A1;ABCA5;HMGCR;CLN6
prerank,DNA duplex unwinding (GO:0032508),0.36573101608148756,1.0305967786170145,0.4426419466975666,0.8834430848096654,1.0,10/50,9.89%,ASCC3;MCM2;MCM7;CHD1L;MCM4;MCM9;RTEL1;DHX9;RBX1;TWNK
prerank,response to organic cyclic compound (GO:0014070),0.3621452665698047,1.0303781909437186,0.4423076923076923,0.8834963722397909,1.0,12/52,17.34%,DHFR;TRPM2;STAT3;CCL5;CDKN2D;CTNNB1;GGT7;SOCS2;CHRNB2;TIPARP;IL18;TLR3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3089004692533103,-1.0301929452314327,0.41530054644808745,1.0,1.0,15/27,29.29%,PAK2;RHPN2;CLASP2;SHANK3;WAS;WASF2;F11R;CLASP1;SHANK1;ARHGAP6;PPFIA1;ARHGEF18;TJP1;ARHGAP28;PRKN
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.320991907241917,-1.0301307301051117,0.39669421487603307,1.0,1.0,11/21,21.20%,PPARG;NFKBIA;RXRA;SIRT1;EEPD1;TREM2;PLTP;ABCA7;ABCA3;NR1H3;CAV1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.44451718838636683,1.030002604563314,0.4482758620689655,0.8839680350126594,1.0,2/16,4.56%,AOAH;PGM2L1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.39927373645816394,1.0299575811859107,0.4421182266009852,0.8834953192575398,1.0,10/28,21.21%,CD47;CCL5;MITF;EIF6;RAC1;CTNS;JAK2;SIRPA;ADIPOR1;MFSD12
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3777251165989846,1.029623970289824,0.44379391100702575,0.8838576572508642,1.0,11/41,21.96%,TRPM2;GRIN2D;SLC8A1;ITPR1;CHERP;HTR2A;TRPV4;PTPRC;ERO1A;LCK;FGF2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3890529924539125,1.0295742826801346,0.4275184275184275,0.883402518010793,1.0,3/29,3.85%,SPRY2;SFRP2;MAD2L2
prerank,ncRNA export from nucleus (GO:0097064),0.37752052240633094,1.0295102990977778,0.44258373205741625,0.8830012516809334,1.0,11/36,20.35%,NUP37;PHAX;NUP153;NCBP2;RAE1;NPM1;NUP155;NUP88;TSC1;NUP133;NUP43
prerank,regulation of primary metabolic process (GO:0080090),0.3369239809006733,1.029500888962869,0.4325437693099897,0.8824280488710053,1.0,44/126,25.96%,HELZ2;PSMB10;PSME2;PSMA5;PSME4;NCOA1;PSMA3;EDF1;RUBCNL;PSMB9;FDFT1;TGS1;PSMD2;AZIN1;PSME3;APOE;GGPS1;PSMA4;IRS2;PPARD;SREBF1;IDI1;LDLR;PSMD7;CERS2;PSMD8;PSMD9;NR1D2;PSMF1;ADIPOR1;PSMB6;TNFAIP8L3;PSMC2;PSMD12;HMGCS1;PSMD4;HMGCR;PSMA2;NCOR2;PRKAB2;BBS4;PLPP1;PSMD1;PSMD11
prerank,regulation of neurogenesis (GO:0050767),0.35975550234397213,1.0293538770573034,0.448512585812357,0.8822515053139829,1.0,11/55,13.63%,PER2;B2M;LRP2;BHLHE40;CTNNB1;CX3CL1;YTHDF2;SNW1;SORL1;HOOK3;NUMBL
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.36198132411311407,-1.0292359712677992,0.41155234657039713,1.0,1.0,3/16,14.96%,PPP1R16B;HMOX1;JCAD
prerank,negative regulation of response to wounding (GO:1903035),0.42855402742017495,1.0291456841223807,0.44642857142857145,0.8822090917624305,1.0,9/19,26.89%,EPHA4;GIT1;CRK;MDK;CERS2;RTN4RL1;FGF2;PTPRS;AJAP1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4805340481567667,1.028901199515134,0.4257871064467766,0.8822837288856261,1.0,2/10,5.48%,CTNNB1;CX3CL1
prerank,synaptic vesicle cycle (GO:0099504),0.3929791314395463,1.0285049217833995,0.4348894348894349,0.8828077853909141,1.0,14/30,28.34%,SLC18A2;CPLX1;SYT7;PIP5K1C;VAMP2;SLC32A1;BRSK1;PCLO;RAB3A;DNAJC5;PLD2;CDK5;CPLX2;SYNDIG1
prerank,regulation of spindle organization (GO:0090224),0.41922708243254736,1.0284639064915981,0.43866666666666665,0.882346754082962,1.0,3/18,8.14%,RNF4;DYNC1H1;RAE1
prerank,negative regulation of biosynthetic process (GO:0009890),0.4400532416683872,1.0282928351814664,0.4295676429567643,0.8822627866044043,1.0,3/16,9.47%,SLC18A2;ASXL3;ABCD1
prerank,wound healing (GO:0042060),-0.24449640321238744,-1.0273940901910292,0.3488372093023256,1.0,1.0,12/62,10.63%,PAK1;DST;MACF1;AHNAK2;MYOF;HMOX1;FGF10;TPM1;SCARB1;TGFB2;ANXA6;PLEC
prerank,protein autophosphorylation (GO:0046777),0.32920145929514155,1.0273468693947803,0.4475025484199796,0.8843717249588418,1.0,32/157,16.65%,EIF2AK2;TAOK3;FLT1;DAPK3;CAMK2D;KDR;CAMK2B;CHEK2;HCK;PEAK1;CDK12;EPHA4;MKNK1;FGFR2;HTATIP2;LYN;INSR;TNIK;SIK1;PIM1;MAP2K2;NEK6;CLK2;JAK2;STK25;MINK1;TAOK2;OXSR1;FGFR3;MTOR;IRAK1;STK39
prerank,calcium ion transmembrane transport (GO:0070588),0.3379836294271543,1.027315571361334,0.4439746300211416,0.8838583025620093,1.0,15/86,15.80%,TRPM5;TRPM2;CACNA2D4;GRIN2D;TRPM6;SLC8A1;CACNA1A;P2RX4;MCUR1;TRPM3;MCOLN2;TRPV4;MICU2;TRPM7;SLC24A3
prerank,homeostasis of number of cells (GO:0048872),-0.3924433123208196,-1.0272692529136631,0.4161490683229814,1.0,1.0,5/12,21.15%,NAPEPLD;CX3CR1;CARD9;OCIAD2;F2R
prerank,negative regulation of bone mineralization (GO:0030502),-0.3833519150999153,-1.0271961544888624,0.41946308724832215,1.0,1.0,5/13,16.64%,SRGN;TRPM4;CCL3;CCR1;ECM1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.39539951458252753,1.0271012846614533,0.44209215442092153,0.8838846610403214,1.0,14/27,24.56%,ZC3H12C;XRN1;ZC3H12A;RNASE1;PCF11;NUDT16;DICER1;RPP30;TRIR;ERN1;RNASEH1;RNASE4;PDE12;NHP2
prerank,external encapsulating structure organization (GO:0045229),0.32787520349533894,1.0266471792516656,0.42611336032388664,0.8845701818893871,1.0,38/205,18.19%,COL13A1;ITGA2;COMP;KDR;ADAMTS3;COL9A1;MMP14;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;AGRN;GFOD2;COL3A1;ADAMTS2;COL11A2;ST7;ADAMTS6;NID2;ADAMTS12;JAM3;ITGA4;COL15A1;VIT;NF1
prerank,regulation of ruffle assembly (GO:1900027),0.410156244710952,1.0258958022543043,0.44331210191082804,0.8860600108380898,1.0,5/23,12.02%,EVL;P2RX4;KANK1;DEF8;STAP1
prerank,regulation of small molecule metabolic process (GO:0062012),0.38992257432731225,1.0257708876083658,0.42700729927007297,0.8858228580286139,1.0,11/28,24.92%,ACADL;RORA;FOXK1;BCKDK;EPHX2;APOE;PANK2;TTC39B;ADIPOR1;NCOR2;ACADVL
prerank,organelle organization (GO:0006996),0.3208467966869877,1.0257124036968883,0.41382765531062127,0.8853876553507768,1.0,115/388,23.27%,CHMP4A;CHMP4B;VPS51;TOR1AIP2;MTFR2;CCL7;FMNL2;BLZF1;CHMP1B;AUP1;KLHL20;TJAP1;ATL1;YTHDF1;CNTNAP1;THY1;PEX7;COG3;GOLGA8B;GOLGA5;CHCHD10;LONP2;BRWD3;SEC16A;POLG2;SPRYD3;PRPF40A;ANK1;ARHGEF7;STX7;CUL7;TFB2M;ARHGAP4;VPS11;TMED5;ATAD3A;FBXW8;PPIA;DOP1B;RAB43;YTHDF2;ZMYM3;VAPB;ABCD1;PEX2;MAST3;TWNK;UBXN2B;TNIK;TMED10;PHIP;FNBP1L;TRAPPC12;ATXN7;COG2;RAB14;DNAJA3;ARL1;CHMP3;FAF2;LONP1;CAPZB;ARHGAP21;ARHGAP10;PPARGC1A;APOE;FGD6;NCKIPSD;ZRANB1;AFG1L;PLEKHM2;VPS13D;STX4;ZMYM6;RAB32;DYNC2H1;MDK;CHCHD2;TMED1;PLCE1;SH3D19;TMED3;RHOT2;CHMP5;GBF1;FMNL3;GABPB1;GOLPH3L;MARK1;NUMA1;SIPA1L3;TTC17;RANBP9;VPS13C;GORASP2;RAB1A;VPS18;PNPLA3;ABCD4;TMED7;OPTN;ADCK1;MTX1;HUWE1;CHMP1A;ATP5F1B;RAB2A;PRDX3;PTCD2;SSBP1;OPA1;PAK5;RAB29;LIMD1;PCLO
prerank,Wnt signaling pathway (GO:0016055),0.3402757539045006,1.0256994363565095,0.43736730360934184,0.8848449046467164,1.0,12/92,10.36%,WNT11;SKP1;WNT5A;RARG;SFRP2;CTNNB1;TCF7L2;WNT7B;FRZB;RBX1;USP34;BTRC
prerank,regulation of lipid storage (GO:0010883),0.4194353471831692,1.0256562935067228,0.4557291666666667,0.8843729121916154,1.0,5/22,10.58%,ALKBH7;IKBKE;FBXW7;NFKB1;ZC3H12A
prerank,cellular response to pH (GO:0071467),0.431486175395846,1.0256416994694455,0.438957475994513,0.883826891962809,1.0,2/17,8.08%,HYAL1;RAB11B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3594291379249797,1.0255554487918117,0.4221698113207547,0.8834634490244213,1.0,14/48,18.69%,MYBBP1A;MYO1C;ARID1B;CHEK1;ARID1A;POLR2K;SPHK2;SERTAD2;TAF1B;ACTB;SERTAD1;ELOF1;POLR1G;TAF1C
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.457828731075304,1.0255388177348157,0.44490934449093444,0.8829260803069989,1.0,2/13,4.98%,RGPD1;KPNB1
prerank,regulation of protein localization to membrane (GO:1905475),0.40266336981578776,1.0255032844652825,0.4434447300771208,0.8824519572509524,1.0,8/28,14.33%,MMP14;STX7;STX8;LDLRAP1;GSN;VTI1B;ACTB;FYN
prerank,regulation of cellular respiration (GO:0043457),0.42553925530560527,1.025001456658225,0.42857142857142855,0.8832708307035463,1.0,8/17,27.54%,PNPT1;NOP53;IL10RB;NOA1;IDE;VCP;TRAP1;PRELID1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.3975578938854962,-1.0247217389515006,0.4554140127388535,1.0,1.0,3/11,12.51%,TGFB1;TGFB2;EFNB2
prerank,macrophage migration (GO:1905517),0.46002008543834505,1.0246935587509411,0.44963503649635034,0.8835252435553465,1.0,4/13,12.40%,CCL5;TAFA4;P2RX4;CXCL17
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3886394242029234,1.0245068196219698,0.42216687422166876,0.8834905152494846,1.0,8/29,18.10%,NR1H2;SLC27A1;SLC45A3;APOE;LPGAT1;MTOR;SREBF1;LDLR
prerank,antibacterial humoral response (GO:0019731),0.4395607500623073,1.0244295507677335,0.45604395604395603,0.8831333824660466,1.0,6/16,24.23%,SLPI;RNASE7;PLA2G6;ANG;CAMP;RNASE3
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.4288645591072221,1.024287364747099,0.4183535762483131,0.8829411558698438,1.0,2/17,7.89%,CLTRN;UNC13D
prerank,electron transport chain (GO:0022900),0.4391619195272705,1.0241641342317636,0.468232044198895,0.8827253297287518,1.0,8/15,29.65%,NDUFA5;ENOX2;PPARGC1A;SDHB;NDOR1;UQCRFS1;SDHA;ETFDH
prerank,regulated exocytosis (GO:0045055),0.325689638822926,1.0241463977403786,0.45197168857431747,0.8821926123325992,1.0,23/173,13.51%,LGALS3BP;CLTRN;CLU;ACTN1;ACTN2;LAMP2;MAGED2;CRHBP;CPLX1;CDC37L1;SYT7;ISLR;RAB11B;SYT3;LYN;APP;SCCPDH;TMED10;VEGFD;CHID1;PIP5K1C;VAMP2;VTI1B
prerank,regulation of neutrophil migration (GO:1902622),-0.42644107601315917,-1.0235451489637504,0.42592592592592593,1.0,1.0,3/10,6.52%,MPP1;NCKAP1L;RAC2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3713596310773101,1.0230235604193099,0.460093896713615,0.8847594635048222,1.0,7/39,11.00%,NOD2;STAT3;TM2D3;ENHO;MAML2;SNW1;NOTCH4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4811565318053146,1.0228299744425111,0.42879019908116384,0.8847544778581499,1.0,4/10,20.21%,SMOX;ALDH7A1;COMT;SLC44A1
prerank,cellular amide metabolic process (GO:0043603),0.3380409459935211,1.0226099043844705,0.4408033826638478,0.8847851849064069,1.0,26/102,21.99%,MTHFR;DHFR;ACOT9;ASAH2;NSMAF;SLC46A1;SLC19A1;ACBD6;ABCB9;ST6GAL1;NLN;AEBP1;ST3GAL1;ACOT13;GNE;SHMT1;PANK2;MCCC1;MIPEP;MTHFD1;SGPL1;OXSM;PLA2G4E;SLC5A6;PLPP2;NIT1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.46396746557783897,1.0225062313591287,0.45132743362831856,0.8845080963534426,1.0,2/11,8.96%,CDH13;P2RX4
prerank,positive regulation of protein phosphorylation (GO:0001934),0.32057765205015315,1.0224094142341433,0.44844844844844844,0.8842313726306995,1.0,60/348,15.61%,IRGM;IL15;AGT;SPRY2;KDR;DAXX;BDNF;DDRGK1;GDF9;SEMA4D;CD40;ACVR1;LCP2;S1PR2;SFRP2;MAD2L2;CCND2;HSP90AB1;CACUL1;SOX9;CX3CL1;CCND1;TNKS1BP1;TRAF4;MYDGF;CAB39;MT3;MAP2K3;CSF1;CSNK2B;AGAP2;PPIA;MTCP1;RAPGEF2;CSPG4;LYN;LEPR;APP;INSR;PRNP;BMPR2;PRKAG1;TNIK;SNX9;CIB1;VEGFD;FGF9;PTPN11;AKAP9;RACK1;NRP1;RAC1;DAB2;JAK2;RB1CC1;HSP90AA1;NPTN;CALM3;BMPR1A;TAOK2
prerank,cellular response to inorganic substance (GO:0071241),0.41551581974243684,1.0224032625211366,0.42933333333333334,0.8836674493088749,1.0,6/21,18.95%,TIMELESS;ADCY10;MT3;DDX11;RTF2;DDI2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.3827883457216334,-1.0221611109158972,0.4155405405405405,1.0,1.0,4/12,13.06%,SMARCA4;ZBTB7A;SIRT1;FOXP1
prerank,chromatin organization (GO:0006325),0.32972056854825815,1.0218207150569276,0.4517453798767967,0.8847111927084568,1.0,30/132,17.11%,LOXL2;GATAD1;HMGN3;DAXX;LRWD1;CHD1L;SOX9;ARID1A;KDM4D;SMARCE1;SMARCC2;NUDT5;MTA2;TADA2A;TADA2B;BPTF;NPM1;SETD5;SETDB2;HCFC2;DDX11;RB1;HDAC8;SMARCA1;SOX2;EZH2;MYB;SMARCD2;INO80C;MPND
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3418147733791578,1.0217710465735703,0.4240780911062907,0.8842695515338278,1.0,31/76,27.24%,BIRC2;FBXW7;PRICKLE1;UBE3A;DCUN1D4;UBA2;UBQLN1;TNIP1;ZC3H12A;PAXIP1;UBE2L3;BIRC3;MYCBP2;PIAS1;SPRTN;TANK;RIPK2;HSPBP1;HUWE1;STUB1;DCUN1D5;CUL3;SENP2;XIAP;HDAC4;AXIN1;COMMD1;NDFIP1;PIAS4;GNL3;FKBP1A
prerank,chromatin remodeling (GO:0006338),0.3342540331528963,1.0213316602037892,0.45188284518828453,0.884928427095669,1.0,26/100,17.11%,GATAD1;DAXX;ARID1B;CHD1L;SOX9;ARID1A;KDM4D;MBD2;SMARCE1;SMARCC2;NUDT5;MTA2;TADA2A;ACTR8;TADA2B;BPTF;NPM1;HCFC2;RB1;ACTB;SMARCA1;MYB;SMARCD2;BAHD1;INO80C;MPND
prerank,negative regulation of cell development (GO:0010721),0.39573807374140996,1.0211009266591657,0.44814814814814813,0.8849595367798239,1.0,5/25,13.58%,B2M;FBXW7;FBN1;SORL1;HOOK3
prerank,extracellular structure organization (GO:0043062),0.325864172604965,1.0210563106016362,0.4418604651162791,0.8845264902069363,1.0,38/204,18.19%,COL13A1;ITGA2;COMP;KDR;ADAMTS3;COL9A1;MMP14;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;AGRN;GFOD2;COL3A1;ADAMTS2;COL11A2;ST7;ADAMTS6;NID2;ADAMTS12;JAM3;ITGA4;COL15A1;VIT;NF1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.37957839550829187,-1.0210410738707205,0.41216216216216217,1.0,1.0,4/13,8.41%,TGFB1;IRAK3;SIRT1;TGFB2
prerank,transport across blood-brain barrier (GO:0150104),0.33907985579840816,1.0206344720553684,0.4603174603174603,0.8851471125291707,1.0,13/83,11.18%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC38A1;LRP2;SLC15A2;ATP8A1;SLC19A1;SLC38A3;LEPR;INSR;ABCC1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3622378203199365,1.020535223725001,0.44366197183098594,0.8848405633555283,1.0,15/46,19.96%,SPRY2;DUSP3;DUSP29;CNKSR3;LYN;TNIP1;DUSP26;DUSP10;DLG1;SPRED3;PTPRC;SPRED1;PIN1;RANBP9;SIRPA
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3439904872774021,1.0205080653540461,0.44623655913978494,0.8843461156852592,1.0,15/78,17.56%,PKMYT1;CCNJ;CCND2;CDKN2D;CCND1;CCNT2;CNPPD1;MEN1;MNAT1;PROX1;CCNI;ACTB;SERTAD1;CCNK;CDC37
prerank,limb morphogenesis (GO:0035108),-0.32738192251914,-1.0204032241745118,0.4326530612244898,1.0,1.0,4/20,8.41%,FBXW4;LRP6;NIPBL;TGFB2
prerank,positive regulation of cell differentiation (GO:0045597),0.32204706493360735,1.0201647550356108,0.4501510574018127,0.8847269752859269,1.0,48/237,16.90%,LOXL2;AGT;KDR;ZFP36;CDS1;ACVR1;KITLG;SFRP2;MEDAG;ZHX3;BRINP3;AAMDC;DHX36;HSP90AB1;SOX9;CTNNB1;TCF4;NFKB1;WNT7B;CSF1;SRF;FRZB;SMAD2;RAPGEF2;BAMBI;GDNF;PDPN;BMPR2;MAPK14;ZC3H12A;ZFP36L1;XBP1;RIN2;NELL1;DAB2;RANBP3L;PRKCH;EZH2;BMPR1A;SOX5;SPAG9;MEF2A;PPARD;SMYD1;IL18;MTOR;MDK;PCP4
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4460650418486822,1.0198903334720757,0.4605809128630705,0.8849441825176942,1.0,6/16,15.92%,RBMX;SNW1;DAZAP1;NCBP1;RBM3;SF3B4
prerank,vascular transport (GO:0010232),0.3396620233350216,1.0194605652868276,0.46390658174097665,0.8855480993213386,1.0,13/81,11.18%,ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC38A1;LRP2;SLC15A2;ATP8A1;SLC19A1;SLC38A3;LEPR;INSR;ABCC1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.35057231708810616,-1.0193443630149712,0.4212328767123288,1.0,1.0,6/16,20.18%,TOP2B;SLX4;FANCM;TOP2A;EME2;CENPX
prerank,regulation of lipid kinase activity (GO:0043550),0.4790412442955988,1.0193381576347162,0.44925373134328356,0.8853339025985972,1.0,4/11,20.38%,RBL1;RB1;WDR91;PPP2R5A
prerank,atrial septum morphogenesis (GO:0060413),0.49726974100459626,1.0188652231032662,0.4599406528189911,0.8860924189971591,1.0,2/10,9.54%,ACVR1;BMPR2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3471057944686492,1.0186187542904594,0.44004400440044006,0.8862016442673455,1.0,23/70,16.08%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;RAC1;ACTB;FYN;MYH2;HSP90AA1;CRK;BAIAP2
prerank,response to fatty acid (GO:0070542),0.4337768528004824,1.0185724527592814,0.46404341926729986,0.885758200665307,1.0,2/17,5.43%,IRS1;SOX9
prerank,morphogenesis of an epithelium (GO:0002009),0.41016715777084956,1.0184660654001647,0.46441947565543074,0.885488294526392,1.0,3/25,5.99%,TIMELESS;SOX9;FGFR2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3929462841722559,1.0184409809846666,0.45077105575326215,0.8849832756031557,1.0,7/31,14.37%,SEMA4D;SOX9;NBR1;BAMBI;MEN1;PTCH1;RANBP3L
prerank,extracellular matrix organization (GO:0030198),0.3217457532225107,1.0184044900317202,0.46546546546546547,0.8845160677539192,1.0,41/276,13.04%,LOXL2;HAS3;COL13A1;CTSS;ITGA2;COMP;KDR;P4HA1;ADAMTS3;COL9A1;HAS1;MMP14;ADAM8;LAMC1;LAMB2;COL4A2;CD47;ITGAD;COL14A1;TNC;P3H1;ITGA3;ITGB8;COL5A3;COL8A1;ADAMTS19;COL22A1;FBN1;MFAP5;SMOC2;APP;SCX;AGRN;GFOD2;TIMP2;COL3A1;GSN;CAPNS1;ADAMTS2;COL11A2;CAPN1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4412642999527822,1.0183709985896188,0.463448275862069,0.8840507698767853,1.0,7/16,22.85%,HASPIN;NAA50;MAU2;RB1;POGZ;PDS5B;PDS5A
prerank,microtubule anchoring (GO:0034453),-0.3778698880192166,-1.0183690686605786,0.444794952681388,1.0,1.0,7/12,30.99%,PCM1;GCC2;CLASP2;BCCIP;CLASP1;DAG1;CAMSAP3
prerank,thyroid hormone generation (GO:0006590),0.488076604313761,1.0181185400075061,0.4695121951219512,0.884185632740138,1.0,2/10,9.77%,CPQ;TG
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.46471220777862277,1.0171916887659933,0.44619799139167865,0.8862219126167515,1.0,3/11,20.65%,BMPR1A;LGALS9;CD46
prerank,mitochondrial translation (GO:0032543),0.3374478321891038,1.016840890694506,0.45768025078369906,0.8866419042401567,1.0,27/104,19.21%,MRPL36;IARS2;ERAL1;MTIF3;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;NOA1;MRPL24;MRPS10;MRPL13;MTRF1L;MRPL57;FASTKD2;MRPS11;MRPL40;MRPL22
prerank,rRNA transcription (GO:0009303),0.42439413639318463,1.0166736482191048,0.466484268125855,0.8865214353863627,1.0,10/17,23.84%,TCOF1;GTF3C5;TAF1B;GTF3C3;POLR1G;CAVIN1;BRF1;SPIN1;GTF3C1;ANG
prerank,tryptophan catabolic process (GO:0006569),-0.3902409371123543,-1.0165746844741463,0.44483985765124556,1.0,1.0,5/11,39.98%,KMO;IL4I1;AFMID;IDO2;KYAT1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.36452821240604316,1.0165416250993198,0.4518002322880372,0.8863154152809317,1.0,10/48,20.87%,ISG15;TLR8;IL27;CD276;IL12RB2;IL18;LGALS9;TLR3;PDE4B;EBI3
prerank,response to amyloid-beta (GO:1904645),0.37165619896844065,1.016394443279359,0.4626334519572954,0.886110310745659,1.0,9/44,14.33%,CASP4;EPHA4;CACNA1A;APP;PRNP;ABCC1;PSEN1;FCGR2B;FYN
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4281159120603932,1.016079476710016,0.46469833119383824,0.8864164562542072,1.0,7/19,23.22%,RUNX1;FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2444519406779532,-1.015763086489862,0.43478260869565216,1.0,1.0,17/59,13.17%,TAB1;NFKBIA;CARD11;TRAF2;ROCK1;NKIRAS1;TICAM2;BCL3;TRAF6;IKBKG;RIPK1;DAB2IP;UBB;IRAK1BP1;TRADD;UBC;AKT1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.40419923118145173,1.0156542036416212,0.47600518806744485,0.8870235439100448,1.0,11/22,26.03%,RNF5;AMFR;MAN1A2;RNF185;RNF103;MAN1C1;TRIM13;EDEM2;EDEM3;DERL2;EDEM1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3986173674248124,1.0152018929491486,0.445409429280397,0.8876725901316483,1.0,5/26,10.66%,HYAL1;CCND2;CCND1;TFDP1;CDK10
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3774292800870769,1.0151070174374015,0.4373522458628842,0.8873499955412167,1.0,8/36,7.98%,BDNF;ASAH2;CX3CL1;TRIM39;CYLD;CSNK2A2;PPIA;TPD52L1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3758738086622032,-1.0150851889806551,0.40823970037453183,1.0,1.0,8/13,30.68%,SHISA9;SHISA6;CLN3;SHISA7;SLC8A2;PPFIA3;SHISA8;SLC4A10
prerank,positive regulation of vacuole organization (GO:0044090),0.4734021742589293,1.0146196312200317,0.4542728635682159,0.8881305844538291,1.0,2/10,6.36%,LRSAM1;SH3GLB1
prerank,protein localization to cell junction (GO:1902414),-0.31888745739251856,-1.0143629536957035,0.4046692607003891,1.0,1.0,5/22,8.00%,KIF3A;DLG4;NECTIN1;PAK2;NLGN2
prerank,polyol metabolic process (GO:0019751),0.36001372346363386,1.0143523425374414,0.48014018691588783,0.8883264971316795,1.0,11/46,18.99%,PLCB4;ITPKC;SYNJ1;PPIP5K1;ITPK1;PLCB3;INPP4B;OCRL;NUDT4;PLCE1;MINPP1
prerank,carbohydrate catabolic process (GO:0016052),-0.27928101936700067,-1.0142409943541846,0.4117647058823529,1.0,1.0,10/38,10.78%,ENO1;PFKL;PGAM1;PGAM4;MANBA;MAN2B1;PKM;PFKFB2;ENO2;PGK1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3892584038034259,1.0142363572486084,0.445859872611465,0.8880816188806829,1.0,3/28,1.42%,IRGM;NOD2;NOD1
prerank,regulation of receptor internalization (GO:0002090),0.37424142468102245,1.0138177887235968,0.45235223160434257,0.8886775424175477,1.0,7/35,11.10%,WDR54;MAGI2;INSR;MKLN1;LRPAP1;ARRB2;SCYL2
prerank,negative regulation of mRNA processing (GO:0050686),0.4369497565200673,1.0137191656247126,0.46482758620689657,0.8883695317175314,1.0,6/15,17.11%,RBMX;BARD1;RNPS1;SRSF7;SRSF4;PCBP4
prerank,cilium movement (GO:0003341),0.35753937699363475,1.0137041226986543,0.46039035591274396,0.887838204669728,1.0,8/48,14.22%,ODAD2;CABYR;CCDC40;ADCY10;CFAP54;SPEF1;ODAD4;CFAP73
prerank,organelle fission (GO:0048285),0.39969837515917117,1.013636861666659,0.4653846153846154,0.8874596130688558,1.0,10/24,26.74%,MTFR2;FIS1;GDAP1;DNM2;MTFP1;CORO1C;OPA1;DNM3;WASHC5;DNM1
prerank,regulation of cell killing (GO:0031341),0.43108361011354646,1.0135469978878882,0.4650537634408602,0.8871407444134513,1.0,2/16,2.89%,WNT5A;CD55
prerank,glycolytic process (GO:0006096),-0.29769453642666643,-1.0135338089119037,0.400990099009901,1.0,1.0,8/28,10.78%,ENO1;PFKL;PGAM1;PGAM4;PKM;PFKFB2;ENO2;PGK1
prerank,primary miRNA processing (GO:0031053),0.4747334882481733,1.0135266622572296,0.4783904619970194,0.8866260288092743,1.0,3/10,7.85%,SRRT;HNRNPA2B1;SMAD2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.38897872793748606,1.0130681466842306,0.4586374695863747,0.8873183362029432,1.0,5/33,8.18%,HYAL1;DDRGK1;CCND2;CCND1;TFDP1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.3038547452684539,-1.0129720555363289,0.4127659574468085,1.0,1.0,4/23,7.16%,TGFB1;TGFBR3;TPM1;ID2
prerank,regulation of microtubule-based movement (GO:0060632),0.4701461765101608,1.012775683514828,0.47592067988668557,0.8875432006472012,1.0,4/11,23.76%,IGBP1;DYNLT2B;LAMP1;HDAC6
prerank,lytic vacuole organization (GO:0080171),0.3790539251281811,1.0125668612457017,0.4851116625310174,0.8875346487416611,1.0,9/32,19.98%,ABCA1;GNPTAB;NAGPA;HOOK2;HOOK1;HOOK3;MTOR;ZKSCAN3;VPS18
prerank,dorsal/ventral pattern formation (GO:0009953),0.4224859067762936,1.012523342109587,0.461038961038961,0.887098016901966,1.0,7/20,23.94%,ACVR1;MDFI;PTCH1;BMPR1A;DSCAML1;ACVRL1;LMX1B
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.36900009925463206,-1.0125089649415908,0.4263322884012539,1.0,1.0,6/13,23.37%,CSTF2;FIP1L1;CPSF7;CPSF4;TUT1;CPSF2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.45420416663741614,1.01250097709905,0.4846715328467153,0.8865881822216217,1.0,5/14,17.85%,DDX18;NOL9;RPL7L1;ZNHIT3;WDR12
prerank,regulation of T cell cytokine production (GO:0002724),0.43570944089039065,1.0124979236667297,0.4515235457063712,0.8860315658972714,1.0,2/15,2.89%,B2M;CD55
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.38866767131203345,1.0123640070389708,0.48553459119496856,0.8858234986137155,1.0,11/29,29.23%,LARP1;GDNF;TENT5A;TENT5C;TAF15;FUS;NOCT;EIF4ENIF1;HNRNPU;SLC11A1;PABPC1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.34126115995481343,1.0122414275761025,0.4588744588744589,0.8856022533641387,1.0,20/76,19.82%,DYNC1H1;HCK;EVL;CX3CL1;PDXP;CARMIL1;KATNBL1;NCK1;NCK2;PROX1;SNX9;STAP1;SYNPO;PRKCE;NRP1;BAIAP2;BAIAP2L1;CFL2;NUMA1;NCKAP1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.45026674414471274,1.0119993691253708,0.44733044733044736,0.8857171684364439,1.0,6/12,19.18%,KIF2C;CDT1;MIS12;CHAMP1;RMDN1;NDC80
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4175822080119577,1.0109808619612308,0.47493036211699163,0.8879846603432741,1.0,2/18,4.28%,IRS1;CRHBP
prerank,platelet degranulation (GO:0002576),0.32688840002676534,1.0109643528270367,0.4639175257731959,0.8874704596485821,1.0,14/118,13.51%,LGALS3BP;CLU;ACTN1;ACTN2;LAMP2;MAGED2;CDC37L1;ISLR;LYN;APP;SCCPDH;VEGFD;CHID1;VTI1B
prerank,entry into host (GO:0044409),0.4550761403725668,1.0108131192361085,0.45874125874125876,0.887345149359634,1.0,4/13,8.67%,CXCR4;CTNNB1;PPIA;MET
prerank,acylglycerol catabolic process (GO:0046464),0.38333956528289526,1.0105780245579377,0.449874686716792,0.887405696922058,1.0,5/30,14.70%,PNPLA2;ABHD2;LIPC;LYPLA2;DAGLA
prerank,polyol biosynthetic process (GO:0046173),0.4263820638598006,1.0104309550390302,0.44722222222222224,0.8872448742317249,1.0,4/16,15.93%,ITPKC;PPIP5K1;CYP27A1;ACER3
prerank,lipoprotein transport (GO:0042953),-0.39728614325444245,-1.0097800984677059,0.44021739130434784,1.0,1.0,1/10,1.69%,PPARG
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3246467910229784,1.009759196998538,0.4898373983739837,0.8885430979782261,1.0,49/168,21.13%,HELZ2;POLR2G;ZFP36;XRN2;RPL36;DDX5;MAGOHB;SMG7;CNOT4;CNOT7;NCBP2;GSPT1;RPL22;XRN1;TNKS1BP1;RPS21;DCP2;ZC3H12A;ZFP36L1;RNPS1;SMG5;UPF2;UPF3A;RPS6;DIS3L2;EXOSC9;PATL2;RPS11;RPL30;ETF1;NCBP1;RPL32;RPL23A;RPL11;TUT7;UPF1;RPL10A;PPP2R2A;RPS15A;DCPS;RPL24;PAN3;RPL37A;RPL3;RC3H2;CSDE1;RPL29;MTPAP;RPL5
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.37741700182998145,1.0095512692166404,0.47058823529411764,0.8885632798712161,1.0,7/34,18.55%,NOD2;WNT5A;SPHK2;XBP1;STX4;PTPRC;LACC1
prerank,positive regulation of proteolysis (GO:0045862),0.35572389399845383,1.009524022168174,0.46885617214043035,0.8880640375346166,1.0,18/55,23.27%,ASPH;SNX33;ADAM8;CTSC;CTSH;TNIP1;BTRC;SNX9;ZC3H12A;APOE;BAD;AURKAIP1;IST1;SH3D19;TANK;STUB1;HDAC2;CLN6
prerank,myoblast differentiation (GO:0045445),0.4458854984478702,1.0091227081398915,0.4907801418439716,0.8885825750601676,1.0,4/14,18.45%,DDX5;TCF7L2;RB1;HINFP
prerank,cardiac muscle cell development (GO:0055013),-0.32107791184407836,-1.0088429462505213,0.4356060606060606,1.0,1.0,10/20,34.59%,PDLIM5;SORBS2;CXADR;FHOD3;PDGFRA;PDGFRB;MYH11;HEY2;OBSL1;MYL2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.35609830935710207,1.0088255994059452,0.45691609977324266,0.8888626991800639,1.0,19/50,23.77%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;AZIN1;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3437658275552097,1.0087816929653057,0.46314631463146316,0.8884232998512438,1.0,23/71,16.08%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;RAC1;ACTB;FYN;MYH2;HSP90AA1;CRK;BAIAP2
prerank,regulation of endocytosis (GO:0030100),0.34935842172082354,1.008182698599176,0.4684385382059801,0.8895469593545936,1.0,25/61,26.35%,CDH13;SNX33;LRSAM1;RAB5C;LRPAP1;AP2S1;APOE;RUBCN;STON1;DAB2;TFR2;OPHN1;CBLL1;STON2;RAB5B;MCTP1;ABL2;CD22;SNX17;SNX12;PACSIN1;SYT11;PTPN1;CALY;LRP1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.346221481699038,-1.008116247096001,0.449438202247191,1.0,1.0,8/17,37.01%,TGFB2;JAG1;SMAD6;ROBO1;BMP4;HEY1;HEY2;HEYL
prerank,non-motile cilium assembly (GO:1905515),-0.29171610439514367,-1.0078612885094616,0.415,1.0,1.0,17/30,33.36%,RPGRIP1L;PCM1;IFT88;VANGL2;IFT57;BBS1;TMEM216;RPGRIP1;BBS10;FUZ;TMEM17;TTC8;CSNK1D;CEP250;TMEM107;CCDC13;CEP290
prerank,regulation of calcium ion import (GO:0090279),0.40892338063766903,1.007150626387757,0.4642857142857143,0.8917700602453096,1.0,5/21,14.33%,SLC30A1;CTNNB1;PRNP;SPHK2;FYN
prerank,organelle assembly (GO:0070925),0.31285551683265195,1.0070745097461082,0.475,0.8914196982751185,1.0,110/385,24.47%,IRGM;CNGB1;CHMP4A;CHMP4B;CHMP1B;AUP1;CENPJ;CEP19;ATP6V0D1;BBIP1;RAB8B;RBM14;CDS1;B9D2;ACTR2;YTHDF1;CEP162;MVB12A;DYNC1H1;GOLGA8B;UBQLN2;RILP;RILPL1;SNX10;TTC39C;STX7;ACTR3;NPHP3;KIF3B;MAPRE1;RAB43;YTHDF2;MKS1;VPS37A;UBXN2B;UBQLN1;CFAP54;FNBP1L;WDR35;NPM1;TMEM138;CEP131;CHMP3;EXOC6;GSN;NEK6;TMOD3;DYNLT2B;VPS28;MAP1LC3B;SYNPO;DYNLL1;E2F4;POGZ;CCDC61;EIF2S1;PATL2;RB1CC1;PIBF1;DZIP1;CFAP20;MIS12;TMEM67;DBNL;BBS2;HGS;CCDC66;ARF4;RAB11A;RAB32;DHX37;WDR19;DYNC2H1;SH3PXD2B;OCRL;IST1;CEP89;DCDC2;CHMP5;GBF1;IFT46;NEK7;OGFOD1;MRPL22;BECN1;GORASP2;RAB1A;CSDE1;DDX3X;STARD9;G3BP1;TRAPPC14;HAUS3;CHMP1A;TSG101;TRAPPC6A;VPS36;FARP2;MAPRE3;IFT140;ZFYVE1;LIMD1;NOTCH1;LSM4;HDAC6;UBAP2L;EXOC2;BSCL2;BBS7;FLNA
prerank,negative regulation by host of viral transcription (GO:0043922),0.45821134367297633,1.0070723564674142,0.4636627906976744,0.8908644599727237,1.0,6/12,24.44%,TARDBP;CCL5;INPP5K;HDAC1;CCL4;TFAP4
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3181301907867592,-1.0070649723406366,0.4475806451612903,1.0,1.0,9/21,25.50%,NFAM1;CD81;CARD11;IKBKG;FOXP1;CD226;TESPA1;NECTIN2;RPS3
prerank,positive regulation of filopodium assembly (GO:0051491),-0.30182358996720315,-1.0069295468402495,0.4238095238095238,1.0,1.0,7/24,14.28%,WASL;DPYSL3;CDC42;RHOQ;PALM;GPM6A;RIPOR2
prerank,cellular response to hypoxia (GO:0071456),0.3262556987667992,1.0068520394339338,0.4865702479338843,0.8908881271003551,1.0,47/126,26.82%,PSMB10;PSME2;PSMA5;PSME4;ADAM8;EGLN2;NOP53;HYOU1;PSMA3;BACH1;MT3;PSMB9;RBX1;PLK3;RORA;UBQLN1;ELOC;ZFP36L1;PSMD2;AK4;SCN2A;PSME3;NPEPPS;BAD;PSMA4;MTOR;CPEB2;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;STUB1;PSMD4;LIMD1;TIGAR;PSMA2;CUL2;SIRT2;EPAS1;PSMD1;PSMD11;HIGD1A;FMN2;BNIP3L
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.4197005863127852,1.0062547867663998,0.4807692307692308,0.8919446592919886,1.0,4/18,13.98%,DHX33;UBTF;POLR2K;WDR43
prerank,positive regulation of telomere maintenance (GO:0032206),0.38687499293332067,1.0059774513547166,0.4564676616915423,0.8921434506003557,1.0,6/31,9.63%,PML;DHX36;RTEL1;HNRNPA2B1;SIRT6;PPP1R10
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3234008255087074,-1.0052671421257597,0.44360902255639095,1.0,1.0,5/18,11.66%,ROCK1;SELPLG;JAM2;CX3CR1;GOLPH3
prerank,lysosome organization (GO:0007040),0.3734557703187911,1.0052302000387388,0.4779951100244499,0.8936283212488921,1.0,12/36,23.71%,ABCA1;GNPTAB;VPS33A;NAGPA;HOOK2;HOOK1;HOOK3;MTOR;ZKSCAN3;VPS18;CLN6;TMEM165
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.37145580862648697,1.0048552235417612,0.4911452184179457,0.8941119634457892,1.0,6/38,10.95%,STAT1;TRIM39;RORA;TNIP1;ZC3H12A;RIOK3
prerank,protein deubiquitination (GO:0016579),0.31762924978113866,1.0047307664046814,0.5120481927710844,0.8939005587054363,1.0,74/242,24.14%,USP18;IFIH1;PSMB10;PSME2;BIRC2;INO80E;USP50;PSMA5;PSME4;USP25;USP21;USP15;OTUD3;POLB;USP40;PSMA3;CYLD;SMAD2;UCHL5;PSMB9;UCHL3;ACTR8;USP34;BARD1;TADA2B;TRAF3;VCPIP1;JOSD2;ARRB2;TNIP1;ZC3H12A;FOXK1;OTUD1;ATXN7;PSMD2;USP14;PSME3;ZRANB1;USP45;BIRC3;ACTB;PSMA4;TNIP2;USP37;HGS;TNIP3;OTULINL;INO80C;ENY2;BABAM2;PSMD7;OTUD6B;PSMD8;BECN1;PSMD9;MBD6;NFRKB;PSMF1;USP5;PSMB6;USP8;PSMC2;PSMD12;SENP8;USP33;SMURF2;ADRM1;PSMD4;VCP;PSMA2;KAT2B;ACTL6A;USP10;USP32
prerank,transcription by RNA polymerase I (GO:0006360),-0.2722085660841443,-1.0044715846881118,0.4318181818181818,1.0,1.0,14/34,18.28%,POLR1A;MAPK3;ERCC3;TBP;TTF1;ERCC2;RRN3;TAF1D;TAF1;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3
prerank,neuron projection organization (GO:0106027),0.4379196264478538,1.0043720623161287,0.46563814866760167,0.8943796353793932,1.0,5/15,12.27%,APP;INSR;ABCD1;PRNP;PSEN1
prerank,regulation of fat cell differentiation (GO:0045598),0.33965906334126766,1.0042801413231575,0.4799566630552546,0.8940624020243875,1.0,14/74,12.85%,TRIB3;WNT5A;ZFP36;CDS1;SFRP2;MEDAG;AAMDC;FRZB;TAF8;RORA;ZC3H12A;ZFP36L1;XBP1;ENPP1
prerank,protein K63-linked ubiquitination (GO:0070534),0.3649388706041782,1.003536066991158,0.46938775510204084,0.8955168255224982,1.0,8/41,11.44%,RNF4;TRIM21;RNF5;BFAR;UBE2B;UBE2E3;TRAF3;TRAF5
prerank,transcription by RNA polymerase III (GO:0006383),0.3800915938684172,1.003461168376237,0.46758104738154616,0.8951671606201956,1.0,10/27,20.43%,SNAPC2;RO60;GTF3C5;POLR3GL;POLR2K;ICE2;SNAPC5;GTF3C3;BRF1;SNAPC4
prerank,mismatch repair (GO:0006298),0.38372928521968297,1.0034357597677197,0.4581218274111675,0.8946725605056476,1.0,4/27,6.35%,MSH2;POLD4;RNASEH2A;MCM9
prerank,fatty acid elongation (GO:0030497),-0.36642463980520756,-1.0034347709113767,0.4368932038834951,1.0,1.0,6/13,22.30%,TECR;HACD1;ELOVL5;ELOVL1;ELOVL7;ELOVL6
prerank,regulation of trophoblast cell migration (GO:1901163),0.44245466247320475,1.0032660088054812,0.47960618846694797,0.894585499191299,1.0,2/14,5.33%,AGO2;SYDE1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.47921356842074314,1.003024205998775,0.48615384615384616,0.8946361965335882,1.0,3/10,9.99%,CHEK1;KMT2A;SPHK2
prerank,regulation of myoblast differentiation (GO:0045661),0.3823275615481433,1.00291856139861,0.4708029197080292,0.8943746434439013,1.0,9/32,16.99%,EID2B;SOX9;SRA1;MAPK14;ZFP36L1;RANBP3L;SMYD1;FLOT2;TRIP4
prerank,potassium ion import across plasma membrane (GO:1990573),-0.26353481597045075,-1.0023746059545582,0.41935483870967744,1.0,1.0,5/41,3.69%,SLC12A6;ATP1B1;SLC12A2;ATP1B2;KCNJ10
prerank,superoxide metabolic process (GO:0006801),0.3860332018212821,1.0017922432552837,0.44862155388471175,0.8968742594729686,1.0,4/29,6.57%,SOD2;CYBB;TAFA4;MT3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.40569871510341493,1.0014484283252367,0.46866840731070497,0.897229579344224,1.0,2/21,3.75%,CAMK2D;SLC8A1
prerank,peptide hormone secretion (GO:0030072),0.39208767615844065,1.0012025235419149,0.4585987261146497,0.8973217568069923,1.0,2/26,8.16%,GAL;SNX19
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.310991663517752,1.0008218221958838,0.509,0.8977584338141695,1.0,87/390,18.28%,AXL;NAMPT;FLT1;POLR2G;IRS1;KDR;BDNF;ATP6V0D1;NRP2;STAT3;ELMO2;LCP2;ACTR2;ZNF106;GRB10;CYBB;COL4A2;HNRNPH1;HCK;NCBP2;CYFIP1;AP2A1;EPHA4;FGFR2;PAK3;ARHGEF7;ACTR3;CSF1;RET;HNRNPM;EPHA6;RAPGEF2;BCAR1;LTK;NCK1;MET;LYN;NCK2;POLR2K;INSR;KIF16B;VAV1;MAPK14;GFRA2;ROR2;PHIP;GIT1;AP2S1;RAB14;VEGFD;FGF9;ARPC5;DDIT4;SOS1;STAP1;HNRNPA1;PTPN11;PSEN1;SOCS2;CHN1;SIPA1L1;PIK3CB;RAPGEF1;NRP1;TIAL1;RAC1;ACTB;JAK2;FYN;APH1A;IRS2;HSP90AA1;APH1B;NCBP1;CRK;FGFR3;BAIAP2;TCIRG1;BLNK;ATP6V1B2;FLRT2;FIBP;GIGYF1;MPZL1;ATP6V1G1;ARPC1B;POLR1G
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.35202715484310276,1.0008119562325388,0.47801578354002255,0.8972233586793872,1.0,9/53,12.35%,PSME2;DDRGK1;OSBPL7;HSP90AB1;FBXW7;UCHL5;USP14;PSME3;APOE
prerank,histone acetylation (GO:0016573),0.34300173739327544,1.000743732249641,0.4762419006479482,0.89684414748955,1.0,30/69,28.87%,JADE3;NAA50;EP400;BRD1;KAT14;TADA2A;SUPT7L;WDR5;BRPF1;APBB1;KAT8;SGF29;KAT7;PER1;RUVBL2;ING5;TADA1;KAT6A;KAT5;JADE2;KAT2B;ACTL6A;YEATS2;ZZZ3;RUVBL1;EP300;BRD8;CHD5;BRPF3;YEATS4
prerank,calcium ion transport into cytosol (GO:0060402),0.4098047107774325,1.0003204636062806,0.47688243064729197,0.897441658323717,1.0,3/21,3.75%,TRPM2;GRIN2D;SLC8A1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.44025949658329455,1.000131115453373,0.4795486600846262,0.8973790388163218,1.0,5/14,12.85%,ENPP3;CMPK2;AK4;AK3;ENPP1
prerank,positive regulation of apoptotic process (GO:0043065),0.315279087639792,1.0001302728028203,0.5055165496489469,0.8968217980114834,1.0,48/293,13.38%,ZBP1;TNFSF10;IFIT2;DAPK3;MYBBP1A;CLU;PRMT2;RARG;GADD45G;TNFRSF8;MLLT11;BCL2L11;SFRP2;PLEKHN1;SIAH1;CTNNB1;ARHGEF7;BCL6;DDX20;PTRH2;TRIM39;TFAP2B;FRZB;TPD52L1;ABR;BARD1;HMGB1;PRNP;VAV1;SPHK2;PRR7;ZC3H12A;DIABLO;DNM2;PHLDA1;RNF122;RNPS1;SIK1;RYBP;ARHGEF11;SOS1;PSEN1;RACK1;RPS6;BAD;APBB1;AKAP13;TIAM2
prerank,response to calcium ion (GO:0051592),0.3279585657106504,0.9999359979164959,0.48783068783068784,0.8968208171319335,1.0,16/102,15.98%,KCNMB3;CAMK2D;RASA4;CLIC4;WNT5A;CPNE3;TRPM2;CRHBP;SYT7;SYT3;ADGRV1;AHCYL1;SLC25A12;CALM3;MEF2A;CARF
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.34830237699428673,0.9997913769811888,0.481941309255079,0.8966389230062825,1.0,10/57,12.41%,TAOK3;CHEK2;CHEK1;NOP53;TIPIN;CCND1;TRIM39;WAC;RINT1;PRKDC
prerank,vascular process in circulatory system (GO:0003018),-0.3726539618877162,-0.9996389299929963,0.4560260586319218,1.0,1.0,2/13,3.78%,ROCK1;GCLM
prerank,regulation of tube diameter (GO:0035296),-0.3726539618877162,-0.9996389299929963,0.4560260586319218,1.0,1.0,2/13,3.78%,ROCK1;GCLM
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4304888349848946,0.9995640775518083,0.4652777777777778,0.8967272111438463,1.0,6/15,19.75%,TRPT1;TSEN2;FAM98B;RTCB;TSEN34;ERN1
prerank,nuclear transport (GO:0051169),0.4258859179270117,0.9995027282370526,0.47448275862068967,0.8963306429867457,1.0,4/16,10.72%,NXT1;BANF1;NPM1;RSRC1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3406992165999508,0.9994824647304487,0.46864686468646866,0.8958324478508896,1.0,23/73,16.08%,MYO1C;ELMO2;ACTR2;HCK;HSP90AB1;CYFIP1;ACTR3;NCK1;LYN;FCGR1A;VAV1;ARPC5;PRKCE;FCGR2B;PIK3CB;NCKIPSD;RAC1;ACTB;FYN;MYH2;HSP90AA1;CRK;BAIAP2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.41067198955590545,0.9994225702890406,0.49267643142476697,0.8948777140150119,1.0,3/19,9.31%,POLR2G;DAXX;POLR2K
prerank,regulation of DNA recombination at telomere (GO:0072695),0.41067198955590545,0.9994225702890406,0.49267643142476697,0.8948777140150119,1.0,3/19,9.31%,POLR2G;DAXX;POLR2K
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3760607851643053,0.999415178150846,0.47123623011015914,0.8943415687927508,1.0,8/33,16.79%,PRMT2;RBL1;CDKN2D;DACT1;PLK3;RB1;DLG1;BRD7
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3460724183642942,0.9990932433841385,0.4753914988814318,0.8946607729329915,1.0,9/62,9.31%,NUP37;POLR2G;ZFP36;AGO2;STAT3;NUP153;DHX9;RAE1;POLR2K
prerank,response to reactive oxygen species (GO:0000302),-0.24669581521957448,-0.9986382232227637,0.456,1.0,1.0,10/54,7.84%,PTPRK;APOD;MPV17;PXN;EGFR;APTX;MAPK3;HMOX1;TPM1;SIRT1
prerank,cytoskeleton organization (GO:0007010),0.32614205314500977,0.9985235224675091,0.4932920536635707,0.8956475117278903,1.0,32/114,19.56%,CCL7;FMNL2;LRCH3;KLHL20;CNTNAP1;THY1;RHOF;BRWD3;SPRYD3;PRPF40A;ANK1;ARHGAP4;EPB41L3;ZMYM3;MAST3;TNIK;PHIP;CAPZB;ARHGAP10;APOE;FGD6;NCKIPSD;ZRANB1;RAC1;ZMYM6;MDK;PLCE1;SH3D19;FMNL3;MARK1;SIPA1L3;RANBP9
prerank,protein localization to cell surface (GO:0034394),0.3966256413911907,0.9984514362880467,0.48253557567917205,0.8952793849911032,1.0,7/26,19.58%,WNT11;CTNNB1;GGA3;SMURF1;JAM3;PTPRU;PIGK
prerank,negative regulation of cyclase activity (GO:0031280),-0.35616288618198527,-0.9984353884623377,0.44554455445544555,1.0,1.0,4/14,12.68%,GRM3;EDNRB;PALM;CCR2
prerank,regulation of leukocyte activation (GO:0002694),-0.36307658798774545,-0.9980060813017583,0.4444444444444444,1.0,1.0,6/14,17.03%,GPR137B;MYO18A;PLSCR1;MIF;PJA2;SHPK
prerank,leukocyte tethering or rolling (GO:0050901),-0.32804588779128036,-0.9973504584332753,0.45955882352941174,1.0,1.0,5/17,11.66%,ROCK1;SELPLG;JAM2;CX3CR1;GOLPH3
prerank,modulation by symbiont of host process (GO:0044003),-0.39103152581086154,-0.9971837712270873,0.44135802469135804,1.0,1.0,7/10,17.44%,ENO1;MRC1;UBB;PGK1;UBC;UBA52;RPS27A
prerank,positive regulation of transmembrane transport (GO:0034764),0.44438017083656123,0.9971150617792154,0.47092198581560285,0.8983179109563381,1.0,4/13,13.29%,AZIN2;ACSL5;AZIN1;CA2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3710201907805394,0.9969635612516499,0.49347568208778175,0.8981623514414836,1.0,7/35,10.48%,SPRY2;TNFAIP1;ITGA3;MYOC;MET;KANK1;STMN3
prerank,regulation of neuron migration (GO:2001222),0.3862838841466229,0.9968384257301097,0.4720101781170484,0.8979376315575535,1.0,8/26,16.89%,PLXNB2;CAMK2B;CX3CL1;RAPGEF2;COL3A1;SRGAP2;IGSF10;MDK
prerank,regulation of chromosome organization (GO:0033044),-0.3138004956035748,-0.9968196549469279,0.4444444444444444,1.0,1.0,5/22,7.70%,WAPL;XRCC5;CENPV;TERF2IP;YLPM1
prerank,MAPK cascade (GO:0000165),0.3119409988473864,0.9967805147110622,0.5025025025025025,0.8975386771162115,1.0,70/295,19.56%,TAOK3;RGL3;PSMB10;RASA4;SKP1;IRS1;KDR;PSME2;GOLGA7;ZFP36;CAMK2B;PSMA5;KITLG;TGFA;PSME4;MAP3K8;ACTN2;PTGER4;CCL5;SOX9;FGFR2;PSMA3;NFKB1;MT3;RET;PAQR3;RAPGEF2;CTSH;PSMB9;MET;GDNF;PTPN7;RBX1;MEN1;GFRA2;TNIK;BTRC;ZFP36L1;WDR83;PSMD2;FGF9;MAP2K2;SOS1;PSME3;LAMTOR3;FGF13;PIK3CB;RASAL1;JAK2;FYN;PSMA4;DLG1;IRS2;TNIP2;MINK1;TAOK2;MEF2A;FGFR3;IL18;LGALS9;CSF2RA;PRKG2;NF1;PSMD7;FNTA;SPRED1;PSMD8;CAMKK2;PSMD9;RANBP9
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3148980727311197,-0.9962643475385484,0.47641509433962265,1.0,1.0,10/21,25.69%,COX16;PET100;COX15;COX10;TIMM21;SCO1;SURF1;COA3;COA6;COX18
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.35849800405067594,0.9962640522180237,0.4874715261958998,0.8983554791382599,1.0,8/48,10.50%,KDR;CD40;RHOJ;MAP2K3;P2RX4;HMGB1;MAPK14;CIB1
prerank,cellular response to organic substance (GO:0071310),0.32613557309185054,0.9960190137060202,0.5076923076923077,0.8984054805832281,1.0,25/116,18.19%,CXCR4;CPNE3;ACVR1;STAT3;ASAH2;PTPN18;LRP2;CCL5;NCOA1;CTNNB1;PTPN7;BMPR2;LDLRAP1;CIB1;SLIT3;PTPN11;SOCS2;RACK1;INPP5K;BMPR1A;TIPARP;IL18;PTPN9;DCPS;ACVR2A
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3924295003625632,0.9957124181396034,0.49039692701664533,0.8980916992880159,1.0,8/23,27.30%,HSP90AB1;MEN1;SNW1;DAB2;STK11;CITED2;SDCBP;EP300
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3924295003625632,0.9957124181396034,0.49039692701664533,0.8980916992880159,1.0,8/23,27.30%,HSP90AB1;MEN1;SNW1;DAB2;STK11;CITED2;SDCBP;EP300
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3710872669029964,0.9956371075913552,0.4908200734394125,0.8977296596861355,1.0,4/35,12.30%,PCDHB13;CDH13;CDH9;PCDHB16
prerank,negative regulation of bone remodeling (GO:0046851),0.4626669124417941,0.995454888623738,0.47126436781609193,0.8976596951134964,1.0,1/11,0.60%,CALCA
prerank,bone development (GO:0060348),0.3723445136425875,0.995402537748267,0.4976635514018692,0.8972706382268072,1.0,11/39,17.40%,SBDS;PTGER4;P3H1;FGFR2;MYOC;CYP26B1;AKAP13;RANBP3L;FGFR3;SH3PXD2B;PTPRC
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.39504196884911824,0.995130902102323,0.4801536491677337,0.8974214964829968,1.0,5/23,12.27%,NFKB1;ENTPD5;APP;INSR;PSEN1
prerank,regulation of neuron projection development (GO:0010975),0.31745144750485094,0.9950772712569452,0.5091649694501018,0.8970182934551153,1.0,43/163,18.79%,WNT5A;PLXNB2;BDNF;CAMK2B;FBXO7;RETREG3;RUFY3;PLXNB3;CX3CL1;P3H1;EPHA4;PAK3;MT3;RET;MAGI2;EFHC2;PAQR3;RAPGEF2;CCDC88A;LTK;LYN;KANK1;ROR2;CIB1;MAG;PSEN1;APOE;CHN1;TRPV4;SIPA1L1;MYLIP;RAPGEF1;RTN4IP1;NPTN;SCN1B;PTPN9;MDK;STMN2;CAMSAP2;ITM2C;FUT9;MARK1;BRSK1
prerank,regulation of fibroblast migration (GO:0010762),0.4094245826862872,0.9949525558749069,0.5032509752925878,0.8968283890975289,1.0,9/20,21.96%,HAS1;ARHGEF7;PRKCE;RAC1;CORO1C;RFFL;APPL2;DDR2;FGF2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3377744292257451,0.9947521180622199,0.4886731391585761,0.8967628795755049,1.0,23/80,22.48%,PLXNB2;ABCG1;CLU;YTHDF1;NSMAF;ZCCHC4;EPHA4;SPHK2;NPM1;EIF6;LRRTM3;PRKDC;UPF3A;RACK1;RBM3;MTOR;METTL14;IFNGR1;DDX3X;PLA2G6;RPL5;PRKCD;PYM1
prerank,response to interleukin-6 (GO:0070741),-0.3869697783695908,-0.9947088056327871,0.4378531073446328,1.0,1.0,2/10,3.14%,ST3GAL6;SELPLG
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.43809488475562564,0.9944777923194638,0.46438746438746437,0.8968952506105663,1.0,3/14,8.42%,TIMELESS;ACTR2;ARID2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3649803538470004,-0.994263360937884,0.4605263157894737,1.0,1.0,4/13,12.68%,GRM3;EDNRB;PALM;CCR2
prerank,peptidyl-serine modification (GO:0018209),-0.20242511158992338,-0.9940798354170972,0.6,1.0,1.0,45/166,17.03%,CSNK2A1;DYRK1A;STK32A;STK38;PARP2;PRKCQ;SGK1;RPS6KA3;PARP1;ROCK1;PRKCZ;VRK1;PAK2;CSNK1E;PINK1;VRK2;ULK2;RPS6KA2;GSK3B;TTBK1;MKNK2;CAMK4;TAF1;AKT2;RPS6KA6;MAP3K13;CAMK1;GRK2;GALNT2;PRKCI;MAST1;AKT1;ULK3;HIPK1;TTBK2;RPS6KA4;CSNK1G2;MAP3K12;CLSPN;DYRK4;NDNF;DYRK1B;MAST4;MAP4K1;NAA10
prerank,establishment of spindle localization (GO:0051293),0.44445915083807064,0.9939545294342006,0.48739495798319327,0.8977592407226519,1.0,4/14,16.51%,DYNC1H1;KPNB1;MAP4;LLGL1
prerank,cytoplasmic microtubule organization (GO:0031122),0.34818870310129024,0.9934460174295293,0.503370786516854,0.8985368919973785,1.0,20/54,21.35%,KATNAL1;DYNC1H1;KPNB1;HOOK2;CCDC88A;PLK3;HOOK1;STMN3;CIB1;CCDC88B;TRPV4;CLIP2;HOOK3;DLG1;RAB11A;CLIP4;CAMSAP2;NUMA1;FIGN;CRIPT
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.35729324096691883,0.9933042808578402,0.500578034682081,0.8983460264211757,1.0,17/48,19.76%,CARMIL1;ARHGEF7;CUL7;FBXW8;MYOC;CIB1;CUX1;PRKDC;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;CAPRIN1;TESK1;SS18L1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.40895354671849193,0.9932591532525339,0.45901639344262296,0.8979170209490267,1.0,7/20,20.95%,ATIC;HPRT1;ADSL;AK4;AK3;AMPD3;LHPP
prerank,inositol phosphate metabolic process (GO:0043647),0.3536236988027337,0.992649696517371,0.5176056338028169,0.8989717973929575,1.0,11/46,18.99%,PLCB4;ITPKC;SYNJ1;PPIP5K1;ITPK1;PLCB3;INPP4B;OCRL;NUDT4;PLCE1;MINPP1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3439460927485363,0.9921868227471637,0.48606465997770343,0.899623790050973,1.0,6/66,3.66%,NOD2;TAOK3;FLT1;CD40;SASH1;ADAM8
prerank,regulation of mitochondrion organization (GO:0010821),0.35705428056533495,0.9920896017725593,0.49825783972125437,0.8993073362191957,1.0,6/47,12.33%,STAT2;FIS1;FBXW7;CSNK2A2;INF2;PPARGC1A
prerank,RNA export from nucleus (GO:0006405),0.32989234665128475,0.9919762216800609,0.5305263157894737,0.89905056344167,1.0,30/100,21.86%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;HNRNPA1;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,calcium ion import (GO:0070509),0.3800388257685231,0.991974796815758,0.48152866242038217,0.8985057505318447,1.0,10/28,27.95%,SLC8A1;CACNA1A;MCUR1;TRPV4;MICU2;TRPC4;SMDT1;MICU3;SLC25A23;CACNA1D
prerank,regulation of B cell apoptotic process (GO:0002902),0.45237031311581366,0.9917177615113026,0.4823529411764706,0.8986588441606856,1.0,3/12,14.64%,BCL6;LYN;IRS2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.45259501188408235,0.9916648110597189,0.4901129943502825,0.8982607644179209,1.0,4/13,16.03%,SOX9;SRF;NFIB;PPARD
prerank,regulation of macrophage migration (GO:1905521),-0.3999398344146983,-0.9913534326634819,0.4789156626506024,1.0,1.0,6/10,29.44%,CD81;CX3CR1;CD200R1;CD200;EMILIN1;PTK2B
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3300880668125209,0.9911023759384961,0.5243128964059197,0.8991754644261245,1.0,29/96,21.86%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;SLU7;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.27419111235570304,-0.990892297407936,0.4451219512195122,1.0,1.0,13/34,19.15%,TGFB1;ASXL1;ZFPM2;RUNX1T1;SIRT1;TRIO;ANKRD26;FOXO1;CCDC85B;E2F1;BBS12;YAP1;FLCN
prerank,response to laminar fluid shear stress (GO:0034616),0.46406599505269175,0.9906650235192408,0.4909365558912387,0.8998276059976834,1.0,1/10,1.02%,ABCA1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.36943906222157996,0.9900106321273786,0.49150485436893204,0.901027110772217,1.0,6/36,6.51%,TIMELESS;CHEK2;CHEK1;TIPIN;CDT1;BRIP1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.28711454995849633,-0.9897480050543705,0.46745562130177515,1.0,1.0,13/32,20.07%,DYRK1A;FKBP4;TUBB4A;SNCA;CLASP2;APC;HDGFL3;ARHGEF2;CLIP3;TTBK2;TPX2;APC2;CLASP1
prerank,histone deacetylation (GO:0016575),0.35122710915409144,0.9896165946655742,0.5017626321974148,0.9015257718734021,1.0,15/43,25.36%,PER2;RBM14;MTA3;MTA2;SIRT6;MIER1;HDAC8;RCOR3;HDAC1;PER1;HDAC2;HDAC4;HDAC6;SIRT2;SMARCAD1
prerank,apoptotic cell clearance (GO:0043277),-0.28820822352454084,-0.989596696304403,0.4841628959276018,1.0,1.0,13/30,21.00%,ITGAV;XKR6;RAC2;RHOBTB2;SCARB1;RARA;XKR4;TREM2;RHOBTB1;TYRO3;ITGB3;ANXA1;NR1H3
prerank,organelle fusion (GO:0048284),0.4025936225028019,0.9893878505086356,0.49154746423927176,0.901570627448808,1.0,9/22,23.46%,FIS1;GDAP1;VPS11;STX4;MIGA2;BAX;VPS18;OPA1;EEA1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3802349133017355,0.989366626791485,0.4885786802030457,0.9010859009310873,1.0,3/30,2.85%,FLT1;KDR;SBDS
prerank,microtubule depolymerization (GO:0007019),0.4147278760481234,0.98913268706066,0.478494623655914,0.90118139830136,1.0,6/17,18.39%,KIF2C;STMN4;STMN3;KIF2A;STMN2;KIF19
prerank,axon development (GO:0061564),0.334829403773321,0.9888882068194836,0.5220667384284177,0.9012737439010946,1.0,21/78,19.94%,SLITRK6;DHFR;ATL1;GAP43;FGFR2;PAK3;MAPK8IP3;APP;APBB1;ACTB;TAOK2;BAIAP2;DSCAML1;LLGL1;CAMSAP2;SVBP;BRSK1;MAP1B;RTN4RL1;CCK;PLP1
prerank,substrate-dependent cell migration (GO:0006929),0.4325038331594629,0.988665683739197,0.4943181818181818,0.9013010447857295,1.0,4/14,17.40%,ITGA2;NRP1;OPHN1;PTPRC
prerank,dicarboxylic acid metabolic process (GO:0043648),0.35538473060776676,0.9879200858970312,0.5106861642294713,0.9027408105374753,1.0,5/52,6.99%,MTHFR;DHFR;SLC46A1;SLC19A1;IDH1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3341122730027005,0.9876048269899801,0.521598272138229,0.9030060010901468,1.0,9/73,9.06%,IRGM;SPRY2;BDNF;SFRP2;MAD2L2;HSP90AB1;TNKS1BP1;MTCP1;APP
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4027292485213677,0.9873738192005703,0.5107816711590296,0.9030309943063768,1.0,3/20,13.43%,BCKDK;SIK1;CLK2
prerank,lipid oxidation (GO:0034440),0.4472483896674353,0.9871829211753946,0.49037037037037035,0.9029754412832645,1.0,3/12,21.13%,PPARGC1A;ACOX1;ADIPOR1
prerank,cardiac muscle cell contraction (GO:0086003),0.4023452329763171,0.9871689397766914,0.4709066305818674,0.9024655864059956,1.0,4/19,16.74%,CAMK2D;GSN;SCN1B;KCNJ2
prerank,axonogenesis (GO:0007409),0.3132235941251403,0.9869833337890902,0.5346733668341709,0.9024092321057898,1.0,49/237,16.51%,SLITRK6;UNC5B;CXCR4;WNT5A;BDNF;PIK3CD;ATL1;SEMA4D;NRP2;GRB10;DOK1;SIAH1;EVL;HSP90AB1;CYFIP1;EPHA4;FGFR2;PAK3;RET;DOK6;DOK5;EPHA6;GDNF;B4GALT5;APP;RAP1GAP;GFRA2;LYPLA2;SLIT3;SLIT1;SOS1;PTPN11;PIK3CB;APBB1;NRP1;ACTB;FYN;IRS2;HSP90AA1;NPTN;TAOK2;DSCAM;BAIAP2;DSCAML1;SEMA3D;SCN1B;NLGN3;OPHN1;LLGL1
prerank,arachidonate transport (GO:1903963),-0.3964229654255201,-0.9868653642396307,0.4748427672955975,1.0,1.0,7/10,40.64%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,arachidonic acid secretion (GO:0050482),-0.3964229654255201,-0.9868653642396307,0.4748427672955975,1.0,1.0,7/10,40.64%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3297709571195309,0.9868196732125512,0.5121436114044351,0.9022792224681526,1.0,31/80,26.18%,VPS51;RGP1;GOSR2;VPS53;TBC1D23;VPS54;BAIAP3;STX16;ARL1;ANKFY1;VPS50;TMEM87A;VPS52;RIC1;VTI1B;PREPL;SPAG9;VPS26A;SNX1;GBF1;GOSR1;VPS35;SNX2;STX6;RAB29;SNX12;DENND2A;RBSN;DCTN1;TBC1D17;RAB7B
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.31204587252065175,0.9866378139291053,0.5245245245245245,0.9021813774994949,1.0,70/264,18.22%,SRPK3;POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;DDX20;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;BCAS2;POLR2K;RNPC3;SRPK1;HNRNPL;HSPA8;TGS1;RBM17;RSRC1;SNW1;WDR83;RNPS1;RALY;HNRNPH3;HNRNPA1;USP39;RBM41;PAPOLA;SART1;BUD31;CLNS1A;GEMIN7;SNRPD2;SNRPD1;DBR1;EFTUD2;PCF11;DDX39B;RBM15;SNRPG;NCBP1;PRPF40B;DHX16;GEMIN2;SRSF7;SF3B4;SRSF4;METTL14;HNRNPA3;CWF19L1;DDX46;CWC22;SNRPB2;SNRNP48;DDX23;SLU7;SCNM1;DCPS;LSM5
prerank,regulation of hydrolase activity (GO:0051336),0.33583539262079465,0.986625822467379,0.5104052573932092,0.9016720213891891,1.0,17/71,18.30%,PLXNA3;PLXNB2;PLXNB3;EPHA4;RAPGEF6;RAP1GAP;VAV1;STMN3;CHN1;SIPA1L1;FGD6;CFAP73;CRK;TDG;OCRL;NF1;PAFAH1B1
prerank,negative regulation of histone acetylation (GO:0035067),0.463411902397733,0.9866120496711484,0.49779086892488955,0.9011638814208235,1.0,1/11,0.68%,THAP7
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.284761024945208,-0.9860919023431446,0.44571428571428573,1.0,1.0,11/29,22.30%,TECR;HACD1;ELOVL5;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;SCD;ACSL4;ELOVL6
prerank,organophosphate ester transport (GO:0015748),0.3899016043161873,0.9859512817909878,0.4790575916230366,0.9023237959688576,1.0,10/24,23.37%,SLC25A19;OSBPL8;PITPNM1;NPC2;MTTP;LDLR;OSBPL2;PCTP;TNFAIP8L3;PITPNA
prerank,cellular response to unfolded protein (GO:0034620),0.3823122071087769,0.985920114603002,0.4892268694550063,0.9018520234562448,1.0,2/26,1.77%,HSPA1B;DAXX
prerank,positive regulation of monooxygenase activity (GO:0032770),0.39197951609032494,0.9858494742241386,0.4856070087609512,0.9015000357186337,1.0,5/26,13.06%,DHFR;GDNF;GCH1;APOE;PIK3CB
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3580710476290889,-0.9857388585310655,0.47586206896551725,1.0,1.0,3/13,13.19%,ENO1;PINK1;TREM2
prerank,dendritic cell migration (GO:0036336),0.4250324660546364,0.9856038207677231,0.5234159779614325,0.901601588368313,1.0,4/16,9.14%,CXCR4;TRPM2;CCL5;HMGB1
prerank,regulation of microglial cell activation (GO:1903978),0.4316645165476881,0.9854800338297034,0.5072046109510087,0.9013590245954858,1.0,5/15,18.10%,CX3CL1;CST7;STAP1;PTPRC;LDLR
prerank,motor neuron axon guidance (GO:0008045),0.4269589700099925,0.9853732285058273,0.48551724137931035,0.9010885033229085,1.0,4/15,13.91%,EPHA4;SLIT1;CHN1;RAC1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.2888789945933648,-0.9853091753947198,0.49767441860465117,1.0,1.0,12/27,21.20%,PPARG;NFKBIA;RXRA;SIRT1;EEPD1;TREM2;ABCA13;PLTP;ABCA7;ABCA3;NR1H3;CAV1
prerank,response to nitric oxide (GO:0071731),-0.36202539676760176,-0.9853011697054801,0.461038961038961,1.0,1.0,4/13,14.19%,KCNC2;EGLN1;MTR;FOXO1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.35240386459921447,0.9851903625522239,0.500570125427594,0.9010255368456498,1.0,13/48,20.35%,NUP37;PNPT1;SLC2A6;NUP153;RUBCNL;RAE1;PRKAG1;EIF6;NUP155;NOA1;NUP88;NUP133;NUP43
prerank,negative regulation of hydrolase activity (GO:0051346),-0.24656032444084536,-0.9850845506849084,0.4409448818897638,1.0,1.0,16/49,19.42%,CST3;RCC2;SLC39A14;GMIP;DAB2IP;ARL2;URI1;EGLN1;MAPK7;NEIL1;ZCCHC9;TMED2;ECM1;HRAS;F11R;CAMK2A
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2665161860285849,-0.9849363380244542,0.4716981132075472,1.0,1.0,13/40,20.40%,SIRT7;UBE2V2;POLH;FXR2;PARG;CASP9;HMGA2;CRY1;ING2;BCLAF1;MYC;RADX;ABL1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.41438644384594436,0.9848262354383286,0.4932975871313673,0.9014062739750585,1.0,9/18,26.67%,GRIK3;GRIA2;NAPB;NAPA;GRID1;GRIK4;GRIK5;GRIK2;CDH8
prerank,epithelial cell morphogenesis (GO:0003382),0.4163623384389754,0.9847157574263831,0.507343124165554,0.9011284107578678,1.0,5/17,19.11%,RILPL1;COL22A1;MET;COL15A1;SIPA1L3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.21531665904539632,-0.9844517051449215,0.4583333333333333,1.0,1.0,30/128,18.25%,TGFB1;ZMIZ2;PTPRK;HPGD;USP9X;PXN;TGFBR3;RUNX2;PRKCZ;PDCD4;MAPK3;TWSG1;SIRT1;TGFB2;COL1A2;UBB;BMP6;ACVR1B;SRC;RHOA;UBC;APPL1;CBL;SMAD6;UBA52;SMAD4;GDF1;RPS27A;F11R;ACVR1C
prerank,activin receptor signaling pathway (GO:0032924),0.4331008627766477,0.9844094031350342,0.48840381991814463,0.9013869140164978,1.0,2/15,7.85%,ACVR1;SMAD2
prerank,cellular response to radiation (GO:0071478),-0.26490539567045474,-0.9843231010433188,0.46,1.0,1.0,13/40,20.05%,INO80;RHNO1;SPIDR;SIRT1;EEF1D;NSMCE3;HUS1;TP53;CDKN1A;RAD1;NET1;ECT2;RAD51AP1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2870292147192657,-0.9842638029630416,0.4663677130044843,1.0,1.0,10/27,22.36%,CMPK1;CTPS1;DTYMK;TYMS;TXNRD1;RRM2B;NME1;DUT;RRM1;GUK1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.37011716116904253,0.9835145266802242,0.49440993788819876,0.9031401929021836,1.0,10/30,20.17%,XRN1;DCP2;ERCC4;BMPR2;MEN1;HNRNPA1;STN1;DACH1;TERF2;ACVRL1
prerank,protein-containing complex disassembly (GO:0032984),0.34657760203780996,0.9833742446457108,0.5306818181818181,0.9029420410185215,1.0,11/54,13.51%,LAMP2;CTNNB1;VPS33A;LIX1;RUBCNL;HSPA8;UBQLN1;VIPAS39;CHMP3;MAP1LC3B;VTI1B
prerank,mRNA export from nucleus (GO:0006406),0.32652716964976636,0.9832064248262931,0.5169491525423728,0.902840486943114,1.0,31/102,21.86%,NUP37;MAGOHB;SMG7;NUP153;NCBP2;WDR33;NXT1;HNRNPA2B1;RAE1;RNPS1;SMG5;UPF2;ZC3H11A;CHTOP;NUP155;DDX39B;NCBP1;DDX19B;SRSF7;SRSF4;UPF1;NUP88;ENY2;SLU7;DDX19A;NUP133;GLE1;NUP43;THOC7;SRSF5;MCM3AP
prerank,positive regulation of B cell activation (GO:0050871),0.347150290705587,0.9829418769674566,0.501123595505618,0.9029699437042344,1.0,13/50,17.40%,NOD2;CD40;MMP14;MAD2L2;NFATC2;XBP1;SHLD1;PAXIP1;IRS2;TNIP2;CHRNB2;CD27;PTPRC
prerank,phospholipid metabolic process (GO:0006644),-0.23227372359608353,-0.9829353042020817,0.4827586206896552,1.0,1.0,23/71,22.65%,PLCB2;MBOAT1;PLAAT3;CLN8;SMPD3;ABCA2;PLBD1;GPAM;AGPAT4;PLPPR4;PLCD1;ABHD12;LPL;ACP6;AGPAT2;PLPP3;PIP4K2A;PLA2G15;SMPD1;FITM2;SMPD2;LGALS13;PLA2G3
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.2939427368363855,-0.9829346607274888,0.45454545454545453,1.0,1.0,8/26,15.46%,SMARCA4;CRY2;ZBTB7A;SIRT1;KANK2;BRCA1;FOXP1;CRY1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3103452048520226,-0.9825583497463903,0.45849802371541504,1.0,1.0,4/19,16.78%,NCKAP1L;RAC2;RIPOR2;C1QBP
prerank,carnitine metabolic process (GO:0009437),-0.3735414301134392,-0.982448865125087,0.473015873015873,1.0,1.0,6/12,18.15%,ACADM;TMLHE;CROT;CPT2;CPT1C;CRAT
prerank,response to histamine (GO:0034776),-0.38458761470670255,-0.9821950918658404,0.4632768361581921,1.0,1.0,4/10,24.87%,GABRB1;HRH1;GABRB3;DRD2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4573593236853457,0.9820312758097438,0.49273255813953487,0.9048119517593265,1.0,3/11,12.94%,FBXO7;NONO;RACK1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3245225030094709,0.9810777860245556,0.5130718954248366,0.9067258477337606,1.0,24/80,23.72%,TRIB3;BIRC2;ARRDC4;FBXW7;PRICKLE1;UBE3A;DCUN1D4;RBX1;UBQLN1;PAXIP1;UBE2L3;BIRC3;MYCBP2;SPRTN;PIN1;RIPK2;HSPBP1;HUWE1;STUB1;DCUN1D5;CUL3;SENP2;XIAP;AXIN1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.34267324287643675,0.9810624493196324,0.503945885005637,0.9062323816084402,1.0,21/53,28.17%,EYA4;TMEM161A;DDX5;DHX9;NSMCE1;EEF1E1;EYA2;SPRED3;BABAM2;SPRED1;PRKCD;SMCHD1;FBH1;NACC2;TIGAR;TRIM28;EYA3;EYA1;ATR;UBE2N;BABAM1
prerank,protein insertion into membrane (GO:0051205),-0.26837197295513926,-0.9808320536182312,0.4607329842931937,1.0,1.0,9/32,13.91%,TRAM1;CCDC47;EGFR;CYB5A;HMOX1;REEP1;UBE2J2;SEC61G;SEC61B
prerank,peptidyl-asparagine modification (GO:0018196),-0.2848111916178771,-0.9806528231985918,0.4406779661016949,1.0,1.0,11/31,20.10%,ALG5;DPM1;UBE2J1;TUSC3;UGGT2;HIF1AN;STT3A;RPN2;FUT8;DPM3;MGAT2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4234830223223825,0.9806187608987282,0.5209742895805142,0.9068184007737145,1.0,6/16,24.98%,DDRGK1;SEC16A;GBF1;BCAP31;ANK2;BCAP29
prerank,iron ion homeostasis (GO:0055072),0.3414990132674228,0.9801181712195866,0.5089485458612976,0.9075665345988886,1.0,14/58,20.01%,SKP1;ATP6V0D1;B2M;FXN;SLC46A1;SLC11A2;CAND1;TFR2;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.4264774445072152,0.9801138129387093,0.5014084507042254,0.9070364951912421,1.0,5/14,17.83%,TRPT1;TSEN2;FAM98B;RTCB;TSEN34
prerank,response to muscle stretch (GO:0035994),0.43161338113689124,0.9800971182324626,0.5042613636363636,0.9065374649212539,1.0,3/15,11.78%,SLC8A1;CTNNB1;GSN
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.29712301284519427,-0.9798972513751482,0.47738693467336685,1.0,1.0,11/28,25.91%,TGFB1;EFCAB7;PIK3R2;ZIC1;UBR5;DMAP1;BAG3;ECT2;TPR;RBM22;JUP
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3554894971162054,0.9797544654296622,0.5023148148148148,0.9068492552604814,1.0,12/42,18.72%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;PARS2;EEF1E1;YARS2;TARS2;PPA1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.36857378629828663,0.979538950116733,0.513126491646778,0.906853078721905,1.0,13/32,21.61%,ANKLE2;HSP90AB1;MAGI2;PPIA;DUSP26;SPPL3;CALM3;CD300A;MTOR;PPP1R7;PIN1;PPP2R5A;PRKCD
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3522191181752852,0.9794389439073611,0.509478672985782,0.9065833761682759,1.0,10/44,13.91%,WNT11;CD47;EVL;CARMIL1;MYOC;CCDC88A;PPM1F;ARHGEF10;NRP1;RAC1
prerank,platelet aggregation (GO:0070527),0.36942895674638476,0.979168376812841,0.5115995115995116,0.9067644420161145,1.0,11/33,24.47%,CSRP1;ACTN1;MYL9;PPIA;PIK3CB;ACTB;FIBP;MYH9;STXBP3;CLIC1;FLNA
prerank,neuron projection development (GO:0031175),0.31062673144388225,0.979002991971615,0.5436991869918699,0.9066578421515372,1.0,46/168,20.51%,BLOC1S4;TAOK3;BDNF;CNTNAP1;PPP1R9A;GAS7;EPHA4;PAK3;TBC1D23;MYOC;MAPK8IP3;SAMD14;STMN4;RAPGEF2;EPB41L3;LYN;GDNF;APP;HMGB1;TNIK;STMN3;DNM2;ADGRV1;ANKRD27;SRGAP2;APOE;RB1;CTNND2;MAP4;LRP12;MINK1;DBNL;TAOK2;PRMT1;RAB11A;OPHN1;NYAP2;DICER1;STMN2;CAMSAP2;SVBP;DTNBP1;NCKAP1;PLP1;LGI1;DOCK10
prerank,DNA repair (GO:0006281),0.30709964845338317,0.9789886716179161,0.56312625250501,0.9061548732656957,1.0,59/284,16.64%,PARP9;TENT4A;MSH2;ASCC3;DTX3L;EXO5;TIMELESS;CHEK2;PSME4;POLD4;POLE2;APLF;MAD2L2;CHEK1;NOP53;UBE2B;RNASEH2A;CHD1L;CDKN2D;RFC4;POLB;TNKS1BP1;WDR33;HERC2;BRIP1;BACH1;UBXN1;RAD51C;ALKBH1;RPAIN;FEN1;ERCC4;XRCC3;MPG;ACTR8;BARD1;POLK;WDHD1;MEN1;MNAT1;VCPIP1;CIB1;NPM1;POLQ;PRKDC;ZRANB3;APBB1;USP45;MLH3;ALKBH2;ASCC2;NSMCE1;DCLRE1A;RECQL5;ERCC6L2;TDG;SPRTN;UPF1;NEIL2
prerank,reticulophagy (GO:0061709),-0.38025655243940354,-0.9788155410233853,0.4891304347826087,1.0,1.0,5/12,8.91%,UBA5;ULK2;UFM1;ATG2B;ATG2A
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.41348316145988634,0.9787997608924058,0.48655913978494625,0.9061057078828375,1.0,6/17,17.31%,HASPIN;CTCF;RB1;MIS12;CHAMP1;ZWILCH
prerank,negative regulation of protein binding (GO:0032091),0.33323153547947265,0.9787439255805955,0.5208110992529349,0.9057032598171527,1.0,21/71,24.10%,IFIT1;IFIT2;B2M;SLPI;DACT1;LRPAP1;ARRB2;SORL1;DDX11;RACK1;DAB2;ACTB;BAX;ITGA4;PIN1;PTPRF;PRKCD;USP33;DNAJB2;TLE5;ADAM15
prerank,regulation of cellular metabolic process (GO:0031323),0.35023385477744456,0.9787336625643931,0.5166858457997698,0.9051922668403266,1.0,8/45,15.80%,BCO2;ABCG1;KIF16B;MKLN1;EIF6;PANK2;NPC2;ARF4
prerank,regulation of cellular localization (GO:0060341),0.34408900842032375,0.978384808395064,0.5,0.9054960884239869,1.0,12/46,18.93%,CAMK2D;DYNC1H1;ADCY5;HSP90AB1;UNC13D;LYN;PPM1F;GSN;HSP90AA1;GOSR1;BRSK1;NUMA1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.36597747246550927,-0.9779617945897819,0.4827586206896552,1.0,1.0,4/12,18.36%,NABP1;NABP2;BUB1;PLK2
prerank,sulfur compound biosynthetic process (GO:0044272),-0.21738212630971449,-0.9778217997552424,0.4727272727272727,1.0,1.0,39/104,25.48%,CHSY1;CHST1;UST;ST3GAL6;METTL16;VCAN;GCLM;CSGALNACT1;B3GNT2;GSS;MAT2A;SLC10A7;CHST7;CHST15;ST3GAL3;B4GALT3;PAPSS2;CHST3;BGN;GSTO1;GSTA3;SLC35B2;GGT5;DSEL;HAGH;GGCT;GSTM1;CDO1;DCN;SLC35B3;BCAN;GSTA4;ACAN;GSTO2;UGDH;CSPG5;HPGDS;ST3GAL2;B3GNT7
prerank,long-term memory (GO:0007616),-0.3116909800508275,-0.9776793173326662,0.48535564853556484,1.0,1.0,6/19,16.64%,SGK1;RASGRF1;RGS14;CAMK4;CALB1;PJA2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4150178514978683,0.9773055858109826,0.5105820105820106,0.9077572383654867,1.0,2/18,2.15%,KDR;FIS1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2797311190397225,-0.9772846699568014,0.4631578947368421,1.0,1.0,11/30,22.30%,TECR;HACD1;ELOVL5;SLC27A4;ELOVL1;ACSL1;ACSL6;ELOVL7;ACSBG1;SLC27A2;ELOVL6
prerank,cellular macromolecule catabolic process (GO:0044265),0.34838140279636254,0.9770029447445978,0.5252293577981652,0.9079947196398815,1.0,8/49,8.63%,PNPT1;XRN2;CHEK2;RNF5;RNASEH2A;RAB12;RNASEH2C;NGLY1
prerank,ERAD pathway (GO:0036503),0.32898287704917717,0.9768287301876767,0.5254777070063694,0.9078973549004402,1.0,18/83,15.33%,AUP1;TRIM25;TMEM129;RNF5;UBQLN2;POMT2;AMFR;TMUB2;UBQLN1;FAM8A1;RNF103-CHMP3;FAF2;RNF185;UBE4B;ANKZF1;ERLIN2;TMEM67;RNF103
prerank,regulation of store-operated calcium entry (GO:2001256),-0.39223084998260727,-0.9765263028308439,0.476038338658147,1.0,1.0,3/10,6.14%,STIM1;HOMER1;HOMER3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.40475608389777595,0.9763949061473319,0.5144827586206897,0.9084717963258377,1.0,5/18,21.75%,LPAR5;CRTC1;CRTC3;LRP8;CRTC2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.36748301518102744,0.9763712073718073,0.49746192893401014,0.9080111633339696,1.0,8/30,12.63%,FBXW7;SH3GLB1;VPS11;CSNK2A2;RNF31;LEPROT;NPEPPS;UBE2L3
prerank,positive regulation of TOR signaling (GO:0032008),-0.26338850100235506,-0.9761607452088537,0.47058823529411764,1.0,1.0,13/40,19.55%,GPR137C;GPR137B;NCKAP1L;RRAGD;RRAGB;LARS1;SEC13;GOLPH3;TREM2;SLC38A9;LAMTOR2;FLCN;MLST8
prerank,carbohydrate homeostasis (GO:0033500),0.3340339029605887,0.9759392275654103,0.5388768898488121,0.9085754205673587,1.0,15/67,21.75%,IRS1;STAT3;TCF7L2;USF1;TFAP2B;LEPR;INSR;RPS6;BAD;INPP5K;SELENOT;APPL2;ADIPOR1;STK11;CRTC2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4079635879234272,0.9758521893962344,0.5226666666666666,0.9082550310218174,1.0,6/20,16.22%,HSP90AB1;ENTPD5;P2RX4;APP;C3AR1;IL18
prerank,cyclooxygenase pathway (GO:0019371),-0.39156430882229487,-0.9758347294646482,0.47058823529411764,1.0,1.0,6/10,26.62%,PTGDS;PTGS1;PTGES;CBR1;HPGDS;PTGIS
prerank,cellular sodium ion homeostasis (GO:0006883),0.42797925146112353,0.9757147292321638,0.5296551724137931,0.9080776453413681,1.0,2/15,3.75%,ATP1B3;SLC8A1
prerank,regulation of exocytosis (GO:0017157),0.3483645866860602,0.9757079393781457,0.508551881413911,0.9075600133073586,1.0,11/46,16.47%,RAB8B;RAB21;RAB12;CPLX1;UNC13D;CADPS2;CHMP3;RAB2B;VAMP2;STX4;STXBP5L
prerank,phagosome acidification (GO:0090383),-0.2881149990280101,-0.9756173819859294,0.478494623655914,1.0,1.0,6/26,13.24%,ATP6V0A1;ATP6V1H;ATP6V1E1;ATP6V1C1;ATP6V1D;ATP6V1A
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.40059502679897385,0.9755584343374946,0.5139072847682119,0.9074003156738265,1.0,11/21,31.06%,SKP1;MAD2L2;BTRC;RPL11;RAB1A;RPL5;PTEN;MAD2L1;FBXO5;UBE2S;FZR1
prerank,protein localization to centrosome (GO:0071539),0.4133772748497618,0.9754661504111359,0.5,0.9070931344479725,1.0,9/17,27.48%,SNX10;NEDD1;CEP131;HOOK3;PIBF1;CEP83;BBS4;CEP192;CCDC14
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3129853399032652,-0.9753124998302002,0.48659003831417624,1.0,1.0,9/21,20.66%,RPA1;PARP1;ERCC3;ERCC2;ERCC1;RPA3;GTF2H3;XPA;GTF2H4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3129853399032652,-0.9753124998302002,0.48659003831417624,1.0,1.0,9/21,20.66%,RPA1;PARP1;ERCC3;ERCC2;ERCC1;RPA3;GTF2H3;XPA;GTF2H4
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.37300651801188145,-0.9752544256559406,0.46407185628742514,0.9979872134569036,1.0,4/11,15.11%,TGFB1;EGFR;RIPK1;TP53
prerank,negative regulation of receptor internalization (GO:0002091),0.43469122001599836,0.9751937719862264,0.4890190336749634,0.9072437664563073,1.0,3/12,10.02%,UBQLN2;WDR54;LRPAP1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.31047491815232325,0.9747647182300164,0.5697091273821464,0.9078038077069942,1.0,42/199,21.69%,WNT11;LOXL2;IL15;NR1H2;SPRY2;SFRP2;MAD2L2;PTGER4;CRHBP;EVL;SOX9;SRF;N4BP1;NFIB;PPP1R11;BMPR2;LRPAP1;IL17D;ZNF423;DUSP10;RB1;ACOT13;FCGR2B;ALDH1A1;PTCH1;NPTN;BBS2;MCC;RBPJ;MDK;SPRED3;CORO1C;SPRED1;ASB1;PCTP;SFMBT1;IFNGR1;ADIPOR1;USF3;STK11;PGAM5;RHEB
prerank,neutrophil degranulation (GO:0043312),0.30347941592950745,0.9747513843755379,0.582,0.9072984236402427,1.0,111/425,21.93%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;HSP90AB1;KPNB1;FGL2;NAPRT;CYFIP1;SLPI;DEGS1;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;PPIA;PGM1;UNC13D;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;NEU1;HMGB1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;GSN;RAB24;ILF2;PSEN1;SVIP;LAMTOR3;DYNLL1;CMTM6;CAPN1;KCMF1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;SYNGR1;NPC2;DBNL;NHLRC3;PTGES2;CD300A;TLR2;TUBB4B;UBR4;PGRMC1;HMOX2;TCIRG1;IST1;PTPRC;LAMP1;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;CD33;RAB5B;TYROBP;SIRPA;DDX3X;PLAUR;STXBP3;DDOST;PRKCD;PSMC2;TMC6;ARSA;ALDOC;PSMD12;MGST1;HUWE1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4500764568924207,0.9744036931261579,0.5007541478129713,0.9076652565279869,1.0,2/11,6.67%,ITPKC;PPIP5K1
prerank,cell-cell junction maintenance (GO:0045217),-0.3757808257584798,-0.9743368141105847,0.47293447293447294,0.9982873302761601,1.0,7/11,41.89%,NLGN2;F2R;TJP1;PARD6A;INAVA;PRTN3;CD177
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.42393836274957053,0.9742506264762006,0.5269709543568465,0.9069806290844187,1.0,4/15,18.53%,BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.42393836274957053,0.9742506264762006,0.5269709543568465,0.9069806290844187,1.0,4/15,18.53%,BLOC1S4;AP3M2;AP3S2;DTNBP1
prerank,negative regulation of metabolic process (GO:0009892),0.3413948958059152,0.9741238636333786,0.5208791208791209,0.9067558073673357,1.0,15/54,24.02%,IL15;NR1H2;FIS1;ZNF423;RB1;ACOT13;ALDH1A1;RBPJ;PCTP;CCDC3;STK11;PGAM5;RHEB;NOTCH1;ACOT11
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.32767791336615193,0.9740778700137075,0.5461293743372216,0.9063497179992703,1.0,25/88,21.79%,PSMB10;SKP1;FBXL16;PSME2;PSMA5;CUL5;PSME4;FBXW7;PSMA3;PSMB9;RBX1;BTRC;PSMD2;PSME3;FBXL14;PSMA4;AMN1;FBXL5;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.3787463327967251,-0.9740718576887475,0.4953271028037383,0.9965126231371936,1.0,3/11,6.20%,SYK;PRKCQ;ANK3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.31362294473078517,0.9738921035084974,0.5661538461538461,0.9062613026996507,1.0,38/129,23.80%,PSMB10;DAPK3;PSME2;PSMA5;PSME4;SFRP2;UBE2B;FGFR2;PSMA3;NFKB1;TMEM9;PSMB9;DACT1;BAMBI;USP34;KANK1;PSMD2;PSME3;PLEKHA4;PSMA4;PSMD7;PSMD8;PSMD9;PIN1;PSMF1;DDX3X;PSMB6;USP8;PSMC2;PSMD12;SMURF2;PSMD4;GPRC5B;XIAP;VCP;AXIN1;PSMA2;CAPRIN2
prerank,regulation of transport (GO:0051049),0.35771040994976727,0.9737543595172509,0.5105633802816901,0.9060612749933983,1.0,10/36,16.20%,GAPVD1;LEPR;RSC1A1;SCFD1;VAMP2;NRP1;MYO6;ACTB;CLDN10;RAB11A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3550987739078214,0.9728745395507029,0.5034722222222222,0.9077425857858257,1.0,15/39,27.95%,FXYD4;UTRN;FXYD6;SPHK2;AHCYL1;FXYD5;SCN1B;STK39;FXYD7;ANK2;WNK3;YWHAE;CHRM3;SCN4B;CACNA1D
prerank,intracellular protein transmembrane transport (GO:0065002),-0.25679013256799227,-0.9727997534135814,0.5185185185185185,0.9982137325252732,1.0,23/42,31.27%,TOMM20;DNAJC15;TIMM21;AIFM1;SEC61G;SEC61A1;AKT2;SEC61B;PEX26;GRPEL1;PAM16;CHCHD4;ZFAND2B;TIMM17A;GRPEL2;ROMO1;PEX12;PEX1;HSPD1;SEC62;RTN2;SEC63;PEX6
prerank,positive regulation of gene expression (GO:0010628),0.3052362355965964,0.9726218653818904,0.6096096096096096,0.9078252730439509,1.0,68/442,16.81%,EIF2AK2;HSPA1B;WNT11;MOV10;IL15;AGT;TENT4A;WNT5A;MYBBP1A;SPRY2;PLXNB2;CLU;PIK3CD;DDRGK1;AGO2;STAT3;MYO1C;SLC38A2;YTHDF1;DDX5;PTGER4;DHX36;SOX9;ZCCHC4;MT3;ITGB8;CSF1;CTSH;POU3F1;APP;SCX;DNMT1;POLR2K;MAPK14;PRKAG1;SPHK2;PPM1F;CCDC88B;ZC3H12A;NPM1;FAM98B;CTCF;FGF9;MITF;EIF6;GSN;MAP2K2;STAP1;PSEN1;EPHX2;PPARGC1A;PRKDC;UPF3A;TAF1B;PIK3CB;LIMS1;ACTB;MYD88;TFR2;HGS;RBM3;TLR2;SLC24A3;RPL11;MTOR;METTL14;RBPJ;LGALS9
prerank,detection of calcium ion (GO:0005513),0.43426531471127294,0.9724765128800711,0.5187319884726225,0.9076521261471939,1.0,1/13,0.73%,KCNMB3
prerank,macrophage differentiation (GO:0030225),0.43717328388655474,0.9720165627816983,0.5037147102526003,0.908282127023677,1.0,2/13,6.89%,IL15;CSF1
prerank,protein phosphorylation (GO:0006468),0.30201305745568535,0.9719836594589956,0.593,0.9078435611646024,1.0,104/479,19.25%,EIF2AK2;WNT11;TAOK3;FLT1;DAPK3;GLYCTK;CAMK2D;TP53RK;RSKR;SGK3;SGK2;KDR;FASTK;PIK3CD;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;HASPIN;CDC25B;STK38L;PKN2;PNCK;HCK;USP15;CHEK1;IKBKE;ILF3;PEAK1;MORC3;CDK12;EPHA4;MKNK1;FGFR2;PAK3;CAB39;NRBP2;RET;CSNK2B;CSNK2A2;HTATIP2;SMAD2;FAM20B;GMFB;VRK3;LTK;LYN;CLK3;APP;INSR;SRPK1;PIK3R4;BMPR2;MAST3;MAPK14;PRKAG1;CDK19;TNIK;CDK10;NUAK2;CDK20;BCKDK;SIK1;PIM1;NEK6;DYRK2;PRKDC;PRKCE;CLK2;JAK2;FYN;PRKCH;FAM20C;MASTL;STK25;MINK1;BMPR1A;TLR2;NRBP1;TAOK2;OXSR1;FGFR3;MTOR;TBCK;IRAK1;STK39;CSK;BCR;TLR3;SNRK;PRKG2;BIRC6;ACVR2A;FNIP2;COPS8;MARK1;CTBP1;BRSK1;NEK7;STK16;STK3;STK24;CAMKK2
prerank,regulation of protein localization to centrosome (GO:1904779),-0.38916752116099074,-0.9718768906892389,0.48830409356725146,0.9987131422240358,1.0,8/10,36.67%,MARK4;GSK3B;APC;CEP72;CEP250;NUP62;PARD6A;NSFL1C
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2762201854963071,-0.9716474721983807,0.4883720930232558,0.9968465900505444,1.0,5/33,8.54%,CASP8;FES;ID2;TRAF6;RIPK1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4613066664305497,0.9716003343287583,0.5199409158050221,0.9082978607958236,1.0,3/10,14.76%,FEM1B;ETAA1;DDX39B
prerank,intracellular protein transport (GO:0006886),0.30633319116483315,0.971232598944847,0.6042084168336673,0.9087044484167988,1.0,77/304,20.31%,ARF3;TBC1D1;RANBP6;STAT3;MYO1C;RAB21;LAMP2;SRPRA;NUP153;KPNB1;SEC16A;CSE1L;PRICKLE1;AP2A1;TRAK1;STX7;HERC2;ARF5;GGA3;NXT1;TMED5;VPS33A;TBC1D8;UNC93B1;RPAIN;RAB22A;RAB43;RAB5C;STX8;PPP1R10;STX16;TMED10;TBC1D8B;SNX9;NPM1;IFT27;FUT10;VIPAS39;RAB14;ARL1;SORL1;RAB24;SCFD1;IPO8;SMURF1;VPS28;ARL5C;RIC1;TNPO2;MYO6;NAPB;NAPA;STX4;FAM91A1;RANBP3L;NUP155;ARF4;VPS26A;RPL11;RAB32;TBCK;RANBP17;SNX1;TBC1D2;TMED1;NUP88;CDC37;SLU7;TMED3;COPB2;NUP133;RAB5B;SGSM1;RAB1A;SGSM3;TBC1D4;APPL2
prerank,carbohydrate transport (GO:0008643),0.4502472570742591,0.9709719529431661,0.5227920227920227,0.9087926929840647,1.0,1/11,3.33%,AQP11
prerank,bicarbonate transport (GO:0015701),0.3849862704667346,0.9708814989789146,0.5153129161118508,0.908484018117001,1.0,2/25,1.70%,CA4;CYB5R2
prerank,regulation of interleukin-17 production (GO:0032660),0.37470728876526893,0.9708380969341118,0.5323565323565324,0.9080768453865511,1.0,2/31,0.94%,IL15;NOD2
prerank,positive regulation of nervous system process (GO:0031646),-0.3293127671719096,-0.9705986933314239,0.4708333333333333,0.9975769309752177,1.0,8/18,21.84%,TPPP;NLGN2;RIMS1;RNF10;TNFRSF1B;RIMS2;EGR2;NCMAP
prerank,mitotic DNA replication (GO:1902969),0.4599413139833198,0.9703017726684435,0.5258358662613982,0.908880718751405,1.0,2/10,5.06%,MCM2;MCM4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.3192137645129334,-0.9700097435459909,0.48132780082987553,0.9967917750488858,1.0,4/20,7.77%,TGFB1;NUMB;RHOQ;TMBIM1
prerank,axonal transport (GO:0098930),0.357005024058596,0.9697819232610555,0.5167865707434053,0.909620930794962,1.0,6/36,12.10%,BLOC1S4;RAB21;DYNC1H1;KIF3B;AP3M2;AP3S2
prerank,mitochondrial gene expression (GO:0140053),0.34932412629891263,0.9697101021146832,0.5320366132723112,0.9092689541244168,1.0,11/42,19.04%,IARS2;MRPL12;TFB2M;MRPL16;MRPS28;TWNK;MRPS2;NOA1;MRPL57;FASTKD2;MRPS11
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.33588095196345247,0.9695334213941194,0.5296752519596865,0.90918599870089,1.0,13/56,20.17%,GDF9;ACVR1;PMEPA1;CSNK2B;BMPER;BMPR2;DAB2;BMPR1A;ACVR2A;RBPMS;SNX25;PIN1;ACVRL1
prerank,mitochondrion organization (GO:0007005),0.3113181526899817,0.9690415199880633,0.5649087221095335,0.9099131533530346,1.0,66/165,28.22%,IFIT2;MTFR2;PNPT1;FIS1;FBXO7;CHCHD10;POLG2;TRAK1;GDAP1;TFB2M;ATAD3A;TOMM5;TIMM50;SLIRP;TWNK;SAMM50;DNM2;DNAJA3;LONP1;PPARGC1A;TSPO;PITRM1;NDUFS1;AFG1L;VPS13D;AIP;MEF2A;RAB32;MIGA2;MTFP1;CHCHD2;BAX;TOMM40;RHOT2;GABPB1;COX7A2;BCAP31;VPS13C;HIGD2A;ADCK1;AKT3;MTX1;MYH14;ATP5F1B;PRDX3;PTCD2;SSBP1;OPA1;RAB29;DNM3;TFAM;BCS1L;CAV2;SLC25A33;COX7A2L;STOML2;HIGD1A;CYCS;DNM1;BNIP3L;BCL2L1;ESRRA;WASF1;PYROXD2;BID;HSD17B10
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.44501743582124903,0.9688655928872395,0.5359765051395007,0.9098391932835864,1.0,3/11,19.30%,SOCS5;ZC3H12A;RC3H2
prerank,regulation of B cell proliferation (GO:0030888),-0.2553466161753905,-0.968852645638661,0.5,0.9980539142822933,1.0,8/44,8.85%,GPR183;CD38;CD81;NCKAP1L;TNFRSF13B;SASH3;EPHB2;TFRC
prerank,receptor-mediated endocytosis (GO:0006898),0.318443749635226,0.9687654468264392,0.5648148148148148,0.9095411860452103,1.0,29/132,14.87%,DNAJC13;STAB2;CXCL16;LRP2;HYOU1;AP2A1;AP1S1;ACKR3;FCGR1A;INSR;PI4KB;AMN;LDLRAP1;ARRB2;FNBP1L;SNX9;AP2S1;DNM2;SORL1;RABEPK;APOE;FCGR2B;PIP5K1C;MASP1;DAB2;LMBR1L;SNAP91;TFR2;HSP90AA1
prerank,neutrophil mediated immunity (GO:0002446),0.3016017497546191,0.9683062886113495,0.604,0.9101077007064248,1.0,112/432,21.93%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;HSP90AB1;KPNB1;FGL2;NAPRT;CYFIP1;SLPI;DEGS1;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;PPIA;PGM1;UNC13D;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;NEU1;HMGB1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;IRAK4;GSN;RAB24;ILF2;PSEN1;SVIP;LAMTOR3;DYNLL1;CMTM6;CAPN1;KCMF1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;SYNGR1;NPC2;DBNL;NHLRC3;PTGES2;CD300A;TLR2;TUBB4B;UBR4;PGRMC1;HMOX2;TCIRG1;IST1;PTPRC;LAMP1;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;CD33;RAB5B;TYROBP;SIRPA;DDX3X;PLAUR;STXBP3;DDOST;PRKCD;PSMC2;TMC6;ARSA;ALDOC;PSMD12;MGST1;HUWE1
prerank,positive regulation of synapse assembly (GO:0051965),0.3798250897526494,0.9681894922821723,0.5321782178217822,0.9098954983314225,1.0,7/27,16.20%,BDNF;CLSTN1;SEMA4D;AGRN;IL1RAP;CLSTN3;NLGN3
prerank,amyloid fibril formation (GO:1990000),0.3422109896025913,0.9679364369576563,0.5367561260210035,0.9100107747809113,1.0,10/51,15.32%,CALCA;UBE2L6;B2M;SIAH1;GGA3;APP;SORL1;GSN;APH1A;APH1B
prerank,DNA metabolic process (GO:0006259),0.30425525446299895,0.9677320558919187,0.5937813440320963,0.9100178662242141,1.0,47/270,13.64%,SP100;SAMHD1;MSH2;MCM2;LRWD1;TIMELESS;PSME4;POLD4;POLE2;MCM7;CHEK1;NOP53;UBE2B;RNASEH2A;CHD1L;MCM4;RFC4;POLB;RFC1;CDT1;TCF7L2;BACH1;RTEL1;RAD51C;ALKBH1;RPAIN;FEN1;ERCC4;XRCC3;MPG;BARD1;POLK;DNMT1;HMGB1;WDHD1;MEN1;MNAT1;NPM1;LONP1;POLQ;HMGB3;PRKDC;ORC3;ZRANB3;DNASE2;STN1;USP45
prerank,regulation of DNA repair (GO:0006282),0.346876714565955,0.9674653661460352,0.5466200466200466,0.9101288969763659,1.0,3/44,1.15%,PML;EYA4;TMEM161A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.389714713630087,0.9669597063677181,0.5275590551181102,0.9108792859990554,1.0,11/23,23.56%,KIF7;BTRC;ENPP1;RACK1;PTCH1;TULP3;MGRN1;GLI3;HERC4;KCTD21;VCP
prerank,membrane lipid metabolic process (GO:0006643),0.3879189518074571,0.9664340034994825,0.5078740157480315,0.9116599598714968,1.0,4/22,9.99%,ST6GALNAC4;B4GALT4;CERKL;SPHK2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.34658332977801826,0.9662082096992958,0.5245714285714286,0.9117139353003517,1.0,10/46,14.39%,FIS1;FBXO7;TOMM40L;GDAP1;TOMM5;TIMM50;HK1;TSPO;PITRM1;AIP
prerank,hexose biosynthetic process (GO:0019319),0.35420907964077347,0.966185919893778,0.5302325581395348,0.9112510345688353,1.0,6/42,8.02%,SORD;PER2;TPI1;SLC25A1;PGM1;SLC25A10
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4271142170969179,0.9658237531166027,0.5362116991643454,0.9116109472765164,1.0,1/14,1.52%,WNT5A
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4461580607754989,0.9656945823096194,0.5345345345345346,0.9114035822725094,1.0,4/10,17.40%,ARRB2;FCGR2B;LGALS9;PTPRC
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3061185522937579,0.9656206822447769,0.5883534136546185,0.911061866184191,1.0,62/241,18.22%,POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;BCAS2;POLR2K;RNPC3;HNRNPL;HSPA8;RBM17;RSRC1;SNW1;WDR83;RNPS1;RALY;HNRNPH3;HNRNPA1;USP39;RBM41;PAPOLA;SART1;BUD31;GEMIN7;SNRPD2;SNRPD1;DBR1;EFTUD2;PCF11;DDX39B;RBM15;SNRPG;NCBP1;PRPF40B;DHX16;SRSF7;SF3B4;SRSF4;METTL14;HNRNPA3;CWF19L1;DDX46;CWC22;SNRPB2;SNRNP48;DDX23;SLU7;LSM5
prerank,embryonic limb morphogenesis (GO:0030326),-0.26570997950672287,-0.9650390991411426,0.49122807017543857,1.0,1.0,6/34,8.41%,MAP3K20;FBXW4;LRP6;NIPBL;SALL1;TGFB2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.42676435040531646,0.9649748926177629,0.5285913528591353,0.9121271680488231,1.0,7/15,19.62%,UBQLN2;SCYL2;PIK3CB;DAB2;SMAP1;SNAP91;AAK1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.39995419776063446,0.9643505815137376,0.5134048257372654,0.9131412667798144,1.0,3/19,6.89%,MYO1C;RUNX1;SNAI2
prerank,regulation of ATP metabolic process (GO:1903578),0.34023763987146904,0.9641014877086104,0.5406320541760722,0.9132584854054925,1.0,15/54,20.35%,NUP37;FIS1;SLC2A6;NUP153;RAE1;ABCD1;PRKAG1;SPHK2;EIF6;AK4;NUP155;NUP88;COX7A2;NUP133;NUP43
prerank,T-helper cell differentiation (GO:0042093),0.42683717923420855,0.9639481550924328,0.5343839541547278,0.913111598907125,1.0,3/14,9.14%,PTGER4;TMEM98;HMGB1
prerank,interstrand cross-link repair (GO:0036297),-0.24323073527703068,-0.9639221264169233,0.5338983050847458,1.0,1.0,19/53,20.18%,RPA1;FANCC;FAAP20;SLX4;FANCM;DCLRE1B;UBB;FAAP100;UBC;FANCD2;UBA52;NEIL3;FANCG;RPS27A;ERCC1;RPA3;XPA;RAD51AP1;CENPX
prerank,negative regulation of protein catabolic process (GO:0042177),0.35495628362221987,0.9638646760169368,0.5142517814726841,0.9128077355641873,1.0,9/40,13.47%,RGP1;AZIN2;MAD2L2;RILP;AGAP2;TIMP2;AZIN1;RIC1;NELL1
prerank,regulation of platelet activation (GO:0010543),-0.31221804195575,-0.9638284777977765,0.4933920704845815,1.0,1.0,2/21,1.83%,SYK;PRKCQ
prerank,neutrophil activation involved in immune response (GO:0002283),0.2999488319464292,0.9637921080205828,0.626,0.9124572178133765,1.0,111/428,21.93%,HSPA1B;DNAJC13;BST2;CTSS;CPNE3;TRPM2;GOLGA7;B2M;PSMA5;CANT1;CD55;ACTR2;ADAM8;CYBB;RHOF;CD47;LAMP2;DYNC1H1;ATP8A1;ERP44;HSP90AB1;KPNB1;FGL2;NAPRT;CYFIP1;SLPI;DEGS1;CAB39;NFKB1;CPPED1;IDH1;CSNK2B;CTSC;B4GALT1;PPIA;PGM1;UNC13D;CYB5R3;CAND1;CTSH;LAIR1;RAB5C;NEU1;HMGB1;MAPK14;HSPA8;C3AR1;TIMP2;HPSE;CRACR2A;RAB14;PSMD2;FAF2;ARPC5;GSN;RAB24;ILF2;PSEN1;SVIP;LAMTOR3;DYNLL1;CMTM6;CAPN1;KCMF1;GHDC;VAMP2;RAC1;SNAP23;ATP11A;HSP90AA1;SYNGR1;NPC2;DBNL;NHLRC3;PTGES2;CD300A;TLR2;TUBB4B;UBR4;PGRMC1;HMOX2;TCIRG1;IST1;PTPRC;LAMP1;MAGT1;GLB1;BRI3;DERA;GYG1;PSMD7;AMPD3;CD68;PTPRB;CD53;CD33;RAB5B;TYROBP;SIRPA;DDX3X;PLAUR;STXBP3;DDOST;PRKCD;PSMC2;TMC6;ARSA;ALDOC;PSMD12;MGST1;HUWE1
prerank,positive regulation of DNA recombination (GO:0045911),0.37012928095848896,0.9636199908674471,0.5113065326633166,0.9123683275981218,1.0,7/27,15.82%,TIMELESS;ACTR2;MAD2L2;ARID2;SHLD1;PAXIP1;ZCWPW1
prerank,cellular protein localization (GO:0034613),0.3022211666872568,0.9632078401233728,0.5857572718154463,0.9128555130871114,1.0,71/285,20.00%,WNT11;WNT5A;ARF3;TBC1D1;RAB21;CNTNAP1;RTP4;COG3;RRAGC;CTNNB1;TM9SF1;AP2A1;STX7;HERC2;ARF5;GGA3;TMED5;VPS33A;TBC1D8;UNC93B1;RAB22A;CNTLN;RAB43;EPB41L3;RAB5C;STX8;STX16;TMED10;TBC1D8B;SNX9;NPM1;IFT27;VIPAS39;RAB14;ARL1;RAB24;SCFD1;SMURF1;LAMTOR3;ARL5C;RIC1;CORO1B;MYO6;SEPTIN9;NAPB;NAPA;STX4;FAM91A1;BBS2;HGS;ARF4;VPS26A;RAB32;TBCK;JAM3;SNX1;PTPRU;SH3PXD2B;TBC1D2;TMED1;SLU7;TMED3;COPB2;ARMCX3;RAP2A;PIGK;RAB5B;SGSM1;RAB1A;SGSM3;TBC1D4
prerank,regulation of vacuole organization (GO:0044088),-0.3150772942612947,-0.9623746067285607,0.44841269841269843,1.0,1.0,6/20,16.27%,ENO1;LAPTM4B;IFT88;ENO2;RAB1B;MTM1
prerank,protein catabolic process (GO:0030163),0.3360874407140947,0.9622620245061084,0.5406911928651059,0.9145935703963375,1.0,16/59,18.95%,CHEK2;RNF5;LAMP2;SIAH1;RAB12;LRSAM1;NGLY1;UCHL3;HSPA8;APOE;HSP90AA1;ATE1;MTOR;STT3B;SOCS6;DDI2
prerank,aminoglycan catabolic process (GO:0006026),0.37381381790947965,0.962070807694062,0.5485933503836317,0.9145396424207461,1.0,6/28,13.15%,SDC3;HYAL4;SDC4;AGRN;HPSE;HPSE2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.41392287423168017,0.9619911609099268,0.5269541778975741,0.9142131419678878,1.0,5/17,12.35%,CLU;GGA3;PRNP;SORL1;APOE
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.39036967641358067,0.9619288995486109,0.5112881806108898,0.9138338888325971,1.0,5/20,21.96%,SPRY2;SMOC2;NPTN;DSTYK;FGF2
prerank,protein maturation (GO:0051604),0.31087078878368135,0.9618155487276274,0.5602094240837696,0.9135983657331004,1.0,19/95,16.66%,LIPT1;CTSS;ADAMTS3;MMP14;NAA50;LONP2;NFU1;AEBP1;PCSK7;SORL1;NAA35;PSEN1;PITRM1;PTCH1;APH1A;GCSH;APH1B;LMF2;METAP2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3282604385646332,-0.961715584323747,0.5121107266435986,1.0,1.0,8/16,23.35%,AKIRIN1;HIF1AN;BTG1;RIPOR2;BOC;MEF2C;LRRC8A;IGFBP3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.3146552366005215,-0.9615258140958781,0.5040322580645161,1.0,1.0,4/18,8.54%,TGFB1;EGFR;ESR1;RIPK1
prerank,chromatin assembly or disassembly (GO:0006333),0.4443926710281459,0.9614123804540404,0.5112443778110944,0.9140883227019325,1.0,3/11,13.32%,MTA2;CHAF1B;HDAC8
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.36166955197990175,0.961339508657346,0.5471698113207547,0.9137668136775814,1.0,8/32,18.79%,TAOK3;CHEK1;NOP53;TRIM39;RINT1;TAOK2;BABAM2;BRSK1
prerank,snRNA transcription (GO:0009301),0.32267853170828115,0.9612550736639798,0.5475161987041036,0.9134587787173415,1.0,17/70,17.70%,POLR2G;PHAX;SNAPC2;SRRT;NCBP2;CCNT2;RPAP2;TAF8;POLR2K;ICE2;ELL2;SNAPC5;GTF2E2;USPL1;NCBP1;CCNK;POU2F2
prerank,protein modification process (GO:0036211),0.3210358610599191,0.9610282989727231,0.5640473627556513,0.9134752025604473,1.0,23/76,24.03%,LIPT1;LOXL2;UBE2L6;USP25;UBE2M;NAGPA;SEPHS1;ST3GAL1;PPP4R2;PRKDC;UBE2L3;GGCX;RPN1;MSRA;SERP1;UBL5;ERO1A;YES1;ABL2;MMP15;FBXW2;PLAT;LOX
prerank,protein-containing complex subunit organization (GO:0043933),0.31926903889109015,0.9609856398316051,0.5723204994797086,0.9130441475988993,1.0,21/109,16.62%,PML;GPAA1;TEAD2;CD40;LAMC1;MDN1;CHCHD10;TSPAN4;SOX9;TAPBP;KMT2A;SKAP2;DET1;MNAT1;SNX9;MITF;PPARGC1A;VAMP2;IL1RAP;LLGL1;WDR19
prerank,regulation of cell development (GO:0060284),0.3561685762999841,0.9609809674975639,0.53125,0.912535633761795,1.0,5/36,8.46%,PER2;BHLHE40;CTNNB1;CX3CL1;YTHDF2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.34827873886443583,0.9605054930243428,0.5414691943127962,0.9131382544441144,1.0,5/44,11.24%,ACVR1;CCDC40;NPHP3;SRF;SETDB2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4161125176943168,0.9604679816060318,0.5020188425302826,0.9127143750979411,1.0,4/16,13.06%,DHFR;GCH1;APOE;PIK3CB
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.45765700981371205,0.9603000197622164,0.5225903614457831,0.9126073507061342,1.0,2/10,6.38%,CCL5;PODXL
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.44667101624828626,0.9602387836641334,0.5277382645803699,0.9122410196220162,1.0,3/12,10.58%,STAT3;BCDIN3D;ZC3H12A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3804123175532293,0.9601518984216043,0.5343709468223087,0.9119318386400648,1.0,4/23,18.66%,CNGB1;CAMKMT;METAP2;FNTA
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.21938581103036936,-0.959061881107516,0.5581395348837209,1.0,1.0,40/87,27.70%,COX16;NDUFAF5;PET100;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;AIFM1;NDUFC1;UQCC2;NDUFB7;TTC19;TIMMDC1;UQCC1;NDUFAF1;CHCHD4;NDUFA8;NDUFA3;SCO1;NDUFB8;NDUFA2;SURF1;NDUFB10;NDUFB3;NDUFS3;NDUFV3;COA3;NDUFB4;UQCC3;NDUFS6;NDUFA11;NDUFA1;COX18;NDUFAF8;NDUFA6;SDHAF1;NDUFAF4;NDUFA13
prerank,cellular response to BMP stimulus (GO:0071773),0.33018564178728194,0.9587602496293033,0.5476190476190477,0.9147252490986888,1.0,12/66,15.88%,GDF9;ACVR1;DDX5;USP15;SOX9;SMAD2;SCX;BMPR2;RGMB;SMURF1;BMPR1A;ADAMTS12
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4323250717460203,0.9584421592992893,0.521923620933522,0.9150004281131453,1.0,3/12,14.83%,CYP26B1;SNW1;EZH2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4431685658244154,0.9583957280724582,0.5228276877761414,0.9145967573270475,1.0,5/11,23.79%,TMEM106A;XBP1;JAK2;HDAC2;TAF7
prerank,protein O-linked mannosylation (GO:0035269),0.39855505533570723,0.9579716588419428,0.5164835164835165,0.9150986934972725,1.0,5/18,16.18%,TMTC1;POMT1;POMT2;CRPPA;TMTC4
prerank,positive regulation of DNA binding (GO:0043388),-0.279764562291294,-0.9578594859070535,0.5129533678756477,1.0,1.0,5/31,8.81%,TGFB1;PPARG;NIBAN2;TRAF6;PINX1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3156054706998298,0.9578452516865859,0.5739583333333333,0.9148928709333893,1.0,21/108,15.46%,GRB10;SFRP2;RUNX1;CTNNB1;FGFR2;ITGA3;HMGXB4;MDFIC;FRZB;DACT1;APP;KANK1;BTRC;APCDD1;PSEN1;MDFI;RACK1;CXXC4;ZRANB1;CTNND2;TLR2
prerank,protein secretion (GO:0009306),0.33214852776310666,0.957278226410745,0.5619469026548672,0.9157666953436288,1.0,7/56,10.88%,GAL;ABCA1;RAB8B;RAB12;NAGPA;SNX19;TMEM167A
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3895267074840291,0.9572219066020831,0.5137614678899083,0.9153917586049344,1.0,10/22,29.26%,DHX33;UBTF;DDX11;WDR43;MTOR;UTP15;PIH1D1;NCL;SMARCB1;ATF4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.39426814292898754,0.9571417395138929,0.5408299866131191,0.9150776776699713,1.0,7/20,18.57%,ZFP36;HOXA9;CIB1;ZFP36L1;LDB1;PRMT1;HOXA5
prerank,neuron differentiation (GO:0030182),0.3047692069279965,0.9568000487288438,0.5809716599190283,0.9153910872115557,1.0,25/165,19.47%,WNT11;PITX2;LHX2;LMX1A;WNT5A;RUNX1;CTNNB1;NGRN;WNT7B;NRBP2;SRF;DTNB;MET;XBP1;DDIT4;LDB1;SMARCA1;ADNP2;OPHN1;IER2;HS6ST1;ITM2C;FUT9;BRSK1;PIN1
prerank,positive regulation of isotype switching (GO:0045830),0.4094367691945303,0.956737316036925,0.5414965986394558,0.9150361763319445,1.0,4/15,12.60%,CD40;MAD2L2;SHLD1;PAXIP1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.34193402551886604,0.9566552600176641,0.5536529680365296,0.9147138038188825,1.0,14/47,18.86%,CARMIL1;ARHGEF7;MYOC;PDPN;KANK1;CIB1;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;CORO1C;TESK1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4555053881441019,0.9563725678773709,0.5080763582966226,0.9148938968590037,1.0,2/10,10.06%,XYLT2;CSGALNACT2
prerank,regulation of neuroblast proliferation (GO:1902692),0.41068184527065293,0.9562044000512523,0.5356125356125356,0.9147944348625264,1.0,2/15,5.48%,CTNNB1;CX3CL1
prerank,response to hexose (GO:0009746),0.3737455377334104,0.9560007859268634,0.5273885350318471,0.9147761414131749,1.0,7/25,18.89%,TCF7L2;EIF2B2;VAMP2;IRS2;SELENOT;EIF2B5;EIF2B3
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3944749484470892,0.9558812178899734,0.5382585751978892,0.9145626536005741,1.0,5/20,18.55%,ATP1B3;SLC8A1;TFAP2B;KCNJ2;LACC1
prerank,positive chemotaxis (GO:0050918),0.4045685921818616,0.9558633101935993,0.5182679296346414,0.9140885150299447,1.0,4/17,13.47%,PLXNB3;CX3CL1;MET;NRP1
prerank,protein import into nucleus (GO:0006606),0.33022166209558657,0.9558591717998249,0.5589519650655022,0.9135901822816599,1.0,15/66,17.52%,RGPD1;RANBP6;STAT3;NUP153;KPNB1;CSE1L;PRICKLE1;NXT1;RPAIN;PPP1R10;IPO8;TNPO2;NUP155;RANBP17;NUP88
prerank,regulation of DNA recombination (GO:0000018),0.3583520743251031,0.9557418205149399,0.5363748458692972,0.9133653617393842,1.0,7/32,15.82%,MSH2;CHEK1;RTEL1;SIRT6;PPP4R2;ZRANB3;ZCWPW1
prerank,regulation of cell adhesion (GO:0030155),0.3106641833192454,0.9556408384428824,0.5824742268041238,0.9130970100760355,1.0,22/129,17.33%,PLXNA3;HYAL1;CXCR4;PLXNB2;SEMA4D;CDH13;ADAM8;CCL5;PLXNB3;EPHA4;PODXL;RET;YTHDF2;LYN;DUSP26;PTPN11;STX4;MINK1;DSCAM;IL18;MDK;CBLL1
prerank,sodium ion transmembrane transport (GO:0035725),-0.21985984304207212,-0.9555666488046067,0.5492957746478874,1.0,1.0,11/84,9.79%,SLC9A9;ATP1B1;SLC12A2;ATP1B2;NALCN;SLC6A15;SLC8A3;SLC6A8;SCN3A;SLC4A8;TRPM4
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3484259904579424,0.9553258922867169,0.5434272300469484,0.9133254480508023,1.0,9/41,19.96%,SLAMF1;ILRUN;CX3CL1;ZC3H12A;HAVCR2;DICER1;LGALS9;CD33;SIRPA
prerank,sodium ion import across plasma membrane (GO:0098719),-0.3229790260660539,-0.9552954456260714,0.5109489051094891,1.0,1.0,3/17,9.79%,SLC9A9;SLC12A2;TRPM4
prerank,glucose homeostasis (GO:0042593),0.3187040537998291,0.9552627421059283,0.5739769150052466,0.9129503268804333,1.0,14/83,15.25%,IRS1;STAT3;TCF7L2;USF1;TFAP2B;LEPR;INSR;HK1;FOXK1;PPARGC1A;RPS6;BAD;INPP5K;SELENOT
prerank,regulation of acrosome reaction (GO:0060046),0.4504856011571854,0.9550572319919826,0.5190839694656488,0.9129208177298731,1.0,2/10,21.07%,SPINK13;GLRA1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.3338787766597311,-0.9549310905956246,0.5054151624548736,1.0,1.0,7/16,30.04%,IGFBP5;IGFBP4;ZFAND2B;IGFBP6;IGFBP3;BMP5;BMP2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3550392377766499,0.9549014403510082,0.5507246376811594,0.9127636468153134,1.0,9/36,14.83%,PCGF6;CHEK1;TFDP1;RING1;MAX;RYBP;TFDP2;UXT;EZH2
prerank,organic hydroxy compound transport (GO:0015850),0.36285905872597224,0.9540745951874895,0.5491124260355029,0.9141834725632489,1.0,4/36,6.50%,ABCC2;SLCO1C1;NCOA1;SLCO1B1
prerank,negative regulation of potassium ion transport (GO:0043267),0.4226112488547756,0.9536167819169616,0.5363511659807956,0.9147793375375307,1.0,3/13,16.65%,ACTN2;CAB39;STK39
prerank,heterochromatin organization (GO:0070828),0.4196927125950459,0.9536131320287197,0.5272727272727272,0.9142764113614847,1.0,5/14,21.80%,LOXL2;SETDB2;BAHD1;SETD7;SMCHD1
prerank,protein glycosylation (GO:0006486),0.31087027331827605,0.9535068401539231,0.5935550935550935,0.9140316599805842,1.0,31/125,18.78%,TMEM258;AQP11;COG3;POMT1;TRAK1;MPI;POMT2;GALNT7;B4GALT1;GCNT4;GFPT1;ENTPD5;B4GALT5;ST3GAL1;DAD1;FUT10;GALNT18;MGAT4C;B3GALNT1;NPC1;ALG11;RPN1;TET2;GALNT1;MGAT5;ST8SIA1;MAGT1;MAN1C1;FUT9;STT3B;SERP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3513795038367576,-0.9534258004399787,0.5110410094637224,1.0,1.0,9/13,29.26%,GLRX3;CIAO1;MMS19;CIAO2A;BOLA2;ISCA1;GLRX5;CIAO2B;CISD3
prerank,protein kinase B signaling (GO:0043491),0.38023266730197564,0.9531200613834611,0.5676741130091985,0.9144501262148341,1.0,5/23,10.97%,KDR;CCL5;MT3;PLK3;ZFP36L1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.33465622907717835,0.9529936197663784,0.5630057803468208,0.9142552298917003,1.0,12/49,16.91%,CLU;PTGER4;NOP53;PMEPA1;DACT1;HMGB1;RIOK3;ANKRD27;SORL1;SVIP;JAM3;PEX5
prerank,regulation of synapse maturation (GO:0090128),-0.3767241465554241,-0.9529847030946563,0.4755043227665706,1.0,1.0,4/10,9.13%,ADGRL1;YWHAZ;NRXN1;DAB2IP
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.32401827247679327,0.9528860063682234,0.5783783783783784,0.9140064358341965,1.0,22/75,19.81%,SLITRK6;ATL1;FGFR2;PAK3;BTBD3;APP;RB1;APBB1;ACTB;MINK1;TBCD;TAOK2;MEF2A;BAIAP2;DSCAML1;OPHN1;LLGL1;DCDC2;ABITRAM;BRSK1;MAP1B;CCK
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.37416257929709984,-0.9528515191234553,0.4797507788161994,1.0,1.0,5/11,13.81%,CASP8;SLC25A4;YBX3;RIPK1;ARHGEF2
prerank,negative regulation of myotube differentiation (GO:0010832),0.43782028623355396,0.9525935060600483,0.5306427503736921,0.9141783283248291,1.0,5/12,23.50%,BDNF;XBP1;HDAC1;NOTCH1;HDAC4
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.36328469797850443,0.9521221375778447,0.5492788461538461,0.9148103287474637,1.0,11/35,19.01%,DHX36;CTNNB1;RTEL1;CCT4;HNRNPA2B1;CCT7;CCT3;HNRNPA1;MAP3K4;HMBOX1;NEK7
prerank,mitochondrion localization (GO:0051646),-0.3209832362358842,-0.9521205489848407,0.5140562248995983,1.0,1.0,8/19,24.79%,MFN1;TRAK2;BRAT1;ATCAY;MTM1;MUL1;MSTO1;NECTIN2
prerank,protein import into peroxisome matrix (GO:0016558),0.43952212471680174,0.9516787191495731,0.5390173410404624,0.9153346919411562,1.0,4/12,17.03%,PEX7;PEX2;PEX5;PEX13
prerank,positive regulation of histone modification (GO:0031058),-0.26559602113484015,-0.951558459148054,0.5130890052356021,1.0,1.0,10/33,15.54%,ARRB1;NIPBL;SAP30BP;GLYR1;MAPK3;ZBTB7B;BRCA1;RPS6KA4;KDM1A;ING2
prerank,regulation of cell differentiation (GO:0045595),0.3036253944734882,0.9514854852388805,0.6071428571428571,0.915302385565552,1.0,21/148,11.40%,EIF2AK2;BDNF;BIRC2;DDX5;RUNX1;HSP90AB1;FGFR2;BCL6;TFAP2B;CSF1;SNAI2;SRF;MEGF10;CDK5RAP2;LTK;GDNF;TAF8;ZFP36L1;NOTCH4;PHLDB1;SIK1
prerank,regulation of focal adhesion assembly (GO:0051893),0.3352630841688566,0.9511305233436786,0.5490417136414881,0.9156100357356916,1.0,11/54,13.91%,DAPK3;KDR;THY1;PEAK1;DUSP3;MYOC;PPM1F;LDB1;LIMS1;NRP1;RAC1
prerank,negative regulation of lyase activity (GO:0051350),-0.32518828456258336,-0.9508996146173511,0.4931506849315068,1.0,1.0,4/16,12.68%,GRM3;EDNRB;PALM;CCR2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.32072095143956125,0.9504216255976078,0.5612134344528711,0.9168086550353206,1.0,15/71,18.95%,ISG15;CHMP4B;CTSS;UBE2W;RSPRY1;CTSC;CTSH;NGLY1;LONP1;ZRANB1;ATE1;ADAMTS12;HM13;SOCS6;DDI2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3031096875731687,0.9502178464255858,0.6064908722109533,0.916786699696138,1.0,38/151,22.40%,NMRAL1;SLC27A1;SGPP2;MOCS3;CERS6;DEGS1;CSNK2B;CSNK2A2;LPIN2;CEPT1;B4GALT5;NFS1;LPCAT2;VAPB;SPHK2;TNIP1;GCH1;MOCOS;HACD3;APOE;ABHD3;PAM;CHPT1;ACER3;SPTLC2;SGPL1;CERS2;PCYT1A;PCTP;ELOVL4;SLC25A15;SLC44A1;SPTSSA;CHKA;PLPP2;PCYT1B;MGST1;CERT1
prerank,response to ionizing radiation (GO:0010212),-0.22397921870128368,-0.9501710894421044,0.5842696629213483,1.0,1.0,26/70,20.74%,INO80;BRAT1;USP28;NABP1;XRCC4;RHNO1;SPIDR;SIRT1;EEF1D;DCUN1D3;MRNIP;BRCA1;INIP;NABP2;HUS1;FANCD2;TP53;CDKN1A;RAD1;ANXA1;NET1;ECT2;MYC;RAD51AP1;SMPD1;ABRAXAS1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3345172554009178,-0.9501073000793402,0.46601941747572817,1.0,1.0,4/14,12.68%,SYK;CD81;PTPN22;CCR2
prerank,regulation of bone mineralization (GO:0030500),0.3332918877554121,0.949978589302952,0.5602755453501722,0.9168530789300138,1.0,13/55,20.48%,ISG15;ACVR1;SLC8A1;NBR1;ANKH;BMPR2;ADGRV1;ENPP1;NELL1;BMPR1A;ACVR2A;BCOR;DDR2
prerank,sphingosine biosynthetic process (GO:0046512),0.4471471354999046,0.9498657054034999,0.5401146131805158,0.9160951700222365,1.0,4/11,18.30%,ASAH2;SPHK2;ACER3;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.4471471354999046,0.9498657054034999,0.5401146131805158,0.9160951700222365,1.0,4/11,18.30%,ASAH2;SPHK2;ACER3;SPTLC2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.369065098555517,0.9493903940497281,0.5380710659898477,0.9167207462699622,1.0,6/25,13.91%,UBQLN2;WDR54;APP;LRPAP1;PSEN1;RAC1
prerank,regulation of autophagy (GO:0010506),0.3011300410226957,0.9492201561673315,0.6172344689378757,0.9166052434100128,1.0,56/216,21.86%,IRGM;TRIM14;DAPK3;TRIB3;ATP6V0D1;STAT3;TRIM21;UBQLN2;ITPR1;OSBPL7;FBXW7;RRAGC;SH3GLB1;MT3;IL10RA;CSNK2A2;CISD2;MET;LEPR;HMGB1;PRKAG1;UBQLN1;ZC3H12A;FOXK1;CAPNS1;SVIP;LAMTOR3;CAPN1;PIK3CB;BAD;RUBCN;EIF4G3;RB1CC1;TMEM59;BMF;VPS26A;MTOR;SREBF1;KAT8;WDR41;ATP6V1B2;ATP6V1G1;ZKSCAN3;NPRL2;ATP6V1G2;TAB3;ERN1;LAMTOR4;TLK2;MCL1;STK11;OPTN;VPS35;ABL2;RHEB;USP33
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.30611104151340157,0.9489522488674202,0.5933062880324543,0.9167224961262135,1.0,49/148,24.81%,PML;TAF4B;TP53RK;DAXX;PAK1IP1;CHEK2;CHEK1;NOP53;RFC4;PPP2R5C;BRIP1;CSNK2B;RRS1;CSNK2A2;MTA2;TAF2;BARD1;PLK3;MAPK14;PRKAG1;SSRP1;TAF3;DYRK2;NOP2;BRPF1;RMI1;TAF15;RPL11;MTOR;BRD7;HDAC1;RFFL;PIN1;SMYD2;ATRIP;JMY;RPL5;STK11;PRDM1;ING5;HDAC2;KAT6A;RAD9A;PDPK1;KAT5;TAF7;PRKAB2;TAF4;TAF11
prerank,histone mRNA metabolic process (GO:0008334),0.36943590709190055,0.9488816219702472,0.5506883604505632,0.9163657632374479,1.0,10/27,23.57%,NCBP2;XRN1;DCP2;SNRPG;NCBP1;TUT7;UPF1;MTPAP;EXOSC4;SNRPD3
prerank,cellular respiration (GO:0045333),0.34919333257996477,0.948676519780716,0.5486518171160609,0.9163469155764822,1.0,18/41,29.65%,MTFR2;NDUFA5;COQ10B;SDHAF4;PPARGC1A;NDUFS1;UQCR10;NDUFS4;NDUFS8;NDUFS7;SDHB;UQCRFS1;LYRM7;CYCS;SDHA;SDHC;SIRT3;ETFDH
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.34456390757708466,0.9482844644725849,0.5584415584415584,0.9167875981021647,1.0,7/39,13.47%,KDR;SFRP2;CTNNB1;MET;GDNF;NOTCH4;NRP1
prerank,T cell activation (GO:0042110),0.3240529706346444,0.9482080183827103,0.5609756097560976,0.9164596046822825,1.0,17/69,23.13%,TREML2;ICOSLG;PIK3CD;CHD7;CD276;NCK1;LEPR;NCK2;LMBR1L;NHEJ1;MDK;PTPRC;LCK;DDOST;RHOH;MSN;RAB29
prerank,regulation of Notch signaling pathway (GO:0008593),0.31852813357946574,0.9479856865735581,0.5698689956331878,0.9164860291907895,1.0,13/76,11.00%,NOD2;DLK2;STAT3;TM2D3;MMP14;YJEFN3;FBXW7;ENHO;YTHDF2;EGFL7;MAML2;SNW1;NOTCH4
prerank,presynapse assembly (GO:0099054),0.3989241587048228,0.9478483843557554,0.5301369863013699,0.9162816693354412,1.0,7/16,26.53%,WNT5A;LRRTM3;BSN;NLGN3;PCLO;LRP4;PTEN
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.32230654546333787,-0.9475586915658145,0.5370370370370371,1.0,1.0,7/17,15.73%,DOCK4;DOCK7;ADAMTS1;IGFBP5;DOCK5;S100A11;VTN
prerank,negative regulation of transposition (GO:0010529),0.40633617637190533,0.9471972372202031,0.525,0.9173316445755978,1.0,1/16,0.61%,MOV10
prerank,sulfate transport (GO:0008272),0.4143669330659618,0.9470665302741043,0.5356622998544396,0.9171485505156215,1.0,6/14,23.24%,SLC26A1;SLC25A10;SLC26A2;SLC13A4;SLC25A30;SLC26A7
prerank,positive regulation of protein import (GO:1904591),-0.27857628317651767,-0.9467749312091712,0.54,1.0,1.0,10/30,22.88%,TGFB1;EFCAB7;PIK3R2;ZIC1;UBR5;DMAP1;BAG3;ECT2;TPR;RBM22
prerank,positive regulation of developmental process (GO:0051094),0.3044792376726475,0.9467279407141995,0.6146044624746451,0.9174087708029425,1.0,32/164,16.89%,WNT5A;KDR;ESRRB;FIS1;CAMK2B;AGO2;ACVR1;MAD2L2;HSP90AB1;SYDE1;SOX9;ARHGEF7;SRF;GDNF;B4GALT5;SCX;INSR;BMPR2;PHLDB1;XBP1;SORL1;SHLD1;PSEN1;APOE;PAXIP1;CORO1B;RREB1;BMPR1A;SOX5;ANAPC2;LRP8;MDK
prerank,cellular response to starvation (GO:0009267),0.3020617913647888,0.9459839275673174,0.6056910569105691,0.9186282558596349,1.0,37/147,22.25%,EIF2AK2;MYBBP1A;MIOS;ATP6V0D1;LAMP2;RRAGC;KPTN;SH3GLB1;PIK3R4;BMPR2;HSPA8;PRKAG1;ZC3H12A;NUAK2;SIK1;XBP1;KLF10;HNRNPA1;MAP1LC3B;LAMTOR3;EIF2S1;MTOR;TCIRG1;SREBF1;ATP6V1B2;ATP6V1G1;BRSK1;NPRL2;STK24;BECN1;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;USP33;RRAGA
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.353479531996137,-0.9458618278412557,0.5127388535031847,1.0,1.0,4/13,16.32%,EPHB2;SHANK3;CHRNA7;SHISA7
prerank,branched-chain amino acid metabolic process (GO:0009081),0.38536962324770846,0.9458363058260215,0.5455729166666666,0.9179874347646433,1.0,11/20,30.02%,AUH;DLD;BCKDK;ACAT1;HIBADH;MCCC1;DBT;ALDH6A1;HSD17B10;BCKDHA;BCAT2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.38536962324770846,0.9458363058260215,0.5455729166666666,0.9179874347646433,1.0,11/20,30.02%,AUH;DLD;BCKDK;ACAT1;HIBADH;MCCC1;DBT;ALDH6A1;HSD17B10;BCKDHA;BCAT2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.43782678167313216,0.945578780866096,0.552870090634441,0.9180948442488531,1.0,7/11,27.65%,DIABLO;STK25;STK24;PRKCD;ARL6IP5;MAP3K5;PDCD10
prerank,exit from mitosis (GO:0010458),0.43281115660294983,0.9450284126780917,0.5332369942196532,0.9188699301237456,1.0,1/12,0.58%,CHMP4B
prerank,hepaticobiliary system development (GO:0061008),0.3882251957321856,0.9449883819181677,0.5479082321187584,0.918464219362955,1.0,5/20,11.45%,GFER;ARID5B;MET;PROX1;XBP1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.30548865218501786,-0.9442545690803835,0.4978902953586498,1.0,1.0,4/21,11.76%,LRP6;GSK3B;DVL3;APC
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.3424533878548254,-0.9437136555090858,0.5034965034965035,1.0,1.0,7/15,21.61%,DYRK1A;EGFR;MAPK3;IGF1R;TXK;ABL1;DDR1
prerank,synaptic membrane adhesion (GO:0099560),-0.3377016618734733,-0.9434939226137191,0.5642857142857143,1.0,1.0,7/14,30.46%,LRFN5;SLITRK1;GPC4;SLITRK3;SLITRK2;PTPRD;NTNG1
prerank,positive regulation of macroautophagy (GO:0016239),0.3371358192470528,0.9432709638684286,0.5588571428571428,0.9220108192878551,1.0,6/48,6.36%,IRGM;KDR;FYCO1;LARP1;LRSAM1;SH3GLB1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2736201920487981,-0.9429764065976597,0.5396825396825397,1.0,1.0,13/30,22.09%,CASP8;TRAF2;HMOX1;TMBIM1;RIPK1;GSK3B;TRADD;BRCA1;ARHGEF2;FAIM2;FAS;GPX1;TNFAIP3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.360683519239828,0.942838270219895,0.5454545454545454,0.9225525743996978,1.0,7/31,16.79%,PRMT2;RBL1;CDKN2D;DACT1;RB1;DLG1;BRD7
prerank,polyamine metabolic process (GO:0006595),0.42428018552747016,0.9427587172928648,0.5583456425406204,0.9222327140118277,1.0,3/13,7.65%,SAT1;SMOX;SMS
prerank,macrophage chemotaxis (GO:0048246),0.4419766961560616,0.9427570826175655,0.5475113122171946,0.9217334192754366,1.0,3/10,12.40%,CCL5;TAFA4;CXCL17
prerank,zymogen activation (GO:0031638),0.3442166041119235,0.942727338129948,0.5587188612099644,0.9213020524180375,1.0,6/39,13.11%,ASPH;PRSS12;MMP14;CTSH;KLK1;BAD
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2907487002087856,-0.9426190301148543,0.5267489711934157,1.0,1.0,11/24,17.44%,MAP2K6;CASP8;TAB1;TRAF6;IKBKG;ITCH;UBB;AAMP;UBC;UBA52;RPS27A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4286082221187774,0.9422703844636204,0.546242774566474,0.9218835278504749,1.0,2/12,10.36%,SKP1;BTRC
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.31036626645726506,-0.9419942977852078,0.5056179775280899,1.0,1.0,4/17,16.78%,NCKAP1L;RAC2;RIPOR2;C1QBP
prerank,positive regulation of organelle assembly (GO:1902117),0.3380122271419503,0.9418939937336316,0.5649038461538461,0.9222815954285525,1.0,7/44,10.33%,SDC4;DYNC1H1;KCTD17;LRSAM1;SH3GLB1;CCDC88A;G3BP2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3535038416903957,0.9418244252680519,0.5554202192448234,0.9219436129632052,1.0,11/34,18.86%,CARMIL1;ARHGEF7;MYOC;CIB1;LIMS1;NRP1;RAC1;RREB1;CRK;MDK;TESK1
prerank,integrated stress response signaling (GO:0140467),-0.3278888934419248,-0.9416212951804155,0.5468164794007491,1.0,1.0,6/14,33.89%,IMPACT;HERPUD1;CCL2;EIF2AK3;QRICH1;EIF2AK4
prerank,endocardial cushion morphogenesis (GO:0003203),0.402759197153594,0.94142313474805,0.5349143610013175,0.9223712782197611,1.0,5/18,23.22%,ACVR1;SOX9;BMPR1A;ACVRL1;NOTCH1
prerank,negative regulation of axon extension (GO:0030517),-0.27871643010345104,-0.9413444642614404,0.6018957345971564,1.0,1.0,9/30,13.00%,SEMA4C;DIP2B;SEMA4G;SEMA4A;CDKL3;SEMA6A;SEMA4B;SEMA3E;SEMA5B
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.44735046650302956,0.9413089494441442,0.553125,0.922135778977832,1.0,2/10,2.89%,SOCS1;CD55
prerank,ephrin receptor signaling pathway (GO:0048013),0.31572856164115054,0.9409684891992964,0.5735767991407089,0.9223985179177805,1.0,22/82,15.44%,ACTR2;AP2A1;EPHA4;PAK3;ARHGEF7;ACTR3;EPHA6;LYN;NCK2;GIT1;AP2S1;ARPC5;PTPN11;PSEN1;CHN1;SIPA1L1;RAC1;ACTB;FYN;APH1A;APH1B;CRK
prerank,translational termination (GO:0006415),0.3134405849659524,0.940968133076031,0.5903361344537815,0.9218974871684333,1.0,24/95,19.21%,MRPL36;ERAL1;MRPS30;GSPT1;MRPL12;MRPL16;MRPS35;MRPS28;ABCE1;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;ETF1;MRPS10;MRPL13;MTRF1L;MRPL57;MRPS11;MRPL40;MRPL22
prerank,keratan sulfate catabolic process (GO:0042340),0.4250357638916736,0.9407515142930984,0.5465648854961832,0.9218600787677668,1.0,5/11,23.95%,FMOD;GLB1;OGN;GALNS;GNS
prerank,proton transmembrane transport (GO:1902600),0.35239574160880327,0.9405473004321877,0.5810650887573965,0.9218614161149724,1.0,5/36,14.77%,ATP6V0D1;UCP3;SLC46A1;DMAC2L;ATP5PO
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3152848972636967,-0.9403922711982272,0.5148148148148148,1.0,1.0,9/17,46.83%,SCN3B;KCNH2;RYR2;KCNQ1;SNTA1;KCNE3;KCNE4;KCNJ8;KCNE2
prerank,heart process (GO:0003015),0.4070910387576423,0.9398426179741763,0.5557122708039492,0.9229933063799903,1.0,1/14,1.18%,PPCS
prerank,DNA packaging (GO:0006323),0.4053862087218205,0.9396469473860575,0.5726027397260274,0.922958086455374,1.0,3/16,10.23%,PRM1;BANF1;CHAF1B
prerank,positive regulation of protein catabolic process (GO:0045732),0.31557600832347077,0.9396360892428035,0.5763813651137595,0.9224815148589063,1.0,26/84,23.72%,WNT5A;SNX33;ADAM8;EGLN2;RILP;AREL1;VPS11;DACT1;BARD1;PLK3;SNX9;SORL1;SMURF1;APOE;VPS28;HSP90AA1;TIPARP;SH3D19;WWP1;VPS35;HUWE1;SMURF2;IDE;MSN;VCP;AXIN1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.41549342820084745,0.9393722218877194,0.5454545454545454,0.9226038148821634,1.0,5/13,16.18%,IRS1;ECHDC3;SORL1;PTPN11;GKAP1
prerank,negative regulation of heart contraction (GO:0045822),-0.3673371992514408,-0.9391890927312102,0.5203761755485894,1.0,1.0,5/11,22.15%,SPTBN4;PIK3CG;GRK2;FKBP1B;SRI
prerank,response to estradiol (GO:0032355),0.35265825358993647,0.93912717725891,0.5599505562422744,0.9226547623270048,1.0,11/31,23.52%,STAT3;CRHBP;CTNNB1;GGT7;SOCS2;LCOR;CCDC62;STRN3;NRIP1;RUVBL2;KAT5
prerank,artery development (GO:0060840),0.37623440840969713,0.9390402297366413,0.5526641883519207,0.9223595285331784,1.0,5/23,20.17%,BMPR2;NRP1;HECTD1;NF1;ACVRL1
prerank,response to steroid hormone (GO:0048545),0.3572246652926691,0.9389619296845246,0.5700123915737298,0.9220380039479603,1.0,5/31,12.63%,CATSPER4;ABHD2;UBE3A;NR3C1;UBE2L3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.33004665263072286,-0.938902202461554,0.5365853658536586,1.0,1.0,3/15,5.60%,SYK;HSPH1;PNP
prerank,positive regulation of programmed cell death (GO:0043068),0.2963819468641204,0.9387840053878709,0.6760280842527583,0.9219344825237027,1.0,41/272,13.38%,ZBP1;TNFSF10;IFIT2;DAPK3;CLU;PRMT2;RARG;GADD45G;TNFRSF8;MLLT11;BCL2L11;SFRP2;PLEKHN1;SIAH1;CTNNB1;ARHGEF7;BCL6;DDX20;FRZB;HTATIP2;ABR;BARD1;HMGB1;VAV1;SPHK2;PRR7;DIABLO;DNM2;PHLDA1;RNF122;RNPS1;RYBP;ARHGEF11;SOS1;PSEN1;RACK1;RPS6;BAD;APBB1;AKAP13;TIAM2
prerank,ribosome biogenesis (GO:0042254),0.30037255510769045,0.9386929065371292,0.6387487386478304,0.9216395752804719,1.0,58/187,22.95%,PWP2;LTV1;MRPL36;XRN2;PAK1IP1;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;LSG1;RRS1;ABCE1;NOLC1;NPM1;EIF6;DDX54;RPS6;NOP16;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;TSC1;MRPL22;UTP3;EMG1;RPL29;URB2;RPL5;RRP9;EXOSC4;UTP15;RPL6;LTO1;NOL6;UTP14A
prerank,neutral amino acid transport (GO:0015804),0.3577370787469154,0.9386485509579701,0.5813664596273292,0.9212430546602645,1.0,6/28,16.66%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;CTNS;SLC36A4
prerank,response to amino acid starvation (GO:1990928),0.31768036530866084,0.938625122228518,0.5824295010845987,0.9207981916777415,1.0,20/72,22.25%,EIF2AK2;MIOS;ATP6V0D1;LARP1;RRAGC;KPTN;SH3GLB1;LAMTOR3;EIF2S1;MTOR;TCIRG1;ATP6V1B2;ATP6V1G1;NPRL2;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;RRAGA
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.39087212885888784,0.9384857651593589,0.5492227979274611,0.9206208219194105,1.0,7/19,19.47%,CLU;GGA3;PRNP;SORL1;APOE;FLOT2;PIN1
prerank,rRNA 3'-end processing (GO:0031125),-0.3779572251581439,-0.9380418245616621,0.5306748466257669,1.0,1.0,4/10,13.21%,EXOSC7;EXOSC10;ERI1;EXOSC3
prerank,negative regulation of receptor binding (GO:1900121),0.45325344531874656,0.9380023996413432,0.581570996978852,0.9211987783587786,1.0,1/10,2.20%,B2M
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3205378207695483,0.9378463532583591,0.5751633986928104,0.9210565503555851,1.0,20/65,22.66%,PSMB10;SKP1;PSME2;PSMA5;PSME4;CHEK1;PSMA3;PSMB9;RBX1;PSMD2;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4
prerank,neural tube development (GO:0021915),0.41506379401856064,0.9377704315655031,0.5856741573033708,0.9207409010587406,1.0,4/15,13.53%,DACT1;PROX1;ALDH1A2;PTCH1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.34992581966508174,-0.9376771852474421,0.5160256410256411,1.0,1.0,2/12,2.45%,AKR1B1;STARD3NL
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3932790214002431,0.9374182092130321,0.559254327563249,0.9210298036933561,1.0,4/20,10.08%,CCND2;HSP90AB1;CCND1;PROX1
prerank,negative regulation of autophagy (GO:0010507),0.3261171392191245,0.9373192932229535,0.5756207674943566,0.9207717646916179,1.0,21/54,25.96%,STAT3;MT3;NRBP2;IL10RA;MET;LEPR;FOXK1;RUBCN;EIF4G3;BMF;MTOR;ZKSCAN3;TSC1;TAB3;TLK2;MCL1;RRAGA;PIK3CA;EIF4E;SIRT2;SNRNP70
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.42636918261096934,0.9371354783121072,0.5534682080924855,0.9207002544937815,1.0,4/12,14.58%,TRIB3;ACADL;ERLIN2;PIBF1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.39676926624165143,0.9370357294339263,0.5704514363885089,0.9204426706197091,1.0,4/18,17.40%,ZFP36;PRNP;HAVCR2;PTPRC
prerank,ERBB signaling pathway (GO:0038127),0.32503792638247536,0.9365732829846497,0.5863586358635864,0.9210147716779254,1.0,14/64,17.68%,CPNE3;GAREM1;CUL5;TGFA;PTPN18;SOX9;BCAR1;NCK2;KIF16B;SOS1;PTPN11;HSP90AA1;CDC37;PLCE1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.22443411950656347,-0.936525445158123,0.5688073394495413,1.0,1.0,21/59,26.59%,PTPRK;IMPACT;MPV17;PXN;EGFR;MAPK3;TPM1;SIRT1;RIPK1;AKT1;MAPK7;ANXA1;NET1;ECT2;ABL1;ROMO1;TNFAIP3;PDGFRA;PPIF;RPS3;MAPK8
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3800584088176526,0.9356906869390742,0.5551181102362205,0.922545115316253,1.0,5/21,16.89%,CCL5;CSF1;STAP1;CXCL17;MDK
prerank,ncRNA processing (GO:0034470),0.29763112993878793,0.9356830587208483,0.6394763343403826,0.9220644733623704,1.0,63/200,23.64%,PWP2;XRN2;ADAR;TRPT1;AGO2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;TARBP2;MDN1;SRRT;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;AARS1;HNRNPA2B1;SMAD2;NOLC1;DDX54;RPS6;ADAT1;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;TUT7;DHX37;DDX47;DICER1;RPL10A;RPP30;PRKRA;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;UTP3;EMG1;RPL29;RPL5;RRP9;PUS10;EXOSC4;UTP15;RPL6;AGO4;NOL6;UTP14A;RPP21;RRP36;INTS1
prerank,epithelial cell development (GO:0002064),0.3825773259705043,0.9355350388480107,0.5505913272010512,0.921919237444528,1.0,3/20,9.17%,RILPL1;WNT7B;BFSP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.38163187372645124,0.9355160489786436,0.5742705570291777,0.9214701202119255,1.0,4/19,16.82%,MAD2L2;PPM1F;NOTCH4;PTPRU
prerank,regulation of lamellipodium organization (GO:1902743),0.4138286849398528,0.9355063203866155,0.5561959654178674,0.9209945933496476,1.0,4/14,13.91%,CARMIL1;PDPN;CAPZB;RAC1
prerank,chromatin disassembly (GO:0031498),0.4103314192388066,0.9354431571147995,0.5611814345991561,0.9201390880740755,1.0,6/14,19.23%,ARID1A;SMARCE1;SMARCC2;ARID2;SMARCD2;SET
prerank,nucleosome disassembly (GO:0006337),0.4103314192388066,0.9354431571147995,0.5611814345991561,0.9201390880740755,1.0,6/14,19.23%,ARID1A;SMARCE1;SMARCC2;ARID2;SMARCD2;SET
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.2985046408551107,0.9352686572046449,0.6233502538071066,0.9200484320263744,1.0,51/166,24.81%,TAF4B;NR1H2;ESR2;POLR2G;ESRRB;RARG;TEAD2;UBTF;TFB2M;TBPL1;TAF2;TAF8;POLR2K;MAML2;MNAT1;NR2C1;RORA;SNW1;NOTCH4;TAF3;PPARGC1A;NR3C1;GTF2E2;TAF1B;NRBP1;TAF15;PPARD;MED27;RBPJ;HDAC1;POLR1G;CAVIN1;TAF1C;BRF1;MED7;NR1D2;CDK9;GTF3C1;NOTCH1;NR2C2AP;BRF2;TAF7;NCOR2;KAT2B;POLR2C;POLR1F;TFAM;CCN2;TAF4;RARB;TAF11
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.35846840733387586,0.9351937191347123,0.5800492610837439,0.9197303213010766,1.0,4/33,3.81%,PRMT2;DDRGK1;DDX5;RUNX1
prerank,smooth muscle tissue development (GO:0048745),0.43608663901993583,0.9350678890415087,0.5391849529780565,0.9195268023692816,1.0,3/10,18.19%,PROX1;PTCH1;NF1
prerank,regulation of exit from mitosis (GO:0007096),0.3422974288064701,0.9350457464030034,0.5656934306569343,0.9190865428523065,1.0,8/38,16.23%,CDC26;ANAPC5;ANAPC4;UBE2E1;CDC16;CDC27;ANAPC15;ANAPC2
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3721665810311242,0.9349967891412243,0.5525291828793775,0.9187169461218546,1.0,9/25,23.22%,SMAD2;BMPR2;ZNF423;BMPR1A;RBPJ;ACVR2A;NUMA1;ACVRL1;NOTCH1
prerank,necroptotic process (GO:0070266),0.4052868592457693,0.9349916505933509,0.5365168539325843,0.9182363536281937,1.0,6/16,21.42%,MLKL;CYLD;ITPK1;TRPM7;TLR3;PGAM5
prerank,histone H3-K9 demethylation (GO:0033169),0.42774382837134517,0.934828225316574,0.5564142194744977,0.9181379046835949,1.0,4/11,15.96%,KDM4D;HR;KDM3B;KDM7A
prerank,mitochondrial transport (GO:0006839),0.3311199682377528,0.9343281907362934,0.5860091743119266,0.9187687117553439,1.0,14/53,19.57%,FIS1;FBXO7;GDAP1;SLC25A16;TOMM5;STARD3;TSPO;BAD;PITRM1;AIP;HSP90AA1;TOMM40;FLVCR1;BCAP31
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.32048780764030255,0.934182897735936,0.5652654867256637,0.918605922894868,1.0,12/67,16.05%,IL15;FLT1;KDR;HCK;EPHA4;FGFR2;LYN;INSR;JAK2;FYN;PIBF1;FGFR3
prerank,mitochondrial translational elongation (GO:0070125),0.31360092831245157,0.93398003007462,0.5932560590094836,0.9185608733883969,1.0,22/88,19.21%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;MRPS10;MRPL13;MRPL57;MRPS11;MRPL40;MRPL22
prerank,melanosome organization (GO:0032438),0.3651143105954029,0.9336542159479245,0.5759096612296111,0.9187765152791603,1.0,8/26,26.49%,BLOC1S4;LYST;RAB32;DTNBP1;TRAPPC6A;RAB29;AP3B1;SHROOM2
prerank,response to UV (GO:0009411),0.30851815765188323,0.9334458159518589,0.6080084299262382,0.9187762638685628,1.0,20/95,15.97%,MSH2;TMEM161A;UVSSA;UBE2B;DHX36;CDKN2D;CCND1;USF1;FEN1;N4BP1;ERCC4;POLK;MEN1;NPM1;ZRANB3;MAP3K4;UBE4B;EIF2S1;BMF;SPRTN
prerank,regulation of acute inflammatory response (GO:0002673),0.3927615478726736,0.9332895541672882,0.5461847389558233,0.9186655706039559,1.0,1/18,3.66%,ADAM8
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.28349792152865433,-0.9332101704676511,0.5482233502538071,1.0,1.0,4/26,3.76%,PAK1;FES;DRG1;CLIP1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3371392133584204,-0.9328266100197301,0.5236486486486487,1.0,1.0,3/14,10.41%,TRAF2;TRAF6;ZFP91
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.30737405461609585,0.932763307767816,0.5983263598326359,0.9193751382478094,1.0,21/101,16.97%,AGT;NR1H2;ASPH;PLXNB2;YTHDF1;ZCCHC4;VPS11;CSF1;DACT1;BTRC;NPM1;EIF6;PRKDC;UPF3A;BAD;AURKAIP1;HSP90AA1;RBM3;MTOR;METTL14;IST1
prerank,response to acidic pH (GO:0010447),0.41676712646311087,0.9326743395111855,0.5553977272727273,0.9190984907750953,1.0,2/13,8.08%,CTSS;RAB11B
prerank,regulation of establishment of protein localization (GO:0070201),0.41338552452660415,0.9326642750260417,0.5482014388489208,0.9186314355872998,1.0,5/14,18.83%,CENPJ;GAPVD1;SCFD1;CEP295;CEP135
prerank,positive regulation of neurogenesis (GO:0050769),0.318566172753806,0.9325128612712016,0.5929978118161926,0.9184773972962907,1.0,13/68,14.89%,PLXNA3;PLXNB2;LRP2;PLXNB3;CTNNB1;CX3CL1;CUL7;FBXW8;SNW1;CUX1;TIAM2;NUMBL;NPTN
prerank,myeloid leukocyte differentiation (GO:0002573),0.3186358688863907,0.9317707851553343,0.5948372615039281,0.9195910343953645,1.0,7/65,6.89%,PML;IL15;PIK3CD;BATF3;RUNX1;SNX10;CSF1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.2751146559374086,-0.9317488495825357,0.5212765957446809,1.0,1.0,10/30,17.62%,ITGAV;MMD2;FGF10;RASGRF1;SRC;SHOC2;CRKL;RASGRP4;RASGEF1A;LRRC59
prerank,protein localization to chromatin (GO:0071168),0.3927542866244377,0.9316954116505312,0.5783783783783784,0.9192547616820649,1.0,3/18,6.35%,MSH2;LRWD1;MCM9
prerank,magnesium ion transport (GO:0015693),-0.35159651095800126,-0.9311483491953728,0.5487012987012987,1.0,1.0,5/12,21.99%,TUSC3;NIPAL3;MMGT1;CNNM4;NIPAL2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.36095103440818294,0.9311042147191386,0.5686777920410783,0.9200664761937485,1.0,9/26,22.77%,KMT2A;SETD3;EEF2KMT;SETD5;TET2;ATPSCKMT;SMYD5;KMT5C;KMT2D
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3634849347611362,0.9309556643404086,0.5902255639097744,0.9199210356129561,1.0,6/26,14.64%,IRS1;ARPP19;OSBPL8;INSR;PTPN11;IRS2
prerank,phospholipid dephosphorylation (GO:0046839),-0.2499032622253445,-0.930862293704803,0.5217391304347826,1.0,1.0,11/37,16.27%,INPP5F;PLPP4;MTMR1;MTMR4;INPP5B;MTMR9;SYNJ2;MTMR10;PLPPR4;PLPP3;MTM1
prerank,embryonic digestive tract development (GO:0048566),-0.3164738687395653,-0.9308220885268332,0.5127118644067796,1.0,1.0,4/18,8.41%,NIPBL;SALL1;ID2;TGFB2
prerank,regulation of intracellular signal transduction (GO:1902531),0.2909083918890947,0.9306746643305721,0.711,0.9200529276952993,1.0,109/420,21.28%,PML;TAF4B;TAOK3;TP53RK;WNT5A;DAXX;BIRC2;PAK1IP1;CHEK2;TAGAP;RHOF;SLC15A2;CHEK1;NOP53;RFC4;SYDE1;RRAGC;RHOJ;PPP2R5C;TRAF4;PAK3;ARHGEF7;TMBIM4;ARHGAP4;BRIP1;WDR54;PIP5K1A;CSNK2B;RRS1;CYLD;CSNK2A2;MTA2;MYOC;ABR;PRKAR2B;ENTPD5;LYN;TAF2;BARD1;SYDE2;PLK3;VAV1;MAPK14;PRKAG1;TRAF3;SSRP1;SPHK2;TNIK;AKAP12;STARD8;ARHGAP25;TRAF5;ARHGEF11;SRGAP2;SRGAP3;TAF3;DDIT4;SOS1;ARHGAP21;ARHGAP10;DYRK2;NOP2;BRPF1;CHN1;ARHGAP11A;PIP5K1C;AKAP13;TIAM2;TELO2;ARHGAP39;ARHGAP30;BIRC3;RAC1;DLG1;PRDM11;MINK1;RMI1;CRK;TAF15;MOB3B;TAOK2;RPL11;MTOR;OPHN1;TBCK;BRD7;OCRL;PRKAR2A;BCR;ARHGAP29;RHOT2;HDAC1;RFFL;SPRED1;ARAP1;STK3;ARHGAP24;DIPK2A;PIN1;SMYD2;ARHGAP18;ATRIP;ARHGAP31;JMY;RPL5;STK11;ZFAND6;RHOH;OPTN
prerank,regulation of actin filament polymerization (GO:0030833),0.3158813971896048,0.9305969862923641,0.5968992248062015,0.9197425967238559,1.0,27/69,28.93%,HCK;EVL;CARMIL1;PAK3;NCK1;KANK1;SSH3;NCK2;SNX9;PRKCE;DBNL;BAIAP2;BAIAP2L1;ABITRAM;GBA2;ARHGAP18;NCKAP1;PRKCD;TWF1;CDC42EP3;TENM1;PFN2;WASHC5;FER;SLIT2;ARFGEF1;VASP
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2993557430980534,0.9304482023870051,0.6408952187182095,0.9196033931132918,1.0,43/146,22.66%,PSMB10;SKP1;PSME2;CENPJ;PSMA5;MECP2;PSME4;CDC25B;DYNC1H1;CCND1;PSMA3;ACTR1A;RAD51C;MAPRE1;CDK5RAP2;PSMB9;PRKAR2B;RBX1;NEDD1;PSMD2;CEP131;CEP152;CEP70;PSME3;AKAP9;DYNLL1;PSMA4;HSP90AA1;TUBB4B;RAB11A;DCTN3;PAFAH1B1;PSMD7;CEP135;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;HAUS3;PSMD12;YWHAG;PSMD4
prerank,mucosal immune response (GO:0002385),-0.3272573806347328,-0.9302651012286066,0.5375939849624061,1.0,1.0,5/15,35.95%,RPL39;DEFA6;OTUD7B;IFNLR1;LTF
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3474330513192704,-0.9301223793586029,0.5384615384615384,1.0,1.0,4/13,14.74%,UBAC2;UBE2J1;UBE2G2;YOD1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.44452944664058197,0.9300178326667522,0.5690690690690691,0.9201010481718046,1.0,2/10,9.76%,IFI35;WDFY1
prerank,calcium ion transport (GO:0006816),0.30303937516163254,0.9295037008361425,0.6147455867082036,0.9207799228758552,1.0,20/113,15.80%,TRPM5;TRPM2;CACNA2D4;TRPM6;SLC8A1;CCL5;ITPR1;CACNA1A;P2RX4;MCUR1;TRPM3;CRACR2A;PANX1;PSEN1;MCOLN2;TRPV4;FYN;CHRNB2;TRPM7;SLC24A3
prerank,neuron apoptotic process (GO:0051402),0.3828770468280515,0.9284789196211645,0.5636114911080712,0.9225188510214493,1.0,4/19,12.21%,SIAH1;APP;DIABLO;SCN2A
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.22650322519796456,-0.9283980591994274,0.6224489795918368,1.0,1.0,19/62,21.29%,LPAR1;ARRB1;AUTS2;MMD2;FGF10;RASGRF1;PIK3CG;SHOC2;CRKL;PRAG1;RASGRP4;ARHGEF3;MAP4K4;RASGEF1A;LRRC59;F11R;NET1;F2R;RASGRP1
prerank,regulation of intracellular transport (GO:0032386),0.3416369679182988,0.9281822549620042,0.5769230769230769,0.9226860054744099,1.0,11/38,18.93%,DYNC1H1;RAB11B;MLC1;DNAJC30;SCFD1;RINT1;GAS1;DYNLT2B;ATPSCKMT;LAMP1;NUMA1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.43031026207033685,0.9279153368494231,0.5571428571428572,0.9227757448357023,1.0,2/11,4.26%,ACVR1;USP15
prerank,regulation of synapse organization (GO:0050807),-0.27767948721365165,-0.927871747612735,0.555,1.0,1.0,14/26,25.40%,PDLIM5;IL1RAPL1;GRIPAP1;CTNNA2;YWHAZ;ABHD17B;ABHD17C;CLN3;NEDD4;ABL1;MEF2C;KLK8;SLITRK2;MDGA1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3633898911188524,0.9278222636045735,0.5633986928104575,0.9225121825327718,1.0,7/26,13.19%,FMOD;B4GALT4;B4GALT1;B4GALT5;ST3GAL1;B4GALT2;CHST2
prerank,negative regulation of neuron projection development (GO:0010977),0.32150382400484945,0.9276765232402638,0.5995500562429696,0.9223456088933647,1.0,20/56,25.19%,THY1;RUFY3;EPHA4;MT3;PAQR3;KANK1;CIB1;MAG;APOE;TRPV4;MYLIP;PTPN9;STMN2;ITM2C;RTN4RL1;HDAC2;RAB29;LINGO1;PTPRS;LRP4
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.312158661407802,0.9273927395358398,0.6023835319609967,0.9224829233811171,1.0,16/69,17.70%,POLR2G;PHAX;SNAPC2;SRRT;NCBP2;CCNT2;RPAP2;TAF8;POLR2K;ICE2;ELL2;SNAPC5;GTF2E2;NCBP1;CCNK;POU2F2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.38469479102063814,0.9269931500231345,0.5498652291105122,0.9228893312704811,1.0,7/18,23.30%,MCM7;MCM4;RFC4;GINS2;GINS4;GINS3;LIG3
prerank,positive regulation of transporter activity (GO:0032411),0.41295199043157454,0.9269388397903168,0.5625,0.9225244295653622,1.0,2/13,5.61%,SGK2;KMT2A
prerank,establishment of protein localization to membrane (GO:0090150),0.3132771192056082,0.926862225259491,0.6090808416389811,0.9221941903130807,1.0,13/66,16.20%,GOLGA7;MYO1C;AQP11;RTP4;ZDHHC21;ZDHHC20;RAB11B;VPS37A;NACA;NECTIN3;NPC1;TAOK2;RAB11A
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3370829842609334,-0.9267599272326081,0.543046357615894,1.0,1.0,4/14,17.31%,RHOA;KLF4;MAP2K5;ITGB1BP1
prerank,synapse organization (GO:0050808),0.29985889958105133,0.9266616155079601,0.6240913811007269,0.9221837118298665,1.0,23/125,16.23%,SLITRK6;PCDHB13;ELFN1;BDNF;CHCHD10;CYFIP1;CX3CL1;PAK3;WNT7B;DOK7;APP;AGRN;SDK1;PSEN1;PCDHB16;ARHGAP39;PPFIA4;CTNND2;DNER;DBNL;DSCAM;NLGN3;C1QB
prerank,positive regulation of phosphorylation (GO:0042327),0.29390097056708087,0.9266493799472589,0.6897590361445783,0.9217238771085314,1.0,38/240,14.89%,AXL;IRGM;FLT1;KDR;DAXX;SEMA4D;CD40;CCL5;CCND2;SOX9;CCND1;EPHA4;MYDGF;FGFR2;MT3;RET;EPHA6;PPIA;LTK;ENTPD5;MET;LYN;LEPR;APP;INSR;ROR2;TNIK;CIB1;VEGFD;FGF9;PSEN1;RACK1;NRP1;RAC1;DAB2;RB1CC1;HSP90AA1;NPTN
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.29176113237311335,0.9260599960512028,0.6943887775551102,0.9225703231460038,1.0,69/348,22.13%,HSPA1B;WNT11;MOV10;DTX3L;RESF1;WNT5A;SPRY2;CLU;PIK3CD;DDRGK1;AGO2;STAT3;SLC38A2;DHX36;SOX9;MT3;ITGB8;CSF1;MAGI2;CTSH;POU3F1;APP;SCX;DNMT1;INSR;MAPK14;PRKAG1;ARRB2;PPM1F;ZC3H12A;FAM98B;CTCF;SCYL2;SETDB2;FGF9;MITF;GSN;STAP1;PSEN1;EPHX2;PPARGC1A;PIK3CB;LIMS1;MYD88;HGS;TLR2;SLC24A3;RPL11;MTOR;RBPJ;LGALS9;TLR3;ATAD1;HINFP;DTNBP1;HOXA5;TERF2;TYROBP;POU3F3;IFNGR1;DDX3X;CD46;RPL5;F3;CITED2;VPS35;FGF2;MAPK9;TASOR
prerank,B cell differentiation (GO:0030183),-0.22917976822792732,-0.9257726203483055,0.6153846153846154,1.0,1.0,10/46,17.42%,NFAM1;KLF6;DCAF1;ZBTB7A;LYL1;PTPN2;DNAJB9;JAK3;SLC25A5;ADGRG3
prerank,post-translational protein modification (GO:0043687),0.2907007614025553,0.9257391423509121,0.7147147147147147,0.9228196336655795,1.0,86/332,22.66%,PSMB10;SKP1;FBXL16;PSME2;PNPLA2;DCAF17;KLHL20;PSMA5;CUL5;RCN1;FBXO7;PSME4;RBBP5;SERPINC1;LAMC1;LAMB2;FEM1B;FBXW7;TNC;PSMA3;CUL7;UBE2M;CSF1;KLHL13;FBN1;SPSB1;FBXW8;CAND1;RAB11B;PSMB9;UCHL3;SOCS5;MXRA8;RBX1;APP;LRRC41;MEN1;WDR5;COPS7B;WSB2;ELOC;BTRC;ASB7;PSMD2;PDIA6;ASB10;PSME3;APOE;FBXL14;KLHL9;SOCS2;KTN1;FBXL19;DCAF4;PSMA4;FAM20C;RAB11A;LMO7;ASB3;FBXL5;SPARCL1;COPS8;STT3B;PSMD7;ASB1;SOCS6;PSMD8;PSMD9;RAB1A;FBXO30;PSMF1;APLP2;SUMF1;PSMB6;PSMC2;NUB1;PSMD12;SENP8;DCAF5;ASB13;COPS7A;HSP90B1;PTP4A2;RAB2A;FBXW2;PSMD4
prerank,positive regulation of organelle organization (GO:0010638),0.34996614863654696,0.9256461970647583,0.5794621026894865,0.9225405998161244,1.0,5/32,12.33%,IRGM;SYNJ1;FYCO1;KATNBL1;PPARGC1A
prerank,regulation of signal transduction (GO:0009966),0.2931922433119207,0.9255762405731118,0.6663286004056795,0.9221987742444179,1.0,41/190,18.53%,SP100;CLU;ACVR1;CD55;KIF26A;RUNX1;GNG4;UBTF;YJEFN3;CX3CL1;FGFR2;ITGA3;AMFR;DOK5;MDFIC;PPIA;NCK1;GDNF;SOCS5;APP;NCK2;PRNP;RORA;GIT1;SNW1;GAS1;SOCS2;RGS16;SHARPIN;PTCH1;FYN;CRK;IRAK1;LLGL1;CSK;ELF1;TULP3;PLCE1;DCDC2;FRRS1L;DTNBP1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3309767967300984,-0.9254611789050023,0.5582191780821918,1.0,1.0,3/15,9.90%,SMARCA4;CCNT1;CTDP1
prerank,hexose transmembrane transport (GO:0008645),0.37348749883212184,0.925446662410063,0.576379974326059,0.9220117826675341,1.0,4/21,16.03%,SLC2A6;SLC45A3;SLC2A9;PPARD
prerank,gluconeogenesis (GO:0006094),0.34175100331592984,0.925315411684015,0.586046511627907,0.9218108078846247,1.0,11/39,22.32%,PER2;TPI1;SLC25A1;PGM1;SLC25A10;PPARGC1A;SLC25A12;CRTC2;ALDOC;GOT1;MDH1
prerank,positive regulation of actin nucleation (GO:0051127),0.4249569040760131,0.9250462188734417,0.5626822157434402,0.921933892853729,1.0,5/11,22.50%,CYFIP1;GSN;WHAMM;NCKAP1;BRK1
prerank,telomere organization (GO:0032200),0.3330945536570889,0.9250008716582367,0.5813679245283019,0.9215574272730034,1.0,6/43,13.61%,SP100;POLD4;RTEL1;ERCC4;PRKDC;STN1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.31952572818012254,0.9247321610695598,0.6035437430786268,0.9216716024325116,1.0,21/61,23.82%,PSMB10;PSME2;PSMA5;PSME4;PSMA3;PSMB9;PSMD2;AZIN1;PSME3;PSMA4;PANK2;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;PSMA2;NCOR2
prerank,ERBB2 signaling pathway (GO:0038128),0.3465639983020182,0.924522990927568,0.5773955773955773,0.9216829436012698,1.0,11/31,25.65%,CPNE3;CUL5;PTPN18;MYOC;SOS1;HSP90AA1;CDC37;STUB1;ERBB3;PIK3CA;SHC1
prerank,muscle cell migration (GO:0014812),-0.37080576418474004,-0.9244712837090112,0.5552325581395349,1.0,1.0,5/10,21.61%,ROCK1;AAMP;ITGB1BP1;ITGB3;DDR1
prerank,nervous system development (GO:0007399),0.2882100518307913,0.9241538836195381,0.741,0.9219786856759098,1.0,71/429,16.92%,IGF2BP1;AXL;PCDHA3;SLITRK6;PMP22;PCDHB13;CXCR4;BDNF;NRSN2;IGF2BP3;STAT3;MSI1;ECRG4;CHD7;PAFAH1B3;ANKLE2;SH3GL1;SIAH1;EVL;TMEM223;CHERP;TRAK1;RAPGEFL1;GMFB;CDK5RAP2;DACT1;MET;EIF2B2;BTBD3;GDNF;JRKL;POU3F1;BTBD2;SCD5;GFRA2;PROX1;DHX30;STMN3;FUT10;ALDH1A2;ADGRV1;NAB1;RBFOX1;PPP2R5D;GSN;SDK1;HPCAL4;SCN2A;LDB2;LDB1;PCDHB16;MOBP;ATXN1;FGF13;MYLIP;NELL1;NUMBL;DNER;RBM45;DAGLA;RBFOX3;DBNL;RNF103;NHEJ1;DSCAM;DSCAML1;NLGN3;OPHN1;PCDHA4;MDK;MPZ
prerank,glycerolipid catabolic process (GO:0046503),0.38241043717078543,0.9239458403249026,0.5625841184387618,0.9219762434643262,1.0,5/19,19.67%,ABHD2;LYPLA2;PNPLA6;ENPP6;PLA2G4E
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3940190142164179,0.9233340034535205,0.5763888888888888,0.9229250425874022,1.0,5/14,22.70%,MAD2L2;SHLD1;PAXIP1;HMCES;KMT5C
prerank,positive regulation of dephosphorylation (GO:0035306),-0.27423041692769057,-0.9231020350927072,0.5792079207920792,1.0,1.0,8/27,12.21%,TGFB1;PPP1R16B;PTPA;MTMR9;SYMPK;NSMF;SRC;CAMTA1
prerank,TOR signaling (GO:0031929),0.3631678346788747,0.9227424752168142,0.5701863354037268,0.9237347902035836,1.0,11/26,27.77%,LARP1;RHEBL1;EIF4EBP2;CCDC88A;RPS6;MTOR;NPRL3;TIPRL;FNIP1;RPS6KB2;RPS6KB1
prerank,histone mRNA catabolic process (GO:0071044),0.40126948140825586,0.92272372598634,0.5630252100840336,0.9232934236329026,1.0,6/15,21.94%,XRN1;DCP2;TUT7;UPF1;MTPAP;EXOSC4
prerank,positive regulation of signal transduction (GO:0009967),0.290929200672295,0.9225140930593889,0.6966966966966966,0.9233164221795627,1.0,45/238,17.92%,AXL;NOD2;TUBD1;IRS1;BDNF;ADAMTS3;SASH1;STAT3;MYO1C;TM2D3;GRB10;KIF7;LY86;FGFR2;MT3;TRIM39;ENHO;TPD52L1;UCHL5;DACT1;SMOC2;KANK1;MAML2;PHIP;PDCL;SNW1;NOTCH4;XBP1;SORL1;PTPN11;LIMS1;ZRANB1;NRP1;JAK2;NPTN;TLR2;GKAP1;NLGN3;MGAT5;RBPJ;BAX;PTPRC;EPN2;CRADD;DCDC2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3629191666466467,-0.9222051205299983,0.5375375375375375,1.0,1.0,4/10,13.41%,NCKAP1L;C3;TREM2;RAB31
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2955731714312449,-0.9219133254269931,0.5469387755102041,1.0,1.0,2/20,2.45%,AKR1B1;STARD3NL
prerank,alanine transport (GO:0032328),0.4346111183932614,0.921771234633238,0.559593023255814,0.9245178748412181,1.0,5/10,25.52%,SLC38A3;SLC36A4;SLC6A6;SLC6A17;SLC36A1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3079939480395895,-0.9215937455929388,0.5665236051502146,1.0,1.0,11/20,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3079939480395895,-0.9215937455929388,0.5665236051502146,1.0,1.0,11/20,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3079939480395895,-0.9215937455929388,0.5665236051502146,1.0,1.0,11/20,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.33545165676098365,0.9215629436484218,0.5916167664670658,0.9245000279136778,1.0,7/37,9.08%,POLD4;CHD1L;RFC4;RFC1;ERCC4;RBX1;POLK
prerank,acute-phase response (GO:0006953),-0.3493989357093562,-0.9214387467293095,0.546031746031746,1.0,1.0,2/12,13.78%,PLSCR1;CEBPB
prerank,mitotic chromosome condensation (GO:0007076),0.36303006188783843,0.9212903710985854,0.5824873096446701,0.9246063404172259,1.0,5/26,12.75%,TENT4A;CSNK2B;CSNK2A2;NCAPG2;RB1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.39310643671327555,0.9209633314027188,0.5620736698499318,0.9248678983959199,1.0,8/16,25.44%,GSPT1;INSR;ETF1;UPF1;OGFOD1;GLE1;HDAC6;TNF
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3119733490240189,0.9207010772964923,0.5954935622317596,0.9249567142710646,1.0,16/70,17.60%,ACTN1;LAMC1;LAMB2;PARVB;PEAK1;RILPL1;YTHDF2;PROX1;SRGAP2;ANTXR1;RB1;NRP1;RAC1;TBCD;OPHN1;ITGA4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2241750531769307,-0.9205206283990234,0.6041666666666666,1.0,1.0,27/56,27.70%,NDUFAF5;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;NDUFC1;NDUFB7;TIMMDC1;NDUFAF1;NDUFA8;NDUFA3;NDUFB8;NDUFA2;NDUFB10;NDUFB3;NDUFS3;NDUFV3;NDUFB4;NDUFS6;NDUFA11;NDUFA1;NDUFAF8;NDUFA6;NDUFAF4;NDUFA13
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2241750531769307,-0.9205206283990234,0.6041666666666666,1.0,1.0,27/56,27.70%,NDUFAF5;ECSIT;DMAC2;NDUFAF6;NDUFA9;TMEM126A;TIMM21;NDUFC1;NDUFB7;TIMMDC1;NDUFAF1;NDUFA8;NDUFA3;NDUFB8;NDUFA2;NDUFB10;NDUFB3;NDUFS3;NDUFV3;NDUFB4;NDUFS6;NDUFA11;NDUFA1;NDUFAF8;NDUFA6;NDUFAF4;NDUFA13
prerank,activation of protein kinase activity (GO:0032147),0.3015388663493115,0.9203034099494954,0.6544502617801047,0.9253771794234575,1.0,30/106,23.84%,CALCA;TAOK3;WNT5A;ADCY5;OSBPL8;PAK3;MT3;PPIA;CCDC88A;PRKAR2B;INSR;TNIK;JAK2;PIBF1;MINK1;TAOK2;IL18;MTOR;IRAK1;PRKAR2A;TLR3;COPS8;STK3;STK11;PRKCD;PAK5;ADCY7;PDPK1;AXIN1;ANG
prerank,base-excision repair (GO:0006284),-0.23869285717118738,-0.9198453014114865,0.6779661016949152,1.0,1.0,20/48,21.09%,APEX2;RPA1;RFC2;PARP1;PARG;DNA2;PNKP;RFC3;LIG1;HMGA2;OGG1;NEIL1;NEIL3;RPA3;XPA;RFC5;USP47;POLD1;POLE;POLL
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3046992027420115,0.9194785209672295,0.631190727081138,0.9266826073211765,1.0,13/86,14.33%,IL15;AGT;SEMA4D;ACVR1;SFRP2;CNOT7;CSPG4;APP;PRNP;PTPN11;NRP1;JAK2;FYN
prerank,cell chemotaxis (GO:0060326),0.31806310490797707,0.9192383304279635,0.6232044198895028,0.9267099945632915,1.0,11/60,13.56%,CXCR4;ELMO2;PLXNB3;CX3CL1;PIP5K1A;BCAR1;ACKR3;ARRB2;ABCC1;NRP1;CORO1B
prerank,regulation of G0 to G1 transition (GO:0070316),0.336718017258654,0.9188048868881661,0.6104513064133017,0.9272027328232164,1.0,9/38,14.83%,PCGF6;CHEK1;TFDP1;RING1;MAX;RYBP;TFDP2;UXT;EZH2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3064178550899825,-0.9186035745372305,0.5447154471544715,1.0,1.0,8/18,21.83%,TOMM20;DNAJC15;TIMM21;GRPEL1;PAM16;TIMM17A;GRPEL2;ROMO1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3219812550478637,0.91834283160811,0.6099210822998873,0.927713669677278,1.0,11/59,16.09%,PLXNB2;CDH13;NECTIN4;PLXNB3;NECTIN3;SDK1;CD84;NPTN;HMCN1;DSCAM;DSCAML1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.2545597362640809,-0.9183369005452476,0.580110497237569,1.0,1.0,13/34,24.87%,GRIN2A;GABRG3;GRIN2B;GRIN1;GSK3B;GABRA2;AKT1;GABRA5;MEF2C;CHRNA4;INSYN2A;MAPK8IP2;DRD2
prerank,ameboidal-type cell migration (GO:0001667),-0.2392227733434326,-0.9183047986369428,0.5652173913043478,1.0,1.0,15/51,16.19%,PDXDC1;CENPV;SEMA4C;SEMA4G;SEMA4A;SEMA6A;PDLIM1;ANXA6;SEMA4B;SEMA3E;SEMA5B;AKT1;SOX10;AMOTL1;AMOT
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.2564803120389405,-0.9182532268563325,0.6032608695652174,1.0,1.0,8/33,16.44%,EPN1;PPP1R16B;PKM;E2F2;SEMA6A;CEACAM1;S100A1;KLF4
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3217411316609152,-0.9182479086678556,0.5785714285714286,0.999917521326817,1.0,4/16,9.22%,ARHGAP44;AUTS2;RASGRF1;PIK3CG
prerank,inorganic ion transmembrane transport (GO:0098660),-0.34165315746505176,-0.9181887255232862,0.5545722713864307,0.9978777617821393,1.0,8/12,47.85%,TRPM4;PKD2L1;ABCC8;CACNA1H;P2RX3;RHAG;KCNJ8;ATP1B4
prerank,nitric oxide mediated signal transduction (GO:0007263),0.39409021956866436,0.9180915927816606,0.5848275862068966,0.92780385157707,1.0,1/16,0.65%,AGT
prerank,camera-type eye morphogenesis (GO:0048593),-0.3729858400986217,-0.9180850733550281,0.5415282392026578,0.9959222720850754,1.0,2/10,10.55%,LRP6;TENM3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.39201977081705097,0.9179653457204456,0.5934065934065934,0.9275959369640783,1.0,3/17,13.47%,KDR;SRF;NRP1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.26444021142317464,-0.9176820483830095,0.6040609137055838,0.9947541316505474,1.0,9/30,14.85%,SMARCA4;AR;KDM4C;ZBTB7A;RNF14;SIRT1;FOXP1;SAFB2;KDM1A
prerank,vacuolar acidification (GO:0007035),-0.28924219260584993,-0.9176202969415913,0.5895196506550219,0.9927438464501723,1.0,9/21,20.77%,ATP6V0A1;ATP6V1H;DMXL1;DMXL2;CLN5;CCDC115;CLN3;ATP6V0E2;TMEM199
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3629960512681783,0.9176201052281246,0.570281124497992,0.9278728906107696,1.0,2/22,10.66%,LRP2;ALDH1A2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.25983079891061717,-0.9176016225493762,0.5853658536585366,0.9906019324213486,1.0,10/31,18.74%,CASP8;PPP3R1;PPP3CC;YWHAQ;YWHAZ;GSK3B;PPP1R13B;TP53;E2F1;BAK1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4255936407260165,0.9175857269882922,0.5824508320726173,0.92746911250155,1.0,1/11,1.21%,CAMK2D
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.41203748106435895,0.9175024608464315,0.5748587570621468,0.9271657961726577,1.0,4/14,16.89%,CCL5;CSF1;CXCL17;MDK
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2968246996773171,0.9172487243243784,0.6663254861821903,0.9272477386476788,1.0,39/138,24.81%,TAF4B;NR1H2;ESR2;POLR2G;ESRRB;RARG;TEAD2;TAF2;TAF8;POLR2K;MAML2;MNAT1;NR2C1;RORA;SNW1;NOTCH4;TAF3;PPARGC1A;NR3C1;GTF2E2;NRBP1;TAF15;PPARD;MED27;RBPJ;HDAC1;MED7;NR1D2;CDK9;NOTCH1;NR2C2AP;TAF7;NCOR2;KAT2B;POLR2C;CCN2;TAF4;RARB;TAF11
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.25085876239983473,-0.9170973655825496,0.615,0.9898477202109468,1.0,5/30,7.60%,TGFB1;TGFBR3;TWSG1;TRIM33;PCSK6
prerank,regulation of aerobic respiration (GO:1903715),0.39511987728859027,0.9168610124672417,0.5775978407557355,0.9275952424144026,1.0,8/15,26.01%,NOP53;ABCD1;AK4;COX7A2;IDE;VCP;SLC25A33;COX7A2L
prerank,detection of mechanical stimulus (GO:0050982),-0.30715989612161093,-0.9167209705784677,0.5719844357976653,0.9887098629851411,1.0,6/19,26.29%,CDH2;PKD2L1;PKD1L2;PKD2L2;JUP;PKD1L3
prerank,DNA biosynthetic process (GO:0071897),0.3977497467537625,0.9166970141951891,0.5950752393980848,0.9274646785592907,1.0,3/16,7.75%,POLD4;CDKN2D;PPIA
prerank,positive regulation of embryonic development (GO:0040019),-0.30445904856919637,-0.9166592534178475,0.5688888888888889,0.9867284214326821,1.0,3/19,5.06%,CFL1;NIBAN2;RBM19
prerank,positive regulation of protein metabolic process (GO:0051247),0.30078323472443896,0.9163943390315895,0.643298969072165,0.9276358318204061,1.0,22/110,16.22%,AGT;NR1H2;WNT5A;CLU;EGLN2;RILP;AREL1;CSF1;DACT1;BARD1;APP;IL17D;SORL1;SMURF1;LDB1;PSEN1;APOE;VPS28;TFR2;PRMT1;TIPARP;IL18
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4298596611274376,0.9159312355662407,0.5705882352941176,0.9281682105360414,1.0,3/10,9.14%,SOCS1;RUNX1;HMGB1
prerank,positive regulation of growth (GO:0045927),0.3125018806285906,0.9159201015348452,0.5991140642303433,0.9277125107832281,1.0,12/64,15.65%,HYAL1;CXCL16;MMP14;SFRP2;FXN;DDX49;INSR;CIB1;PPM1F;EXOSC9;NCBP1;ADNP2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.27453369371062414,-0.915837919069475,0.5874439461883408,0.9869171412931935,1.0,8/22,24.30%,APC;NR2F2;CEBPA;INCA1;CDKN1A;HEXIM1;CDKN1B;CDK5RAP1
prerank,selective autophagy (GO:0061912),0.31769270758432216,0.9157453354021292,0.6097285067873304,0.927644651402494,1.0,13/56,19.26%,AUP1;DDRGK1;DYNC1H1;DYNC1LI2;NBR1;UBQLN1;MAP1LC3B;DYNLL1;RB1CC1;PEX5;RETREG1;UBE2V1;BECN1
prerank,extracellular matrix disassembly (GO:0022617),0.3223113654395766,0.9157246480757976,0.6102857142857143,0.9272139532952874,1.0,8/53,13.04%,CTSS;MMP14;ADAM8;LAMC1;TIMP2;GSN;CAPNS1;CAPN1
prerank,cellular response to insulin stimulus (GO:0032869),0.29597428977117396,0.9155855742670618,0.6533333333333333,0.9270406479861496,1.0,27/124,18.42%,NAMPT;TRIB3;IRS1;ATP6V0D1;SLC27A1;RAB8B;ZNF106;GRB10;RAB12;USF1;LPIN2;BCAR1;INSR;PHIP;ZFP36L1;XBP1;SOS1;PRKDC;ENPP1;VAMP2;IRS2;INPP5K;BAIAP2;TCIRG1;ATP6V1B2;ATP6V1G1;CPEB2
prerank,regulation of endocytic recycling (GO:2001135),0.4231964253428108,0.915514126171727,0.5545851528384279,0.9267107489747501,1.0,5/11,23.70%,ACTN2;RAB11B;SORL1;PLA2G4E;ARHGAP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.29491850820305454,0.9154356947958433,0.6608784473953013,0.9264121151248104,1.0,19/133,15.86%,PML;CALCA;CCL7;CAMK2D;CD40;SLC8A1;CCL5;KCTD17;SLC30A1;CHERP;VAPB;CCL14;HTR2A;PSEN1;TRPV4;MICU2;NPTN;SLC24A3;HCRTR1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.2929087069144733,-0.9153054052900644,0.5659574468085107,0.9863101124864363,1.0,2/19,1.84%,PPP3R1;PPP3CC
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.33715736044867933,0.915293785850581,0.592326139088729,0.9262513378808424,1.0,5/39,6.07%,SPRY2;TGFA;PTPN18;DUSP3;ARHGEF7
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3512535202496609,0.9152358701789116,0.5848101265822785,0.9259079353090931,1.0,5/27,14.43%,CAMK2D;CTNNA3;AKAP9;FGF13;DLG1
prerank,mRNA processing (GO:0006397),0.28996821977591436,0.9151674367809015,0.7294589178356713,0.9255973075285197,1.0,92/287,24.22%,POLR2G;RBM14;DDX5;MAGOHB;TXNL4A;PRPF18;HNRNPH1;RBMX;SRRT;NCBP2;CHERP;HNRNPK;GPATCH1;PRPF40A;WDR33;HNRNPM;DHX9;HNRNPA2B1;SF3B6;NONO;RNMT;BCAS2;POLR2K;RNPC3;HNRNPL;HSPA8;MNAT1;RBM17;RSRC1;SNW1;WDR83;RNPS1;RALY;HNRNPH3;HNRNPA1;PPARGC1A;USP39;RBM41;ZC3H11A;PAPOLA;CHTOP;SART1;BUD31;GEMIN7;SNRPD2;SNRPD1;DBR1;EFTUD2;PCF11;AURKAIP1;DDX39B;RBM15;SNRPG;NCBP1;PRPF40B;DHX16;GEMIN2;SRSF7;SF3B4;SRSF4;METTL14;HNRNPA3;CWF19L1;DDX46;CWC22;SNRPB2;SNRNP48;DDX23;SLU7;LSM5;TBRG4;HNRNPF;UBL5;ERN1;THOC7;SRSF5;SF3A2;PPIH;BUD13;TCERG1;SRSF10;WBP4;SART3;HNRNPUL1;SRSF2;TRA2B;LSM4;MAGOH;SNRPD3;RPRD2;POLR2C;SON
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3628072593305105,0.9146958505196393,0.574002574002574,0.926162463713594,1.0,7/24,18.68%,CGAS;UBE2B;RAPGEF2;PRKAR2B;PDE3A;PRKAR2A;MGRN1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.32975646226844246,-0.9146910396620196,0.5182724252491694,0.9859246236845484,1.0,5/13,11.79%,CASP8;GRIN2A;TBC1D10A;NLRC4;CYFIP2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.37670568084828404,-0.9146177216201132,0.5549132947976878,0.9839687310378177,1.0,3/10,15.26%,CEACAM1;CD9;PRKG1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.32612615008081747,0.9146049749027511,0.6126126126126126,0.9258993221740706,1.0,13/46,24.02%,IL15;NR1H2;ZNF423;RB1;ACOT13;ALDH1A1;RBPJ;PCTP;STK11;PGAM5;RHEB;NOTCH1;ACOT11
prerank,stem cell development (GO:0048864),0.3937423580637684,0.9143953142642499,0.5813630041724618,0.9258717923547766,1.0,3/16,8.34%,TCOF1;SNAI2;NOLC1
prerank,regulation of cytokinesis (GO:0032465),0.30833470324066087,0.9143891888498484,0.6202127659574468,0.9254113395530872,1.0,19/78,19.47%,CDC25B;PKN2;PDXP;PRPF40A;SH3GLB1;KLHL13;ZFYVE26;PLK3;PIK3R4;GIT1;KLHL9;PRKCE;AHCTF1;CALM3;RAB11A;BIRC6;UVRAG;BECN1;PIN1
prerank,glucose metabolic process (GO:0006006),0.3212551290285748,0.9143738225093883,0.6170212765957447,0.9249718911205467,1.0,11/58,16.03%,SORD;PER2;TPI1;SLC25A1;TFAP2B;PGM1;SLC25A10;PPARGC1A;IRS2;SLC25A12;PPARD
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3942155025190956,0.9142074188983694,0.5827538247566064,0.9248561191350544,1.0,5/15,22.98%,ATL1;REEP2;REEP3;RAB10;ZFYVE27
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.28956209794378307,0.913858700039405,0.67472306143001,0.9251219856214646,1.0,73/185,28.30%,PSMB10;SKP1;PSME2;CENPJ;PSMA5;CDC26;PSME4;ANAPC5;DYNC1H1;PSMA3;ACTR1A;MAPRE1;CDK5RAP2;PSMB9;ANAPC4;PRKAR2B;UBE2E1;BTRC;NEDD1;ZFP36L1;PSMD2;CEP131;CEP152;CDC16;CDC27;CEP70;NEK6;PSME3;AKAP9;DYNLL1;ANAPC15;PSMA4;HSP90AA1;TUBB4B;ANAPC2;DCTN3;PAFAH1B1;PSMD7;CEP135;PSMD8;PSMD9;PSMF1;APPL2;PSMB6;PSMC2;HAUS3;PSMD12;YWHAG;PSMD4;CUL3;ZFP36L2;PSMA2;PTPN6;KLHL18;TFAP4;YWHAE;TUBA4A;CEP192;SIRT2;HAUS6;DCTN1;PSMD1;PSMD11;CEP57;ANAPC10;CDC14A;SFI1;MAD2L1;HECW2;ANAPC11;CNTRL;DDB1;CEP76
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.340586114570208,-0.9137349836287014,0.5782312925170068,0.9842373388654474,1.0,3/12,14.03%,APOD;SNCA;CBL
prerank,maintenance of blood-brain barrier (GO:0035633),-0.25444220001942314,-0.9132863880218475,0.6,0.9834885491726743,1.0,17/30,33.63%,SLC12A2;DMD;LAMA2;JAM2;SLC1A1;F11R;GJB6;LSR;VCL;TJP1;PECAM1;ESAM;OCLN;TJP3;MFSD2A;CLDN1;CDH5
prerank,sensory perception of pain (GO:0019233),-0.2852580370486271,-0.9125319514369943,0.6016597510373444,0.9836152416153859,1.0,10/21,25.20%,OPRM1;CCR2;KCNA2;PTGES;SCN9A;CHRNA4;CCL2;P2RX7;OPRL1;OPRK1
prerank,regulation of glucose metabolic process (GO:0010906),0.33792359553709883,0.9124550929207933,0.6004901960784313,0.92771397018297,1.0,7/34,14.64%,IRS1;RUBCNL;SLC45A3;RORA;FOXK1;BCKDK;IRS2
prerank,adenine nucleotide transport (GO:0051503),-0.3086520725719088,-0.9122771445054517,0.5759717314487632,0.9822922386804677,1.0,6/17,21.24%,SLC25A4;SLC17A9;SLC35B2;SLC25A5;SLC25A42;LRRC8A
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.2804899755544462,-0.9122620610203016,0.5682819383259912,0.9802155778184639,1.0,13/24,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.27258087263934877,-0.9122250877705922,0.5808080808080808,0.978222574473009,1.0,12/27,27.00%,TAB1;IRAK3;TRAF6;UBB;UBC;UBA52;RPS27A;CD14;BTK;TLR4;HSPD1;TLR5
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.33162479410319007,-0.9117859814762473,0.54375,0.977324381012101,1.0,5/14,21.40%,NT5M;ERH;UMPS;NT5E;DHODH
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3102458144317656,0.9117589802663517,0.6192560175054704,0.9287311440126967,1.0,17/68,22.91%,TPST1;ACOT9;ACBD6;SULT6B1;HPRT1;AK4;AK3;ENPP1;ACOT13;BAD;ACAT1;OXSM;AMPD3;BPNT1;PDE9A;ENTPD7;OPA1
prerank,"transcription, DNA-templated (GO:0006351)",0.2878011048333992,0.9115937078382736,0.7066532258064516,0.928607032461915,1.0,44/207,16.87%,TAF4B;POLR2G;GMEB2;NFX1;SNAPC2;DDX5;RBMX;NCBP2;UBTF;MRPL12;RRAGC;CCNT2;TFB2M;NFKB1;TBPL1;GLIS3;RO60;TFDP1;GTF3C5;POLR3GL;RNMT;TAF2;SCX;POLR2K;IRF9;MNAT1;TWNK;SSRP1;ARRB2;ELOC;RNPS1;XBP1;TAF3;GTF2E2;TAF1B;RREB1;MLLT3;NCBP1;SOX5;TAF15;MEF2A;GTF3C3;CCNK;MED16
prerank,gastrulation (GO:0007369),0.39902938447710623,0.911392387379021,0.5784313725490197,0.9285352459865946,1.0,2/15,7.85%,NPHP3;SMAD2
prerank,digestive tract development (GO:0048565),-0.25394454871794175,-0.9113882060197931,0.5967741935483871,0.9763577820024382,1.0,6/33,12.02%,COBL;NIPBL;EDNRB;SALL1;TGFB2;CCDC39
prerank,prostanoid biosynthetic process (GO:0046457),-0.31849416872383657,-0.9112119465181008,0.5287769784172662,0.9747824239575849,1.0,6/15,27.77%,PTGDS;PTGS1;MIF;PTGES;PTGIS;PRXL2B
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3205908128705856,-0.9106796306884841,0.5943396226415094,0.9742888405261659,1.0,6/14,23.37%,CSTF2;FIP1L1;CPSF7;CPSF4;TUT1;CPSF2
prerank,nucleotide biosynthetic process (GO:0009165),-0.3013089465104421,-0.9106432799765173,0.5977443609022557,0.9723022692509683,1.0,9/18,24.92%,NMNAT2;PNP;PRPSAP1;ME1;RRM2B;RRM1;PPAT;PRPS1;PRPS1L1
prerank,excitatory postsynaptic potential (GO:0060079),-0.29071269747631756,-0.9105406683551143,0.603112840466926,0.970507479594452,1.0,9/19,27.08%,GRIN2A;GRIN2B;GRIN1;GSK3B;AKT1;MEF2C;MAPK8IP2;DRD2;GRID2
prerank,mesenchymal cell development (GO:0014031),0.3882743130806268,0.9102679381442421,0.596,0.9304680526423852,1.0,3/18,8.34%,TCOF1;SNAI2;NOLC1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3624780347429766,-0.9101887667024212,0.5694050991501416,0.9694352447271688,1.0,3/10,10.48%,PDCD4;PTPN22;MAPK8IP1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3623005224468644,-0.9098934644659321,0.5484764542936288,0.9682248694455877,1.0,5/10,21.92%,JARID2;SIRT1;BRCA1;KDM1A;ATRX
prerank,positive regulation of intracellular transport (GO:0032388),0.33001220955080035,0.9095077938776691,0.594047619047619,0.9316289805461043,1.0,17/38,28.56%,ACTN2;RUFY3;DYNC1H1;PLK3;MLC1;CEP131;SORL1;VAMP2;NUMA1;PLA2G4E;STK11;RAB29;TENM1;TBC1D20;STX18;PDCD10;ICE1
prerank,cellular component disassembly (GO:0022411),0.31884243120551103,0.909219647717797,0.6112994350282486,0.9317688365026915,1.0,8/53,13.04%,CTSS;MMP14;ADAM8;LAMC1;TIMP2;GSN;CAPNS1;CAPN1
prerank,catecholamine biosynthetic process (GO:0042423),0.42314797203091237,0.9091478874558896,0.5976331360946746,0.9314616823038724,1.0,2/11,10.24%,DDC;GCH1
prerank,secretory granule organization (GO:0033363),0.4259930218849406,0.908488009442406,0.5729483282674772,0.9323998183599908,1.0,3/10,18.53%,ABCA1;LYST;DTNBP1
prerank,metal ion export (GO:0070839),-0.2551150089101523,-0.9083953816225214,0.6101694915254238,0.9704409707474834,1.0,14/31,37.91%,ATP1B1;ATP1B2;KCND3;KCNT2;KCNK5;KCNH2;ATP2B4;ATP1A1;ATP1A3;FXYD2;KCNQ1;KCNIP2;ATP1A2;KCNE3
prerank,response to light stimulus (GO:0009416),0.31584400395661955,0.9080593570755748,0.6323024054982818,0.932850792218357,1.0,9/55,15.97%,UVSSA;UBE2B;CDKN2D;USF1;ERCC4;MEN1;ZRANB3;UBE4B;SPRTN
prerank,modulation by host of symbiont process (GO:0051851),-0.25530717993950774,-0.9079470755671233,0.6206896551724138,0.9695365491682779,1.0,9/31,12.95%,SMARCA4;CCNT1;SAP30BP;REST;NAPEPLD;CX3CR1;CTDP1;CCL3;HMGA2
prerank,sodium-independent organic anion transport (GO:0043252),0.4336141276005022,0.9078866254344072,0.5806451612903226,0.932750586582316,1.0,2/10,6.50%,SLCO1C1;SLCO1B1
prerank,kidney development (GO:0001822),0.3087916683061958,0.9075023260995628,0.6136865342163356,0.9331392538246912,1.0,8/65,10.65%,AGT;GREB1L;TFAP2B;NPHP3;CTSH;GDNF;PROX1;IFT27
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3443816120157077,-0.9072755733657842,0.5662251655629139,0.9693573590194978,1.0,4/12,17.09%,GCLM;GSS;HAGH;GGCT
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.3206247431222269,-0.9072667651643886,0.6048109965635738,0.967343781219967,1.0,6/15,30.04%,LRP6;EDA;ROGDI;FOXC1;GLI2;BMP2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.37026100007605667,-0.9071602723362608,0.5740181268882175,0.9655981831263535,1.0,4/10,15.11%,ESR1;THRA;PSMC4;TP53
prerank,triglyceride homeostasis (GO:0070328),0.35929497373646174,0.9063996080822991,0.5924050632911393,0.9350292619719275,1.0,6/26,16.22%,LIPC;RORA;XBP1;APOE;APOC4;IL18
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.32606722647536884,0.9063235341061003,0.6093023255813953,0.934716805517431,1.0,10/42,15.50%,ARID1B;ARID1A;MBD2;SMARCE1;SMARCC2;MTA2;ACTR8;ACTB;SMARCA1;SMARCD2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.34912735262276823,0.9061310192196513,0.5979772439949431,0.9346087316527986,1.0,4/27,13.37%,CLTRN;SYT7;SYT3;VAMP2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.27133887629149567,-0.9060332468906692,0.5852534562211982,0.9666818881467063,1.0,13/27,24.13%,CHSY1;VCAN;CSGALNACT1;B3GAT1;CHST7;CHST15;CHST3;BGN;DCN;PXYLP1;BCAN;UGDH;CSPG5
prerank,iron ion transmembrane transport (GO:0034755),0.4293038765434709,0.9057383619701023,0.5942684766214178,0.9349509076753885,1.0,4/10,21.40%,SLC11A2;ABCB7;ABCC5;SLC25A28
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.30594871726829215,0.9057163561552187,0.6087912087912087,0.9345255986479798,1.0,11/72,9.89%,POLR2G;UVSSA;POLD4;RFC4;RFC1;ERCC4;RBX1;POLK;POLR2K;MNAT1;COPS7B
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.3571091900746704,0.905065986335659,0.6025806451612903,0.9354096312419636,1.0,10/25,24.80%,CTSS;ATP1B3;ACTN2;AKAP9;STK39;GLRX;COX17;ANK2;WNK3;CFTR
prerank,negative regulation of B cell activation (GO:0050869),-0.28315677634170544,-0.9049184495129217,0.625,0.9677962179609634,1.0,4/21,7.67%,SAMSN1;TNFRSF13B;ID2;BANK1
prerank,carboxylic acid transport (GO:0046942),0.31447125985221025,0.9049063378547272,0.624439461883408,0.935256225854481,1.0,10/55,16.66%,SLC38A2;SLC38A1;SLC38A3;SLC25A10;SLC38A6;SLC7A6;SLC16A13;SLC16A14;SLC16A6;SLC36A4
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3431398550748983,0.9045460263649572,0.5985130111524164,0.9350782394217606,1.0,5/31,9.74%,POLR2G;NCBP2;RNMT;POLR2K;MNAT1
prerank,7-methylguanosine RNA capping (GO:0009452),0.3431398550748983,0.9045460263649572,0.5985130111524164,0.9350782394217606,1.0,5/31,9.74%,POLR2G;NCBP2;RNMT;POLR2K;MNAT1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3472845389672736,0.9044731802073069,0.5917602996254682,0.9347568807722788,1.0,13/29,29.28%,PWP2;RPS21;RRS1;KRI1;DHX37;MRPS11;UTP3;RRP36;NGDN;BMS1;NOL10;HELB;RPS19
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3683626058403998,0.9042542262748913,0.6135204081632653,0.9347576860137904,1.0,4/22,10.97%,ZFP36;FGFR2;SNAI2;ZFP36L1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3362784633788387,0.9041775448403322,0.6229314420803782,0.934453531148172,1.0,8/40,15.01%,TIMELESS;TIPIN;ETAA1;MCM9;RTEL1;ZRANB3;DDX11;GEN1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3980392623420033,0.9040019404788626,0.5826086956521739,0.9343537308937768,1.0,6/14,26.88%,CX3CL1;CST7;PTPRC;LDLR;SYT11;GRN
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.2831794757124343,-0.9038931546340613,0.5864978902953587,0.9686562430866789,1.0,10/23,34.77%,GABPA;MAPK3;SNCA;GNG2;ABL1;ATP2B4;MAPK1;PRKN;RYR2;KCNQ1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3675431825279426,0.9037374827564241,0.5923076923076923,0.9344691092189064,1.0,3/21,5.29%,DAPK3;PEAK1;DUSP3
prerank,histone deubiquitination (GO:0016578),0.3768328832070268,0.9036010788250152,0.6105702364394993,0.9343173033676532,1.0,4/18,17.66%,USP21;USP15;ATXN7;ENY2
prerank,positive regulation of hormone secretion (GO:0046887),-0.30007419911231914,-0.9034951657633363,0.5703971119133574,0.9677625169311247,1.0,14/17,50.64%,SNX4;VAMP7;PLA2G3;C1QTNF3;GRP;HCAR2;SPP1;VAMP8;RASL10B;NMB;EDN3;CYP19A1;EDN1;SOX11
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.42486398328037794,0.9034339982634598,0.5929721815519766,0.9342086228037465,1.0,3/10,12.95%,ST6GAL1;ST3GAL1;GNE
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.425049356925026,0.903043815896718,0.6005917159763313,0.9345477478128223,1.0,3/10,11.82%,NBR1;LYN;MAP2K2
prerank,glucose import (GO:0046323),0.39700429615153987,0.9030259824278303,0.602322206095791,0.9341087607802048,1.0,1/13,2.36%,SLC27A1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.4041896388080712,0.9026960751737481,0.5930232558139535,0.9343259398337205,1.0,5/12,18.30%,EPHA4;NFIB;MYCBP2;CHRNB2;PAFAH1B1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.21042303918763458,-0.9025808393777915,0.7529411764705882,0.968306720204567,1.0,11/75,10.83%,SLC12A6;SLC9A9;ATP1B1;SLC12A2;ATP1B2;KCNJ10;SLC39A14;CACNA2D1;SLC8A3;TRPM4;SLC39A12
prerank,epithelial tube morphogenesis (GO:0060562),0.3459161186259912,0.9024782660160495,0.6239316239316239,0.9343304900694698,1.0,5/32,8.67%,ACVR1;CTNNB1;PODXL;CSNK2B;MET
prerank,response to insulin (GO:0032868),0.2999834714536734,0.9016644954611973,0.6495176848874598,0.9355685132738372,1.0,16/80,14.95%,TRIB3;IRS1;SLC27A1;RAB8B;RAB12;USF1;LPIN2;INSR;ZFP36L1;XBP1;EIF6;PRKDC;ENPP1;VAMP2;IRS2;INPP5K
prerank,lipid transport (GO:0006869),0.3012208732665825,0.9011571840199292,0.6694648478488983,0.936149044539313,1.0,25/97,22.58%,ABCC2;ABCA1;ABCG1;SLC27A1;SLCO1C1;ATP8A1;OSBPL8;NCOA1;PITPNM1;SLCO1B1;ABCD1;APOE;PLEKHA3;NPC2;PPARD;OSBP;MTTP;LDLR;OSBPL2;PCTP;GLTP;CHKA;TNFAIP8L3;CERT1;ABCA5
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.26112964805883754,-0.9010243256243378,0.6391752577319587,0.9705567396750517,1.0,6/29,8.05%,PATL1;EXOSC7;DIS3;DDX6;DCP1A;EXOSC5
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4088058711686531,0.9009891263988312,0.5814977973568282,0.9360282389312119,1.0,3/12,12.03%,LY6E;GSN;TRIM26
prerank,energy reserve metabolic process (GO:0006112),0.3739649040357249,0.9008118331665861,0.5894039735099338,0.9359287026701361,1.0,4/19,16.50%,MT3;GFPT1;LEPR;PHKG2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.36917920288505746,0.9007938457319179,0.6028645833333334,0.9354930813668302,1.0,8/21,16.94%,RUNX1;LYN;STAP1;FCGR2B;PRKCH;SLC39A10;CD300A;ELF1
prerank,transcription by RNA polymerase II (GO:0006366),0.2828195397419881,0.900499684741816,0.756,0.9356454227133241,1.0,61/305,16.93%,TAF4B;NR1H2;ESR2;POLR2G;GMEB2;ESRRB;RARG;NFX1;PHAX;TEAD2;SNAPC2;DDX5;RBMX;SRRT;NCBP2;CDK12;CCNT2;WDR33;NFKB1;TBPL1;GLIS3;TFDP1;RPAP2;RNMT;ELP2;TAF2;TAF8;POLR2K;MAML2;IRF9;MNAT1;NR2C1;SSRP1;RORA;ARRB2;ELOC;SNW1;NOTCH4;XBP1;TAF3;ICE2;ELL2;PPARGC1A;SNAPC5;NR3C1;GTF2E2;PAPOLA;PCF11;RREB1;SNRPG;MLLT3;NCBP1;SOX5;NRBP1;TAF15;PPARD;MED27;CCNK;RBPJ;MED16;ELOF1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.4247766026386186,0.9003447579231094,0.5944363103953147,0.9350416042091471,1.0,3/10,13.39%,AP2A1;AP2S1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.4247766026386186,0.9003447579231094,0.5944363103953147,0.9350416042091471,1.0,3/10,13.39%,AP2A1;AP2S1;MYLIP
prerank,cardiac muscle contraction (GO:0060048),0.3285759233366553,0.9002550654554855,0.6072727272727273,0.9347675220274556,1.0,6/34,17.45%,CAMK2D;SLC8A1;TNNC1;GSN;SCN1B;TNNI2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.304261039936548,0.900127863274245,0.6706263498920086,0.9345755421095551,1.0,16/75,18.86%,AGT;SPRY2;SLC8A1;PAQR3;PRKAR2B;LYN;MEN1;SORL1;APOE;RB1;PIK3CB;INPP5K;CD300A;PRKAR2A;NF1;TESK1
prerank,glycolipid metabolic process (GO:0006664),0.32030325296560364,0.9000785811725031,0.6424452133794695,0.9342086402628553,1.0,14/47,22.61%,PIGW;ST6GALNAC4;GBGT1;ST6GALNAC6;NEU1;SCCPDH;B3GALNT1;GLB1;GBA2;PGAP3;GLTP;SUMF1;ARSA;ESYT2
prerank,hexose metabolic process (GO:0019318),0.32884073438335193,0.8996503568199823,0.6169212690951822,0.9346179392997083,1.0,8/39,16.03%,GALT;SORD;TFAP2B;PGM1;HK1;GALK2;IRS2;PPARD
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2949542876346539,0.899649368463827,0.7104446742502585,0.9341521341035838,1.0,21/117,19.09%,AGXT;AOAH;BCO2;ALKBH7;PER2;GRHPR;PTGR1;DLD;CYP26B1;GNPAT;ECHDC3;ALDH1A2;PDHX;LDHB;NPC1;PANK2;PPARD;MCCC1;AASDH;SGPL1;GBA2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3260483895445148,0.8995615941060432,0.6351829988193625,0.93385813898951,1.0,11/41,21.55%,PTGR1;DEGS1;FADS3;SCD5;ABCD1;FADS2;DAGLA;ACOX1;GPX4;DECR2;PNPLA8
prerank,negative regulation of histone methylation (GO:0031061),0.4152223721272015,0.8993345781150152,0.5891238670694864,0.9338548766859837,1.0,3/10,9.79%,AASS;DNMT1;WDR5
prerank,aorta morphogenesis (GO:0035909),0.37807185174307506,0.8991492334678085,0.5991620111731844,0.933760024844019,1.0,5/17,20.17%,TFAP2B;PROX1;BMPR1A;RBPJ;ACVRL1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.35882498238263344,-0.8990804592806341,0.5523255813953488,0.9738778906131323,1.0,4/10,9.13%,PPARG;RXRB;RXRA;RARA
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.40182716409270974,0.8988893155583236,0.5928473177441541,0.9338413582437266,1.0,6/13,23.22%,FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2913204974647741,-0.8988529900017328,0.6163793103448276,0.9725274344402846,1.0,11/21,32.49%,MAD1L1;APC;TEX14;BUB1;CENPF;TPR;TRIP13;BUB3;KNTC1;TTK;PLK1
prerank,BMP signaling pathway (GO:0030509),0.3111182296604227,0.8988498999907604,0.643640350877193,0.9334646033476852,1.0,9/62,12.20%,GDF9;ACVR1;DDX5;USP15;SMAD2;SCX;BMPR2;RGMB;SMURF1
prerank,mitotic spindle assembly (GO:0090307),0.3306790286276036,0.8983902008075809,0.6371158392434988,0.9339667996388623,1.0,11/42,16.20%,CHEK2;KPNB1;WRAP73;KIF3B;STAG1;ARHGEF10;TOGARAM2;CCDC61;PIBF1;KIF2A;RAB11A
prerank,membrane repolarization during action potential (GO:0086011),-0.32732887751661366,-0.898301183550012,0.593103448275862,0.9719446902250559,1.0,8/13,40.12%,ATP1B1;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2;KCNE3;KCNE4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3659573405839027,0.8975586523718851,0.6236702127659575,0.9351772995485971,1.0,6/20,16.43%,HCK;CCL5;LYN;PRKCE;IL18;IRAK1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3181880389170842,0.8974773333186769,0.6394948335246843,0.934419967970098,1.0,11/50,20.35%,NUP37;POLR2G;AGO2;NUP153;RAE1;POLR2K;IPO8;NUP155;NUP88;NUP133;NUP43
prerank,regulation of gene silencing by RNA (GO:0060966),0.3181880389170842,0.8974773333186769,0.6394948335246843,0.934419967970098,1.0,11/50,20.35%,NUP37;POLR2G;AGO2;NUP153;RAE1;POLR2K;IPO8;NUP155;NUP88;NUP133;NUP43
prerank,error-prone translesion synthesis (GO:0042276),0.361761561813796,0.8971420838928563,0.5870967741935483,0.9346708087850212,1.0,5/21,9.08%,POLE2;MAD2L2;RFC4;RFC1;POLK
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.30058299423593177,0.8968069546233025,0.6684723726977249,0.9349004624590487,1.0,15/79,18.19%,AGT;SPRY2;LRP2;BAMBI;BMPER;BMPR2;SKIL;SORL1;SMURF1;HGS;BMPR1A;HTRA3;ADAMTS12;EPN2;ACVR2A
prerank,maturation of 5.8S rRNA (GO:0000460),0.38378762555678564,0.8967738199178342,0.614441416893733,0.9345005750715779,1.0,6/17,21.94%,NOL9;LAS1L;EIF6;PRKDC;WDR12;EXOSC4
prerank,phagosome maturation (GO:0090382),-0.24846025664949284,-0.8966973097604052,0.6329113924050633,0.9743416201343529,1.0,10/35,18.57%,ATP6V0A1;ATP6V1H;ATP6V1E1;CORO1A;ATP6V1C1;ATP6V1D;ATP6V1A;RAB31;MREG;ATP6V0E2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3511864179376931,0.8966616167120891,0.6206451612903225,0.9342674239052184,1.0,5/24,9.08%,POLD4;RFC4;POLB;RFC1;POLK
prerank,indolalkylamine catabolic process (GO:0046218),-0.35107228593609574,-0.8963021553806709,0.5765472312703583,0.9733820901400952,1.0,4/10,39.98%,KMO;IL4I1;IDO2;KYAT1
prerank,mRNA splice site selection (GO:0006376),0.34134508788940143,0.8962391664231804,0.6171779141104294,0.9346935562877264,1.0,1/30,0.16%,NOL3
prerank,RNA polyadenylation (GO:0043631),0.3502508045249888,0.8960857274215815,0.6021897810218978,0.9340532112663285,1.0,6/26,14.32%,PNPT1;WDR33;APP;AHCYL1;PAPOLA;PCF11
prerank,mRNA polyadenylation (GO:0006378),0.3502508045249888,0.8960857274215815,0.6021897810218978,0.9340532112663285,1.0,6/26,14.32%,PNPT1;WDR33;APP;AHCYL1;PAPOLA;PCF11
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.345792785461697,0.8959611157364528,0.6123737373737373,0.933856530649146,1.0,1/29,0.40%,SYCP1
prerank,RNA destabilization (GO:0050779),-0.3050986538561191,-0.8957957383920023,0.5889328063241107,0.9727161088242539,1.0,6/18,13.03%,ROCK1;METTL16;GIGYF2;RIDA;METTL3;ZC3H18
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3592942354625903,0.8955887342934729,0.5994659546061415,0.9341553413589125,1.0,6/21,21.96%,DNMT1;LDLRAP1;FGF9;BMPR1A;ERN1;FGF2
prerank,regulation of telomere capping (GO:1904353),-0.272129286230688,-0.895540351981748,0.6008583690987125,0.9714747794984478,1.0,5/23,12.53%,PRKCQ;NBN;MAPK3;PNKP;NABP2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3692773240563347,0.8953423882797712,0.5932885906040268,0.9341936687404844,1.0,2/18,6.22%,CAMK2D;CAB39
prerank,metanephros development (GO:0001656),0.34988672016267025,0.895316771969397,0.6174242424242424,0.9337852927705693,1.0,5/26,18.19%,WNT7B;CTSH;GDNF;PTCH1;NF1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3594866911127732,0.8946930689852117,0.6071428571428571,0.9346357980679637,1.0,7/21,21.12%,XDH;HPRT1;NUDT16;NUDT4;ACAT1;AMPD3;PDE9A
prerank,organelle disassembly (GO:1903008),-0.24778801934563055,-0.894442929424842,0.6319018404907976,0.972431088033882,1.0,9/33,11.71%,UBA5;VRK1;EIF2D;KIF9;ULK2;UFM1;ATG2B;ATG2A;ZFAND1
prerank,sister chromatid segregation (GO:0000819),-0.24821680763738252,-0.8943042979991768,0.6569767441860465,0.9708350580503874,1.0,12/31,23.21%,TOP2B;SMC1A;INO80;KIF18A;TOP2A;CENPK;KNSTRN;NUSAP1;NSL1;CDCA8;DSN1;KIFC1
prerank,calcium import into the mitochondrion (GO:0036444),0.42360641714095737,0.8942868675737647,0.5957120980091883,0.9350293224358296,1.0,5/10,25.83%,MCUR1;MICU2;SMDT1;MICU3;SLC25A23
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.32378342418254985,0.8942307593875741,0.6412395709177592,0.9346796149408921,1.0,7/39,9.08%,POLD4;CHD1L;RFC4;RFC1;ERCC4;RBX1;POLK
prerank,melanocyte differentiation (GO:0030318),0.41740005168119987,0.8940372047424546,0.6124818577648766,0.9346264508223292,1.0,3/11,12.85%,LRMDA;MITF;ENPP1
prerank,neuron projection morphogenesis (GO:0048812),0.28869494409465674,0.8938073102579871,0.6927029804727647,0.9346471045630719,1.0,36/137,19.82%,SLITRK6;TAOK3;BDNF;ATL1;LRP2;CNTNAP1;CTNNB1;GAS7;FGFR2;PAK3;EPB41L3;BTBD3;APP;TNIK;DNM2;ANKRD27;SRGAP2;APBB1;ACTB;CTNND2;MINK1;DBNL;TAOK2;MEF2A;BAIAP2;DSCAML1;LLGL1;NYAP2;DICER1;DCDC2;ABITRAM;DTNBP1;BRSK1;MAP1B;CCK;NCKAP1
prerank,cellular iron ion homeostasis (GO:0006879),0.31130409318595587,0.8930837798156072,0.6391061452513966,0.9356633260471119,1.0,13/55,20.01%,SKP1;ATP6V0D1;FXN;SLC46A1;SLC11A2;CAND1;TFR2;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2
prerank,regulation of cell cycle (GO:0051726),0.2816847425255894,0.8926496708473163,0.7685370741482966,0.9361073037928562,1.0,60/271,21.62%,PML;DAPK3;MYBBP1A;PER2;PNPT1;ZBTB17;BIRC2;GADD45G;CDC26;TARDBP;STAT3;ASAH2;RNF40;TRIM21;CHEK1;NOP53;HSP90AB1;JUNB;CDKN2D;SOX9;SRA1;CCND1;FGFR2;TCF7L2;MAGI2;CYLD;CSNK2A2;BARD1;MEN1;LIN9;PROX1;CDK10;SIK1;NEK6;RB1;RACK1;APBB1;WHAMM;BIRC3;SOX2;MASTL;PRDM11;PHACTR4;RPS15A;PTPRC;ZBTB49;WDR12;GBF1;TBRG4;CTBP1;NEK7;TSC1;BEX2;ERN1;JMY;GADD45A;STK11;CKS2;CITED2;CDK9
prerank,glutathione biosynthetic process (GO:0006750),-0.344392331271041,-0.8926276876201549,0.6403785488958991,0.9732552899587589,1.0,4/11,17.09%,GCLM;GSS;HAGH;GGCT
prerank,monocarboxylic acid transport (GO:0015718),0.31576846621357607,0.8923792022542637,0.6415525114155252,0.9362077737279944,1.0,8/51,14.78%,ABCC2;SLC27A1;SLCO1C1;NCOA1;SLCO1B1;SLC16A13;SLC16A14;SLC16A6
prerank,microtubule polymerization (GO:0046785),-0.25210557012997387,-0.8921455147169721,0.6847290640394089,0.9726343980755233,1.0,11/29,17.21%,NDE1;TPPP;TUBGCP3;CLASP2;TUBGCP4;TUBGCP6;TUBGCP2;HDGFL3;CCDC57;GOLGA2;TPX2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.30137695838876977,-0.8921100214157037,0.6176470588235294,0.9707635174444827,1.0,8/18,27.77%,PTGDS;PTGS1;MIF;PTGES;CBR1;HPGDS;PTGIS;PRXL2B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.2282793807828214,-0.8920086424214567,0.7191780821917808,0.9690699053474461,1.0,17/46,23.49%,TGFB1;ANP32B;EFCAB7;GSK3B;PIK3R2;CAMK1;RAPGEF3;TP53;ZIC1;UBR5;DMAP1;BAG3;ECT2;NEDD4;TPR;RBM22;IL1B
prerank,Golgi ribbon formation (GO:0090161),-0.3231841928910386,-0.8919471440100468,0.6097560975609756,0.9672894496658696,1.0,6/13,16.84%,TRIP11;GCC2;PRMT5;MYO18A;GOLPH3;GOLGA2
prerank,positive regulation of phosphatase activity (GO:0010922),0.3601604207580179,0.8918009901070062,0.5936675461741425,0.9369346551697533,1.0,5/21,16.32%,HSP90AB1;MAGI2;CALM3;CD300A;MTOR
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.37600702125467095,0.8917223802510279,0.6137931034482759,0.9366266983827728,1.0,3/17,7.41%,ITGA3;TFAP2B;DOK5
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3554145664339842,0.8916583552493935,0.6163682864450127,0.9362948581123249,1.0,6/22,18.09%,HSCB;FXN;NFU1;NFS1;CIAPIN1;ABCB7
prerank,protein N-linked glycosylation (GO:0006487),0.3032081844674803,0.8908802199268863,0.6559734513274337,0.9374177815799638,1.0,22/66,25.24%,TMEM258;ST6GAL1;B4GALT1;GFPT1;ENTPD5;ST3GAL1;DAD1;MGAT4C;ALG13;ALG11;RPN1;MGAT5;MAGT1;MAN1C1;STT3B;KRTCAP2;DDOST;DPAGT1;DOLPP1;TMEM165;PMM2;MGAT5B
prerank,endodermal cell fate commitment (GO:0001711),-0.3560740686561859,-0.8907792648299174,0.5887573964497042,0.9684574932237939,1.0,1/10,1.76%,CTR9
prerank,nucleus organization (GO:0006997),0.3184152766950711,0.890736877793683,0.6263096623981373,0.9372481155629583,1.0,11/47,19.63%,CHMP4A;CHMP4B;CHMP1B;ATXN7;SUN2;CHMP3;REEP3;NUP155;CHMP5;NUMA1;NUP133
prerank,regulation of melanin biosynthetic process (GO:0048021),0.424209229215491,0.8906434738237091,0.6140089418777943,0.9369721545333549,1.0,3/10,21.21%,RAPGEF2;CTNS;MFSD12
prerank,cellular response to alcohol (GO:0097306),0.3221013250075781,0.8905079059754193,0.6261682242990654,0.9367935141483356,1.0,10/42,15.37%,PTGER4;LARP1;ADCY5;OSBPL7;CTNNB1;MLC1;SPHK2;GLRA2;PTCH1;GRAMD1C
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3188109373148743,0.8904358136586744,0.6344086021505376,0.9364894885872121,1.0,5/44,12.57%,KCNMB3;ATP1B3;ACTN2;GABBR2;AKAP9
prerank,regulation of isotype switching (GO:0045191),0.3866279673493803,0.8901535816320781,0.6145404663923183,0.9366006465176924,1.0,5/14,22.70%,MAD2L2;SHLD1;PAXIP1;HMCES;KMT5C
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.262284297541759,-0.890089029950242,0.6394230769230769,0.9682732058265393,1.0,9/25,17.61%,AR;NCKAP1L;EGFR;SNCA;SRC;MIF;KCTD20;FZD7;GLMN
prerank,positive regulation of cell growth (GO:0030307),0.2917807962515213,0.8893420220182514,0.6726128016789087,0.937757007348952,1.0,17/96,15.65%,HYAL1;BDNF;SEMA4D;CXCL16;MMP14;SFRP2;FXN;RUFY3;DDX49;SYT3;CIB1;SMURF1;RASAL1;EXOSC9;DBNL;NCBP1;ADNP2
prerank,phospholipid biosynthetic process (GO:0008654),0.331498905802177,0.888908794910019,0.6357056694813028,0.9381766952109485,1.0,7/36,12.63%,CPNE3;PCYT2;AGPAT5;PIP5K1A;GNPAT;SPHK2;DHDDS
prerank,artery morphogenesis (GO:0048844),0.338429560798835,0.8887282352830095,0.633495145631068,0.9380799708947567,1.0,6/30,18.19%,LRP2;TFAP2B;BMPR2;NRP1;BMPR1A;NF1
prerank,T cell mediated immunity (GO:0002456),0.40000374174699627,0.8887074725772948,0.6086330935251798,0.9376665247915544,1.0,2/13,8.22%,CD55;CTSH
prerank,histone H4 deacetylation (GO:0070933),0.41608568971706783,0.8882785257078596,0.6023564064801178,0.9380930045997925,1.0,6/10,25.36%,HDAC8;HDAC1;HDAC2;HDAC4;SIRT2;SMARCAD1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.36412689958540717,0.8879350444599333,0.6024930747922438,0.9383296537602156,1.0,6/20,18.14%,SPPL2A;NFKB1;PSEN1;APH1A;APH1B;HM13
prerank,cellular response to metal ion (GO:0071248),0.2881248212522658,0.8878635517469758,0.7044284243048403,0.9380069383523294,1.0,16/123,11.06%,CAMK2D;RASA4;CLIC4;WNT5A;DAXX;CPNE3;TRPM2;B2M;CRHBP;MT3;SYT7;SYT3;P2RX4;PRNP;ADGRV1;GLRA2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.30541211959233666,-0.8878198575521559,0.6,0.9723780586241093,1.0,7/16,25.81%,SNCAIP;FLOT1;RIMS1;MCTP2;CAMK2A;MEF2C;KCNMB4
prerank,negative regulation of ossification (GO:0030279),-0.2698493987988267,-0.8876936075355889,0.6543778801843319,0.970796967854328,1.0,7/23,16.64%,CHSY1;SRGN;TRPM4;CCL3;SMAD6;CCR1;ECM1
prerank,actin filament organization (GO:0007015),0.28605254716181594,0.8874195924043178,0.7080366225839267,0.9384291944623911,1.0,28/151,16.36%,ACTN1;MYO1C;ELMO2;MAD2L2;RHOF;RUFY3;PPP1R9A;EVL;CARMIL1;SAMD14;BCAR1;PROX1;ARHGAP25;CORO7;GSN;FAT1;TMOD3;TRPV4;WHAMM;CORO1B;MYO6;RAC1;DLG1;GAS2L3;SH3BP1;BAIAP2;AIF1;BAIAP2L1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.2329017213282566,-0.8872590323409701,0.6753246753246753,0.9700054155841394,1.0,14/40,21.91%,SYT2;SYT10;SNCA;RIMS1;SNAP47;STX1B;RIMS3;UNC13A;SYT8;BLOC1S6;RIMS2;SYT1;OTOF;STX1A
prerank,sulfation (GO:0051923),-0.34630430516163746,-0.887218207355114,0.6094674556213018,0.9682088965709902,1.0,4/11,23.04%,UST;SULT1A1;HS3ST5;SULT4A1
prerank,chromosome condensation (GO:0030261),0.3307331123437106,0.8870669940593551,0.6290516206482593,0.9386481827302092,1.0,6/36,12.75%,TENT4A;CSNK2B;CSNK2A2;BANF1;NCAPG2;RB1
prerank,Golgi to plasma membrane transport (GO:0006893),0.3139763028726036,0.886980784879707,0.6406779661016949,0.9383581080904573,1.0,18/47,24.87%,BLZF1;GOLGA7;GGA3;AMN;EXOC6;ARFGEF2;VAMP2;VAMP4;BBS2;PREPL;LLGL1;VAMP5;GOLPH3L;OPTN;RAB10;RABEP1;EXOC2;COMMD1
prerank,transport along microtubule (GO:0010970),-0.3329762644699268,-0.8867663013435346,0.6175548589341693,0.9674236553772119,1.0,7/13,25.87%,SPG11;CDC42;CLIP3;BAG3;DYNC1I2;COPG2;APBA1
prerank,positive regulation of developmental growth (GO:0048639),0.3132308868502112,0.88673032485973,0.6434285714285715,0.9383904140508461,1.0,9/49,15.18%,BDNF;SEMA4D;RUFY3;SYT3;INSR;AGRN;SMURF1;RASAL1;DBNL
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.35848922641486924,-0.8865266362138802,0.5988200589970502,0.9660904339090535,1.0,2/10,6.84%,IMPACT;MVP
prerank,regulation of lipid metabolic process (GO:0019216),0.30164707285082,0.8863360035289293,0.6984126984126984,0.9387495213117347,1.0,24/88,25.46%,HELZ2;NCOA1;EDF1;RUBCNL;FDFT1;TGS1;RORA;GGPS1;PANK2;IRS2;NPC2;PPARD;SREBF1;IDI1;CERS2;NR1D2;CCDC3;ADIPOR1;TNFAIP8L3;HMGCS1;HMGCR;NCOR2;BBS4;PLPP1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.36397710610064793,0.886333104017753,0.6229946524064172,0.9382955069722991,1.0,2/20,3.75%,CAMK2D;SLC8A1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3460872129644605,-0.8862781840139967,0.6050955414012739,0.9648388167534305,1.0,5/11,27.70%,TIMM13;TIMM8B;TIMM9;ROMO1;NDUFA13
prerank,regulation of MAPK cascade (GO:0043408),0.28219852686299074,0.8861213056596153,0.7160367722165475,0.9382500780177901,1.0,21/157,10.16%,TAOK3;FLT1;KDR;GPR37L1;DHX33;DUSP3;CX3CL1;MYDGF;FGFR2;PAK3;WDR54;GPR37;NBR1;RET;TMEM106A;MYOC;LYN;HMGB1;INSR;ROR2;TNIK
prerank,cellular response to amino acid starvation (GO:0034198),0.3006835295920547,0.8858898575176529,0.6710097719869706,0.9382452434393278,1.0,19/71,22.25%,EIF2AK2;MIOS;ATP6V0D1;RRAGC;KPTN;SH3GLB1;LAMTOR3;EIF2S1;MTOR;TCIRG1;ATP6V1B2;ATP6V1G1;NPRL2;NPRL3;ATP6V1G2;LAMTOR4;RHEB;WDR59;RRAGA
prerank,cellular response to osmotic stress (GO:0071470),0.35809392747321883,0.8853508824599327,0.6161745827984596,0.9388571584846082,1.0,8/21,21.43%,CAB39;ZFP36L1;SCN2A;TRPV4;OXSR1;STK39;DDX3X;RCSD1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2601699074858121,-0.8852817053432595,0.580110497237569,0.9655729235695636,1.0,10/30,20.10%,ALG5;DPM1;UBE2J1;TUSC3;UGGT2;STT3A;RPN2;FUT8;DPM3;MGAT2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4031036760577098,0.8849751915416709,0.6049562682215743,0.9391658682942882,1.0,2/12,6.00%,TIPIN;CDT1
prerank,lipoprotein catabolic process (GO:0042159),-0.34382494561024,-0.8849265359555676,0.6141479099678456,0.9645651031242459,1.0,4/11,10.92%,LYPLA1;LYPLAL1;ABHD17B;ABHD17C
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3671208493395307,0.8843821891829027,0.6276150627615062,0.9399050423029948,1.0,7/19,24.28%,DHX36;ZNF76;ICE2;MTOR;BRF2;CHD8;TENM1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3359449502406632,-0.8841037239677524,0.581039755351682,0.9647170258396457,1.0,5/11,30.99%,KIFC3;VCL;JUP;CCN3;CAMSAP3
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4094974862277292,0.8840675114891792,0.6034732272069464,0.940094941753303,1.0,5/12,24.16%,APOC4;SOAT2;SOAT1;MTTP;ACSL3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2774570601232704,0.8836394577676684,0.7570564516129032,0.9404839900201847,1.0,48/214,21.96%,NOD2;CCL7;SLAMF1;SPRY2;KDR;GAREM1;CCL5;FBXW7;DUSP3;CX3CL1;FGFR2;MT3;DUSP29;RAPGEF2;CNKSR3;ACKR3;LYN;APP;HMGB1;BMPER;ROR2;ARRB2;TNIP1;CIB1;DUSP26;CCL14;HTR2A;PTPN11;APOE;DUSP10;NRP1;DLG1;MTURN;FGFR3;LGALS9;SPRED3;PTPRC;DSTYK;SPRED1;MFHAS1;PIN1;RANBP9;SIRPA;CCL4;TNFAIP8L3;ROR1;GCNT2;FGF2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3011898787188876,-0.88305283753057,0.6130268199233716,0.965483950191881,1.0,3/15,6.14%,GRM3;HOMER1;HOMER3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3671552126636664,0.8828315532932052,0.6077127659574468,0.9416023825035379,1.0,3/19,10.58%,CX3CL1;GIT1;ZC3H12A
prerank,positive regulation of protein polymerization (GO:0032273),0.3003147089046381,0.8827890952439547,0.6688668866886689,0.94123319986936,1.0,16/65,16.36%,HCK;EVL;CARMIL1;MAPRE1;CDK5RAP2;NCK1;MET;NCK2;SNX9;TPPP3;AKAP9;PRKCE;RAC1;HSP90AA1;BAIAP2;BAIAP2L1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.2937536650581598,-0.8821938811743223,0.6167247386759582,0.9658602434065392,1.0,3/17,6.48%,ADCY9;ADCY3;PRKACB
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.38699661934435725,0.8821429698383615,0.6276445698166432,0.9421000005778657,1.0,6/14,22.30%,RBMX;RNPS1;SRSF7;SRSF4;PCBP4;SRSF10
prerank,protein prenylation (GO:0018342),-0.34281330813326183,-0.8816829748421703,0.596875,0.96527949192775,1.0,6/10,21.89%,CHML;RABGGTA;PGGT1B;FNTB;CHM;RCE1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.32559560516528385,-0.8816791124009604,0.6075085324232082,0.9633997860824971,1.0,2/13,5.29%,SYK;FGR
prerank,fatty acid metabolic process (GO:0006631),0.28858189161637166,0.8812706360875874,0.7159209157127991,0.9433745545968065,1.0,23/115,21.95%,MCAT;AOAH;ALKBH7;PER2;ACSL5;LIPC;LPIN2;PEX2;GNPAT;ECHDC3;XBP1;PPARGC1A;PPARD;AASDH;ACOX1;SGPL1;OXSM;GPX4;ELOVL4;PNPLA3;ADIPOR1;PNPLA8;PON3
prerank,L-amino acid transport (GO:0015807),0.33960709679008816,0.8812324109800356,0.6275,0.9429841436412972,1.0,10/28,25.52%,SLC25A22;SLC38A2;SLC38A3;CTNS;SLC25A12;SLC36A4;SFXN1;SLC1A3;ARL6IP5;SLC36A1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3797205462473765,0.8810347909816235,0.6129476584022039,0.9429274731515466,1.0,2/15,2.65%,AUP1;TMEM129
prerank,blood vessel morphogenesis (GO:0048514),0.30431865411907777,0.8808491788080777,0.6535874439461884,0.9428184003590592,1.0,10/54,18.19%,FLT1;KDR;CUL7;ITGB8;EGFL7;PROX1;NRP1;AGGF1;RBPJ;NF1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.37837483055965954,0.8801077974545727,0.6171662125340599,0.9438391445841606,1.0,6/15,21.49%,ZC3H12C;ZC3H12A;NUDT16;DICER1;RPP30;RNASEH1
prerank,Golgi localization (GO:0051645),0.40572078981446785,0.8796277886528313,0.6117824773413897,0.9442863118513252,1.0,5/11,19.13%,TBCCD1;ARHGAP21;HOOK3;STK25;UVRAG
prerank,ESCRT complex disassembly (GO:1904896),0.4152085516151681,0.8790098083762692,0.6385542168674698,0.9445714405486927,1.0,4/10,22.00%,CHMP1B;IST1;CHMP5;CHMP1A
prerank,ESCRT III complex disassembly (GO:1904903),0.4152085516151681,0.8790098083762692,0.6385542168674698,0.9445714405486927,1.0,4/10,22.00%,CHMP1B;IST1;CHMP5;CHMP1A
prerank,membrane fusion (GO:0061025),0.33114145032860587,0.8789741717643796,0.6630824372759857,0.944175472941105,1.0,17/33,30.06%,UBXN2B;DNM2;VAMP2;VTI1B;NAPA;SNAP23;HUWE1;OPA1;RABEP1;DNM3;GCA;CHP1;RABIF;DNM1;NAPG;HACE1;SNAP29
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2952862151619388,0.878856633435621,0.684887459807074,0.9439532698503985,1.0,9/88,6.77%,HAS3;HYAL1;CLU;BCL2L11;SDC4;CX3CL1;CDT1;SH3GLB1;SLF2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3349837698962225,0.8788155812606284,0.652760736196319,0.9435783142006209,1.0,6/33,14.83%,PSME2;DDRGK1;FBXW7;TRIM39;PSME3;EZH2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3178107097166369,0.8786487377040916,0.6500607533414338,0.9434582201149713,1.0,8/38,12.63%,FBXW7;SH3GLB1;VPS11;CSNK2A2;RNF31;LEPROT;NPEPPS;UBE2L3
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4038316595555047,0.8784094965495685,0.6124260355029586,0.9434630122977925,1.0,2/11,13.43%,SIK1;CLK2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.31409807087694147,0.8778736834940404,0.6632768361581921,0.944078783381146,1.0,8/45,12.26%,GAREM1;TGFA;SOX9;BCAR1;NCK2;KIF16B;SOS1;PTPN11
prerank,regulation of chromosome segregation (GO:0051983),-0.30195514203600293,-0.8775393482122464,0.6254545454545455,0.9719265240541375,1.0,6/16,19.27%,CSNK2A1;RAD18;SMC6;MKI67;BUB1;IHO1
prerank,regulation of catecholamine secretion (GO:0050433),-0.2512796641427668,-0.8773777214618762,0.6878306878306878,0.9704123682845558,1.0,15/29,29.30%,SYT2;SYT10;SNCA;GRK2;KCNA2;SYT8;SYT1;CHRNA4;STX1A;CHGA;SYT13;DRD2;SYT5;PRKN;SYT17
prerank,regulation of mast cell degranulation (GO:0043304),0.3888261716126416,0.8773650215073513,0.6372413793103449,0.9446103777148951,1.0,6/14,16.81%,UNC13D;LYN;SPHK2;CD84;CD300A;LGALS9
prerank,clathrin-dependent endocytosis (GO:0072583),0.3512770824756767,0.8771573664804742,0.6314465408805031,0.9445668001545444,1.0,6/26,14.25%,SIGLEC1;AP2A1;FNBP1L;AP2S1;PIP5K1C;SNAP91
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4114385345544651,0.8767734369769484,0.6263237518910741,0.9448814093021145,1.0,8/10,32.54%,ACADL;ACADS;GCDH;ACADVL;ETFDH;ACAD11;ETFA;ETFB
prerank,serine family amino acid catabolic process (GO:0009071),0.4136988393320401,0.8764475281353726,0.6063348416289592,0.9450818592005872,1.0,3/10,15.03%,DLD;SHMT1;GCSH
prerank,cilium assembly (GO:0060271),0.2734801418905377,0.8759747470075071,0.7987987987987988,0.9455728892132559,1.0,61/297,18.43%,CNGB1;CENPJ;CEP19;ATP6V0D1;BBIP1;RAB8B;B9D2;KIF3C;ACTR2;CEP162;DYNC1H1;CCDC40;RILP;RILPL1;SNX10;TTC39C;ACTR1A;ACTR3;NPHP3;KIF3B;TMEM80;MAPRE1;CDK5RAP2;PRKAR2B;MKS1;SPATA6;CFAP54;FNBP1L;WDR35;IFT27;NEDD1;TMEM138;CEP131;CEP152;EXOC6;CEP70;GSN;DYNC2LI1;DYNLT2B;AKAP9;DYNLL1;E2F4;PIBF1;DZIP1;CFAP20;HSP90AA1;TMEM67;BBS2;CCDC66;TUBB4B;ARF4;RAB11A;WDR19;DYNC2H1;OCRL;CEP89;DCDC2;DCTN3;GBF1;PAFAH1B1;IFT46
prerank,negative regulation of neuron differentiation (GO:0045665),0.35810313359493556,0.875567314516168,0.6328125,0.9459010202617907,1.0,2/22,5.43%,B2M;SOX9
prerank,cAMP biosynthetic process (GO:0006171),0.41110214210204166,0.8755608516517718,0.6344725111441307,0.9454594858567908,1.0,2/10,6.17%,ADCY5;ADCY10
prerank,cell cycle G1/S phase transition (GO:0044843),0.30490289826807215,0.8754572743099314,0.6766004415011038,0.9452220567366002,1.0,10/61,12.75%,ACVR1;CUL5;GSPT1;CDKN2D;CACUL1;CCND1;PLK3;MNAT1;MAX;RB1
prerank,leukotriene biosynthetic process (GO:0019370),-0.3116237132840592,-0.875453909358004,0.6153846153846154,0.973641078809532,1.0,2/14,4.65%,LTC4S;ALOX5AP
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3969030850312443,0.8753602532978089,0.6187050359712231,0.9449530908056188,1.0,2/13,2.74%,ABCA1;CDH13
prerank,mitochondrial translational termination (GO:0070126),0.2935033129347853,0.8752819667322778,0.7032734952481521,0.94464445555128,1.0,21/88,19.21%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;MRPL42;MRPL4;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;MRPS10;MRPL13;MTRF1L;MRPL57;MRPS11;MRPL40;MRPL22
prerank,protein localization to cilium (GO:0061512),0.33582078664381665,0.8749758948102021,0.6520100502512562,0.9447972254821116,1.0,12/32,25.63%,SNX10;TUB;WDR35;ZNF423;ODAD4;WDR19;TULP3;RABEP1;RAB29;IFT140;BBS4;INVS
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.26916278473844935,-0.8748372079847365,0.6581196581196581,0.9733420733763232,1.0,3/22,3.34%,PPM1E;DUSP6;PPM1G
prerank,positive regulation of cyclase activity (GO:0031281),-0.3135923658470131,-0.8746562294226305,0.6123778501628665,0.9718932247702339,1.0,2/14,5.67%,STIM1;MAPK3
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2980924341073433,0.8746204467907251,0.6828193832599119,0.9450137677264895,1.0,12/65,13.11%,ADAM8;EGLN2;NOP53;HYOU1;MT3;RORA;UBQLN1;ZFP36L1;AK4;SCN2A;NPEPPS;BAD
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.365854145258658,0.874000245358184,0.6398929049531459,0.945788283205105,1.0,5/19,16.89%,CCL5;CSF1;CXCL17;JAM3;MDK
prerank,cell junction organization (GO:0034330),0.2996952882303552,0.8739687084682058,0.6897689768976898,0.9453924551797904,1.0,16/71,16.35%,ELFN1;RAB8B;PAK3;WNT7B;APP;AGRN;SDK1;PSEN1;TJP2;LIMS1;PPFIA4;ACTB;CTNND2;SH3BP1;NLGN3;OPHN1
prerank,regulation of establishment of cell polarity (GO:2000114),0.3780967594043536,0.8737376259751264,0.6419919246298789,0.9453910058200029,1.0,4/16,12.94%,RUFY3;KANK1;GSN;RACK1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.2555846588670798,-0.8736883498165325,0.6919831223628692,0.972423112932625,1.0,10/25,22.08%,CDK13;EAF2;LARP7;NELFB;BRD4;EAF1;ELL;NELFE;HEXIM1;NELFA
prerank,positive regulation of protein sumoylation (GO:0033235),0.41342779171813554,0.8727980662450268,0.6440922190201729,0.9467580637061623,1.0,6/10,29.59%,UBA2;PIAS1;HDAC4;PIAS4;GNL3;RWDD3
prerank,neuron remodeling (GO:0016322),0.4180483347194925,0.8725823206179069,0.6462480857580398,0.9466984294626642,1.0,2/10,9.06%,CX3CL1;APP
prerank,negative regulation of RNA splicing (GO:0033119),-0.2787620999885098,-0.8722531742435201,0.640926640926641,0.9740156358750833,1.0,8/19,20.71%,TMBIM6;RPS26;SRSF6;SFSWAP;PTBP3;C1QBP;PTBP1;U2AF2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.41793402045756556,0.8722129024284764,0.6357039187227866,0.9469699891034178,1.0,3/10,10.73%,CCT4;CCT7;CCT3
prerank,regulation of wound healing (GO:0061041),-0.23135693989186235,-0.8717481105345891,0.7394366197183099,0.9733589281933382,1.0,12/42,24.01%,SRSF6;DMTN;EPHB2;VTN;HRAS;ANXA1;CD109;F2R;CAV1;HBEGF;TNFAIP3;ADRA2A
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3504531060785733,0.8717004751729,0.6409921671018277,0.9470642143841159,1.0,3/22,5.22%,GOLGA7;ZDHHC21;ZDHHC20
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3504531060785733,0.8717004751729,0.6409921671018277,0.9470642143841159,1.0,3/22,5.22%,GOLGA7;ZDHHC21;ZDHHC20
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.197283150983065,-0.8714854785954619,0.8360655737704918,0.9721507235153695,1.0,25/98,17.90%,CASP8;SORBS1;PPP3R1;CD81;PPP3CC;EGFR;EFCAB7;ANK3;YWHAQ;TCAF1;YWHAZ;EPHB2;MTCL1;CEMIP;AKT2;PRKCI;AKT1;TREM2;CLIP3;PPP1R13B;TP53;E2F1;ITGB1BP1;HRAS;ZDHHC5
prerank,chromosome organization (GO:0051276),0.2858364089954546,0.8712865879167021,0.7273684210526316,0.9473978976958518,1.0,20/99,19.63%,MTHFR;GATAD1;MSH2;HMGN3;LRWD1;CDT1;TCF7L2;RAE1;RBX1;COPS7B;LDB1;HDAC8;SOX2;NUP155;EZH2;BAHD1;HDAC1;COPS8;NDC80;NUP133
prerank,ear morphogenesis (GO:0042471),0.35858539288581165,0.8708318411352662,0.6302083333333334,0.9478431846828447,1.0,3/20,13.69%,CHD7;FGFR2;MYO6
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.2543559426541314,-0.8708226595752778,0.6743119266055045,0.9719318514035753,1.0,11/25,27.08%,GRIN2A;GRIN2B;GRIN1;GSK3B;AKT1;MEF2C;CHRNA4;INSYN2A;MAPK8IP2;DRD2;GRID2
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.23730000444329702,-0.8706656157807378,0.6748466257668712,0.9704758230402867,1.0,8/37,11.40%,DLG4;ITGAV;PINK1;EDNRB;ANKRD13A;ABCA2;SIRT5;BRCA1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3177776082470423,-0.8705176519345783,0.6234177215189873,0.968961201694303,1.0,7/13,29.94%,NAPEPLD;ZBTB7B;VSTM2A;SOX13;FNDC5;TFE3;METRNL
prerank,ceramide catabolic process (GO:0046514),0.3861831042437381,0.8704570764675663,0.665742024965326,0.948112594783879,1.0,3/14,15.93%,ASAH2;NEU1;ACER3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3330951070865984,0.8703138329968929,0.644918444165621,0.9479459547783142,1.0,5/28,9.09%,DLK2;MMP14;FBXW7;YTHDF2;EGFL7
prerank,cell-cell junction organization (GO:0045216),-0.201038290359772,-0.8701895151393719,0.8289473684210527,0.9679418873902748,1.0,10/79,8.41%,TGFB1;CDH10;CDH2;CTNNA1;CADM3;NECTIN1;ARVCF;SDK2;NLGN2;TGFB2
prerank,endoplasmic reticulum organization (GO:0007029),0.2926421710706684,0.8701138323598516,0.7015086206896551,0.9478764295720737,1.0,12/72,13.44%,TOR1AIP2;ATL1;REEP2;SEC16A;DOP1B;APP;VAPB;TRAM2;PRNP;VCPIP1;VAMP2;REEP3
prerank,response to X-ray (GO:0010165),0.3819327836301014,0.8697437841698352,0.6453407510431154,0.9481583284579962,1.0,1/14,0.99%,MSH2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.28020837027803247,-0.8696329928006726,0.6271929824561403,0.9675466118374684,1.0,3/20,7.20%,TGFB1;NIBAN2;TRAF6
prerank,positive regulation of lipid storage (GO:0010884),-0.27807243651006786,-0.8696249683017244,0.6528925619834711,0.9657272674082134,1.0,6/21,14.63%,OSBPL11;SCARB1;C3;EHD1;VSTM2A;LPL
prerank,replication fork processing (GO:0031297),0.32658054304784656,0.8694058152170538,0.671746776084408,0.9483659990103964,1.0,6/38,15.01%,SAMHD1;ETAA1;RTEL1;ZRANB3;DDX11;GEN1
prerank,regulation of protein polymerization (GO:0032271),-0.23811448651784503,-0.868547830093985,0.7307692307692307,0.9666070236839385,1.0,7/35,11.25%,FCHSD2;PRUNE1;TPPP;COTL1;TTBK1;ARL2;PLEKHG2
prerank,cellular response to interleukin-12 (GO:0071349),0.30763128236406767,0.8684171622676164,0.670547147846333,0.9498039621996104,1.0,16/48,25.46%,PSME2;SOD2;CD47;HNRNPA2B1;PPIA;IL12RB2;HNRNPDL;JAK2;AIP;HNRNPF;SIRPA;TALDO1;MSN;PITPNA;JAK1;ANXA2
prerank,negative regulation of phosphorylation (GO:0042326),0.28582080691205974,0.867984632932751,0.6922268907563025,0.9502046726513823,1.0,17/85,14.95%,XDH;TARDBP;ANKLE2;CDKN2D;PPIA;PAQR3;LYN;PRNP;MEN1;GIT1;CIB1;ZC3H12A;STAP1;PRKDC;DYNLL1;IRS2;INPP5K
prerank,positive regulation of cellular component organization (GO:0051130),0.28673644573244955,0.8679157608959993,0.7196652719665272,0.9498769394788941,1.0,23/107,18.23%,ATP10A;HAS3;HYAL1;CLU;CAMK2B;BCL2L11;RUNX1;CDT1;SH3GLB1;SLF2;INSR;APOE;RB1;RACK1;PLEKHM2;DAB2;TFR2;BMF;ANAPC2;BAX;CBLL1;ABCB7;FNIP2
prerank,ketone body metabolic process (GO:1902224),0.41034588085706136,0.8677901452669837,0.6413690476190477,0.9496828689466683,1.0,3/10,17.02%,HMGCL;OXCT1;ACAT1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.35306570553492417,0.867679818252145,0.6355140186915887,0.9494513764780987,1.0,3/21,9.47%,SLC18A2;MT3;ABCD1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.3840336815052555,0.867485251028812,0.636615811373093,0.9493623686674949,1.0,7/15,29.90%,DDRGK1;NPM1;EZH2;CUL3;KLHL18;CDC73;PAF1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.29785221384123267,0.8673953828240124,0.6789587852494577,0.9490846413546292,1.0,8/66,12.27%,PARP9;DTX3L;MEPCE;CCT4;CCT7;ZC3H12A;CCT3;PSEN1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.2657633469804752,-0.8670718139698277,0.6745283018867925,0.9684495607714803,1.0,12/24,28.45%,PAK2;RHPN2;CLASP2;WAS;WASF2;F11R;CLASP1;ARHGAP6;PPFIA1;ARHGEF18;TJP1;ARHGAP28
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.29057549838936547,0.8670482816404328,0.7122994652406417,0.9493010673134021,1.0,19/86,21.54%,GDF9;ACVR1;HSP90AB1;CSNK2B;SMAD2;BMPR2;MEN1;SNW1;ZNF423;DAB2;JAK2;BMPR1A;RBPJ;ACVR2A;RBPMS;NUMA1;ACVRL1;STK11;CITED2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.276265453313536,0.8669014361420826,0.763506625891947,0.9491210331148103,1.0,36/150,19.00%,XDH;TRIB3;SPRY2;SEMA4D;TARDBP;THY1;SFRP2;TARBP2;PMEPA1;PPIA;PAQR3;CNKSR3;NCK1;LYN;NCK2;PRNP;MEN1;CIB1;PPM1F;ZC3H12A;DDIT4;PRKDC;AKT1S1;RB1;ENPP1;RACK1;INPP5K;CALM3;SPRED3;PTPRC;CORO1C;NF1;DTNBP1;SPRED1;TESK1;SNX25
prerank,negative regulation of locomotion (GO:0040013),-0.331515924744633,-0.8667184389177338,0.6170886075949367,0.9674650549900732,1.0,5/12,16.00%,FRMD5;SPOCK3;PTPN2;WAS;CCDC125
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.303756185136608,0.866657433644935,0.6705882352941176,0.9491358788303221,1.0,5/50,9.81%,NOL3;CDKN2D;IGBP1;MT3;DNAJB6
prerank,positive regulation of bone resorption (GO:0045780),0.4000328008357509,0.8666378492057554,0.6386430678466076,0.9487277741833727,1.0,2/11,10.09%,ADAM8;DEF8
prerank,regulation of cation transmembrane transport (GO:1904062),-0.25187617683166985,-0.8665406957495556,0.696078431372549,0.9660374563824365,1.0,3/29,5.77%,KCNIP3;SLMAP;HOMER1
prerank,actin filament network formation (GO:0051639),0.4043351584051589,0.8660039918653855,0.61875,0.9494881550178791,1.0,2/11,6.05%,ACTN1;CARMIL1
prerank,regulation of actomyosin structure organization (GO:0110020),0.3890204780503815,0.8659753171214587,0.6558988764044944,0.9490878574589353,1.0,5/13,19.19%,PTGER4;AKAP13;RAC1;ASAP3;TSC1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.32346198856623015,-0.8658873967429651,0.6288659793814433,0.96576540872781,1.0,2/13,3.63%,ATP1B1;ATP1B2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2925429813066217,0.8655900531447749,0.6985854189336235,0.9494041564924441,1.0,4/73,1.42%,TNFSF10;CASP4;XDH;NOD1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.35248593195764916,0.8653314564425362,0.6608811748998665,0.9494510502772043,1.0,7/22,21.68%,DHX36;SRF;MED12;PAXIP1;MED16;MED24;PSMC2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.25013053157236803,-0.8651666939602563,0.7309941520467836,0.9657243589498122,1.0,8/31,11.79%,PDLIM5;CFL1;ARHGAP44;SRCIN1;PPFIA2;TANC2;SHANK3;ZDHHC15
prerank,peptide metabolic process (GO:0006518),0.28871118658751477,0.8649049021919788,0.6917211328976035,0.9498592221342447,1.0,12/75,14.18%,ETHE1;ERAP1;ABCB9;CPQ;NLN;AEBP1;GSR;SPCS1;PSEN1;NPEPPS;SPPL3;CTNS
prerank,integrin-mediated signaling pathway (GO:0007229),0.29274845251285037,0.8645486800561121,0.7172489082969432,0.9500899826554114,1.0,10/73,13.95%,ISG15;ITGA2;THY1;CD47;HCK;ITGB8;BCAR1;COL3A1;NRP1;DAB2
prerank,activation of GTPase activity (GO:0090630),0.2856918233381406,0.8639012196252774,0.7167199148029819,0.950899136362043,1.0,26/89,20.00%,TBC1D1;SYDE1;PIP5K1A;TBC1D8;ABR;RAP1GAP;SYDE2;SIPA1L2;TBC1D8B;ARHGAP25;ARHGEF10;SIPA1L1;TIAM2;TBCK;BCR;TBC1D2;RALGAPB;ARHGAP29;CORO1C;SIPA1L3;TSC1;ARHGAP24;ARHGAP42;SGSM1;SGSM3;TBC1D4
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.28334558541428023,0.8637686376634545,0.7162303664921466,0.9507021737239831,1.0,24/108,21.46%,TNFSF10;CASP4;XDH;NOD1;FIS1;CFLAR;HMGB1;PRR7;PPM1F;DIABLO;GSN;RACK1;BAD;ST18;JAK2;UACA;LGALS9;BAX;CRADD;BCAP31;DDX3X;LCK;MTCH1;F3
prerank,early endosome to Golgi transport (GO:0034498),-0.3263013066394758,-0.8635594004648629,0.6394557823129252,0.9678438158929586,1.0,3/11,11.06%,SNX8;SURF4;TRAPPC10
prerank,positive regulation of glycolytic process (GO:0045821),0.3521469939751144,0.8634003285452042,0.6563307493540051,0.9505039226953444,1.0,4/20,12.27%,ENTPD5;APP;INSR;PSEN1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3521469939751144,0.8634003285452042,0.6563307493540051,0.9505039226953444,1.0,4/20,12.27%,ENTPD5;APP;INSR;PSEN1
prerank,potassium ion homeostasis (GO:0055075),0.34515355763121264,0.8633112349971314,0.6347941567065073,0.9502276199494432,1.0,4/23,8.76%,ATP1B3;SLC12A5;TFAP2B;SLC12A8
prerank,negative regulation of cell communication (GO:0010648),0.35384648650600536,0.8631527652288425,0.6426701570680629,0.9500752398563642,1.0,3/21,8.86%,ACVR1;KIF26A;SOCS5
prerank,negative regulation of axonogenesis (GO:0050771),0.32809664113081904,0.8617982969203334,0.6613102595797281,0.9521653359065018,1.0,5/27,13.05%,THY1;RUFY3;MT3;MAG;FGF13
prerank,protein localization to vacuole (GO:0072665),0.38993563851855073,0.8615517668613982,0.647226173541963,0.9521824173402376,1.0,6/13,27.16%,KPTN;SH3GLB1;LAMTOR4;SZT2;GLMP;LMBRD1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.2720112395848962,-0.8612759844735141,0.6900826446280992,0.9716035562713634,1.0,8/22,27.07%,DMD;AHNAK;CACNB1;CBARP;SRI;NOS1AP;DRD2;CRHR1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.31956635198095257,0.8611158059834497,0.6594202898550725,0.9525935133243366,1.0,8/35,16.89%,DAPK3;TRPM2;HCK;STAP1;NRP1;BAIAP2;BAIAP2L1;MDK
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.28514437805431764,-0.8603147233752082,0.6276150627615062,0.9720664259274695,1.0,10/17,37.34%,ATP1B1;ATP1B2;FKBP1B;GJD3;GJC1;ATP1A1;ATP1A3;RYR2;CACNA1C;ATP1A2
prerank,negative regulation of developmental process (GO:0051093),0.2930249127201801,0.8602898083493405,0.6948968512486428,0.9536929813655098,1.0,8/69,11.07%,WNT11;LOXL2;THY1;SOX9;NFIB;KANK1;NOTCH4;IL17D
prerank,regulation of cellular protein localization (GO:1903827),0.3086940417127708,0.8596489645840248,0.6898148148148148,0.9544730978152338,1.0,11/45,19.47%,BDNF;SUMO3;HSP90AB1;CTNNB1;RAB11B;VCPIP1;PPM1F;HSP90AA1;CCDC66;GBF1;PIN1
prerank,regulation of urine volume (GO:0035809),0.4085568967862646,0.8596146886202721,0.6473214285714286,0.9540951174110276,1.0,2/10,14.95%,TFAP2B;INPP5K
prerank,gene expression (GO:0010467),0.2698856588639036,0.8595250146978779,0.8598598598598599,0.9538096987312674,1.0,88/348,21.25%,APOBEC1;NUP37;POLR2G;MRPL36;XRN2;ADAR;IGF2BP3;AGO2;RPL36;MAGOHB;HARS2;SMG7;HNRNPH1;NUP153;NCBP2;GSPT1;NOL9;RPL22;RRAGC;HNRNPK;EIF4EBP2;RPS21;WDR33;RBMS2;DDX20;NXT1;HNRNPA2B1;RAE1;SCX;POLR2K;HNRNPL;TNIP1;RNPS1;MRPL42;ABCF1;SMG5;SORL1;HNRNPH3;UPF2;DDX54;ZC3H11A;TAF1B;ATXN1;RPS6;CHTOP;DUSP11;RPS11;NUP155;DDX39B;RPL30;MRPL24;RBM39;NCBP1;RBM3;DDX19B;RPL32;SRSF7;MEF2A;RPL23A;LMF2;RPL11;SRSF4;UPF1;YARS2;RPL10A;RPS15A;MRPL13;NUP88;HBS1L;SLU7;SRBD1;RBPMS;RSL24D1;RPL24;RPL37A;FASTKD2;RPL3;MRPS11;HNRNPF;NUP133;RRBP1;GLE1;NUP43;THOC7;RPL29;RPL5;SRSF5;FARSB
prerank,regulation of dendrite morphogenesis (GO:0048814),0.32860467332803556,0.8594769700479682,0.660217654171705,0.9534417885304217,1.0,10/32,19.76%,SEMA4D;CUL7;FBXW8;RAPGEF2;TNIK;CUX1;CHRNB2;CAPRIN1;RAP2A;SS18L1
prerank,positive regulation of cytokinesis (GO:0032467),-0.239891807540774,-0.859138383831999,0.7142857142857143,0.973074316168418,1.0,9/32,18.64%,CENPV;CDC42;CIT;KIF20B;RACGAP1;RHOA;KIF23;CSPP1;ECT2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3475014648846216,0.8586406075200933,0.6710013003901171,0.9545993819459297,1.0,3/23,5.13%,AUP1;TMEM129;SEC16A
prerank,retrograde axonal transport (GO:0008090),-0.29829159467353633,-0.8576000668150868,0.6461538461538462,0.9749861739717667,1.0,3/16,8.92%,DST;MAP1A;FBXW11
prerank,regulation of cellular catabolic process (GO:0031329),0.29689539087302674,0.857565448050791,0.707641196013289,0.9561303070451294,1.0,8/62,9.47%,DAPK3;TRIB3;LONP2;ITPR1;OSBPL7;RRAGC;CISD2;ABCD1
prerank,positive regulation of cilium assembly (GO:0045724),0.3562605508510074,0.8574269718205509,0.639300134589502,0.9559238258996142,1.0,6/18,21.06%,KCTD17;WRAP73;CCDC88A;SEPTIN9;CEP135;ENTR1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.27966810069869347,0.8569963811961315,0.737064413938754,0.9562877892849344,1.0,18/102,14.95%,TRIB3;IRS1;RAB8B;CRHBP;ADCY5;RAB12;NFKB1;USF1;LPIN2;PRKAR2B;INSR;ZFP36L1;XBP1;PRKDC;ENPP1;VAMP2;IRS2;INPP5K
prerank,hydrogen peroxide catabolic process (GO:0042744),0.39463748036812746,0.8569053536020655,0.6524926686217009,0.9560030841622972,1.0,2/11,14.26%,PXDNL;PRDX2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3838194835872965,0.8565970380148212,0.6391304347826087,0.9561575390443814,1.0,6/13,29.96%,ALG13;ALG11;DPAGT1;ALG12;ALG9;ALG14
prerank,regulation of Rho protein signal transduction (GO:0035023),0.2923717896753396,0.8562347653202339,0.7128927410617552,0.9563938692583337,1.0,15/72,17.13%,ABCA1;TNFAIP1;ITGA3;MYOC;MET;KANK1;STARD8;COL3A1;APOE;GPR35;AKAP13;NRP1;RAC1;OPHN1;BCR
prerank,DNA methylation (GO:0006306),-0.2719871819081588,-0.8558803631246992,0.6692913385826772,0.9773439640578955,1.0,13/23,30.28%,EHMT1;KMT2E;N6AMT1;METTL4;TEX15;BEND3;DMAP1;ATRX;PPM1D;BAZ2A;PICK1;ZFP57;FOS
prerank,cellular response to estrogen stimulus (GO:0071391),0.37714383090773695,0.8555582441796781,0.6494252873563219,0.9571827676247249,1.0,2/14,5.44%,CRHBP;SRA1
prerank,cellular response to organonitrogen compound (GO:0071417),0.2815900382511657,0.8550642058877596,0.7445482866043613,0.9576586086545007,1.0,25/99,22.25%,TRPM2;LARP1;CRHBP;RRAGC;SOX9;CTNNB1;PDXP;RAPGEF2;P2RX4;ZFP36L1;GLRA2;XBP1;AKAP9;LAMTOR3;RAPGEF1;ACTB;INPP5K;MTOR;PDE3A;LAMTOR4;GLRA1;HCN2;GABRB2;HSP90B1;RRAGA
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.369663220638023,0.8549567519409602,0.6780141843971631,0.9574183907849847,1.0,2/15,10.83%,TMC1;ADGRV1
prerank,glycoprotein biosynthetic process (GO:0009101),0.28697988870310737,0.8546534353485413,0.7219827586206896,0.9575344001067697,1.0,20/79,22.10%,CANT1;COG3;MPI;TMEM106A;FAM20B;B4GALT5;BMPR2;CSGALNACT2;TNIP1;DAD1;FUT10;B3GALNT1;NPC1;ST8SIA1;FUT9;SERP1;DDOST;XYLT1;GCNT2;CHST11
prerank,rRNA processing (GO:0006364),0.27410259229525935,0.8545436238757386,0.7890466531440162,0.9572893207502047,1.0,49/172,22.09%,PWP2;XRN2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;RSL1D1;NOP53;MRM2;HELQ;NOL9;RPL22;LAS1L;NOLC1;RIOK3;EIF6;NOP2;PRKDC;DDX54;RPS6;SART1;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;UTP3;EMG1;RPL29;RPL5;RRP9;EXOSC4;UTP15;RPL6
prerank,glutathione derivative metabolic process (GO:1901685),-0.2727940250018881,-0.8544917428499428,0.7063492063492064,0.9770705129043403,1.0,7/20,30.05%,GSTO1;GSTA3;GSTM1;GSTA4;GSTO2;HPGDS;GSTM5
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.2727940250018881,-0.8544917428499428,0.7063492063492064,0.9770705129043403,1.0,7/20,30.05%,GSTO1;GSTA3;GSTM1;GSTA4;GSTO2;HPGDS;GSTM5
prerank,cellular response to cAMP (GO:0071320),0.32590655294722043,0.8540784172616488,0.6747572815533981,0.9577044009759035,1.0,6/30,14.95%,CRHBP;RAPGEF2;ZFP36L1;AKAP9;RAPGEF1;INPP5K
prerank,receptor metabolic process (GO:0043112),0.299958081446691,0.8540177022059017,0.70917225950783,0.9573707112642408,1.0,15/53,19.26%,MVB12A;SH3GLB1;RAB11B;ACKR3;KIF16B;PIK3R4;LDLRAP1;ARRB2;DNM2;SMURF1;ARFGEF2;SNX1;SNX25;UVRAG;BECN1
prerank,lipoprotein localization (GO:0044872),-0.3301226367534985,-0.8535015795170007,0.6497005988023952,0.977603924569914,1.0,1/11,1.69%,PPARG
prerank,glycosphingolipid metabolic process (GO:0006687),-0.22901876025951656,-0.8533670260204268,0.7720588235294118,0.9761017918348661,1.0,8/42,9.32%,ST3GAL5;GM2A;CTSA;ASAH1;SMPD3;ST8SIA5;ABCA2;GALC
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3815085794966996,0.8531938656603434,0.647887323943662,0.9584325428576635,1.0,4/13,18.20%,ZDHHC21;IRAK1;MDK;FUT9
prerank,tryptophan metabolic process (GO:0006568),-0.326467530179554,-0.8531592824427765,0.6458333333333334,0.9748414121202927,1.0,4/11,39.98%,KMO;IL4I1;IDO2;KYAT1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.26951210569033357,-0.853023310187376,0.6936170212765957,0.9733607246925667,1.0,7/22,16.73%,CDK13;CCNT1;THOC5;BRD4;HMGN1;THOC1;ELL
prerank,diacylglycerol metabolic process (GO:0046339),0.34114585598536973,0.8528608202481569,0.6658064516129032,0.9585893481278466,1.0,7/23,18.37%,PNPLA2;DGKB;DGKK;DAGLA;DGKA;PLCE1;DGKI
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3132033714047341,0.8528055559845176,0.7051129607609988,0.9582487149013998,1.0,11/41,20.35%,NUP37;SLC2A6;NUP153;RAE1;PRKAG1;EIF6;NUP155;NUP88;LACC1;NUP133;NUP43
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.34086571615395456,0.8525544705395897,0.6675257731958762,0.9582842253528292,1.0,3/23,14.33%,CAMK2D;PRNP;FYN
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.35912395473181546,0.8521135450578168,0.6452054794520548,0.9586673906992205,1.0,7/17,25.49%,AUP1;TMEM129;FAF2;HM13;HSP90B1;VCP;DERL2
prerank,regulation of protein metabolic process (GO:0051246),0.30537234306255495,0.85203112797759,0.6945080091533181,0.9583868252537254,1.0,11/44,21.66%,CHEK2;HSP90AB1;TMEM9;APP;TRAF3;APOE;HGS;LDLR;SPOP;PLAUR;VPS35
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3572166773524518,0.8520141826537577,0.6518817204301075,0.9579654325340831,1.0,6/19,18.83%,CENPJ;CCT4;CCT7;CCT3;CEP295;CEP135
prerank,nucleic acid-templated transcription (GO:0097659),-0.2218216717378781,-0.8517928439548056,0.75,0.9744764069279858,1.0,19/42,25.48%,THRB;DRG1;EPC1;BCL3;PTMA;MMS19;POLR2F;POLR2J;CREBL2;NFKBIB;E2F1;HOXD3;POLR2A;THAP1;PPP5C;NR4A2;PAX8;POLR2L;BAZ2A
prerank,cilium-dependent cell motility (GO:0060285),-0.2598749376394482,-0.8515665223220205,0.7296137339055794,0.9732295077073475,1.0,16/22,41.86%,CCDC39;CFAP44;DNAH8;EFHC1;DNAH2;DNAI3;RSPH9;RFX3;DNAH3;DRC1;GAS8;DNAAF2;DNAH17;CCDC65;DNAH1;TEKT5
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3463080453834249,0.851238584415861,0.6709511568123393,0.9589416233184357,1.0,4/21,15.67%,SPRY2;ARHGAP25;LZTR1;SH3BP1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.38431998237917486,0.8510580106325418,0.6413502109704642,0.9588427509496559,1.0,3/13,11.93%,SOCS1;RUNX1;NKAP
prerank,regulation of DNA replication (GO:0006275),-0.21427449214437277,-0.8505288759679025,0.7906976744186046,0.9738452658834639,1.0,12/49,17.60%,WAPL;FAF1;EGFR;PPP2R1A;ESCO1;SMC3;CDAN1;DNA2;RAD17;S100A11;TERF1;TSPYL2
prerank,positive regulation of potassium ion transport (GO:0043268),0.3096041352589442,0.8503711478202398,0.665083135391924,0.9596520932723455,1.0,5/38,16.74%,KCNMB3;ACTN2;GABBR2;DLG1;KCNJ2
prerank,negative regulation of protein depolymerization (GO:1901880),0.33677085711616905,0.8503406343004248,0.6893840104849279,0.959261105662714,1.0,7/24,17.49%,SPEF1;CIB1;ATXN7;FGF13;PLEKHH2;STMN2;CAMSAP2
prerank,phasic smooth muscle contraction (GO:0014821),0.4035095882239938,0.849961260811651,0.6550680786686838,0.959508318242518,1.0,2/10,8.81%,PTGER3;GDNF
prerank,apoptotic process (GO:0006915),0.2692685557301364,0.8499156940305463,0.8193743693239153,0.9591456199757608,1.0,33/203,16.32%,CASP4;CASP7;IFIT2;DAPK3;CXCR4;MCM2;BCL2L11;FEM1B;CASP6;SIAH1;CHEK1;MRPS30;TNFAIP1;RRAGC;CFLAR;PPIA;APP;PLK3;CIB1;DIABLO;AHCYL1;DDIT4;SCN2A;PRKCE;BAD;NDUFS1;JAK2;MYD88;TLR2;TAOK2;BMF;PPARD;MTOR
prerank,histone H4-K16 acetylation (GO:0043984),0.34871836852494814,0.8496812823651849,0.6675461741424802,0.959134602157623,1.0,5/19,19.72%,JADE3;KMT2A;WDR5;KAT8;KAT7
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.28871056213584806,0.8496730707586733,0.7462845010615711,0.9587018977495938,1.0,22/84,17.55%,DDX5;RBMX;HNRNPK;SRPK1;HNRNPL;SNW1;RNPS1;RBFOX1;HNRNPA1;CELF6;DAZAP1;RBM15;MBNL2;RBFOX3;RBM39;NCBP1;RBM3;SRSF7;SF3B4;SRSF4;PCBP4;CWC22
prerank,ATP transport (GO:0015867),-0.3425029791753295,-0.84933860064195,0.6457142857142857,0.974752301502607,1.0,4/10,19.10%,SLC25A4;SLC17A9;SLC25A5;SLC25A42
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.30158943398600563,0.8492770690232927,0.6918671248568156,0.9589799793897101,1.0,6/46,9.83%,SLC27A1;PLA2G12A;AGPAT5;ABHD8;GNPAT;DGKB
prerank,fat cell differentiation (GO:0045444),-0.21591470468858526,-0.8492167805118365,0.7938144329896907,0.9733013891884441,1.0,16/57,16.44%,OSBPL11;PPARG;MAFB;BBS9;ZBTB7A;PSMB8;SIRT1;TMEM120A;AKT2;CEBPA;HMGA2;CLIP3;FOXO1;SMAD6;WNT5B;KLF4
prerank,regulation of glycolytic process (GO:0006110),0.2916550379010791,0.8483137314693541,0.7390350877192983,0.960339111851166,1.0,24/68,27.82%,NUP37;SLC2A6;NUP153;RAE1;ENTPD5;APP;INSR;PRKAG1;GIT1;EIF6;PSEN1;NUP155;NUP88;NUP133;NUP43;ZBTB20;TIGAR;HDAC4;NUP205;SLC4A4;SEH1L;NUP188;EP300;RANBP2
prerank,negative regulation of cell adhesion (GO:0007162),0.28847523815638654,0.8482235204734039,0.7312633832976445,0.9600648889437475,1.0,8/72,6.89%,PLXNA3;PLXNB2;SEMA4D;CDH13;PLXNB3;CX3CL1;PODXL;SNAI2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.28472910945427005,0.848038066744012,0.7318681318681318,0.9599603977619697,1.0,12/80,15.24%,TNFSF10;NOD1;FIS1;CDKN2D;IGBP1;MT3;HMGB1;DNAJB6;PPM1F;BAD;SOX2;UACA
prerank,alpha-amino acid metabolic process (GO:1901605),0.30907000417370706,0.8476402921889251,0.7132947976878613,0.9602262766306275,1.0,11/45,23.01%,MTHFR;THAP4;SLC25A12;GLUD1;FOLH1;MTHFD1;GADL1;MMUT;GPT2;GOT1;RIMKLA
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.24588009214239803,-0.8475637997913001,0.7216494845360825,0.9754584688980255,1.0,12/30,20.66%,POLR1A;ERCC3;TBP;TTF1;ERCC2;TAF1D;POLR2F;POLR1C;TAF1A;POLR1H;GTF2H3;GTF2H4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.27765946346207315,0.8475210685223448,0.7575442247658689,0.9600038371772108,1.0,30/105,24.24%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;TYROBP;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;PSMD4;PDPK1;PSMA2;RAF1
prerank,cellular response to oxygen levels (GO:0071453),0.4030377604990622,0.8474295913032156,0.6574074074074074,0.9597298124481227,1.0,1/10,2.09%,ATP6V0D1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.27849182146402124,0.8473511094517968,0.7624481327800829,0.9594440231462749,1.0,27/110,18.98%,HELZ2;RPL36;MAGOHB;SMG7;NCBP2;GSPT1;RPL22;RPS21;RNPS1;SMG5;UPF2;UPF3A;RPS6;RPS11;RPL30;ETF1;NCBP1;RPL32;RPL23A;RPL11;UPF1;RPL10A;PPP2R2A;RPS15A;RPL24;RPL37A;RPL3
prerank,chloride transmembrane transport (GO:1902476),-0.21619114070933065,-0.8467876428087981,0.7841726618705036,0.9754281655672364,1.0,14/48,22.21%,SLC12A6;GABRG3;SLC12A2;GABRB1;GLRB;GABRA2;SLC4A8;GLRA3;GABRB3;SLC1A1;SLC12A9;GABRA5;LRRC8A;ANO6
prerank,positive regulation of nuclear division (GO:0051785),0.3334375524180515,0.8462767561087413,0.6657789613848203,0.9609316102371731,1.0,3/25,10.21%,TGFA;INSR;PHIP
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.24334044865551396,-0.8458327808892877,0.7560975609756098,0.9758806542963179,1.0,6/28,9.55%,MAP1A;PRUNE1;FKBP4;SKA2;CLASP2;ARL2
prerank,C4-dicarboxylate transport (GO:0015740),0.3753208733019531,0.8458127305609222,0.660377358490566,0.9613127969572581,1.0,3/14,14.80%,SLC25A22;SLC25A10;SLC25A12
prerank,cellular response to lectin (GO:1990858),0.2776747508645215,0.8455146505952023,0.7546972860125261,0.9609562644509567,1.0,30/104,24.24%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;TYROBP;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;PSMD4;PDPK1;PSMA2;RAF1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2776747508645215,0.8455146505952023,0.7546972860125261,0.9609562644509567,1.0,30/104,24.24%,PSMB10;SKP1;PSME2;PSMA5;PSME4;PAK3;PSMA3;NFKB1;PSMB9;LYN;BTRC;PSMD2;RELB;PSME3;FYN;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;TYROBP;PSMF1;PSMB6;PRKCD;PSMC2;PSMD12;PSMD4;PDPK1;PSMA2;RAF1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3852382423526246,0.8454490568199636,0.6759941089837997,0.9606345994688815,1.0,3/12,14.59%,GALT;GFPT1;SLC35A3
prerank,neural crest cell migration (GO:0001755),0.3100343614307225,0.8454082133791219,0.6824644549763034,0.9602708250095986,1.0,7/36,18.05%,PITX2;SEMA4D;GDNF;NRP1;PHACTR4;SEMA3D;CORO1C
prerank,regulation of interleukin-2 production (GO:0032663),-0.21729875224976986,-0.8450034431314997,0.7972027972027972,0.9760656230594654,1.0,20/43,29.12%,CARD11;TRAF2;PNP;HOMER3;TRAF6;CCR2;CD86;GLMN;ANXA1;IRF4;CD28;TNFAIP3;IL1B;IL1A;CD80;RPS3;VSIG4;HDAC7;CD34;PDE4D
prerank,insulin receptor signaling pathway (GO:0008286),0.28489047239118437,0.84488160608704,0.7313432835820896,0.960801632577331,1.0,14/69,17.81%,NAMPT;IRS1;ATP6V0D1;ZNF106;GRB10;BCAR1;INSR;PHIP;SOS1;IRS2;BAIAP2;TCIRG1;ATP6V1B2;ATP6V1G1
prerank,regulation of secretion by cell (GO:1903530),0.2979861099247566,0.8448442770413961,0.7181510710259301,0.9604307475369146,1.0,11/54,16.51%,RAB8B;RAB21;RAB12;CPLX1;P3H1;RHBDF2;RIC1;VAMP2;STX4;STXBP5L;LLGL1
prerank,histone H4-K8 acetylation (GO:0043982),0.36504958797496057,0.8448263961805528,0.6690340909090909,0.959584640245755,1.0,5/15,23.96%,JADE3;WDR5;KAT8;KAT7;JADE2
prerank,histone H4-K5 acetylation (GO:0043981),0.36504958797496057,0.8448263961805528,0.6690340909090909,0.959584640245755,1.0,5/15,23.96%,JADE3;WDR5;KAT8;KAT7;JADE2
prerank,steroid biosynthetic process (GO:0006694),0.2970655476972908,0.8448148044582728,0.714614499424626,0.9591628585884606,1.0,13/56,20.73%,OSBPL7;CH25H;HSD11B1;FDFT1;OSBPL3;DHRS11;CYP27A1;OSBPL9;OSBP;EBP;OSBPL2;CYP39A1;SRD5A1
prerank,regulation of gastrulation (GO:0010470),0.37427554987248124,0.8442875410848887,0.6767537826685007,0.9596662970681296,1.0,3/14,12.94%,SCX;PHLDB1;RACK1
prerank,snRNA metabolic process (GO:0016073),-0.2807966609959017,-0.8441097932183994,0.7321428571428571,0.9763211777848311,1.0,6/17,22.54%,RBM7;INTS10;INTS12;INTS2;TUT1;INTS6
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.33721504344053693,0.844057148987501,0.6902887139107612,0.9596395304789855,1.0,5/24,14.33%,FIS1;MYO1C;PRNP;CIB1;FYN
prerank,peptidyl-lysine acetylation (GO:0018394),-0.3485339408311081,-0.8438982169480195,0.673352435530086,0.975014656319436,1.0,2/10,7.84%,ESCO1;SIRT1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3218090868226846,0.8438170184662153,0.6978155339805825,0.959641261143878,1.0,8/30,19.58%,PIGW;GPAA1;PIGV;PGAP2;PIGQ;PIGB;PGAP3;PIGK
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3421180590211329,0.8436078500995581,0.6698113207547169,0.9595966284638193,1.0,3/21,7.48%,ADCY5;ADCY10;NPPC
prerank,ion homeostasis (GO:0050801),0.32393582481488553,0.8435749005200422,0.7038413878562577,0.9592180176820213,1.0,2/30,5.09%,CAMK2D;SLC12A5
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.29916157361930257,0.8435174032688582,0.7044673539518901,0.9588773590994999,1.0,9/45,20.17%,GDF9;ACVR1;CSNK2B;BMPR2;DAB2;BMPR1A;ACVR2A;RBPMS;ACVRL1
prerank,negative regulation of chemotaxis (GO:0050922),-0.24193184103653204,-0.843389196280822,0.7094972067039106,0.9744458507701604,1.0,16/31,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;PTPN2;SEMA4B;SEMA3E;SEMA5B;ANGPT2;SEMA6D;SEMA4F;ROBO1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.36992123904119867,0.8429749462415825,0.6685393258426966,0.9593974244562933,1.0,2/15,4.85%,CHEK2;TIPIN
prerank,neuronal action potential (GO:0019228),0.33743939431170195,0.8429270814143012,0.6811397557666214,0.9590556207016239,1.0,1/22,0.73%,KCNMB3
prerank,cellular metal ion homeostasis (GO:0006875),0.2773911146211637,0.8426433410022148,0.7607555089192025,0.9591203564713319,1.0,15/102,16.74%,CCL7;CD40;ATP1B3;SLC8A1;CCL5;SLC30A1;CHERP;MT3;VAPB;CCL14;HTR2A;TRPV4;NPTN;SLC24A3;KCNJ2
prerank,purine nucleotide metabolic process (GO:0006163),-0.25404342221550824,-0.8420269184340663,0.7226890756302521,0.9758102586775121,1.0,11/24,24.92%,FHIT;GDA;PNP;PRPSAP1;ITPA;NT5E;GPX1;GUK1;PPAT;PRPS1;PRPS1L1
prerank,positive regulation of ion transport (GO:0043270),0.29636627459702547,0.8420088951032823,0.7097902097902098,0.9598597856867415,1.0,10/48,16.17%,ACTN2;CCL5;CNKSR3;GDNF;P2RX4;CRACR2A;AHCYL1;DLG1;CHRNB2;SCN1B
prerank,cardiac cell development (GO:0055006),0.3881260163749677,0.8419926682131146,0.6535087719298246,0.9594454867501191,1.0,1/11,3.75%,SLC8A1
prerank,positive regulation of RNA splicing (GO:0033120),0.32446436581428384,0.8419294888995255,0.6882640586797066,0.9591234935846084,1.0,7/29,15.92%,SLC38A2;RBMX;SNW1;DAZAP1;NCBP1;RBM3;SF3B4
prerank,positive regulation of cell communication (GO:0010647),-0.25051192525458954,-0.8418652553599674,0.7185929648241206,0.974433832172353,1.0,11/28,24.10%,DLG4;HOMER1;ANK3;RIMS1;RIMS3;CDKN2AIP;RIMS2;KCTD13;SYT1;NMU;CD80
prerank,regulation of insulin secretion (GO:0050796),0.2744635607093018,0.8415405004003237,0.751578947368421,0.9593814520256346,1.0,10/101,8.44%,PER2;IRS1;CCL5;ADCY5;ITPR1;TCF7L2;TFAP2B;SYT7;KCNS3;CACNA1A
prerank,Fc receptor signaling pathway (GO:0038093),0.27723835007680814,0.8412515566302414,0.7481789802289281,0.9594682815776232,1.0,37/110,25.96%,PSMB10;SKP1;PSME2;PSMA5;PSME4;LCP2;PSMA3;NFKB1;NFATC2;PSMB9;LYN;VAV1;BTRC;PSMD2;SOS1;PSME3;PIK3CB;RAC1;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;PSMF1;PSMB6;PSMC2;PSMD12;MAPK9;PSMD4;PDPK1;PSMA2;PIK3CA;MAP2K4;GAB2;SHC1;PSMD1;PSMD11
prerank,negative regulation of developmental growth (GO:0048640),0.32239146222012177,0.8409511845800821,0.6968944099378882,0.9595847192664364,1.0,7/30,16.05%,MT3;MAG;DUSP10;FGF13;PTCH1;BBS2;FGFR3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.33713765411864965,0.8403501304992804,0.6939597315436241,0.9602990907758953,1.0,5/23,16.10%,MMP14;MAPK14;PROX1;ATP11A;SMYD1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3851899293184521,0.8398946128043671,0.6694677871148459,0.9606710348888886,1.0,3/12,10.73%,CCT4;CCT7;CCT3
prerank,regulation of stress fiber assembly (GO:0051492),0.28437853431537,0.8398625670170752,0.7288503253796096,0.9602777548482775,1.0,14/74,14.95%,WNT11;CD47;PTGER4;EVL;CARMIL1;MYOC;CCDC88A;MET;PPM1F;ARHGEF10;NRP1;RAC1;ASAP3;INPP5K
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.27639907133744074,0.8392158829513328,0.7484407484407485,0.9610054252898713,1.0,37/109,25.96%,PSMB10;SKP1;PSME2;PSMA5;PSME4;LCP2;PSMA3;NFKB1;NFATC2;PSMB9;LYN;VAV1;BTRC;PSMD2;SOS1;PSME3;PIK3CB;RAC1;PSMA4;PSMD7;PSMD8;PSMD9;TAB3;PSMF1;PSMB6;PSMC2;PSMD12;MAPK9;PSMD4;PDPK1;PSMA2;PIK3CA;MAP2K4;GAB2;SHC1;PSMD1;PSMD11
prerank,response to metal ion (GO:0010038),0.28837211012865066,0.8389153991984621,0.730299667036626,0.9611081403553678,1.0,10/67,15.21%,LOXL2;FXN;SLC30A5;MT3;SLC11A2;AHCYL1;TFR2;SLC25A12;PAM;CALM3
prerank,aerobic respiration (GO:0009060),0.35071798071165317,0.8386336025149371,0.675392670157068,0.9611993750382105,1.0,5/20,21.11%,MTFR2;UQCR10;NDUFS8;NDUFS7;SDHB
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.2784661983036919,-0.8382501251136254,0.7161016949152542,0.9807753757874291,1.0,5/18,17.68%,GSK3B;RIMS1;SLC4A8;RIMS3;RIMS2
prerank,secretion (GO:0046903),-0.3023509001825825,-0.8379812587138735,0.6596491228070176,0.9796787376439983,1.0,10/14,49.36%,RIMS1;PRKCI;GUCA1B;NPR1;FBLN5;DRD3;VIP;ABCB11;SLC22A2;SLC22A6
prerank,actin cytoskeleton reorganization (GO:0031532),0.2913619262842977,0.8377813277495558,0.7334070796460177,0.9622079061030184,1.0,17/63,19.49%,S1PR2;PARVB;SYDE1;PIP5K1A;BCAR1;MKLN1;TNIK;GSN;ANTXR1;TRPV4;SIPA1L1;WHAMM;NRP1;MINK1;MYH9;DTNBP1;RAP2A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.23984392410871647,-0.837310901692354,0.7941176470588235,0.9795007456800353,1.0,8/33,17.89%,TGFB1;SMARCA4;PPARG;TGFB2;EGR1;TP53;KLF4;TEAD1
prerank,potassium ion transmembrane transport (GO:0071805),-0.18070027684897527,-0.8372437164719274,0.92,0.9779185716833383,1.0,47/135,33.94%,SLC12A6;SLC9A9;ATP1B1;SLC12A2;KCNC2;KCNH1;ATP1B2;KCNJ10;NALCN;KCNQ5;KCND2;KCND1;KCND3;KCNK6;KCNK12;PKD2L1;KCNA2;KCNC3;KCNG2;KCNC1;SLC12A9;SLC9A8;KCNT2;KCNJ6;KCNAB1;HCN3;KCNK9;KCNJ13;KCNB2;KCNH5;KCNK5;ABCC8;KCNC4;KCNH2;SLC12A1;KCNQ4;ATP1A1;ATP1A3;FXYD2;KCNJ12;HCN4;LRRC55;KCNJ16;KCNK4;KCNH4;KCNN1;KCNK13
prerank,heart morphogenesis (GO:0003007),0.30408097076342977,0.8371595024681108,0.7230941704035875,0.962877405749286,1.0,7/50,20.17%,ACVR1;CHD7;SOX9;INSR;BMPR1A;FLRT2;ACVRL1
prerank,regulation of protein dephosphorylation (GO:0035304),0.31040470688740174,0.8370370168189202,0.7071178529754959,0.962648855285284,1.0,16/37,24.88%,ARPP19;ANKLE2;PPIA;PPP6R3;SPPL3;CALM3;PPP1R7;MFHAS1;TSC1;PIN1;PPP2R5A;PRKCD;HSP90B1;ENSA;CALM2;TIPRL
prerank,cilium organization (GO:0044782),0.2646714373890951,0.8369060333778048,0.8435923309788093,0.9624373343819264,1.0,41/210,18.43%,CNGB1;CENPJ;CEP19;ATP6V0D1;BBIP1;RAB8B;B9D2;ACTR2;CEP162;RILP;RILPL1;SNX10;TTC39C;ACTR3;NPHP3;KIF3B;MKS1;CFAP54;FNBP1L;WDR35;TMEM138;CEP131;EXOC6;GSN;DYNLT2B;DYNLL1;PIBF1;DZIP1;CFAP20;TMEM67;BBS2;CCDC66;ARF4;RAB11A;WDR19;DYNC2H1;OCRL;CEP89;DCDC2;GBF1;IFT46
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.2691967972111617,0.83689555557155,0.8168724279835391,0.9620187762573925,1.0,41/152,23.80%,PSMB10;DAPK3;PSME2;PSMA5;PSME4;SFRP2;UBE2B;FGFR2;PSMA3;NFKB1;TMEM9;PSMB9;DACT1;BAMBI;USP34;KANK1;PSMD2;PSME3;PLEKHA4;ZRANB1;PSMA4;TLR2;PSMD7;PSMD8;PSMD9;PIN1;PSMF1;SPIN1;DDX3X;PSMB6;USP8;PSMC2;PSMD12;SMURF2;PSMD4;GPRC5B;XIAP;VCP;AXIN1;PSMA2;CAPRIN2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3410273591331664,0.8367721737022576,0.6805369127516778,0.9617918340001195,1.0,8/21,25.83%,FIS1;MCUR1;MICU2;BCAP31;TGM2;SMDT1;MICU3;SLC25A23
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3092325299685835,0.836461767504218,0.6985294117647058,0.9619019934284196,1.0,3/31,8.74%,CLTRN;SYT7;SYT3
prerank,positive regulation of sodium ion transport (GO:0010765),0.3790030701483572,0.8361991386326808,0.6671511627906976,0.9619276403008092,1.0,5/12,26.99%,CNKSR3;AHCYL1;SCN1B;WNK3;SCN4B
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3420343154943859,0.8360660276747611,0.6821808510638298,0.9617264504602828,1.0,4/20,18.69%,ZDHHC21;RAPGEF2;AKAP13;LMBRD2
prerank,steroid catabolic process (GO:0006706),0.39424267910771776,0.8359839301305422,0.6869158878504673,0.9614370253512712,1.0,1/10,8.33%,HSD11B1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.34974091367454885,0.8354675504202732,0.6909090909090909,0.9619092662452727,1.0,4/19,15.34%,ACVR1;BMPR2;SLIT3;BMPR1A
prerank,triglyceride biosynthetic process (GO:0019432),-0.2740537692585159,-0.8353299492872914,0.7142857142857143,0.9803859582548805,1.0,7/18,26.13%,MOGAT3;DGAT1;GPAM;PCK2;GPAT4;GPAT3;DGAT2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34144809405395987,0.8353151615438189,0.6718954248366014,0.9617219478074056,1.0,11/20,31.66%,MT3;XBP1;CARF;RBPJ;NOTCH1;SMAD1;EP300;CHD6;ATF4;RELA;SESN2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.388217078348311,0.8350861596125077,0.6893491124260355,0.9617027901443765,1.0,3/11,13.91%,BCAR1;NRP1;RAC1
prerank,Golgi to lysosome transport (GO:0090160),0.38920859989702544,0.8349230578763509,0.6642441860465116,0.9615686886130367,1.0,4/11,25.09%,ANKFY1;LAMP1;RBSN;CCDC91
prerank,brain morphogenesis (GO:0048854),0.372231725176051,0.834890934133624,0.6779411764705883,0.9611858887861565,1.0,5/12,26.53%,VPS51;BBS2;PAFAH1B1;BBS4;PTEN
prerank,keratan sulfate metabolic process (GO:0042339),0.3136868271029354,0.834527230215051,0.6885245901639344,0.9613727474370868,1.0,11/31,23.95%,FMOD;B4GALT4;B4GALT1;B4GALT5;ST3GAL1;B4GALT2;CHST2;GLB1;OGN;GALNS;GNS
prerank,negative regulation of transmembrane transport (GO:0034763),0.39485406206268514,0.8345267028931522,0.6741741741741741,0.9609402101439984,1.0,3/10,14.95%,RSC1A1;IRS2;INPP5K
prerank,striated muscle cell development (GO:0055002),-0.3054225228416215,-0.8344212981522264,0.6644736842105263,0.9807518515835324,1.0,10/14,47.85%,CAPN3;PGM5;TMOD1;KLHL41;SDC1;LMOD3;TMOD2;LMOD1;MYH6;TMOD4
prerank,glycoprotein catabolic process (GO:0006516),-0.2768901413646477,-0.834097443349471,0.7415254237288136,0.9797120870456953,1.0,3/17,5.73%,OGA;CTSL;MANBA
prerank,cellular response to ATP (GO:0071318),0.36756854767763003,0.8340345924806414,0.686382393397524,0.9613583261141462,1.0,2/14,8.96%,PDXP;P2RX4
prerank,regulation of BMP signaling pathway (GO:0030510),0.28483360632120464,0.8339298428355651,0.7508269018743109,0.961116301703357,1.0,20/73,23.22%,LRP2;ITGA3;TFAP2B;SMAD2;BAMBI;BMPER;BMPR2;SKIL;SORL1;ZNF423;SMURF1;BMPR1A;HTRA3;RBPJ;ACVR2A;NUMA1;ACVRL1;SMURF2;XIAP;NOTCH1
prerank,purine-containing compound catabolic process (GO:0072523),0.3667047046542908,0.833482343053057,0.6643059490084986,0.9615041707763337,1.0,1/13,1.39%,XDH
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3509971930249769,0.833185512977804,0.6903485254691689,0.9615957185052114,1.0,7/18,23.05%,VPS11;CTSC;DACT1;APOE;HSP90AA1;VPS35;MSN
prerank,blood vessel endothelial cell migration (GO:0043534),0.33710079043606983,0.8329536974510963,0.7075098814229249,0.9615514406307507,1.0,5/22,21.96%,KDR;SRF;NRP1;MYH9;FGF2
prerank,cellular response to nutrient levels (GO:0031669),0.2846331142441768,0.8329531864692267,0.7324414715719063,0.961120891450042,1.0,19/62,26.45%,LAMP2;RRAGC;BMPR2;HSPA8;XBP1;KLF10;MAP1LC3B;MTOR;SREBF1;CD68;STK24;TSC1;USP33;RRAGA;ZFYVE1;FNIP1;KCNB1;WRN;EHMT2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3601640857142305,0.8319827117600224,0.6983471074380165,0.9623416135336345,1.0,3/17,10.08%,CCND2;CCND1;PROX1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.3568647439212785,0.8318639180480782,0.702557200538358,0.9621182647751694,1.0,6/16,23.22%,FGFR2;PIM1;BMPR1A;RBPJ;FGF2;NOTCH1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3249524626669432,0.831818627461817,0.678477690288714,0.9617659194726197,1.0,3/23,8.76%,SLC12A5;TFAP2B;SLC12A8
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.384057218843854,0.8318171551352929,0.6774193548387096,0.961335597043346,1.0,3/11,19.90%,STAP1;STX4;TYROBP
prerank,phosphatidylcholine catabolic process (GO:0034638),0.39482230785770744,0.8317775616323585,0.6983154670750383,0.9609780721331024,1.0,4/10,26.86%,LIPC;PLA2G6;PNPLA8;PLA2G4A
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.32236663961166395,0.8315971976069716,0.7211055276381909,0.9608636295183586,1.0,7/27,20.61%,THY1;CD47;CCDC88B;IRAK1;MDK;SIRPA;LCK
prerank,mitotic nuclear division (GO:0140014),0.2858313880348044,0.8315240036364315,0.7497255762897914,0.9605655024440167,1.0,14/71,16.20%,CHMP4B;CHEK2;KPNB1;WRAP73;KIF3B;STAG1;NCAPG2;ARHGEF10;TOGARAM2;CCDC61;PIBF1;MIS12;KIF2A;RAB11A
prerank,embryonic digit morphogenesis (GO:0042733),-0.2722396296176137,-0.8313172595534147,0.6920415224913494,0.9838703175931842,1.0,3/18,14.17%,MAP3K20;SALL1;INTU
prerank,transition metal ion homeostasis (GO:0055076),0.32071666587277814,0.8312671573523885,0.6894409937888198,0.9605807040818694,1.0,9/28,25.45%,B2M;MT3;TFR2;HMOX2;FBXL5;ABCB7;XIAP;COMMD1;CP
prerank,membrane lipid biosynthetic process (GO:0046467),0.2856267975354009,0.8311635969109435,0.7304643261608154,0.9603256214184219,1.0,16/58,22.40%,SGPP2;GBGT1;CERS6;DEGS1;VAPB;SCCPDH;SPHK2;HACD3;ACER3;SPTLC2;SGPL1;CERS2;ELOVL4;SPTSSA;PLPP2;CERT1
prerank,transepithelial transport (GO:0070633),0.3586515746166113,0.8310763767757654,0.677376171352075,0.9600514707115243,1.0,4/15,22.21%,ABCC2;ABCC1;ABCG2;SLC1A3
prerank,atrial septum development (GO:0003283),0.3769817332811126,0.8309688990836435,0.6905444126074498,0.9598004415264508,1.0,2/13,9.54%,NPHP3;BMPR2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.25665968114054355,-0.8308694967304336,0.7053941908713693,0.9831664007983799,1.0,7/20,24.30%,APC;NR2F2;CEBPA;INCA1;HEXIM1;CDKN1B;CDK5RAP1
prerank,lipid phosphorylation (GO:0046834),-0.3321995924601394,-0.8308586010812821,0.6441717791411042,0.9814589227849263,1.0,4/10,12.32%,DGKH;DGKZ;DGKD;DGKE
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2873219940673264,0.830539487895541,0.728735632183908,0.9601136640356256,1.0,23/58,28.17%,POLM;POLB;HERC2;ERCC4;BARD1;HMGB1;POLQ;PRKDC;PAXIP1;NSMCE2;DCLRE1A;NHEJ1;BABAM2;UVRAG;DCLRE1C;SUMO1;LIG3;KAT5;NSD2;PIAS4;PRPF19;UBE2N;BABAM1
prerank,cellular response to ketone (GO:1901655),0.30954849899283116,0.8298966901183407,0.7097944377267231,0.9607882650479949,1.0,15/35,28.93%,PTGER4;LARP1;ADCY5;SPHK2;NR3C1;ACOD1;DCPS;MSN;NDOR1;ADAM15;CFTR;NCOA4;ADCY6;GNB1;KLF9
prerank,rRNA metabolic process (GO:0016072),0.26570504630994307,0.8297719605425385,0.8213197969543147,0.960581590351704,1.0,47/160,22.95%,PWP2;XRN2;SBDS;DDX27;SENP3;RPL36;NOB1;DDX49;MDN1;NOP53;MRM2;HELQ;NOL9;RPL22;XRN1;LAS1L;NOLC1;DDX54;RPS6;WDR43;EXOSC9;RPL30;RPL32;RPL23A;RPL11;DHX37;DDX47;RPL10A;RRP1;RRP1B;PELP1;WDR12;RPL24;RPL37A;RPL3;ESF1;UTP3;TRIR;EMG1;RPL29;RPL5;RRP9;EXOSC4;UTP15;RPL6;NOL6;UTP14A
prerank,translational elongation (GO:0006414),0.27549478985418663,0.829468833459664,0.7876569037656904,0.9606768848024156,1.0,23/101,19.21%,MRPL36;ERAL1;MRPS30;MRPL12;MRPL16;MRPS35;MRPS28;GFM1;TUFM;MRPL42;MRPL4;RACK1;MRPS23;MRPS2;MRPS22;AURKAIP1;MRPL24;MRPS10;MRPL13;MRPL57;MRPS11;MRPL40;MRPL22
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.23823523954498213,-0.8294325086064419,0.7613636363636364,0.9829332750903989,1.0,8/31,15.65%,LRRC7;DLG3;CDC42;MTCL1;PRKCI;RHOA;PDZD11;SCRIB
prerank,muscle cell development (GO:0055001),-0.23832148449642393,-0.8290367058396554,0.7563451776649747,0.9820424966437513,1.0,14/30,34.84%,DMD;BIN1;MYOF;NEBL;KDM1A;CXADR;NEB;EFEMP2;SGCZ;RAMP2;SDC1;MYH11;HEY2;HES1
prerank,protein export from nucleus (GO:0006611),-0.2366875272649667,-0.829024016944418,0.7557603686635944,0.9803493766142785,1.0,10/27,24.12%,TGFB1;STYX;STRADB;XPO5;CCHCR1;EGR2;TPR;RANBP3;XPO7;XPO1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3472755302809909,0.8287799234090397,0.7030386740331491,0.9614170160884691,1.0,4/17,16.68%,ABHD2;NR3C1;UBE2L3;ACOD1
prerank,T cell differentiation (GO:0030217),0.30245579072613793,0.828773602672547,0.7204819277108434,0.9609978453294109,1.0,11/40,23.55%,PIK3CD;CHD7;LEPR;ZFP36L1;LMBR1L;NHEJ1;PTPRC;LCK;RHOH;GLI3;ZFP36L2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.2969770985856164,-0.8282709783127803,0.7260726072607261,0.9802426442411739,1.0,6/13,33.77%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.39561410634772676,0.8276168491923405,0.6955177743431221,0.9625764782724748,1.0,3/10,14.28%,STAT3;LYN;JAK2
prerank,protein localization to plasma membrane (GO:0072659),0.26903868964284205,0.827139622184912,0.8127572016460906,0.9629518468646312,1.0,40/129,25.78%,PIGW;RAB8B;ATP1B3;ACTN2;SEC16A;RAB12;ANK1;PIP5K1A;RAPGEF6;RAPGEF2;CCDC88A;EPB41L3;TNIK;EFR3A;NECTIN3;SMURF1;FGF13;PTCH1;DLG1;INPP5K;RAB11A;ASB3;FLOT2;RAP2A;GORASP2;ZDHHC3;RAB10;ZFYVE27;C2CD5;ZDHHC22;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32
prerank,response to glucose (GO:0009749),0.29452350932701815,0.8269736690769336,0.7297921478060047,0.9628309841083118,1.0,12/46,23.34%,TCF7L2;EIF2B2;XBP1;RACK1;VAMP2;IRS2;SELENOT;EIF2B5;EIF2B3;ERN1;ZBTB20;TRA2B
prerank,response to glucagon (GO:0033762),-0.26758424621870786,-0.8266608712367085,0.7067137809187279,0.9819189910744834,1.0,5/19,16.07%,ADCY9;ADCY3;PRKACB;CRY1;CREB1
prerank,maturation of SSU-rRNA (GO:0030490),0.3082363556516954,0.8265995248156829,0.7196149217809867,0.963048271061568,1.0,14/34,29.84%,PWP2;NOB1;RIOK3;DHX37;MRPS11;UTP3;RRP36;NGDN;BMS1;NOL10;HELB;DDX52;RPS19;TSR3
prerank,metal ion transport (GO:0030001),0.27508143363349474,0.8263567794799248,0.7664543524416136,0.963016297852155,1.0,17/86,17.65%,TRPM2;LRP2;SLC8A1;CCL5;ITPR1;SLC30A1;SLC30A5;MT3;CACNA1A;PANX1;PSEN1;TRPV4;FYN;CHRNB2;TRPM7;NIPA2;MAGT1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.38922094502894333,0.8259971050746077,0.6971080669710806,0.963196724024946,1.0,4/11,24.05%,LYN;ACOD1;MFHAS1;CYBA
prerank,response to nutrient levels (GO:0031667),0.35013524186519035,0.8257405978948421,0.7158034528552457,0.9632200121314679,1.0,7/17,33.59%,MTOR;CD68;KCNB1;RPS6KB1;ATF4;EIF4G1;PRKAA1
prerank,regulation of lamellipodium assembly (GO:0010591),0.3108128301616407,0.8254202501710863,0.7060270602706027,0.9633123724277388,1.0,11/34,24.63%,ACTR2;PLXNB3;CYFIP1;ACTR3;CAPZB;RAC1;PLCE1;NCKAP1;BRK1;TWF1;PIK3CA
prerank,regulation of mononuclear cell migration (GO:0071675),0.33283272031870625,0.8251604126347348,0.6967005076142132,0.9633168748083376,1.0,6/23,16.89%,CCL5;CSF1;LYN;CXCL17;AIF1;MDK
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3765001876338689,0.8251391358077701,0.6828193832599119,0.9629241079776827,1.0,2/12,8.46%,ESRRB;YTHDF2
prerank,innate immune response in mucosa (GO:0002227),-0.33377206462913256,-0.8250865961081891,0.6962025316455697,0.983579200662056,1.0,2/10,15.86%,RPL39;DEFA6
prerank,synaptic vesicle recycling (GO:0036465),0.3090827234944988,0.8250020481487418,0.7118226600985221,0.9627306795325654,1.0,8/31,17.70%,SYNJ1;SYT7;PIP5K1C;VAMP2;STON1;NLGN3;OPHN1;STON2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3645144919475705,0.8247713679409648,0.6774647887323944,0.9626896022728371,1.0,4/14,14.28%,STAT3;LYN;SOCS2;JAK2
prerank,modulation by host of viral genome replication (GO:0044827),0.37327527176631703,0.8246688137970911,0.6976744186046512,0.9624261755511386,1.0,4/13,25.59%,ZC3H12A;CCNK;TBC1D20;PPIB
prerank,ceramide biosynthetic process (GO:0046513),0.29595659121588014,0.8246502345848349,0.7238095238095238,0.9620309438163203,1.0,5/40,7.43%,ST6GALNAC4;ASAH2;CERS6;DEGS1;ST6GALNAC6
prerank,RNA 3'-end processing (GO:0031123),0.28007762961601534,0.8245008704579261,0.7574786324786325,0.9618640281316598,1.0,22/69,24.06%,TENT4A;PNPT1;MAGOHB;NCBP2;WDR33;RNPS1;ZC3H11A;PAPOLA;CHTOP;PCF11;DDX39B;NCBP1;SRSF7;SRSF4;TUT7;SLU7;THOC7;MTPAP;SRSF5;SRSF2;MAGOH;RPRD2
prerank,renal water homeostasis (GO:0003091),0.3279744966226107,0.8241729413486352,0.704,0.961968210541091,1.0,6/23,17.08%,ADCY5;TFAP2B;AQP4;PRKAR2B;RAB11A;PRKAR2A
prerank,regulation of protein targeting to membrane (GO:0090313),0.3184910892625623,0.8239100598385953,0.7049180327868853,0.9620034831649701,1.0,6/28,14.95%,FIS1;MYO1C;PRNP;CIB1;FYN;INPP5K
prerank,protein localization to lysosome (GO:0061462),0.3193296582404136,0.8238338219318433,0.6929824561403509,0.9617116532638111,1.0,11/28,27.16%,KPTN;GGA3;NAGPA;SORL1;HGS;LAMTOR4;M6PR;SZT2;GLMP;NCOA4;LMBRD1
prerank,smooth muscle cell differentiation (GO:0051145),-0.3105821003968272,-0.8238291071064677,0.6838709677419355,0.9845075960545353,1.0,8/12,37.75%,EDNRB;MRTFB;TMEM204;MEF2C;BMP4;HEY1;HEY2;APLNR
prerank,amino acid transport (GO:0006865),0.2894572741008981,0.8236942066953348,0.7482837528604119,0.9615252126886767,1.0,9/49,16.80%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;PDPN;SLC7A6;SLC25A47;SLC36A4;SLC25A45
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3643311751669677,0.8235550233525948,0.6979768786127167,0.9613101163690561,1.0,1/14,1.57%,SPRY2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.26678697394878326,0.8235052383067718,0.7835051546391752,0.9609644665861186,1.0,25/124,16.96%,BLOC1S4;PPP1R9A;CYFIP1;CARMIL1;TBC1D23;MYOC;SAMD14;STMN4;RAPGEF2;LYN;GDNF;APP;HMGB1;STMN3;PLEKHA1;APOE;RB1;CORO1B;RAC1;MAP4;LRP12;PRMT1;RAB11A;OPHN1;STMN2
prerank,DNA strand elongation (GO:0022616),0.3471101351698069,0.8231386869154699,0.687757909215956,0.9611485108117834,1.0,6/18,20.43%,MCM7;MCM4;RFC4;GINS2;GINS4;GINS3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3724643885872074,0.8229586738866012,0.6927621861152142,0.9610472245654125,1.0,2/12,7.65%,DDC;SMS
prerank,positive regulation of chromatin organization (GO:1905269),0.3718140985475066,0.8225579710844462,0.6995645863570392,0.9612837405438005,1.0,3/12,19.00%,DAXX;MIER1;TERF2
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.31931538124826236,-0.8224972795445461,0.6768707482993197,0.9855681441822066,1.0,4/11,23.64%,CEACAM1;AHR;IL4I1;KLRD1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.33673669412579493,0.8222951962739357,0.7009102730819246,0.9612988395434785,1.0,3/21,10.97%,ZFP36;RUNX1;ZFP36L1
prerank,synaptic vesicle transport (GO:0048489),0.3821632669252001,0.8220411993658793,0.6757925072046109,0.9613068496816934,1.0,2/11,10.62%,SYNJ1;DNM2
prerank,cellular response to leucine (GO:0071233),-0.3294330674767145,-0.8218196949067516,0.7097791798107256,0.9835937506212876,1.0,2/10,7.56%,RRAGD;LARS1
prerank,response to leucine (GO:0043201),-0.3294330674767145,-0.8218196949067516,0.7097791798107256,0.9835937506212876,1.0,2/10,7.56%,RRAGD;LARS1
prerank,spliceosomal snRNP assembly (GO:0000387),0.30349453703369167,0.8217481060781172,0.7419738406658739,0.9613838088615156,1.0,14/38,23.57%,DDX20;TGS1;SART1;CLNS1A;GEMIN7;SNRPD2;SNRPD1;SNRPG;GEMIN2;SNUPN;SRSF10;SART3;LSM4;SNRPD3
prerank,regulation of sequestering of triglyceride (GO:0010889),0.3544662635918846,0.8214589873115689,0.6824712643678161,0.9614562818909651,1.0,2/15,4.73%,PNPLA2;OSBPL8
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3825859398172585,0.8211140295944189,0.7024320457796852,0.9616165768036645,1.0,3/11,10.73%,CCT4;CCT7;CCT3
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3590451038076633,0.8208487438939726,0.6787790697674418,0.961613396862662,1.0,4/14,15.32%,ABCG1;PSEN1;APH1A;APH1B
prerank,inner dynein arm assembly (GO:0036159),0.3751528881997759,0.8207687065106886,0.6863354037267081,0.9613291446810911,1.0,2/11,14.22%,CCDC40;CFAP73
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2851968750960029,0.820336962206518,0.748040313549832,0.9616718803089168,1.0,16/57,23.51%,LTV1;MRPL36;PAK1IP1;RRS1;TGS1;NPM1;RPS6;NOP16;RPL11;DHX37;WDR12;EMG1;URB2;RPL5;LTO1;RRP36
prerank,protein acylation (GO:0043543),0.29793615954836333,0.8198125087110295,0.7237762237762237,0.9621483359440244,1.0,16/38,27.30%,ZDHHC21;ZDHHC20;HHAT;NAT9;ZDHHC13;ZDHHC8;ZDHHC3;ING5;ZDHHC18;KAT6A;ZDHHC22;KAT2B;ZDHHC17;ZDHHC16;ZDHHC7;EP300
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3092325174072502,0.8194499125059658,0.717391304347826,0.9623233976788378,1.0,6/35,8.63%,POLD4;RFC4;POLB;RFC1;FEN1;MPG
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3664400909545614,0.8190910270223263,0.6875891583452212,0.9624956627451225,1.0,1/13,3.66%,ADAM8
prerank,positive regulation of macrophage activation (GO:0043032),0.34762427944824503,0.8189045256490495,0.7024128686327078,0.962382035317429,1.0,3/17,14.67%,WNT5A;STAP1;TNIP2
prerank,cellular response to organic cyclic compound (GO:0071407),0.26302774304028687,0.8187599873601212,0.8246687054026504,0.9622174576858539,1.0,25/141,16.84%,CASP7;TRPM2;CASP6;LARP1;CRHBP;CCL5;ADCY5;CTNNB1;PDXP;RAPGEF2;P2RX4;RORA;ZC3H12A;RIOK3;ZFP36L1;NR3C1;LCOR;AKAP9;UBE2L3;RAPGEF1;ACTB;INPP5K;TIPARP;IL18;PDE3A
prerank,regulation of cytoplasmic translation (GO:2000765),0.36154096836606686,0.8184152936232292,0.7002881844380403,0.9623851435454508,1.0,2/14,7.25%,DHX36;DHX9
prerank,peptide cross-linking (GO:0018149),-0.24376774111021618,-0.8179723805587251,0.7804878048780488,0.9898120322305011,1.0,17/25,49.34%,F13A1;NDNF;ANXA1;ABCA7;CD247;FCGR3A;TGM4;DSP;EVPL;TGM1;KRT10;TGM6;TGM5;EPB42;TGM7;CD3G;SPRR1A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2276411606580438,-0.8179674233262922,0.7828571428571428,0.9881266396318522,1.0,9/32,18.54%,MAP3K3;PIK3C2A;HMOX1;RHOA;JCAD;KLF4;MAP2K5;ITGB1BP1;ANXA1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.26699038185804863,0.8179174506572157,0.8014477766287487,0.9628160625290638,1.0,21/107,19.75%,CASP4;TRIB3;DDRGK1;BCL2L11;RNF5;ITPR1;ERP44;HYOU1;SEC16A;ATF6B;NCK1;UBQLN1;RNF185;EIF2S1;BAX;EIF2B5;CREB3L2;BCAP31;ERO1A;GORASP2;ERN1
prerank,neuron maturation (GO:0042551),0.3438169675153356,0.8175437319033518,0.7004103967168263,0.9629864154790696,1.0,3/18,9.06%,CX3CL1;B4GALT5;APP
prerank,autophagosome assembly (GO:0000045),0.28629259727872514,0.8175078734916378,0.7328843995510662,0.9626276844724787,1.0,8/52,14.56%,IRGM;UBQLN2;RAB43;UBXN2B;UBQLN1;SMURF1;MAP1LC3B;RB1CC1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2743270136163979,0.817467209248403,0.7850267379679144,0.9622758545597411,1.0,29/86,26.41%,PSMB10;PSME2;PSMA5;PSME4;EGLN2;CHEK1;PSMA3;BACH1;PSMB9;RBX1;ELOC;PSMD2;PSME3;PSMA4;PSMD7;PSMD8;PSMD9;PSMF1;PSMB6;PSMC2;PSMD12;PSMD4;LIMD1;PSMA2;CUL2;EPAS1;PSMD1;PSMD11;HIGD1A
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.26893689030364326,-0.817375686654342,0.7413127413127413,0.9877109269818483,1.0,6/18,22.86%,LTBP1;ITGAV;TGFB2;SMAD4;HIF1A;CD200
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3153161824833988,-0.8171834073685854,0.7,0.9864402191302026,1.0,6/11,36.03%,ATP1B1;KCND3;KCNH2;ATP1A1;KCNQ1;KCNIP2
prerank,regulation of phospholipase activity (GO:0010517),0.3860452078696266,0.8171749898451793,0.7033639143730887,0.9623268313640289,1.0,4/10,26.35%,FGFR2;FGFR3;PDPK1;LRP1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.34257107162472566,0.8168369979033338,0.6928374655647382,0.962450155272993,1.0,6/17,26.38%,ATP5MC1;DMAC2L;ATP5PO;ATP5F1B;VPS9D1;STOML2
prerank,purine nucleotide catabolic process (GO:0006195),0.3626514546091554,0.816400602234318,0.7165242165242165,0.9627593147034044,1.0,1/13,1.39%,XDH
prerank,regulation of NMDA receptor activity (GO:2000310),0.3034878708201778,0.8159848157040726,0.7184115523465704,0.9630068342061529,1.0,8/32,16.24%,CAMK2B;ACTN2;CRHBP;GRIA2;APP;CAPN1;DLG1;GRIA4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3689728237803213,0.8159237675834211,0.7044117647058824,0.9626814590246925,1.0,4/12,16.18%,IRS1;SORL1;PTPN11;GKAP1
prerank,mitotic cytokinesis (GO:0000281),0.29232460361996926,0.8156351260699275,0.752542372881356,0.9627492281501573,1.0,5/47,10.39%,CHMP4B;SNX33;CUL7;EFHC2;SNX9
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.37176107104691186,0.8153529439174825,0.6940509915014165,0.9627915468616921,1.0,4/12,19.77%,KPNB1;CLCN2;SREBF1;SEC14L2
prerank,regulation of axon regeneration (GO:0048679),0.36910032360531764,0.8151151527521739,0.6888888888888889,0.9627629392623729,1.0,6/12,26.88%,EPHA4;CERS2;STK24;RTN4RL1;PTPRS;GRN
prerank,regulation of proteolysis (GO:0030162),0.2858185821757863,0.815077588943123,0.7283236994219653,0.9624128692667854,1.0,14/48,23.76%,TM4SF20;ASPH;TRAF3;BTRC;BAD;AURKAIP1;IST1;SPOP;PLAUR;STUB1;HDAC2;CLN6;PLAT;HDAC6
prerank,histone lysine demethylation (GO:0070076),0.32413695088119227,0.814881427142555,0.734640522875817,0.9623088149511693,1.0,6/25,15.96%,KDM4D;HR;KDM3B;RIOX2;KDM8;KDM7A
prerank,mitotic spindle organization (GO:0007052),0.2633717383332025,0.8145408129745509,0.8466257668711656,0.962446084421943,1.0,27/153,14.71%,NUP37;CHEK2;MECP2;SBDS;B9D2;DYNC1H1;KPNB1;KIF2C;WRAP73;DYNC1LI2;KIF3B;EFHC2;MAPRE1;STAG1;NEK9;CENPN;SUN2;ARHGEF10;NEK6;TOGARAM2;DYNLL1;CCDC61;AHCTF1;PIBF1;MAP4;MIS12;KIF2A
prerank,nucleotide-excision repair (GO:0006289),0.26707047035734743,0.8143911248394609,0.7987421383647799,0.9622792033677812,1.0,14/101,9.89%,POLR2G;UVSSA;POLD4;CHD1L;RFC4;POLB;RFC1;BRIP1;ERCC4;RBX1;POLK;POLR2K;MNAT1;COPS7B
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.27680699924754276,0.8143486544207865,0.7876787678767877,0.9619277707578465,1.0,14/69,18.19%,IRS1;PIK3CD;PLCB4;LTK;PLCB3;PI4KB;ZFP36L1;PLEKHA1;HTR2A;PIK3CB;IRS2;NYAP2;PLCE1;NF1
prerank,cellular response to estradiol stimulus (GO:0071392),0.33304193426391454,0.813582144892511,0.7161803713527851,0.9627114028595266,1.0,6/18,23.52%,CRHBP;LCOR;CCDC62;NRIP1;RUVBL2;KAT5
prerank,cell projection assembly (GO:0030031),0.32482810179227123,0.8129113941872281,0.7146596858638743,0.9634188807064346,1.0,8/22,23.57%,PARVB;CYFIP1;RHOJ;GSN;RAC1;NCKAP1;RHOH;PARVG
prerank,adherens junction organization (GO:0034332),0.29413530186359876,0.8125180984514214,0.7811059907834101,0.9636356049282623,1.0,11/48,18.14%,CDH13;NECTIN4;CTNNB1;CDH9;NECTIN3;PIP5K1C;ACTB;TBCD;JAM3;CSK;CADM2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2892507738650408,0.8122047526860312,0.751412429378531,0.9637562478897267,1.0,20/52,26.59%,ZFP36;CNOT4;CNOT7;TNKS1BP1;DCP2;EXOSC9;PATL2;NT5C3B;TUT7;HBS1L;DCPS;LSM5;PAN3;RC3H2;EXOSC4;LSM4;PDE12;DCP1B;CNOT3;CNOT2
prerank,vesicle transport along microtubule (GO:0047496),0.31977102004075164,0.8119339182593646,0.74375,0.9638048976422745,1.0,4/23,6.83%,FYCO1;DYNC1H1;TRAK1;KIF3B
prerank,triglyceride metabolic process (GO:0006641),-0.2119004295168312,-0.8117212227976186,0.8403361344537815,0.9957905332981246,1.0,13/48,22.84%,PLAAT3;MOGAT3;LIPH;DGAT1;SIRT1;SEL1L;GPAM;LPL;GK5;FABP4;CAV1;GPAT4;GPAT3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.31919204697218173,0.8116719830441681,0.7222222222222222,0.9638130038422247,1.0,2/24,4.58%,SLC27A1;PLA2G12A
prerank,neurotransmitter uptake (GO:0001504),0.3759061009434121,0.8113730835198214,0.7180616740088106,0.9638768225020536,1.0,1/12,3.41%,SLC38A1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.29908282805832304,0.8113557452130719,0.7417452830188679,0.9634858857249551,1.0,2/39,2.63%,KDR;CD40
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2769270501798491,0.8111338141381094,0.7734806629834254,0.963448886962746,1.0,15/67,18.36%,TRPM2;TBC1D1;GAP43;RABEP2;PODXL;TBC1D8;CYLD;P2RX4;CAPZB;DYNC2LI1;DYNLT2B;RAC1;TBC1D2;DCDC2;ABITRAM
prerank,positive regulation of wound healing (GO:0090303),0.29981509275071866,0.8108147798472565,0.7283511269276394,0.9635414734872834,1.0,7/36,16.32%,SMOC2;KANK1;HPSE;XBP1;PRKCE;RREB1;MTOR
prerank,protein-DNA complex disassembly (GO:0032986),0.34605126277729203,0.8106165911036467,0.71875,0.9634466870457693,1.0,4/16,8.42%,ARID1A;SMARCE1;SMARCC2;ARID2
prerank,small GTPase mediated signal transduction (GO:0007264),0.26728638980839675,0.8105794826980315,0.8140495867768595,0.9630826761021114,1.0,38/103,26.69%,USP50;RHEBL1;RRAGC;RAPGEF6;RAPGEF2;CCDC88A;ABR;DNMT1;MAPK14;G3BP2;HACD3;RIN2;SOS1;RB1;TIAM2;ARHGAP30;RAC1;RREB1;BCR;RUNDC3A;PLCE1;NF1;ARHGAP18;ARHGAP31;RIT1;G3BP1;USP8;RHEB;FGF2;ARHGAP1;RGL2;TRIM28;CDKN2A;SHC1;CHP1;PLD2;RERG;TIAM1
prerank,neuromuscular process (GO:0050905),-0.27038579378603916,-0.8105477248881912,0.7402135231316725,0.996443838687852,1.0,3/16,8.56%,UBA5;AGTPBP1;NRXN1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3250106749434549,0.8104605753441784,0.7323037323037324,0.9628683374915176,1.0,8/24,24.63%,ACTR2;CYFIP1;ACTR3;RAC1;PLCE1;NCKAP1;BRK1;PIK3CA
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2968520417587157,0.8104487494462891,0.7393364928909952,0.9624706069082218,1.0,10/41,20.35%,NUP37;SLC2A6;NUP153;RAE1;PRKAG1;EIF6;NUP155;NUP88;NUP133;NUP43
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.28484903476766066,0.8101918326623321,0.7693156732891833,0.9624861997312235,1.0,14/60,19.01%,HSP90AB1;RFC4;POLG2;CTNNB1;CCT4;CCT7;SMOC2;CCT3;HNRNPA1;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,regulation of protein catabolic process (GO:0042176),0.2663763575082241,0.8098034864356601,0.7824267782426778,0.9627038432129239,1.0,35/99,27.46%,WNT5A;AZIN2;CHEK2;MAD2L2;EGLN2;RILP;AREL1;TMEM9;AGAP2;DACT1;BARD1;AZIN1;SORL1;SMURF1;VPS28;HGS;TIPARP;WWP1;WDR91;PIN1;HUWE1;SMURF2;IDE;HMGCR;VCP;AXIN1;SNX12;FLNA;SIRT2;TNF;SEC22B;SNF8;FMN2;MAD2L1;HECW2
prerank,long-chain fatty acid import into cell (GO:0044539),0.38215735889949765,0.8095516285159621,0.6900149031296572,0.9627050186388183,1.0,1/10,2.36%,SLC27A1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.27501085746290344,0.8093702217728811,0.7916666666666666,0.9626004826655553,1.0,17/72,18.10%,CLU;PFDN5;MAPRE1;KANK1;SSH3;HSPA8;SPEF1;CIB1;ATXN7;PFDN4;APOE;FGF13;PLEKHH2;TBCD;STMN2;CAMSAP2;LDLR
prerank,peptidyl-lysine dimethylation (GO:0018027),0.33621868511138314,0.8092337816400859,0.7156208277703605,0.9623973011182472,1.0,6/18,22.77%,KMT2A;SETD3;ASH1L;SMYD2;SETD7;KMT2D
prerank,endothelial cell development (GO:0001885),0.3160121057366163,0.8082184104363261,0.7291399229781772,0.9636054354136114,1.0,5/25,17.72%,COL22A1;RAPGEF2;MET;RAPGEF1;COL15A1
prerank,cAMP metabolic process (GO:0046058),0.3562696288677503,0.8081856021452003,0.7158931082981715,0.9632488273917036,1.0,2/13,6.17%,ADCY5;ADCY10
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.2867995291909409,-0.8078923641443574,0.742671009771987,0.9998467605728143,1.0,3/13,10.02%,TGFB1;BMP6;NUP93
prerank,lysosome localization (GO:0032418),0.2964361506419066,0.8075491653108487,0.7401197604790419,0.9638431437393367,1.0,11/37,25.55%,PIK3CD;VPS33A;DEF8;PLEKHM2;SPAG9;KLC2;MYH9;S100A13;HDAC6;KXD1;RAB3A
prerank,regulation of mRNA polyadenylation (GO:1900363),0.33470831473208607,0.8074750616112265,0.7238493723849372,0.96354639887916,1.0,6/17,23.18%,RNF40;NCBP2;NCBP1;ZC3H3;CDK9;ZC3H14
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3312652379019003,0.80710915334937,0.723404255319149,0.9637243763079114,1.0,5/19,19.00%,XRN1;DCP2;HNRNPA1;STN1;TERF2
prerank,DNA catabolic process (GO:0006308),0.3714601566154689,0.806897911948303,0.7018813314037626,0.9636400172546281,1.0,1/11,2.26%,XRN2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.31418569436964033,0.8068420985392614,0.7420584498094028,0.9633234511730631,1.0,8/27,21.96%,SMOC2;BMPR2;SMG5;HMBOX1;DACH1;TERF2;ACVRL1;FGF2
prerank,L-glutamate transmembrane transport (GO:0015813),0.38554457046445173,0.8066886492422288,0.7249240121580547,0.9631487095755203,1.0,1/10,0.81%,SLC25A22
prerank,negative regulation of coagulation (GO:0050819),-0.29026554716534547,-0.8063627371486821,0.6959459459459459,1.0,1.0,8/14,40.09%,VTN;HS3ST5;THBD;CD34;PROCR;APOH;ADTRP;TFPI
prerank,sphingolipid catabolic process (GO:0030149),-0.28375946296277954,-0.8062598856253146,0.7323420074349443,0.9996196085872838,1.0,7/15,25.44%,PDXDC1;SMPDL3A;ASAH1;ACER2;SMPD1;SMPD2;PPT1
prerank,synaptic vesicle localization (GO:0097479),0.3619172076601089,0.8062437517046663,0.7115117891816921,0.9634563956963338,1.0,2/13,10.62%,SYNJ1;DNM2
prerank,positive regulation of viral transcription (GO:0050434),0.31711801266542966,0.8060090823193935,0.7371134020618557,0.9634227462137197,1.0,4/25,9.31%,POLR2G;DHX9;MDFIC;POLR2K
prerank,regulation of protein neddylation (GO:2000434),0.38741753708759324,0.8058193840203082,0.7162576687116564,0.9633024938276495,1.0,6/10,28.71%,DCUN1D4;RPL11;RPL5;DCUN1D5;EPAS1;DCUN1D1
prerank,odontogenesis (GO:0042476),0.3005248864476785,0.8058143691408437,0.7339782345828295,0.9628954193786208,1.0,2/35,5.99%,PITX2;FGFR2
prerank,negative regulation of synaptic transmission (GO:0050805),0.3236442274590612,0.8056612259499365,0.7535483870967742,0.9627087485649947,1.0,2/23,5.28%,GRIK3;SLC30A1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.30755046754624815,0.8055852357131212,0.72090112640801,0.9624137649086723,1.0,2/27,3.41%,SLC25A22;SLC38A1
prerank,defense response to tumor cell (GO:0002357),-0.3223316280061378,-0.8051596141016181,0.7142857142857143,1.0,1.0,4/10,16.44%,DAPK1;RBMS3;ABI3;KLF4
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.24314788654548786,-0.805049947382935,0.8165938864628821,0.9985661525600045,1.0,8/23,20.27%,ZFYVE19;NABP1;NABP2;BUB1;PLK2;CDK5RAP3;VPS4A;SETMAR
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3190484078314298,0.804487548672577,0.733502538071066,0.9637794241666516,1.0,8/25,19.72%,HTATSF1;CCNT2;SETD5;LDB1;WDR43;DDX39B;CCNK;KAT7
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.3664168683836571,0.8043972953947848,0.7128712871287128,0.9631033185238242,1.0,3/12,14.16%,CHERP;CIB1;SPPL3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.3664168683836571,0.8043972953947848,0.7128712871287128,0.9631033185238242,1.0,3/12,14.16%,CHERP;CIB1;SPPL3
prerank,organophosphate catabolic process (GO:0046434),0.3680632705237852,0.8042487452512544,0.7094890510948905,0.9629229746173963,1.0,1/11,5.65%,PDXP
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.28897645200223226,-0.8041207871619717,0.7455830388692579,0.998721316217165,1.0,4/14,11.13%,CMPK1;NMNAT2;PNP;ME1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.37868812379257916,0.8039995621767082,0.7021604938271605,0.9629029987648653,1.0,4/10,19.66%,RTEL1;DCLRE1A;TERF2;DCLRE1C
prerank,iron-sulfur cluster assembly (GO:0016226),0.3150444537011746,0.8038636384435052,0.7386363636363636,0.9627044333737167,1.0,4/24,9.03%,HSCB;FXN;NFU1;NFS1
prerank,actin-myosin filament sliding (GO:0033275),0.2925223007498295,0.8038549589015859,0.7449101796407186,0.9618929931033174,1.0,6/38,20.13%,ACTN2;TNNC1;MYL1;MYH2;TNNI2;TPM3
prerank,muscle filament sliding (GO:0030049),0.2925223007498295,0.8038549589015859,0.7449101796407186,0.9618929931033174,1.0,6/38,20.13%,ACTN2;TNNC1;MYL1;MYH2;TNNI2;TPM3
prerank,phosphate ion transport (GO:0006817),0.33796698246252943,0.803502567224992,0.7120567375886525,0.9620583013160369,1.0,5/16,22.93%,SLC25A10;SLC37A2;SLC20A2;SLC37A1;SLC25A30
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.289919296582672,0.8034684057920515,0.763953488372093,0.9617001369908768,1.0,5/47,10.58%,AGT;XDH;DHRS4;MAPK14;ZC3H12A
prerank,phosphatidic acid metabolic process (GO:0046473),0.2850590503895969,0.8034378259018201,0.7562929061784897,0.9613388513850248,1.0,6/48,9.83%,SLC27A1;PLA2G12A;AGPAT5;ABHD8;GNPAT;DGKB
prerank,glycolipid biosynthetic process (GO:0009247),0.2962555655751849,0.8032842508103718,0.7413173652694611,0.9611808613815813,1.0,9/38,19.28%,PIGW;GBGT1;PIGV;SCCPDH;PGAP2;ST8SIA1;PIGQ;PIGB;PGAP3
prerank,regulation of microtubule depolymerization (GO:0031114),0.311750496026523,0.8030910770592851,0.7247119078104993,0.9610709489770148,1.0,8/25,19.02%,SPEF1;CIB1;ATXN7;TRPV4;FGF13;STMN2;CAMSAP2;MAP1B
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3226011843623547,0.8026598813885789,0.7301587301587301,0.9613492147840719,1.0,6/21,20.24%,DUSP3;LST1;FCGR2B;PIBF1;PAG1;TNFAIP8L2
prerank,negative regulation of signaling (GO:0023057),0.31833204264449977,0.8025117968255647,0.7144686299615877,0.9611730317056355,1.0,3/25,8.86%,ACVR1;KIF26A;SOCS5
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3304453772258923,-0.802156322088749,0.6770538243626062,1.0,1.0,3/10,5.39%,NINL;KIF3A;PCM1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.37669316665182895,0.8016775132580346,0.7223042836041359,0.9621239205709625,1.0,2/10,10.82%,KLF15;SETD5
prerank,intestinal absorption (GO:0050892),0.35977412489946997,0.8015260876795589,0.749266862170088,0.961955676733088,1.0,2/13,12.29%,SLC46A1;TJP2
prerank,histone methylation (GO:0016571),0.30741113681195553,0.8014769316958396,0.754320987654321,0.9616218429516427,1.0,7/26,19.50%,PRMT2;NTMT1;NSD3;EZH2;PRMT1;SMYD1;SMYD2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3075220155264227,-0.8013337339463592,0.7282229965156795,1.0,1.0,3/13,16.84%,ABCA2;ALG10B;GOLGA2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.33933299155811825,0.8011247106651379,0.7344398340248963,0.9617852817099216,1.0,3/16,14.77%,ATP5MC1;DMAC2L;ATP5PO
prerank,DNA conformation change (GO:0071103),0.3376050484690626,0.8010319884504657,0.7222222222222222,0.9615119812507297,1.0,4/17,14.70%,PRM1;HMGB1;HMGB3;TOP1MT
prerank,spindle assembly (GO:0051225),0.27652104382815595,0.8009260660450055,0.7882096069868996,0.9612696287618091,1.0,25/67,26.57%,CHEK2;GOLGA8B;KPNB1;WRAP73;KIF3B;MAPRE1;STAG1;ARHGEF10;NEK6;TOGARAM2;CCDC61;PIBF1;KIF2A;RAB11A;NUMA1;NEK7;STARD9;HAUS3;MAPRE3;FLNA;CEP192;HAUS6;MAPRE2;ABRAXAS2;TUBGCP5
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3124665147059936,-0.8003550294114574,0.7284345047923323,1.0,1.0,3/10,16.10%,PDE3B;NEXMIF;ACER2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.2862859195708193,0.8003159510375163,0.7773892773892774,0.9617988779643432,1.0,18/43,31.13%,ACVR1;ZHX3;WNT7B;BMPR2;NELL1;BMPR1A;ACVR2A;DDR2;FERMT2;IL6R;ATRAID;FBXO5;IL6ST;LRP5;WWTR1;PRKD1;CCN1;IGF1
prerank,cellular response to sterol (GO:0036315),0.35811191402874715,0.7998924635043414,0.7190201729106628,0.9620148172135747,1.0,5/13,15.37%,OSBPL7;MLC1;RORA;PTCH1;GRAMD1C
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.311888183416972,0.7997694916998869,0.7430379746835443,0.9618066446975364,1.0,6/27,15.61%,SKP1;MAP3K8;NFKB1;BTRC;TNIP2;TAOK2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3114342752374398,0.7993711107715034,0.7477820025348543,0.9620245265691921,1.0,11/29,27.53%,RBBP5;CTNNB1;TCF7L2;MEN1;PYGO1;HDAC1;KMT2D;KAT5;RUVBL1;EP300;CDC73
prerank,nucleotide metabolic process (GO:0009117),0.32238439840696975,0.7992165678503087,0.7284595300261096,0.961854413726834,1.0,6/23,15.34%,ENPP3;DCK;NUDT5;CMPK2;AK4;RNASEH2B
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.284254390588728,0.7992120573138163,0.7786790266512167,0.961456794235477,1.0,11/51,18.19%,LRP2;FBN1;BAMBI;BMPER;BMPR2;SKIL;SORL1;SMURF1;BMPR1A;HTRA3;ACVR2A
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3772031225029391,0.7991677637060124,0.7048458149779736,0.961108000381334,1.0,1/10,4.38%,THAP4
prerank,neuropeptide signaling pathway (GO:0007218),0.28067418400473854,0.7990798338267074,0.7748868778280543,0.9608441082272523,1.0,6/58,11.65%,GAL;GPR37;RAPGEF2;GLRA2;GALR1;SORL1
prerank,central nervous system development (GO:0007417),0.25310450811445034,0.7987924316028289,0.8931451612903226,0.9608800470783617,1.0,49/250,19.95%,CXCR4;PLXNB2;GRIN2D;STAT3;ECRG4;CHD7;PAFAH1B3;ANKLE2;SH3GL1;SYNJ1;PHGDH;CIC;SOX9;PITPNM1;UBE3A;TBC1D23;MEIS3;CDK5RAP2;EIF2B2;NFIB;JRKL;BPTF;PROX1;DHX30;DNAJC30;SCYL2;GSN;DDIT4;HPCAL4;PTPN11;ATXN1;PTCH1;SMARCA1;CTNS;DNER;POU6F1;RNF103;NHEJ1;DSCAML1;NDUFS4;DHX37;VIT;NF1;WWP1;EIF2B5;GBA2;UTP3;NCKAP1;POU3F3
prerank,regulation of rRNA processing (GO:2000232),0.34292607113772106,0.7986662418209646,0.7347222222222223,0.9606759464214474,1.0,7/16,23.97%,YTHDF2;DIMT1;WDR43;NUDT16;BUD23;UTP15;KAT2B
prerank,neural crest cell differentiation (GO:0014033),0.3341077387168002,0.798635161705415,0.7385019710906702,0.9603161850044453,1.0,3/18,8.34%,TCOF1;SNAI2;NOLC1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3204383650381344,0.7983911503919554,0.7401273885350318,0.9599013425758408,1.0,4/24,10.61%,TPI1;PFKM;HK1;FOXK1
prerank,canonical glycolysis (GO:0061621),0.3204383650381344,0.7983911503919554,0.7401273885350318,0.9599013425758408,1.0,4/24,10.61%,TPI1;PFKM;HK1;FOXK1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3261110580242285,0.7982752163089181,0.7347767253044655,0.9596886715983222,1.0,7/18,25.49%,RNF5;AMFR;RNF185;RNF103;TRIM13;EDEM2;DERL2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.29699829148016577,-0.7981562576405695,0.7651006711409396,1.0,1.0,6/12,33.77%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,N-glycan processing (GO:0006491),0.33534542296021164,0.7978190714442241,0.7180192572214581,0.9599738351893028,1.0,5/18,17.84%,GNPTAB;MAN1A2;GANC;ST8SIA1;MAN1C1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.24727762640750162,-0.7978071979691451,0.7983193277310925,1.0,1.0,3/22,13.73%,ATP1B1;HTT;GSTO1
prerank,embryonic axis specification (GO:0000578),0.3539221805322602,0.7977421689110921,0.7309941520467836,0.9596888576468836,1.0,5/15,22.89%,SMAD2;CXXC4;PTCH1;TASOR;RIPPLY2
prerank,amide biosynthetic process (GO:0043604),0.28301885570286217,0.7976482332691095,0.7744982290436836,0.9594113210515309,1.0,4/47,6.18%,NMRAL1;ASAH2;CERS6;DEGS1
prerank,cellular protein metabolic process (GO:0044267),0.24755815957160895,0.7967918037070358,0.946,0.9603278931136705,1.0,88/396,22.31%,LIPT1;LOXL2;UBE2L6;PNPLA2;MRPL36;IGF2BP3;AGO2;CHEK2;RCN1;USP25;RPL36;SERPINC1;HARS2;LAMC1;LAMB2;RNF5;GSPT1;RAB12;RPL22;TNC;EIF4EBP2;RPS21;UBE2M;CSF1;NAGPA;FBN1;SEPHS1;CTSH;MXRA8;APP;PAPPA;MEN1;ST3GAL1;SPCS1;TNIP1;MRPL42;PDIA6;ABCF1;PSEN1;APOE;PPP4R2;PRKDC;UBE2L3;KTN1;GGCX;RPS6;NAPSA;RPN1;SPPL3;APH1A;RPS11;FAM20C;RPL30;MRPL24;APH1B;RPL32;RPL23A;MSRA;RPL11;YARS2;RPL10A;SPARCL1;CSF2RA;RPS15A;MRPL13;HBS1L;SRBD1;HM13;RSL24D1;RPL24;RPL37A;SERP1;RPL3;MRPS11;UBL5;ERO1A;RRBP1;APLP2;RPL29;YES1;RPL5;MSRB1;FARSB;ABL2;RPL6;HSP90B1;IDE;MMP15
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2536937729378665,0.7967569409530283,0.8721047331319235,0.9599614530755859,1.0,45/198,21.76%,PIK3CD;PLCB4;ITPKC;STAT3;SYNJ1;ENPP3;PGM2L1;DUSP3;PFKM;PDXP;PPIP5K1;NUDT5;GFPT1;ITPK1;NADK;PLCB3;HK1;CERKL;SPHK2;DUSP28;BCKDK;EPHX2;DUSP10;ENPP1;PIK3CB;INPP4B;DUSP16;PANK2;INPP5K;MTOR;OCRL;NUDT4;PTPRC;PLCE1;DUSP8;PPA1;MINPP1;PTPRB;PLA2G4E;GPX4;PI4KA;LHPP;TNFAIP8L3;PLPP2;ALDOC
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3132945497263892,0.7967143658101821,0.7477931904161412,0.9596312774734431,1.0,2/25,3.85%,PER2;MAD2L2
prerank,neuron development (GO:0048666),0.2569058165975831,0.7965315495652353,0.8531827515400411,0.9595119467307,1.0,38/141,24.79%,BLOC1S4;RUNX1;PPP1R9A;TBC1D23;SRF;MYOC;SAMD14;STMN4;RAPGEF2;LYN;GDNF;B4GALT5;APP;HMGB1;STMN3;XBP1;APOE;RB1;MAP4;LRP12;TBCD;PRMT1;RAB11A;OPHN1;STMN2;HS6ST1;DTNBP1;GBA2;PLP1;LGI1;TENM4;UNC5A;CDK16;ZFYVE27;PTPRM;SH3GL2;TENM1;PBX4
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2877041087344738,0.7963123917649807,0.7926689576174112,0.9594742872309673,1.0,13/51,19.01%,XRN1;CTNNB1;DCP2;CCT4;CCT7;CCT3;SMG5;HNRNPA1;STN1;MAP3K4;HMBOX1;TERF2;NEK7
prerank,mitochondrion distribution (GO:0048311),-0.3081682188915633,-0.7962857681314922,0.7,1.0,1.0,5/12,21.18%,TRAK2;ATCAY;ARMC1;MTM1;MSTO1
prerank,epidermis development (GO:0008544),0.27666613527310296,0.7962228386039689,0.7835648148148148,0.9591988101961028,1.0,2/56,5.99%,EDAR;FGFR2
prerank,androgen metabolic process (GO:0008209),0.3329079541980285,0.7962065141117958,0.7537619699042407,0.9588150367936668,1.0,1/18,3.58%,HSD17B7
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.3204114735214187,-0.7957739783221544,0.7032640949554896,1.0,1.0,2/10,11.07%,IFT88;WHRN
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.33455578313194023,0.7957008808616161,0.7295081967213115,0.9591994080545033,1.0,3/16,16.21%,NAA50;NAA35;NAA25
prerank,protein localization to kinetochore (GO:0034501),-0.29333273909546376,-0.7956057777681631,0.7465277777777778,1.0,1.0,8/14,31.62%,RCC2;MTBP;KNL1;SPDL1;BUB3;CDK1;AURKB;TTK
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.258192367985068,0.7954738431109702,0.8587512794268168,0.9591353616392015,1.0,36/140,20.41%,TAGAP;RHOF;SYDE1;RHOJ;ARHGEF7;ARHGAP4;ABR;SYDE2;VAV1;STARD8;ARHGAP25;ARHGEF11;SRGAP2;SRGAP3;SOS1;ARHGAP21;ARHGAP10;CHN1;ARHGAP11A;AKAP13;TIAM2;ARHGAP39;ARHGAP30;RAC1;SH3BP1;OPHN1;OCRL;BCR;PLCE1;ARHGAP29;RHOT2;ARAP1;ARHGAP24;ARHGAP18;TGM2;ARHGAP31
prerank,cellular response to oxidative stress (GO:0034599),0.2604402733529467,0.7953510862989955,0.837696335078534,0.9589229107528034,1.0,20/118,16.91%,HSPA1B;TMEM161A;PNPT1;SOD2;CYBB;SRXN1;MT3;PPIA;GSR;ZC3H12A;LONP1;PPARGC1A;STX4;EIF2S1;PRDX2;ERCC6L2;ADNP2;MSRA;AIF1;CHCHD2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3599221111016736,0.7952887748122524,0.7020958083832335,0.9586267442569587,1.0,4/12,25.44%,THY1;LCK;GCNT2;TNF
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.33589810214622706,0.7952024767007669,0.7272727272727273,0.9583708599481396,1.0,6/18,21.86%,ZC3H11A;DDX19B;ENY2;DDX19A;NUP133;MCM3AP
prerank,regulation of protein kinase activity (GO:0045859),0.26176841633134657,0.7948881164101107,0.8247639034627492,0.9584656499323341,1.0,25/106,19.25%,TRIB3;DAXX;LCP2;THY1;TARBP2;CACUL1;TRAF4;MAP2K3;CSF1;AGAP2;PPIA;RAPGEF2;PRKAG1;SNX9;PPM1F;AKT1S1;RB1;INPP5K;PTPRC;PLCE1;NF1;DTNBP1;SPRED1;UVRAG;CAMKK2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.29061160374412354,0.7940431989727559,0.7603911980440098,0.9593603518102166,1.0,10/37,18.43%,KIF3C;KIF3B;WDR35;IFT27;CEP131;DYNC2LI1;DYNLL1;WDR19;DYNC2H1;IFT46
prerank,protein palmitoylation (GO:0018345),0.3034224314219956,0.7939350634425877,0.7428924598269468,0.9591133200936429,1.0,12/30,27.23%,GOLGA7;ZDHHC21;ZDHHC20;HHAT;ZDHHC13;ZDHHC8;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;ZDHHC16;ZDHHC7
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3656555075489227,0.7938322481687595,0.7218045112781954,0.9584760611179236,1.0,3/11,16.96%,SYNJ1;INPP5K;OCRL
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3656555075489227,0.7938322481687595,0.7218045112781954,0.9584760611179236,1.0,3/11,16.96%,SYNJ1;INPP5K;OCRL
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2626409551517028,0.7937186003626409,0.8481675392670157,0.9582393787709789,1.0,23/95,18.83%,CENPJ;B9D2;CEP162;DYNC1H1;ACTR1A;MAPRE1;CDK5RAP2;PRKAR2B;MKS1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;HSP90AA1;TMEM67;TUBB4B;RAB11A;CEP89;DCTN3;PAFAH1B1;CEP135
prerank,negative regulation of protein polymerization (GO:0032272),-0.23401899298659457,-0.7937154607949495,0.8109452736318408,1.0,1.0,4/27,7.55%,SSH2;DYRK1A;TUBB4A;SNCA
prerank,negative regulation of interleukin-1 production (GO:0032692),0.31911837529843523,0.7936284570521095,0.7442455242966752,0.9579701218814412,1.0,3/23,10.58%,CX3CL1;GIT1;ZC3H12A
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3316142565663594,0.7935236053331692,0.7275242047026279,0.9577254500038128,1.0,5/18,23.50%,BDNF;XBP1;HDAC1;NOTCH1;HDAC4
prerank,activation of adenylate cyclase activity (GO:0007190),0.29245618948048074,0.79303318418169,0.7611580217129071,0.9580695621848789,1.0,3/35,7.02%,RXFP2;ADCY5;TMIGD3
prerank,anion transport (GO:0006820),0.30480233726279526,0.792902483449896,0.7544696066746126,0.9578733119092036,1.0,9/33,25.51%,SLC19A1;SLCO1B1;TSPO;SLC13A4;SLC4A2;ABCG2;VDAC2;SLC26A7;SLC17A5
prerank,RNA biosynthetic process (GO:0032774),-0.22653398100675623,-0.7925117601625363,0.8031914893617021,1.0,1.0,7/31,18.76%,TAF12;TBP;TTF1;PRMT5;TAF5;TAF10;POLR2A
prerank,chondrocyte differentiation (GO:0002062),0.3095792653089683,0.7924909552583417,0.7762998790810157,0.9581151448445029,1.0,9/32,18.96%,RUNX1;SOX9;SNX19;NFIB;SCX;BMPR2;SOX5;FGFR3;CREB3L2
prerank,peptidyl-proline modification (GO:0018208),-0.23775724012447588,-0.7922540358874575,0.7901234567901234,1.0,1.0,4/25,6.61%,P3H2;PPIL3;FKBP4;PPIL2
prerank,acidic amino acid transport (GO:0015800),0.3364156567880624,0.7917112911835219,0.7270233196159122,0.9589127503145504,1.0,1/17,0.81%,SLC25A22
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3099868454066283,0.7915254002303699,0.76375,0.9587968631550741,1.0,5/26,14.36%,PTGER4;CX3CL1;SYNPO;RAC1;ASAP3
prerank,ganglioside metabolic process (GO:0001573),0.3251268518231605,0.7914004195737409,0.7554697554697555,0.9585847173942988,1.0,3/20,9.08%,ST6GALNAC4;ST6GALNAC6;NEU1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.286056421198708,0.7908123712262594,0.7564102564102564,0.9590808750221989,1.0,10/44,20.66%,PER2;OSBPL7;CH25H;OSBPL3;CYP27A1;OSBPL9;OSBP;EBP;OSBPL2;CYP39A1
prerank,glycine metabolic process (GO:0006544),0.3564244004042814,0.7907773775236687,0.7217391304347827,0.9587306541482989,1.0,3/12,15.03%,DLD;SHMT1;GCSH
prerank,acylglycerol biosynthetic process (GO:0046463),0.309658060354618,0.7906809807648927,0.7568988173455979,0.9584907680267089,1.0,7/23,23.89%,PNPLA2;LPIN2;LPGAT1;PLCE1;PNPLA3;ANG;AWAT2
prerank,regulation of histone deacetylation (GO:0031063),0.3533517764290106,0.7901031324556083,0.7361878453038674,0.9589779791226155,1.0,2/13,9.99%,CAMK2D;SPHK2
prerank,regulation of Golgi organization (GO:1903358),-0.2651442976104808,-0.7896793176370807,0.7620817843866171,1.0,1.0,4/17,9.91%,ARMH3;MAPK3;RAB33B;USP6NL
prerank,cellular transition metal ion homeostasis (GO:0046916),0.2640638636251978,0.7895557345754374,0.8232804232804233,0.9594062550150626,1.0,23/91,20.88%,SKP1;ATP6V0D1;FXN;SLC46A1;SLC30A1;SLC30A5;MT3;SLC11A2;CAND1;APP;PRNP;COX19;TFR2;SLC39A10;HMOX2;FBXL5;ATP6V1G1;ABCB7;FLVCR1;ABCG2;SLC31A1;LCK;SLC31A2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.35373015768046295,0.789208522329028,0.7307152875175316,0.959502787894221,1.0,2/12,6.84%,TMEM9;VPS33A
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2631913581558246,0.7890772023079282,0.8122977346278317,0.9592922199012113,1.0,18/78,17.36%,MMP14;STX7;ITGA3;STX8;LDLRAP1;RSC1A1;CIB1;PRKCE;VTI1B;DAB2;STX4;ACTB;DLG1;PRKCH;TMEM59;STAC3;PTPN9;ZDHHC8
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.28101270925343685,0.7885451850377281,0.7779083431257344,0.9597152368428148,1.0,9/43,20.15%,TAOK3;CHEK1;NOP53;TRIM39;RINT1;TAOK2;BABAM2;BRSK1;ORC1
prerank,outer dynein arm assembly (GO:0036158),0.34208229574567894,0.7883628198102296,0.7288135593220338,0.9595886465098553,1.0,3/15,16.34%,ODAD2;ODAD4;DNAL1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.31713195067277433,0.7882360301494303,0.7365728900255755,0.9593866495360028,1.0,6/22,18.86%,ANKLE2;CDKN2D;STAP1;DYNLL1;INPP5K;TESK1
prerank,negative regulation of cell aging (GO:0090344),-0.27019915365167263,-0.787785604247648,0.7683823529411765,1.0,1.0,4/16,14.76%,MAP3K3;SIRT1;HMGA2;MIF
prerank,inositol phosphate catabolic process (GO:0071545),0.35611582475389725,0.787538557355426,0.7325408618127786,0.9600317878979818,1.0,3/12,16.96%,SYNJ1;INPP5K;OCRL
prerank,signal peptide processing (GO:0006465),-0.29877844125679753,-0.7868307057682153,0.7254335260115607,1.0,1.0,3/11,13.32%,SEC11C;SPCS3;CLN5
prerank,purine ribonucleotide transport (GO:0015868),-0.27030199466739646,-0.786716962583772,0.7482517482517482,1.0,1.0,5/16,21.24%,SLC25A4;SLC17A9;SLC35B2;SLC25A42;LRRC8A
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3165873475274343,0.7863269496584999,0.7493368700265252,0.961448806212138,1.0,6/21,17.49%,SPEF1;CIB1;ATXN7;FGF13;STMN2;CAMSAP2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.3555327173844813,0.7861391934572745,0.728021978021978,0.9613062889097975,1.0,5/12,19.56%,PRNP;TMED10;APOE;FLOT2;RANBP9
prerank,glycerophospholipid metabolic process (GO:0006650),0.2681636787736464,0.7860351264701997,0.8075268817204301,0.9610593485073411,1.0,16/75,20.54%,PIGW;CPNE3;SYNJ1;PDXP;PIP5K1A;PIGV;PLCB3;PNPLA6;ABHD3;ENPP6;PAFAH1B1;PIGQ;PIGB;PLA2G4E;PNPLA3;PLA2G6
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.1962447425828151,-0.7850619669983518,0.9056603773584906,1.0,1.0,5/57,4.01%,ADCY9;GNAL;LPAR1;ADCY3;OPRM1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.36811770598292015,0.7850010598406251,0.7157584683357879,0.9621993988120591,1.0,2/10,14.77%,ATP5MC1;ATP5PO
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.26669254245756413,-0.7848992600631178,0.7619047619047619,1.0,1.0,8/17,23.11%,TGFB1;BIN1;ID2;TNFRSF1B;IL34;EGR2;PTPRZ1;CLCF1
prerank,cell junction assembly (GO:0034329),0.25893467213776655,0.7847730477194182,0.8411703239289446,0.9621162574757052,1.0,16/100,16.35%,SLITRK6;PCDHB13;BDNF;CDH9;SDK1;PCDHB16;TRPV4;LIMS1;ACTB;CTNND2;DNER;DBNL;SH3BP1;DSCAM;NLGN3;OPHN1
prerank,cellular response to light stimulus (GO:0071482),0.2682989006323093,0.7843044046351384,0.8011111111111111,0.962427951685579,1.0,7/66,10.61%,CNGB1;TMEM161A;DHX36;N4BP1;ERCC4;POLK;NPM1
prerank,ribosomal small subunit assembly (GO:0000028),0.33868314704368196,0.7840147624589123,0.7566807313642757,0.9624395889911415,1.0,2/16,4.05%,PWP2;ERAL1
prerank,glycogen metabolic process (GO:0005977),0.3072654828477728,0.7838971093899938,0.7632241813602015,0.9622122255534694,1.0,3/27,7.78%,PER2;PGM2L1;PGM1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.28297888152469447,0.7838152673098051,0.7847222222222222,0.9619339484389607,1.0,5/43,8.86%,SPRY2;TGFA;DUSP3;ARHGEF7;SOCS5
prerank,heart looping (GO:0001947),0.28545903402100503,0.7831925085116237,0.7569193742478941,0.9624607384118775,1.0,4/40,11.24%,CCDC40;NPHP3;SRF;SETDB2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.30926614936408203,-0.7831261089607747,0.7225609756097561,1.0,1.0,1/10,0.09%,DLGAP1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.32935642635510065,0.7829143642790019,0.7400530503978779,0.9624889476807508,1.0,4/18,10.73%,DCP2;CCT4;CCT7;CCT3
prerank,regulation of phospholipase C activity (GO:1900274),0.3412518448512654,0.7828667293460284,0.7465564738292011,0.9621606927978233,1.0,1/15,1.08%,FLT1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.23161608185235283,-0.7827065073732513,0.827906976744186,1.0,1.0,12/29,29.29%,SSH2;CORO1A;FKBP4;SHANK3;SMAD4;SSH1;CLASP1;SHANK1;KANK3;TJP1;KANK4;PRKN
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.2528487194225515,-0.7822606999354009,0.7838983050847458,1.0,1.0,5/21,8.69%,PPP1R8;CRY2;PPP1R16B;PTPA;GSK3B
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2846620729058803,0.781931534692091,0.7978971962616822,0.9631674614894056,1.0,10/38,19.65%,NDUFA5;NDUFB9;NDUFB11;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,positive regulation of vascular permeability (GO:0043117),-0.27955247972174363,-0.7816091307983227,0.7799352750809061,1.0,1.0,7/12,32.01%,TGFB1;BMP6;PDE2A;FGFBP3;TJP1;OCLN;TJP3
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3535456165001434,0.7813428795204381,0.7420749279538905,0.9636621890828646,1.0,1/13,6.12%,STX7
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.2689239492495991,-0.7808774114196255,0.7810457516339869,1.0,1.0,9/15,35.40%,ETV4;FOXC1;NME2;NCOA3;BMP4;SFRP4;SFN;TRIM16;SULT2B1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.26906827751990753,0.7808570200813814,0.7937915742793792,0.9639778866164567,1.0,13/62,16.93%,POLR2G;NCBP2;CDK12;CCNT2;ELP2;POLR2K;MNAT1;SSRP1;ELOC;MLLT3;NCBP1;CCNK;ELOF1
prerank,regulation of myoblast fusion (GO:1901739),0.3647037271789087,0.7805145602988615,0.7386861313868613,0.9640841205900137,1.0,3/11,19.38%,CFLAR;MAPK14;CD53
prerank,negative regulation of inflammatory response (GO:0050728),0.2491012151014569,0.7799354364622626,0.9002016129032258,0.9645803410592352,1.0,33/182,21.66%,CALCA;AOAH;RXFP2;ENPP3;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;RORA;GIT1;RHBDF2;APOE;CXCL17;RB1;SHARPIN;FYN;PPARD;ACOD1;MDK;PRKAR2A;MYH9;MFHAS1;ADCYAP1R1;SIRPA;TNFAIP8L2;YES1;GPR176;GIPR;PRKCD;VPS35
prerank,protein localization to membrane (GO:0072657),0.24780528341414107,0.779840759366986,0.9069767441860465,0.9643103986648738,1.0,60/187,26.55%,PIGW;RAB8B;ATP1B3;THY1;ACTN2;SEC16A;RAB12;TM9SF1;ANK1;SH3GLB1;PIP5K1A;MAGI2;RAPGEF6;RAB11B;RAPGEF2;EPB41L3;AGRN;TNIK;EFR3A;SMURF1;ARL5C;FGF13;PTCH1;NPC1;DLG1;NUP155;INPP5K;HGS;RAB11A;RAB32;WDR19;SH3PXD2B;FLOT2;ITGA4;RAP2A;LRRC4;TM9SF4;ZDHHC3;SAV1;RAB10;ZFYVE27;C2CD5;ZDHHC22;RABEP1;RAB29;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32;FERMT2;TM9SF2;LIN7C;RAB3D;ARL5A
prerank,regulation of smooth muscle cell migration (GO:0014910),0.3141303346620751,0.7794037933008432,0.7636849132176236,0.9645512462987214,1.0,4/20,15.34%,CCL5;SORL1;NRP1;BMPR1A
prerank,translation (GO:0006412),0.24828407602165098,0.7793192207282253,0.8996990972918756,0.964271199154962,1.0,47/208,19.04%,VARS1;MRPL36;IGF2BP3;AGO2;RARS1;RPL36;HARS2;IARS2;GSPT1;RPL22;EIF4EBP2;RPS21;MRPL16;AARS1;MRPS28;TUFM;ABCE1;TNIP1;MRPL42;ABCF1;IARS1;RPS6;NARS1;MRPS2;RPS11;RPL30;NOA1;MRPL24;ETF1;RPL32;RPL23A;RPL11;EEF1E1;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;RSL24D1;RPL24;MRPL57;RPL37A;PPA1;FASTKD2;RPL3;MRPS11
prerank,actin filament-based transport (GO:0099515),0.31246189290397364,0.7791870492484301,0.7580853816300129,0.9640641428790793,1.0,4/21,13.69%,MYO1C;FNBP1L;SUN2;MYO6
prerank,regulation of nervous system process (GO:0031644),-0.25540944001169913,-0.7790672195502896,0.8055555555555556,1.0,1.0,4/18,15.24%,DLGAP1;SLC8A3;CHRNA7;NPTX1
prerank,ethanol metabolic process (GO:0006067),-0.2969339745188174,-0.7785571791141057,0.7330960854092526,1.0,1.0,3/12,18.68%,ALDH2;ACSS1;SULT1A1
prerank,muscle tissue morphogenesis (GO:0060415),-0.26965233807697647,-0.7784183976007527,0.7758007117437722,1.0,1.0,7/16,35.04%,TGFBR3;ZFPM1;EFEMP2;BMP2;BMP4;HEY2;MYLK
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3193056760965543,0.7784023790767721,0.7456021650879567,0.9648143167910648,1.0,6/20,28.53%,CD40;GSN;ITGA4;PIAS4;ECSCR;PLCG1
prerank,prostaglandin metabolic process (GO:0006693),-0.22842345246581008,-0.7779522780908169,0.8578431372549019,1.0,1.0,9/26,27.77%,HPGD;PTGDS;PTGS1;MIF;PTGES;GSTM1;HPGDS;PTGIS;PRXL2B
prerank,organonitrogen compound catabolic process (GO:1901565),0.2717336565642032,0.7779192359473391,0.8060538116591929,0.9651256075188216,1.0,17/57,23.27%,SIAH1;LRSAM1;ERAP1;CPQ;LIPC;UCHL3;BCKDK;NPEPPS;MTOR;GADL1;SGPL1;PLA2G6;PNPLA8;IDE;TRHDE;TXN2;CLN6
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.27554436500501206,0.777475788858406,0.7886178861788617,0.9653747071699741,1.0,8/46,14.39%,PSME2;SOD2;HNRNPA2B1;PPIA;IL12RB2;HNRNPDL;JAK2;AIP
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.22465162833352786,-0.7774346881473528,0.8324324324324325,1.0,1.0,15/30,36.60%,LPAR1;ARRB1;PRAG1;ARHGEF3;F11R;NET1;F2R;ROBO1;LPAR6;GPR18;F2RL2;GPR65;RTN4R;GPR174;LPAR4
prerank,fatty acid transmembrane transport (GO:1902001),0.31602736552190647,0.7767945965551164,0.7436582109479306,0.9659558475481729,1.0,2/19,9.47%,SLC27A1;ABCD1
prerank,catecholamine metabolic process (GO:0006584),0.3410038481899097,0.7762446876399748,0.7549019607843137,0.9663875762216243,1.0,3/14,20.71%,DDC;COMT;RNF180
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.24521491564509157,0.7760437979952431,0.9428857715430862,0.9662618132678071,1.0,66/306,20.36%,EXT1;POLR2G;MCM2;MRPL36;TIMELESS;IGF2BP3;AGO2;POLE2;RPL36;HARS2;MCM7;CHEK1;TIPIN;RNASEH2A;GSPT1;MCM4;RFC4;RPL22;RRAGC;EIF4EBP2;RPS21;MCM9;BRIP1;FEN1;TUFM;B4GALT5;BARD1;SCX;POLR2K;PTMS;TNIP1;RNPS1;MRPL42;ABCF1;APOE;ORC3;TAF1B;RPS6;RPS11;TOP1MT;RPL30;RMI1;MRPL24;RECQL5;RPL32;MEF2A;RPL23A;RPL11;UPF1;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;FUT9;RSL24D1;RPL24;RPL37A;RPL3;MRPS11;SET;KAT7;RRBP1;ORC1;ATRIP
prerank,negative regulation of protein kinase activity (GO:0006469),0.2592136702220908,0.7754184192692622,0.8380952380952381,0.966785810282436,1.0,22/88,19.25%,TRIB3;ADAR;THY1;SLC8A1;TARBP2;DUSP3;PPIA;DUSP26;PPM1F;NPM1;SORL1;AKT1S1;DUSP10;RB1;INPP5K;PTPRC;CORO1C;NF1;DTNBP1;SPRED1;TESK1;PTPRB
prerank,protein deacetylation (GO:0006476),0.27885403148112986,0.7753020904458364,0.7957244655581948,0.9665545024362412,1.0,12/41,25.29%,RBM14;MTA3;MTA2;SIRT6;MIER1;RCOR3;HDAC1;HDAC2;HDAC4;HDAC6;FLNA;SIRT2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3055329881340162,0.7748298614379818,0.7744458930899609,0.9668518265694017,1.0,5/24,13.61%,XRN1;DCP2;ERCC4;HNRNPA1;STN1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.29045665274474936,0.7746948685709119,0.7767106842737095,0.9666585589869838,1.0,13/34,26.49%,PTPN18;DUSP3;PTPN11;DUSP10;DUSP16;PTPN9;DUSP8;PTPRB;PTPRF;PTPN6;PTPRS;PTPN1;DUSP7
prerank,apoptotic nuclear changes (GO:0030262),0.3051777638380583,0.7744500219915642,0.7571801566579635,0.9666197782340055,1.0,6/24,20.98%,KPNB1;HMGB1;DFFA;DNASE2;DICER1;BLCAP
prerank,membrane repolarization (GO:0086009),-0.26645909086645225,-0.7741896676677933,0.8013468013468014,1.0,1.0,3/15,10.51%,ATP1B1;ATP1B2;KCND3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.331149706655675,0.7738186221123301,0.7507042253521127,0.967133914444615,1.0,3/16,24.45%,CLDN10;CLDN11;CLDN12
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3212426787146329,0.7727645825886302,0.7699468085106383,0.9682397628422477,1.0,3/19,7.33%,FBXO7;FBXW7;CSNK2A2
prerank,microtubule bundle formation (GO:0001578),-0.20311722443636818,-0.7727147016340851,0.8909090909090909,1.0,1.0,7/42,9.41%,TTLL3;CLIP1;TPPP;NCKAP5L;MARK4;AAAS;MTCL1
prerank,regulation of protein kinase A signaling (GO:0010738),0.3173351423001368,0.772681300944854,0.7590673575129534,0.9679549932722519,1.0,4/20,17.08%,PRKAR2B;AKAP12;ADGRV1;PRKAR2A
prerank,covalent chromatin modification (GO:0016569),0.3435644869873451,0.7726116092347353,0.7545582047685835,0.967667170183269,1.0,7/14,26.73%,MBD2;MT3;SETD5;HDAC1;HLCS;HELLS;UFL1
prerank,positive regulation of cell cycle process (GO:0090068),0.2559916753227788,0.7724650816570006,0.8472075869336143,0.9675044353425418,1.0,15/91,15.54%,TGFA;CDC25B;PKN2;DYNC1H1;FEN1;XRCC3;INSR;UBXN2B;PHIP;DDX11;PRKCE;RANBP1;CEP295;GEN1;NUDT16
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2639698614497962,0.7723049682653118,0.8114663726571113,0.9673073492128135,1.0,13/64,16.93%,POLR2G;NCBP2;CDK12;CCNT2;ELP2;POLR2K;MNAT1;SSRP1;ELOC;MLLT3;NCBP1;CCNK;ELOF1
prerank,negative regulation of GTPase activity (GO:0034260),0.31159809798096993,0.7720182110603776,0.7706422018348624,0.9673119124375292,1.0,5/22,18.42%,RASA4;PLXNB3;LRCH1;RRP1B;CPEB2
prerank,P-body assembly (GO:0033962),-0.2927693255640916,-0.7715162414791762,0.7455621301775148,1.0,1.0,2/12,4.15%,PATL1;DDX6
prerank,regulation of glucose transmembrane transport (GO:0010827),0.320771229519805,0.7707773859247117,0.7459893048128342,0.9687254904931432,1.0,3/18,14.95%,TRIB3;RSC1A1;INPP5K
prerank,positive regulation of telomere capping (GO:1904355),-0.25965456214525395,-0.770569043950249,0.7905138339920948,1.0,1.0,4/17,12.53%,PRKCQ;MAPK3;PNKP;NABP2
prerank,positive regulation of secretion (GO:0051047),0.35864315805508296,0.7701914291788162,0.7823529411764706,0.9691444171551075,1.0,2/11,24.16%,XBP1;ACSL3
prerank,establishment of epithelial cell polarity (GO:0090162),-0.256191485089415,-0.7700961163830661,0.8178137651821862,1.0,1.0,5/19,13.10%,CDC42;CYTH1;MYO18A;GOLPH3;RHOA
prerank,arachidonic acid metabolic process (GO:0019369),-0.20855774680101818,-0.7699344241535079,0.8457142857142858,1.0,1.0,14/35,30.34%,PTGDS;PTGS1;MGLL;CYP2A6;FAAH;PTGES;CBR1;GPX1;HPGDS;EPHX1;PTGIS;PLA2G4C;CYP1A1;ALOXE3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3350614838822772,0.7696525732351389,0.7636887608069164,0.9695097195766009,1.0,1/14,2.63%,CD40
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.30985276675603735,-0.7694460949680428,0.7582089552238805,1.0,1.0,4/10,20.38%,IMPACT;HIF1AN;BAG3;DNAJB1
prerank,ceramide transport (GO:0035627),-0.29958413892473534,-0.7691559574339847,0.7662337662337663,1.0,1.0,4/12,20.48%,PLEKHA8;ABCA2;ABCA13;PLTP
prerank,positive regulation of JUN kinase activity (GO:0043507),0.3085979683914508,0.7691385568544461,0.75,0.9698907014042313,1.0,2/23,2.87%,TAOK3;SASH1
prerank,presynaptic endocytosis (GO:0140238),0.30396569724703,0.7687940227163078,0.7568270481144344,0.9699703715524906,1.0,7/24,17.70%,SYNJ1;PIP5K1C;VAMP2;STON1;NLGN3;OPHN1;STON2
prerank,smoothened signaling pathway (GO:0007224),-0.2143987382048097,-0.7685772113970544,0.8624338624338624,1.0,1.0,15/32,26.60%,PKD2L1;ULK3;HIPK1;TTBK2;TCTN2;GPC2;DISP3;HIPK2;EVC2;TCTN3;TMEM231;TMEM17;STIL;GLI2;MAP3K10
prerank,glycoprotein metabolic process (GO:0009100),0.27219902912740945,0.7685491594497853,0.8017917133258678,0.9699304443467653,1.0,8/53,10.67%,ERP44;ST6GALNAC6;MAN1A2;NGLY1;B4GALT5;GANC;TNIP1;HPSE
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.2782492393645057,-0.7684059332719875,0.7841726618705036,1.0,1.0,5/14,18.54%,PRKCZ;RARA;NFKBID;CD86;ANXA1
prerank,protein K63-linked deubiquitination (GO:0070536),0.2921454701146157,0.7679985107039423,0.8032378580323786,0.9703357485362109,1.0,13/31,29.16%,USP50;USP25;CYLD;OTUD1;ZRANB1;BABAM2;USP8;USP33;OTUD5;ABRAXAS2;STAMBPL1;BABAM1;ATXN3
prerank,negative regulation by host of viral process (GO:0044793),0.3660588719437885,0.767980106049426,0.7609682299546142,0.969963169036182,1.0,2/10,16.45%,ZC3H12A;CCNK
prerank,stabilization of membrane potential (GO:0030322),0.33310386461517777,0.7679534413791251,0.7724137931034483,0.969602750267729,1.0,2/16,11.77%,CHCHD10;KCNK3
prerank,calcium ion homeostasis (GO:0055074),0.25362378229378746,0.7679429844058095,0.848421052631579,0.9692217821872797,1.0,13/95,15.80%,CCL7;CD40;SLC8A1;CCL5;SLC30A1;CHERP;TFAP2B;VAPB;CCL14;HTR2A;TRPV4;NPTN;SLC24A3
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3067955943984278,0.7679404953920298,0.7827191867852605,0.9688309115168025,1.0,4/25,10.61%,TPI1;PFKM;HK1;FOXK1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2856700649185698,0.7679125045154688,0.7954545454545454,0.9684709860266147,1.0,7/36,18.24%,TGFA;FBXW7;NRP1;BUD31;JAK2;NLGN3;HDAC1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2912199065188734,-0.7678314275082518,0.8161290322580645,1.0,1.0,4/11,32.54%,ATG9A;PACS2;MFN2;ATG9B
prerank,lymphocyte proliferation (GO:0046651),0.3121686758832703,0.7674128629610398,0.7626903553299492,0.9687816023130764,1.0,4/22,17.40%,CD40;ELF4;LMBR1L;PTPRC
prerank,cobalamin metabolic process (GO:0009235),0.3296249433860585,0.7670651694771093,0.7980769230769231,0.9688838733690909,1.0,7/17,28.03%,AMN;ABCC1;ABCD4;MMUT;MMAB;LMBRD1;CD320
prerank,regulation of oxidative phosphorylation (GO:0002082),0.32655838679713506,0.7667361309251489,0.7580645161290323,0.9689509853970738,1.0,7/16,26.01%,ABCD1;AK4;COX7A2;VCP;PDE12;SLC25A33;COX7A2L
prerank,iron ion transport (GO:0006826),0.274696568889023,0.7665209846472377,0.8195402298850575,0.9688708658732734,1.0,11/47,19.38%,ATP6V0D1;SLC11A2;RAB11B;TTYH1;DNM2;TFR2;TCIRG1;ATP6V1B2;ATP6V1G1;ABCB7;ATP6V1G2
prerank,inorganic cation transmembrane transport (GO:0098662),0.23941341914715286,0.7664045048055308,0.9417670682730924,0.9686420642415597,1.0,26/268,12.84%,TRPM5;TRPM2;ATP6V0D1;CACNA2D4;UCP3;TRPM6;ATP1B3;KCNH8;SLC8A1;SLC46A1;SLC30A1;SLC30A5;ASIC4;SLC11A2;KCNS3;CACNA1A;P2RX4;KCNA4;CCDC51;TRPM3;DMAC2L;SLC30A6;KCNK3;SCN2A;MCOLN2;TRPV4
prerank,synaptic vesicle endocytosis (GO:0048488),0.28974290354061055,0.7660028329020774,0.7933168316831684,0.9688114403530971,1.0,12/33,23.85%,SYNJ1;DNM2;PIP5K1C;VAMP2;STON1;SNAP91;NLGN3;OPHN1;STON2;ITSN2;DNM3;PACSIN1
prerank,cortical cytoskeleton organization (GO:0030865),0.2811694704574333,0.7654537578254049,0.8133802816901409,0.9691761327830357,1.0,11/41,21.28%,FMNL2;RHOF;EPB41L3;TRPV4;RAC1;DLG1;LLGL1;FMNL3;NCKAP1;RND2;RHOH
prerank,positive regulation of phospholipid transport (GO:2001140),-0.3055208074120416,-0.7653687722210197,0.8012232415902141,1.0,1.0,3/10,20.61%,DBI;ABCA7;ABCA3
prerank,inositol lipid-mediated signaling (GO:0048017),0.26988913738925785,0.7653166797611055,0.821590909090909,0.9689710936554369,1.0,8/50,14.64%,IRS1;PIK3CD;PLCB4;ADAP2;PLCB3;PI4KB;PIK3CB;IRS2
prerank,determination of heart left/right asymmetry (GO:0061371),0.2765466708460096,0.7651546391942317,0.7825567502986858,0.968786971077399,1.0,4/43,11.24%,CCDC40;NPHP3;SRF;SETDB2
prerank,positive regulation of catabolic process (GO:0009896),0.26199378217089997,0.765134715329838,0.835920177383592,0.9684212029555831,1.0,26/65,29.62%,WNT5A;EGLN2;RILP;AREL1;DACT1;BARD1;SORL1;SMURF1;VPS28;TIPARP;WWP1;HUWE1;SMURF2;IDE;VCP;AXIN1;TNF;SEC22B;SNF8;VSIR;HECW2;DDB1;TRIM32;HACE1;TNFSF12;RAB7A
prerank,purine-containing compound salvage (GO:0043101),0.3511126381801141,0.7648600356926883,0.7710144927536232,0.9684199869784341,1.0,3/12,18.85%,DCK;HPRT1;AMPD3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.30792133523401016,0.7648175255676168,0.7776365946632783,0.9680879865122314,1.0,4/22,12.57%,UBAP1;MVB12A;VPS37A;VPS28
prerank,actomyosin structure organization (GO:0031032),0.2575846427127155,0.7647300028405544,0.8237837837837838,0.9678200293860846,1.0,8/75,12.77%,MYOZ2;CSRP1;ACTN2;TNFAIP1;FRMD6;EPB41L3;TMOD3;EPB41L5
prerank,positive regulation of nervous system development (GO:0051962),0.27523961539120867,0.7646509922704579,0.8064889918887601,0.9675433564110971,1.0,8/42,16.20%,BDNF;CLSTN1;LRP2;SNW1;NUMBL;IL1RAP;CLSTN3;NLGN3
prerank,protein localization to cell periphery (GO:1990778),0.2481919968057356,0.7643899923535878,0.8892307692307693,0.9675286979955721,1.0,41/133,26.50%,PIGW;RAB8B;ATP1B3;ACTN2;SEC16A;RAB12;ANK1;PIP5K1A;RAPGEF6;RAPGEF2;EPB41L3;TNIK;EFR3A;SMURF1;FGF13;PTCH1;DLG1;INPP5K;RAB11A;WDR19;FLOT2;RAP2A;ZDHHC3;RAB10;ZFYVE27;C2CD5;ZDHHC22;RABEP1;RAB29;PACSIN1;FLNA;ANK2;WNK3;DPP10;DPP6;TNF;KCNB1;RAB3A;TSPAN32;LIN7C;RAB3D
prerank,positive regulation of lyase activity (GO:0051349),-0.27397197424818265,-0.7642032541742378,0.7830508474576271,1.0,1.0,2/14,6.60%,STIM1;ISCU
prerank,second-messenger-mediated signaling (GO:0019932),0.25711806097536755,0.763870968797828,0.8560687432867884,0.9678511985642244,1.0,7/82,8.96%,AGT;CXCR4;RCAN1;PPP1R9A;SAMD14;ACKR3;P2RX4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.2729983581353764,-0.7635090987583549,0.7747440273037542,1.0,1.0,6/14,23.35%,TPM1;IGFBP5;TRIB1;PRKG1;MEF2C;IGFBP3
prerank,prostanoid metabolic process (GO:0006692),-0.27970120843929586,-0.7633545408165199,0.7932203389830509,1.0,1.0,4/13,18.41%,HPGD;PTGS1;PTGES;GSTM1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3046257454536582,0.7632845811084711,0.7931034482758621,0.9682849640244028,1.0,9/22,24.63%,AEBP1;HSPA8;APOE;AKAP13;CAMSAP2;MAP1B;GBA2;MAPRE3;PIK3CA
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2508024176393677,0.7628537355523436,0.86875,0.9685116326266935,1.0,20/125,14.71%,NUP37;MECP2;SBDS;B9D2;DYNC1H1;KPNB1;KIF2C;DYNC1LI2;KIF3B;EFHC2;MAPRE1;NEK9;CENPN;SUN2;NEK6;DYNLL1;AHCTF1;MAP4;MIS12;KIF2A
prerank,negative regulation of microtubule polymerization (GO:0031115),0.34320499082885153,0.7628091368694538,0.7655571635311144,0.9681789136054708,1.0,4/12,16.96%,ARHGEF7;MAPRE1;TBCD;STMN2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3214117478164265,0.7622553209395506,0.7750342935528121,0.9685233134308492,1.0,5/17,16.36%,HCK;STAP1;NRP1;BAIAP2;BAIAP2L1
prerank,phosphatidylserine metabolic process (GO:0006658),0.29282585202139866,0.7619875317734233,0.7922403003754693,0.968511129006947,1.0,3/32,4.73%,SLC27A1;PLA2G12A;OSBPL8
prerank,limb development (GO:0060173),0.2963380136939029,0.7612217477967891,0.794044665012407,0.9692477045279408,1.0,2/28,3.32%,COMP;CHD7
prerank,chemical synaptic transmission (GO:0007268),0.23918954798573747,0.7611425727480936,0.944,0.9689670100473495,1.0,46/284,19.25%,CHRNA9;PDE7B;PMP22;PCDHB13;GRIN2D;GRIK3;SLC18A2;CRHBP;UTS2;SLC12A5;CPLX1;GRIA2;PTCHD1;PRKAR2B;CACNA1A;MYCBPAP;HSPA8;GLRA2;RAPSN;GABBR2;KCNK3;HTR2A;PCDHB16;APOE;AKAP9;HTR1F;VAMP2;NAPB;BSN;NAPA;DLG1;MINK1;CHRNB2;GRID1;HCRTR1;NLGN3;GRIA4;STAC3;MPZ;PRKAR2A;SLC32A1;GAD1;PAFAH1B1;BRSK1;GABRG1;CAMKK2
prerank,neuron projection extension (GO:1990138),0.28533530852084055,0.7608683087777618,0.7932692307692307,0.9689748815495608,1.0,8/32,19.02%,NRP2;HSP90AB1;CYFIP1;CTNNB1;NRP1;HSP90AA1;NLGN3;MAP1B
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.292634463538413,0.7608594555015192,0.7995049504950495,0.9685987185185366,1.0,9/31,18.22%,POLR2G;CNOT7;DCP2;DIS3L2;EXOSC9;NT5C3B;HBS1L;DCPS;LSM5
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.20866919294509798,-0.7607234002655818,0.8715083798882681,1.0,1.0,7/32,16.10%,SORBS1;ASAH1;C3;AKT1;CEACAM1;CREB1;CREBL2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3492963580920552,0.7606465289144287,0.7434017595307918,0.9684834885556236,1.0,5/11,28.09%,ZC3H12A;DFFA;SIRT2;BCL2L1;FZD3
prerank,cellular response to hexose stimulus (GO:0071331),-0.23275479302530255,-0.7604681981283898,0.8114035087719298,1.0,1.0,7/23,21.21%,SLC39A14;SLC2A5;PCK2;IGF1R;PDK3;SLC26A6;SOX4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.2496518198308469,-0.7604680516771417,0.813953488372093,1.0,1.0,4/19,9.98%,PNP;ADK;APRT;TYMS
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3112456939104291,0.7603235924187292,0.773224043715847,0.9685436503197888,1.0,2/21,4.73%,PLA2G12A;OSBPL8
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.25577168195322025,-0.760187576528039,0.7848605577689243,1.0,1.0,4/18,12.87%,GPR137B;MAFB;CCL3;TMEM178A
prerank,cellular response to interleukin-4 (GO:0071353),-0.3095725987304418,-0.759769159559258,0.7633802816901408,1.0,1.0,6/10,33.97%,JAK3;SHPK;LEF1;STAT6;TCF7;GATA3
prerank,positive regulation of protein modification process (GO:0031401),0.2421566480055208,0.7594687572333148,0.9153225806451613,0.9693398031301375,1.0,30/203,15.21%,IRGM;KDR;DAXX;SEMA4D;CD40;ANKLE2;CCND2;SOX9;CCND1;MYDGF;MT3;PPIA;LYN;LEPR;APP;INSR;TNIK;CIB1;VEGFD;FGF9;SVIP;RACK1;RAC1;DAB2;SPPL3;CEP295;RB1CC1;HSP90AA1;NPTN;CALM3
prerank,negative regulation of insulin secretion (GO:0046676),0.31958933784023696,0.7594557698364859,0.7740112994350282,0.968967731231036,1.0,5/17,25.44%,IRS1;MIDN;PSMD9;PIM3;KCNB1
prerank,neuron migration (GO:0001764),0.266317795227584,0.7583747498863318,0.8241379310344827,0.9700765352685979,1.0,14/48,19.81%,TUBB2B;RAPGEF2;DDIT4;FGF13;NRP1;RAC1;DNER;LRP12;PEX13;DCDC2;PAFAH1B1;MARK1;MAP1B;CCK
prerank,peptidyl-proline hydroxylation (GO:0019511),0.35144545745181766,0.7582743581314906,0.7680722891566265,0.9698323012147744,1.0,2/11,4.14%,P4HA1;EGLN2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.24369795531926736,-0.7578423528436932,0.8473895582329317,1.0,1.0,6/20,14.35%,ARRB1;DIP2B;GLYR1;MAPK3;BRCA1;RPS6KA4
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.2294528157539338,-0.7578081617676591,0.889763779527559,1.0,1.0,3/21,10.02%,TGFB1;BMP6;NUP93
prerank,acetyl-CoA metabolic process (GO:0006084),0.33443638664416997,0.7575092693241886,0.7810650887573964,0.9704734764529863,1.0,1/15,1.18%,PPCS
prerank,sulfur amino acid catabolic process (GO:0000098),-0.30827574010293707,-0.7574769243352638,0.7685714285714286,0.9994256382950453,1.0,6/10,35.99%,BLMH;ADO;TST;MPST;CBS;CTH
prerank,protein lipidation (GO:0006497),0.26477319885829026,0.7571632928108638,0.8396017699115044,0.9705294697750488,1.0,22/59,27.89%,PIGW;ZDHHC21;ZDHHC20;PIGV;HHAT;PGAP2;ZDHHC13;ZDHHC8;PIGQ;PIGB;PGAP3;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;PGAP4;ZDHHC16;PIGN;ZDHHC7;ATG12;WDR45B;PIGF
prerank,regulation of synapse assembly (GO:0051963),0.2759871520876252,0.7571277858851008,0.8227114716106605,0.9701915007326258,1.0,10/46,16.20%,BDNF;CLSTN1;APP;SETD5;SLIT1;IL1RAP;CLSTN3;CHRNB2;TLR2;NLGN3
prerank,regulation of cilium assembly (GO:1902017),0.2606427436372318,0.7568062683065339,0.8453837597330367,0.9702254184026717,1.0,21/62,25.80%,TBC1D1;KCTD17;RABEP2;TBC1D8;CYLD;CCDC88A;CDK10;ODF2L;DYNC2LI1;DYNLT2B;TBC1D2;DCDC2;TESK1;SGSM3;ENTR1;IFT140;TBC1D2B;BBS4;EVI5L;TBC1D20;TBC1D17
prerank,phagosome-lysosome fusion (GO:0090385),0.360280518564745,0.7566013804603815,0.7802037845705968,0.9701277060189731,1.0,4/10,29.62%,SYT7;RAB7B;RAB20;RAB7A
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.29753150345184387,-0.756407097642294,0.7904761904761904,0.9995779402429379,1.0,5/11,27.65%,GLRX3;FOXO1;SMAD4;MLIP;ATP2B4
prerank,regulation of lipid catabolic process (GO:0050994),-0.2475572983060969,-0.7557913258092673,0.8346774193548387,0.9988870121606863,1.0,2/19,3.11%,PDE3B;ALK
prerank,T cell proliferation (GO:0042098),0.34471327258993006,0.7555153593153187,0.7956834532374101,0.9712381597759717,1.0,1/13,1.46%,DOCK8
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.34554848762465645,0.7553397240370575,0.7817919075144508,0.9710806039755951,1.0,6/13,30.74%,DDX20;SRSF10;SART3;PRPF19;AAR2;USP4
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.35104225940930467,0.7552669617420407,0.7771173848439822,0.9707949457728657,1.0,4/11,19.79%,RAPGEF6;RAPGEF2;TJP2;RAB1A
prerank,leukotriene metabolic process (GO:0006691),0.3146620859912941,0.7549744977323718,0.7911646586345381,0.9708036413965095,1.0,3/19,11.18%,PTGR1;DPEP2;ABCC1
prerank,regulation of plasminogen activation (GO:0010755),0.3472403686109302,0.7549737411727863,0.7592319054652881,0.9704150992788361,1.0,1/12,3.81%,RUNX1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2858171202333078,0.7549726351731295,0.8106435643564357,0.9700272698563644,1.0,6/31,16.78%,LRP2;TNNC1;FGFR2;PROX1;BMPR1A;RBPJ
prerank,phosphate ion transmembrane transport (GO:0035435),0.3380245534755007,0.7544485154145371,0.7750759878419453,0.9703284286532291,1.0,5/12,22.93%,SLC25A10;SLC37A2;SLC20A2;SLC37A1;SLC25A30
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2746229891767503,-0.7543429308782987,0.7828947368421053,0.9995909191033091,1.0,2/13,9.13%,NIBAN2;DAB2IP
prerank,pulmonary valve development (GO:0003177),-0.2524034233033912,-0.7542677938180733,0.8433734939759037,0.9981662140660578,1.0,9/18,37.01%,TGFB2;JAG1;TNFRSF1B;SMAD6;ROBO1;BMP4;HEY1;HEY2;HEYL
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.30404335634383794,0.7538935800565697,0.8041237113402062,0.9706802946026439,1.0,6/22,17.85%,NOL9;RPS21;RRS1;KRI1;EXOSC9;WDR12
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3352343196563212,0.7534826068642011,0.7899280575539568,0.9708622534056344,1.0,4/13,26.92%,KPTN;STK11;SZT2;SESN1
prerank,plasma membrane repair (GO:0001778),-0.2790258553282762,-0.7531837951652156,0.8287671232876712,0.99829962127418,1.0,3/13,9.75%,AHNAK2;MYOF;ANXA6
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.23872513585498537,-0.7528859710588774,0.8565400843881856,0.9972083805531062,1.0,3/20,8.41%,TGFBR3;PDCD4;TGFB2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3033055384310276,0.7527428640268534,0.7875647668393783,0.97146455408567,1.0,5/23,16.69%,KPNB1;HMGB1;DFFA;DNASE2;DICER1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.31698547579004543,0.7526160098552627,0.7820855614973262,0.9712553854032092,1.0,3/18,10.50%,KDR;RHOJ;CIB1
prerank,cristae formation (GO:0042407),0.29206840920855304,0.7517225980944225,0.8081683168316832,0.9721077768082051,1.0,5/27,14.77%,ATP5MC1;CHCHD6;DMAC2L;SAMM50;ATP5PO
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2970119681741602,0.7514864578395297,0.8097014925373134,0.97203544338071,1.0,3/26,9.99%,SLC18A2;ABCD1;SPHK2
prerank,mRNA modification (GO:0016556),0.3030845645296681,0.7514764373653966,0.7889908256880734,0.97166141248472,1.0,7/22,19.33%,TRMT61B;TRMT10C;ZC3H13;PUS7;METTL14;CBLL1;WTAP
prerank,regulation of protein autophosphorylation (GO:0031952),0.2763563453561716,0.750946190320025,0.83729216152019,0.9719785598199226,1.0,11/36,20.51%,PPP2R5C;TNKS1BP1;MOB1B;PPP2R5D;ENPP1;CALM3;TAOK2;TESK1;RAP2A;PPP2R5A;DDX3X
prerank,axonemal dynein complex assembly (GO:0070286),0.29021887705092875,0.7509052547858417,0.7899484536082474,0.9716456384353328,1.0,5/28,16.34%,ODAD2;CCDC40;ODAD4;CFAP73;DNAL1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.26925537039156844,0.7502846192490974,0.8253783469150174,0.9720800589325598,1.0,12/45,23.83%,BRINP3;CHEK1;CTNNB1;BCL6;ZFP36L1;GAS1;AURKAIP1;ZWILCH;WEE1;TOM1L2;ZFP36L2;ZWINT
prerank,Golgi inheritance (GO:0048313),0.35572865119727604,0.7502761915302002,0.7639939485627837,0.9717042091501332,1.0,4/11,18.12%,PLK3;VCPIP1;STK25;GBF1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.33916030043709655,0.7502705135113861,0.7888730385164051,0.9713246647632162,1.0,2/13,8.39%,HYAL1;CSPG4
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3048098846623004,0.7499564920048817,0.7953063885267275,0.9713534557476304,1.0,6/22,20.31%,IFI35;LYN;WDFY1;ACOD1;MFHAS1;APPL2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.27926035594955045,-0.7496534504617048,0.8193979933110368,1.0,1.0,6/13,41.67%,SCN3B;GJC1;KCNQ1;CACNA1C;CACNB2;KCNJ5
prerank,tetrapyrrole metabolic process (GO:0033013),0.3166361574633215,0.7494814556224805,0.8153638814016172,0.9715985309352859,1.0,7/18,28.03%,AMN;ABCC1;ABCD4;MMUT;MMAB;LMBRD1;CD320
prerank,icosanoid secretion (GO:0032309),-0.28106754428133196,-0.7494008085953278,0.7896440129449838,0.9993388501266548,1.0,7/12,40.64%,ANXA1;DRD2;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,acylglycerol metabolic process (GO:0006639),0.27727360613786184,0.7492475555554043,0.8090024330900243,0.9715326431830689,1.0,9/37,20.01%,PNPLA2;ABHD2;DGKB;DGKK;LYPLA2;APOE;DGKA;DGKI;PNPLA3
prerank,cellular amino acid catabolic process (GO:0009063),0.25385888665964584,0.7491630966054321,0.8700745473908413,0.9712474826184115,1.0,16/87,18.08%,HYKK;AUH;HMGCL;ALDH7A1;DLD;AASS;BCKDK;SHMT1;GCSH;GCDH;PIPOX;GLUD1;ACAT1;HIBADH;MCCC1;GAD1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.26430209897655565,-0.7482083310247759,0.8211678832116789,0.9996187278106291,1.0,2/15,10.51%,ATP1B1;KCND3
prerank,regulation of dephosphorylation (GO:0035303),0.3213034750745942,0.7481848051824813,0.7834757834757835,0.9721193283499511,1.0,4/15,14.95%,SMG7;IGBP1;SMG5;INPP5K
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.33041496266369696,0.7479761094994246,0.7924791086350975,0.97201067735755,1.0,2/16,6.88%,PIGW;PIGV
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.24825598416034025,0.7475736166653878,0.8697033898305084,0.9721614045979691,1.0,8/90,8.85%,CXCR4;PER2;GADD45G;GRB10;DYNC1H1;ACADL;SIRT6;LEPR
prerank,regulation of peptidase activity (GO:0052547),0.3066137939841067,0.7472603040797802,0.8092105263157895,0.9721985423132464,1.0,5/19,18.41%,PSMA3;CTSH;CST7;HDAC1;SVBP
prerank,cell-cell junction assembly (GO:0007043),0.2596843934202146,0.7468891375802983,0.8502202643171806,0.9723295742031561,1.0,12/63,17.35%,CNTNAP1;PKN2;CTNNB1;CDH9;EPB41L3;TRPV4;PIP5K1C;ACTB;CTNND2;TBCD;JAM3;CLDN11
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3235068990315565,0.7468058649542053,0.7875354107648725,0.9720702370655298,1.0,6/16,22.60%,NCBP2;SART1;DDX23;DCPS;PRPF39;WBP4
prerank,methylguanosine-cap decapping (GO:0110156),-0.295357477330022,-0.746342375187207,0.8162650602409639,1.0,1.0,2/10,6.15%,PATL1;DCP1A
prerank,phagolysosome assembly (GO:0001845),0.34456142803631784,0.7462947505830501,0.7917261055634808,0.9723714168943719,1.0,2/12,10.99%,SYT7;RAB14
prerank,positive regulation of exocytosis (GO:0045921),0.275474977317255,0.7460526171573599,0.8325358851674641,0.9723165880410257,1.0,13/35,28.08%,SDC4;UNC13D;CADPS2;RAB2B;HGS;CADPS;TSG101;CFTR;RAB3A;SNF8;RAB3D;SDCBP;PDCD6IP
prerank,mammary gland development (GO:0030879),0.30208522725532183,0.7459678043267404,0.8002610966057441,0.9720424650934897,1.0,3/21,14.28%,WNT7B;NOTCH4;JAK2
prerank,negative regulation of cholesterol transport (GO:0032375),0.3577517970024526,0.7455739104477505,0.7972136222910217,0.9721955420689984,1.0,1/10,6.30%,NFKB1
prerank,copper ion transport (GO:0006825),0.345990356858384,0.7455162964772991,0.7909356725146199,0.9718839657756903,1.0,5/11,25.60%,SLC11A2;SLC31A1;SLC31A2;COX17;ATP7B
prerank,heart development (GO:0007507),-0.1563912644578162,-0.7451943835586543,1.0,1.0,1.0,17/150,10.46%,PDLIM5;TGFB1;CASP8;SGCD;NTRK3;TGFBR3;NIPBL;ZFPM2;SALL1;CACYBP;ID2;TGFB2;TSC2;LDB3;SMYD4;PDLIM1;KDM6B
prerank,autophagosome organization (GO:1905037),0.26188394876624327,0.743746290212803,0.82559456398641,0.9738288917839856,1.0,7/50,14.56%,IRGM;UBQLN2;RAB43;UBXN2B;UBQLN1;MAP1LC3B;RB1CC1
prerank,regulation of embryonic development (GO:0045995),0.2801282781150687,0.7434534972766121,0.8300970873786407,0.9738208045355958,1.0,6/34,11.27%,DHX36;NPHP3;B4GALT5;INSR;RAB14;PHLDB1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3155647875351293,0.7431536174462536,0.7833787465940054,0.9738476213831926,1.0,2/16,7.43%,ST6GALNAC4;ST6GALNAC6
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3358295026091115,0.7429454670519687,0.7885714285714286,0.9737332957962077,1.0,6/13,26.03%,SEC16A;SORL1;BCAP31;TM9SF4;EDEM2;EDEM1
prerank,tRNA processing (GO:0008033),0.25443568275268513,0.7426492288767158,0.8463251670378619,0.9737319921938078,1.0,13/61,17.83%,TRMT9B;TRPT1;ADAT2;TRMT1;AARS1;TSEN2;FAM98B;WDR4;TRMT10C;ADAT1;RTCB;RPP30;TSEN34
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.28761288381378664,0.7422956904101661,0.8207426376440461,0.9737885194475953,1.0,11/27,27.19%,FBXO7;EFHC2;CCDC88A;PSEN1;FCGR2B;MARK1;BRSK1;VPS35;NTNG2;PTEN;ULK4
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.2371680713923963,-0.7420840268030972,0.8516949152542372,1.0,1.0,5/20,16.42%,ST3GAL6;ST3GAL3;B3GALT5;B3GALT2;FUT8
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2724684274906566,0.7420057045469588,0.8354876615746181,0.9737765047314894,1.0,5/39,11.63%,MAD2L2;PODXL;PPM1F;NOTCH4;FXYD5
prerank,cellular response to increased oxygen levels (GO:0036295),0.34301244356339833,0.742005601486625,0.7880116959064327,0.9733920686854051,1.0,1/11,2.09%,ATP6V0D1
prerank,positive regulation of histone acetylation (GO:0035066),0.3032143137869875,0.7417485913106078,0.8130718954248366,0.9733327448130885,1.0,8/23,22.35%,TADA2A;TADA2B;SPHK2;PPARGC1A;PAXIP1;BRD7;KAT7;RUVBL2
prerank,response to ATP (GO:0033198),0.31083173646306017,0.7414702749940709,0.8048128342245989,0.9733110373658949,1.0,4/18,22.41%,PDXP;P2RX4;HSP90B1;ABCC9
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.28810554180121284,0.7413781651282031,0.8040973111395646,0.9730414853135266,1.0,4/28,12.35%,YTHDF1;EPHA4;APP;APOE
prerank,positive regulation of phospholipase C activity (GO:0010863),0.27164544393082224,0.7412247416215718,0.8176538908246226,0.9728523628188548,1.0,3/40,5.55%,FLT1;BDNF;GNA15
prerank,mRNA methylation (GO:0080009),0.3225345666489976,0.7407008431670963,0.7745098039215687,0.9731733372479482,1.0,6/15,19.33%,TRMT61B;TRMT10C;ZC3H13;METTL14;CBLL1;WTAP
prerank,negative regulation of platelet activation (GO:0010544),-0.258726955286531,-0.740553105934083,0.8450704225352113,1.0,1.0,5/16,24.08%,CEACAM1;CD9;PRKG1;THBD;PDGFRA
prerank,regulation of actin filament-based movement (GO:1903115),0.35264450319441404,0.7404631878103819,0.7908011869436202,0.9730885513163032,1.0,3/10,24.63%,PDPN;PDE4B;ANK2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.31526396040342447,0.740151319807295,0.8075880758807588,0.9731025049487383,1.0,2/17,4.38%,S1PR2;ZDHHC21
prerank,chloride transport (GO:0006821),0.24799246564598784,0.7399867309418146,0.8676148796498906,0.9729179960482668,1.0,18/74,23.24%,CLIC4;SLC26A1;SLC12A5;CLCN2;CLCN6;SLC12A8;TTYH1;GLRA2;ANO10;ANO5;CLCN1;GABRG1;GLRA1;GABRB2;SLC1A3;CLIC1;GABRA3;SLC26A7
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.22955388733594395,-0.7394475127589805,0.8626609442060086,1.0,1.0,9/23,23.36%,SRCIN1;MVP;SH3BP5;SH3BP5L;CBL;ZFYVE28;DUSP22;CAV1;CHMP6
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2566950518976126,0.7394337015217735,0.8302961275626424,0.9732640743280637,1.0,11/52,13.11%,FBXW7;SH3GLB1;VPS11;CSNK2A2;TFDP1;RNF31;LEPROT;TFDP2;NPEPPS;UBE2L3;BAD
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.26905532420752126,-0.7392420892714313,0.815068493150685,1.0,1.0,4/13,19.81%,NT5M;OGG1;NEIL1;DUT
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2490043632758169,0.7391315468961847,0.8683351468988031,0.9732877981170779,1.0,12/72,13.90%,XRN2;POLD4;CHD1L;RFC4;RFC1;FEN1;ERCC4;RBX1;POLK;ZC3H12A;ENPP1;RNASE1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.3062222397311398,0.7391063222157624,0.8148148148148148,0.9729387124390074,1.0,5/19,24.05%,PXDNL;PRDX2;ACOX1;PRDX3;CYBA
prerank,regulation of RNA splicing (GO:0043484),0.2542160949398305,0.738655647988116,0.8605150214592274,0.9731256265648867,1.0,27/69,29.53%,FASTK;SLC38A2;HNRNPH1;HNRNPK;CLK3;SRPK1;HNRNPL;HNRNPH3;CLK2;MBNL2;RBM39;RRP1B;CWC22;HNRNPF;ERN1;SRSF10;TRA2B;SON;ZNF326;FUS;SNRNP70;SRPK2;KHDRBS2;SETX;PIK3R1;KHDRBS1;QKI
prerank,positive regulation of myelination (GO:0031643),-0.2954173726880569,-0.7384498319842128,0.801980198019802,1.0,1.0,5/11,21.84%,TPPP;RNF10;TNFRSF1B;EGR2;NCMAP
prerank,eye photoreceptor cell development (GO:0042462),0.31591968449412905,0.7382209248994714,0.7957446808510639,0.9732915245244332,1.0,1/15,3.56%,THY1
prerank,cardiocyte differentiation (GO:0035051),-0.2962361553947946,-0.7377475828140488,0.7893175074183977,1.0,1.0,4/10,19.31%,TGFB2;KDM6B;EEF1AKMT4-ECE2;CBY1
prerank,mitochondrial fusion (GO:0008053),0.30933475510431774,0.7372050665269408,0.8141711229946524,0.9742016020527933,1.0,4/18,17.13%,FIS1;GDAP1;MIGA2;BAX
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.2070141868594823,-0.7371419359842347,0.8923076923076924,1.0,1.0,14/30,40.12%,CACNA2D1;SCN3B;GJC1;SCN2B;KCNH2;CACNA1G;ATP1A1;RYR2;KCNQ1;SNTA1;CACNA1C;KCNE3;FGF12;KCNE4
prerank,regulation of hemopoiesis (GO:1903706),0.3558778232260018,0.7369583203886273,0.7804511278195488,0.9741414995185765,1.0,2/10,11.07%,RUNX1;IL17D
prerank,protein localization to chromosome (GO:0034502),0.27790130508227534,0.736552991203594,0.8229548229548229,0.9742922516769754,1.0,6/34,12.75%,MSH2;HASPIN;MCM9;SLF2;CTCF;RB1
prerank,positive regulation of protein maturation (GO:1903319),0.33864470656162293,0.7363751070634961,0.7918486171761281,0.9741264051570941,1.0,2/11,14.72%,ADAM8;TFR2
prerank,heart contraction (GO:0060047),-0.19460376320341397,-0.736216030116125,0.9177215189873418,1.0,1.0,6/41,13.22%,SGCD;ATP1B1;DMD;TPM1;GRK2;SCN3B
prerank,actin filament polymerization (GO:0030041),0.283368205411618,0.7359246466872765,0.8061349693251534,0.9743021963565731,1.0,12/29,27.79%,GAS7;CORO7;GSN;RAC1;JAK2;AIF1;TTC17;MSRB1;ANG;DIAPH1;WASHC5;WASF1
prerank,digestive tract morphogenesis (GO:0048546),-0.26713365003447276,-0.7357303445316918,0.8078291814946619,1.0,1.0,2/14,7.16%,NIPBL;ID2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.27853466880004724,0.7352312637854534,0.8288075560802833,0.9747940822045233,1.0,7/36,14.87%,DHFR;ZDHHC21;GCH1;DNM2;APOE;PIK3CB;HSP90AA1
prerank,aerobic electron transport chain (GO:0019646),0.25163546835089395,0.734325526474535,0.8624052004333694,0.9755745962433993,1.0,15/68,20.27%,UQCRQ;NDUFA5;NDUFB9;NDUFB11;NDUFS1;UQCR10;AFG1L;CYC1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7;SDHD
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3111231308752508,0.7341369511193633,0.7934336525307798,0.9754183205667455,1.0,7/17,29.96%,DHDDS;ALG13;DPAGT1;DOLPP1;ALG12;ALG9;ALG14
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3186483737714883,0.7336873119714279,0.8166894664842681,0.9756227589662488,1.0,6/15,25.44%,NSMAF;SPHK2;RACK1;PLA2G6;PRKCD;TNF
prerank,cellular glucose homeostasis (GO:0001678),-0.19062233070391976,-0.7336192471067084,0.9367088607594937,1.0,1.0,11/41,21.24%,FOXK2;SLC39A14;SIRT1;PIK3R2;FOXO1;PCK2;IGF1R;PDK3;HIF1A;SOX4;LRRC8A
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.2817708241274767,-0.7333884221706464,0.7724550898203593,1.0,1.0,2/11,5.87%,REST;PINK1
prerank,acute inflammatory response (GO:0002526),-0.22466237654033555,-0.7329978686698521,0.8625,0.9992591947801517,1.0,10/23,48.55%,PLSCR1;CEBPB;ANO6;LBP;HPR;HP;SIGIRR;CRP;VNN1;CD6
prerank,V(D)J recombination (GO:0033151),-0.28444447573617115,-0.7329586923632985,0.7982456140350878,0.9978063920642889,1.0,3/11,12.66%,XRCC4;DCAF1;LIG1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3219582680222294,0.7312608336268387,0.8002853067047075,0.978313715580628,1.0,3/13,23.22%,SFRP2;RBPJ;NOTCH1
prerank,female gamete generation (GO:0007292),0.2812517957488508,0.7306769019832055,0.8231631382316313,0.9786533011002252,1.0,6/29,22.77%,GDF9;MCM9;MARF1;MDK;MEI4;KMT2D
prerank,negative regulation of protein modification process (GO:0031400),0.24463528002867255,0.7304912954272362,0.8880434782608696,0.9784952824081229,1.0,13/79,13.10%,XDH;TARDBP;ARPP19;P3H1;PPIA;PAQR3;LYN;PRNP;MEN1;CIB1;ZC3H12A;PRKDC;CDYL
prerank,regulation of cellular amide metabolic process (GO:0034248),0.27282839666853925,0.7303230878752048,0.8199513381995134,0.9783401295414091,1.0,6/32,10.71%,TCOF1;CYFIP1;NOLC1;APP;TMED10;PUM3
prerank,regulation of keratinocyte differentiation (GO:0045616),0.29262715545936724,0.7302142002945682,0.8105263157894737,0.9780926784732907,1.0,5/24,18.93%,ZFP36;RUNX1;ZFP36L1;PRKCH;NUMA1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.3293215120517728,0.7299903065970956,0.7827380952380952,0.9779777323654195,1.0,6/12,25.49%,CEP19;HOOK3;NIN;BICD2;BBS4;DCTN1
prerank,membrane depolarization during action potential (GO:0086010),0.281951536203865,0.7297962354315309,0.8371501272264631,0.9778323544343223,1.0,6/26,21.72%,SLC8A1;SCN2A;SCN1B;KCNJ2;SCN8A;HCN2
prerank,negative regulation of cell cycle process (GO:0010948),0.2507700939485131,0.7297605622813562,0.8740245261984393,0.9774911241420773,1.0,11/61,14.83%,PCGF6;CHEK1;TFDP1;PPP1R10;RING1;MAX;RYBP;TFDP2;UXT;AURKAIP1;EZH2
prerank,protein dephosphorylation (GO:0006470),0.2362297525465684,0.7290075248332837,0.9164086687306502,0.978065483427013,1.0,45/135,26.64%,EYA4;PTPN18;DUSP3;PPP2R5C;PDXP;SBF1;DUSP29;TIMM50;RPAP2;NCK1;PTPN7;BTRC;DUSP26;PPM1F;PPP2R5D;PTPN11;PPP4R2;DUSP10;DUSP16;DUSP11;PTPN9;PTPRU;PPP2R2A;EYA2;PTPRC;DUSP8;PTPRB;PTPRF;PPTC7;PPP2R5A;LHPP;STK11;PPP2R3A;PTPRM;PPP1R12A;PTPN6;PTPRS;PPM1H;PDP1;EYA3;PTPN1;PPM1A;DUSP7;PTEN;EYA1
prerank,pharyngeal system development (GO:0060037),0.31810994859362485,0.7288533183320258,0.8194842406876791,0.9778921005265249,1.0,3/15,15.34%,BMPR2;PTCH1;BMPR1A
prerank,estrogen metabolic process (GO:0008210),0.31024702780317626,0.7286674069163956,0.7991746905089409,0.9777399501329408,1.0,1/15,3.58%,HSD17B7
prerank,negative regulation of cellular senescence (GO:2000773),-0.2618206572302407,-0.728660239770387,0.8333333333333334,1.0,1.0,3/13,12.95%,MAP3K3;SIRT1;HMGA2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.30920674697041123,0.7286210498388958,0.8094594594594594,0.9774047551134036,1.0,4/18,16.51%,RUFY3;KANK1;RACK1;LLGL1
prerank,regulation of chromatin organization (GO:1902275),0.31406464065122,0.7280932859361132,0.7979651162790697,0.9777166936132448,1.0,5/14,21.62%,SSRP1;SETD5;MLLT3;TLK2;CDK9
prerank,cellular response to acid chemical (GO:0071229),0.2823479198258419,0.728024547615104,0.8298969072164949,0.9774270359490429,1.0,8/27,22.25%,RRAGC;GLRA2;XBP1;LAMTOR3;MTOR;LAMTOR4;GLRA1;RRAGA
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2292914301363876,0.727774058617609,0.9587525150905433,0.9773580011161882,1.0,34/224,19.25%,CHRNA9;PDE7B;PMP22;PCDHB13;SLC18A2;UTS2;SLC12A5;CPLX1;GRIA2;PTCHD1;PRKAR2B;CACNA1A;MYCBPAP;GLRA2;RAPSN;GABBR2;KCNK3;HTR2A;PCDHB16;AKAP9;HTR1F;BSN;DLG1;MINK1;CHRNB2;HCRTR1;NLGN3;GRIA4;MPZ;PRKAR2A;GAD1;PAFAH1B1;GABRG1;CAMKK2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2739583783827639,0.7276443527035179,0.8333333333333334,0.9767753528400629,1.0,12/32,27.82%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,tRNA export from nucleus (GO:0006409),0.2739583783827639,0.7276443527035179,0.8333333333333334,0.9767753528400629,1.0,12/32,27.82%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.29645011418847234,0.7275876236133466,0.8524804177545692,0.9764631335864378,1.0,1/24,1.72%,KDR
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.34430504782484156,0.7275185205783194,0.8059259259259259,0.976183094101485,1.0,2/10,15.21%,GPR35;CALM3
prerank,cellular response to amino acid stimulus (GO:0071230),0.27159815446567737,0.7272058207659164,0.8349753694581281,0.9761812512289828,1.0,11/33,23.91%,RRAGC;GLRA2;XBP1;LAMTOR3;FYN;MTOR;LAMTOR4;GLRA1;RRAGA;UBR2;UBR1
prerank,regulation of cell size (GO:0008361),0.2917777003454443,0.7271693112441079,0.8104993597951344,0.9758517241484658,1.0,7/23,23.05%,RARG;VAV1;AKT1S1;RAC1;MTOR;LAMTOR4;MSN
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.24147073385485204,0.7268752308347893,0.8963675213675214,0.9758581808045057,1.0,22/87,22.86%,BST2;DAPK3;TRPM2;RHOF;PAK3;CCDC88A;CDK10;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR;MDK;TESK1;ARHGAP18;RND2;RHOH;PRKCD;ABL2;IQGAP2;TWF1
prerank,regulation of fibrinolysis (GO:0051917),0.3184500085038203,0.7267142926451541,0.7949790794979079,0.9756729178541351,1.0,1/13,6.61%,USF1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.2914555492629045,-0.7259931244889536,0.8152173913043478,1.0,1.0,4/10,24.21%,NIPSNAP2;CACNA2D1;SRI;NOS1AP
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.20460115190443767,-0.7259579617152689,0.9028571428571428,1.0,1.0,12/34,22.09%,TICAM2;IRAK3;DAB2IP;TREM2;CACTIN;OTUD4;SMPDL3B;TYRO3;CD14;LRRC14;NLRP2B;TNFAIP3
prerank,vasoconstriction (GO:0042310),0.3360173235849744,0.7258863622371902,0.8032786885245902,0.9763045048367398,1.0,1/11,3.75%,SLC8A1
prerank,GPI anchor metabolic process (GO:0006505),0.2857464991213757,0.7250886074897047,0.8241206030150754,0.9769091793230462,1.0,6/26,19.28%,PIGW;PIGV;PGAP2;PIGQ;PIGB;PGAP3
prerank,acyl-CoA metabolic process (GO:0006637),0.26835915219677936,0.7242657794198392,0.850909090909091,0.9775320294791859,1.0,3/35,6.64%,ACOT9;MCEE;ACBD6
prerank,signal release from synapse (GO:0099643),0.26377207205179404,0.7241184521681212,0.8647058823529412,0.9773370867560501,1.0,17/43,27.70%,CPLX1;HSPA8;PIP5K1C;VAMP2;SLC32A1;GAD1;BRSK1;STXBP3;PCLO;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;CDK5;CPLX2
prerank,glycine transport (GO:0015816),0.34442282342602476,0.7238727158464776,0.8149779735682819,0.9772521331246313,1.0,10/10,65.58%,SLC6A17;SLC36A1;SLC6A20;SLC6A9;SLC7A8;SLC6A5;SLC38A5;SLC36A3;SLC25A38;SLC36A2
prerank,peptidyl-lysine methylation (GO:0018022),0.283055739232076,0.7237843223753313,0.8356510745891277,0.9769833472460131,1.0,7/26,20.89%,METTL21A;SETD3;EEF2KMT;SMYD1;ATPSCKMT;SMYD2;SETD7
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.27423746853259684,-0.7236815068574352,0.8343949044585988,1.0,1.0,6/12,31.48%,RCC2;DMTN;ITGB1BP1;AP1AR;FBLN1;SPRY4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.27423746853259684,-0.7236815068574352,0.8343949044585988,1.0,1.0,6/12,31.48%,RCC2;DMTN;ITGB1BP1;AP1AR;FBLN1;SPRY4
prerank,establishment of vesicle localization (GO:0051650),0.30636982737676577,0.72352016310723,0.8216216216216217,0.9769110064380558,1.0,7/18,27.47%,SYNJ1;DNM2;RAB11A;TESK1;CCDC186;SYT11;CDK5
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.2983120125847952,0.723102602800459,0.8232931726907631,0.9770802402443671,1.0,5/18,31.65%,LYN;MDK;IL6R;SLIT2;MTUS1
prerank,regulation of cell motility (GO:2000145),0.2350083434793045,0.7228752807465701,0.9070247933884298,0.9769695533737663,1.0,27/121,22.53%,DAPK3;PLXNA3;SGK3;PLXNB2;SPATA13;PKN2;PLXNB3;OSGIN1;TBCCD1;FGF9;LDB2;LDB1;RAC1;CFAP20;KIF2A;AMOTL2;MINK1;CRK;MEMO1;CAVIN1;PIN1;ARHGAP18;DOCK10;CCDC25;ABL2;FGF2;ERBB3
prerank,muscle contraction (GO:0006936),0.23360611035518722,0.722657621322609,0.9152016546018614,0.9768659247164755,1.0,15/126,17.59%,ASPH;UTRN;MYL9;SLC8A1;ACTN2;UTS2;TNNC1;MYL1;ARHGEF11;TMOD3;MYH2;CHRNB2;SSPN;TNNI2;CLCN1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.2250991105551461,-0.7221468521005152,0.8481012658227848,1.0,1.0,6/22,23.75%,SLC16A2;ID2;KDM1A;PTPRZ1;DISP3;SHCBP1
prerank,hemidesmosome assembly (GO:0031581),0.33401844059226626,0.7220976384096036,0.8220946915351507,0.9771457250989984,1.0,1/11,3.80%,LAMC1
prerank,peptidyl-threonine modification (GO:0018210),0.24752112608992716,0.7220096244171854,0.871319520174482,0.976874506401009,1.0,12/66,16.65%,CAMK2D;ACVR1;CHEK1;CSNK2B;CSNK2A2;GALNTL6;CDK10;DYRK2;PRKDC;GALNT1;OXSR1;STK39
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2331969932556065,-0.7217873669773991,0.8604651162790697,1.0,1.0,6/20,17.09%,GCLM;GSS;PLOD2;PLSCR1;HAGH;GGCT
prerank,negative regulation of double-strand break repair (GO:2000780),0.27325702334829843,0.7217254722757571,0.8329268292682926,0.9768317812154548,1.0,8/30,22.11%,CGAS;MAD2L2;POLQ;SHLD1;KLHL15;SMCHD1;FBH1;UBQLN4
prerank,positive regulation of integrin activation (GO:0033625),-0.27678487147572695,-0.7217216786886842,0.822429906542056,1.0,1.0,3/11,28.56%,SRC;SKAP1;RAP1B
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.263234520386001,-0.7213409066271869,0.8441558441558441,0.9992158833443756,1.0,7/13,27.29%,LARP7;NELFB;NELFE;HEXIM1;NELFA;SUPT4H1;RNF168
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.23865068994993882,-0.7210044360181425,0.8767123287671232,0.9981626262103845,1.0,6/18,20.40%,NCKAP1L;METTL3;CCR2;IKZF3;IL4I1;ABL1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2467502602170174,0.720864928352695,0.8782327586206896,0.9775181561510258,1.0,15/69,20.27%,UQCRQ;NDUFA5;NDUFB9;NDUFB11;NDUFS1;UQCR10;AFG1L;CYC1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7;SDHD
prerank,positive regulation of metabolic process (GO:0009893),0.23706819225703823,0.7208512018326221,0.897489539748954,0.9771616637387927,1.0,9/103,9.33%,CXCR4;PER2;GADD45G;GRB10;DYNC1H1;ACADL;SIRT6;LEPR;INSR
prerank,carboxylic acid catabolic process (GO:0046395),-0.2737721676165654,-0.7207873753202347,0.8372881355932204,0.9969852070321364,1.0,6/12,29.75%,GNPDA1;NPL;IL4I1;ACOT8;GNPDA2;NAGK
prerank,regulation of gluconeogenesis (GO:0006111),0.27876707021172187,0.7207153995898014,0.833756345177665,0.97695462546638,1.0,4/27,13.43%,ARPP19;SIK1;PPARGC1A;CLK2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2580714931622804,0.7205991476235696,0.8713789107763615,0.9767249535335482,1.0,7/45,13.98%,PNPT1;SLC38A2;DDX5;NFKB1;DIMT1;MAP2K2;WDR43
prerank,positive regulation of leukocyte activation (GO:0002696),0.3019837738211001,0.7200036711305681,0.8326639892904953,0.9770465332279745,1.0,1/18,1.52%,WNT5A
prerank,aggrephagy (GO:0035973),0.27707399699606705,0.7198019028178405,0.8187660668380463,0.976916212071727,1.0,10/27,27.80%,DYNC1H1;DYNC1LI2;UBQLN1;DYNLL1;UBE2V1;HDAC6;WDFY3;CFTR;DYNC1LI1;UBE2N
prerank,transferrin transport (GO:0033572),0.27145389860766184,0.7195213930385098,0.838748495788207,0.9768620095575046,1.0,8/33,19.38%,ATP6V0D1;RAB11B;DNM2;TFR2;TCIRG1;ATP6V1B2;ATP6V1G1;ATP6V1G2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.272990851871568,0.7193460448909762,0.8439450686641697,0.9766967581352991,1.0,8/31,22.70%,MAD2L2;XBP1;SHLD1;PAXIP1;STX4;PTPRC;HMCES;KMT5C
prerank,mitochondrion disassembly (GO:0061726),0.27153446835857015,0.7192776695064166,0.8605769230769231,0.9763935951315996,1.0,7/34,20.07%,FIS1;FBXO7;CISD2;MAP1LC3B;RB1CC1;BECN1;FUNDC1
prerank,ovarian follicle development (GO:0001541),0.32162911199101385,0.7178993994831124,0.8108108108108109,0.9776963862470402,1.0,4/13,27.56%,EIF2B2;EIF2B5;ANG;EIF2B4
prerank,glucose transmembrane transport (GO:1904659),0.2973995778411894,0.7175132070735528,0.8269754768392371,0.9777991641458812,1.0,3/18,16.03%,SLC2A6;SLC2A9;PPARD
prerank,visual system development (GO:0150063),-0.19568775456369214,-0.7174349933665392,0.9615384615384616,0.9996048472523906,1.0,14/37,29.52%,PBX2;C3;TGFB2;MEIS2;HIPK1;BMPR1B;HIPK2;SMG9;FOXC1;SALL2;FREM2;MAB21L2;RAB18;MEIS1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3040326590963784,0.716872287481331,0.8328877005347594,0.9782095887890163,1.0,4/17,16.78%,ACVR1;SNAI2;BMPR1A;RBPJ
prerank,regulation of hippo signaling (GO:0035330),-0.24053287371123366,-0.7165294520396893,0.8819188191881919,0.9991959987662572,1.0,3/17,7.68%,SCHIP1;WTIP;CIT
prerank,response to lipid (GO:0033993),0.2368551657662792,0.7162313496952162,0.9084210526315789,0.9785992937007701,1.0,16/105,16.81%,TMEM161A;ABCG1;RARG;STAT3;CDKN2D;SOX9;CTNNB1;SLPI;CTSH;GCH1;GGT7;SOCS2;JAK2;PPARD;IRAK1;LGALS9
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.24752912639046626,-0.7161521386369271,0.8597785977859779,0.998179552180335,1.0,6/17,21.20%,CEACAM1;CEBPB;CD24;KLF7;MAFF;CAV1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3138235574258973,0.7159094424760803,0.8402777777777778,0.978598853584766,1.0,7/15,27.15%,CCT4;CCT7;CCT3;RUVBL2;NHP2;RUVBL1;TCP1
prerank,ventricular septum morphogenesis (GO:0060412),0.2791199629454521,0.7158670438894266,0.8509615384615384,0.9782748851457856,1.0,5/27,15.34%,ACVR1;BMPR2;PROX1;SLIT3;BMPR1A
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2609357381691049,0.7157398502426557,0.8831018518518519,0.9780603767724059,1.0,7/39,18.41%,ABCA1;RAB8B;RAB12;TMEM167A;MIA2;MTTP;SVBP
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2682581743796161,0.7154998360066785,0.8683901292596945,0.9779601997543849,1.0,7/35,17.02%,SLC25A1;HMGCL;SCD5;GGT7;PAM;GCDH;ACAT1
prerank,action potential (GO:0001508),0.2558795632945948,0.7154809102759431,0.8485915492957746,0.9776087981663991,1.0,3/44,6.08%,KCNMB3;GNA15;GNA14
prerank,cGMP metabolic process (GO:0046068),0.3209957510461631,0.7142997863422065,0.8397058823529412,0.9786308434642542,1.0,4/12,26.20%,NPPC;NPR2;PDE9A;GUCY1B1
prerank,actin filament depolymerization (GO:0030042),-0.2809415222939921,-0.714246943867102,0.8360128617363344,0.9989316377164956,1.0,2/11,5.14%,CFL1;MICAL1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3146572737390913,0.7138439790908472,0.794682422451994,0.9787947265207941,1.0,4/14,19.79%,SEC24D;SEC23A;SEC24A;RAB1A
prerank,anterior/posterior axis specification (GO:0009948),0.3062915986437271,0.7131044562946116,0.819047619047619,0.9792789667096822,1.0,15/15,69.40%,TASOR;RIPPLY2;WLS;DDIT3;SKI;MESP2;SIX2;WNT8A;CDX1;TBXT;TBX3;SHH;HOXD8;LHX1;FZD5
prerank,positive regulation of coagulation (GO:0050820),-0.2924324471408249,-0.7129055846114701,0.8362573099415205,0.9976291294321615,1.0,4/10,28.22%,DMTN;ENPP4;F2R;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),-0.2924324471408249,-0.7129055846114701,0.8362573099415205,0.9976291294321615,1.0,4/10,28.22%,DMTN;ENPP4;F2R;ST3GAL4
prerank,regulation of neuroinflammatory response (GO:0150077),-0.23045350341639448,-0.7124950109266684,0.8884297520661157,0.9966991066687232,1.0,6/19,25.37%,TNFRSF1B;TREM2;CD200R1;CD200;IL1B;NUPR1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.2322737747251865,0.7124731234211361,0.9302564102564103,0.9796488878635884,1.0,12/116,14.33%,CALCA;RXFP2;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14;RHBDF2;FCGR2B;FYN
prerank,membrane depolarization (GO:0051899),0.2678495813615444,0.7123676180629159,0.8460575719649562,0.9794083490729978,1.0,6/32,17.93%,CACNA1A;P2RX4;SCN2A;CHRNB2;SCN1B;SCN8A
prerank,regulation of integrin activation (GO:0033623),0.30757372338071953,0.7118196908821007,0.8363636363636363,0.9796863121110145,1.0,5/15,25.79%,PTGER4;JAM3;FARP2;PIEZO1;FERMT2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2578557724291049,0.7117488546852645,0.8635294117647059,0.9794014888533124,1.0,13/40,27.54%,BCO2;ABCD1;RNF122;BAD;NDUFS1;BAX;PRDX3;VCP;ARL6IP5;SLC25A33;STOML2;BCL2L1;PRELID1
prerank,negative regulation of catabolic process (GO:0009895),0.25687138045757746,0.7105257962314481,0.8831018518518519,0.9804178168787664,1.0,18/47,27.39%,AZIN2;MAD2L2;RILP;AGAP2;GIT1;AZIN1;PIN1;HMGCR;TIGAR;HDAC4;SNX12;BSCL2;FLNA;SIRT2;TNF;FMN2;ZDHHC7;MAD2L1
prerank,mesoderm development (GO:0007498),0.2891409566404716,0.710437140252236,0.8151041666666666,0.9801528442541029,1.0,3/18,14.28%,HCK;IKZF1;JAK2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.22590379540932018,0.7104027214418678,0.9369183040330921,0.979824914339426,1.0,25/144,14.33%,FIS1;MYO1C;RUFY3;SEC16A;FBXW7;TCF7L2;SH3GLB1;VPS11;CSNK2A2;TFDP1;RNF31;LEPROT;PLK3;PRNP;CIB1;ZC3H12A;CEP131;TFDP2;SORL1;PSEN1;NPEPPS;UBE2L3;BAD;VAMP2;FYN
prerank,nuclear envelope organization (GO:0006998),0.2945163788606238,0.7100655052617725,0.8293650793650794,0.9798496458004838,1.0,4/20,14.75%,TOR1AIP1;SUN2;REEP3;NUP155
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.28300437439088755,-0.7099950196614148,0.845945945945946,0.9981024767024563,1.0,2/10,9.15%,GABRG3;GABRA2
prerank,meiosis I (GO:0007127),0.28323710574553046,0.7097096794284061,0.822477650063857,0.9798766533512705,1.0,3/23,19.28%,BCL2L11;ZCWPW1;PTTG1
prerank,cellular response to drug (GO:0035690),0.27852324260331074,0.7097007632020524,0.8484076433121019,0.9795155573803351,1.0,3/25,10.55%,AIM2;CRHBP;PPM1F
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3238232244237139,0.7096982248128049,0.8333333333333334,0.9791463282972772,1.0,2/12,8.12%,PHGDH;SEPHS1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.268258373190974,-0.7089948819979597,0.8214285714285714,0.9977779511738364,1.0,5/12,24.10%,PAEP;CARD9;RASGRP1;IL1B;CD80
prerank,carbohydrate biosynthetic process (GO:0016051),-0.22344045496178572,-0.7089265974675144,0.8914027149321267,0.9964048706513335,1.0,5/21,16.42%,ST3GAL6;ST3GAL3;B3GALT5;B3GALT2;FUT8
prerank,histone H4 acetylation (GO:0043967),0.2551278382636977,0.7074598021943849,0.8855140186915887,0.9813107958438364,1.0,22/47,31.30%,JADE3;KMT2A;EP400;WDR5;APBB1;KAT8;KAT7;PER1;RUVBL2;ING5;JADE2;ACTL6A;ZZZ3;RUVBL1;EP300;BRD8;CHD5;YEATS4;HCFC1;MORF4L1;JADE1;OGT
prerank,neurotransmitter transport (GO:0006836),0.2403943664443393,0.7072676713886621,0.88113413304253,0.9811599990298854,1.0,20/73,27.38%,SLC18A2;SLC38A2;SLC38A1;SYNJ1;CPLX1;HSPA8;VAMP2;PPFIA4;SLC32A1;GAD1;BRSK1;STXBP3;SLC1A3;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;GLS2
prerank,regulation of catabolic process (GO:0009894),0.29025968437127814,0.7070733814014418,0.8328877005347594,0.9810005364630421,1.0,2/18,6.61%,CHEK2;TMEM9
prerank,ventricular septum development (GO:0003281),0.26373714590345443,0.7066607108198745,0.8707403055229143,0.9810777996856792,1.0,7/37,17.29%,ACVR1;BMPR2;PROX1;SLIT3;MATR3;BMPR1A;HECTD1
prerank,sulfur compound catabolic process (GO:0044273),0.25754637663465607,0.7065942138938722,0.8685503685503686,0.9807826847372213,1.0,12/38,23.95%,HYAL1;FMOD;CSPG4;GGT7;ACAT1;GADL1;GLB1;CHAC2;OGN;GALNS;TXN2;GNS
prerank,melanosome transport (GO:0032402),-0.23068697347232509,-0.7063531680337533,0.8686131386861314,0.9963586718391597,1.0,7/18,24.45%,BBS5;BLOC1S5;BLOC1S6;MREG;RAB27A;ARL6;MKKS
prerank,pigment granule transport (GO:0051904),-0.23068697347232509,-0.7063531680337533,0.8686131386861314,0.9963586718391597,1.0,7/18,24.45%,BBS5;BLOC1S5;BLOC1S6;MREG;RAB27A;ARL6;MKKS
prerank,primary alcohol metabolic process (GO:0034308),-0.21595919680916797,-0.7051681137527501,0.9049773755656109,0.9963040951074678,1.0,2/25,5.15%,GPD2;NAPEPLD
prerank,negative regulation of cilium assembly (GO:1902018),0.31942443770583506,0.7043181537603609,0.844851904090268,0.9830121966641252,1.0,4/12,18.86%,CDK10;ODF2L;MAP4;TESK1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.25177607669182095,-0.7043160833453016,0.8869257950530035,0.9957093315081451,1.0,3/14,20.44%,PTPN2;TRAIP;NLRP2B
prerank,oogenesis (GO:0048477),0.30220218713837876,0.7040725045104055,0.8260869565217391,0.9829071629608072,1.0,5/15,26.51%,MARF1;MDK;MEI4;KMT2D;FMN2
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3353570913496614,0.7037475505255884,0.8283582089552238,0.9828982311273765,1.0,3/10,16.81%,SPHK2;IL18;LGALS9
prerank,regulation of cation channel activity (GO:2001257),0.23616344086868324,0.7036654039044302,0.9192348565356004,0.9826063010837454,1.0,15/89,16.24%,CAMK2D;CTSS;CAMK2B;ACTN2;CRHBP;CNIH3;GRIA2;NETO1;APP;CAPN1;FGF13;VAMP2;DLG1;MINK1;GRIA4
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.3223077149271374,0.7035411742851524,0.8189910979228486,0.9823675170864901,1.0,3/11,15.09%,PLEKHA4;DAB2;MLLT3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.18327614796977393,-0.703449849966371,0.9716312056737588,0.995210746356591,1.0,16/40,31.04%,TGFB1;SORBS1;GRIN1;AKT1;CREB1;CREBL2;SUCO;WNT4;MTPN;F2R;RAB27A;TLR4;VIM;CREB3L1;ADGRB1;BMP4
prerank,membrane assembly (GO:0071709),0.2623186090433393,0.7032330669444506,0.8609756097560975,0.9823660318131822,1.0,6/34,16.98%,CHMP4B;TLCD2;UBXN2B;STX4;NLGN3;FLOT2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3349699115019987,0.7025376590945698,0.8318965517241379,0.9827701194769761,1.0,1/10,4.86%,HSP90AB1
prerank,regulation of macroautophagy (GO:0016241),0.23139445347922089,0.7023194209294608,0.93717277486911,0.9826460205155183,1.0,26/105,22.25%,KDR;ATP6V0D1;LARP1;UBQLN2;RRAGC;SH3GLB1;NRBP2;WAC;PRKAG1;UBQLN1;CAPNS1;LAMTOR3;CAPN1;RB1CC1;VPS26A;MTOR;ATP6V1B2;ATP6V1G1;TSC1;ATP6V1G2;ERN1;LAMTOR4;TRIM13;VPS35;RHEB;RRAGA
prerank,glucan catabolic process (GO:0009251),-0.2501104723259401,-0.7020591085618195,0.8745519713261649,0.9953581418031039,1.0,2/15,4.69%,PYGB;PGM2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2968445249591086,0.7018129769952102,0.8627450980392157,0.9828265340912187,1.0,3/19,15.11%,RAPSN;APOE;CHRNB2
prerank,regulation of muscle cell differentiation (GO:0051147),0.271759420968444,0.7017426901169068,0.8855721393034826,0.9825235143171502,1.0,7/31,15.90%,CTNNB1;FGFR2;SRF;MEGF10;MAPK14;SPAG9;MEF2A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2512034946396053,-0.7015364915590703,0.9047619047619048,0.9944847504921542,1.0,4/16,16.24%,DPYSL3;NT5M;CRMP1;NT5E
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.22177643939907343,-0.7015037789222274,0.8847736625514403,0.9930837627354356,1.0,6/22,20.09%,RPL23;SPRED2;UBB;RPL37;CDK5RAP3;HEXIM1
prerank,response to prostaglandin E (GO:0034695),0.33129084708379486,0.7013773939829122,0.8368580060422961,0.98256300029165,1.0,1/10,4.12%,PTGER4
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.26257596534136585,0.7013360853948677,0.8706166868198307,0.9822417026027526,1.0,6/33,12.26%,SFRP2;SNAI2;RET;LYN;CIB1;PTPN11
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.21597189610409467,-0.7013304555087971,0.9454545454545454,0.9918333676320951,1.0,2/23,2.35%,HPGD;LTC4S
prerank,mammary gland epithelium development (GO:0061180),-0.2492435892023276,-0.7012856029006221,0.8590163934426229,0.990448729542882,1.0,5/14,20.26%,ID2;AKT2;AKT1;SCRIB;WNT4
prerank,cranial nerve development (GO:0021545),0.32771992100840824,0.7012500321849721,0.8330804248861912,0.9819627834963076,1.0,3/11,22.53%,CHD7;CHRNB2;ERBB3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2784213983862632,0.7006965247623382,0.848761408083442,0.9822339033996087,1.0,5/23,13.58%,HOOK2;CCDC88A;HOOK1;CCDC88B;HOOK3
prerank,JNK cascade (GO:0007254),0.25809417860046463,0.7004436796852112,0.8764988009592326,0.9821433359452568,1.0,3/40,4.12%,NOD2;NOD1;PTGER4
prerank,positive regulation of cell development (GO:0010720),0.2606821198261718,0.6994619373707196,0.889308176100629,0.9828392278943444,1.0,8/31,21.67%,LRP2;SNW1;BAD;NUMBL;PDE3A;TYROBP;TGM2;FAIM
prerank,divalent inorganic cation homeostasis (GO:0072507),0.278325819680851,0.699460195690837,0.8615179760319573,0.9824695391799866,1.0,3/25,6.71%,SLC8A1;MT3;TFAP2B
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.2563148729400016,0.6993187791047657,0.8845265588914549,0.9822562283337587,1.0,6/43,12.48%,STAT3;DDX5;SOX9;SRF;NFIB;NR3C1
prerank,positive regulation of secretion by cell (GO:1903532),0.23975204799348276,0.6990862174490902,0.9038876889848813,0.9821460950045808,1.0,20/70,25.55%,ABCG1;ADAM8;PPIA;UNC13D;BAIAP3;P2RX4;CADPS2;TMED10;RAB2B;APBB1;DTNBP1;GOLPH3L;CD33;CADPS;FRMD4A;ANG;CD2AP;CFTR;KCNB1;RAB3A
prerank,regulation of calcium ion transport (GO:0051924),0.24375996014965953,0.6987942865836959,0.8857782754759238,0.9821242571515878,1.0,8/54,14.95%,CAMK2B;CCL5;GRAMD2A;CTNNB1;P2RX4;CRACR2A;CD84;INPP5K
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2314196112039696,-0.6986526825296867,0.8838174273858921,0.9917483640101326,1.0,7/18,25.69%,COX16;PET100;TIMM21;SCO1;SURF1;COA3;COX18
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3184878124533279,0.6979938768691186,0.8550512445095169,0.9826315097483411,1.0,1/12,2.71%,CHEK2
prerank,positive regulation of cell killing (GO:0031343),0.3116531748703269,0.6978989783532852,0.851063829787234,0.9823711712841383,1.0,1/13,1.52%,WNT5A
prerank,regulation of immunoglobulin production (GO:0002637),-0.21712304705540075,-0.6977883623286214,0.9035087719298246,0.9912590215914053,1.0,7/23,23.11%,SASH3;EPHB2;VAMP3;DNAJB9;CD86;PHB2;CLCF1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.2937865356034327,0.6973403725471884,0.8383561643835616,0.9826215521144614,1.0,3/16,11.15%,RORA;FOXK1;BCKDK
prerank,endoderm formation (GO:0001706),0.26032031660991073,0.6968432175915533,0.8655256723716381,0.9828210891049417,1.0,3/35,7.32%,MMP14;COL4A2;COL8A1
prerank,regulation of phosphatase activity (GO:0010921),-0.20869319920739465,-0.696568450859954,0.9027777777777778,0.9911474267528095,1.0,5/24,14.11%,HTT;PTPA;MTMR9;URI1;ZCCHC9
prerank,regulation of cholesterol efflux (GO:0010874),0.2647713186826938,0.6964346362328384,0.8688725490196079,0.9828897291860715,1.0,6/30,19.23%,NR1H2;YJEFN3;APOE;PTCH1;ZDHHC8;TTC39B
prerank,heme biosynthetic process (GO:0006783),0.28133737849358403,0.696222283321767,0.8519480519480519,0.9827577388571964,1.0,6/22,20.01%,FXN;TSPO;UROS;PGRMC1;FLVCR1;ABCG2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.31016576746303914,0.6960459249689999,0.8451519536903039,0.9825828020849042,1.0,4/14,18.73%,NGRN;RCC1L;TRMT10C;FASTKD2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2644911333283851,0.6959284852962826,0.8669201520912547,0.9823370358416134,1.0,10/28,25.44%,DAXX;DIABLO;DDX47;BAX;CRADD;DDX3X;ZDHHC3;DEDD;DELE1;TNF
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.22768560262313323,0.6958767327119536,0.9473140495867769,0.982027689011931,1.0,9/117,9.64%,CALCA;RXFP2;PTGER4;HCK;ADCY5;PRKAR2B;LYN;FCGR1A;MAPK14
prerank,positive regulation of protein transport (GO:0051222),0.23957345081534467,0.6953479806026015,0.9073064340239912,0.9822243588208367,1.0,11/67,13.37%,ABCG1;ADAM8;RUFY3;PPIA;PLK3;TMED10;CEP131;VPS28;RACK1;APBB1;VAMP2
prerank,axoneme assembly (GO:0035082),-0.20009792331372142,-0.6950641421080958,0.9521276595744681,0.9913257803005755,1.0,19/31,40.34%,DNAI4;TTLL3;CCDC39;DNAAF3;RSPH9;FOXJ1;DCX;CFAP74;JHY;DNAJB13;CFAP206;DRC1;GAS8;DNAAF2;RSPH1;RP1;RSPH4A;DNAAF1;CCDC65
prerank,T cell differentiation in thymus (GO:0033077),0.30173559366470004,0.69488393510431,0.8366477272727273,0.982339442797747,1.0,4/14,23.55%,ZFP36L1;PTPRC;GLI3;ZFP36L2
prerank,UV protection (GO:0009650),-0.2830160668821843,-0.6948734942380901,0.8450292397660819,0.9901365443506487,1.0,7/10,38.41%,ERCC2;CAT;XPA;GPX1;SCARA3;ERCC5;MFAP4
prerank,modulation of chemical synaptic transmission (GO:0050804),0.231367017339585,0.6948344061410079,0.922675026123302,0.9820229062386892,1.0,38/107,27.70%,BDNF;CLSTN1;GRIK3;CPLX1;EIF4EBP2;BAIAP3;ABR;CACNA1A;APP;AKAP9;IQSEC2;CLSTN3;CHRNB2;GRID1;NLGN3;LRP8;OPHN1;BCR;DGKI;LRRC4;LGI1;MCTP1;BEGAIN;GRIK4;SYN1;GRM7;DLGAP4;DLGAP3;GRM4;GRIK5;GRIK2;CLSTN2;TNF;DLGAP2;PTEN;CDK5;ITGB1;CPLX2
prerank,amyloid-beta metabolic process (GO:0050435),-0.2384216150330932,-0.694414185317988,0.8655737704918033,0.9891958246288295,1.0,6/16,24.20%,DYRK1A;MGAT3;BACE1;ABCA7;PSEN2;NCSTN
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.24235015002281804,-0.6943929963317607,0.8934707903780069,0.9878272939491546,1.0,6/15,18.40%,SPCS3;RAB3GAP2;SEC61G;SEC61A1;ZFAND2B;SRPRB
prerank,regulation of astrocyte differentiation (GO:0048710),-0.2647978251181894,-0.694367294985015,0.8653198653198653,0.9864457878674988,1.0,2/12,7.16%,BIN1;ID2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.23940166892034748,0.6941599961975341,0.8981173864894795,0.9823806025361055,1.0,10/59,16.65%,CAMK2D;ACVR1;CHEK1;CSNK2B;CSNK2A2;CDK10;DYRK2;PRKDC;OXSR1;STK39
prerank,protein hydroxylation (GO:0018126),0.29990721704645046,0.6940106442658445,0.8479776847977685,0.9821795286789865,1.0,5/15,19.16%,ASPH;P3H1;VIPAS39;JMJD4;OGFOD1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.24783668936027098,0.6938513432257174,0.88,0.9819993111907419,1.0,8/46,13.91%,LAMC1;LAMB2;PARVB;PEAK1;SRGAP2;ANTXR1;NRP1;RAC1
prerank,epiboly involved in wound healing (GO:0090505),0.29930668444560726,0.6936763773418138,0.8581363004172462,0.9818109499674887,1.0,2/16,9.06%,MRTFA;PDPN
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.24887706984134594,-0.6934300998768345,0.8876404494382022,0.9860207124822762,1.0,5/14,30.78%,CHAT;NOS1;MOXD1;ACHE;ALDH9A1
prerank,central nervous system neuron differentiation (GO:0021953),0.26311091242296636,0.6931178448096962,0.8778443113772455,0.982057968619797,1.0,3/33,10.08%,LMX1A;CTNNB1;PROX1
prerank,establishment of spindle orientation (GO:0051294),0.2659163887985748,0.6929278175878836,0.8674846625766871,0.9819118428885094,1.0,7/28,19.18%,CDK5RAP2;UBXN2B;MAP4;LLGL1;PAFAH1B1;NUMA1;NDC80
prerank,Rap protein signal transduction (GO:0032486),0.3271682214582225,0.6924231034396725,0.8278443113772455,0.9821093960422136,1.0,4/10,19.85%,RAPGEF2;RAPGEF1;RAP2A;SGSM3
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.20684786252206172,-0.6914825457740852,0.9038461538461539,0.9865452077104379,1.0,12/25,30.30%,ITGAV;PARVA;NINJ1;CD200R1;ITGB3;CXADR;ITGB7;CD200;ITGB2;JUP;CD2;DSG2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.27413079964531706,0.6910948480145227,0.87001287001287,0.9831834386949921,1.0,1/24,1.21%,CAMK2D
prerank,epithelial cell differentiation (GO:0030855),0.22838155191203777,0.6910259577440979,0.926595744680851,0.9828868096417409,1.0,18/88,25.64%,KDR;TDRD7;CASP6;FGFR2;EDF1;PROX1;HNRNPH3;E2F4;DAB2;ANXA4;HDAC1;CNN3;ALDOC;HDAC2;RAB10;ANXA7;ACADVL;PIH1D1
prerank,defense response to fungus (GO:0050832),0.2977717448482302,0.69101017049762,0.8771929824561403,0.9825378364171049,1.0,2/17,8.61%,RNASE7;FAM3A
prerank,cardiac atrium morphogenesis (GO:0003209),0.3002971733747566,0.690884925350474,0.8760563380281691,0.9823062285386809,1.0,2/16,10.08%,BMPR2;PROX1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.31723033694167235,0.6906980366172565,0.8666666666666667,0.982131823354742,1.0,1/11,1.64%,IRS1
prerank,regulation of dendritic spine development (GO:0060998),0.28819156929129464,0.6902499772899252,0.8317757009345794,0.9822605911908989,1.0,3/19,12.35%,CAMK2B;PSEN1;APOE
prerank,regulation of mast cell activation (GO:0033003),0.3271956464604266,0.689487698066326,0.8512269938650306,0.9827158113923299,1.0,3/10,18.65%,LYN;CD84;CD300LF
prerank,protein depolymerization (GO:0051261),0.2685297190027305,0.6893433287065204,0.8717310087173101,0.9825024723772148,1.0,9/27,22.86%,KIF2C;STMN4;STMN3;GSN;KIF2A;STMN2;CFL2;DSTN;TWF1
prerank,receptor clustering (GO:0043113),0.26358636612348363,0.6890321687354003,0.8801020408163265,0.9824604997094224,1.0,9/27,25.19%,THY1;MAGI2;AGRN;DNAJA3;DLG1;ITGA4;SAV1;FLNA;LRP4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2497516266201489,0.6883417159888789,0.8918918918918919,0.9828398621515981,1.0,8/39,19.31%,TCF7L2;MYRIP;BAD;IRS2;TFR2;SELENOT;GLUD1;PSMD9
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.22757466631154732,0.6881949604774081,0.9365750528541226,0.9826300849764525,1.0,21/95,22.24%,SPRY2;PMEPA1;HSP90AB1;ITGA3;SMAD2;BAMBI;MEN1;DKK3;SNW1;SKIL;SMURF1;DAB2;HTRA3;SPRED3;SPRED1;SNX25;PIN1;STK11;CITED2;SMURF2;STUB1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.29684353924769885,0.687845257127534,0.8571428571428571,0.9826187971132361,1.0,4/16,15.53%,VAMP2;LYST;PLEKHM2;TUBB4B
prerank,neurotransmitter secretion (GO:0007269),0.24982966455573724,0.6875760195284889,0.9009433962264151,0.9825259697562516,1.0,17/44,27.70%,CPLX1;HSPA8;PIP5K1C;VAMP2;SLC32A1;GAD1;BRSK1;STXBP3;PCLO;SYN1;GRM4;RAB3A;DNAJC5;LIN7C;SNPH;CDK5;CPLX2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.2795638621060538,0.687159905752086,0.8653846153846154,0.9825947509147573,1.0,1/19,1.35%,CLIC4
prerank,dephosphorylation (GO:0016311),0.2213740251282818,0.6869298045712428,0.9425641025641026,0.9824799478961698,1.0,48/147,26.53%,SGPP2;PTPN18;DUSP3;PPP2R5C;PDXP;SBF1;DUSP29;TIMM50;PTPN7;BTRC;DUSP28;DUSP26;PPM1F;PPP2R5D;EPHX2;PPP4R2;DUSP10;DUSP16;DUSP11;INPP5K;PTPN9;PTPRU;PPP2R2A;PTPRC;DUSP8;PTPRB;PTPRF;PPP2R5A;LHPP;STK11;PLPP2;PPP2R3A;PTPRM;PLPPR2;PPP1R12A;PLPPR1;FRA10AC1;PTPN6;PTPRS;PPM1H;PLPP6;PDP1;PLPP1;PTPN1;NT5C;PPM1A;DUSP7;PTEN
prerank,positive regulation of rRNA processing (GO:2000234),0.3208573778467717,0.6865091842756372,0.8348214285714286,0.9825505632097111,1.0,4/10,22.05%,DIMT1;WDR43;BUD23;UTP15
prerank,cardiac conduction system development (GO:0003161),-0.2105257630195762,-0.6862632622474067,0.941908713692946,0.990390515266126,1.0,11/24,43.51%,SMAD4;GJB6;CACNA1G;BMP4;HCN4;HEY1;HEY2;MSC;GJA5;MSX1;SHOX2
prerank,fatty acid transport (GO:0015908),0.2946370342355028,0.6857295150802624,0.8585034013605443,0.9829980030739699,1.0,3/17,16.03%,SLC27A1;APOE;PPARD
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.2817061179992009,0.6856229475116613,0.8596026490066225,0.9827468957471448,1.0,6/20,24.75%,SLC25A1;SCD5;GCDH;ACSL3;FAR2;CBR4
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2521818735182108,-0.6843565780138083,0.8970099667774086,0.9907774570791285,1.0,5/12,25.37%,TTBK1;CCL3;TREM2;IL1B;NUPR1
prerank,regulation of actin nucleation (GO:0051125),0.30888375087187125,0.6843550854212455,0.8583815028901735,0.983701158992545,1.0,3/12,13.56%,GSN;WHAMM;CORO1B
prerank,regulation of exosomal secretion (GO:1903541),0.2872656205619114,0.6841015370529062,0.8705234159779615,0.9836070513536731,1.0,8/19,29.62%,SDC4;CHMP3;HGS;TSG101;SNF8;SDCBP;PDCD6IP;RAB7A
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.2416269858129544,0.6838798242972377,0.9005464480874317,0.9834932468710688,1.0,10/52,15.17%,DDX5;RBMX;HNRNPL;RNPS1;RBFOX1;HNRNPA1;CELF6;RBM15;MBNL2;RBFOX3
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2280735031756712,0.6837611182892028,0.9381663113006397,0.9832516494280668,1.0,18/83,18.83%,CENPJ;DYNC1H1;ACTR1A;MAPRE1;CDK5RAP2;PRKAR2B;NPM1;NEDD1;CEP131;CEP152;CEP70;AKAP9;DYNLL1;HSP90AA1;TUBB4B;DCTN3;PAFAH1B1;CEP135
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2634393217299138,0.6836071306610779,0.872366790582404,0.9830415369338783,1.0,4/29,19.90%,STX7;STAP1;LAMP1;TYROBP
prerank,positive regulation of protein secretion (GO:0050714),0.23235236582245675,0.6833970790483801,0.9097744360902256,0.98290124631179,1.0,14/69,19.69%,ABCG1;ADAM8;TCF7L2;PPIA;TMED10;MYRIP;BAD;APBB1;IRS2;TLR2;GLUD1;GOLPH3L;PSMD9;CD33
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.23004769118272195,-0.6827234793308208,0.9185185185185185,0.9909443064502083,1.0,5/18,19.10%,PTPN22;AKT1;JAK3;ASS1;IL4I1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.25365876359865314,0.682242851434707,0.8667466986794717,0.9837412312693741,1.0,8/34,24.63%,SLC8A1;P2RX4;ZC3H12A;CALM3;ASB3;PDE4B;CALM2;ANK2
prerank,proteasome assembly (GO:0043248),0.3137615744442137,0.6821577385335801,0.8401759530791789,0.9834690024129429,1.0,7/11,29.19%,PSMG2;OTUD6B;PSMD9;ADRM1;PSMD4;PSMD11;PSMG1
prerank,regulation of dendrite extension (GO:1903859),-0.2243983602427545,-0.6819745731836994,0.9404761904761905,0.9902874481606443,1.0,7/18,23.05%,SYT2;RNF157;RIMS1;UNC13A;RIMS2;SYT1;CPNE5
prerank,regulation of neurotransmitter secretion (GO:0046928),0.25240959798005247,0.6819211136769002,0.888622754491018,0.9833517813449638,1.0,9/32,24.54%,SLC30A1;CPLX1;BAIAP3;PREPL;DTNBP1;VPS18;MCTP1;SYN1;SYT11
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2244545140945222,0.6810674564187772,0.9426485922836287,0.9838793076320178,1.0,19/104,19.47%,SPRY2;ACVR1;LRP2;PMEPA1;MAGI2;SMAD2;BAMBI;BMPER;BMPR2;SKIL;SORL1;SMURF1;BMPR1A;HTRA3;SPRED3;ACVR2A;SPRED1;SNX25;PIN1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.26281073929108784,0.6809518415494159,0.8875305623471883,0.983623692017532,1.0,4/33,16.89%,KDR;TCF7L2;TNIP2;MDK
prerank,gas transport (GO:0015669),-0.2772406934687831,-0.6809227629558903,0.8696883852691218,0.9898675142902857,1.0,2/10,19.34%,IPCEF1;MYC
prerank,dendritic spine organization (GO:0097061),0.26440624629161985,0.6804648759636296,0.8934324659231723,0.9837775243077076,1.0,6/26,14.33%,PAK3;ITGA3;INSR;PRNP;CTNND2;FYN
prerank,histone H3-K36 demethylation (GO:0070544),0.32468293564066714,0.6796850427503368,0.850381679389313,0.9841984066764333,1.0,3/10,15.96%,RIOX2;KDM8;KDM7A
prerank,regulation of cytoskeleton organization (GO:0051493),0.22211060592376825,0.6793894298112799,0.9285714285714286,0.9841390771044595,1.0,18/108,16.32%,BST2;CLIC4;RHOF;SYDE1;PAK3;CYLD;KATNBL1;CCDC88A;SPEF1;STMN3;CDK10;PHLDB1;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR
prerank,cGMP biosynthetic process (GO:0006182),0.322396009201374,0.6791200556911506,0.8621212121212121,0.9840523151245438,1.0,3/10,26.20%,NPPC;NPR2;GUCY1B1
prerank,aortic valve development (GO:0003176),0.2564106301852418,0.6790207800357321,0.8795749704840614,0.9837733541071811,1.0,5/34,12.75%,SOX9;SNAI2;BMPR2;SLIT3;RB1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.2824222662175753,0.677944788126848,0.8552456839309429,0.984512327376328,1.0,3/18,12.75%,RUNX1;PDPN;RB1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.27652181180859253,0.6778930761871829,0.8820375335120644,0.9841981680311225,1.0,3/21,11.45%,BCL2L11;NCK1;XBP1
prerank,negative regulation of cell activation (GO:0050866),-0.24139129227038336,-0.6777217758865083,0.8870431893687708,0.9915295566479714,1.0,5/14,26.12%,TREM2;CD200;THBD;PDGFRA;EMILIN1
prerank,positive regulation of exosomal secretion (GO:1903543),0.2919908464600226,0.6774945837994719,0.8569444444444444,0.9842386807688354,1.0,7/15,29.62%,SDC4;HGS;TSG101;SNF8;SDCBP;PDCD6IP;RAB7A
prerank,fibrinolysis (GO:0042730),0.2986564540431943,0.6770644754622378,0.8544117647058823,0.984308812814945,1.0,13/13,70.16%,PLAUR;PLAT;SERPINE1;GP1BA;FGG;F2;KRT1;CPB2;HRG;PLG;SERPINB2;SERPINF2;PLAU
prerank,membrane raft organization (GO:0031579),0.29577877084878085,0.6767354114309282,0.8804034582132565,0.9842595988469336,1.0,3/15,16.98%,YJEFN3;NPC1;FLOT2
prerank,negative regulation of dephosphorylation (GO:0035305),-0.22412805078918369,-0.6766790992259901,0.9029850746268657,0.9911326402083888,1.0,5/18,14.11%,PPP1R8;PPP1R16B;PTPA;URI1;ZCCHC9
prerank,engulfment of apoptotic cell (GO:0043652),0.28808045923249015,0.6764890485445689,0.8652482269503546,0.9841463520805008,1.0,3/15,13.91%,XKR7;MEGF10;RAC1
prerank,oligosaccharide metabolic process (GO:0009311),0.2426867597548998,0.6761847657494026,0.907744874715262,0.984080575218438,1.0,7/46,18.20%,ST6GALNAC4;ST6GALNAC6;B4GALT1;NEU1;MAN2C1;ST8SIA1;FUT9
prerank,nuclear pore complex assembly (GO:0051292),0.3197675702269013,0.6761135838703352,0.8523076923076923,0.9837842942156743,1.0,2/10,13.95%,NUP153;AHCTF1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.2862302349562178,0.6758684655093505,0.8546195652173914,0.983666539088003,1.0,7/17,27.95%,SLC8A1;SCN1B;KCNJ2;HCN2;ANK2;SCN4B;CACNA1D
prerank,melanosome localization (GO:0032400),0.2773624154341142,0.6754031704278509,0.8879781420765027,0.9837578053072477,1.0,7/21,26.49%,VPS33A;RAB11B;BBS2;RAB11A;BBS7;BBS4;SHROOM2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.29277327808124565,0.6744687092136046,0.8523878437047757,0.984308490576004,1.0,14/14,70.75%,ECE1;CORIN;NOS3;EDN1;AGTR1;AVPR1A;EDN2;EDN3;OXTR;ACE2;ACE;AVPR2;RASL10B;ENPEP
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.20885369804121756,-0.6742684901264154,0.9205020920502092,0.9919737867917107,1.0,3/23,9.82%,MBOAT1;PLAAT3;PLBD1
prerank,glutathione metabolic process (GO:0006749),0.24987026945721946,0.6739038454839106,0.9045893719806763,0.9844951593304959,1.0,7/38,20.70%,ETHE1;GSR;GGT7;CTNS;GCLC;CNDP2;CHAC2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.2590450402659519,0.6737012078069002,0.8871359223300971,0.9843337281913034,1.0,6/31,17.18%,PEX7;TOMM40L;TIMM50;PEX2;PEX5;TOMM40
prerank,regulation of intracellular pH (GO:0051453),-0.18548005942790313,-0.6732468458861985,0.9742268041237113,0.9914902150784091,1.0,9/34,22.21%,SLC9A9;NOX1;SLC4A8;GPR89B;GPR89A;CLN3;SLC9A8;SLC26A6;SLC4A3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.28669089636579936,0.6724753187676328,0.8829931972789116,0.9852188724884273,1.0,5/16,17.43%,SPHK2;DNAJC30;AK4;PPARGC1A;ATPSCKMT
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.25723149979778853,0.6723619168336771,0.897908979089791,0.9849646459562071,1.0,3/29,10.08%,TNNC1;FGFR2;PROX1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.28879231813997164,0.6722232195536784,0.8549723756906077,0.984738279979502,1.0,6/16,23.08%,ABCD1;ZC3H12A;CHID1;SIRPA;APPL2;ADCY7
prerank,peptidyl-glutamic acid modification (GO:0018200),0.26431659352031656,0.6719414413159255,0.8851174934725848,0.9846861745379744,1.0,4/24,14.63%,TTLL8;TTLL7;GGCX;CFAP20
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2556016453815421,0.6715854313318698,0.9058240396530359,0.9843211296581029,1.0,5/29,18.83%,ACOT9;ACBD6;ACOT13;ACAT1;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2556016453815421,0.6715854313318698,0.9058240396530359,0.9843211296581029,1.0,5/29,18.83%,ACOT9;ACBD6;ACOT13;ACAT1;OXSM
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2777655991729383,0.6713296537493592,0.8857901726427623,0.9842176538641101,1.0,5/20,19.82%,FMNL2;DLG1;LLGL1;FMNL3;NCKAP1
prerank,regulation of potassium ion transport (GO:0043266),-0.19214736697969653,-0.6706788832245878,0.9521531100478469,0.9924224451725352,1.0,11/31,29.44%,KCNIP3;ANK3;FHL1;KCNAB1;ADRA2A;DRD2;NOS1;KIF5B;KCNIP4;KCNH2;PTK2B
prerank,renal filtration (GO:0097205),0.3165858212880164,0.6705552238187256,0.862371888726208,0.9846269292762739,1.0,2/10,10.31%,ITGA3;TBC1D8B
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2364148672472974,0.6704668328380906,0.9227373068432672,0.9843522200482361,1.0,8/56,18.00%,CHMP4B;SNX33;CUL7;EFHC2;SNX9;SEPTIN9;IST1;DCTN3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.2945969534667865,0.6703117277940634,0.8784530386740331,0.9841399097074908,1.0,3/14,17.08%,RAPGEF2;PRKAR2B;PRKAR2A
prerank,regulation of fatty acid metabolic process (GO:0019217),0.2850752192999617,0.6696010575680279,0.8780160857908847,0.9844185280062329,1.0,5/17,24.41%,EIF6;PANK2;PPARD;ADIPOR1;PRKAB2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.22392855619749033,0.6684958078016345,0.9406150583244963,0.9851007431442981,1.0,16/86,17.68%,SPRY2;DENND1A;LYN;KANK1;VAV1;STARD8;AKAP13;RAPGEF1;JAK2;IRS2;LZTR1;SH3BP1;DENND4A;OPHN1;BCR;PLCE1
prerank,cell projection organization (GO:0030030),0.25360215243376055,0.6684758475081055,0.8955974842767296,0.9847589875843737,1.0,5/30,13.91%,PARVB;CYFIP1;RHOJ;GSN;RAC1
prerank,endodermal cell differentiation (GO:0035987),0.2557101944052609,0.6684596504071695,0.8905472636815921,0.9844086627923063,1.0,3/31,7.32%,MMP14;COL4A2;COL8A1
prerank,neuromuscular junction development (GO:0007528),0.26677075009295215,0.6679754734357912,0.8883116883116883,0.9844997898088088,1.0,3/24,11.02%,DOK7;AGRN;DNAJA3
prerank,substantia nigra development (GO:0021762),0.2487702919619876,0.6672849974391641,0.9050480769230769,0.9847924548678985,1.0,14/37,27.48%,SEC16A;FGF9;DYNLL1;ACTB;CALM3;GLUD1;PLP1;ZNF148;CALM2;YWHAE;SIRT2;CKB;BASP1;CCDC14
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2589810227678289,0.6669889866821433,0.9023199023199023,0.9846814765485942,1.0,8/32,19.01%,CTNNB1;CCT4;CCT7;CCT3;HNRNPA1;MAP3K4;HMBOX1;NEK7
prerank,histone H2A acetylation (GO:0043968),0.2879547293621483,0.6663060899282865,0.8651994497936726,0.9850057857685971,1.0,8/16,31.03%,EP400;SPHK2;RUVBL2;ACTL6A;RUVBL1;BRD8;YEATS4;MORF4L1
prerank,organic cation transport (GO:0015695),0.2770405525862037,0.6654055940911308,0.8833780160857909,0.9855117997674605,1.0,5/20,28.66%,SLC25A19;SLC44A1;SLC25A26;SLC22A4;SLC5A7
prerank,icosanoid metabolic process (GO:0006690),-0.1853690894571284,-0.6649781730096532,0.9387755102040817,0.9959301357705402,1.0,8/40,16.58%,HPGD;LTC4S;ALOX5AP;PTGS1;ABCC10;MGLL;GGT5;FAAH
prerank,kinetochore organization (GO:0051383),0.29699435705614396,0.6646807758623804,0.8630338733431517,0.9858429017350909,1.0,4/13,19.18%,CDT1;POGZ;MIS12;NDC80
prerank,Ras protein signal transduction (GO:0007265),0.21660868463789762,0.6646387449473854,0.9714867617107943,0.9855238675012745,1.0,38/137,24.01%,USP50;CDH13;KPNB1;CYFIP1;ARHGAP4;RAPGEF6;RAPGEF2;PDPN;DNMT1;MAPK14;G3BP2;ARHGEF11;HACD3;SOS1;RB1;RAPGEF1;RAC1;RREB1;DBNL;PHACTR4;AIF1;PLCE1;ARHGAP29;NF1;RAP2A;NCKAP1;SGSM3;CTNNAL1;RIT1;G3BP1;RHOH;USP8;FGF2;BRK1;FARP2;ARHGAP1;CDC42EP3;RGL2
prerank,peptide biosynthetic process (GO:0043043),0.2141596582164367,0.6643796497585069,0.9653767820773931,0.9854003665013126,1.0,35/153,21.25%,MRPL36;IGF2BP3;AGO2;RPL36;HARS2;GSPT1;RPL22;EIF4EBP2;RPS21;TNIP1;MRPL42;ABCF1;GGT7;RPS6;RPS11;RPL30;MRPL24;RPL32;RPL23A;RPL11;YARS2;RPL10A;RPS15A;MRPL13;HBS1L;SRBD1;RSL24D1;RPL24;RPL37A;RPL3;MRPS11;RRBP1;RPL29;RPL5;FARSB
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.2238573703919583,-0.6634569570269294,0.9386281588447654,0.9958342776414522,1.0,10/16,46.38%,CD226;RASGRP1;KLRD1;NECTIN2;KLRK1;CADM1;CRTAM;KLRC2;PVR;IL12A
prerank,positive regulation of dendrite extension (GO:1903861),-0.22441282242553084,-0.6629039028852743,0.9525691699604744,0.9949174846629261,1.0,7/17,23.05%,SYT2;RNF157;RIMS1;UNC13A;RIMS2;SYT1;CPNE5
prerank,cell junction maintenance (GO:0034331),0.2889266172376249,0.6627291861628974,0.8742857142857143,0.9865611428081463,1.0,1/14,4.40%,CHCHD10
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.2724787936625472,0.6626658512286301,0.8672922252010724,0.9862564756208195,1.0,1/18,1.37%,ALKBH7
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.26000370620704144,-0.6623215051747813,0.8938547486033519,0.9940018611610214,1.0,1/10,0.45%,EHMT1
prerank,sensory perception of sound (GO:0007605),0.22214394296632212,0.6614342116148556,0.9371614301191766,0.9870603249812525,1.0,8/88,12.53%,TMC1;LRP2;NDUFB9;MYO3B;SNAI2;ALDH7A1;ADGRV1;COL11A2
prerank,positive regulation of DNA replication (GO:0045740),0.2804815793668073,0.661416108532522,0.8679775280898876,0.9867136216072787,1.0,4/16,19.72%,CDT1;DHX9;STN1;KAT7
prerank,regulation of cell-cell adhesion (GO:0022407),0.24160952647753303,0.6607316242999501,0.9056603773584906,0.9869765076297388,1.0,7/39,18.20%,ADAM8;CD47;PODXL;MEGF10;MINK1;FLOT2;FUT9
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2524550868404905,-0.6605856263808347,0.8964401294498382,0.994044873928031,1.0,3/11,15.99%,CEBPB;TP53;ATF3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.28106025512700084,0.6602497674475123,0.8955431754874652,0.9870585882110086,1.0,2/16,9.11%,RUNX1;SCX
prerank,regulation of ion transport (GO:0043269),0.2231872862513038,0.6600594833349667,0.9394594594594594,0.9868803861353753,1.0,14/76,20.04%,B2M;SYT7;RAB11B;SYT3;GDNF;P2RX4;SIK1;CA2;VAMP2;CLDN10;CHRNB2;KCNJ2;DTNBP1;PER1
prerank,protein localization to cell-cell junction (GO:0150105),-0.22529341508174316,-0.6592334750998474,0.9219858156028369,0.99368503516039,1.0,9/15,34.40%,PAK2;SCRIB;F11R;LSR;ARHGEF18;TJP1;TJP3;CDH5;MPP7
prerank,hippo signaling (GO:0035329),0.25737997017325165,0.6584648475087064,0.9029374201787995,0.9879561892456987,1.0,7/26,21.29%,TEAD2;MOB1B;TJP2;AMOTL2;STK3;MOB1A;SAV1
prerank,myotube cell development (GO:0014904),-0.2599962337580817,-0.6583411626326207,0.8888888888888888,0.9930006191400478,1.0,10/10,74.02%,SELENON;ACTA1;LMOD3;KLHL40;RYR1;MYORG;SIX1;SKI;IGF1;CAV2
prerank,regulation of transposition (GO:0010528),-0.2458034447967289,-0.6579143163131408,0.9022801302931596,0.9919929689452914,1.0,4/13,27.83%,SIRT7;TEX15;DDX4;PIWIL2
prerank,sodium ion transport (GO:0006814),0.2188492052405047,0.6577234004501704,0.9509594882729211,0.9882514741080419,1.0,4/85,6.08%,CATSPER4;ATP1B3;SLC8A1;ASIC4
prerank,DNA alkylation (GO:0006305),0.27633487222922193,0.6575622271981414,0.8789546079779917,0.9876826848940305,1.0,3/19,9.13%,GATAD2A;DNMT3A;DNMT1
prerank,DNA methylation or demethylation (GO:0044728),0.27633487222922193,0.6575622271981414,0.8789546079779917,0.9876826848940305,1.0,3/19,9.13%,GATAD2A;DNMT3A;DNMT1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.25606745619745797,0.6546452355531517,0.9078104993597952,0.9899112742588637,1.0,4/26,15.21%,THADA;UBQLN1;GPR35;CALM3
prerank,lung epithelium development (GO:0060428),0.31256413969610275,0.6544428545556301,0.8736842105263158,0.9897269531549118,1.0,1/10,6.45%,WNT7B
prerank,regulation of multicellular organism growth (GO:0040014),0.2879541700673226,0.6543754240921998,0.8929577464788733,0.9894293906926356,1.0,5/15,25.59%,APP;PTCH1;BBS2;STAT5A;PPIB
prerank,positive regulation of cell division (GO:0051781),0.24096599059051402,0.6539842089444647,0.9158767772511849,0.9894188420318561,1.0,3/38,5.99%,CDC25B;PKN2;FGFR2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.20988645710208512,0.6538089607280916,0.9807692307692307,0.9892101293323571,1.0,19/153,12.80%,CAMK2D;SGK3;SGK2;STK38L;PKN2;PNCK;IKBKE;MORC3;MKNK1;CAB39;CSNK2A2;VRK3;MAST3;MAPK14;MAP2K2;NEK6;DYRK2;PRKDC;PRKCE
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.18575945556690335,-0.6537176238079627,0.9567901234567902,0.9937601045802593,1.0,8/33,22.87%,GCLM;ALDH18A1;DDAH1;NIT2;OAT;PRODH;ALDH4A1;PYCR3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.21896784003110292,-0.6536917953983408,0.9407407407407408,0.9924231424733891,1.0,11/17,47.86%,CD226;RASGRP1;KLRD1;NECTIN2;KLRK1;CADM1;CRTAM;KLRC2;PVR;IL12A;IL12B
prerank,actin crosslink formation (GO:0051764),0.298889551470075,0.6532635176412361,0.888243831640058,0.9893402313844549,1.0,4/12,16.36%,GAS2L3;BAIAP2;AIF1;BAIAP2L1
prerank,ceramide metabolic process (GO:0006672),0.22922680518024882,0.6530175243624541,0.9309551208285386,0.9892023190040061,1.0,11/49,21.47%,ASAH2;NSMAF;CERS6;DEGS1;ST6GALNAC6;ACER3;SPTLC2;SGPL1;CERS2;SPTSSA;PLPP2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.2383160796163088,-0.6527438908098478,0.8764044943820225,0.9917809519698314,1.0,6/13,33.66%,EPS8;HRAS;NDEL1;PLEKHM1;EPS8L1;CARMIL2
prerank,steroid hormone biosynthetic process (GO:0120178),0.2489556826065927,0.6524569164402841,0.8877679697351829,0.9893621683854251,1.0,3/29,12.95%,HSD17B7;STARD3;TSPO
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3058019256137901,0.6523578167765174,0.8707280832095097,0.9890886665774644,1.0,6/11,28.64%,NOP53;DDX11;MTOR;PIH1D1;NCL;SMARCB1
prerank,negative regulation of hippo signaling (GO:0035331),0.30378799728091826,0.6522164294697753,0.8726993865030674,0.9888608163705432,1.0,2/12,9.64%,MAP2K3;MAPK14
prerank,autophagy of mitochondrion (GO:0000422),0.2412375237446933,0.6517355832338686,0.918854415274463,0.9888908484406655,1.0,7/38,20.07%,FIS1;FBXO7;CISD2;MAP1LC3B;RB1CC1;BECN1;FUNDC1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2513963411667267,0.651671143770326,0.8938618925831202,0.9885923795169081,1.0,6/27,19.50%,DDX5;SNAI2;EEF1E1;SPRED3;SPRED1;SMYD2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.2890565342130653,0.6514665912358119,0.8912429378531074,0.9884252530205518,1.0,4/14,20.27%,NCK1;PPM1F;PPP2R2A;PPTC7
prerank,cardiac ventricle morphogenesis (GO:0003208),0.23417005556378567,0.6512092737763553,0.9203233256351039,0.9882941943639887,1.0,6/41,16.78%,SFRP2;TNNC1;FGFR2;PROX1;BMPR1A;RBPJ
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2598405975930734,0.6504389663182829,0.897172236503856,0.988595887630729,1.0,5/23,23.50%,GIT1;SIK1;CLK2;TIGAR;HDAC4
prerank,regulation of TOR signaling (GO:0032006),0.22365289896637155,0.6499131698871584,0.9600862998921251,0.9886981655891703,1.0,21/67,26.43%,MIOS;RRAGC;DDIT4;AKT1S1;LAMTOR3;TELO2;TBCK;RFFL;NPRL2;TSC1;NPRL3;LAMTOR4;RHEB;WDR59;RRAGA;UBR2;UBR1;PIK3CA;FNIP1;PIH1D1;SEH1L
prerank,regulation of pH (GO:0006885),0.3010671688637791,0.6495142736410067,0.8740629685157422,0.9886864802767843,1.0,11/11,69.91%,LACC1;SLC9A7;CLCN3;SLC9A1;ATP1A4;ATP6V1B1;SLC26A4;PDK4;ATP6AP1;ATP6V0A4;PDK2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.22493104413595533,0.6487432102491442,0.9321266968325792,0.9890221488144935,1.0,20/52,28.73%,ITGA3;CIB1;PRKCE;RACK1;STX4;DLG1;PRKCH;STAC3;PTPN9;ZDHHC8;PDPK1;ACSL3;WNK3;DPP10;TNF;LRP1;SPTBN1;ITGB1;STAC2;PIK3R1
prerank,skeletal system morphogenesis (GO:0048705),-0.17054617932985477,-0.6486999935803875,0.9733333333333334,0.9934256283160018,1.0,9/42,20.59%,DYNC2I1;LRP6;HHIP;RAB33B;HOXC4;HOXD3;HOXC9;FUZ;HOXB9
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.26452714028007235,-0.6486108492592357,0.8906752411575563,0.9921258229334926,1.0,1/10,3.01%,NCKAP1L
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.25744094888913316,0.6484882898617569,0.8980891719745223,0.9888798755560855,1.0,7/24,23.48%,FXN;TSPO;UROS;PGRMC1;FLVCR1;ABCG2;RSAD1
prerank,phospholipid catabolic process (GO:0009395),-0.1991851350596785,-0.6478324237215709,0.9545454545454546,0.9913335769534409,1.0,5/24,20.30%,SMPDL3A;PLBD1;ABHD12;GPCPD1;SMPD1
prerank,tRNA 5'-end processing (GO:0099116),0.28148502605074155,0.647656877341204,0.8928571428571429,0.9892420426222484,1.0,5/15,22.98%,TRMT10C;RPP30;RPP14;RPP25L;RPP21
prerank,regulation of developmental growth (GO:0048638),0.24948703700987584,0.647136531067794,0.90375,0.9893272420885549,1.0,5/29,16.05%,APP;INSR;DNM2;APOE;FGFR3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.2227427723045326,-0.6466659760150792,0.9105058365758755,0.9908249188163696,1.0,5/15,24.87%,NLGN2;CLN3;ZDHHC12;CNTNAP4;DRD2
prerank,regulation of biomineral tissue development (GO:0070167),0.2519914200618989,0.6463764928977362,0.9177215189873418,0.9896339544473968,1.0,4/26,12.85%,SOX9;NBR1;ANKH;ENPP1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.30836887620380077,0.6463182044829963,0.8961424332344213,0.9893349548338993,1.0,1/10,6.57%,MT3
prerank,regulation of protein sumoylation (GO:0033233),0.27531127225833335,0.6460873527376503,0.8809849521203831,0.9891696709499129,1.0,6/17,26.86%,CTNNB1;UBA2;PIAS1;HDAC4;PIAS4;GNL3
prerank,protein localization to condensed chromosome (GO:1903083),-0.25120966894546726,-0.6459465676451281,0.89,0.9899555402269018,1.0,7/12,31.62%,MTBP;KNL1;SPDL1;BUB3;CDK1;AURKB;TTK
prerank,pteridine-containing compound metabolic process (GO:0042558),0.2897798165574208,0.643172622742129,0.8835904628330996,0.9913035655538094,1.0,3/13,17.83%,GCH1;HSP90AA1;PRKG2
prerank,retinol metabolic process (GO:0042572),0.28421578780386964,0.6425508160708548,0.8909348441926346,0.9914796959481256,1.0,1/14,7.90%,RDH11
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.254648014992516,0.6425046016892905,0.9019354838709678,0.9911656448255891,1.0,4/24,17.62%,GRB10;MT3;HGS;EPN2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.2948240037747373,0.6423287130359452,0.883551673944687,0.9909508071803684,1.0,5/13,27.85%,SOCS5;SOCS4;TSG101;CBLB;ZGPAT
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.25407608536149734,0.6422671189997923,0.8990944372574385,0.990648006944547,1.0,5/22,25.44%,THY1;FLOT2;LCK;GCNT2;TNF
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.24141829378394547,0.6420499678244534,0.9211514392991239,0.990467806066742,1.0,6/33,17.01%,THY1;DUSP3;SH2D1A;PRNP;CD300A;UBASH3A
prerank,sterol biosynthetic process (GO:0016126),0.24082231460598708,0.641159298467643,0.921968787515006,0.9908510635704543,1.0,9/33,25.22%,HSD17B7;CH25H;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.2563265066215716,-0.6402439886949329,0.9173789173789174,0.9925157771308493,1.0,2/10,6.56%,PDE3B;RNF157
prerank,purine nucleotide biosynthetic process (GO:0006164),0.29401276278327243,0.6399410376099998,0.8854166666666666,0.9914966690060316,1.0,3/12,17.54%,HPRT1;ADSL;MTHFD1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.30168479444756835,0.6397756953360891,0.879154078549849,0.9912748863429596,1.0,4/10,23.05%,SH3BP1;OPHN1;RAP2A;MSN
prerank,positive regulation of ATP metabolic process (GO:1903580),0.24185842986646622,0.6392646785463987,0.9300361881785284,0.9913326409758662,1.0,5/32,12.33%,ENTPD5;APP;INSR;PSEN1;PPARGC1A
prerank,positive regulation of lipid transport (GO:0032370),-0.24090698368049232,-0.6389613517781703,0.9177631578947368,0.9919523402841197,1.0,1/12,2.47%,DBI
prerank,vesicle transport along actin filament (GO:0030050),0.260991602348114,0.6380827083774523,0.9059602649006623,0.9919546745632124,1.0,3/19,13.69%,MYO1C;FNBP1L;MYO6
prerank,positive regulation of telomerase activity (GO:0051973),0.2451539338581634,0.638008478494321,0.9227985524728589,0.9916537161516821,1.0,8/33,19.01%,HSP90AB1;CTNNB1;CCT4;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.24180322393997938,0.6379013402235039,0.9246913580246914,0.9913792611746796,1.0,9/33,23.22%,MECP2;CSNK2B;HMGB1;APOE;ACVRL1;GADD45A;FGF2;VASH1;NOTCH1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.305549580958108,0.6377872351967608,0.8954344624447718,0.9911111227781352,1.0,2/10,19.30%,ZC3H12A;RC3H2
prerank,peptidyl-arginine modification (GO:0018195),0.27102338379686036,0.6369591372717652,0.904054054054054,0.9914261185108887,1.0,3/15,20.23%,ART4;PRMT1;KRTCAP2
prerank,neuromuscular synaptic transmission (GO:0007274),-0.21505942938066347,-0.6368039464553897,0.9536679536679536,0.9920982427802227,1.0,5/18,27.65%,FCHSD2;DTNA;TSPOAP1;CHAT;FCHSD1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.2683129044282577,0.6364671754418946,0.9133425034387895,0.9914790182949068,1.0,2/17,9.11%,RUNX1;SCX
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.27111925373260637,0.6356914992111252,0.9156293222683264,0.9917627320205687,1.0,2/16,17.40%,STX7;PTPRC
prerank,positive regulation of neutrophil migration (GO:1902624),0.2686178071679601,0.6354054122684071,0.9,0.9916501245878304,1.0,3/18,16.89%,ADAM8;RAC1;MDK
prerank,regulation of cellular component size (GO:0032535),0.24367759477755252,0.6347496134843413,0.9305555555555556,0.9918146371575726,1.0,9/30,26.53%,RARG;RAB22A;VAV1;RAC1;MTOR;LAMTOR4;MSN;RIN3;PTEN
prerank,regulation of mitochondrial translation (GO:0070129),0.25976731574458944,0.6346872514598678,0.9007731958762887,0.991506689265447,1.0,6/21,20.76%,NGRN;RCC1L;ALKBH1;TRMT10C;FASTKD2;MTG2
prerank,mRNA 3'-end processing (GO:0031124),0.21504028608701573,0.6343600724253192,0.9513742071881607,0.991419788307848,1.0,33/78,30.73%,MAGOHB;NCBP2;WDR33;APP;AHCYL1;RNPS1;ZC3H11A;PAPOLA;CHTOP;PCF11;DDX39B;NCBP1;SRSF7;SRSF4;SLU7;THOC7;MTPAP;SRSF5;SRSF2;MAGOH;RPRD2;SCAF8;SARNP;CDC73;DDX39A;UPF3B;PABPC1;CPSF3;PAF1;PAPOLG;TENT2;SSU72;U2AF1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.25175202542461605,0.6341115091858529,0.911651728553137,0.991265469109432,1.0,3/23,10.76%,ITGA3;SMAD2;DKK3
prerank,sphingolipid metabolic process (GO:0006665),0.2053134774992756,0.6322318181209075,0.98125,0.9923832425154391,1.0,26/108,22.61%,SGPP2;ASAH2;NSMAF;CERS6;DEGS1;ST6GALNAC6;NEU1;VAPB;CERKL;SPHK2;HACD3;B3GALNT1;ACER3;GLB1;SPTLC2;SGPL1;CERS2;GBA2;ELOVL4;GLTP;SPTSSA;SUMF1;PLPP2;ARSA;CERT1;ESYT2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.26714980235619806,0.6312337906842976,0.9098250336473755,0.9928043733550791,1.0,3/17,19.67%,PLA2G12A;LPGAT1;PLA2G4E
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.20673044663952295,0.6297080510444092,0.9661885245901639,0.993616026309685,1.0,20/112,20.37%,WNT5A;GDF9;ACVR1;USP15;SOX9;SMAD2;BAMBI;ARRB2;ZFP36L1;COL3A1;SMURF1;NR3C1;LIMS1;BMPR1A;SOX5;PDE3A;FNTA;ACVRL1;APPL2;WWOX
prerank,eye photoreceptor cell differentiation (GO:0001754),0.2865151432414844,0.6296348478801469,0.8837209302325582,0.9933177724546198,1.0,1/12,2.87%,STAT3
prerank,eye development (GO:0001654),0.22251702619155453,0.6283131500010094,0.9547511312217195,0.9939975249641914,1.0,3/54,8.00%,PITX2;FBN1;MEIS3
prerank,osteoclast differentiation (GO:0030316),0.25356293962810295,0.6278474417982758,0.9229747675962815,0.9939912558505299,1.0,3/22,9.64%,SNX10;CSF1;MAPK14
prerank,regulation of metal ion transport (GO:0010959),0.26657605728368344,0.6275464913499487,0.9238227146814404,0.9938628991261971,1.0,1/16,2.31%,CAMK2B
prerank,negative regulation of wound healing (GO:0061045),-0.18142717812423614,-0.6274027386831281,0.975609756097561,0.9967347865884173,1.0,6/28,24.07%,SLC12A2;CLASP2;VTN;CD109;CLASP1;THBD
prerank,cardiac muscle cell action potential (GO:0086001),-0.18509692341001785,-0.626847316987713,0.9893617021276596,0.9957143285510278,1.0,5/30,13.22%,ATP1B1;DMD;CACNA2D1;KCND3;SCN3B
prerank,negative regulation of interleukin-6 production (GO:0032715),0.24097492312353733,0.6262860268957217,0.9298245614035088,0.994461914262815,1.0,3/27,10.58%,SLAMF1;CX3CL1;ZC3H12A
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2352086774544376,-0.6258386744719219,0.9290123456790124,0.9949660085000864,1.0,6/12,27.29%,LARP7;NELFB;NELFE;HEXIM1;NELFA;RNF168
prerank,response to hydrogen peroxide (GO:0042542),0.22262050074181988,0.6238607143029141,0.9590163934426229,0.9958937848586871,1.0,12/45,23.76%,TRPM2;FXN;PLEKHA1;ANKZF1;FYN;STK25;STK24;SIRPA;PRKCD;OSER1;PRDX3;HDAC6
prerank,purine-containing compound biosynthetic process (GO:0072522),0.24808516471062517,0.6236364166569665,0.9190231362467867,0.9957051578603634,1.0,6/25,18.85%,DCK;HPRT1;ADSL;SHMT1;MTHFD1;AMPD3
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.1924334599672436,-0.6232717869212833,0.9703389830508474,0.9952101042487566,1.0,10/22,30.38%,NBN;RASSF2;RAP2C;NEK10;TOM1L1;MRE11;RAD50;PDGFC;GREM1;PDGFD
prerank,sensory perception of mechanical stimulus (GO:0050954),0.20904227759419128,0.6228137291089028,0.9675324675324676,0.9959675114365817,1.0,8/85,12.53%,LRP2;NDUFB9;MYO3B;SNAI2;ALDH7A1;P2RX4;ADGRV1;COL11A2
prerank,glutamate metabolic process (GO:0006536),-0.20995735081807618,-0.622558521484202,0.9690265486725663,0.994286721517352,1.0,4/19,18.32%,GCLM;ALDH18A1;OAT;PRODH
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2658017642150645,0.622439341855604,0.9121813031161473,0.9958812099330632,1.0,2/17,14.79%,PLA2G12A;LPGAT1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.2345385874241025,-0.622438517106975,0.9375,0.993008111505061,1.0,8/12,39.31%,BIN1;TRPM4;CAV1;JUP;DSG2;RYR2;CACNA1C;DSP
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.27434706173609674,0.622390249185489,0.9200561009817672,0.9955580961361662,1.0,3/14,25.44%,CSF1;TYROBP;TNF
prerank,regulation of cell communication (GO:0010646),0.22694790803021206,0.6221875759920141,0.944578313253012,0.9953530715459603,1.0,2/35,3.75%,CAMK2D;SLC8A1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2657420475511499,0.6221322785250788,0.9295580110497238,0.995047870012054,1.0,5/17,24.01%,FIS1;GIT1;TIGAR;HDAC4;PDE12
prerank,regulation of telomerase activity (GO:0051972),0.22571146273675144,0.6220956313497065,0.9476744186046512,0.9947250410729811,1.0,10/45,19.01%,HSP90AB1;CTNNB1;CCT4;ERCC4;MEN1;MAP3K4;HSP90AA1;HMBOX1;PTGES3;NEK7
prerank,regulation of axon extension (GO:0030516),0.22762256506535058,0.6220675934593006,0.9445100354191264,0.9943949497953044,1.0,6/37,15.18%,RUFY3;MT3;DNM2;MAG;APOE;DBNL
prerank,cGMP-mediated signaling (GO:0019934),0.27365040827113596,0.6219185726664868,0.9020172910662824,0.9941560366328439,1.0,5/13,27.87%,APOE;PDE3A;PDE9A;GUCY1B1;HTR2B
prerank,serine family amino acid metabolic process (GO:0009069),0.26922094424791154,0.6217402591175349,0.9218967921896792,0.9939393972252584,1.0,4/16,17.54%,SEPSECS;SHMT1;GCLC;MTHFD1
prerank,pore complex assembly (GO:0046931),0.26030288391818696,0.6217240104905439,0.9319444444444445,0.9935946126462257,1.0,4/19,19.10%,NUP153;BAD;AHCTF1;PLEKHA7
prerank,urogenital system development (GO:0001655),0.2940064912299897,0.6216317555328729,0.9039301310043668,0.9933017308188916,1.0,1/11,5.43%,SOX9
prerank,regulation of interleukin-1 production (GO:0032652),0.27061781880440605,0.6207111217553659,0.922752808988764,0.9936148400897665,1.0,2/15,10.19%,HMGB1;TMED10
prerank,protein polyglutamylation (GO:0018095),0.2862162194491587,0.620405097453461,0.8957055214723927,0.9934684779649079,1.0,2/11,14.63%,TTLL7;CFAP20
prerank,actin polymerization or depolymerization (GO:0008154),0.22134542349398184,0.619061219979519,0.9606741573033708,0.9940720602027023,1.0,15/50,26.02%,EVL;GAS7;CORO7;GSN;RAC1;JAK2;AIF1;CFL2;TTC17;DSTN;MSRB1;TWF1;ANG;DIAPH1;WASHC5
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.20883590975790878,0.6190603077322308,0.9670212765957447,0.9937193021969526,1.0,21/80,24.95%,ACTR2;KCTD17;CYFIP1;ACTR3;CCDC88A;AGRN;DEF8;FNBP1L;NRP1;RAC1;MIEN1;PLCE1;ARAP1;NCKAP1;ENTR1;BRK1;DOCK11;CDC42EP3;TENM1;PIK3CA;BBS4
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.22890268969225258,-0.6189862456969356,0.93125,0.9935817662910714,1.0,5/14,22.75%,GMPS;ADK;IMPDH2;RFK;PPAT
prerank,neural crest cell development (GO:0014032),0.22232795737705263,0.6183572586586935,0.9627906976744186,0.9938764095656655,1.0,5/44,8.81%,SEMA4D;TCOF1;SNAI2;NOLC1;GDNF
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.19985670619792276,-0.6179590019492694,0.947565543071161,0.9927548153223484,1.0,6/20,18.31%,PPIL3;FKBP4;PPIL2;NKTR;PPIL1;FKBP1B
prerank,manganese ion transport (GO:0006828),0.27003142206206276,0.6176714145039375,0.9074889867841409,0.9940131418958312,1.0,6/14,28.81%,SLC11A2;TRPC4;TRPC1;TMEM165;SLC11A1;TRPC7
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.24067519725389425,0.6167759813790615,0.9366286438529785,0.9942947706932952,1.0,1/27,1.21%,CAMK2D
prerank,response to interleukin-4 (GO:0070670),-0.2501987316314255,-0.616461714849902,0.9362880886426593,0.9922903482324941,1.0,5/10,33.97%,JAK3;SHPK;LEF1;TCF7;GATA3
prerank,regulation of striated muscle contraction (GO:0006942),-0.1804423061820692,-0.6159628054012848,0.9768518518518519,0.991250945802617,1.0,13/27,37.34%,DMD;SLC8A3;GRK2;TNNI1;SRI;NOS1;HCN4;RNF207;RYR2;MYL2;MYBPC3;TNNT3;ATP1A2
prerank,regulation of actin filament-based process (GO:0032970),0.20790967668908467,0.6151110443104597,0.9630434782608696,0.9951090749931704,1.0,17/70,22.77%,BST2;RHOF;PAK3;CCDC88A;CDK10;RAC1;CRK;TAOK2;SH3BP1;BAIAP2;MTOR;TESK1;ARHGAP18;RND2;RHOH;PRKCD;IQGAP2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.24436472480950383,0.6144206706346553,0.9303882195448461,0.9952374126341907,1.0,9/22,29.86%,KANK1;SSH3;GSN;PRKCD;TWF1;PFN2;SLIT2;ARFGEF1;PFN1
prerank,natural killer cell mediated immunity (GO:0002228),0.26674485115083696,0.6142680563368798,0.9193324061196105,0.9949982359664974,1.0,3/15,15.53%,LYST;PLEKHM2;TUBB4B
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.2414695253789512,-0.6142444916181442,0.9436619718309859,0.9908653076585988,1.0,1/10,3.12%,LRP6
prerank,positive regulation of axon extension (GO:0045773),0.24491997627141765,0.6142073989174283,0.9308093994778068,0.9946882540657477,1.0,4/22,15.87%,RUFY3;NRP1;DBNL;DSCAM
prerank,negative regulation of hormone secretion (GO:0046888),-0.23740757885548838,-0.6140292512371257,0.9228486646884273,0.9896597863892274,1.0,2/10,23.49%,OSM;IL1B
prerank,aortic valve morphogenesis (GO:0003180),0.23487181144130154,0.6140223489965126,0.9242788461538461,0.9944678878465508,1.0,4/30,12.75%,SOX9;SNAI2;SLIT3;RB1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.24434578619619554,-0.6136528582556545,0.9288025889967637,0.9885394659582325,1.0,4/10,33.41%,HERPUD1;CCL2;EIF2AK3;QRICH1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.28876986620323136,0.6131077200130717,0.8955882352941177,0.9947562051161124,1.0,3/11,17.79%,AGO2;SOAT1;ITM2C
prerank,histone H3-K4 trimethylation (GO:0080182),0.27896940904531753,0.6127551235479889,0.9210526315789473,0.9946412561315044,1.0,3/11,22.77%,KMT2A;TET2;KMT2D
prerank,regulation of myelination (GO:0031641),0.24236794383278237,0.6112748831885179,0.9341614906832298,0.9952939560930419,1.0,3/25,8.79%,NKX6-2;TMEM98;CST7
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.2117999821191965,0.6108895596271321,0.9554794520547946,0.9951973191093313,1.0,19/52,28.73%,ITGA3;CIB1;PRKCE;STX4;DLG1;PRKCH;STAC3;PTPN9;ZDHHC8;NUMA1;PDPK1;WNK3;DPP10;TNF;LRP1;SPTBN1;ITGB1;STAC2;PIK3R1
prerank,activation of phospholipase C activity (GO:0007202),0.23411530730501873,0.6105505914099324,0.9374233128834356,0.9950653383268242,1.0,3/29,11.92%,BDNF;GNA15;HTR2A
prerank,positive regulation of blood coagulation (GO:0030194),0.2533812229286678,0.6101418179780891,0.9295212765957447,0.9949815941596188,1.0,2/17,10.67%,USF1;HPSE
prerank,tRNA transport (GO:0051031),0.22552348346765616,0.6101217850622568,0.9561510353227771,0.9946445376940997,1.0,12/35,27.82%,NUP37;NUP153;RAE1;NUP155;NUP88;NUP133;NUP43;NOL6;NUP205;SEH1L;NUP188;RANBP2
prerank,negative regulation of interferon-beta production (GO:0032688),0.2870393356547271,0.6097541306460318,0.9024390243902439,0.9945429600720967,1.0,4/10,24.58%,RELB;REL;SIRPA;PTPRS
prerank,establishment of skin barrier (GO:0061436),0.26500103921580487,0.6090706350770253,0.9152777777777777,0.9942933582115523,1.0,1/15,8.67%,MET
prerank,regulation of water loss via skin (GO:0033561),0.26500103921580487,0.6090706350770253,0.9152777777777777,0.9942933582115523,1.0,1/15,8.67%,MET
prerank,cellular response to hydrogen peroxide (GO:0070301),0.22888161013681785,0.6088363944908591,0.9515527950310559,0.9940969547853408,1.0,8/33,23.76%,TRPM2;FXN;PLEKHA1;ANKZF1;SIRPA;PRKCD;OSER1;HDAC6
prerank,spermatid development (GO:0007286),0.22360567895487357,0.6075371495804301,0.9493201483312732,0.9945753920083638,1.0,4/32,14.27%,NME5;CIB1;CDYL;ZMYND15
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.22105000969793132,0.6071866735962276,0.9543269230769231,0.9944630708314487,1.0,5/38,16.74%,CAMK2D;CTNNA3;AKAP9;SCN1B;KCNJ2
prerank,negative regulation of TOR signaling (GO:0032007),0.22636379917973612,0.6071083530308014,0.9499404052443385,0.994168328539721,1.0,12/36,26.92%,KPTN;DDIT4;AKT1S1;NPRL2;TSC1;NPRL3;STK11;UBR2;UBR1;FNIP1;SZT2;SESN1
prerank,polarized epithelial cell differentiation (GO:0030859),0.27127699407434386,0.6057512793759208,0.9318181818181818,0.9947023424288014,1.0,6/13,27.23%,SH3BP1;OPHN1;RAP2A;RAB10;MSN;ZDHHC7
prerank,L-serine metabolic process (GO:0006563),0.28547387221223186,0.6051446199097231,0.9063444108761329,0.9947234346725446,1.0,2/10,13.78%,PHGDH;SHMT1
prerank,regulation of B cell differentiation (GO:0045577),0.2535707189097314,0.6047533590048548,0.9586206896551724,0.9946214456084919,1.0,4/17,15.90%,MMP14;ZFP36L1;XBP1;CD27
prerank,transcription preinitiation complex assembly (GO:0070897),0.272954992904033,0.6031855830620453,0.9267935578330894,0.9952893926313271,1.0,2/12,12.90%,BDP1;TAF1B
prerank,intermediate filament organization (GO:0045109),0.25089044693408563,0.601881857389593,0.9106145251396648,0.995748614640787,1.0,2/17,9.81%,BFSP1;DNAJB6
prerank,sphingolipid biosynthetic process (GO:0030148),0.20286013840855513,0.6016685944833251,0.980110497237569,0.9955495029394307,1.0,16/71,22.40%,SGPP2;ASAH2;CERS6;DEGS1;VAPB;SPHK2;HACD3;ACER3;ST8SIA1;SPTLC2;SGPL1;CERS2;ELOVL4;SPTSSA;PLPP2;CERT1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.24522433697465745,-0.6015073362690614,0.9451219512195121,0.9933473261088861,1.0,3/10,22.34%,ANK3;CAV1;KCNAB1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.19274171647153282,0.5995198079938638,0.994908350305499,0.996514322589567,1.0,25/159,21.77%,PCDHB13;PLXNB2;CDH13;ACVR1;NECTIN4;PLXNB3;CDH9;NECTIN3;MAG;SDK1;PCDHB16;CD84;CLDN10;NPTN;HMCN1;DSCAM;DSCAML1;MPZ;CLDN11;LRRC4;PTPRF;FGFRL1;VCAM1;TENM4;KIRREL3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.2794261846862605,0.5990453596965715,0.9129129129129129,0.9964710209174552,1.0,1/10,6.00%,CDT1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2254830249996464,0.598896249774161,0.9456521739130435,0.9962148602122674,1.0,9/30,27.11%,HSD17B7;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6;ACAT2
prerank,neuron projection fasciculation (GO:0106030),0.2859186344637668,0.5988906518876473,0.9316493313521546,0.9958698840170656,1.0,1/10,5.76%,EPHA4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.21388480177165714,0.598806135299743,0.9567307692307693,0.9955747305731011,1.0,5/44,9.81%,CDKN2D;IGBP1;MT3;CST7;DNAJB6
prerank,regulation of regulated secretory pathway (GO:1903305),0.2195949101494407,0.5983356545260092,0.9474327628361858,0.9955072131579503,1.0,12/34,26.75%,SYT7;UNC13D;SYT3;PREPL;DTNBP1;VPS18;SYN1;SYT12;SYT11;RAB3A;RAB3D;SYT4
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.21988270806922805,0.5981635471143629,0.9453032104637337,0.9952598313911792,1.0,5/37,11.27%,CYLD;MAPRE1;STMN4;STMN3;PHLDB1
prerank,cardiolipin metabolic process (GO:0032048),0.2665517451620885,0.59685559597475,0.9174041297935103,0.9956909193330854,1.0,4/13,21.55%,SLC27A1;HADHA;PLA2G6;PNPLA8
prerank,positive regulation of calcium ion transport (GO:0051928),0.2187289482098283,0.5960038332743396,0.9553679131483716,0.995862912271595,1.0,4/36,10.75%,CCL5;P2RX4;SPHK2;CRACR2A
prerank,mitochondrial membrane organization (GO:0007006),0.22443880773628466,0.5936347571970575,0.9593094944512947,0.9968982961750129,1.0,5/32,13.11%,RCC1L;CHCHD6;TIMM50;SAMM50;BAD
prerank,establishment of mitotic spindle localization (GO:0040001),0.2263756017268284,0.5925740154425188,0.9506172839506173,0.9971774718059083,1.0,6/28,19.18%,KPNB1;CDK5RAP2;UBXN2B;PAFAH1B1;NUMA1;NDC80
prerank,negative regulation of glycolytic process (GO:0045820),-0.2409688640869252,-0.5917660673847756,0.9244712990936556,0.9951714339175594,1.0,1/10,2.11%,CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.2409688640869252,-0.5917660673847756,0.9244712990936556,0.9951714339175594,1.0,1/10,2.11%,CBFA2T3
prerank,glycogen catabolic process (GO:0005980),0.25755836924378117,0.5912625741934732,0.9289693593314763,0.9975553706948561,1.0,3/15,16.50%,PGM2L1;RB1CC1;PHKG2
prerank,axonal transport of mitochondrion (GO:0019896),0.27413950957750544,0.5909640194289134,0.9306784660766961,0.9973730130799611,1.0,1/11,5.77%,TRAK1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.23697032439039967,0.589841149422327,0.9433465085638999,0.9976531320041909,1.0,6/21,27.95%,AKAP9;SCN1B;FLNA;ANK2;SCN4B;CACNA1D
prerank,"wound healing, spreading of cells (GO:0044319)",0.23481750951699226,0.5896225607112386,0.9579617834394905,0.997437929397916,1.0,9/24,31.64%,MRTFA;PDPN;ARHGAP24;ACVRL1;FLNA;PDCD10;CCN1;TOR1A;ARHGAP35
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.26247312046387533,0.5894994921010862,0.9322533136966127,0.9971538710318728,1.0,3/13,17.40%,JAK2;MGAT5;PTPRC
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.25119735202542126,0.5893934658806046,0.9438202247191011,0.9968609068708448,1.0,8/16,31.02%,ATIC;ADSL;AMPD3;LHPP;PAICS;ADSS2;PFAS;AMPD2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.2277753711652869,-0.589123164777846,0.9648562300319489,0.995059867402328,1.0,3/12,23.49%,CCR2;IL1R1;IL1B
prerank,regulation of macrophage activation (GO:0043030),0.22536116250306837,0.5880707284412201,0.9525593008739076,0.9972860801383729,1.0,4/30,14.67%,WNT5A;ZC3H12A;FCGR2B;TNIP2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.20514516229639962,0.5872848834186876,0.9715585893060296,0.9973757349516521,1.0,6/54,16.74%,KCNMB3;CAB39;GABBR2;DLG1;STK39;KCNJ2
prerank,positive regulation of protein processing (GO:0010954),0.2409077508830277,0.5872688676460661,0.9429708222811671,0.9970399751170304,1.0,3/19,18.18%,ADAM8;GSN;MYH9
prerank,regulation of interleukin-13 production (GO:0032656),0.265603084902064,0.5862925716765978,0.9570200573065902,0.9972324574177087,1.0,3/13,16.81%,SPHK2;IL18;LGALS9
prerank,glial cell differentiation (GO:0010001),0.22944678377348715,0.586124659492821,0.9511002444987775,0.9969735336123449,1.0,3/28,8.83%,STAT3;SOX9;NFIB
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.24615265950478715,0.5852579525705734,0.9308005427408412,0.9971051040092088,1.0,2/18,9.54%,GNA15;AGRN
prerank,placenta development (GO:0001890),0.2656301342977664,0.5851731887007802,0.9292035398230089,0.9968030907460934,1.0,1/12,6.27%,CUL7
prerank,clathrin coat assembly (GO:0048268),0.2565340595629416,0.5843981007197943,0.9166666666666666,0.996877013011393,1.0,2/15,10.59%,NSG2;AP2S1
prerank,signal transduction by p53 class mediator (GO:0072331),0.22240708522355426,0.5835952166563573,0.9556962025316456,0.9969788090267473,1.0,4/30,13.69%,MYBBP1A;DDX5;PAXIP1;MYO6
prerank,negative regulation of phosphatase activity (GO:0010923),0.22915567998115355,0.5829329876615418,0.955470737913486,0.9969800383491301,1.0,4/25,14.97%,SEMA4D;PPP1R11;PPP1R26;MASTL
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.2598675240027126,0.582617147322398,0.9333333333333333,0.9968079020649041,1.0,3/14,16.22%,IL17D;CD84;IL18
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.2732458557549677,0.5816272522697109,0.9342723004694836,0.9969598288563762,1.0,1/10,6.72%,NT5C3A
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.25758025084998665,0.5796530572016068,0.937592867756315,0.9976435828660647,1.0,3/12,18.27%,ABCD1;FADS2;ACOX1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2448573088042482,0.5793332015218534,0.9475138121546961,0.9974518817525213,1.0,5/17,22.50%,CYFIP1;GMFB;CORO1B;NCKAP1;BRK1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.22728244783575868,0.5779796457210197,0.9487179487179487,0.9978131256675046,1.0,3/24,10.16%,SEMA4D;CCL5;TNIP1
prerank,axonal fasciculation (GO:0007413),0.26705956595489977,0.5764282750352752,0.9460641399416909,0.9982723157217532,1.0,1/12,5.76%,EPHA4
prerank,lipid modification (GO:0030258),0.21272199662439184,0.5759247117764089,0.9618593563766389,0.99818780946968,1.0,11/37,25.46%,SGPP2;DGKB;DGKK;EPHX2;DGKA;DGKI;PLPP2;PLPPR2;PLPPR1;PLPP6;PLPP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.18658116934094462,-0.5740536903520896,0.9881889763779528,0.9997363735115918,1.0,13/18,46.80%,TGFBR3;TGFB2;S1PR1;BMP5;TEK;HEY1;BMP7;NOG;ADGRG6;DLL4;RBP4;ENG;NRG1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25981941936872205,0.5737090283906316,0.9372262773722628,0.9989715592547761,1.0,2/12,11.87%,NEK9;NEK6
prerank,anterior/posterior pattern specification (GO:0009952),0.2036196062345643,0.5733676173682112,0.9853932584269663,0.9987835563375195,1.0,5/53,12.43%,BHLHE40;SMAD2;HOXA9;BMPR2;HOXB6
prerank,regulation of collagen biosynthetic process (GO:0032965),0.23682792414452963,0.5726171022627188,0.9590723055934516,0.9988018898081259,1.0,2/19,9.11%,RUNX1;SCX
prerank,myeloid cell differentiation (GO:0030099),0.20422291041769947,0.5722839223001441,0.9759725400457666,0.9986175522279419,1.0,11/47,22.93%,RUNX1;LYN;IKZF1;JAK2;TET2;KAT8;SNRK;FLVCR1;MFHAS1;PRDX3;KAT6A
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2231693190405987,0.5718199118011925,0.9599499374217773,0.9984913736752523,1.0,5/29,14.88%,CAMK2B;NETO1;APP;APOE;SYNGR1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.25840492289983924,0.5695803916498667,0.9546783625730995,0.9991972385804029,1.0,3/12,22.28%,IDH1;GLUD1;IDH3A
prerank,female gonad development (GO:0008585),-0.18090483767440957,-0.5690610428590069,0.9831932773109243,1.0,1.0,5/19,23.34%,NR2F2;CEBPB;NUP107;INHBA;COL9A3
prerank,telomere capping (GO:0016233),0.24286264816743597,0.5684819105052981,0.9488950276243094,0.999365068844742,1.0,5/16,19.66%,PRKDC;STN1;DCLRE1A;TERF2;DCLRE1C
prerank,cellular glucan metabolic process (GO:0006073),-0.21116996324101722,-0.5681125329944727,0.9808917197452229,0.9991168964148396,1.0,8/11,46.34%,GSK3B;PPP1R3C;GBE1;PRKAG2;PYGM;PHKB;PHKA1;G6PC1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.2484183115767981,0.5668479278863257,0.9574468085106383,0.9997934786166485,1.0,7/15,31.29%,BMPER;FGF2;PDPK1;JAK1;SMAD1;FGF1;JMJD8
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.24659933317279029,0.5661513578518474,0.9586305278174037,0.9997763762938502,1.0,3/15,11.87%,CDC16;CDC27;NEK6
prerank,regulation of organelle organization (GO:0033043),0.19049098806129855,0.5660406872626159,0.9915878023133544,0.9994824665970495,1.0,8/80,12.57%,CLIC4;FIS1;SYDE1;CDT1;VPS11;SPEF1;STMN3;AKAP9
prerank,protein deneddylation (GO:0000338),0.2723065091302227,0.5658438288299881,0.9425981873111783,0.9992369614313502,1.0,3/10,22.07%,COPS7B;COPS8;COPS7A
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.1898776611354534,0.5652381346352902,0.9934782608695653,0.9991795110757623,1.0,11/75,18.68%,CNGB1;GNG4;CCL5;CAMKMT;GIT1;RGS16;METAP2;TULP3;PLCE1;FNTA;MGRN1
prerank,positive regulation of locomotion (GO:0040017),0.21962382183658902,0.5641518626585463,0.9646910466582598,0.9993165046189684,1.0,6/27,20.60%,PPM1F;STX4;CFAP20;AIF1;CAVIN1;CCDC25
prerank,inorganic anion transmembrane transport (GO:0098661),0.18950082484869218,0.562888682165238,0.9878318584070797,0.999525457137676,1.0,17/63,22.97%,SLC12A5;SLC25A10;SLC12A8;GLRA2;SLC26A2;SLC37A2;ANO5;CLCN1;SLC20A2;GABRG1;SLC37A1;SLC5A6;GLRA1;GABRB2;SLC1A3;SLC25A30;GABRA3
prerank,I-kappaB phosphorylation (GO:0007252),0.258374948690804,0.562857478268202,0.9534534534534534,0.9991937033050415,1.0,3/10,23.37%,TLR2;TLR3;TLR7
prerank,smooth muscle contraction (GO:0006939),0.2513830499747534,0.5619767137735647,0.9406657018813314,0.9992505841770561,1.0,2/14,15.11%,SLC8A1;CHRNB2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.2189559630526388,-0.5608813567633828,0.9579288025889967,0.9988939711592433,1.0,3/11,22.15%,GSTO1;FKBP1B;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.2189559630526388,-0.5608813567633828,0.9579288025889967,0.9988939711592433,1.0,3/11,22.15%,GSTO1;FKBP1B;SRI
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.19287287168478226,0.5602091779647947,0.9855072463768116,0.9996960433545378,1.0,15/65,23.43%,SPRY2;PMEPA1;FBN1;SMAD2;BAMBI;SKIL;SMURF1;HTRA3;SPRED3;SPRED1;SNX25;PIN1;SMURF2;STUB1;PDPK1
prerank,spinal cord development (GO:0021510),0.2543924607428199,0.5600552258925053,0.9521739130434783,0.9994091995282749,1.0,2/12,18.19%,VIT;NF1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.21904835407709417,0.5582291744878026,0.9672346002621232,0.9998612129589356,1.0,5/24,22.13%,DNMT3A;DNMT1;EZH2;SMYD5;TASOR
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.24427760662343068,0.557935144773131,0.9538670284938942,0.9996422662333739,1.0,2/15,17.54%,FGFR2;MTHFD1
prerank,amino acid import (GO:0043090),0.22347408615396797,0.5577325966720627,0.9703989703989704,0.9993882217117848,1.0,6/21,26.96%,SFXN2;SFXN1;SLC6A6;SLC1A3;SLC36A1;SLC22A4
prerank,negative regulation of hemostasis (GO:1900047),-0.21218355048922172,-0.5574077604416335,0.9864406779661017,0.9987796869301286,1.0,6/12,40.09%,VTN;THBD;CD34;APOH;ADTRP;TFPI
prerank,dicarboxylic acid catabolic process (GO:0043649),0.24834039747702014,0.5573970344136249,0.9449275362318841,0.9991878980792379,1.0,4/13,26.70%,GLUD1;GAD1;GOT1;MTHFS
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.20698937821797134,-0.5571708678586588,0.976897689768977,0.9975567235682589,1.0,4/13,25.17%,DDAH1;PRODH;ALDH4A1;NOS1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.23559453749751608,0.5570736240626598,0.9569444444444445,0.9989776976614486,1.0,2/17,13.32%,RAPGEF2;AKAP13
prerank,regulation of sodium ion transport (GO:0002028),0.21116427230163193,0.5556674689758886,0.9705882352941176,0.9992026178229192,1.0,6/34,16.17%,CNKSR3;P2RX4;AHCYL1;SIK1;DLG1;SCN1B
prerank,nucleoside catabolic process (GO:0009164),0.2546415409028871,0.5554581779458223,0.9418070444104135,0.9989470038460444,1.0,4/11,29.48%,NT5C3A;DERA;NT5C;DPYD
prerank,peptidyl-methionine modification (GO:0018206),0.25208285610376313,0.5538535500657358,0.9398826979472141,0.9992535403428576,1.0,2/12,16.66%,NAA25;METAP2
prerank,response to molecule of bacterial origin (GO:0002237),0.18663246355708502,0.5525200241577045,0.9889624724061811,0.9994622698181874,1.0,18/69,27.06%,C4B;SLPI;GCH1;GGT7;FCGR2B;JAK2;IRAK1;ACOD1;LGALS9;PRDX3;PELI1;IRF5;OTUD5;SIRT2;MAPKAPK2;NOCT;FER;LY96
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.24943614165370798,0.5524021723799969,0.9680232558139535,0.9991620135273742,1.0,3/13,18.96%,GFPT1;SLC35A3;UAP1
prerank,oligodendrocyte differentiation (GO:0048709),0.233395856049338,0.5518492953166013,0.9765013054830287,0.9990404796967488,1.0,4/19,18.89%,SOX9;EIF2B2;EIF2B5;EIF2B3
prerank,mitochondrion transport along microtubule (GO:0047497),0.24669957924102823,0.5507497476224554,0.961764705882353,0.9991164319672794,1.0,5/13,27.44%,UXT;RHOT2;OPA1;LRPPRC;MAP1S
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.25587415799509683,0.5505982576203513,0.9555555555555556,0.9988334789657894,1.0,3/11,17.34%,UNC93B1;TNIP2;TLR3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.2624889553647931,0.5501439741994238,0.9471228615863142,0.9986595097768065,1.0,1/10,4.55%,GAP43
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.20146296245328932,0.5487784732053407,0.9780487804878049,0.9988380719981852,1.0,5/37,15.34%,SOD2;DNMT1;LDLRAP1;FGF9;BMPR1A
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.24891666345908434,0.548575097136178,0.9512893982808023,0.9985727075358695,1.0,2/13,15.78%,UBA2;UBA1
prerank,GTP metabolic process (GO:0046039),-0.193899706396273,-0.5483247938492386,0.9652777777777778,0.9988240197961954,1.0,7/15,31.80%,MFN1;RHOQ;IMPDH2;GTPBP1;GNAI3;IMPDH1;EFL1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.24947607423430485,0.5480705837442887,0.9641791044776119,0.998419641818589,1.0,6/12,30.17%,ATIC;ADSL;LHPP;PAICS;ADSS2;PFAS
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.21152342471397262,0.5453961588690354,0.9740420271940667,0.9990883588911706,1.0,8/28,25.39%,PAK3;DBNL;SH3BP1;ABITRAM;GBA2;ARHGAP18;BRK1;PFN2
prerank,regulation of response to oxidative stress (GO:1902882),0.25168814405261675,0.5450268740971866,0.9459459459459459,0.9988864187320006,1.0,2/11,12.06%,ABCD1;GGT7
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2178432682707165,0.5441354677540752,0.9669631512071156,0.9988467785327269,1.0,11/24,32.65%,MT3;ATF6B;RBPJ;NOTCH1;ATF6;CHD6;ATF4;KLF2;HSF1;SESN2;DDIT3
prerank,synaptic vesicle membrane organization (GO:0048499),0.2299349520307986,0.5413775824369743,0.9633649932157394,0.9995057324344603,1.0,3/17,14.88%,STX4;SNAP23;SYNGR1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.23151932275396664,0.5390371965351636,0.967032967032967,0.9999839881712305,1.0,4/17,23.06%,VAMP2;KCNRG;KCNS1;SUMO1
prerank,establishment of melanosome localization (GO:0032401),0.22401967175329437,0.5359203069396092,0.9711141678129298,1.0,1.0,6/19,26.49%,RAB11B;BBS2;RAB11A;BBS7;BBS4;SHROOM2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.21091440478370677,0.534765334887935,0.9727979274611399,1.0,1.0,8/23,27.51%,CDK5RAP2;UBXN2B;PAFAH1B1;NUMA1;NDC80;DCTN1;MAD2L1;ITGB1
prerank,Notch signaling involved in heart development (GO:0061314),0.24988294996264124,0.5330831068070269,0.9540740740740741,1.0,1.0,3/11,23.22%,SNAI2;RBPJ;NOTCH1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.18778995267521972,0.5320282111866065,0.9909194097616345,1.0,1.0,1/53,0.65%,AGT
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.21059168153154564,-0.5317823410495812,0.9818181818181818,1.0,1.0,3/10,20.33%,FGF10;MAP4K4;ADAM9
prerank,T cell activation involved in immune response (GO:0002286),0.2391236110239185,0.5314672259670713,0.9603399433427762,1.0,1.0,12/12,76.11%,MDK;SLC11A1;LILRB1;IFNK;F2RL1;CD74;TNFSF18;ICAM1;EIF2AK4;ITGAL;FCER1G;LCP1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.21321693218839657,0.5296207505408564,0.9818181818181818,1.0,1.0,3/23,17.45%,ARRB2;LGALS9;LAMP1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.21749052328779264,0.52946913100373,0.9658344283837057,1.0,1.0,7/20,28.86%,AGRN;CHRNB2;LY6G6D;RGS10;CHRM3;CDK5R1;GNB1
prerank,establishment of endothelial barrier (GO:0061028),0.20216654681960985,0.5290802281847912,0.9839108910891089,1.0,1.0,4/29,13.46%,RAPGEF6;RAPGEF2;TJP2;RAPGEF1
prerank,circulatory system development (GO:0072359),0.17495417600630195,0.5290675504658411,0.9979057591623036,1.0,1.0,26/118,24.78%,ACVR1;FBXW7;SOX9;SRF;FBN1;ADAP2;NOTCH4;COL3A1;PTPN11;AKAP13;POU6F1;MEF2A;PDLIM3;SH3PXD2B;MTHFD1;PLCE1;NF1;ACVRL1;BCOR;STK11;CITED2;ERBB3;NOTCH1;KAT2B;PIK3CA;ECE1
prerank,cholesterol biosynthetic process (GO:0006695),0.19977408457223123,0.5289926429734634,0.9806996381182147,0.9998605567379248,1.0,9/31,27.11%,HSD17B7;FDFT1;GGPS1;IDI1;EBP;HMGCS1;HMGCR;PLPP6;ACAT2
prerank,linoleic acid metabolic process (GO:0043651),0.2217247778853969,0.528188888056906,0.9750692520775623,0.9997800573841769,1.0,2/17,12.42%,ABCD1;FADS2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.22269908978208403,0.5278160274887458,0.9739726027397261,0.9995556637248055,1.0,4/17,19.00%,MPG;TDG;NEIL2;TERF2
prerank,nuclear membrane disassembly (GO:0051081),0.22902458936443432,0.5256932770409317,0.9692737430167597,0.9998718176559865,1.0,2/14,11.87%,NEK9;NEK6
prerank,nuclear pore organization (GO:0006999),0.23003622042018113,0.5256379831584544,0.961038961038961,0.9995508476805239,1.0,5/14,26.43%,NUP153;AHCTF1;NUP133;NUP205;SEH1L
prerank,long-chain fatty acid metabolic process (GO:0001676),0.17819746234512235,0.5224364161233608,0.9933035714285714,1.0,1.0,13/64,24.33%,ASAH2;ACADL;ACSL5;ABCD1;EPHX2;FADS2;DAGLA;ACOX1;GPX4;PNPLA3;PNPLA8;ACSL3;AIG1
prerank,regulation of T cell differentiation (GO:0045580),0.1931335348396562,0.5199298078744538,0.98661800486618,1.0,1.0,6/33,22.22%,RUNX1;NFATC2;XBP1;MDK;RHOH;PRDM1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.23730476852753724,0.5182055097902452,0.9730113636363636,1.0,1.0,3/13,22.04%,IDH1;GPT2;GOT1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.23553685325509077,0.5177635556306671,0.9728571428571429,1.0,1.0,3/12,20.61%,MDK;FUT9;LCK
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.17941210572230187,-0.5169195171539938,0.9923076923076923,1.0,1.0,7/16,30.38%,PIK3C2A;RGS14;ABL1;PDGFRA;PDGFC;PDGFRB;PDGFD
prerank,regulation of dopamine secretion (GO:0014059),0.20241347249092595,0.5159172388733124,0.9844760672703752,1.0,1.0,5/25,18.53%,SYT7;SYT3;GDNF;CHRNB2;DTNBP1
prerank,striated muscle contraction (GO:0006941),0.17664874197343383,0.5138261371581848,0.9943757030371203,1.0,1.0,8/53,22.06%,SLC8A1;TNNC1;ARHGEF11;SCN1B;STAC3;TNNI2;RCSD1;MYH14
prerank,long-chain fatty acid transport (GO:0015909),0.19469443199033196,0.512382871067339,0.9827160493827161,1.0,1.0,3/30,12.35%,SLC27A1;ABCD1;APOE
prerank,negative regulation of vascular permeability (GO:0043116),-0.19395493920842455,-0.5106802599457206,0.987460815047022,1.0,1.0,5/12,35.32%,DDAH1;CEACAM1;PDE2A;RAMP2;CLDN5
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.24409294095189024,0.5102878929588008,0.9697452229299363,1.0,1.0,2/10,18.93%,PRKCH;NUMA1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.174076865109269,-0.5098345504954785,1.0,1.0,1.0,17/17,82.62%,HMGA2;KDM1A;PDCD2;CCNE1;N4BP2L2;TERT;THPO;CITED1;SOX11;NANOG;EPCAM;GJA1;LTBP3;HNRNPU;FERMT2;KAT7;PTPRC
prerank,glycerophospholipid catabolic process (GO:0046475),0.1979988154108476,0.5087766598732562,0.9838709677419355,1.0,1.0,6/27,21.55%,LIPC;PNPLA6;ENPP6;PLA2G4E;PLA2G6;PNPLA8
prerank,protein O-linked glycosylation via serine (GO:0018242),0.24461351773347476,0.5087278221911333,0.9637155297532656,1.0,1.0,3/10,25.24%,GALNT1;GALNT13;MGAT5B
prerank,hematopoietic stem cell differentiation (GO:0060218),0.23684760178860717,0.5000150419565745,0.9763779527559056,1.0,1.0,2/10,15.09%,LMBR1L;MLLT3
prerank,negative regulation of signaling receptor activity (GO:2000272),0.2029976254696952,0.499885091356292,0.9862671660424469,1.0,1.0,7/25,27.85%,CRHBP;SOCS5;SOCS4;TSG101;TNF;CBLB;ZGPAT
prerank,protein acetylation (GO:0006473),0.18887815319754586,0.499845725268475,0.9963636363636363,1.0,1.0,7/30,23.97%,NAA50;NAA35;NAT9;ING5;KAT6A;KAT5;KAT2B
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2272098840126853,0.49691159657057754,0.9836552748885586,1.0,1.0,2/12,14.18%,STX4;SNAP23
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.20325927268311927,0.4951576397834955,0.9877717391304348,1.0,1.0,7/20,26.38%,MCUR1;MICU2;SMDT1;MICU3;SLC25A23;PMPCB;STOML2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.2349920145017202,0.49413090916356034,0.9803328290468987,1.0,1.0,4/10,26.66%,PPM1F;SNX12;NDFIP1;DNAJA1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.1711634258372052,-0.4940714105912635,0.9966666666666667,1.0,1.0,8/16,38.07%,SALL1;MYC;PAX8;BMP2;BMP4;FOXD1;SHH;NPNT
prerank,tRNA 5'-leader removal (GO:0001682),0.22062431998320553,0.4914754691443,0.9758522727272727,1.0,1.0,4/13,22.98%,RPP30;RPP14;RPP25L;RPP21
prerank,inner mitochondrial membrane organization (GO:0007007),0.17456530966945957,0.48719235153671403,0.9942660550458715,1.0,1.0,10/47,23.42%,ATP5MC1;CHCHD6;DMAC2L;SAMM50;ATP5PO;GHITM;MTX1;ATP5F1B;OPA1;TIMM29
prerank,aorta development (GO:0035904),0.21311108370477028,0.486727769041824,0.9876543209876543,1.0,1.0,2/14,17.29%,TFAP2B;HECTD1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.18571589208877148,-0.4856488499575743,0.9908536585365854,1.0,1.0,5/11,30.33%,MIF;NBL1;CCN3;GREM1;DUSP1
prerank,amino sugar biosynthetic process (GO:0046349),-0.18155694250333732,-0.4844371538101214,0.9937694704049844,1.0,1.0,6/12,32.34%,GNPDA1;PGM3;GNPDA2;NAGK;GFPT2;NANP
prerank,cytosolic calcium ion transport (GO:0060401),0.18787857798561536,0.48340784917737756,0.992462311557789,1.0,1.0,3/28,13.17%,SLC8A1;MCUR1;MICU2
prerank,positive regulation of behavior (GO:0048520),0.23045692434822998,0.48189562841343897,0.9844961240310077,1.0,1.0,2/10,23.62%,CFAP20;AGRP
prerank,rRNA pseudouridine synthesis (GO:0031118),0.22585292707223575,0.4815250331109049,0.9787234042553191,1.0,1.0,3/10,24.56%,GAR1;RPUSD1;NHP2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.20671123470870073,0.47981481712014074,0.9848066298342542,1.0,1.0,2/17,13.11%,SOX9;BAD
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.19571267347806856,0.47691189937861533,0.9876712328767123,1.0,1.0,6/18,28.68%,CHCHD10;BAX;SLC35F6;FZD9;BID;MPV17L
prerank,cardiac myofibril assembly (GO:0055003),0.20364830476742532,0.47554868404820566,0.9788732394366197,1.0,1.0,3/15,22.76%,PROX1;MEF2A;NRAP
prerank,negative regulation of calcium ion transport (GO:0051926),0.20584582703883492,0.4751791404873471,0.9848066298342542,1.0,1.0,3/15,19.69%,SLC30A1;INPP5K;CD33
prerank,negative regulation of ion transport (GO:0043271),0.18867417917769072,0.47513705752073476,0.9922680412371134,1.0,1.0,5/24,24.70%,ACTN2;INPP5K;CD33;SYT11;WNK3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.21112550721825596,0.47462773817960036,0.9829059829059829,1.0,1.0,4/13,22.91%,AK4;AK3;ENTPD7;OPA1
prerank,regulation of cellular pH (GO:0030641),-0.13567702973344545,-0.47312595568301313,1.0,1.0,1.0,15/29,41.52%,SLC9A9;SLC4A8;CLN3;SLC9A8;SLC26A6;SLC4A3;SLC4A9;SLC4A10;SLC4A7;ATP6AP1;SLC9A4;SLC9B1;SLC9A3;SLC4A1;SLC4A5
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.2000687621919841,0.47258608336595537,0.9917127071823204,1.0,1.0,4/17,26.99%,AKAP9;SCN1B;ANK2;SCN4B
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.16439560439560438,-0.47205269413072654,0.9923076923076923,1.0,1.0,16/16,83.58%,TRAF6;RHOA;ITGB2;ST3GAL4;FUT4;ETS1;ALOX5;SELE;SELP;FUT7;IL6;RELA;NFAT5;TNF;MDK;IRAK1
prerank,cell differentiation in hindbrain (GO:0021533),0.22294289907615827,0.4717452738766902,0.9881656804733728,1.0,1.0,2/11,16.35%,PROX1;OPHN1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.20733868423523324,0.47032386016475525,0.9883040935672515,1.0,1.0,4/14,23.05%,SH3BP1;OPHN1;RAP2A;MSN
prerank,regulation of biosynthetic process (GO:0009889),0.21947709408744662,0.4702486788513176,0.9801136363636364,1.0,1.0,1/11,9.99%,SPHK2
prerank,potassium ion transport (GO:0006813),0.15209390537258127,0.4681303375249892,1.0,1.0,1.0,7/120,11.77%,KCNMB3;ATP1B3;KCNH8;KCNS3;KCNA4;CCDC51;KCNK3
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.17322960382814362,-0.4665541116621896,0.9967532467532467,0.9997127727613092,1.0,4/12,26.70%,VANGL2;SCRIB;FUZ;TRAF3IP1
prerank,sensory organ development (GO:0007423),0.16373422330066542,0.4599234654584821,1.0,1.0,1.0,12/51,26.49%,CHD7;MEIS3;SOX2;SH3PXD2B;SIPA1L3;ADAMTS18;SMCHD1;ECE1;PBX4;ATF6;ZDHHC16;SHROOM2
prerank,dendrite self-avoidance (GO:0070593),0.19658340950710998,0.45826889751131666,0.9836289222373806,1.0,1.0,3/16,16.09%,NPTN;DSCAM;DSCAML1
prerank,negative regulation of secretion (GO:0051048),0.21354134418406528,0.457104045195042,0.9938271604938271,1.0,1.0,1/10,8.40%,PTGER3
prerank,positive regulation of response to wounding (GO:1903036),0.1795740830403208,0.4537884303810472,0.9936868686868687,1.0,1.0,7/24,28.74%,KANK1;PRKCE;MDK;INSL3;GRN;ITGB1;ARFGEF1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.17804801649754493,-0.4527530774181206,0.996875,0.9994210302716652,1.0,5/11,29.95%,GNPDA1;PGM3;GNPDA2;NAGK;GFPT2
prerank,mitochondrial protein processing (GO:0034982),0.19983598070983621,0.4437399265324578,0.9881129271916791,1.0,1.0,5/11,32.12%,MIPEP;PMPCB;STOML2;ATP23;IMMP2L
prerank,regulation of keratinocyte migration (GO:0051547),0.20067964759771362,0.44332164835055665,0.9885550786838341,1.0,1.0,4/12,26.53%,MTOR;IQSEC1;MAPRE2;PTEN
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.20657437570023823,0.4410924124318283,0.9942028985507246,1.0,1.0,2/10,19.10%,MYD88;CD68
prerank,negative regulation of cation channel activity (GO:2001258),0.169970801731889,0.4384325779144688,0.9937733499377335,1.0,1.0,3/26,15.21%,UBQLN1;GPR35;CALM3
prerank,negative regulation of blood coagulation (GO:0030195),0.1575803307552035,0.43270486484105136,1.0,1.0,1.0,38/38,84.28%,APOE;PLAUR;F3;F8;PLAT;SERPING1;SERPINE1;C1QTNF1;GP1BA;NOS3;FGG;F2;KRT1;KNG1;PROC;CPB2;SERPINE2;PDGFA;EDN1;PDGFB;HRG;F12;PLG;KLKB1;F11;SERPINB2;TFPI;ADTRP;SERPINF2;APOH;F10;PLAU;CD34;F7;PDGFRA;THBD;A2M;VTN
prerank,peptidyl-amino acid modification (GO:0018193),0.20475801895675122,0.4324619671194611,0.9923547400611621,1.0,1.0,10/10,79.54%,METAP2;FKBP7;ATP7A;APOA1;APOA2;METAP1D;PDF;FKBP10;METAP1;TTLL4
prerank,regulation of membrane repolarization (GO:0060306),0.19033098189794,0.4264578269917541,0.997093023255814,1.0,1.0,3/13,24.83%,AKAP9;KCNJ2;YWHAE
prerank,positive regulation of calcium ion import (GO:0090280),0.1936324590065547,0.42515170889633636,0.9914651493598862,1.0,1.0,1/12,9.99%,SPHK2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.1995434399630868,0.42501693109671607,0.9955621301775148,1.0,1.0,4/10,26.52%,ZNHIT3;RUVBL2;PIH1D1;RUVBL1
prerank,lipoprotein biosynthetic process (GO:0042158),0.1966049947142175,0.42457860412716053,0.9971550497866287,0.9998343493006016,1.0,1/11,12.35%,APOE
prerank,intracellular lipid transport (GO:0032365),0.1679398433013778,0.41747080717507284,1.0,0.9999213128650886,1.0,5/21,24.41%,ABCD1;NPC2;ABCD4;CERT1;PRKAB2
prerank,striated muscle cell differentiation (GO:0051146),0.1779718700902897,0.4092191571126458,0.9972375690607734,1.0,1.0,2/16,13.32%,SIK1;AKAP13
prerank,cardiac ventricle development (GO:0003231),-0.13171283210853588,-0.4043584792357474,1.0,0.999684816617083,1.0,20/20,86.85%,SALL1;PDE2A;HEY1;HEY2;GATA3;HES1;MDM4;HEYL;DLL4;GJA5;ENG;STRA6;TMEM65;TBX5;GATA4;SCN5A;DAND5;NOTCH1;HECTD1;MATR3
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.15306163300297992,0.3965097712953152,0.9987623762376238,1.0,1.0,2/31,8.82%,FGFR2;HOXA9
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.1704721817745146,0.3844154765498805,0.995702005730659,1.0,1.0,2/14,15.61%,LIMS1;PHACTR4
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.1574599968030273,0.35435263860353133,1.0,1.0,1.0,5/13,29.73%,FBN1;CD46;FSTL1;DAND5;CHRDL1
prerank,cardiac muscle tissue development (GO:0048738),0.12485152106315321,0.35160270245505315,0.9988584474885844,1.0,1.0,4/50,15.34%,BMPR2;SIK1;AKAP13;BMPR1A
prerank,regulation of ion transmembrane transport (GO:0034765),0.1293011754308454,0.34918170410162463,1.0,0.9998255327458261,1.0,7/33,27.58%,AHCYL1;AKAP9;KCNJ2;WNK3;YWHAE;CHRM3;KCNJ9
